{"items":[{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f2535773-3266-4a50-8477-2b4adcfeea1e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f2535773-3266-4a50-8477-2b4adcfeea1e","type":"Claim","title":"The equilibrium conversion between monomer and paranucleus is rapid.","label":"Bitan G et al.; The equilibrium conversion between monom...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:f2535773-3266-4a50-8477-2b4adcfeea1e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8afdb873-97c3-4b76-aec2-5b538b924cc0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8afdb873-97c3-4b76-aec2-5b538b924cc0","type":"Claim","title":"PS1-G384A mutant produced increased levels of Abeta42 in PS1 deficient fibroblasts that stably express APP695Swe.","label":"Bentahir M et al.; PS1-G384A mutant produced increased leve...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:8afdb873-97c3-4b76-aec2-5b538b924cc0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a150d750-4adf-40b2-b9b3-2c04dd562082&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a150d750-4adf-40b2-b9b3-2c04dd562082","type":"Claim","title":"The time course of Aβ effect on I<sub>KA<\/sub> current enhancement shows statistically significant maximal enhancement of peak current after 2 h preincubation.","label":"Plant L et al.; The time course of Aβ effect on I<sub>KA...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:a150d750-4adf-40b2-b9b3-2c04dd562082"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6a030cb9-059a-4dc6-aafa-06560479aa06&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6a030cb9-059a-4dc6-aafa-06560479aa06","type":"Claim","title":"APP is an integral membrane protein and may be the first of this class of proteins to be identified as a physiological substrate for cdc2 kinase.","label":"Suzuki T et al.; APP is an integral membrane protein and ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:6a030cb9-059a-4dc6-aafa-06560479aa06"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:57bbd890-4d3a-4cfe-8e25-7fc519d9f374&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:57bbd890-4d3a-4cfe-8e25-7fc519d9f374","type":"Claim","title":"In vivo two-photon imaging on mouse models of amyloidogenesis gives important clues for Alzheimer disease pathogenesis.","label":"Kumar-Singh S; In vivo two-photon imaging on mouse mode...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Kumar-Singh Samir","id":"urn:lsid:swan.org:researchstatement:57bbd890-4d3a-4cfe-8e25-7fc519d9f374"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9087a849-d51c-4349-a54a-4170d9a99cc9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9087a849-d51c-4349-a54a-4170d9a99cc9","type":"Claim","title":"The opposing effect on Aβ42 production relative to other substrate cleavages exerted by γ-secretase inhibitors and PS mutations suggests a multimeric enzyme subject to allosteric regulation, consistent with evidence for PS dimerization and dominant-negative effects of PS mutations.","label":"Shen J et al.; The opposing effect on Aβ42 production r...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:9087a849-d51c-4349-a54a-4170d9a99cc9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:020855ef-cfa1-473b-a183-7cc5e2a7865c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:020855ef-cfa1-473b-a183-7cc5e2a7865c","type":"Claim","title":"APOE4 genotype was found to profoundly increase late-onset AD (LOAD) risk compared with the other variants APOE2 or APOE3. ","label":"Small S et al.; APOE4 genotype was found to profoundly i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:020855ef-cfa1-473b-a183-7cc5e2a7865c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2988ff02-c571-4505-ac46-b934c39f679b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2988ff02-c571-4505-ac46-b934c39f679b","type":"Claim","title":"Aβ may give rise to small toxic derivatives other than the highly aggregated species found in amyloid deposits.","label":"Lambert M et al.; Aβ may give rise to small toxic derivati...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:2988ff02-c571-4505-ac46-b934c39f679b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:673746d2-c7ff-454d-a206-f78533fd45b5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:673746d2-c7ff-454d-a206-f78533fd45b5","type":"Claim","title":"A 56-kDa and 40-kDa soluble Aβ species are candidates for Aβ assemblies that cause memory deficits.","label":"Lesné S et al.; A 56-kDa and 40-kDa soluble Aβ species a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Koh Ming Teng","Kotilinek Linda","Kayed Rakez","Glabe Charles G","Yang Austin","Gallagher Michela","Ashe Karen H"],"firstAuthor":"Lesné Sylvain","referenceYear":"2006","referenceDate":"2006-03-16","id":"urn:lsid:swan.org:researchstatement:673746d2-c7ff-454d-a206-f78533fd45b5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:44a9e9b6-c1f5-440c-9759-19c5cb5ff4a4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:44a9e9b6-c1f5-440c-9759-19c5cb5ff4a4","type":"Claim","title":"The tumor suppressor p53, an important mediator of cell death, may play an important role in mediating neuroprotection via SIRT1 activation and resveratrol.","label":"Kim D et al.; The tumor suppressor p53, an important m...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:44a9e9b6-c1f5-440c-9759-19c5cb5ff4a4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a612dfcc-58b1-4de8-8348-c8e91cb02025&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a612dfcc-58b1-4de8-8348-c8e91cb02025","type":"Claim","title":"Large polymeric aggregates may represent inactive reservoirs of neurotoxic assemblies.","label":"Hardy J et al.; Large polymeric aggregates may represent...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:a612dfcc-58b1-4de8-8348-c8e91cb02025"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:fe275403-9634-4294-b27a-dbcefa84df16&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:fe275403-9634-4294-b27a-dbcefa84df16","type":"Question","title":"Does overexpression of inflammatory factors, such as IL-6 in the brain, drive senescent markers in CNS cells?","label":"Does overexpression of inflammatory fact...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:fe275403-9634-4294-b27a-dbcefa84df16"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:871727be-1202-4652-ae98-5a14315d3560&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:871727be-1202-4652-ae98-5a14315d3560","type":"Claim","title":"The clinical mutation in PS1 served not only to exaggerate IP3-mediated calcium responses but also to increase the relative number of neurons that produce a strong calcium elevation rather than a weaker one.","label":"Smith I et al.; The clinical mutation in PS1 served not ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:871727be-1202-4652-ae98-5a14315d3560"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9a70fa61-5ec7-475a-a533-869cb64efdb8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9a70fa61-5ec7-475a-a533-869cb64efdb8","type":"Claim","title":"The conversion of paranuclei into protofibrils is slow, but reversible.","label":"Bitan G et al.; The conversion of paranuclei into protof...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:9a70fa61-5ec7-475a-a533-869cb64efdb8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b912318d-9b29-4d90-b052-1be8ca5e8eb8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b912318d-9b29-4d90-b052-1be8ca5e8eb8","type":"Claim","title":"It is possible that APP is phosphorylated in glial cells, a major source of secretion of Aβ peptide.","label":"Suzuki T et al.; It is possible that APP is phosphorylate...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:b912318d-9b29-4d90-b052-1be8ca5e8eb8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:8cd07492-a2c4-4cc2-b569-f12d44ad0942&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:8cd07492-a2c4-4cc2-b569-f12d44ad0942","type":"Question","title":"Could the speculation by Marchesi regarding development of therapeutics be an explanation for the lack of clinical response in the aborted active Aβ vaccination trial from Elan?","label":"Could the speculation by Marchesi regard...","icon":"../icons/ontological/discourse-element/research-question.png","firstAuthor":"Koo Edward H","id":"urn:lsid:swan.org:researchquestion:8cd07492-a2c4-4cc2-b569-f12d44ad0942"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f36f81ae-97a5-455a-9fa4-a3d1e8474815&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f36f81ae-97a5-455a-9fa4-a3d1e8474815","type":"Claim","title":"Chronic transgenic overexpression of IDE (2-fold over endogeneous) in mice overexpressing human APP harboring both APP717 and APP670/671 missense mutations revealed a 50% decrease in both soluble and insoluble AβX-40 and AβX-42 levels.","label":"Tanzi R et al.; Chronic transgenic overexpression of IDE...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:f36f81ae-97a5-455a-9fa4-a3d1e8474815"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2c1deeac-8051-4019-9ded-1e0d058697af&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2c1deeac-8051-4019-9ded-1e0d058697af","type":"Claim","title":"The regional distribution of amyloid plaques correlates poorly with the pattern and severity of dementia in AD, whereas synaptic loss correlates well with these clinical features.","label":"Shen J et al.; The regional distribution of amyloid pla...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:2c1deeac-8051-4019-9ded-1e0d058697af"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:06f140d9-772c-441a-b2f6-b5850b3f5f59&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:06f140d9-772c-441a-b2f6-b5850b3f5f59","type":"Claim","title":"No change from baseline in neuritic curvature was detected on the day of plaque appearance.  After two days the damage became more prominent; after five days it resembled the robust neuritic damage seen after one week. Thus the neurite changes progressed over days after a short lag phase.","label":"Meyer-Luehmann M et al.; No change from baseline in neuritic curv...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:06f140d9-772c-441a-b2f6-b5850b3f5f59"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:961a7b56-cc9d-4924-a309-9bb6440965af&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:961a7b56-cc9d-4924-a309-9bb6440965af","type":"Hypothesis","title":"Impaired DNA repair in neurons sensitizes them to oxidative damage induced by Aβ.","label":"Kruman I et al.; Impaired DNA repair in neurons sensitize...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Kumaravel T S","Lohani Althaf","Pedersen Ward A","Cutler Roy G","Kruman Yuri","Haughey Norman","Lee Jaewon","Evans Michele","Mattson Mark P"],"firstAuthor":"Kruman Inna I","referenceYear":"2002","referenceDate":"2002-03-01","id":"urn:lsid:swan.org:researchstatement:961a7b56-cc9d-4924-a309-9bb6440965af"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d3f0721e-f70a-4b98-8cf6-e0e92c266c54&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d3f0721e-f70a-4b98-8cf6-e0e92c266c54","type":"Claim","title":"It has been demonstrated that treatment of cells with okadaic acid, a potent inhibitor of protein phosphatases 1 and 2A, results in the activation of cdc2 kinase through the indirect stimulation of protein phosphatase cdc25.","label":"Suzuki T et al.; It has been demonstrated that treatment ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:d3f0721e-f70a-4b98-8cf6-e0e92c266c54"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0514e5a2-0077-467f-852a-48fc190ab255&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0514e5a2-0077-467f-852a-48fc190ab255","type":"Claim","title":"Microglia are commonly observed associated with TdT-positive neurons, consistent with the existence of apoptotic mechanisms.","label":"Cotman C et al.; Microglia are commonly observed associat...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:0514e5a2-0077-467f-852a-48fc190ab255"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6b042b23-3f8b-4954-b0a2-265f35ae13e2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6b042b23-3f8b-4954-b0a2-265f35ae13e2","type":"Claim","title":"While LRP appears to mediate the efflux of Aβ from the brain to the periphery, RAGE has been strongly implicated in Aβ influx back into the CNS.","label":"Tanzi R et al.; While LRP appears to mediate the efflux ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:6b042b23-3f8b-4954-b0a2-265f35ae13e2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e0c8e389-8ea7-4988-9509-7b93ae248068&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e0c8e389-8ea7-4988-9509-7b93ae248068","type":"Hypothesis","title":"A \u2018\u2018dual pathway\u2019\u2019 model of AD causality, whereby Aβ and tau can be linked by\nseparate mechanisms driven by a common upstream driver.","label":"Small S et al.; A \u2018\u2018dual pathway\u2019\u2019 model of AD causality...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:e0c8e389-8ea7-4988-9509-7b93ae248068"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b5f503c8-3101-453c-9b28-1b57415e616f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b5f503c8-3101-453c-9b28-1b57415e616f","type":"Claim","title":"An example of activation-induced programmed cell death (PCD), the active generation of a death signal, is the crosslinking of specific membrane receptors by multivalent ligands, which initiates a signal transduction event that triggers apoptosis.","label":"Cotman C et al.; An example of activation-induced program...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:b5f503c8-3101-453c-9b28-1b57415e616f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:dd600ebc-53df-4460-8ef8-ff0cb3413e7f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:dd600ebc-53df-4460-8ef8-ff0cb3413e7f","type":"Claim","title":"LRP, located at the BBB, favors clearance of Aβ40 over the much more amyloidogenic peptide, Aβ42.","label":"Tanzi R et al.; LRP, located at the BBB, favors clearanc...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:dd600ebc-53df-4460-8ef8-ff0cb3413e7f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d20c4a8d-768b-4122-be6f-3504b2345632&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d20c4a8d-768b-4122-be6f-3504b2345632","type":"Claim","title":"Tissue-transglutaminase-induced oligomeric Aβ species are resistant to both NEP and IDE, while the monomer was readily degraded by both metalloproteases.","label":"Hartley D et al.; Tissue-transglutaminase-induced oligomer...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:d20c4a8d-768b-4122-be6f-3504b2345632"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:690ab06f-813c-43c5-a403-f954d9265e37&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:690ab06f-813c-43c5-a403-f954d9265e37","type":"Claim","title":"Accumulating intraneuronal Aβ42 and especially Aβ oligomers are associated with subcellular destruction, which equals neuronal dysfunction.","label":"Gouras G; Accumulating intraneuronal Aβ42 and espe...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Gouras Gunnar K","id":"urn:lsid:swan.org:researchstatement:690ab06f-813c-43c5-a403-f954d9265e37"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3bedd066-48b0-43ea-b89e-6bd638025a40&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3bedd066-48b0-43ea-b89e-6bd638025a40","type":"Claim","title":"Isolation of low molecular weight (LMW) Aβ40 species results in a comparable, reproducible starting material, but LMW species of Aβ42 are not homogenous.","label":"LaDu M; Isolation of low molecular weight (LMW) ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"LaDu Mary Jo","id":"urn:lsid:swan.org:researchstatement:3bedd066-48b0-43ea-b89e-6bd638025a40"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2fb1f006-7b21-41ae-b08e-d16abcff5950&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2fb1f006-7b21-41ae-b08e-d16abcff5950","type":"Claim","title":"Phosphorylation of APP at Thr668 has also been demonstrated with phosphorylation-state specific antibodies.","label":"Suzuki T; Phosphorylation of APP at Thr668 has als...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Suzuki Toshiharu","id":"urn:lsid:swan.org:researchstatement:2fb1f006-7b21-41ae-b08e-d16abcff5950"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8c35bf6a-f822-4e7f-92d6-397927f788f0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8c35bf6a-f822-4e7f-92d6-397927f788f0","type":"Claim","title":"People who are likely to develop AD but do not yet show dementia symptoms can be identified by using brain blood flow measurements and brain PET scans.","label":"Aliev G; People who are likely to develop AD but ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Aliev Gjumrakch","id":"urn:lsid:swan.org:researchstatement:8c35bf6a-f822-4e7f-92d6-397927f788f0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b96e3f9a-10c6-434e-bd13-1f0ea60f7a5f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b96e3f9a-10c6-434e-bd13-1f0ea60f7a5f","type":"Claim","title":"Fibrillar Aβ may be directly neurotoxic or indirectly toxic due to inflammatory response.","label":"Holtzman D; Fibrillar Aβ may be directly neurotoxic ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:b96e3f9a-10c6-434e-bd13-1f0ea60f7a5f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d9ec2fb5-b22b-4669-a3e3-f3cf933b86d2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d9ec2fb5-b22b-4669-a3e3-f3cf933b86d2","type":"Claim","title":"The amyloid hypothesis has been widely challenged because an imperfect correlation exists between amyloid deposits and dementia, and also, doses of fibrillar Aβ needed to kill neurons in culture appear excessive.","label":"Lambert M et al.; The amyloid hypothesis has been widely c...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:d9ec2fb5-b22b-4669-a3e3-f3cf933b86d2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7676fd4e-f6fa-46ca-b18f-cdfafcc96038&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7676fd4e-f6fa-46ca-b18f-cdfafcc96038","type":"Claim","title":"PDAPP mice demonstrate age-dependent object recognition memory impairment.","label":"Dodart J et al.; PDAPP mice demonstrate age-dependent obj...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:7676fd4e-f6fa-46ca-b18f-cdfafcc96038"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2c12dd6d-fdae-4873-a275-9eeb1c4b5639&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2c12dd6d-fdae-4873-a275-9eeb1c4b5639","type":"Claim","title":"Increased rate and/or state of phosphorylation and various other pathological events, including Aβ-mediated toxicity, as well as oxidative stress and inflammation, trigger or contribute (independently or in combination) to an abnormal detachment of tau from the MTs.","label":"Ballatore C et al.; Increased rate and/or state of phosphory...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Lee Virginia M-Y","Trojanowski John Q"],"firstAuthor":"Ballatore Carlo","referenceYear":"2007","referenceDate":"2007-09","id":"urn:lsid:swan.org:researchstatement:2c12dd6d-fdae-4873-a275-9eeb1c4b5639"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2760d829-58d8-44d0-bd2c-49a416d9f22b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2760d829-58d8-44d0-bd2c-49a416d9f22b","type":"Claim","title":"In a previous study, tau was enriched in fractions of Triton soluble and heat-stable preparations.","label":"Yuan A et al.; In a previous study, tau was enriched in...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:2760d829-58d8-44d0-bd2c-49a416d9f22b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1e660c67-f4c7-4c54-90f9-396ca72db2e9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1e660c67-f4c7-4c54-90f9-396ca72db2e9","type":"Claim","title":"The rate of fast transport in 13-month-old T44 mice exceeded that previously seen in 12-month-old wild-type mice.","label":"Yuan A et al.; The rate of fast transport in 13-month-o...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:1e660c67-f4c7-4c54-90f9-396ca72db2e9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7a0b4265-0e57-4817-96b0-1aa03f88046a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7a0b4265-0e57-4817-96b0-1aa03f88046a","type":"Claim","title":"Aβ, however, selectively interacts with various molecules, including proteins found in neuritic plaques.","label":"Lambert M et al.; Aβ, however, selectively interacts with ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:7a0b4265-0e57-4817-96b0-1aa03f88046a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:df0b2a98-390f-4eac-a839-85aa8e406ec7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:df0b2a98-390f-4eac-a839-85aa8e406ec7","type":"Claim","title":"Purified cdc2 kinase-cyclin B complex phosphorylates APP645-694 at threonyl residue(s).","label":"Suzuki T et al.; Purified cdc2 kinase-cyclin B complex ph...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:df0b2a98-390f-4eac-a839-85aa8e406ec7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f79e6190-eafa-430c-b732-d122ca076b08&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f79e6190-eafa-430c-b732-d122ca076b08","type":"Claim","title":"PS clinical mutations may affect the stoichiometry of the γ-secretase complex mainly reflected by 220 kdal complex formation.","label":"Bentahir M et al.; PS clinical mutations may affect the sto...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:f79e6190-eafa-430c-b732-d122ca076b08"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1d12ca8e-22aa-403c-97a6-19a9fd0433fe&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1d12ca8e-22aa-403c-97a6-19a9fd0433fe","type":"Claim","title":"Reduced proteasome activity did not correlate with different levels of tau phosphorylation around Ser202 (AT8 antibody) or Ser396/Ser404 (PHF-1 antibody).","label":"Keck S et al.; Reduced proteasome activity did not corr...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:1d12ca8e-22aa-403c-97a6-19a9fd0433fe"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:74fb3f20-2c59-4504-8da3-769878baf8b3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:74fb3f20-2c59-4504-8da3-769878baf8b3","type":"Question","title":"If soluble Aβ is involved in the memory impairment associated with AD, as suggested by several recent studies, then passive immunization with certain antibodies may rapidly reduce cognitive impairment in AD patients apart from any effect it may have on amyloid deposition.","label":"If soluble Aβ is involved in the memory ...","icon":"../icons/ontological/discourse-element/research-question.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","id":"urn:lsid:swan.org:researchquestion:74fb3f20-2c59-4504-8da3-769878baf8b3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:399a8f62-28fb-42d0-ab94-eb4415452993&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:399a8f62-28fb-42d0-ab94-eb4415452993","type":"Claim","title":"CAD cells are a useful model system for studying the switching from microtubule- to actin-based transport.","label":"Muresan Z et al.; CAD cells are a useful model system for ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","id":"urn:lsid:swan.org:researchstatement:399a8f62-28fb-42d0-ab94-eb4415452993"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:01a802d9-8c89-41eb-8b14-c76a17d517db&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:01a802d9-8c89-41eb-8b14-c76a17d517db","type":"Claim","title":"The 26S proteasome decomposes easily to the 19S 'cap' complex and 20S proteasome, even during cellular 'stress' conditions, such as oxidation or energy depletion.","label":"Keck S et al.; The 26S proteasome decomposes easily to ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:01a802d9-8c89-41eb-8b14-c76a17d517db"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:57d3b060-896c-4fc8-9528-97fe3dd3cf5f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:57d3b060-896c-4fc8-9528-97fe3dd3cf5f","type":"Claim","title":"The differential effect of PS mutations on alternative cleavage positions in the APP transmembrane domain seems not to represent a simple shift in substrate preference or specificity, because the degree of elevation in Aβ42 levels with individual mutations does not correlate with the degree of depression in Aβ40 or AICD levels.","label":"Shen J et al.; The differential effect of PS mutations ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:57d3b060-896c-4fc8-9528-97fe3dd3cf5f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:37b7b253-1b77-4f79-a7ec-fb96be7b2def&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:37b7b253-1b77-4f79-a7ec-fb96be7b2def","type":"Claim","title":"Axonal transport defects, synapse loss and neuroinflammation may be among the earliest signs of neurodegeneration that results from tau hyperphosphorylation, whereas fibrillary tau tangles may be late-stage contributors to AD progression by physically interfering with normal cellular functions.","label":"Ballatore C et al.; Axonal transport defects, synapse loss a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Lee Virginia M-Y","Trojanowski John Q"],"firstAuthor":"Ballatore Carlo","referenceYear":"2007","referenceDate":"2007-09","id":"urn:lsid:swan.org:researchstatement:37b7b253-1b77-4f79-a7ec-fb96be7b2def"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8eb3b40f-ed42-4e8f-9f7c-5716c9766f82&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8eb3b40f-ed42-4e8f-9f7c-5716c9766f82","type":"Claim","title":"Evidence of therapeutic plaque removal in patients who already have dementia does not seem to correlate with a change in the trajectory of cognitive deterioration.","label":"Jack C et al.; Evidence of therapeutic plaque removal i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:8eb3b40f-ed42-4e8f-9f7c-5716c9766f82"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:00c36d8d-1d8c-42de-8a23-af97e81a6106&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:00c36d8d-1d8c-42de-8a23-af97e81a6106","type":"Claim","title":"Aβ channels could be blocked by Zn2+, by tromethamine and Al3+, and by antibodies against the Aβ peptide itself.","label":"Smith I et al.; Aβ channels could be blocked by Zn2+, by...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:00c36d8d-1d8c-42de-8a23-af97e81a6106"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c0663d1c-3436-4176-b094-2a9de09f5399&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c0663d1c-3436-4176-b094-2a9de09f5399","type":"Claim","title":"Temporal ordering among the neurodegenerative biomarkers might ultimately differ from that in our proposed model since recent data suggest that MRI atrophy might precede increases in CSF tau.","label":"Jack C et al.; Temporal ordering among the neurodegener...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:c0663d1c-3436-4176-b094-2a9de09f5399"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a75da59e-b114-4920-bd48-d865881067da&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a75da59e-b114-4920-bd48-d865881067da","type":"Claim","title":"Aggregation of Aβ42, as occurs in the AD brain, might deplete Aβ42 monomers, thus depriving neurons of a trophic support, is a \u201closs-of-function\u201d hypothesis of neuronal death that must also consider that monomers of Aβ40, which predominates over Aβ42 were also neuroprotective.","label":"Giuffrida M et al.; Aggregation of Aβ42, as occurs in the AD...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Caraci Filippo","Pignataro Bruno","Cataldo Sebastiano","De Bona Paolo","Bruno Valeria","Molinaro Gemma","Pappalardo Giuseppe","Messina Angela","Palmigiano Angelo","Garozzo Domenico","Nicoletti Ferdinando","Rizzarelli Enrico","Copani Agata"],"firstAuthor":"Giuffrida Maria Laura","referenceYear":"2009","referenceDate":"2009-08-26","id":"urn:lsid:swan.org:researchstatement:a75da59e-b114-4920-bd48-d865881067da"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:238cef30-b960-4243-bd43-a8f97339b29e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:238cef30-b960-4243-bd43-a8f97339b29e","type":"Claim","title":"Pentamers or hexamers of A&#946;42 self-associate to form larger beaded superstructures.","label":"Bitan G et al.; Pentamers or hexamers of A&#946;42 self-...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:238cef30-b960-4243-bd43-a8f97339b29e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e17f3dbb-c5a7-47b1-a866-b1a0aa9809c8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e17f3dbb-c5a7-47b1-a866-b1a0aa9809c8","type":"Claim","title":"Previous studies in human lymphocytes have shown that Bcl-2 may exert its protective effects at a stage downstream to the initiation of DNA strand cleavage, consistent with the degree of TdT labeling observed in AD brain.","label":"Cotman C et al.; Previous studies in human lymphocytes ha...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:e17f3dbb-c5a7-47b1-a866-b1a0aa9809c8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f661905e-bf9a-4245-9e3b-236a73440478&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f661905e-bf9a-4245-9e3b-236a73440478","type":"Claim","title":"Increased CSF tau correlates with the presence of NFTs at autopsy.","label":"Jack C et al.; Increased CSF tau correlates with the pr...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:f661905e-bf9a-4245-9e3b-236a73440478"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e3237096-017d-4685-9558-a96e73a00824&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e3237096-017d-4685-9558-a96e73a00824","type":"Claim","title":"The degree of enhancement of Aβ42 production elicited by γ-secretase inhibitors is strongly correlated with their inhibitory potency, suggesting that increased Aβ42 generation is mechanistically related to active site-directed inhibition.","label":"Shen J et al.; The degree of enhancement of Aβ42 produc...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:e3237096-017d-4685-9558-a96e73a00824"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5cc0cfe3-8aa8-426d-8e21-7764c326a17c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5cc0cfe3-8aa8-426d-8e21-7764c326a17c","type":"Claim","title":"Amyloid and amyloid like aggregates regardless of their peptide or protein subunit can be shown to bind and activate a whole array of PRRs, including Toll-like receptors, formyl peptide receptors, receptor for advanced glycation end products, scavenger receptors, complement and pentraxins.","label":"Golde T et al.; Amyloid and amyloid like aggregates rega...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:5cc0cfe3-8aa8-426d-8e21-7764c326a17c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3cd45e66-4b8d-492c-ae74-735ae7bf7620&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3cd45e66-4b8d-492c-ae74-735ae7bf7620","type":"Claim","title":"All of the plaques in the PSAPP model were dense-core in morphology, with co-staining of amyloid-beta immunofluorescence and methoxy-XO4, an amyloid imaging agent that detects beta-pleated sheets.","label":"Meyer-Luehmann M et al.; All of the plaques in the PSAPP model we...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:3cd45e66-4b8d-492c-ae74-735ae7bf7620"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a9122abf-e749-4409-ab49-473671df9854&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a9122abf-e749-4409-ab49-473671df9854","type":"Claim","title":"Aβ, tau and other protein aggregates in neurodegenerative diseases are almost always found in an abnormal structural conformation compared to the non-aggregated protein and many of these aggregates also have characteristic features of amyloid.","label":"Golde T et al.; Aβ, tau and other protein aggregates in ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:a9122abf-e749-4409-ab49-473671df9854"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e30495cd-0252-4ad3-8239-6842c2bba0c6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e30495cd-0252-4ad3-8239-6842c2bba0c6","type":"Claim","title":"Autophagy, an additional potential link between senescence and neurodegeneration, has been implicated in AD and many other neurodegenerative conditions, since genetic removal of autophagy genes results in neurodegeneration, and genetic alterations that induce premature aging phenotypes are associated with autophagy induction.","label":"Golde T et al.; Autophagy, an additional potential link ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:e30495cd-0252-4ad3-8239-6842c2bba0c6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:3de684ec-2226-4736-9100-5c6dfd21898f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:3de684ec-2226-4736-9100-5c6dfd21898f","type":"Question","title":"Are amyloid plaques or their constituents sufficient to induce all of the biochemical and cellular malfunctions associated with Alzheimer disease?","label":"Are amyloid plaques or their constituent...","icon":"../icons/ontological/discourse-element/research-question.png","firstAuthor":"Goldstein Lawrence S B","id":"urn:lsid:swan.org:researchquestion:3de684ec-2226-4736-9100-5c6dfd21898f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:afc15aa0-6d7a-4f98-bfbd-6c13ce088afc&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:afc15aa0-6d7a-4f98-bfbd-6c13ce088afc","type":"Claim","title":"Various preparations of aggregated Aβ can inhibit LTP.","label":"Hartley D et al.; Various preparations of aggregated Aβ ca...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:afc15aa0-6d7a-4f98-bfbd-6c13ce088afc"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:63e5e22a-b31d-4bed-921d-9fede1cc23f4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:63e5e22a-b31d-4bed-921d-9fede1cc23f4","type":"Claim","title":"The pathogenic role of amyloid fibrils has not been universally accepted because of a poor correlation between neurological deficits and amyloid plaque burden, in human AD brain as well as transgenic mouse models.","label":"Gong Y et al.; The pathogenic role of amyloid fibrils h...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:63e5e22a-b31d-4bed-921d-9fede1cc23f4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cd40790c-e15d-42b7-b27a-02478d5cb2fd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cd40790c-e15d-42b7-b27a-02478d5cb2fd","type":"Claim","title":"Inhibition of hippocampal LTP in vivo is specifically due to presence of oligomeric Aβ, not monomers or fibrils.","label":"Walsh D et al.; Inhibition of hippocampal LTP in vivo is...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Klyubin Igor","Fadeeva Julia V","Cullen William K","Anwyl Roger","Wolfe Michael S","Rowan Michael J","Selkoe Dennis J"],"firstAuthor":"Walsh Dominic M","referenceYear":"2002","referenceDate":"2002-04-04","id":"urn:lsid:swan.org:researchstatement:cd40790c-e15d-42b7-b27a-02478d5cb2fd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:68d09960-71f4-4d94-9771-28337a7a5062&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:68d09960-71f4-4d94-9771-28337a7a5062","type":"Claim","title":"Therapeutics to prevent Aβ induced synaptotoxicity and neurodegeneration are in development.","label":"Hardy J et al.; Therapeutics to prevent Aβ induced synap...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:68d09960-71f4-4d94-9771-28337a7a5062"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ebc67c10-384c-4ca1-984d-71709f5d3d74&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ebc67c10-384c-4ca1-984d-71709f5d3d74","type":"Hypothesis","title":"Cell cycle-dependent regulation of APP metabolism and phosphorylation play a key role in AD pathogenesis.","label":"Suzuki T et al.; Cell cycle-dependent regulation of APP m...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:ebc67c10-384c-4ca1-984d-71709f5d3d74"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b76e37d6-8776-4021-b483-2ed2aced825e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b76e37d6-8776-4021-b483-2ed2aced825e","type":"Claim","title":"Increased GSK3 activity would serve to augment Aβ production and in turn tau hyper-phosphorylation and neuronal degeneration in both FAD and sporadic cases, in line with the amyloid cascade hypothesis of AD.","label":"Hooper C et al.; Increased GSK3 activity would serve to a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:b76e37d6-8776-4021-b483-2ed2aced825e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c9128139-b3c1-4deb-9688-8d68047a2098&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c9128139-b3c1-4deb-9688-8d68047a2098","type":"Claim","title":"Therapies directed an extracellular Aβ may not target the most toxic factors.","label":"Marchesi V; Therapies directed an extracellular Aβ m...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:c9128139-b3c1-4deb-9688-8d68047a2098"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5bad8a6b-7c1b-490e-986b-bb5e204f2386&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5bad8a6b-7c1b-490e-986b-bb5e204f2386","type":"Claim","title":"Soluble, stable Aβ oligomers can be produced by cultured cells.","label":"Walsh D et al.; Soluble, stable Aβ oligomers can be prod...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Klyubin Igor","Fadeeva Julia V","Cullen William K","Anwyl Roger","Wolfe Michael S","Rowan Michael J","Selkoe Dennis J"],"firstAuthor":"Walsh Dominic M","referenceYear":"2002","referenceDate":"2002-04-04","id":"urn:lsid:swan.org:researchstatement:5bad8a6b-7c1b-490e-986b-bb5e204f2386"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5bbdd793-d5d9-45b9-ab9c-e1f687b07bfe&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5bbdd793-d5d9-45b9-ab9c-e1f687b07bfe","type":"Claim","title":"The normal transport patterns of NF-L and snap25 along optic axons of tau-null mice indicate that tau is not essential for axonal transport in vivo and may be compensated by other proteins as suggested by the absence of detectable phenotype in mice lacking tau.","label":"Yuan A et al.; The normal transport patterns of NF-L an...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:5bbdd793-d5d9-45b9-ab9c-e1f687b07bfe"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:79e0f87d-991d-4102-955a-843f5b063b68&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:79e0f87d-991d-4102-955a-843f5b063b68","type":"Claim","title":"Anti-Aβ antibody titres at long-term follow-up of AN1792-treated survivors at 5 or 6 years showed a modest positive correlation with the mean anti-AN1792 antibody titres found during the initial treatment study period.  ","label":"Holmes C et al.; Anti-Aβ antibody titres at long-term fol...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:79e0f87d-991d-4102-955a-843f5b063b68"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7f2c5fe7-226b-47af-81d6-71e1896b95f3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7f2c5fe7-226b-47af-81d6-71e1896b95f3","type":"Claim","title":"Drug therapy reported to improve AD symptoms (including prescriptive drugs now available for AD) all increase blood flow to the brain.","label":"Aliev G; Drug therapy reported to improve AD symp...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Aliev Gjumrakch","id":"urn:lsid:swan.org:researchstatement:7f2c5fe7-226b-47af-81d6-71e1896b95f3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5cc0bfe5-00ce-4c76-9791-813e7c946ca3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5cc0bfe5-00ce-4c76-9791-813e7c946ca3","type":"Claim","title":"Early identification & treatment of insulin resistance may delay or prevent AD and Vascular Dementia in vulnerable adults, through exercise, caloric restriction / dietary manipulation, pharmacologic insulin sensitization, and possibly intranasal administration of insulin.","label":"Craft S; Early identification & treatment of insu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft Suzanne","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:5cc0bfe5-00ce-4c76-9791-813e7c946ca3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4352c73c-2565-4c53-ab51-2ba06c31551e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4352c73c-2565-4c53-ab51-2ba06c31551e","type":"Claim","title":"There is extensive overlap between the biomarkers that comprise the core senescence-associated secretory (SASP) phenotype and secreted biomarkers of AD  providing evidence for a SASP in both the human AD brain and mouse models of AD, suggesting that the \u2018immune-system dysregulation\u2019 may, in fact, reflect senescence.","label":"Golde T et al.; There is extensive overlap between the b...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:4352c73c-2565-4c53-ab51-2ba06c31551e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ac258874-ecee-4092-be9c-20f0e3f04946&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ac258874-ecee-4092-be9c-20f0e3f04946","type":"Claim","title":"CR1, the gene that encodes for the main receptor of the complement C3b protein, is associated with AD risk.","label":"Lambert J et al.; CR1, the gene that encodes for the main ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Heath Simon","Even Gael","Campion Dominique","Sleegers Kristel","Hiltunen Mikko","Combarros Onofre","Zelenika Diana","Bullido Maria J","Tavernier Béatrice","Letenneur Luc","Bettens Karolien","Berr Claudine","Pasquier Florence","Fiévet Nathalie","Barberger-Gateau Pascale","Engelborghs Sebastiaan","De Deyn Peter","Mateo Ignacio","Franck Ana","Helisalmi Seppo","Porcellini Elisa","Hanon Olivier","de Pancorbo Marian M","Lendon Corinne","Dufouil Carole","Jaillard Céline","Leveillard Thierry","Alvarez Victoria","Bosco Paolo","Mancuso Michelangelo","Panza Francesco","Nacmias Benedetta","Bossù Paola","Piccardi Paola","Annoni Giorgio","Seripa Davide","Galimberti Daniela","Hannequin Didier","Licastro Federico","Soininen Hilkka","Ritchie Karen","Blanché Hélène","Dartigues Jean-François","Tzourio Christophe","Gut Ivo","Van Broeckhoven Christine","Alpérovitch Annick","Lathrop Mark","Amouyel Philippe"],"firstAuthor":"Lambert Jean-Charles","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:ac258874-ecee-4092-be9c-20f0e3f04946"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5868eace-23a8-427a-813b-1e1be8fa8ca9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5868eace-23a8-427a-813b-1e1be8fa8ca9","type":"Claim","title":"Calcium deficits were also observed in cells deficient in APP, and could be rescued by adding back various fragments, provided that APP was intact.","label":"Smith I et al.; Calcium deficits were also observed in c...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:5868eace-23a8-427a-813b-1e1be8fa8ca9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3a3e6406-1a60-43d8-9bc4-ccab3eadf0b7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3a3e6406-1a60-43d8-9bc4-ccab3eadf0b7","type":"Claim","title":"It is quite possible that in the presence of detergents, Aβ forms dimers in rafts only after tissue homogenization (i.e., an artifact of tissue homogenization).","label":"Holtzman D; It is quite possible that in the presenc...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman David M","id":"urn:lsid:swan.org:researchstatement:3a3e6406-1a60-43d8-9bc4-ccab3eadf0b7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:acdf2a70-1659-4446-8220-96d6927765e6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:acdf2a70-1659-4446-8220-96d6927765e6","type":"Claim","title":"Senile plaque formation is a very rapid event, with five new plaques appearing precipitously within 24 h after the last imaging session.","label":"Meyer-Luehmann M et al.; Senile plaque formation is a very rapid ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:acdf2a70-1659-4446-8220-96d6927765e6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:48570be8-2d95-45be-ae31-86d73107f9f7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:48570be8-2d95-45be-ae31-86d73107f9f7","type":"Claim","title":"Cleavage of APP by alpha-secretase or by beta-cleavage alone may leave APP cleavage products within the membrane.","label":"Marchesi V; Cleavage of APP by alpha-secretase or by...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:48570be8-2d95-45be-ae31-86d73107f9f7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8df5706e-8b82-4aad-a05e-61ec2ca65e69&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8df5706e-8b82-4aad-a05e-61ec2ca65e69","type":"Claim","title":"The life-long accumulation of Aβ in the brain is determined by the rate of Aβ generation versus clearance.","label":"Tanzi R et al.; The life-long accumulation of Aβ in the ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:8df5706e-8b82-4aad-a05e-61ec2ca65e69"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:28d8e223-70e5-4549-8c8d-4d344840d4fa&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:28d8e223-70e5-4549-8c8d-4d344840d4fa","type":"Claim","title":"The abnormal somatodendritic accumulation of tau in neurofibrillary tangles is one of the two hallmark pathologies in Alzheimer\u2019s disease (AD) and correlates strongly with the extent of neuronal cell loss and the degree of cognitive decline.","label":"Yuan A et al.; The abnormal somatodendritic accumulatio...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:28d8e223-70e5-4549-8c8d-4d344840d4fa"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c933af7d-0eb5-4f91-9385-93120fdf81c9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c933af7d-0eb5-4f91-9385-93120fdf81c9","type":"Claim","title":"An additional copy of the SIR2 gene extends lifespan in yeast and metazoans by a process seemingly analogous to caloric restriction, a diet that delays diseases of aging in mammals including neurodegeneration.","label":"Kim D et al.; An additional copy of the SIR2 gene exte...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:c933af7d-0eb5-4f91-9385-93120fdf81c9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c17dbd76-aba8-4893-9ae0-c2266ec052eb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c17dbd76-aba8-4893-9ae0-c2266ec052eb","type":"Claim","title":"The myelin model helps to explain why the first three large scale attempts to treat human AD by removing Aβ using active immunization, reducing Aβ production by inhibiting the key γ-secretase enzymatic step (with Flurizan), and dissolving amyloid deposits (with Alzhemed) have failed to impact the clinical syndrome, even though they may have succeeded in eliminating brain amyloid.","label":"Bartzokis G; The myelin model helps to explain why th...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:c17dbd76-aba8-4893-9ae0-c2266ec052eb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b31c831d-4157-49fb-9601-d2d4273b5e77&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b31c831d-4157-49fb-9601-d2d4273b5e77","type":"Claim","title":"Synaptic responsiveness in hippocampal slices from young adult PrP null mice is normal, but the Aβ oligomer blockade of long-term potentiation is absent.","label":"Laurén J et al.; Synaptic responsiveness in hippocampal s...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Gimbel David A","Nygaard Haakon B","Gilbert John W","Strittmatter Stephen M"],"firstAuthor":"Laurén Juha","referenceYear":"2009","referenceDate":"2009-02-26","id":"urn:lsid:swan.org:researchstatement:b31c831d-4157-49fb-9601-d2d4273b5e77"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e9edfa07-9a07-480a-bb92-26ad340d6212&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e9edfa07-9a07-480a-bb92-26ad340d6212","type":"Hypothesis","title":"Extracellular tau aggregates can transmit a misfolded state from the outside to the inside of a cell, similar to prions.","label":"Frost B et al.; Extracellular tau aggregates can transmi...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Jacks Rachel L","Diamond Marc I"],"firstAuthor":"Frost Bess","referenceYear":"2009","referenceDate":"2009-05-08","id":"urn:lsid:swan.org:researchstatement:e9edfa07-9a07-480a-bb92-26ad340d6212"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fa86cd31-0f06-459e-86c0-c744cf4278ba&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fa86cd31-0f06-459e-86c0-c744cf4278ba","type":"Hypothesis","title":"Tau plays a role in the malfunctioning of axonal transport.","label":"Mandelkow E et al.; Tau plays a role in the malfunctioning o...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Stamer K","Vogel R","Thies E","Mandelkow E"],"firstAuthor":"Mandelkow E-M","referenceYear":"2003","referenceDate":"2003-12","id":"urn:lsid:swan.org:researchstatement:fa86cd31-0f06-459e-86c0-c744cf4278ba"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8858fc07-4515-4e9c-9c19-3c0b1147817d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8858fc07-4515-4e9c-9c19-3c0b1147817d","type":"Claim","title":"Positive intervention into SIRT1 activity, such as through intake of SIRT1-activating molecules, may have profound therapeutic benefits against various age-dependent neurodegenerative diseases.","label":"Kim D et al.; Positive intervention into SIRT1 activit...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:8858fc07-4515-4e9c-9c19-3c0b1147817d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:eb456dec-9a1f-4c03-b6e4-483e5a3652e6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:eb456dec-9a1f-4c03-b6e4-483e5a3652e6","type":"Claim","title":"Noncross-linked Aβ40 exists as an amorphous population of threads of varying length, composed of a consistent particle size of 1-2 nm in EM morphologic analysis and cross-linking this material resulted in similar but slightly larger threads.","label":"Bitan G et al.; Noncross-linked Aβ40 exists as an amorph...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:eb456dec-9a1f-4c03-b6e4-483e5a3652e6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2ed08a7d-8e79-44ec-954f-fae03a3d96a4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2ed08a7d-8e79-44ec-954f-fae03a3d96a4","type":"Claim","title":"ApoE in CSF-lipoproteins and astrocyte-secreted rodent apoE are good ligands for LDLR, which is expressed by astrocytes","label":"Holtzman D; ApoE in CSF-lipoproteins and astrocyte-s...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:2ed08a7d-8e79-44ec-954f-fae03a3d96a4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2e2dff40-c143-4695-a8b4-c04631b7a1d8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2e2dff40-c143-4695-a8b4-c04631b7a1d8","type":"Claim","title":"Aβ induces degeneration in primary neuronal cultures via an apoptotic pathway, a conclusion also supported by previous experiments.","label":"Cotman C et al.; Aβ induces degeneration in primary neuro...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:2e2dff40-c143-4695-a8b4-c04631b7a1d8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b22e896f-3a78-4147-9a4c-bd77d48caae6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b22e896f-3a78-4147-9a4c-bd77d48caae6","type":"Claim","title":"Regulation of cell surface MHC I expression by THOP1 has been reported to occur in vivo.","label":"Pollio G et al.; Regulation of cell surface MHC I express...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hoozemans Jeroen J","Andersen Claus A","Roncarati Renza","Rosi Maria Cristina","van Haastert Elise S","Seredenina Tamara","Diamanti Daniela","Gotta Stefano","Fiorentini Anna","Magnoni Letizia","Raggiaschi Roberto","Rozemuller Annemieke J","Casamenti Fiorella","Caricasole Andrea","Terstappen Georg C"],"firstAuthor":"Pollio Giuseppe","referenceYear":"2008","referenceDate":"2008-07","id":"urn:lsid:swan.org:researchstatement:b22e896f-3a78-4147-9a4c-bd77d48caae6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ea5a99c9-fa41-46e0-85d9-37b9129cdd5f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ea5a99c9-fa41-46e0-85d9-37b9129cdd5f","type":"Claim","title":"The two major endopeptidases involved in Aβ degradation are zinc metalloendopeptidases, referred to as insulin degrading enzyme (IDE) or insulysin, and neprilysin (NEP).","label":"Tanzi R et al.; The two major endopeptidases involved in...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:ea5a99c9-fa41-46e0-85d9-37b9129cdd5f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:678f7aec-a012-494b-a7ae-400382bcc806&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:678f7aec-a012-494b-a7ae-400382bcc806","type":"Claim","title":"APOE can affect both Aβ /plaque accumulation and tau/tangle accumulation.","label":"Small S et al.; APOE can affect both Aβ /plaque accumula...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:678f7aec-a012-494b-a7ae-400382bcc806"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:02a5046e-ceae-48a5-944b-148277013bc5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:02a5046e-ceae-48a5-944b-148277013bc5","type":"Claim","title":"APP is retrieved from the cell surface by clathrin-mediated endocytosis, while inhibition of endocytosis reduces APP internalization and reduces Aβ production and release.","label":"Harold D et al.; APP is retrieved from the cell surface b...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Abraham Richard","Hollingworth Paul","Sims Rebecca","Gerrish Amy","Hamshere Marian L","Pahwa Jaspreet Singh","Moskvina Valentina","Dowzell Kimberley","Williams Amy","Jones Nicola","Thomas Charlene","Stretton Alexandra","Morgan Angharad R","Lovestone Simon","Powell John","Proitsi Petroula","Lupton Michelle K","Brayne Carol","Rubinsztein David C","Gill Michael","Lawlor Brian","Lynch Aoibhinn","Morgan Kevin","Brown Kristelle S","Passmore Peter A","Craig David","McGuinness Bernadette","Todd Stephen","Holmes Clive","Mann David","Smith A David","Love Seth","Kehoe Patrick G","Hardy John","Mead Simon","Fox Nick","Rossor Martin","Collinge John","Maier Wolfgang","Jessen Frank","Schürmann Britta","van den Bussche Hendrik","Heuser Isabella","Kornhuber Johannes","Wiltfang Jens","Dichgans Martin","Frölich Lutz","Hampel Harald","Hüll Michael","Rujescu Dan","Goate Alison M","Kauwe John S","Cruchaga Carlos","Nowotny Petra","Morris John C","Mayo Kevin","Sleegers Kristel","Bettens Karolien","Engelborghs Sebastiaan","De Deyn Peter P","Van Broeckhoven Christine","Livingston Gill","Bass Nicholas J","Gurling Hugh","McQuillin Andrew","Gwilliam Rhian","Deloukas Panagiotis","Al-Chalabi Ammar","Shaw Christopher E","Tsolaki Magda","Singleton Andrew B","Guerreiro Rita","Mühleisen Thomas W","Nöthen Markus M","Moebus Susanne","Jöckel Karl-Heinz","Klopp Norman","Wichmann H-Erich","Carrasquillo Minerva M","Pankratz V Shane","Younkin Steven G","Holmans Peter A","O'Donovan Michael","Owen Michael J","Williams Julie"],"firstAuthor":"Harold Denise","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:02a5046e-ceae-48a5-944b-148277013bc5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ec178ec1-ed35-4d50-a6c7-ce47ff52d19e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ec178ec1-ed35-4d50-a6c7-ce47ff52d19e","type":"Claim","title":"In G2/M phase cells, the content of mature APP and immature APP measured by immunoblot analysis did not change significantly compared with the levels found in G1 phase cells.","label":"Suzuki T et al.; In G2/M phase cells, the content of matu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:ec178ec1-ed35-4d50-a6c7-ce47ff52d19e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:87a69f31-c965-46d3-a8ec-23eb1a11f8ad&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:87a69f31-c965-46d3-a8ec-23eb1a11f8ad","type":"Claim","title":"Nicotinic acetylcholine receptor α4β2 antagonists and selective agonists were found to block the protective effects of nicotine against β-amyloid induced neuronal death in cultured cells.","label":"Cook L et al.; Nicotinic acetylcholine receptor α4β2 an...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Ho Luk W","Taylor Alison E","Brayne Carol","Evans John Grimley","Xuereb John","Cairns Nigel J","Pritchard Antonia","Lemmon Helen","Mann David","St Clair David","Turic Dragana","Hollingworth Paul","Moore Pamela J","Jehu Luke","Archer Nicola","Walter Sarah","Foy Catherine","Edmondson Amanda","Powell John","Lovestone Simon","Owen Michael J","Williams Julie","Lendon Corinne","Rubinsztein David C"],"firstAuthor":"Cook Lynnette J","referenceYear":"2004","referenceDate":"2004-03-25","id":"urn:lsid:swan.org:researchstatement:87a69f31-c965-46d3-a8ec-23eb1a11f8ad"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d03b9884-8fc3-4931-aae7-ac04dd60ab64&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d03b9884-8fc3-4931-aae7-ac04dd60ab64","type":"Claim","title":"Clusterin protects against Aβ40 toxicity.","label":"Lambert M et al.; Clusterin protects against Aβ40 toxicity...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:d03b9884-8fc3-4931-aae7-ac04dd60ab64"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:13ae900a-add5-477f-ac4e-699a63b85487&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:13ae900a-add5-477f-ac4e-699a63b85487","type":"Hypothesis","title":"Amyloid beta oligomers induce impairment of neuronal insulin receptors.","label":"Zhao W et al.; Amyloid beta oligomers induce impairment...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["De Felice Fernanda G.","Fernandez Sara J","Chen Hui","Lambert Mary P","Quon Michael J.","Krafft Grant A","Klein William L"],"firstAuthor":"Zhao Wei-Qin","referenceYear":"2008","referenceDate":"2008-01","id":"urn:lsid:swan.org:researchstatement:13ae900a-add5-477f-ac4e-699a63b85487"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:71e7ae5e-de55-47bf-b0e7-77148b8618a5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:71e7ae5e-de55-47bf-b0e7-77148b8618a5","type":"Claim","title":"The level of tau on microtubules shows no significant difference between adult and aged mice.","label":"Takashima A; The level of tau on microtubules shows n...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Takashima Akihiko","id":"urn:lsid:swan.org:researchstatement:71e7ae5e-de55-47bf-b0e7-77148b8618a5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ae0066cd-d8ad-4193-bcfe-7cfb81d0b0a5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ae0066cd-d8ad-4193-bcfe-7cfb81d0b0a5","type":"Claim","title":"The observation that the CHIP/Hsp70 complex specifically ubiquitinates AD-type hyperphosphorylated tau (p-tau) suggested that phosphorylation is the signal for at least one tau ubiquitination pathway.","label":"Carrettiero D et al.; The observation that the CHIP/Hsp70 comp...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hernandez Israel","Neveu Pierre","Papagiannakopoulos Thales","Kosik Kenneth S"],"firstAuthor":"Carrettiero Daniel C","referenceYear":"2009","referenceDate":"2009-02-18","id":"urn:lsid:swan.org:researchstatement:ae0066cd-d8ad-4193-bcfe-7cfb81d0b0a5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:827e31cf-487a-48f7-8f56-938ef72a492b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:827e31cf-487a-48f7-8f56-938ef72a492b","type":"Claim","title":"Mutations in APP, PS1 and PS2, or variant ApoE4 alter Aβ production that promotes amyloid aggregation.","label":"Golde T; Mutations in APP, PS1 and PS2, or varian...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde T","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:827e31cf-487a-48f7-8f56-938ef72a492b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:66df4851-91e9-4403-86b0-fd3c5cc945d7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:66df4851-91e9-4403-86b0-fd3c5cc945d7","type":"Claim","title":"Other molecules elevated in AD brain may chaperone Aβ42 self-association, leading to toxic Aβ oligomers that are diffusible and potentially more pernicious than fibrillar Aβ.","label":"Lambert M et al.; Other molecules elevated in AD brain may...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:66df4851-91e9-4403-86b0-fd3c5cc945d7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b847aa2b-a522-41a5-adc9-22ce336108d5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b847aa2b-a522-41a5-adc9-22ce336108d5","type":"Hypothesis","title":"Infection with the organism Chlamydia pneumoniae is a risk factor for late-onset Alzheimer disease.","label":"Balin B et al.; Infection with the organism Chlamydia pn...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Gérard H C","Arking E J","Appelt D M","Branigan P J","Abrams J T","Whittum-Hudson J A","Hudson A P"],"firstAuthor":"Balin B J","referenceYear":"1998","referenceDate":"1998-06","id":"urn:lsid:swan.org:researchstatement:b847aa2b-a522-41a5-adc9-22ce336108d5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:a6b80a0a-a0c1-4d92-af2e-b8010823479d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:a6b80a0a-a0c1-4d92-af2e-b8010823479d","type":"Comment","title":"Goldstein on Meyer-Luehmann","label":"Goldstein L; Goldstein on Meyer-Luehmann","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Goldstein Lawrence S B","id":"urn:lsid:swan.org:comment:a6b80a0a-a0c1-4d92-af2e-b8010823479d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0be96ba1-413b-4a38-b5e0-2a796f720fa5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0be96ba1-413b-4a38-b5e0-2a796f720fa5","type":"Claim","title":"Reduced α4 nicotinic acetylcholine receptors (nAChR) protein levels have been confirmed in AD brains both immunohistochemically and by Western blot analysis.","label":"Cook L et al.; Reduced α4 nicotinic acetylcholine recep...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Ho Luk W","Taylor Alison E","Brayne Carol","Evans John Grimley","Xuereb John","Cairns Nigel J","Pritchard Antonia","Lemmon Helen","Mann David","St Clair David","Turic Dragana","Hollingworth Paul","Moore Pamela J","Jehu Luke","Archer Nicola","Walter Sarah","Foy Catherine","Edmondson Amanda","Powell John","Lovestone Simon","Owen Michael J","Williams Julie","Lendon Corinne","Rubinsztein David C"],"firstAuthor":"Cook Lynnette J","referenceYear":"2004","referenceDate":"2004-03-25","id":"urn:lsid:swan.org:researchstatement:0be96ba1-413b-4a38-b5e0-2a796f720fa5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:10a055cf-0997-40f0-97e2-4faca03e9281&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:10a055cf-0997-40f0-97e2-4faca03e9281","type":"Claim","title":"The morphology of RGC and optic axons appears normal, with no neuropathology, in 8c mice, consistent with the notion that axonal transport is not hindered by moderate tau expression","label":"Yuan A et al.; The morphology of RGC and optic axons ap...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:10a055cf-0997-40f0-97e2-4faca03e9281"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:244f4940-dd2a-4e47-a925-28de24961253&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:244f4940-dd2a-4e47-a925-28de24961253","type":"Claim","title":"The results of in vivo studies of tau-null and tau overexpressing mice contrast with earlier proposals that tau overexpression impedes axonal transport.","label":"Yuan A et al.; The results of in vivo studies of tau-nu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:244f4940-dd2a-4e47-a925-28de24961253"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:63b56865-45bd-4fd5-be2e-b7a0f5d5b3a4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:63b56865-45bd-4fd5-be2e-b7a0f5d5b3a4","type":"Claim","title":"GSK3 promotes actin and tubulin assembly, processes required for synaptic reorganization during memory formation.","label":"Hooper C et al.; GSK3 promotes actin and tubulin assembly...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:63b56865-45bd-4fd5-be2e-b7a0f5d5b3a4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4bb86997-c654-492e-b5f8-b35289ad30ed&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4bb86997-c654-492e-b5f8-b35289ad30ed","type":"Claim","title":"Tau knockout mice develop cognitive and motor abnormalities with age, signifying that reducing tau levels may have negative consequences.","label":"Lee V et al.; Tau knockout mice develop cognitive and ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Trojanowski John Q"],"firstAuthor":"Lee Virginia M-Y","id":"urn:lsid:swan.org:researchstatement:4bb86997-c654-492e-b5f8-b35289ad30ed"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5aed563b-01ff-4cd6-b715-1271a3e0be7c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5aed563b-01ff-4cd6-b715-1271a3e0be7c","type":"Claim","title":"Cultured neurons treated with Aβ for 24 to 48 hours exhibit asynchronous somal condensation whereas the plasma membrane integrity is maintained.","label":"Cotman C et al.; Cultured neurons treated with Aβ for 24 ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:5aed563b-01ff-4cd6-b715-1271a3e0be7c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:62df87e2-eed3-4cad-9082-d0e430f32cf9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:62df87e2-eed3-4cad-9082-d0e430f32cf9","type":"Question","title":"In future experiments, it will be very interesting to determine how other Aβ chaperones influence the oligomerization process and \"paranuclei\" formation.","label":"In future experiments, it will be very i...","icon":"../icons/ontological/discourse-element/research-question.png","firstAuthor":"Holtzman David M","id":"urn:lsid:swan.org:researchquestion:62df87e2-eed3-4cad-9082-d0e430f32cf9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9e07a52c-d928-4482-bde7-e5bde43a8c26&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9e07a52c-d928-4482-bde7-e5bde43a8c26","type":"Claim","title":"The low-density lipoprotein receptor related protein 6 (LRP6), a co-receptor for Wnt signaling, has recently been identified as a risk gene for late onset AD in apolipoprotein E4-ε4 negative individuals, implicating aberrant Wnt signalling in AD pathology.","label":"Hooper C et al.; The low-density lipoprotein receptor rel...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:9e07a52c-d928-4482-bde7-e5bde43a8c26"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a5dd829f-21be-46c3-be49-970fbfcf7239&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a5dd829f-21be-46c3-be49-970fbfcf7239","type":"Claim","title":"Using myelin basic protein as substrate, approximately equal levels of mitogen-activated protein kinase (MAPK) activity are found in samples immunoprecipitated from either GI or G2/M phase cells. In contrast, no phosphorylation of APP654-694 is detected in either of the immunoprecipitated samples.","label":"Suzuki T et al.; Using myelin basic protein as substrate,...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:a5dd829f-21be-46c3-be49-970fbfcf7239"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9cd6f7d6-4fb3-4f8c-a58f-fe2c75927c42&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9cd6f7d6-4fb3-4f8c-a58f-fe2c75927c42","type":"Claim","title":"The net increases in the phosphorylation state of imAPP and mAPP are ~2.5- and 1.6-fold, respectively at the G2/M phase compared with cells at the GI phase.","label":"Suzuki T et al.; The net increases in the phosphorylation...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:9cd6f7d6-4fb3-4f8c-a58f-fe2c75927c42"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:971e40e4-2aca-4462-86da-a965748544be&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:971e40e4-2aca-4462-86da-a965748544be","type":"Claim","title":"The overexpression of a NF-H-LacZ fusion protein in transgenic mice inhibits export of a subpopulation of newly synthesized neurofilament protein into axons and induces alpha-internexin and neurofilament triplet to aggregate in neuronal perikarya. However, the transport rate of NF-L that escapes into axons remains normal.","label":"Yuan A et al.; The overexpression of a NF-H-LacZ fusion...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:971e40e4-2aca-4462-86da-a965748544be"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d6d233ca-1cd9-46bc-8862-de7cee5204cc&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d6d233ca-1cd9-46bc-8862-de7cee5204cc","type":"Claim","title":"It is hard to imagine that massive numbers of amyloid plaques in the brain would not interfere with neuronal function.","label":"Goldstein L; It is hard to imagine that massive numbe...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Goldstein Lawrence S B","id":"urn:lsid:swan.org:researchstatement:d6d233ca-1cd9-46bc-8862-de7cee5204cc"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6f89a1d0-26a9-4310-a85b-913dd9c8a85f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6f89a1d0-26a9-4310-a85b-913dd9c8a85f","type":"Claim","title":"The accumulation of DNA damage as the result of deficient DNA repair has previously been suggested to have a role in neurodegeneration in AD and may be the result of an acceleration of DNA damage.","label":"Cotman C et al.; The accumulation of DNA damage as the re...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:6f89a1d0-26a9-4310-a85b-913dd9c8a85f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:471b60a0-fc9a-41b6-9e95-ad8009ae2bdf&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:471b60a0-fc9a-41b6-9e95-ad8009ae2bdf","type":"Hypothesis","title":"Cerebral Aβ amyloidosis can be induced by infectious protein.","label":"Walker L et al.; Cerebral Aβ amyloidosis can be induced b...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Levine Harry","Jucker Mathias"],"firstAuthor":"Walker Lary","referenceYear":"2006","referenceDate":"2006-07","id":"urn:lsid:swan.org:researchstatement:471b60a0-fc9a-41b6-9e95-ad8009ae2bdf"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:66943590-972c-4159-a9dd-797dd48250f1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:66943590-972c-4159-a9dd-797dd48250f1","type":"Claim","title":"BAG2, in its role as a CHIP inhibitor, prevents and reduces the ubiquitination of tau, suggesting that BAG2 may be shuttling tau to a ubiquitin-independent pathway.  ","label":"Carrettiero D et al.; BAG2, in its role as a CHIP inhibitor, p...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hernandez Israel","Neveu Pierre","Papagiannakopoulos Thales","Kosik Kenneth S"],"firstAuthor":"Carrettiero Daniel C","referenceYear":"2009","referenceDate":"2009-02-18","id":"urn:lsid:swan.org:researchstatement:66943590-972c-4159-a9dd-797dd48250f1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e38cdded-81de-47af-a7f5-a065a263cdf0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e38cdded-81de-47af-a7f5-a065a263cdf0","type":"Claim","title":"PICUP shows that oligomer size distribution of A&#946;42 includes a minor fraction of monomer to trimer form, a major population of tetramer through octamer with intense peaks at pentamer and hexamer forms, and additional peak intensities at dodecamer and octadecamer.","label":"Bitan G et al.; PICUP shows that oligomer size distribut...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:e38cdded-81de-47af-a7f5-a065a263cdf0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:dcd4509d-3cfd-48bf-9b0f-e300bf7a36d8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:dcd4509d-3cfd-48bf-9b0f-e300bf7a36d8","type":"Claim","title":"The Tg2576 transgenic mouse model of AD develops parenchymal plaque pathology and prominent CAA beginning at 9 months of age.","label":"Fryer J et al.; The Tg2576 transgenic mouse model of AD ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:dcd4509d-3cfd-48bf-9b0f-e300bf7a36d8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cf832751-2947-4bd1-a831-e3cd1e6759b1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cf832751-2947-4bd1-a831-e3cd1e6759b1","type":"Claim","title":"While it remains unclear whether LRP also mediates Aβ influx into brain from the bloodstream, the major player in this arena appears to be RAGE, a multifunctional receptor in the immunoglobulin superfamily, which like LRP, binds a large array of different ligands.","label":"Tanzi R et al.; While it remains unclear whether LRP als...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:cf832751-2947-4bd1-a831-e3cd1e6759b1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:aeff334d-b5e1-4d12-924a-2c6ae1381256&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:aeff334d-b5e1-4d12-924a-2c6ae1381256","type":"Claim","title":"It has been recently proposed that amyloid deposits followed axonal trafficking defects, marked morphologically as neuritic dystrophies.","label":"Meyer-Luehmann M et al.; It has been recently proposed that amylo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:aeff334d-b5e1-4d12-924a-2c6ae1381256"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f6542349-31dd-45dd-bd8d-7f6136eef6bd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f6542349-31dd-45dd-bd8d-7f6136eef6bd","type":"Claim","title":"The pattern of cellular damage in early AD cases is characteristically nonuniform and affected cells occur in small groups that always include healthy cells among those degenerating.","label":"Cotman C et al.; The pattern of cellular damage in early ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:f6542349-31dd-45dd-bd8d-7f6136eef6bd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8b0dd105-c865-43b0-91a3-e01bb363f995&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8b0dd105-c865-43b0-91a3-e01bb363f995","type":"Claim","title":"The effect of AD mutations in increasing Aβ production in cultured cells does not correlate with age of onset of disease in affected individuals.","label":"Hardy J et al.; The effect of AD mutations in increasing...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:8b0dd105-c865-43b0-91a3-e01bb363f995"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:58dec333-ba81-4fad-8dc4-b0d5c43d7944&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:58dec333-ba81-4fad-8dc4-b0d5c43d7944","type":"Claim","title":"Phosphorylation of the mature (mAPP) and the immature (imAPP) forms of APP is elevated at the G2/M phase, demonstrating that APP is a physiological substrate for cdc2 kinase in vivo, when cdc2 kinase is most active.","label":"Suzuki T et al.; Phosphorylation of the mature (mAPP) and...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:58dec333-ba81-4fad-8dc4-b0d5c43d7944"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:40121ce8-9732-4a00-86d2-5a093fbb981c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:40121ce8-9732-4a00-86d2-5a093fbb981c","type":"Claim","title":"The identification of the epsilon-N-(gamma glutamyl)lysine isopeptide bond specific to tissue-transglutaminase activity in the CSF has high sensitivity and selectivity for the diagnosis of AD.","label":"Hartley D et al.; The identification of the epsilon-N-(gam...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:40121ce8-9732-4a00-86d2-5a093fbb981c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:947eb65f-d8db-4e3d-b2e8-5e241d734aee&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:947eb65f-d8db-4e3d-b2e8-5e241d734aee","type":"Claim","title":"The nicastrin ectodomain provides a separate substrate docking site for γ-secretase substrates.","label":"Bentahir M et al.; The nicastrin ectodomain provides a sepa...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:947eb65f-d8db-4e3d-b2e8-5e241d734aee"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:202c63b3-cf18-4079-bce5-96971a764d19&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:202c63b3-cf18-4079-bce5-96971a764d19","type":"Claim","title":"Aβ42 cleavage is less affected by PS1 clinical mutations than Aβ40 production.","label":"Bentahir M et al.; Aβ42 cleavage is less affected by PS1 cl...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:202c63b3-cf18-4079-bce5-96971a764d19"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:452940d2-bef7-4f35-b207-549c45f3b65f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:452940d2-bef7-4f35-b207-549c45f3b65f","type":"Claim","title":"An increased level of APP, or increased processing of APP is unlikely to be the cause of the neuritic Aβ accumulations.","label":"Muresan Z et al.; An increased level of APP, or increased ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","referenceYear":"2008","referenceDate":"2008","id":"urn:lsid:swan.org:researchstatement:452940d2-bef7-4f35-b207-549c45f3b65f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0cdebf14-43c9-4489-88a0-810e0f6216a0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0cdebf14-43c9-4489-88a0-810e0f6216a0","type":"Claim","title":"De-lipidated apoE4 forms SDS-stable complexes with Aβ more rapidly than apoE3.","label":"Holtzman D; De-lipidated apoE4 forms SDS-stable comp...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:0cdebf14-43c9-4489-88a0-810e0f6216a0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d9de6652-8084-4bbd-931e-f6fb2e70c218&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d9de6652-8084-4bbd-931e-f6fb2e70c218","type":"Claim","title":"Altering the kinetics of plaque growth may change the rate of AD progression.","label":"Meyer-Luehmann M et al.; Altering the kinetics of plaque growth m...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:d9de6652-8084-4bbd-931e-f6fb2e70c218"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:eb71c87f-49e8-453c-a440-9cc96929129c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:eb71c87f-49e8-453c-a440-9cc96929129c","type":"Claim","title":"AD brain derived ADDLs bound the same p140 and p260 proteins from rat cortical extracts, but also bound a 100 kDa band predominantly.","label":"Gong Y et al.; AD brain derived ADDLs bound the same p1...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:eb71c87f-49e8-453c-a440-9cc96929129c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9ff7886f-55e1-43b8-b10a-e2fda389d11c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9ff7886f-55e1-43b8-b10a-e2fda389d11c","type":"Claim","title":"The current resolution of this technique does not permit visualization of small, dense plaques.","label":"Kumar-Singh S; The current resolution of this technique...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Kumar-Singh Samir","id":"urn:lsid:swan.org:researchstatement:9ff7886f-55e1-43b8-b10a-e2fda389d11c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6bab68e7-1dba-4d7f-baa1-91d4c49e0ea2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6bab68e7-1dba-4d7f-baa1-91d4c49e0ea2","type":"Claim","title":"The enhanced IP3-mediated calcium response observed in mutant PS1 mice was attributable to an increase in the size of intracellular calcium stores.","label":"Smith I et al.; The enhanced IP3-mediated calcium respon...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:6bab68e7-1dba-4d7f-baa1-91d4c49e0ea2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a84561fd-bef6-457e-be20-2e3f996e42d3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a84561fd-bef6-457e-be20-2e3f996e42d3","type":"Claim","title":"APP clinical mutations may not only render Aβ more prone to amyloid formation, but may also impede efflux out of the brain via LRP.","label":"Tanzi R et al.; APP clinical mutations may not only rend...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:a84561fd-bef6-457e-be20-2e3f996e42d3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:894be954-c982-4e88-a8c4-f125ccada10d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:894be954-c982-4e88-a8c4-f125ccada10d","type":"Claim","title":"Substrate or transition state analogs can have biphasic effects on the activity of allosteric enzymes, similar to the effect of γ-secretase inhibitors on Aβ42 production, exemplified by dicarboxylic acids such as maleate which perform as activators at low concentrations and inhibitors at higher concentrations with the classic allosteric enzyme aspartate transcarbamylase.","label":"Shen J et al.; Substrate or transition state analogs ca...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:894be954-c982-4e88-a8c4-f125ccada10d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:8b3ddd28-6408-4eb8-99f2-f8882a4f8d59&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:8b3ddd28-6408-4eb8-99f2-f8882a4f8d59","type":"Question","title":"Is tau a good target for AD drug discovery?","label":"Is tau a good target for AD drug discove...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:8b3ddd28-6408-4eb8-99f2-f8882a4f8d59"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:85f41cd2-d4bd-480f-b283-d70559184007&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:85f41cd2-d4bd-480f-b283-d70559184007","type":"Claim","title":"Synthetic Aβ oligomers bind to differentiated hippocampal neurons at binding sites that colocalize with the synaptic marker PSD-95 suggesting that oligomers target synapses.","label":"Gong Y et al.; Synthetic Aβ oligomers bind to different...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:85f41cd2-d4bd-480f-b283-d70559184007"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f5843557-2d16-485d-a6b2-3c3c17d60f73&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f5843557-2d16-485d-a6b2-3c3c17d60f73","type":"Claim","title":"No intracellular or membrane-associated Aβ or CTFs correlated with the onset of memory deficits.","label":"Lesné S et al.; No intracellular or membrane-associated ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Koh Ming Teng","Kotilinek Linda","Kayed Rakez","Glabe Charles G","Yang Austin","Gallagher Michela","Ashe Karen H"],"firstAuthor":"Lesné Sylvain","referenceYear":"2006","referenceDate":"2006-03-16","id":"urn:lsid:swan.org:researchstatement:f5843557-2d16-485d-a6b2-3c3c17d60f73"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3a4b886e-28dd-4bdd-86fb-c10e63c69d3b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3a4b886e-28dd-4bdd-86fb-c10e63c69d3b","type":"Claim","title":"Amyloid β can alter ion channel expression in neurons.","label":"Plant L et al.; Amyloid β can alter ion channel expressi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:3a4b886e-28dd-4bdd-86fb-c10e63c69d3b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:343d0ef3-ceea-4ded-9810-70a2960f9782&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:343d0ef3-ceea-4ded-9810-70a2960f9782","type":"Claim","title":"The amino acid sequence of amyloid &#946;-peptide (A&#946;) was first identified from Alzheimer Disease patient blood vessels and Downs syndrome.","label":"Hardy J et al.; The amino acid sequence of amyloid &#946...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:343d0ef3-ceea-4ded-9810-70a2960f9782"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e96911c5-9a0f-4efa-ac70-4b0dac240612&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e96911c5-9a0f-4efa-ac70-4b0dac240612","type":"Claim","title":"It is likely that oligomeric proteins resemble viruses or virus-like particles, which are known to function as pathogen-associated molecular patterns (PAMPs).","label":"Golde T et al.; It is likely that oligomeric proteins re...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:e96911c5-9a0f-4efa-ac70-4b0dac240612"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b9819b53-c836-4f41-a7a3-78dbaaae4776&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b9819b53-c836-4f41-a7a3-78dbaaae4776","type":"Claim","title":"Fractionation experiments also have indicated the existence of water soluble oligomers of Aβ that are increased 12-fold in AD brains.","label":"Lambert M et al.; Fractionation experiments also have indi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:b9819b53-c836-4f41-a7a3-78dbaaae4776"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:637c3af9-493d-415d-ad79-cf26de71b41f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:637c3af9-493d-415d-ad79-cf26de71b41f","type":"Claim","title":"The gamma-secretase-generated carboxy-terminal sequence of APP, the AICD, consists of the last 50 carboxy-terminal residues of the APP protein and is a potential nuclear signalling molecule and present in both healthy brains and in the brains of AD patients.","label":"Smith I et al.; The gamma-secretase-generated carboxy-te...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:637c3af9-493d-415d-ad79-cf26de71b41f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5242d3d2-57c6-482c-826b-84cbd7de8b38&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5242d3d2-57c6-482c-826b-84cbd7de8b38","type":"Claim","title":"Cleavage of APP and secretion of APP<sub>s<\/sub> are altered in a cell cycle-dependent manner, and a qualitative change of immature APP electrophoretic mobility and the accumulation of APPCOOH correlate with the enhanced phosphorylation of APP at the G2/M phase of the cell cycle.","label":"Suzuki T et al.; Cleavage of APP and secretion of APP<sub...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:5242d3d2-57c6-482c-826b-84cbd7de8b38"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4a099aa2-14d2-4e20-9918-a9f8ce4c7a84&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4a099aa2-14d2-4e20-9918-a9f8ce4c7a84","type":"Claim","title":"Previous studies revealed loss of brain tau in dysphasic disinhibition dementia 2, a form of frontotemporal dementia.","label":"Yuan A et al.; Previous studies revealed loss of brain ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:4a099aa2-14d2-4e20-9918-a9f8ce4c7a84"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2a7a63b3-53db-4f29-9852-7fe05961eab0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2a7a63b3-53db-4f29-9852-7fe05961eab0","type":"Claim","title":"CDC2 kinase is the first protein kinase that has been shown to phosphorylate APP in cells. In addition, several proline-directed protein kinases such as CDK5 and JNK are known to phosphorylate APP at Thr668.","label":"Suzuki T; CDC2 kinase is the first protein kinase ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Suzuki Toshiharu","id":"urn:lsid:swan.org:researchstatement:2a7a63b3-53db-4f29-9852-7fe05961eab0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3d88373a-60ee-4e16-9138-1c1be59d27aa&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3d88373a-60ee-4e16-9138-1c1be59d27aa","type":"Claim","title":"Tarenflurbil (Flurizan™, Myriad Pharmaceuticals) acts by decreasing the production of Aβ42. ","label":"Small S et al.; Tarenflurbil (Flurizan™, Myriad Pharmace...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:3d88373a-60ee-4e16-9138-1c1be59d27aa"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a624c0d2-5673-451d-a052-f28b920d99a1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a624c0d2-5673-451d-a052-f28b920d99a1","type":"Claim","title":"AICD may regulate IP3-mediated calcium signalling suggesting a new physiological signalling role for APP.","label":"Smith I et al.; AICD may regulate IP3-mediated calcium s...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:a624c0d2-5673-451d-a052-f28b920d99a1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9014251f-91cf-4faa-b468-fd0be0dad67a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9014251f-91cf-4faa-b468-fd0be0dad67a","type":"Claim","title":"The major risk factor for developing AD and other neurodegenerative diseases is age, but it is aging, specifically referring to distinct biological processes that are altered as an organism grows older, that contributes to the risk of developing AD or other neurodegenerative conditions.","label":"Golde T et al.; The major risk factor for developing AD ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:9014251f-91cf-4faa-b468-fd0be0dad67a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:30c15428-7d3b-406d-b721-660ebdd8171e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:30c15428-7d3b-406d-b721-660ebdd8171e","type":"Claim","title":"Direct cause-and-effect links have been established between tau malfunctions and an overall imbalance in the activity levels or regulation of tau kinases and phosphatases.","label":"Ballatore C et al.; Direct cause-and-effect links have been ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Lee Virginia M-Y","Trojanowski John Q"],"firstAuthor":"Ballatore Carlo","referenceYear":"2007","referenceDate":"2007-09","id":"urn:lsid:swan.org:researchstatement:30c15428-7d3b-406d-b721-660ebdd8171e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:68021f14-3dee-46b1-98b8-a188c8f7b739&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:68021f14-3dee-46b1-98b8-a188c8f7b739","type":"Claim","title":"Aβ*56 has the ability to disrupt memory function directly and is the principal cause of memory decline.","label":"Lesné S et al.; Aβ*56 has the ability to disrupt memory ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Koh Ming Teng","Kotilinek Linda","Kayed Rakez","Glabe Charles G","Yang Austin","Gallagher Michela","Ashe Karen H"],"firstAuthor":"Lesné Sylvain","referenceYear":"2006","referenceDate":"2006-03-16","id":"urn:lsid:swan.org:researchstatement:68021f14-3dee-46b1-98b8-a188c8f7b739"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6b487c5d-128d-4356-b656-2e11da59dfc6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6b487c5d-128d-4356-b656-2e11da59dfc6","type":"Claim","title":"Changes in NMDA receptor populations appear not to be responsible for the beneficial effects of the α7nAChR loss of function in the APP α7nAChRKO mouse model.","label":"Dziewczapolski G et al.; Changes in NMDA receptor populations app...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Glogowski Carolina M","Masliah Eliezer","Heinemann Stephen F"],"firstAuthor":"Dziewczapolski Gustavo","referenceYear":"2009","referenceDate":"2009-07-08","id":"urn:lsid:swan.org:researchstatement:6b487c5d-128d-4356-b656-2e11da59dfc6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d8221a00-583b-4f53-9743-d9d85e5bd42d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d8221a00-583b-4f53-9743-d9d85e5bd42d","type":"Hypothesis","title":"Brainstem neurons are initiators of neuritic plaques.","label":"Muresan Z et al.; Brainstem neurons are initiators of neur...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","referenceYear":"2008","referenceDate":"2008","id":"urn:lsid:swan.org:researchstatement:d8221a00-583b-4f53-9743-d9d85e5bd42d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0ff7ae6e-b415-4ccb-b22c-699e4fa90876&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0ff7ae6e-b415-4ccb-b22c-699e4fa90876","type":"Claim","title":"In AD cases, intensity of THOP1 neuronal staining in the temporal cortex and hippocampus was decreased in comparison to non-demented control cases, while increased THOP1 immunoreactivity was found in neurofibrillary tangles and neuritic plaques and co-localized with AT8 detection of hyperphosphorylated tau. ","label":"Pollio G et al.; In AD cases, intensity of THOP1 neuronal...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hoozemans Jeroen J","Andersen Claus A","Roncarati Renza","Rosi Maria Cristina","van Haastert Elise S","Seredenina Tamara","Diamanti Daniela","Gotta Stefano","Fiorentini Anna","Magnoni Letizia","Raggiaschi Roberto","Rozemuller Annemieke J","Casamenti Fiorella","Caricasole Andrea","Terstappen Georg C"],"firstAuthor":"Pollio Giuseppe","referenceYear":"2008","referenceDate":"2008-07","id":"urn:lsid:swan.org:researchstatement:0ff7ae6e-b415-4ccb-b22c-699e4fa90876"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fe9a429e-a347-4ff8-a342-4c2976d32ae0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fe9a429e-a347-4ff8-a342-4c2976d32ae0","type":"Claim","title":"Increased expression of Ref-1 is particularly interesting because this DNA repair enzyme has also been shown to regulate the DNA binding activity of the transcriptional regulator c-Jun.","label":"Cotman C et al.; Increased expression of Ref-1 is particu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:fe9a429e-a347-4ff8-a342-4c2976d32ae0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6be455fd-733d-4c61-8f12-930c9dd1fa41&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6be455fd-733d-4c61-8f12-930c9dd1fa41","type":"Claim","title":"In vitro assembled PHFs from recombinant human tau were capable of inhibiting proteasome activity more severely than brain isolated PHF-A.","label":"Keck S et al.; In vitro assembled PHFs from recombinant...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:6be455fd-733d-4c61-8f12-930c9dd1fa41"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8638fb18-518f-4b2a-9219-9552828cb843&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8638fb18-518f-4b2a-9219-9552828cb843","type":"Claim","title":"Specific ApoE isoforms promote fibrillogenesis of Aβ.","label":"Holtzman D; Specific ApoE isoforms promote fibrillog...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:8638fb18-518f-4b2a-9219-9552828cb843"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c342a6c2-c630-4bab-acc9-8ac21db039ea&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c342a6c2-c630-4bab-acc9-8ac21db039ea","type":"Claim","title":"Degeneration can result \u2018passively\u2019 from the loss of support from trophic factors such as nerve growth factor (NGF).  ","label":"Nikolaev A et al.; Degeneration can result \u2018passively\u2019 from...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["McLaughlin Todd","O'Leary Dennis D","Tessier-Lavigne Marc"],"firstAuthor":"Nikolaev Anatoly","referenceYear":"2009","referenceDate":"2009-02-19","id":"urn:lsid:swan.org:researchstatement:c342a6c2-c630-4bab-acc9-8ac21db039ea"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:82892ed6-913f-467e-a4f2-08a88ea665e9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:82892ed6-913f-467e-a4f2-08a88ea665e9","type":"Claim","title":"APP isolated from adult rat brain is phosphorylated at Thr668, although it is unclear whether APP phosphorylation occurs in postmitotic neurons and/or in glial cells which are capable of cell division.","label":"Suzuki T et al.; APP isolated from adult rat brain is pho...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:82892ed6-913f-467e-a4f2-08a88ea665e9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:319b4ab0-0503-4f23-aa16-80f3cbc8c877&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:319b4ab0-0503-4f23-aa16-80f3cbc8c877","type":"Hypothesis","title":"Axonal transport is not impaired by changes in tau gene expression levels.","label":"Yuan A et al.; Axonal transport is not impaired by chan...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne M","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:319b4ab0-0503-4f23-aa16-80f3cbc8c877"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:595e8027-35e4-4211-b1f9-154bea0630ab&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:595e8027-35e4-4211-b1f9-154bea0630ab","type":"Claim","title":"NEP has been implicated as a rate-limiting Aβ-degrading enzyme in the brain.","label":"Tanzi R et al.; NEP has been implicated as a rate-limiti...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:595e8027-35e4-4211-b1f9-154bea0630ab"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:96a1eb87-1fbd-4c60-8f93-e516d9f0bc17&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:96a1eb87-1fbd-4c60-8f93-e516d9f0bc17","type":"Hypothesis","title":"Oligomerization of Aβ 40 and 42 occurs via distinct pathways.","label":"Bitan G et al.; Oligomerization of Aβ 40 and 42 occurs v...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:96a1eb87-1fbd-4c60-8f93-e516d9f0bc17"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:545f298d-307f-4b6c-a663-1a1af9620f89&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:545f298d-307f-4b6c-a663-1a1af9620f89","type":"Claim","title":"ApoE3 or E4 transgenic human delayed Aβ deposition by ~6 months.","label":"Holtzman D; ApoE3 or E4 transgenic human delayed Aβ ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:545f298d-307f-4b6c-a663-1a1af9620f89"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8f2daf93-4477-496a-8802-09d937723588&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8f2daf93-4477-496a-8802-09d937723588","type":"Claim","title":"Human LAG-1 homologue, LAG1Hs, is highly expressed in brain.","label":"Human LAG-1 homologue, LAG1Hs, is highly...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:8f2daf93-4477-496a-8802-09d937723588"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2492c81b-45db-4be0-bde9-aa3b58dd07f8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2492c81b-45db-4be0-bde9-aa3b58dd07f8","type":"Claim","title":"γ-secretase activity is responsible for the final cleavage of the amyloid precursor protein (APP), causing release of the Aβ peptide, cleaves Notch, N-Cadherin, and other important signaling molecules and is mediated by a multiprotein complex consisting of Presenilin (PS), Aph1, Pen2, and Nicastrin (NCT).","label":"Serneels L et al.; γ-secretase activity is responsible for ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Van Biervliet Jérôme","Craessaerts Katleen","Dejaegere Tim","Horré Katrien","Van Houtvin Tine","Esselmann Hermann","Paul Sabine","Schäfer Martin K","Berezovska Oksana","Hyman Bradley T","Sprangers Ben","Sciot Raf","Moons Lieve","Jucker Mathias","Yang Zhixiang","May Patrick C","Karran Eric","Wiltfang Jens","D'Hooge Rudi","De Strooper Bart"],"firstAuthor":"Serneels Lutgarde","referenceYear":"2009","referenceDate":"2009-05-01","id":"urn:lsid:swan.org:researchstatement:2492c81b-45db-4be0-bde9-aa3b58dd07f8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2a9d818a-b516-4da2-a953-3190f42f156b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2a9d818a-b516-4da2-a953-3190f42f156b","type":"Claim","title":"ApoE is secreted as HDL-like particles by astrocytes and is present in CSF at concentrations of approximately 5 micrograms/mL","label":"Holtzman D; ApoE is secreted as HDL-like particles b...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:2a9d818a-b516-4da2-a953-3190f42f156b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f0a1a4ac-515d-4dd5-b51e-acef71d5759d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f0a1a4ac-515d-4dd5-b51e-acef71d5759d","type":"Claim","title":"Following nucleation via a seeded nucleation-dependent process, the ongoing production of a \u2018normal\u2019 precursor drives additional amyloid formation.","label":"Golde T et al.; Following nucleation via a seeded nuclea...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:f0a1a4ac-515d-4dd5-b51e-acef71d5759d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:647d8c44-dc5b-4580-9805-19dc50c0e8a3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:647d8c44-dc5b-4580-9805-19dc50c0e8a3","type":"Claim","title":"DR6 functions in axonal pruning in vivo.","label":"Nikolaev A et al.; DR6 functions in axonal pruning in vivo.","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["McLaughlin Todd","O'Leary Dennis D","Tessier-Lavigne Marc"],"firstAuthor":"Nikolaev Anatoly","referenceYear":"2009","referenceDate":"2009-02-19","id":"urn:lsid:swan.org:researchstatement:647d8c44-dc5b-4580-9805-19dc50c0e8a3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1d562113-ab57-448c-8f02-0cb845635fa3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1d562113-ab57-448c-8f02-0cb845635fa3","type":"Claim","title":"Aβ enhances expression of Kv4.2 and Kv4.3 protein levels after 2 and 24 h but decreases at 48 h preincubation.","label":"Plant L et al.; Aβ enhances expression of Kv4.2 and Kv4....","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:1d562113-ab57-448c-8f02-0cb845635fa3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a46c2824-3ac4-4c49-b277-9b8f1360ab4f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a46c2824-3ac4-4c49-b277-9b8f1360ab4f","type":"Claim","title":"Mouse cells can undergo replicative senescence without shortened telomeres suggesting that nuclear biomarkers of human replicative senescence may not apply to studies of CNS senescence.","label":"Golde T et al.; Mouse cells can undergo replicative sene...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:a46c2824-3ac4-4c49-b277-9b8f1360ab4f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5759fe72-207e-40bd-ad0c-f0a95cbf3c27&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5759fe72-207e-40bd-ad0c-f0a95cbf3c27","type":"Claim","title":"Late onset AD (LOAD) is associated with both environmental and genetic risk factors, including hypercholesterolemia, atherosclerosis, history of head trauma, stroke.","label":"Late onset AD (LOAD) is associated with ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:5759fe72-207e-40bd-ad0c-f0a95cbf3c27"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:574c0272-10cc-47e2-aa9b-90d76d86a300&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:574c0272-10cc-47e2-aa9b-90d76d86a300","type":"Claim","title":"The relationship between soluble and insoluble brain Aβ concentrations and memory impairment in transgenic mice is task specific and complex.","label":"Dodart J et al.; The relationship between soluble and ins...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:574c0272-10cc-47e2-aa9b-90d76d86a300"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5c55a298-13de-42a7-b226-10dc2ec12fe4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5c55a298-13de-42a7-b226-10dc2ec12fe4","type":"Hypothesis","title":"  \t\n\nAlzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation.","label":"Li J et al.;   \t\n\nAlzheimer presenilins in the nuclea...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Xu M","Zhou H","Ma J","Potter H"],"firstAuthor":"Li J","referenceYear":"1997","referenceDate":"1997-09-05","id":"urn:lsid:swan.org:researchstatement:5c55a298-13de-42a7-b226-10dc2ec12fe4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5e780071-196b-4b78-8110-fc583b1ff358&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5e780071-196b-4b78-8110-fc583b1ff358","type":"Claim","title":"A major peptidase responsible for the degradation of Aβ is NEP (EC 3.4.24.15), also referred to as neutral endopeptidase and enkephalinase. NEP is a type II membrane protein, which like IDE hydrolyzes circulating biologically active peptides, including enkephalin, cholecystokinin, neuropeptide Y, and substance P.","label":"Tanzi R et al.; A major peptidase responsible for the de...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:5e780071-196b-4b78-8110-fc583b1ff358"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2cc12c78-2449-4e0f-8ec1-b7dfedb151ec&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2cc12c78-2449-4e0f-8ec1-b7dfedb151ec","type":"Claim","title":"Soluble Aβ oligomers, not monomers or fibrils, interfere with synaptic plasticity.","label":"Hardy J et al.; Soluble Aβ oligomers, not monomers or fi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:2cc12c78-2449-4e0f-8ec1-b7dfedb151ec"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4c2369fb-5435-4471-8b86-70d7dba31b5d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4c2369fb-5435-4471-8b86-70d7dba31b5d","type":"Claim","title":"Beta amyloid burden in transgenic animal models can be attenuated by either peripheral or cerebral infusion of exogenous anti-Aβ antibodies (passive immunization) or by immunization with synthetic Aβ peptide.","label":"Tanzi R et al.; Beta amyloid burden in transgenic animal...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:4c2369fb-5435-4471-8b86-70d7dba31b5d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2dc11ccb-6c2a-4821-9d9d-423ada52d9c0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2dc11ccb-6c2a-4821-9d9d-423ada52d9c0","type":"Hypothesis","title":"Viruses and dementia, and the role of apolipoprotein (ApoE).","label":"Itzhaki R; Viruses and dementia, and the role of ap...","icon":"../icons/ontological/discourse-element/h-research-statement.png","firstAuthor":"Itzhaki R F","id":"urn:lsid:swan.org:researchstatement:2dc11ccb-6c2a-4821-9d9d-423ada52d9c0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3f483cd3-fdf9-4cee-99f0-7dc15f7d0767&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3f483cd3-fdf9-4cee-99f0-7dc15f7d0767","type":"Claim","title":"The intramembranous APP C-terminal fragments may be toxic in situ.","label":"Marchesi V; The intramembranous APP C-terminal fragm...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:3f483cd3-fdf9-4cee-99f0-7dc15f7d0767"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1198ed76-018b-41e8-841f-7d3eefc02f3e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1198ed76-018b-41e8-841f-7d3eefc02f3e","type":"Claim","title":"Internalized tau aggregates displace tubulin, co-localize with dextran, a marker of fluid-phase endocytosis, and induce fibrillization of intracellular full-length tau.","label":"Frost B et al.; Internalized tau aggregates displace tub...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Jacks Rachel L","Diamond Marc I"],"firstAuthor":"Frost Bess","referenceYear":"2009","referenceDate":"2009-05-08","id":"urn:lsid:swan.org:researchstatement:1198ed76-018b-41e8-841f-7d3eefc02f3e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1377bf42-dcf2-4ed9-af72-d59a1af84e0f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1377bf42-dcf2-4ed9-af72-d59a1af84e0f","type":"Hypothesis","title":"The catastrophic loss of cerebral neurons in Alzheimer disease is the result of an autoimmune process.","label":"D'Andrea M; The catastrophic loss of cerebral neuron...","icon":"../icons/ontological/discourse-element/h-research-statement.png","firstAuthor":"D'Andrea Michael R","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:1377bf42-dcf2-4ed9-af72-d59a1af84e0f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:23ceb403-fd1f-40e8-b046-b219dfb44160&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:23ceb403-fd1f-40e8-b046-b219dfb44160","type":"Claim","title":"A sporadic or hereditary primary dysfunction of the ubiquitin-proteasome system has been reported.","label":"Keck S et al.; A sporadic or hereditary primary dysfunc...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:23ceb403-fd1f-40e8-b046-b219dfb44160"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3524730c-5f91-48b7-9fc5-134f25a9c85d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3524730c-5f91-48b7-9fc5-134f25a9c85d","type":"Claim","title":"PS1 has 150+ known mutations that cause EOAD.","label":"Marchesi V; PS1 has 150+ known mutations that cause ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:3524730c-5f91-48b7-9fc5-134f25a9c85d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:09c7433c-b638-4946-b1fe-67eb1148f14d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:09c7433c-b638-4946-b1fe-67eb1148f14d","type":"Claim","title":"The prediction that reducing Aβ and plaques would ameliorate Alzheimer symptoms and the observation that Aβ immunization immediately ameliorated the subtle behavioral alterations in transgenic APP animals, interpreted as indicating that this prediction had been fulfilled in animals, was perhaps premature.","label":"Hardy ; The prediction that reducing Aβ and plaq...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Hardy","referenceYear":"2009","referenceDate":"2009-05-18","id":"urn:lsid:swan.org:researchstatement:09c7433c-b638-4946-b1fe-67eb1148f14d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:43204a59-434a-4c65-a83b-33176d835797&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:43204a59-434a-4c65-a83b-33176d835797","type":"Claim","title":"Intracellular cholesterol distribution regulates amyloidogenic APP processing.","label":"Intracellular cholesterol distribution r...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:43204a59-434a-4c65-a83b-33176d835797"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3526132b-6c51-457e-89b9-15e5ab81d6ae&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3526132b-6c51-457e-89b9-15e5ab81d6ae","type":"Claim","title":"At least some of presenilins effects on calcium signalling are due to the γ-secretase-dependent signalling pathway.","label":"Smith I et al.; At least some of presenilins effects on ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:3526132b-6c51-457e-89b9-15e5ab81d6ae"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2a019495-fae9-4d05-b775-6d2dafce6204&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2a019495-fae9-4d05-b775-6d2dafce6204","type":"Claim","title":"Genetic knock-out of aromatase in male APP23 mice, as a model to study the estrogen-independent effect of testosterone on AD-like neuropathology and on cognition, increases endogenous testosterone levels and decreases estrogen levels in serum and in the brain.","label":"McAllister C et al.; Genetic knock-out of aromatase in male A...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Long Jiangang","Bowers Adrienne","Walker Aaron","Cao Philip","Honda Shin-Ichiro","Harada Nobuhiro","Staufenbiel Matthias","Shen Yong","Li Rena"],"firstAuthor":"McAllister Carrie","referenceYear":"2010","referenceDate":"2010-05-26","id":"urn:lsid:swan.org:researchstatement:2a019495-fae9-4d05-b775-6d2dafce6204"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:52d7345c-aedd-4d91-827a-c770e9306cdd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:52d7345c-aedd-4d91-827a-c770e9306cdd","type":"Claim","title":"Nicastrin (Nct), anterior pharynx defective 1 (Aph-1), and presenilin enhancer 2 (Pen-2) are required for stability and activity of γ-secretase.","label":"Bentahir M et al.; Nicastrin (Nct), anterior pharynx defect...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:52d7345c-aedd-4d91-827a-c770e9306cdd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7be2e539-96d7-4a59-8f90-4951b73f6278&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7be2e539-96d7-4a59-8f90-4951b73f6278","type":"Claim","title":"The prevalence of late-onset AD (LOAD) doubles with every decade after age 60 and reaches 50% of individuals older than 85.","label":"The prevalence of late-onset AD (LOAD) d...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:7be2e539-96d7-4a59-8f90-4951b73f6278"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5dedc364-9c45-4bf1-ae28-ad0d444f315f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5dedc364-9c45-4bf1-ae28-ad0d444f315f","type":"Claim","title":"Noncross-linked Aβ42 appears as spheroid 5 nm diameter structures in EM morphologic analysis, and cross-linking of this material results in chains with a higher variability in diameter (up to 30 nm).","label":"Bitan G et al.; Noncross-linked Aβ42 appears as spheroid...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:5dedc364-9c45-4bf1-ae28-ad0d444f315f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0b54b09b-cebb-4199-8cc4-239942e836fb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0b54b09b-cebb-4199-8cc4-239942e836fb","type":"Claim","title":"As opposed to >50 kDa oligomers, monomers of Aβ42 were not toxic to pure cultures of rat cortical neurons, but rather increased the expression of the antiapoptotic protein, Bcl-2.","label":"Giuffrida M et al.; As opposed to >50 kDa oligomers, monomer...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Caraci Filippo","Pignataro Bruno","Cataldo Sebastiano","De Bona Paolo","Bruno Valeria","Molinaro Gemma","Pappalardo Giuseppe","Messina Angela","Palmigiano Angelo","Garozzo Domenico","Nicoletti Ferdinando","Rizzarelli Enrico","Copani Agata"],"firstAuthor":"Giuffrida Maria Laura","referenceYear":"2009","referenceDate":"2009-08-26","id":"urn:lsid:swan.org:researchstatement:0b54b09b-cebb-4199-8cc4-239942e836fb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3579e8bd-5c7b-43f9-a651-1354298ad1b1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3579e8bd-5c7b-43f9-a651-1354298ad1b1","type":"Claim","title":"A high-fidelity extraction procedure allowed quantification and comparison of four independent pools of transgene-derived Aβ peptides.","label":"Lesné S et al.; A high-fidelity extraction procedure all...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Koh Ming Teng","Kotilinek Linda","Kayed Rakez","Glabe Charles G","Yang Austin","Gallagher Michela","Ashe Karen H"],"firstAuthor":"Lesné Sylvain","referenceYear":"2006","referenceDate":"2006-03-16","id":"urn:lsid:swan.org:researchstatement:3579e8bd-5c7b-43f9-a651-1354298ad1b1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f62e826e-da29-4606-b5ca-af4ef51552c5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f62e826e-da29-4606-b5ca-af4ef51552c5","type":"Claim","title":"SIRT1 regulates CREB through miR-134 transcriptional regulation.","label":"Gao J et al.; SIRT1 regulates CREB through miR-134 tra...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wang Wen-Yuan","Mao Ying-Wei","Gräff Johannes","Guan Ji-Song","Pan Ling","Mak Gloria","Kim Dohoon","Su Susan C","Tsai Li-Huei"],"firstAuthor":"Gao Jun","referenceYear":"2010","referenceDate":"2010-07-11","id":"urn:lsid:swan.org:researchstatement:f62e826e-da29-4606-b5ca-af4ef51552c5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:08a31275-efce-4875-8705-cbb88a6df923&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:08a31275-efce-4875-8705-cbb88a6df923","type":"Claim","title":"In the absence of ApoE, Aβ accumulates mostly in diffuse deposits.","label":"Golde T; In the absence of ApoE, Aβ accumulates m...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde Todd E","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:08a31275-efce-4875-8705-cbb88a6df923"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b850abf4-5545-48f5-94b2-d32585e27c69&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b850abf4-5545-48f5-94b2-d32585e27c69","type":"Claim","title":"ApoE4 allele frequency in a population of AD patients was 50% compared to 15% in a control population.","label":"Holtzman D; ApoE4 allele frequency in a population o...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:b850abf4-5545-48f5-94b2-d32585e27c69"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bd6f847a-e67a-47b1-bb23-09a7db7f0629&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bd6f847a-e67a-47b1-bb23-09a7db7f0629","type":"Claim","title":"THOP1 is primarily present in tissues rich in neuropeptides and hormones, suggesting a role in the processing of bioactive peptides.  ","label":"Pollio G et al.; THOP1 is primarily present in tissues ri...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hoozemans Jeroen J","Andersen Claus A","Roncarati Renza","Rosi Maria Cristina","van Haastert Elise S","Seredenina Tamara","Diamanti Daniela","Gotta Stefano","Fiorentini Anna","Magnoni Letizia","Raggiaschi Roberto","Rozemuller Annemieke J","Casamenti Fiorella","Caricasole Andrea","Terstappen Georg C"],"firstAuthor":"Pollio Giuseppe","referenceYear":"2008","referenceDate":"2008-07","id":"urn:lsid:swan.org:researchstatement:bd6f847a-e67a-47b1-bb23-09a7db7f0629"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:45fba0b2-8a5c-4ef5-b7eb-a609fb6df240&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:45fba0b2-8a5c-4ef5-b7eb-a609fb6df240","type":"Claim","title":"A comparison of untreated or sham-treated T44 tau overexpressing mice to wild-type mice demonstrated a similar fast transport rate.","label":"Nixon R; A comparison of untreated or sham-treate...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Nixon Ralph A","id":"urn:lsid:swan.org:researchstatement:45fba0b2-8a5c-4ef5-b7eb-a609fb6df240"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:28bf7fef-69af-483b-bb6c-0aa4e28f2dff&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:28bf7fef-69af-483b-bb6c-0aa4e28f2dff","type":"Claim","title":"Amyloidogenic processing to produce endogenous Aβ is linked to regulation of Ca2+ signaling.","label":"Plant L et al.; Amyloidogenic processing to produce endo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:28bf7fef-69af-483b-bb6c-0aa4e28f2dff"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c44cff9b-3051-48c0-9e0a-c64d45c43b90&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c44cff9b-3051-48c0-9e0a-c64d45c43b90","type":"Claim","title":"Tubulin-binding repeats bind to specific pockets in β-tubulin at the inner surface of the MTs, whereas the positively charged proline-rich regions are tightly bound to the negatively charged MT-surface, and the negatively charged projection domain branches away from the MT-surface, possibly owing to electrostatic repulsion.  ","label":"Ballatore C et al.; Tubulin-binding repeats bind to specific...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Lee Virginia M-Y","Trojanowski John Q"],"firstAuthor":"Ballatore Carlo","referenceYear":"2007","referenceDate":"2007-09","id":"urn:lsid:swan.org:researchstatement:c44cff9b-3051-48c0-9e0a-c64d45c43b90"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0d1f680f-12c3-4e30-82d2-a3ffe06690bf&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0d1f680f-12c3-4e30-82d2-a3ffe06690bf","type":"Claim","title":"Statistically significant increased I<sub>KA<\/sub> current is also observed in cells preincubated with Aβ for 24 h, but not after 48 h.","label":"Plant L et al.; Statistically significant increased I<su...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:0d1f680f-12c3-4e30-82d2-a3ffe06690bf"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d25130c2-cbb2-417b-82ac-877abf4c001d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d25130c2-cbb2-417b-82ac-877abf4c001d","type":"Claim","title":"An Aβ/m266 complex was readily detected in CSF only at the two highest doses of m266 (250 μg and 360 μg) shown to be effective in the object recognition memory task.","label":"Dodart J et al.; An Aβ/m266 complex was readily detected ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:d25130c2-cbb2-417b-82ac-877abf4c001d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:1739e803-7e3d-4f21-aa5b-f09fc3b1676e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:1739e803-7e3d-4f21-aa5b-f09fc3b1676e","type":"Question","title":"There may be compensatory mechanisms operating in vivo that mitigate the effects of tau on axonal transport seen at the molecular level.","label":"There may be compensatory mechanisms ope...","icon":"../icons/ontological/discourse-element/research-question.png","firstAuthor":"Holzbaur Erika L F","id":"urn:lsid:swan.org:researchquestion:1739e803-7e3d-4f21-aa5b-f09fc3b1676e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d1bdeb4b-550f-4f35-93ad-6cafdc1b7185&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d1bdeb4b-550f-4f35-93ad-6cafdc1b7185","type":"Claim","title":"In less than an hour, ADDLs disrupt LTP.","label":"Lambert M et al.; In less than an hour, ADDLs disrupt LTP.","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:d1bdeb4b-550f-4f35-93ad-6cafdc1b7185"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8ac38ea6-2439-4233-ba01-ba84377c4f2a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8ac38ea6-2439-4233-ba01-ba84377c4f2a","type":"Claim","title":"Physiological temperatures favor accumulation of 12-mer in synthetic preparations, which was most abundant in solublilized AD brain extracts.","label":"Gong Y et al.; Physiological temperatures favor accumul...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:8ac38ea6-2439-4233-ba01-ba84377c4f2a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:20819d87-242d-40a8-bc07-fa0c2953f3da&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:20819d87-242d-40a8-bc07-fa0c2953f3da","type":"Claim","title":"It has been postulated that abnormal processing of APP to Aβ, or reduced clearance of Aβ from brain, resulting in the parenchymal aggregation of Aβ to form amyloid deposits is an early and crucial event in the pathogenesis of the disease","label":"It has been postulated that abnormal pro...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:20819d87-242d-40a8-bc07-fa0c2953f3da"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:844d19b7-6ad4-4a07-880c-a125c904c91b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:844d19b7-6ad4-4a07-880c-a125c904c91b","type":"Question","title":"It will be important to know whether NMDA receptor surface expression is increased in APP α7KO mice and whether such an increase might underlie the synaptoprotective effect of α7nAChR deletion in APP transgenic mice. ","label":"It will be important to know whether NMD...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:844d19b7-6ad4-4a07-880c-a125c904c91b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1c047c2e-5150-4ee1-a03b-cd036869eba3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1c047c2e-5150-4ee1-a03b-cd036869eba3","type":"Claim","title":"The Aβ-degrading activity of THOP1 appears to be indirect and therefore independent of its secretase activity possibly via activation of a distinct serine protease which remains to be identified.","label":"Pollio G et al.; The Aβ-degrading activity of THOP1 appea...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hoozemans Jeroen J","Andersen Claus A","Roncarati Renza","Rosi Maria Cristina","van Haastert Elise S","Seredenina Tamara","Diamanti Daniela","Gotta Stefano","Fiorentini Anna","Magnoni Letizia","Raggiaschi Roberto","Rozemuller Annemieke J","Casamenti Fiorella","Caricasole Andrea","Terstappen Georg C"],"firstAuthor":"Pollio Giuseppe","referenceYear":"2008","referenceDate":"2008-07","id":"urn:lsid:swan.org:researchstatement:1c047c2e-5150-4ee1-a03b-cd036869eba3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:779e2215-e362-486f-b23c-21d467668ed2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:779e2215-e362-486f-b23c-21d467668ed2","type":"Claim","title":"An alternative therapeutic strategy may be to develop a pharmacological means for preventing the influx of plasma Aβ back into brain via RAGE by specifically blocking this interaction.","label":"Tanzi R et al.; An alternative therapeutic strategy may ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:779e2215-e362-486f-b23c-21d467668ed2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f1cf145f-5ae7-4e61-a31e-38fd9763b667&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f1cf145f-5ae7-4e61-a31e-38fd9763b667","type":"Claim","title":"The PI-3-K inhibitor LY294002 reduced the rescuing effect of Aβ42 monomers on insulin-deprived neurons.","label":"Giuffrida M et al.; The PI-3-K inhibitor LY294002 reduced th...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Caraci Filippo","Pignataro Bruno","Cataldo Sebastiano","De Bona Paolo","Bruno Valeria","Molinaro Gemma","Pappalardo Giuseppe","Messina Angela","Palmigiano Angelo","Garozzo Domenico","Nicoletti Ferdinando","Rizzarelli Enrico","Copani Agata"],"firstAuthor":"Giuffrida Maria Laura","referenceYear":"2009","referenceDate":"2009-08-26","id":"urn:lsid:swan.org:researchstatement:f1cf145f-5ae7-4e61-a31e-38fd9763b667"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3102a26a-db24-4904-9a79-5fbcba079738&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3102a26a-db24-4904-9a79-5fbcba079738","type":"Claim","title":"The concept of dimeric Aβ persisting in membranes differs from widely held view that Aβ is released into extracellular space to form oligomers and fibrils.","label":"Marchesi V; The concept of dimeric Aβ persisting in ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:3102a26a-db24-4904-9a79-5fbcba079738"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:26689e7d-bc99-4325-9f92-a4f4663e26c1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:26689e7d-bc99-4325-9f92-a4f4663e26c1","type":"Claim","title":"A model of cellular toxicity mediated by APP dimerization has been proposed.","label":"Koo E; A model of cellular toxicity mediated by...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Koo Edward H","id":"urn:lsid:swan.org:researchstatement:26689e7d-bc99-4325-9f92-a4f4663e26c1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6f77eceb-1f73-4e6b-8393-52ef9ea22b8a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6f77eceb-1f73-4e6b-8393-52ef9ea22b8a","type":"Claim","title":"The pharmacological manipulation of Tissue-transglutaminase could be a therapeutic strategy for slowing or blocking the progress of AD.","label":"Hartley D et al.; The pharmacological manipulation of Tiss...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:6f77eceb-1f73-4e6b-8393-52ef9ea22b8a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f46dc3cc-85f8-411c-9003-5ceb3f624e59&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f46dc3cc-85f8-411c-9003-5ceb3f624e59","type":"Claim","title":"Aβ40 treated with Tissue-transglutaminase inhibited LTP at 100 nM Aβ40, but not when Aβ or Tissue-transglutaminase were applied individually.","label":"Hartley D et al.; Aβ40 treated with Tissue-transglutaminas...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:f46dc3cc-85f8-411c-9003-5ceb3f624e59"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5cbba601-f0bd-4a99-8020-e4835e679569&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5cbba601-f0bd-4a99-8020-e4835e679569","type":"Claim","title":"Various members of the Bcl-2 protein family can regulate the survival or death of cells.","label":"Cotman C et al.; Various members of the Bcl-2 protein fam...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:5cbba601-f0bd-4a99-8020-e4835e679569"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0b10a16f-a720-4ced-a298-dcce8c095232&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0b10a16f-a720-4ced-a298-dcce8c095232","type":"Claim","title":"Members of a family of protein kinases, initially identified as being associated with regulation of the cell cycle, have important functions in adult brain.","label":"Suzuki T et al.; Members of a family of protein kinases, ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:0b10a16f-a720-4ced-a298-dcce8c095232"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:84d02b39-c1e4-438b-b217-e72a7f5abf41&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:84d02b39-c1e4-438b-b217-e72a7f5abf41","type":"Claim","title":"Low-density lipoprotein receptor (LDLR), very low-density lipoprotein receptor (VLDLR), LR8/apoER2, and LR11/SorLA-1 are known apoE receptors that are expressed in the brain that could contribute to Aβ clearance.","label":"Holtzman D; Low-density lipoprotein receptor (LDLR),...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:84d02b39-c1e4-438b-b217-e72a7f5abf41"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:63b416f5-579e-4504-bac6-82ae87358aa2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:63b416f5-579e-4504-bac6-82ae87358aa2","type":"Claim","title":"Clinical mutations of Ps are associated with partial loss of function.","label":"Bentahir M et al.; Clinical mutations of Ps are associated ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:63b416f5-579e-4504-bac6-82ae87358aa2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fb4b64b6-3c41-4ae7-9d81-5bddd5ba17b5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fb4b64b6-3c41-4ae7-9d81-5bddd5ba17b5","type":"Claim","title":"BACE1-generated production of either Aβ peptide itself, or a soluble Aβ aggregate, is responsible for the induction of neuronal cell cycle events (CCEs).","label":"Varvel N et al.; BACE1-generated production of either Aβ ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bhaskar Kiran","Patil Anita R","Pimplikar Sanjay W","Herrup Karl","Lamb Bruce T"],"firstAuthor":"Varvel Nicholas H","referenceYear":"2008","referenceDate":"2008-10-22","id":"urn:lsid:swan.org:researchstatement:fb4b64b6-3c41-4ae7-9d81-5bddd5ba17b5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:49cb5698-ff87-49a6-b00b-83968dd6df28&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:49cb5698-ff87-49a6-b00b-83968dd6df28","type":"Hypothesis","title":"APP misprocessing causes Alzheimer disease.","label":"Wong C et al.; APP misprocessing causes Alzheimer disea...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Quaranta V","Glenner G G"],"firstAuthor":"Wong C W","referenceYear":"1985","referenceDate":"1985-12","id":"urn:lsid:swan.org:researchstatement:49cb5698-ff87-49a6-b00b-83968dd6df28"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:86de45d6-4a50-4eb9-8707-296500c25917&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:86de45d6-4a50-4eb9-8707-296500c25917","type":"Claim","title":"Single oral administration of two doses of the CNS-penetrant γ-secretase inhibitor (GSI), MK-0752 in healthy male CMP rhesus monkeys demonstrate a dose-related reduction of Aβ40 levels in plasma and CSF Aβ40 and Aβ42 followed by Aβ rebound above baseline in plasma but not in CSF.  ","label":"Cook J et al.; Single oral administration of two doses ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wildsmith Kristin R","Gilberto David B","Holahan Marie A","Kinney Gene G","Mathers Parker D","Michener Maria S","Price Eric A","Shearman Mark S","Simon Adam J","Wang Jennifer X","Wu Guoxin","Yarasheski Kevin E","Bateman Randall J"],"firstAuthor":"Cook Jacquelynn J","referenceYear":"2010","referenceDate":"2010-05-12","id":"urn:lsid:swan.org:researchstatement:86de45d6-4a50-4eb9-8707-296500c25917"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0f651beb-1c3c-41b3-9f9a-363e0d24d55a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0f651beb-1c3c-41b3-9f9a-363e0d24d55a","type":"Hypothesis","title":"Frameshift mutation of APP, Ubiquitin is likely an important factor in nonfamilial early- and late-onset forms of Alzheimer disease.","label":"van Leeuwen F et al.; Frameshift mutation of APP, Ubiquitin is...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["de Kleijn D P","van den Hurk H H","Neubauer A","Sonnemans M A","Sluijs J A","Köycü S","Ramdjielal R D","Salehi A","Martens G J","Grosveld F G","Peter J","Burbach H","Hol E M"],"firstAuthor":"van Leeuwen F W","referenceYear":"1998","referenceDate":"1998-01-09","id":"urn:lsid:swan.org:researchstatement:0f651beb-1c3c-41b3-9f9a-363e0d24d55a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7972a36d-1848-4631-8b9f-4cb0647c91f3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7972a36d-1848-4631-8b9f-4cb0647c91f3","type":"Claim","title":"Exogenous application of 100 nM Aβ peptides mimics calcium channel formation demonstrating whole cell currents through these calcium channels that were small but voltage dependent.","label":"Smith I et al.; Exogenous application of 100 nM Aβ pepti...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:7972a36d-1848-4631-8b9f-4cb0647c91f3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ccc18b5e-4f37-4a31-b787-ebf0b1709e30&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ccc18b5e-4f37-4a31-b787-ebf0b1709e30","type":"Claim","title":"A&#946;*56 is responsible for memory loss in Tg2576 mice.","label":"Lesné S et al.; A&#946;*56 is responsible for memory los...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Koh Ming Teng","Kotilinek Linda","Kayed Rakez","Glabe Charles G","Yang Austin","Gallagher Michela","Ashe Karen H"],"firstAuthor":"Lesné Sylvain","referenceYear":"2006","referenceDate":"2006-03-16","id":"urn:lsid:swan.org:researchstatement:ccc18b5e-4f37-4a31-b787-ebf0b1709e30"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:72c8438c-6786-48d3-9474-1bca8a6c553b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:72c8438c-6786-48d3-9474-1bca8a6c553b","type":"Claim","title":"Transgenic mice expressing different mutant PS1 in the absence of human APP mutations, do not develop amyloid-β plaques and also do not exhibit any appreciable calcium overload compared to their respective controls.  These data suggest that calcium overload requires mutant APP processing and amyloid-β aggregates.","label":"Kuchibhotla K et al.; Transgenic mice expressing different mut...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Goldman Samuel T","Lattarulo Carli R","Wu Hai-Yan","Hyman Bradley T","Bacskai Brian J"],"firstAuthor":"Kuchibhotla Kishore V","referenceYear":"2008","referenceDate":"2008-07-31","id":"urn:lsid:swan.org:researchstatement:72c8438c-6786-48d3-9474-1bca8a6c553b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:df9933fa-826b-456d-92a4-21e02be7f0e2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:df9933fa-826b-456d-92a4-21e02be7f0e2","type":"Claim","title":"Amyloid increases through Aβ concentration-dependent seeded polymerization.","label":"Golde T; Amyloid increases through Aβ concentrati...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde T","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:df9933fa-826b-456d-92a4-21e02be7f0e2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c4142bfb-e85e-4ea6-b5f7-61feca31feb8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c4142bfb-e85e-4ea6-b5f7-61feca31feb8","type":"Claim","title":"Approximately 20\u201340% of cognitively normal elderly people have evidence of significant brain Aβ-plaque deposition, either from amyloid imaging or CSF Aβ42 concentrations.","label":"Jack C et al.; Approximately 20\u201340% of cognitively norm...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:c4142bfb-e85e-4ea6-b5f7-61feca31feb8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2d3d9a90-8e54-4aef-8e3e-d84aba7eb388&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2d3d9a90-8e54-4aef-8e3e-d84aba7eb388","type":"Claim","title":"ApoE\u2013Aβ complexes may be transported from brain parenchymal tissue to interstitial fluid drainage pathways in which they bind to apoE-binding molecules, and the local environment promotes the fibrillogenesis of Aβ.","label":"Fryer J et al.; ApoE\u2013Aβ complexes may be transported fro...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:2d3d9a90-8e54-4aef-8e3e-d84aba7eb388"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b5eb8750-723e-42c6-a77d-964648902a3c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b5eb8750-723e-42c6-a77d-964648902a3c","type":"Hypothesis","title":"Disruption of glial cellular function.","label":"Brenner S; Disruption of glial cellular function.","icon":"../icons/ontological/discourse-element/h-research-statement.png","firstAuthor":"Brenner Steven","id":"urn:lsid:swan.org:researchstatement:b5eb8750-723e-42c6-a77d-964648902a3c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:28398ee9-52a7-420d-a429-97f3c865c38a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:28398ee9-52a7-420d-a429-97f3c865c38a","type":"Hypothesis","title":"The α4 (CHRNΑ4) and β2 (CHRNΒ2) neuronal nicotinic acetylcholine receptor subunit genes may be involved in impaired neuronal survival and the cholinergic system deficits that are evident in AD.","label":"Cook L et al.; The α4 (CHRNΑ4) and β2 (CHRNΒ2) neuronal...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Ho Luk W","Taylor Alison E","Brayne Carol","Evans John Grimley","Xuereb John","Cairns Nigel J","Pritchard Antonia","Lemmon Helen","Mann David","St Clair David","Turic Dragana","Hollingworth Paul","Moore Pamela J","Jehu Luke","Archer Nicola","Walter Sarah","Foy Catherine","Edmondson Amanda","Powell John","Lovestone Simon","Owen Michael J","Williams Julie","Lendon Corinne","Rubinsztein David C"],"firstAuthor":"Cook Lynnette J","referenceYear":"2004","referenceDate":"2004-03-25","id":"urn:lsid:swan.org:researchstatement:28398ee9-52a7-420d-a429-97f3c865c38a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7d312dab-3838-41b3-ba22-3bae398b838a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7d312dab-3838-41b3-ba22-3bae398b838a","type":"Hypothesis","title":"BACE 1 regulates sodium channels and neuronal activity.","label":"Kim D et al.; BACE 1 regulates sodium channels and neu...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Carey Bryce W","Wang Haibin","Ingano Laura A","Binshtok Alexander M","Wertz Mary H","Pettingell Warren H","He Ping","Lee Virginia M-Y","Woolf Clifford J","Kovacs Dora M"],"firstAuthor":"Kim Doo Yeon","referenceYear":"2007","referenceDate":"2007-07","id":"urn:lsid:swan.org:researchstatement:7d312dab-3838-41b3-ba22-3bae398b838a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:57ab7e37-8e36-4fcc-ae49-72b012690434&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:57ab7e37-8e36-4fcc-ae49-72b012690434","type":"Comment","title":"T Bayer on Marchesi","label":"Bayer T; T Bayer on Marchesi","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Bayer T A","referenceYear":"2005","referenceDate":"2005-09-03","id":"urn:lsid:swan.org:comment:57ab7e37-8e36-4fcc-ae49-72b012690434"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4a1c413b-693e-450a-b2ab-efe59eb8437b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4a1c413b-693e-450a-b2ab-efe59eb8437b","type":"Claim","title":"AD-causing APP mutations all localize near or at proteolytic cleavage sites of α-, β- or γ-secretases, and the mutations induce biochemical changes related to AD by either enhancing proteolysis of APP to promote Aβ generation and/or enhancing the aggregation of the Aβ peptides after their generation.","label":"Hardy J et al.; AD-causing APP mutations all localize ne...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:4a1c413b-693e-450a-b2ab-efe59eb8437b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:58c8fa7f-95fd-49cd-9495-a2c3576ab0cf&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:58c8fa7f-95fd-49cd-9495-a2c3576ab0cf","type":"Claim","title":"FAD-linked PS mutations have been reported to cause a variable but general impairment of \u2018\u2018presenilinase\u2019\u2019 activity although the functional significance of deficient presenilinase activity is unclear, as PS1 mutants (e.g., del exon9) refractory to endoproteolysis still support γ-secretase activity.","label":"Shen J et al.; FAD-linked PS mutations have been report...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:58c8fa7f-95fd-49cd-9495-a2c3576ab0cf"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f98b9edf-460b-47bc-acda-86e655d6ad72&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f98b9edf-460b-47bc-acda-86e655d6ad72","type":"Hypothesis","title":"Glutamate toxicity may play a role in the pathogenesis of Alzheimer disease.","label":"Greenamyre J et al.; Glutamate toxicity may play a role in th...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Maragos W F","Albin R L","Penney J B","Young A B"],"firstAuthor":"Greenamyre J T","referenceYear":"1988","referenceDate":"1988","id":"urn:lsid:swan.org:researchstatement:f98b9edf-460b-47bc-acda-86e655d6ad72"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7a2e75de-5eec-4cd3-a126-5aacd7893c1c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7a2e75de-5eec-4cd3-a126-5aacd7893c1c","type":"Claim","title":"The calculated peak and front rates for p135 were 12 and >38.4 mm/d, respectively, whereas the calculated peak and front rates for snap25 were 16.8 and >38.4 mm/d, respectively, in both 8c tau overexpressing and wild-type mouse optical neurons.","label":"Yuan A et al.; The calculated peak and front rates for ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:7a2e75de-5eec-4cd3-a126-5aacd7893c1c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3de2dc22-afa1-4259-82be-d8d4fd79e532&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3de2dc22-afa1-4259-82be-d8d4fd79e532","type":"Hypothesis","title":"The cognitive deficits of early Alzheimer Disease are caused by the disruption of electrical activity and information processing in dendrites of cortical pyramidal neurons.","label":"Morse T et al.; The cognitive deficits of early Alzheime...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Mutalik Pradeep","Cheung Kei","Miller Perry L","Shepherd Gordon"],"firstAuthor":"Morse Thomas M","id":"urn:lsid:swan.org:researchstatement:3de2dc22-afa1-4259-82be-d8d4fd79e532"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d03c631b-b2d1-4922-b575-13e9ca8b773b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d03c631b-b2d1-4922-b575-13e9ca8b773b","type":"Claim","title":"TdT labeling detection of DNA damage could be used as one of the earliest markers of neuronal abnormality in AD brain, and correspondingly, reflect an increased vulnerability of neuronal cells to insult.","label":"Cotman C et al.; TdT labeling detection of DNA damage cou...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:d03c631b-b2d1-4922-b575-13e9ca8b773b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c5fa3d8b-681b-4ed5-b270-007f3fae1373&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c5fa3d8b-681b-4ed5-b270-007f3fae1373","type":"Claim","title":"Once triggered by the proteinopathy, senescent changes are likely to be both self-reinforcing and irreversible in both an autocrine fashion in which inflammatory mediators secreted by the senescent neurons and glia would help to maintain the senescent state and also in a paracrine fashion, senescent cells induce additional inflammation and senescence of neighboring cells.","label":"Golde T et al.; Once triggered by the proteinopathy, sen...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:c5fa3d8b-681b-4ed5-b270-007f3fae1373"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6f7f9e27-0066-4abf-9fe3-29d412142341&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6f7f9e27-0066-4abf-9fe3-29d412142341","type":"Claim","title":"APP phosphorylation at Thr668 regulates another function of APP, the interaction of APP with neuronal Fe65, or intracellular trafficking, rather than direct regulation of APP metabolism.","label":"Suzuki T; APP phosphorylation at Thr668 regulates ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Suzuki Toshiharu","id":"urn:lsid:swan.org:researchstatement:6f7f9e27-0066-4abf-9fe3-29d412142341"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3b8be781-1f65-4318-9a47-67420496b2dd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3b8be781-1f65-4318-9a47-67420496b2dd","type":"Claim","title":"The low-density lipoprotein receptor-related protein (LRP) and the receptor for advanced glycation end products (RAGE) are involved in receptor-mediated flux of Aβ across the blood brain barrier (BBB).","label":"Tanzi R et al.; The low-density lipoprotein receptor-rel...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:3b8be781-1f65-4318-9a47-67420496b2dd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:03844ad2-c07e-4174-b58c-346b1fb09ac5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:03844ad2-c07e-4174-b58c-346b1fb09ac5","type":"Claim","title":"Inhibition of GSK-3β promotes cell survival through a variety of mechanisms including a reduced degradation of β-catenin, which translocates into the nucleus and activates the transcription of protective genes.","label":"Giuffrida M et al.; Inhibition of GSK-3β promotes cell survi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Caraci Filippo","Pignataro Bruno","Cataldo Sebastiano","De Bona Paolo","Bruno Valeria","Molinaro Gemma","Pappalardo Giuseppe","Messina Angela","Palmigiano Angelo","Garozzo Domenico","Nicoletti Ferdinando","Rizzarelli Enrico","Copani Agata"],"firstAuthor":"Giuffrida Maria Laura","referenceYear":"2009","referenceDate":"2009-08-26","id":"urn:lsid:swan.org:researchstatement:03844ad2-c07e-4174-b58c-346b1fb09ac5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:67c79220-feac-495c-86f0-35295831be53&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:67c79220-feac-495c-86f0-35295831be53","type":"Claim","title":"There was no evidence of a difference in decline over the 6-year follow-up period for any of the outcome measures used between the AN1792 treatment group and the placebo group, including ADAS-Cog score, MMSE score, or DAD score.","label":"Holmes C et al.; There was no evidence of a difference in...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:67c79220-feac-495c-86f0-35295831be53"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5c5503b2-b362-43c1-8052-2c94876986aa&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5c5503b2-b362-43c1-8052-2c94876986aa","type":"Claim","title":"Tg2576 mice have a slower progression of disease than B6C3-YFP mice, but confirmed the rapidity of plaque development as demonstrated in the B6C3-YFP mice.","label":"Meyer-Luehmann M et al.; Tg2576 mice have a slower progression of...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:5c5503b2-b362-43c1-8052-2c94876986aa"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ae7d9fdc-fbaf-4903-b5e0-0c2b68070c15&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ae7d9fdc-fbaf-4903-b5e0-0c2b68070c15","type":"Claim","title":"The calculated peak and front rates for p135 were 12 and >38.4 mm/d, respectively, whereas the calculated peak and front rates for soluble snap25, a vesicle marker and the most heavily labeled fast transport marker, were 16.8 and >38.4 mm/d, respectively, in both tau-null and wild-type.","label":"Yuan A et al.; The calculated peak and front rates for ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:ae7d9fdc-fbaf-4903-b5e0-0c2b68070c15"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5f42953a-3d37-49d2-abf8-f2b6d4330858&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5f42953a-3d37-49d2-abf8-f2b6d4330858","type":"Claim","title":"There were no differences in brain cholesterol in mice expressing murine apoE or human apoE3 or apoE4, suggesting that apoE isoform and species did not influence brain cholesterol to somehow influence Aβ.","label":"Fryer J et al.; There were no differences in brain chole...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:5f42953a-3d37-49d2-abf8-f2b6d4330858"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4403157a-b4cd-4e49-a933-c2e422685233&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4403157a-b4cd-4e49-a933-c2e422685233","type":"Claim","title":"AcylCoA:cholesterol acyltransferase (ACAT) modulates generation of Aβ.","label":"AcylCoA:cholesterol acyltransferase (ACA...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:4403157a-b4cd-4e49-a933-c2e422685233"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7d818cc0-ed2d-4721-9b64-f8c1b3fb2804&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7d818cc0-ed2d-4721-9b64-f8c1b3fb2804","type":"Claim","title":"Because the first ectopic cell cycle alterations are observed 6\u20138 months before the onset of Aβ deposition, these data indicate that deposition is not itself the insult necessary for neuronal cell cycle re-entry.","label":"Varvel N et al.; Because the first ectopic cell cycle alt...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bhaskar Kiran","Patil Anita R","Pimplikar Sanjay W","Herrup Karl","Lamb Bruce T"],"firstAuthor":"Varvel Nicholas H","referenceYear":"2008","referenceDate":"2008-10-22","id":"urn:lsid:swan.org:researchstatement:7d818cc0-ed2d-4721-9b64-f8c1b3fb2804"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:35d62fd9-cbfd-455a-8d31-6409ab5fb62d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:35d62fd9-cbfd-455a-8d31-6409ab5fb62d","type":"Hypothesis","title":"Transglutaminase induces protofibril-like amyloid β-protein assemblies that are protease resistant and inhibit long-term potentiation.","label":"Hartley D et al.; Transglutaminase induces protofibril-lik...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:35d62fd9-cbfd-455a-8d31-6409ab5fb62d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0304f93b-7514-43f0-a23d-8002886ed147&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0304f93b-7514-43f0-a23d-8002886ed147","type":"Claim","title":"Abnormal accumulation of Aβ is the common pathogenic event that occurs in all forms of AD.","label":"Abnormal accumulation of Aβ is the commo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:0304f93b-7514-43f0-a23d-8002886ed147"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:528e283f-5ae9-4ce0-af76-a1da96b5f7eb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:528e283f-5ae9-4ce0-af76-a1da96b5f7eb","type":"Claim","title":"Human neuroblastoma cells overexpressing α7nicotinic acetylcholine receptor are killed by Aβ42, whereas alpha-7nAChR agonists protected the cells.","label":"Dziewczapolski G et al.; Human neuroblastoma cells overexpressing...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Glogowski Carolina M","Masliah Eliezer","Heinemann Stephen F"],"firstAuthor":"Dziewczapolski Gustavo","referenceYear":"2009","referenceDate":"2009-07-08","id":"urn:lsid:swan.org:researchstatement:528e283f-5ae9-4ce0-af76-a1da96b5f7eb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:acd1bc67-6c00-4a29-97de-bda0dc7aead2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:acd1bc67-6c00-4a29-97de-bda0dc7aead2","type":"Claim","title":"Soluble Aβ from Alzheimer\u2019s Disease cortex inhibit LTP in mouse hippocampus.","label":"Shankar G et al.; Soluble Aβ from Alzheimer\u2019s Disease cort...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Li Shaomin","Mehta Tapan H","Garcia-Munoz Amaya","Shepardson Nina E","Smith Imelda","Brett Francesca M","Farrell Michael A","Rowan Michael J","Lemere Cynthia A","Regan Ciaran M","Walsh Dominic M","Sabatini Bernardo L","Selkoe Dennis J"],"firstAuthor":"Shankar Ganesh M","referenceYear":"2008","referenceDate":"2008-08","id":"urn:lsid:swan.org:researchstatement:acd1bc67-6c00-4a29-97de-bda0dc7aead2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bec9d6b0-f163-4b3d-90dd-129e60cf5c4c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bec9d6b0-f163-4b3d-90dd-129e60cf5c4c","type":"Claim","title":"ApoE has been shown to be critically important for the formation of fibrillar Aβ in brain parenchyma and CAA in vivo.","label":"Fryer J et al.; ApoE has been shown to be critically imp...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:bec9d6b0-f163-4b3d-90dd-129e60cf5c4c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:eb658d9c-1cc1-467c-afe0-12834384d6df&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:eb658d9c-1cc1-467c-afe0-12834384d6df","type":"Claim","title":"Elevated Aβ42 production caused by PS mutations may represent a symptom of a \u2018\u2018sick\u2019\u2019 and otherwise impaired γ-secretase.","label":"Shen J et al.; Elevated Aβ42 production caused by PS mu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:eb658d9c-1cc1-467c-afe0-12834384d6df"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a4348651-7600-4a10-bf53-5cc05a5ec641&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a4348651-7600-4a10-bf53-5cc05a5ec641","type":"Claim","title":"Recent studies have revealed a remarkable connection between inflammatory mediators and replicative senescence.","label":"Golde T et al.; Recent studies have revealed a remarkabl...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:a4348651-7600-4a10-bf53-5cc05a5ec641"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:21c82d3b-6fbe-4873-b00a-410d86cb7c7b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:21c82d3b-6fbe-4873-b00a-410d86cb7c7b","type":"Claim","title":"Neurofibrillary degeneration increases with age and predate amyloid plaques.","label":"Hardy J et al.; Neurofibrillary degeneration increases w...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:21c82d3b-6fbe-4873-b00a-410d86cb7c7b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:45582f4d-a777-4ef1-9590-88bd97bb26d3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:45582f4d-a777-4ef1-9590-88bd97bb26d3","type":"Claim","title":"Dephosphorylation of downstream substrates of GSK such as glycogen synthase and eukaryotic protein synthesis initiation factor-2B (eIF-2B) elicits an increase in glycogen and protein synthesis.","label":"Hooper C et al.; Dephosphorylation of downstream substrat...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:45582f4d-a777-4ef1-9590-88bd97bb26d3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d82f9441-6234-4864-9818-31281a98d811&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d82f9441-6234-4864-9818-31281a98d811","type":"Claim","title":"CSF biomarkers and PET PiB can predict progression from MCI or early symptomatic AD to more overt DAT.","label":"Morris J et al.; CSF biomarkers and PET PiB can predict p...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Roe Catherine M","Grant Elizabeth A","Head Denise","Storandt Martha","Goate Alison M","Fagan Anne M","Holtzman David M","Mintun Mark A"],"firstAuthor":"Morris John C","referenceYear":"2009","referenceDate":"2009-12","id":"urn:lsid:swan.org:researchstatement:d82f9441-6234-4864-9818-31281a98d811"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ffa63918-838f-4b49-9034-29f4bfe3f8f8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ffa63918-838f-4b49-9034-29f4bfe3f8f8","type":"Claim","title":"Tg2576 mice are a good model to study pre-clinical stages of Alzheimer Disease.","label":"Lesné S et al.; Tg2576 mice are a good model to study pr...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Koh Ming Teng","Kotilinek Linda","Kayed Rakez","Glabe Charles G","Yang Austin","Gallagher Michela","Ashe Karen H"],"firstAuthor":"Lesné Sylvain","referenceYear":"2006","referenceDate":"2006-03-16","id":"urn:lsid:swan.org:researchstatement:ffa63918-838f-4b49-9034-29f4bfe3f8f8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:66969a0f-88e6-471f-a793-309d24494b0e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:66969a0f-88e6-471f-a793-309d24494b0e","type":"Hypothesis","title":"Preclinical AD associated with progression to symptomatic AD is detected by PET Pittsburgh Compound B (PiB).","label":"Morris J et al.; Preclinical AD associated with progressi...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Roe Catherine M","Grant Elizabeth A","Head Denise","Storandt Martha","Goate Alison M","Fagan Anne M","Holtzman David M","Mintun Mark A"],"firstAuthor":"Morris John C","referenceYear":"2009","referenceDate":"2009-12","id":"urn:lsid:swan.org:researchstatement:66969a0f-88e6-471f-a793-309d24494b0e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0743020e-3715-481a-90ec-4b64d50a9e1d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0743020e-3715-481a-90ec-4b64d50a9e1d","type":"Claim","title":"Studies from yeast identified the evolutionarily conserved NAD+-dependent deacetylase Sir2 as a critical regulator of the aging process.","label":"Kim D et al.; Studies from yeast identified the evolut...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:0743020e-3715-481a-90ec-4b64d50a9e1d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6bf79514-047a-49d2-b213-241ff07af2a1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6bf79514-047a-49d2-b213-241ff07af2a1","type":"Claim","title":"Neuronal cell cycle events (CCEs) are also observed in the locus ceruleus and dorsal raphe at 8 months in the R1.40 mice, two brain regions in which no Aβ deposition is observed even at late ages. ","label":"Varvel N et al.; Neuronal cell cycle events (CCEs) are al...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bhaskar Kiran","Patil Anita R","Pimplikar Sanjay W","Herrup Karl","Lamb Bruce T"],"firstAuthor":"Varvel Nicholas H","referenceYear":"2008","referenceDate":"2008-10-22","id":"urn:lsid:swan.org:researchstatement:6bf79514-047a-49d2-b213-241ff07af2a1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6ea11cf3-1400-433c-a5a2-cffd1e9b8ff9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6ea11cf3-1400-433c-a5a2-cffd1e9b8ff9","type":"Claim","title":"Aβ deposition predates NFT formation in Downs syndrome.","label":"Hardy J et al.; Aβ deposition predates NFT formation in ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:6ea11cf3-1400-433c-a5a2-cffd1e9b8ff9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9bd17270-38a7-42e8-aff4-650feeeed93e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9bd17270-38a7-42e8-aff4-650feeeed93e","type":"Claim","title":"The intriguing localization of NEP on the plasma membrane with its catalytic site exposed extracellularly makes this peptidase a prime candidate for peptide degradation at extracellular sites of amyloid accumulation i.e., Abeta-containing diffuse deposits and neuritic plaques.","label":"Tanzi R et al.; The intriguing localization of NEP on th...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:9bd17270-38a7-42e8-aff4-650feeeed93e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:671657d9-cc99-4a90-9253-6228feba69bc&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:671657d9-cc99-4a90-9253-6228feba69bc","type":"Claim","title":"Purification of the gamma-secretase complex on an affinity column generated with a catalytic site-orientated inhibitor resulted in an enrichment of APP CTF, the substrate of the complex.","label":"Bentahir M et al.; Purification of the gamma-secretase comp...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:671657d9-cc99-4a90-9253-6228feba69bc"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8705646c-73b7-44b7-b2ae-c0035682d08d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8705646c-73b7-44b7-b2ae-c0035682d08d","type":"Claim","title":"As neurons are terminally differentiated, it is immediately obvious that one of the critical hallmarks of replicative senescence, inability to divide, does not apply, and it has been suggested that because neurons are terminally differentiated, they cannot senesce.","label":"Golde T et al.; As neurons are terminally differentiated...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:8705646c-73b7-44b7-b2ae-c0035682d08d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f1204734-65f4-4f2c-abe0-11c4beb6a4eb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f1204734-65f4-4f2c-abe0-11c4beb6a4eb","type":"Claim","title":"High levels of htau40 (the longest human tau isoform) overexpression in neuroblastoma, primary cortical neurons, and retinal ganglion cells (RGCs) have been reported to block the trafficking of membranous organelles and neurofilaments, suggesting that rates of fast and slow transport are impaired.","label":"Yuan A et al.; High levels of htau40 (the longest human...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:f1204734-65f4-4f2c-abe0-11c4beb6a4eb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ed497242-a214-45ff-813d-d42efdbaab2e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ed497242-a214-45ff-813d-d42efdbaab2e","type":"Hypothesis","title":"Neprilysin is the primary mechanism of Aβ catabolism in hippocampus.","label":"Iwata N et al.; Neprilysin is the primary mechanism of A...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Tsubuki S","Takaki Y","Watanabe K","Sekiguchi M","Hosoki E","Kawashima-Morishima M","Lee H J","Hama E","Sekine-Aizawa Y","Saido T C"],"firstAuthor":"Iwata N","referenceYear":"2000","referenceDate":"2000-02","id":"urn:lsid:swan.org:researchstatement:ed497242-a214-45ff-813d-d42efdbaab2e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b50437f3-1138-4fc7-afb3-ce196d197fa9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b50437f3-1138-4fc7-afb3-ce196d197fa9","type":"Claim","title":"The relative toxicity of Aβ to neurons should be compared to relative toxicity caused by other environmental influences, mutations, pathways, or polymorphisms that all may reduce or impair the supply of critical materials to synapses by the axonal transport machinery.","label":"Goldstein L; The relative toxicity of Aβ to neurons s...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Goldstein Lawrence S B","id":"urn:lsid:swan.org:researchstatement:b50437f3-1138-4fc7-afb3-ce196d197fa9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bda84887-9eef-43d3-9fd7-4fa6966b1786&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bda84887-9eef-43d3-9fd7-4fa6966b1786","type":"Claim","title":"The S2 cleaved membrane-bound fragment of Notch is rapidly cleaved by gamma-secretase (S3 cleavage) to yield NICD.","label":"Bentahir M et al.; The S2 cleaved membrane-bound fragment o...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:bda84887-9eef-43d3-9fd7-4fa6966b1786"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a92ec525-6f68-48f9-bcbe-e807e9c2998e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a92ec525-6f68-48f9-bcbe-e807e9c2998e","type":"Claim","title":"The amyloid hypothesis has been criticized because its research findings up to now have not generated any benefits in the clinical management and treatment of AD patients nor to an understanding of how the elderly are preferentially affected.","label":"Aliev G; The amyloid hypothesis has been criticiz...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Aliev Gjumrakch","id":"urn:lsid:swan.org:researchstatement:a92ec525-6f68-48f9-bcbe-e807e9c2998e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c9e402d9-c0e6-4767-abc6-3ce846da9e71&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c9e402d9-c0e6-4767-abc6-3ce846da9e71","type":"Claim","title":"The critical residue to promote the initial oligomerization of A&#946;42 is Ile(41).","label":"Bitan G et al.; The critical residue to promote the init...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:c9e402d9-c0e6-4767-abc6-3ce846da9e71"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f0ef7f7a-a4d5-429f-8765-b6481f3c03f2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f0ef7f7a-a4d5-429f-8765-b6481f3c03f2","type":"Claim","title":"CLU, a single copy gene that encodes a major brain apolipoprotein (ApoJ), spans about 16 kb on chromosome 8p21-p12 and encodes an mRNA of approximately 2 kb that translates into a 449-amino-acid primary polypeptide chain.","label":"Harold D et al.; CLU, a single copy gene that encodes a m...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Abraham Richard","Hollingworth Paul","Sims Rebecca","Gerrish Amy","Hamshere Marian L","Pahwa Jaspreet Singh","Moskvina Valentina","Dowzell Kimberley","Williams Amy","Jones Nicola","Thomas Charlene","Stretton Alexandra","Morgan Angharad R","Lovestone Simon","Powell John","Proitsi Petroula","Lupton Michelle K","Brayne Carol","Rubinsztein David C","Gill Michael","Lawlor Brian","Lynch Aoibhinn","Morgan Kevin","Brown Kristelle S","Passmore Peter A","Craig David","McGuinness Bernadette","Todd Stephen","Holmes Clive","Mann David","Smith A David","Love Seth","Kehoe Patrick G","Hardy John","Mead Simon","Fox Nick","Rossor Martin","Collinge John","Maier Wolfgang","Jessen Frank","Schürmann Britta","van den Bussche Hendrik","Heuser Isabella","Kornhuber Johannes","Wiltfang Jens","Dichgans Martin","Frölich Lutz","Hampel Harald","Hüll Michael","Rujescu Dan","Goate Alison M","Kauwe John S","Cruchaga Carlos","Nowotny Petra","Morris John C","Mayo Kevin","Sleegers Kristel","Bettens Karolien","Engelborghs Sebastiaan","De Deyn Peter P","Van Broeckhoven Christine","Livingston Gill","Bass Nicholas J","Gurling Hugh","McQuillin Andrew","Gwilliam Rhian","Deloukas Panagiotis","Al-Chalabi Ammar","Shaw Christopher E","Tsolaki Magda","Singleton Andrew B","Guerreiro Rita","Mühleisen Thomas W","Nöthen Markus M","Moebus Susanne","Jöckel Karl-Heinz","Klopp Norman","Wichmann H-Erich","Carrasquillo Minerva M","Pankratz V Shane","Younkin Steven G","Holmans Peter A","O'Donovan Michael","Owen Michael J","Williams Julie"],"firstAuthor":"Harold Denise","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:f0ef7f7a-a4d5-429f-8765-b6481f3c03f2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:84d64320-83d3-4179-955b-ec8e997743bd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:84d64320-83d3-4179-955b-ec8e997743bd","type":"Claim","title":"Neurons express the mRNAs of, and stain positively for, a number of other secreted inflammatory proteins.","label":"Golde T et al.; Neurons express the mRNAs of, and stain ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:84d64320-83d3-4179-955b-ec8e997743bd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0e317f14-b976-4504-80f7-0e38ae93ea50&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0e317f14-b976-4504-80f7-0e38ae93ea50","type":"Claim","title":"DR6 regulates axonal pruning.","label":"Nikolaev A et al.; DR6 regulates axonal pruning.","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["McLaughlin Todd","O'Leary Dennis D","Tessier-Lavigne Marc"],"firstAuthor":"Nikolaev Anatoly","referenceYear":"2009","referenceDate":"2009-02-19","id":"urn:lsid:swan.org:researchstatement:0e317f14-b976-4504-80f7-0e38ae93ea50"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c0f5d658-d41e-4066-ad5e-e60067acd655&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c0f5d658-d41e-4066-ad5e-e60067acd655","type":"Claim","title":"The second neurodegenerative stage of AD starts when the loss of NMDA receptor-bearing inhibitory neurons is sufficient to unleash a disinhibition excitotoxicity syndrome in which neurons are pathologically overactivated, each neuron being hyperstimulated through several signal transduction pathways at the same time,  and thus neurodegeneration occurs as a network disturbance. ","label":"Olney J et al.; The second neurodegenerative stage of AD...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:c0f5d658-d41e-4066-ad5e-e60067acd655"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:13f54b1f-892d-4122-a75b-22ddd7bcbabb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:13f54b1f-892d-4122-a75b-22ddd7bcbabb","type":"Claim","title":"Amyloid fibril formation and deposition are linked to AD neuropathogenesis","label":"Bitan G et al.; Amyloid fibril formation and deposition ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:13f54b1f-892d-4122-a75b-22ddd7bcbabb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ab1ce556-9c84-4fec-8d35-59224a6cf57c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ab1ce556-9c84-4fec-8d35-59224a6cf57c","type":"Claim","title":"Soluble, stable Aβ oligomers have been detected in extracts of AD brain.","label":"Walsh D et al.; Soluble, stable Aβ oligomers have been d...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Klyubin Igor","Fadeeva Julia V","Cullen William K","Anwyl Roger","Wolfe Michael S","Rowan Michael J","Selkoe Dennis J"],"firstAuthor":"Walsh Dominic M","referenceYear":"2002","referenceDate":"2002-04-04","id":"urn:lsid:swan.org:researchstatement:ab1ce556-9c84-4fec-8d35-59224a6cf57c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:07a7d034-bf27-43dc-b940-bade46a9451a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:07a7d034-bf27-43dc-b940-bade46a9451a","type":"Claim","title":"AD is identified by senile or amyloid plaques, neurofibrillary tangles and amyloid angiopathy accompanied by loss of synapses and neurons in neocortex and hippocampus.","label":"AD is identified by senile or amyloid pl...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:07a7d034-bf27-43dc-b940-bade46a9451a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0e972d31-6824-41b6-831a-31ce5080f433&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0e972d31-6824-41b6-831a-31ce5080f433","type":"Claim","title":"An additional study supports the claim that APPsw but not APPV717F develop CAA.","label":"Holtzman D; An additional study supports the claim t...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman David M","id":"urn:lsid:swan.org:researchstatement:0e972d31-6824-41b6-831a-31ce5080f433"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:139d26f2-44c0-4312-a557-2613f54cdd0f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:139d26f2-44c0-4312-a557-2613f54cdd0f","type":"Claim","title":"Aβ may interfere with protein trafficking and this may be an important physiological role for Aβ.","label":"Plant L et al.; Aβ may interfere with protein traffickin...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:139d26f2-44c0-4312-a557-2613f54cdd0f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a546d499-f61c-4a24-abbd-358392734ffc&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a546d499-f61c-4a24-abbd-358392734ffc","type":"Hypothesis","title":"Insulin resistance plays a role in brain aging and increases the risk of AD and vascular dementia.","label":"Craft S; Insulin resistance plays a role in brain...","icon":"../icons/ontological/discourse-element/h-research-statement.png","firstAuthor":"Craft S","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:a546d499-f61c-4a24-abbd-358392734ffc"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:dcaab6f9-3cbc-42b3-8efa-63a2d7b8e552&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:dcaab6f9-3cbc-42b3-8efa-63a2d7b8e552","type":"Claim","title":"The suggested temporal order that amyloid markers precede tau biomarker change is inconsistent with the conclusion that NFT accumulation is the initiating event in AD, but the currently proposed model is supported by: (1) the genetics data in early-onset AD, which implicate disordered Aβ metabolism as the initiating event; (2) the fact that the final pathological picture is identical between late-onset and early-onset AD cases; and (3) the fact that the major genetic risk factor of late-onset AD (APOE ε4) is implicated in disordered trafficking of Aβ peptide.","label":"Jack C et al.; The suggested temporal order that amyloi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner Michael W","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:dcaab6f9-3cbc-42b3-8efa-63a2d7b8e552"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:c8557df6-f941-4d6a-8fe0-54b44a4fa2d4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:c8557df6-f941-4d6a-8fe0-54b44a4fa2d4","type":"Question","title":"What is the nature of the protease that executes THOP1-mediated Aβ-degradation?","label":"What is the nature of the protease that ...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:c8557df6-f941-4d6a-8fe0-54b44a4fa2d4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:24317bd7-b358-4311-a1e1-52e4d70c9e7f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:24317bd7-b358-4311-a1e1-52e4d70c9e7f","type":"Claim","title":"The subcellular localization of rab4, a protein believed to be important in vesicle trafficking, is regulated upon phosphorylation by cdc2 kinase.","label":"Suzuki T et al.; The subcellular localization of rab4, a ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:24317bd7-b358-4311-a1e1-52e4d70c9e7f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bac46b16-b635-4f94-a335-da8cd3f6854c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bac46b16-b635-4f94-a335-da8cd3f6854c","type":"Hypothesis","title":"The progressive accumulation of altered tau protein results in instability of microtubules in neurons in Alzheimer disease.","label":"Kosik K et al.; The progressive accumulation of altered ...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Joachim C L","Selkoe D J"],"firstAuthor":"Kosik K S","referenceYear":"1986","referenceDate":"1986-06","id":"urn:lsid:swan.org:researchstatement:bac46b16-b635-4f94-a335-da8cd3f6854c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:08118db7-9e98-401c-a05d-a60ea716a522&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:08118db7-9e98-401c-a05d-a60ea716a522","type":"Claim","title":"New plaques do not form any closer to vessels than would be expected by chance, in accord with an earlier study of human Alzheimer\u2019s disease","label":"Meyer-Luehmann M et al.; New plaques do not form any closer to ve...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:08118db7-9e98-401c-a05d-a60ea716a522"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:260252b5-99ac-4577-95c4-0f78c50708a9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:260252b5-99ac-4577-95c4-0f78c50708a9","type":"Hypothesis","title":"NMDA receptor hypoactivity (NRHypo) may have an important contributory role in Alzheimer disease.","label":"Olney J et al.; NMDA receptor hypoactivity (NRHypo) may ...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:260252b5-99ac-4577-95c4-0f78c50708a9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0dd8f287-41b6-420a-8506-75bc4f7aef33&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0dd8f287-41b6-420a-8506-75bc4f7aef33","type":"Claim","title":"Genes that regulate responses to Aβ, neuronal fitness, CNS inflammation or any other component of the Aβ cascade could influence risk for AD.","label":"Golde T; Genes that regulate responses to Aβ, neu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde T","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:0dd8f287-41b6-420a-8506-75bc4f7aef33"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0c26e77c-8b6a-4c40-8f4a-ad0af1f9a694&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0c26e77c-8b6a-4c40-8f4a-ad0af1f9a694","type":"Claim","title":"The posterior cingulate cortex is known to be preferentially vulnerable to AD-related hypometabolic abnormalities and fibrillar amyloid deposition, and is also involved in AD-related memory impairment. ","label":"Reiman E et al.; The posterior cingulate cortex is known ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Jennifer A","Myers Amanda J","Hardy John","Dunckley Travis","Zismann Victoria L","Joshipura Keta D","Pearson John V","Hu-Lince Diane","Huentelman Matthew J","Craig David W","Coon Keith D","Liang Winnie S","Herbert RiLee H","Beach Thomas","Rohrer Kristen C","Zhao Alice S","Leung Doris","Bryden Leslie","Marlowe Lauren","Kaleem Mona","Mastroeni Diego","Grover Andrew","Heward Christopher B","Ravid Rivka","Rogers Joseph","Hutton Michael L","Melquist Stacey","Petersen Ron C","Alexander Gene E","Caselli Richard J","Kukull Walter","Papassotiropoulos Andreas","Stephan Dietrich A"],"firstAuthor":"Reiman Eric M","referenceYear":"2007","referenceDate":"2007-06-07","id":"urn:lsid:swan.org:researchstatement:0c26e77c-8b6a-4c40-8f4a-ad0af1f9a694"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:757ea4f9-419e-45fc-b899-8e273a781387&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:757ea4f9-419e-45fc-b899-8e273a781387","type":"Claim","title":"Amyloid peptides likely exert pleiotropic neurotoxic effects.","label":"Dewachter I et al.; Amyloid peptides likely exert pleiotropi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Van Leuven Fred"],"firstAuthor":"Dewachter Ilse","id":"urn:lsid:swan.org:researchstatement:757ea4f9-419e-45fc-b899-8e273a781387"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:457bca0e-2f93-413d-9c32-d74d12ef3c3d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:457bca0e-2f93-413d-9c32-d74d12ef3c3d","type":"Claim","title":"There are two GSK3 genes from which GSK3α and GSK3β are derived; GSK3β also exists as longer splice variants.  \nCites: \n1.\tThere are two GSK3 genes from which GSK3α and GSK3β are derived; GSK3β also exists as longer splice variants.  \n \n","label":"Hooper C et al.; There are two GSK3 genes from which GSK3...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:457bca0e-2f93-413d-9c32-d74d12ef3c3d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4a32b8c6-7b2b-4ef9-8900-1550aadb76c1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4a32b8c6-7b2b-4ef9-8900-1550aadb76c1","type":"Claim","title":"There are inherent functional differences between mouse and human apoE isoforms on plasma lipoprotein metabolism in vivo.","label":"Holtzman D; There are inherent functional difference...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:4a32b8c6-7b2b-4ef9-8900-1550aadb76c1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b05b905a-dd43-4b4c-b540-36a717e1a05d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b05b905a-dd43-4b4c-b540-36a717e1a05d","type":"Claim","title":"Testosterone may play an important role in the prevention of Alzheimer\u2019s disease (AD) in men.","label":"McAllister C et al.; Testosterone may play an important role ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Long Jiangang","Bowers Adrienne","Walker Aaron","Cao Philip","Honda Shin-Ichiro","Harada Nobuhiro","Staufenbiel Matthias","Shen Yong","Li Rena"],"firstAuthor":"McAllister Carrie","referenceYear":"2010","referenceDate":"2010-05-26","id":"urn:lsid:swan.org:researchstatement:b05b905a-dd43-4b4c-b540-36a717e1a05d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3d8ca9f0-7fcf-4e66-94b4-1becce64c272&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3d8ca9f0-7fcf-4e66-94b4-1becce64c272","type":"Claim","title":"Both the 20S and 26S proteasomes might be inhibited by the binding of PHF-tau.","label":"Keck S et al.; Both the 20S and 26S proteasomes might b...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:3d8ca9f0-7fcf-4e66-94b4-1becce64c272"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:236206c7-6549-418c-a517-f3aaac290427&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:236206c7-6549-418c-a517-f3aaac290427","type":"Claim","title":"One molecular consequence of PS1 mutations is an upregulation in the levels of the RyR.","label":"Smith I et al.; One molecular consequence of PS1 mutatio...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:236206c7-6549-418c-a517-f3aaac290427"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0051110b-3152-4547-a712-fcd8f4df00bc&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0051110b-3152-4547-a712-fcd8f4df00bc","type":"Claim","title":"Re-classification of AD from a neurodegenerative to a vascular and/or mitochondrial disorder may speed the development of truly beneficial treatments or a cure, improve patient management, provide earlier diagnosis, and reduce the number of AD cases in the future by aggressively treating the risk factors that can turn on this dementia.  ","label":"Aliev G; Re-classification of AD from a neurodege...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Aliev Gjumrakch","id":"urn:lsid:swan.org:researchstatement:0051110b-3152-4547-a712-fcd8f4df00bc"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c49d351c-480f-4ba8-ba51-e2247efd55d7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c49d351c-480f-4ba8-ba51-e2247efd55d7","type":"Claim","title":"A&#946;40 and 42 are enriched in sucrose gradient fractions of brain membrane fragments of Tg2576 mice.","label":"Marchesi V; A&#946;40 and 42 are enriched in sucrose...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:c49d351c-480f-4ba8-ba51-e2247efd55d7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:28c0031e-69a3-46b7-93dd-cd5e43a80a9d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:28c0031e-69a3-46b7-93dd-cd5e43a80a9d","type":"Claim","title":"Indirect support of the involvement of myelin repair processes in tau deposits is provided by the observation that unlike adults, very young infants sustaining brain trauma do not seem to develop tau deposits.","label":"Bartzokis G; Indirect support of the involvement of m...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:28c0031e-69a3-46b7-93dd-cd5e43a80a9d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ef72a798-a6db-4c68-992f-cb4aa575fdc5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ef72a798-a6db-4c68-992f-cb4aa575fdc5","type":"Claim","title":"Down-regulation of THOP1 expression in Aβ25\u201335-treated neurons resulted in a concentration-dependent decrease of cell viability.","label":"Pollio G et al.; Down-regulation of THOP1 expression in A...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hoozemans Jeroen J","Andersen Claus A","Roncarati Renza","Rosi Maria Cristina","van Haastert Elise S","Seredenina Tamara","Diamanti Daniela","Gotta Stefano","Fiorentini Anna","Magnoni Letizia","Raggiaschi Roberto","Rozemuller Annemieke J","Casamenti Fiorella","Caricasole Andrea","Terstappen Georg C"],"firstAuthor":"Pollio Giuseppe","referenceYear":"2008","referenceDate":"2008-07","id":"urn:lsid:swan.org:researchstatement:ef72a798-a6db-4c68-992f-cb4aa575fdc5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ed5f2714-3430-41f4-b6ed-c8ef82168e92&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ed5f2714-3430-41f4-b6ed-c8ef82168e92","type":"Claim","title":"Kinetics studies of A&#946;42 fibril formation reveals faster fibril formation over A&#946;40.","label":"Bitan G et al.; Kinetics studies of A&#946;42 fibril for...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:ed5f2714-3430-41f4-b6ed-c8ef82168e92"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2aec79e9-605e-4dfd-a150-053373c34898&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2aec79e9-605e-4dfd-a150-053373c34898","type":"Claim","title":"Aβ induces apoptosis only when in a fibrillar beta-sheet assembly state and when bound to neuronal surfaces, suggesting that Aβ may initiate activation-induced PCD in a manner analogous to superantigens and Fas receptor crosslinking.","label":"Cotman C et al.; Aβ induces apoptosis only when in a fibr...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:2aec79e9-605e-4dfd-a150-053373c34898"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1cfcdf48-2507-4170-b479-1ae9b2903968&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1cfcdf48-2507-4170-b479-1ae9b2903968","type":"Claim","title":"Additional and larger GWAS may be required to identify remaining susceptibility variants for Alzheimer\u2019s disease since many SNPs were observed which, although failing to reach this level of statistical significance, might still reflect true associations with Alzheimer\u2019s disease: for example, variants at the CR1 locus.","label":"Harold D et al.; Additional and larger GWAS may be requir...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Abraham Richard","Hollingworth Paul","Sims Rebecca","Gerrish Amy","Hamshere Marian L","Pahwa Jaspreet Singh","Moskvina Valentina","Dowzell Kimberley","Williams Amy","Jones Nicola","Thomas Charlene","Stretton Alexandra","Morgan Angharad R","Lovestone Simon","Powell John","Proitsi Petroula","Lupton Michelle K","Brayne Carol","Rubinsztein David C","Gill Michael","Lawlor Brian","Lynch Aoibhinn","Morgan Kevin","Brown Kristelle S","Passmore Peter A","Craig David","McGuinness Bernadette","Todd Stephen","Holmes Clive","Mann David","Smith A David","Love Seth","Kehoe Patrick G","Hardy John","Mead Simon","Fox Nick","Rossor Martin","Collinge John","Maier Wolfgang","Jessen Frank","Schürmann Britta","van den Bussche Hendrik","Heuser Isabella","Kornhuber Johannes","Wiltfang Jens","Dichgans Martin","Frölich Lutz","Hampel Harald","Hüll Michael","Rujescu Dan","Goate Alison M","Kauwe John S","Cruchaga Carlos","Nowotny Petra","Morris John C","Mayo Kevin","Sleegers Kristel","Bettens Karolien","Engelborghs Sebastiaan","De Deyn Peter P","Van Broeckhoven Christine","Livingston Gill","Bass Nicholas J","Gurling Hugh","McQuillin Andrew","Gwilliam Rhian","Deloukas Panagiotis","Al-Chalabi Ammar","Shaw Christopher E","Tsolaki Magda","Singleton Andrew B","Guerreiro Rita","Mühleisen Thomas W","Nöthen Markus M","Moebus Susanne","Jöckel Karl-Heinz","Klopp Norman","Wichmann H-Erich","Carrasquillo Minerva M","Pankratz V Shane","Younkin Steven G","Holmans Peter A","O'Donovan Michael","Owen Michael J","Williams Julie"],"firstAuthor":"Harold Denise","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:1cfcdf48-2507-4170-b479-1ae9b2903968"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9eaa47e3-5550-4839-8fbb-840c2eaa5f13&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9eaa47e3-5550-4839-8fbb-840c2eaa5f13","type":"Hypothesis","title":"Cholinergic-Vascular Hypothesis of Alzheimer Disease:  Cholinesterase inhibitors augment cerebral perfusion.","label":"Claassen J et al.; Cholinergic-Vascular Hypothesis of Alzhe...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Jansen René W"],"firstAuthor":"Claassen Jurgen A","referenceYear":"2006","referenceDate":"2006-03","id":"urn:lsid:swan.org:researchstatement:9eaa47e3-5550-4839-8fbb-840c2eaa5f13"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:87473428-fc87-40bd-b19b-1594172d41e8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:87473428-fc87-40bd-b19b-1594172d41e8","type":"Claim","title":"ApoE may contribute to the process of Aβ elimination from the brain through a receptor-mediated transport mechanism, in part via LRP.","label":"Holtzman D; ApoE may contribute to the process of Aβ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:87473428-fc87-40bd-b19b-1594172d41e8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:80f49a22-8884-410a-9cc4-1069264d3e7e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:80f49a22-8884-410a-9cc4-1069264d3e7e","type":"Claim","title":"In extensive studies, no clear correlation between deposited forms of Aβ (such as plaques) and memory impairment in AD patients has been demonstrated.","label":"Dodart J et al.; In extensive studies, no clear correlati...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:80f49a22-8884-410a-9cc4-1069264d3e7e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:621da969-dba7-4be6-8443-4a86037329b2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:621da969-dba7-4be6-8443-4a86037329b2","type":"Claim","title":"Enhanced peripheral clearance and (or) sequestration of Aβ in brain might underlie the rapid reversal of memory impairment that followed the antibody treatment.","label":"Dodart J et al.; Enhanced peripheral clearance and (or) s...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:621da969-dba7-4be6-8443-4a86037329b2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:577feb4b-e28c-4ca1-af79-80c7e3746135&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:577feb4b-e28c-4ca1-af79-80c7e3746135","type":"Claim","title":"TAR DNA binding protein 43 (TDP-43), which forms a major proteinopathy associated with non-tauopathy FTLD, together with progranulin may be involved in basic maintenance functions such as inflammatory response to cell damage that is essential for adequate myelin repair.","label":"Bartzokis G; TAR DNA binding protein 43 (TDP-43), whi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:577feb4b-e28c-4ca1-af79-80c7e3746135"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a267d6fb-7ce6-41db-a154-f38a20e3a700&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a267d6fb-7ce6-41db-a154-f38a20e3a700","type":"Claim","title":"A dysfunction in the intraneuronal degradation of damaged proteins might contribute to protein aggregation and neurodegeneration in AD.","label":"Keck S et al.; A dysfunction in the intraneuronal degra...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:a267d6fb-7ce6-41db-a154-f38a20e3a700"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d8000297-5cce-4783-8b01-51ca9494de33&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d8000297-5cce-4783-8b01-51ca9494de33","type":"Claim","title":"The improvements in AD-like neuropathology and cognitive function that were exhibited in the male APP23/Ar+/-  mice compared with the APP23 mice are most likely due to the estrogen-independent action of testosterone rather than due to the aromatization of testosterone into estrogen.","label":"McAllister C et al.; The improvements in AD-like neuropatholo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Long Jiangang","Bowers Adrienne","Walker Aaron","Cao Philip","Honda Shin-Ichiro","Harada Nobuhiro","Staufenbiel Matthias","Shen Yong","Li Rena"],"firstAuthor":"McAllister Carrie","referenceYear":"2010","referenceDate":"2010-05-26","id":"urn:lsid:swan.org:researchstatement:d8000297-5cce-4783-8b01-51ca9494de33"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:3ce5d455-df14-49c2-91b5-65d2242f0743&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:3ce5d455-df14-49c2-91b5-65d2242f0743","type":"Comment","title":"G. Gouras on Marchesi","label":"Gouras G; G. Gouras on Marchesi","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Gouras Gunnar K","referenceYear":"2005","referenceDate":"2005-10-05","id":"urn:lsid:swan.org:comment:3ce5d455-df14-49c2-91b5-65d2242f0743"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8b50f258-2030-4f44-a4e3-c855116ba74b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8b50f258-2030-4f44-a4e3-c855116ba74b","type":"Claim","title":"Bacterial superantigens, the Fas ligand, and certain viruses are examples of extracellular agents that bind to the cell surface have been reported to initiate activation-induced programmed cell death (PCD).","label":"Cotman C et al.; Bacterial superantigens, the Fas ligand,...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:8b50f258-2030-4f44-a4e3-c855116ba74b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:131ccdd5-9f46-4de8-be6c-3af9a75ec458&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:131ccdd5-9f46-4de8-be6c-3af9a75ec458","type":"Claim","title":"The PSSALRE isoform (cdk5), which has 57% identity to cdc2 kinase based on its predicted amino acid sequence, was expressed at highest levels in human adult brain.","label":"Suzuki T et al.; The PSSALRE isoform (cdk5), which has 57...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:131ccdd5-9f46-4de8-be6c-3af9a75ec458"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:29536a6e-17ac-4c8b-b9fe-a297401fd042&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:29536a6e-17ac-4c8b-b9fe-a297401fd042","type":"Claim","title":"LTP and LTD are associated with glutamate receptor insertion into post-synaptic membranes, a process linked to Src-family kinases","label":"Gong Y et al.; LTP and LTD are associated with glutamat...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:29536a6e-17ac-4c8b-b9fe-a297401fd042"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4b957963-7d51-4a6b-b43c-3831ff18d651&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4b957963-7d51-4a6b-b43c-3831ff18d651","type":"Claim","title":"In a study of 125 AD cases, the severity of CAA was strongly associated with the number of APOE4 alleles, whereas parenchymal Aβ was independent of APOE genotype.","label":"Fryer J et al.; In a study of 125 AD cases, the severity...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:4b957963-7d51-4a6b-b43c-3831ff18d651"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bf96808e-d96f-499c-ab85-d78c3923b2c0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bf96808e-d96f-499c-ab85-d78c3923b2c0","type":"Claim","title":"THOP1 protects against Aβ neurotoxicity in rat cortical neurons.","label":"Pollio G et al.; THOP1 protects against Aβ neurotoxicity ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hoozemans Jeroen J","Andersen Claus A","Roncarati Renza","Rosi Maria Cristina","van Haastert Elise S","Seredenina Tamara","Diamanti Daniela","Gotta Stefano","Fiorentini Anna","Magnoni Letizia","Raggiaschi Roberto","Rozemuller Annemieke J","Casamenti Fiorella","Caricasole Andrea","Terstappen Georg C"],"firstAuthor":"Pollio Giuseppe","referenceYear":"2008","referenceDate":"2008-07","id":"urn:lsid:swan.org:researchstatement:bf96808e-d96f-499c-ab85-d78c3923b2c0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6b3451bb-0c97-43da-813c-c3a103dd7112&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6b3451bb-0c97-43da-813c-c3a103dd7112","type":"Claim","title":"In HeLa cells, immature APP and mature APP have enhanced phosphorylation at the G2/M phase compared with cells at the G1 phase.","label":"Suzuki T et al.; In HeLa cells, immature APP and mature A...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:6b3451bb-0c97-43da-813c-c3a103dd7112"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cbb093a4-6cf5-4a37-8984-2335002f101e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cbb093a4-6cf5-4a37-8984-2335002f101e","type":"Claim","title":"Small hydrophobic peptides can induce dimer formation of platelet-derived growth factor receptor or inhibit dimerization of Erb B receptor.","label":"Marchesi V; Small hydrophobic peptides can induce di...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:cbb093a4-6cf5-4a37-8984-2335002f101e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:c11837af-f470-46d1-8858-de53955c4ae5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:c11837af-f470-46d1-8858-de53955c4ae5","type":"Question","title":"What other good therapeutic targets exist for AD?","label":"What other good therapeutic targets exis...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:c11837af-f470-46d1-8858-de53955c4ae5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cc02a78e-75d6-4ead-860f-a39ff81fcdff&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cc02a78e-75d6-4ead-860f-a39ff81fcdff","type":"Hypothesis","title":"Systems-level organization of cholinergic innervation is altered in Alzheimer disease.","label":"Mesulam M; Systems-level organization of cholinergi...","icon":"../icons/ontological/discourse-element/h-research-statement.png","firstAuthor":"Mesulam M M","referenceYear":"1996","referenceDate":"1996","id":"urn:lsid:swan.org:researchstatement:cc02a78e-75d6-4ead-860f-a39ff81fcdff"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:81026b9d-0ba4-4531-87f0-53bb0e4b978f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:81026b9d-0ba4-4531-87f0-53bb0e4b978f","type":"Claim","title":"The results on tau overexpression do not support the cell culture reports by others suggesting that excess tau in the absence of fibrillary tau inclusions \u201cclogs\u201d microtubules (MTs) and impedes axonal transport.","label":"Lee V et al.; The results on tau overexpression do not...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Trojanowski John Q"],"firstAuthor":"Lee Virginia M-Y","id":"urn:lsid:swan.org:researchstatement:81026b9d-0ba4-4531-87f0-53bb0e4b978f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7f16becf-01b1-406c-8267-e26208a21c5d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7f16becf-01b1-406c-8267-e26208a21c5d","type":"Hypothesis","title":"Oligomeric amyloid beta ligands (ADDLs) are a molecular basis for reversible memory loss.","label":"Gong Y et al.; Oligomeric amyloid beta ligands (ADDLs) ...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Chang Lei","Lambert Mary P","Klein W L","Lacor Pascale N","Finch Caleb E","Krafft Grant A","Viola Kirsten L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:7f16becf-01b1-406c-8267-e26208a21c5d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:976ca2aa-94bb-45cf-ba50-357cc1f06e73&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:976ca2aa-94bb-45cf-ba50-357cc1f06e73","type":"Claim","title":"Ceramide regulates receptor-mediated uptake of lipoprotein-associated cholesterol.","label":"Ceramide regulates receptor-mediated upt...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:976ca2aa-94bb-45cf-ba50-357cc1f06e73"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:559af05f-74a1-47f6-a265-ace7d438edf2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:559af05f-74a1-47f6-a265-ace7d438edf2","type":"Claim","title":"TDP-43 proteinopathology has been noted in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) cases.  ","label":"Yokota O et al.; TDP-43 proteinopathology has been noted ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Davidson Yvonne","Bigio Eileen H","Ishizu Hideki","Terada Seishi","Arai Tetsuaki","Hasegawa Masato","Akiyama Haruhiko","Sikkink Stephen","Pickering-Brown Stuart","Mann David M"],"firstAuthor":"Yokota Osamu","referenceYear":"2010","referenceDate":"2010-07","id":"urn:lsid:swan.org:researchstatement:559af05f-74a1-47f6-a265-ace7d438edf2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:308e22f4-bb35-468d-805a-45307c30470c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:308e22f4-bb35-468d-805a-45307c30470c","type":"Hypothesis","title":"CNS synaptogenesis promoted by glia-derived cholesterol complexed to ApoE.","label":"Mauch D et al.; CNS synaptogenesis promoted by glia-deri...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Nägler K","Schumacher S","Göritz C","Müller E C","Otto A","Pfrieger F W"],"firstAuthor":"Mauch D H","referenceYear":"2001","referenceDate":"2001-11-09","id":"urn:lsid:swan.org:researchstatement:308e22f4-bb35-468d-805a-45307c30470c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fd02ebfd-d188-43bf-b321-2788fa150700&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fd02ebfd-d188-43bf-b321-2788fa150700","type":"Claim","title":"Transgenic PDAPP mice lacking CLU have shown that clusterin protein may strongly influence Aβ fibrillogenesis and increase Aβ neurotoxicity in vivo.","label":"Lambert J et al.; Transgenic PDAPP mice lacking CLU have s...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Heath Simon","Even Gael","Campion Dominique","Sleegers Kristel","Hiltunen Mikko","Combarros Onofre","Zelenika Diana","Bullido Maria J","Tavernier Béatrice","Letenneur Luc","Bettens Karolien","Berr Claudine","Pasquier Florence","Fiévet Nathalie","Barberger-Gateau Pascale","Engelborghs Sebastiaan","De Deyn Peter","Mateo Ignacio","Franck Ana","Helisalmi Seppo","Porcellini Elisa","Hanon Olivier","de Pancorbo Marian M","Lendon Corinne","Dufouil Carole","Jaillard Céline","Leveillard Thierry","Alvarez Victoria","Bosco Paolo","Mancuso Michelangelo","Panza Francesco","Nacmias Benedetta","Bossù Paola","Piccardi Paola","Annoni Giorgio","Seripa Davide","Galimberti Daniela","Hannequin Didier","Licastro Federico","Soininen Hilkka","Ritchie Karen","Blanché Hélène","Dartigues Jean-François","Tzourio Christophe","Gut Ivo","Van Broeckhoven Christine","Alpérovitch Annick","Lathrop Mark","Amouyel Philippe"],"firstAuthor":"Lambert Jean-Charles","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:fd02ebfd-d188-43bf-b321-2788fa150700"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a1bc3cb6-390e-4850-a7d4-818f7b837a7f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a1bc3cb6-390e-4850-a7d4-818f7b837a7f","type":"Claim","title":"Loss of Aph1B and Aph1C does not result in any overt phenotype, although disruption of Nrg1 cleavage in the brain of Aph1BC−/− mice results in behavioral changes that are very similar to the ones observed in β-secretase\u2013deficient (Bace1−/−) mice.","label":"Serneels L et al.; Loss of Aph1B and Aph1C does not result ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Van Biervliet Jérôme","Craessaerts Katleen","Dejaegere Tim","Horré Katrien","Van Houtvin Tine","Esselmann Hermann","Paul Sabine","Schäfer Martin K","Berezovska Oksana","Hyman Bradley T","Sprangers Ben","Sciot Raf","Moons Lieve","Jucker Mathias","Yang Zhixiang","May Patrick C","Karran Eric","Wiltfang Jens","D'Hooge Rudi","De Strooper Bart"],"firstAuthor":"Serneels Lutgarde","referenceYear":"2009","referenceDate":"2009-05-01","id":"urn:lsid:swan.org:researchstatement:a1bc3cb6-390e-4850-a7d4-818f7b837a7f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:38674c84-94a1-48a7-8d8e-a8a6134d8468&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:38674c84-94a1-48a7-8d8e-a8a6134d8468","type":"Claim","title":"Some of the neuronal expression of inflammatory markers can be seen in mouse models of AD and other neurodegenerative disorders.","label":"Golde T et al.; Some of the neuronal expression of infla...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:38674c84-94a1-48a7-8d8e-a8a6134d8468"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3f7d6b09-7076-4ca3-8959-43f63840fa3d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3f7d6b09-7076-4ca3-8959-43f63840fa3d","type":"Claim","title":"Parallel detailed histological analysis including ultrastructural microscopy should make studies of amyloidogenesis even more interesting.","label":"Kumar-Singh S; Parallel detailed histological analysis ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Kumar-Singh Samir","id":"urn:lsid:swan.org:researchstatement:3f7d6b09-7076-4ca3-8959-43f63840fa3d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5641c361-4a4b-4f82-931b-4524f9187bda&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5641c361-4a4b-4f82-931b-4524f9187bda","type":"Claim","title":"The ubiquitin-proteasome system degrades misfolded, unassembled or damaged proteins that could otherwise form potentially toxic aggregates.","label":"Keck S et al.; The ubiquitin-proteasome system degrades...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:5641c361-4a4b-4f82-931b-4524f9187bda"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3e3b5b02-3812-44b1-9239-57fad90665c3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3e3b5b02-3812-44b1-9239-57fad90665c3","type":"Claim","title":"At least one mutation of APP, \"Arctic\" (E693G), enhances the fibrillogenicity of the Aβ peptide.","label":"Golde T; At least one mutation of APP, \"Arctic\" (...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde T","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:3e3b5b02-3812-44b1-9239-57fad90665c3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:16bd5943-4971-4649-ba36-d0a1f698184a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:16bd5943-4971-4649-ba36-d0a1f698184a","type":"Claim","title":"In vivo, apoptotic cells and their fragments (apoptotic bodies) are recognized by macrophages (microglia in the CNS) and phagocytosed.","label":"Cotman C et al.; In vivo, apoptotic cells and their fragm...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:16bd5943-4971-4649-ba36-d0a1f698184a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a69d5c81-07ed-4379-9aa7-a597295e57a7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a69d5c81-07ed-4379-9aa7-a597295e57a7","type":"Claim","title":"Small molecule inhibition of Hsp90, which binds the Hsp70/substrate complex, can decrease p-tau in a mouse tauopathy model.","label":"Carrettiero D et al.; Small molecule inhibition of Hsp90, whic...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hernandez Israel","Neveu Pierre","Papagiannakopoulos Thales","Kosik Kenneth S"],"firstAuthor":"Carrettiero Daniel C","referenceYear":"2009","referenceDate":"2009-02-18","id":"urn:lsid:swan.org:researchstatement:a69d5c81-07ed-4379-9aa7-a597295e57a7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cfb36861-2078-4574-bd17-cafabb2fda01&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cfb36861-2078-4574-bd17-cafabb2fda01","type":"Hypothesis","title":"Alzheimer disease is identified by plaques and tangles in the brain.","label":"Alzheimer A; Alzheimer disease is identified by plaqu...","icon":"../icons/ontological/discourse-element/h-research-statement.png","firstAuthor":"Alzheimer Alois","id":"urn:lsid:swan.org:researchstatement:cfb36861-2078-4574-bd17-cafabb2fda01"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:aaec354f-5c3a-4f71-8b25-42292634d697&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:aaec354f-5c3a-4f71-8b25-42292634d697","type":"Claim","title":"Even APP transgenic mouse models that do not develop fibrillar Aβ deposits across their entire lifespan still develop neuronal cell cycle events (CCEs) in an anatomically appropriate manner, implicating Aβ as the causative factor in the induction of CCEs.","label":"Varvel N et al.; Even APP transgenic mouse models that do...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bhaskar Kiran","Patil Anita R","Pimplikar Sanjay W","Herrup Karl","Lamb Bruce T"],"firstAuthor":"Varvel Nicholas H","referenceYear":"2008","referenceDate":"2008-10-22","id":"urn:lsid:swan.org:researchstatement:aaec354f-5c3a-4f71-8b25-42292634d697"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d819c214-efc0-4704-b384-df3cf6dcb961&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d819c214-efc0-4704-b384-df3cf6dcb961","type":"Claim","title":"It is likely that some PrPc cellular signalling pathways may be altered/disturbed or overactivated by Aβ oligomers.","label":"Prado M; It is likely that some PrPc cellular sig...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Prado Marco","referenceYear":"2009","referenceDate":"2009-03-24","id":"urn:lsid:swan.org:researchstatement:d819c214-efc0-4704-b384-df3cf6dcb961"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2315c1b5-f1fe-4b71-9b1a-f1c06908039c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2315c1b5-f1fe-4b71-9b1a-f1c06908039c","type":"Claim","title":"Two dimensional phosphopeptide mapping analyses of samples obtained from okadaic acid-treated PC12 cells confirmed that Thr668 is the sole phosphorylation site in immature APP<sub>770/751<\/sub> and APP<sub>COOH<\/sub>.","label":"Suzuki T et al.; Two dimensional phosphopeptide mapping a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:2315c1b5-f1fe-4b71-9b1a-f1c06908039c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:be77f15c-262b-4ab9-9c04-609250f8f2d1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:be77f15c-262b-4ab9-9c04-609250f8f2d1","type":"Claim","title":"An intriguing property shared by γ-secretase inhibitors is their paradoxical ability to enhance Aβ42 production while blocking other γ-secretase-dependent cleavages, thus mimicking the effects of PS mutations.","label":"Shen J et al.; An intriguing property shared by γ-secre...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:be77f15c-262b-4ab9-9c04-609250f8f2d1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:85d66b09-4f6c-421b-aec2-10f736faa617&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:85d66b09-4f6c-421b-aec2-10f736faa617","type":"Claim","title":"Mechanisms exist by which Aβ and tau can be regulated by single upstream drivers in late-onset AD (LOAD).","label":"Small S et al.; Mechanisms exist by which Aβ and tau can...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:85d66b09-4f6c-421b-aec2-10f736faa617"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8148ec29-24fb-445a-9f43-81a9759eee04&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8148ec29-24fb-445a-9f43-81a9759eee04","type":"Claim","title":"Cortical extracts from some subjects without Alzheimer\u2019s disease showed modest levels of insoluble Aβ but little soluble Aβ compared to the Alzheimer\u2019s disease cases.","label":"Shankar G et al.; Cortical extracts from some subjects wit...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Li Shaomin","Mehta Tapan H","Garcia-Munoz Amaya","Shepardson Nina E","Smith Imelda","Brett Francesca M","Farrell Michael A","Rowan Michael J","Lemere Cynthia A","Regan Ciaran M","Walsh Dominic M","Sabatini Bernardo L","Selkoe Dennis J"],"firstAuthor":"Shankar Ganesh M","referenceYear":"2008","referenceDate":"2008-08","id":"urn:lsid:swan.org:researchstatement:8148ec29-24fb-445a-9f43-81a9759eee04"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3464de42-d7b2-492f-81aa-9aee10c9917a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3464de42-d7b2-492f-81aa-9aee10c9917a","type":"Claim","title":"Both in vivo imaging studies in APP transgenic mice and cross-sectional pathology studies in inducible APP transgenic mice demonstrate that amyloid is highly resistant to degradation even in the absence of ongoing Aβ production. ","label":"Golde T et al.; Both in vivo imaging studies in APP tran...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:3464de42-d7b2-492f-81aa-9aee10c9917a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:21c20af0-3798-4402-baee-307518c37949&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:21c20af0-3798-4402-baee-307518c37949","type":"Claim","title":"An association of THOP1 with AD is supported by its reported presence in neurofibrillary tangles and senile plaques in autoptic AD tissue.","label":"Pollio G et al.; An association of THOP1 with AD is suppo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hoozemans Jeroen J","Andersen Claus A","Roncarati Renza","Rosi Maria Cristina","van Haastert Elise S","Seredenina Tamara","Diamanti Daniela","Gotta Stefano","Fiorentini Anna","Magnoni Letizia","Raggiaschi Roberto","Rozemuller Annemieke J","Casamenti Fiorella","Caricasole Andrea","Terstappen Georg C"],"firstAuthor":"Pollio Giuseppe","referenceYear":"2008","referenceDate":"2008-07","id":"urn:lsid:swan.org:researchstatement:21c20af0-3798-4402-baee-307518c37949"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5f804c71-6d27-40d9-bad6-9d25a04a4c28&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5f804c71-6d27-40d9-bad6-9d25a04a4c28","type":"Claim","title":"It is unlikely that tau plays a major role in this process, as transgenic mice containing the same PS1 mutation and that overexpress mutant tau to the same level as the 3xTg-AD mice continue to show paired pulse facilitation.","label":"Smith I et al.; It is unlikely that tau plays a major ro...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:5f804c71-6d27-40d9-bad6-9d25a04a4c28"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2e3a25c6-7851-41be-90e5-9382c8ea9aa9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2e3a25c6-7851-41be-90e5-9382c8ea9aa9","type":"Claim","title":"Every transgenic mouse model of AD that has been examined shows Aβ deposition, as well as ectopic neuronal cell cycle events (CCEs), but little evidence of neuronal cell loss.","label":"Varvel N et al.; Every transgenic mouse model of AD that ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bhaskar Kiran","Patil Anita R","Pimplikar Sanjay W","Herrup Karl","Lamb Bruce T"],"firstAuthor":"Varvel Nicholas H","referenceYear":"2008","referenceDate":"2008-10-22","id":"urn:lsid:swan.org:researchstatement:2e3a25c6-7851-41be-90e5-9382c8ea9aa9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:726334fe-3935-4a4a-bdfe-741e462116ce&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:726334fe-3935-4a4a-bdfe-741e462116ce","type":"Claim","title":"Once the neuron degenerates, the insoluble tangles appear to remain as \"ghost\" skeletons or extracellular tangles.","label":"Cotman C et al.; Once the neuron degenerates, the insolub...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:726334fe-3935-4a4a-bdfe-741e462116ce"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:38112a48-62d2-4e60-93ba-a0510afe4c88&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:38112a48-62d2-4e60-93ba-a0510afe4c88","type":"Claim","title":"ApoE may be a pathological chaperone for amyloidogenic proteins.","label":"Holtzman D; ApoE may be a pathological chaperone for...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:38112a48-62d2-4e60-93ba-a0510afe4c88"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c8a69205-898a-4872-837a-29a7fdb970b2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c8a69205-898a-4872-837a-29a7fdb970b2","type":"Claim","title":"Caution needs to be exercised when considering the therapeutic efficacy of gamma-secretase inhibitors, not only because of the potential for adverse effects due to the large number of substrates that undergo presenilin-mediated proteolysis, but also because of their potential for untoward effects on calcium signaling.","label":"Smith I et al.; Caution needs to be exercised when consi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:c8a69205-898a-4872-837a-29a7fdb970b2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:87a385eb-9f02-40c5-9841-cc047c4703ae&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:87a385eb-9f02-40c5-9841-cc047c4703ae","type":"Claim","title":"No ultrastructural evidence of paired helical filaments have been detected; however, even if such evidence cannot be found, this might signify species specificity of this particular abnormality without disqualifying the NRHypo degenerative process as a valid model of the mechanism giving rise to NFTs in human AD brain.","label":"Olney J et al.; No ultrastructural evidence of paired he...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:87a385eb-9f02-40c5-9841-cc047c4703ae"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c18b945a-c1b8-4071-bcab-d4c775a56976&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c18b945a-c1b8-4071-bcab-d4c775a56976","type":"Claim","title":"Soluble amyloid Abeta-(1-40) exists as a stable dimer at low concentrations.","label":"Garzon-Rodriguez W et al.; Soluble amyloid Abeta-(1-40) exists as a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Sepulveda-Becerra M","Milton S","Glabe C G"],"firstAuthor":"Garzon-Rodriguez W","referenceYear":"1997","referenceDate":"1997-08-22","id":"urn:lsid:swan.org:researchstatement:c18b945a-c1b8-4071-bcab-d4c775a56976"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:63d753db-0ef0-47b7-8133-a235b3a7355a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:63d753db-0ef0-47b7-8133-a235b3a7355a","type":"Claim","title":"Understanding how Aβ aggregates may lead to advances in therapeutic development.","label":"Golde T; Understanding how Aβ aggregates may lead...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde T","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:63d753db-0ef0-47b7-8133-a235b3a7355a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5f3a3a5a-1afb-4bd6-9a10-21a746e63284&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5f3a3a5a-1afb-4bd6-9a10-21a746e63284","type":"Claim","title":"New plaques were accepted only if a uniquely identifiable fiduciary point, such as a blood vessel or a dendritic process, could be unambiguously noted in a deeper imaging plane.","label":"Meyer-Luehmann M et al.; New plaques were accepted only if a uniq...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:5f3a3a5a-1afb-4bd6-9a10-21a746e63284"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:69b5971c-88ea-425b-a899-f158265f6098&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:69b5971c-88ea-425b-a899-f158265f6098","type":"Claim","title":"The overload of calcium stores has implications for the pathogenesis of AD as destabilization of intracellular calcium signaling could cause neurodegeneration and memory impairments by affecting synaptic plasticity.","label":"Smith I et al.; The overload of calcium stores has impli...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:69b5971c-88ea-425b-a899-f158265f6098"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:34cc7e66-18da-42b7-9383-8846f5d42b7c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:34cc7e66-18da-42b7-9383-8846f5d42b7c","type":"Claim","title":"Insulin and Aβ may exert reciprocal effects since Aβ oligomers induce the removal of insulin receptors from dendritic plasma membranes, while insulin rescues Aβ oligomer-induced synapse loss and synaptotoxicity.","label":"Craft S; Insulin and Aβ may exert reciprocal effe...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft S","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:34cc7e66-18da-42b7-9383-8846f5d42b7c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:48aa9233-47ae-46b4-b78e-e7dfa0c5435d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:48aa9233-47ae-46b4-b78e-e7dfa0c5435d","type":"Claim","title":"The myelin model proposes overarching \u201cupstream\u201d mechanisms that trigger both Aβ and tau production, oligomerization, and deposition.","label":"Bartzokis G; The myelin model proposes overarching \u201cu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:48aa9233-47ae-46b4-b78e-e7dfa0c5435d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4f7c9c6c-3424-4bac-95c5-126da845f3d1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4f7c9c6c-3424-4bac-95c5-126da845f3d1","type":"Claim","title":"Newly aggregated intracellular tau transfers between co-cultured cells.","label":"Frost B et al.; Newly aggregated intracellular tau trans...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Jacks Rachel L","Diamond Marc I"],"firstAuthor":"Frost Bess","referenceYear":"2009","referenceDate":"2009-05-08","id":"urn:lsid:swan.org:researchstatement:4f7c9c6c-3424-4bac-95c5-126da845f3d1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:51912e82-b05c-49ce-9f73-9ff9a0241784&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:51912e82-b05c-49ce-9f73-9ff9a0241784","type":"Claim","title":"Several pathogenic events might contribute, either directly or indirectly, to tau hyperphosphorylation, misfolding and aggregation.","label":"Ballatore C et al.; Several pathogenic events might contribu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Lee Virginia M-Y","Trojanowski John Q"],"firstAuthor":"Ballatore Carlo","referenceYear":"2007","referenceDate":"2007-09","id":"urn:lsid:swan.org:researchstatement:51912e82-b05c-49ce-9f73-9ff9a0241784"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:05ee1d9e-8d00-4c2c-99f5-9ca6e38d111d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:05ee1d9e-8d00-4c2c-99f5-9ca6e38d111d","type":"Claim","title":"Oxidative insults readily initiate apoptosis and oxidative damage is known to occur in the aging and AD brain.","label":"Cotman C et al.; Oxidative insults readily initiate apopt...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:05ee1d9e-8d00-4c2c-99f5-9ca6e38d111d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:96c46d83-a533-4857-a1fe-cde5bff2ae0a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:96c46d83-a533-4857-a1fe-cde5bff2ae0a","type":"Claim","title":"In the mature nervous system a key adaptive mechanism is to try to keep largely irreplaceable neurons alive, exemplified by pathogenic viruses can be cleared from neurons by activation of the innate and adaptive immune systems in a non-cytolytic fashion.","label":"Golde T et al.; In the mature nervous system a key adapt...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:96c46d83-a533-4857-a1fe-cde5bff2ae0a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6304d1c3-9883-417d-928a-5ad879557c0f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6304d1c3-9883-417d-928a-5ad879557c0f","type":"Claim","title":"Studies of Down syndrome and normal elderly individuals demonstrate that pathology of AD precedes clinical symptoms of dementia by ~10-25 years.","label":"Holtzman D; Studies of Down syndrome and normal elde...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:6304d1c3-9883-417d-928a-5ad879557c0f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a019ead3-1145-42f1-8139-ab7f54077ec9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a019ead3-1145-42f1-8139-ab7f54077ec9","type":"Claim","title":"Outside of APOE, one marker (rs11136000) within CLU on chromosome 8p21-p12 showed statistical significance in the GWAS test that has also been noted in meta-analysis of linkage studies of Alzheimer Disease.","label":"Lambert J et al.; Outside of APOE, one marker (rs11136000)...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Heath Simon","Even Gael","Campion Dominique","Sleegers Kristel","Hiltunen Mikko","Combarros Onofre","Zelenika Diana","Bullido Maria J","Tavernier Béatrice","Letenneur Luc","Bettens Karolien","Berr Claudine","Pasquier Florence","Fiévet Nathalie","Barberger-Gateau Pascale","Engelborghs Sebastiaan","De Deyn Peter","Mateo Ignacio","Franck Ana","Helisalmi Seppo","Porcellini Elisa","Hanon Olivier","de Pancorbo Marian M","Lendon Corinne","Dufouil Carole","Jaillard Céline","Leveillard Thierry","Alvarez Victoria","Bosco Paolo","Mancuso Michelangelo","Panza Francesco","Nacmias Benedetta","Bossù Paola","Piccardi Paola","Annoni Giorgio","Seripa Davide","Galimberti Daniela","Hannequin Didier","Licastro Federico","Soininen Hilkka","Ritchie Karen","Blanché Hélène","Dartigues Jean-François","Tzourio Christophe","Gut Ivo","Van Broeckhoven Christine","Alpérovitch Annick","Lathrop Mark","Amouyel Philippe"],"firstAuthor":"Lambert Jean-Charles","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:a019ead3-1145-42f1-8139-ab7f54077ec9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b88022ac-4c57-4d9a-aed2-6f206d4a8a65&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b88022ac-4c57-4d9a-aed2-6f206d4a8a65","type":"Claim","title":"In vivo radiolabeling does not reveal functional equilibrium between CNS and periphery due to the intact BBB.","label":"In vivo radiolabeling does not reveal fu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:b88022ac-4c57-4d9a-aed2-6f206d4a8a65"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d3181664-4ef1-4671-8b69-468c1f4e1f4a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d3181664-4ef1-4671-8b69-468c1f4e1f4a","type":"Claim","title":"In neuronal cells, toxicity of traditional Aβ preparations also has been linked to transduction molecules associated with focal contact signaling, a cascade that includes Fyn.","label":"Lambert M et al.; In neuronal cells, toxicity of tradition...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:d3181664-4ef1-4671-8b69-468c1f4e1f4a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8331b851-d39b-4d35-ac7a-b348a5546bc4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8331b851-d39b-4d35-ac7a-b348a5546bc4","type":"Claim","title":"Neurons that show Aβ accumulations may attempt to reenter the cell cycle.","label":"Muresan Z et al.; Neurons that show Aβ accumulations may a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","referenceYear":"2008","referenceDate":"2008","id":"urn:lsid:swan.org:researchstatement:8331b851-d39b-4d35-ac7a-b348a5546bc4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2bf2960c-cd55-4720-80f8-5b0fec39e4c9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2bf2960c-cd55-4720-80f8-5b0fec39e4c9","type":"Claim","title":"Intraneuronal Aβ42 accumulation in the somatodendritic compartment may have an influence on axonal trafficking and integrity.","label":"Bayer T; Intraneuronal Aβ42 accumulation in the s...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bayer T A","id":"urn:lsid:swan.org:researchstatement:2bf2960c-cd55-4720-80f8-5b0fec39e4c9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c812e6fe-8737-4ff2-be6b-323ce2315359&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c812e6fe-8737-4ff2-be6b-323ce2315359","type":"Claim","title":"Oligomerization and aggregation of the amyloid β-protein (Aβ) is thought to be a central mechanism in the initiation and progression of Alzheimer disease.","label":"Hartley D et al.; Oligomerization and aggregation of the a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:c812e6fe-8737-4ff2-be6b-323ce2315359"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2787de24-d604-4488-b8c9-e6deab9ebae6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2787de24-d604-4488-b8c9-e6deab9ebae6","type":"Claim","title":"Key inflammatory pathways, including those mediated by IL-6 and CXCR2 ligands, are not only upregulated by senescence but may play a critical role in inducing and maintaining senescence. ","label":"Golde T et al.; Key inflammatory pathways, including tho...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:2787de24-d604-4488-b8c9-e6deab9ebae6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f5414569-6470-4c40-a304-aa3784135750&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f5414569-6470-4c40-a304-aa3784135750","type":"Claim","title":"c-Jun is selectively induced in neurons undergoing apoptosis, but not necrosis, in a neuron culture system.","label":"Cotman C et al.; c-Jun is selectively induced in neurons ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:f5414569-6470-4c40-a304-aa3784135750"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0cd5c953-f155-4cb9-8be5-1832e3ea0912&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0cd5c953-f155-4cb9-8be5-1832e3ea0912","type":"Claim","title":"One RAGE ligand is Aβ, for which RAGE has an affinity in the nanomolar range, supporting the possibility for an endogenous physiological interaction between Aβ and RAGE.","label":"Tanzi R et al.; One RAGE ligand is Aβ, for which RAGE ha...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:0cd5c953-f155-4cb9-8be5-1832e3ea0912"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:22b2c766-5545-4ea5-bdef-e84da41ee8c7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:22b2c766-5545-4ea5-bdef-e84da41ee8c7","type":"Claim","title":"Possible mechanisms through which insulin resistance increases risk of AD and memory impairment include disrupted regulation of β-amyloid (Aβ) trafficking and clearance, impaired synaptic maintenance, increased inflammation, tau phosphorylation, impaired vascular function and reduced brain insulin uptake/signaling.","label":"Craft S; Possible mechanisms through which insuli...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft S","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:22b2c766-5545-4ea5-bdef-e84da41ee8c7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c7b671f1-df96-4058-aa29-faf67123da43&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c7b671f1-df96-4058-aa29-faf67123da43","type":"Claim","title":"PDAPP mice treated acutely or subchronically with m266 showed improved learning and memory performance without alteration in percentage of cortical or hippocampal surface area covered by Aβ deposits, suggesting that a reduction in amyloid deposition is probably not responsible for the improvements.","label":"Dodart J et al.; PDAPP mice treated acutely or subchronic...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:c7b671f1-df96-4058-aa29-faf67123da43"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:306e384f-5e76-4f14-ae27-be965075c780&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:306e384f-5e76-4f14-ae27-be965075c780","type":"Claim","title":"Between-patient variation in the lag period between Aβ deposition and the neurodegenerative cascade is probably an indication of differences in Aβ processing, in the effects of abnormal Aβ processing on neuronal injury, and differences in brain resilience or cognitive reserve. Other pathological changes, particularly cerebrovascular, α-synuclein, and TAR DNA-binding protein 43 proteinopathy mechanisms, also contribute significantly to between-individual variations in clinical disease expression.","label":"Jack C et al.; Between-patient variation in the lag per...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:306e384f-5e76-4f14-ae27-be965075c780"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:8ec428ca-b1fe-4609-8564-4ee1db2718db&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:8ec428ca-b1fe-4609-8564-4ee1db2718db","type":"Comment","title":"Suzuki update on Suzuki hypothesis \u201cCell cycle-dependent regulation of APP metabolism and phosphorylation play a key role in AD pathogenesis.\u201d","label":"Suzuki T; Suzuki update on Suzuki hypothesis \u201cCell...","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Suzuki Toshiharu","id":"urn:lsid:swan.org:comment:8ec428ca-b1fe-4609-8564-4ee1db2718db"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4a60cd69-94db-493d-82a8-65e3d2a981b2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4a60cd69-94db-493d-82a8-65e3d2a981b2","type":"Hypothesis","title":"Cardiovascular Hypothesis of Alzheimer Disease:  Heart disease may be a forerunner to Alzheimer disease.","label":"Sparks D et al.; Cardiovascular Hypothesis of Alzheimer D...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Hunsaker J C","Scheff S W","Kryscio R J","Henson J L","Markesbery W R"],"firstAuthor":"Sparks D L","referenceYear":"1990","referenceDate":"1990","id":"urn:lsid:swan.org:researchstatement:4a60cd69-94db-493d-82a8-65e3d2a981b2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f5d3ac09-8191-40c0-b2e9-67cf41313a59&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f5d3ac09-8191-40c0-b2e9-67cf41313a59","type":"Claim","title":"Fibrillar Aβ kills cultured neurons.","label":"Gong Y et al.; Fibrillar Aβ kills cultured neurons.","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:f5d3ac09-8191-40c0-b2e9-67cf41313a59"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5b8bce34-52e4-4610-979b-f49d168167bc&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5b8bce34-52e4-4610-979b-f49d168167bc","type":"Claim","title":"Other known substrates of SIRT1 may be involved in neuroprotective effects of SIRT1, such as Ku70, a protein that sequesters the apoptotic protein Bax from mitochondria.","label":"Kim D et al.; Other known substrates of SIRT1 may be i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:5b8bce34-52e4-4610-979b-f49d168167bc"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4a0ae017-4a44-470a-9f84-1dcccf574f1c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4a0ae017-4a44-470a-9f84-1dcccf574f1c","type":"Claim","title":"ADDLs may manifest unique epitopes absent from fibrils.","label":"Gong Y et al.; ADDLs may manifest unique epitopes absen...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:4a0ae017-4a44-470a-9f84-1dcccf574f1c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c3ed464e-db97-484a-90d0-526aa432fbdf&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c3ed464e-db97-484a-90d0-526aa432fbdf","type":"Claim","title":"Studies of transgenic mouse models of tauopathies have increased efforts to develop tau-focused interventions for AD and related tauopathies.","label":"Lee V et al.; Studies of transgenic mouse models of ta...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Trojanowski John Q"],"firstAuthor":"Lee Virginia M-Y","id":"urn:lsid:swan.org:researchstatement:c3ed464e-db97-484a-90d0-526aa432fbdf"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9f604792-3e5b-4660-a6ed-a6ae1d1189cd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9f604792-3e5b-4660-a6ed-a6ae1d1189cd","type":"Claim","title":"FAD PS1-L166P is a strong loss of function clinical mutation, with the least ability to restore APP, syndecan 3 and N-cadherin CTF turnover.","label":"Bentahir M et al.; FAD PS1-L166P is a strong loss of functi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:9f604792-3e5b-4660-a6ed-a6ae1d1189cd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ba18a363-095c-4d06-8ecb-e17883e7548a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ba18a363-095c-4d06-8ecb-e17883e7548a","type":"Claim","title":"Combined daily and weekly imaging resulted in 26 new plaques found in 14 animals over 238 sites, imaged a total of 1,285 times.","label":"Meyer-Luehmann M et al.; Combined daily and weekly imaging result...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:ba18a363-095c-4d06-8ecb-e17883e7548a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d6f7732f-5f80-4a13-be6c-d19f10f749ce&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d6f7732f-5f80-4a13-be6c-d19f10f749ce","type":"Claim","title":"AD-derived oligomers, binds the same three bands (p140, p260 and p100) as synthetic Aβ oligomers, but most robustly to p100.  Binding is completely disease dependent, as control extracts showed no signal.","label":"Gong Y et al.; AD-derived oligomers, binds the same thr...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:d6f7732f-5f80-4a13-be6c-d19f10f749ce"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:85aaaa72-bd44-4cd2-af85-167771f60ef6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:85aaaa72-bd44-4cd2-af85-167771f60ef6","type":"Claim","title":"Kv4.2 and 4.3 currents are activated at sub-threshold potentials, prevent back propagation of action potentials and control frequency of slow repetitive spike firing.","label":"Plant L et al.; Kv4.2 and 4.3 currents are activated at ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:85aaaa72-bd44-4cd2-af85-167771f60ef6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b6be9bc7-9db0-4968-a8aa-3b8d90a18bfc&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b6be9bc7-9db0-4968-a8aa-3b8d90a18bfc","type":"Claim","title":"Alternative hypotheses (altered calcium metabolism, transcriptional consequences of genetic mutations, induction of apoptosis) cannot account for all AD&#8211;related pathogenesis.","label":"Golde T; Alternative hypotheses (altered calcium ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde T","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:b6be9bc7-9db0-4968-a8aa-3b8d90a18bfc"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9aa88d11-e286-4486-bbf3-cedf316167eb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9aa88d11-e286-4486-bbf3-cedf316167eb","type":"Claim","title":"Human ApoE4 enhances fibrillar deposition relative to human ApoE3 in ApoE knock out mice.","label":"Golde T; Human ApoE4 enhances fibrillar depositio...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde Todd E","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:9aa88d11-e286-4486-bbf3-cedf316167eb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:374a1763-b6a0-4672-94cd-32e0774175e8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:374a1763-b6a0-4672-94cd-32e0774175e8","type":"Claim","title":"Aβ42 is more amyloidogenic than Aβ40.","label":"Bitan G et al.; Aβ42 is more amyloidogenic than Aβ40.","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:374a1763-b6a0-4672-94cd-32e0774175e8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c0113756-ac66-4f63-af3e-0a4d57246f2d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c0113756-ac66-4f63-af3e-0a4d57246f2d","type":"Claim","title":"The calculated peak rates at 15 and 30 d were 0.23 mm/d (3.5 mm divided by 15 d) and 0.18 mm/d (5.5 mm divided by 30 d) for NF-L, NF-M, and NF-H in both 8c tau overexpressing and wild-type mouse optical axons.","label":"Yuan A et al.; The calculated peak rates at 15 and 30 d...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:c0113756-ac66-4f63-af3e-0a4d57246f2d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3599f177-56b4-4793-a3bb-cb7f0ff671d7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3599f177-56b4-4793-a3bb-cb7f0ff671d7","type":"Claim","title":"Caspase activation and apoptosis may be initiated following insertion of Aβ channels into specific neuronal organelles such as the ER or mitochondria.","label":"Smith I et al.; Caspase activation and apoptosis may be ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:3599f177-56b4-4793-a3bb-cb7f0ff671d7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0f12187c-cd01-44a8-80e6-85721fd2a174&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0f12187c-cd01-44a8-80e6-85721fd2a174","type":"Claim","title":"Dementia as a neocortical disconnection syndrome: morphological and biochemical characterization of the vulnerable neurons.","label":"Hof P; Dementia as a neocortical disconnection ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Hof P R","referenceYear":"1997","referenceDate":"1997","id":"urn:lsid:swan.org:researchstatement:0f12187c-cd01-44a8-80e6-85721fd2a174"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b3eff047-b733-4bb7-b9b2-bed3d74f7cc6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b3eff047-b733-4bb7-b9b2-bed3d74f7cc6","type":"Claim","title":"Toxin receptors recently have been identified for conventionally prepared fibrillar Aβ.","label":"Lambert M et al.; Toxin receptors recently have been ident...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:b3eff047-b733-4bb7-b9b2-bed3d74f7cc6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fc4f4182-9edc-4760-bc0f-66ad11449727&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fc4f4182-9edc-4760-bc0f-66ad11449727","type":"Claim","title":"The presence of elevated concentration of soluble amyloid beta (Aβ) protein in entorhinal cortex or superior frontal gyrus is well correlated with the prediction of AD.","label":"Morse T et al.; The presence of elevated concentration o...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Mutalik Pradeep","Cheung Kei","Miller Perry L","Shepherd Gordon"],"firstAuthor":"Morse Thomas M","id":"urn:lsid:swan.org:researchstatement:fc4f4182-9edc-4760-bc0f-66ad11449727"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ea98bbec-7298-4e8c-bc5d-e1d88a6c72bc&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ea98bbec-7298-4e8c-bc5d-e1d88a6c72bc","type":"Claim","title":"The presence of Aβ-plaque deposition alone, even in substantial quantities, is not sufficient to produce dementia, although abnormalities in biomarkers of Aβ deposition precede clinical/cognitive symptoms.","label":"Jack C et al.; The presence of Aβ-plaque deposition alo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:ea98bbec-7298-4e8c-bc5d-e1d88a6c72bc"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:3a53a75c-eab8-499e-bcb6-cd099a5ef450&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:3a53a75c-eab8-499e-bcb6-cd099a5ef450","type":"Comment","title":"Nixon and Yuan on Yuan","label":"Nixon R; Nixon and Yuan on Yuan","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Nixon Ralph A","referenceYear":"2008","referenceDate":"2008-04-02","id":"urn:lsid:swan.org:comment:3a53a75c-eab8-499e-bcb6-cd099a5ef450"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:405c8825-7952-4219-ac59-b54addf31993&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:405c8825-7952-4219-ac59-b54addf31993","type":"Claim","title":"GSK3β is negatively regulated by both the Wnt and insulin pathways and inhibition of GSK3β follows the induction of LTP in wild-type mice suggesting that GSK3β might mediate the effects of insulin and Wnt on LTP.","label":"Hooper C et al.; GSK3β is negatively regulated by both th...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:405c8825-7952-4219-ac59-b54addf31993"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2a43fe68-36d7-4a42-b343-a18fe288fd86&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2a43fe68-36d7-4a42-b343-a18fe288fd86","type":"Claim","title":"Deficiency in the sorLA protein has been reliably observed in a large number of late-onset AD (LOAD) brains, more commonly than would be expected from this rare genetic variant.","label":"Small S et al.; Deficiency in the sorLA protein has been...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:2a43fe68-36d7-4a42-b343-a18fe288fd86"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2e393d25-abc2-4611-8451-a1c9fa42deed&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2e393d25-abc2-4611-8451-a1c9fa42deed","type":"Claim","title":"Brefeldin A treatment to block ER/Golgi transport blocked Aβ-induced increase of I<sub>KA<\/sub>.","label":"Plant L et al.; Brefeldin A treatment to block ER/Golgi ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:2e393d25-abc2-4611-8451-a1c9fa42deed"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:14197479-e4f9-4c92-bf05-3ae485256337&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:14197479-e4f9-4c92-bf05-3ae485256337","type":"Claim","title":"A significant age-related increase in THOP1 expression in the hippocampus of TgCRND8 mice indicates a link between THOP1 protein levels and Aβ plaque formation.","label":"Pollio G et al.; A significant age-related increase in TH...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hoozemans Jeroen J","Andersen Claus A","Roncarati Renza","Rosi Maria Cristina","van Haastert Elise S","Seredenina Tamara","Diamanti Daniela","Gotta Stefano","Fiorentini Anna","Magnoni Letizia","Raggiaschi Roberto","Rozemuller Annemieke J","Casamenti Fiorella","Caricasole Andrea","Terstappen Georg C"],"firstAuthor":"Pollio Giuseppe","referenceYear":"2008","referenceDate":"2008-07","id":"urn:lsid:swan.org:researchstatement:14197479-e4f9-4c92-bf05-3ae485256337"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e806fe07-5797-4d63-ab38-a555e5c40267&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e806fe07-5797-4d63-ab38-a555e5c40267","type":"Claim","title":"Synapses are extremely \u201cplastic\u201d (routinely lost and reacquired), are lost in a variety of other disorders, and are often sacrificed in old age (even in healthy individuals,) in the attempt to repair myelin and axon damage/deafferentation.","label":"Bartzokis G; Synapses are extremely \u201cplastic\u201d (routin...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:e806fe07-5797-4d63-ab38-a555e5c40267"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9bd37711-6a73-4e0a-acc4-68e9b58f5685&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9bd37711-6a73-4e0a-acc4-68e9b58f5685","type":"Claim","title":"Cellular and animal models of aging are needed to study AD pathogenesis.","label":"Cellular and animal models of aging are ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:9bd37711-6a73-4e0a-acc4-68e9b58f5685"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fb0d1904-0346-4b72-a98c-34be7fb729a1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fb0d1904-0346-4b72-a98c-34be7fb729a1","type":"Claim","title":"Exogenously added ceramide can affect apoptosis.","label":"Exogenously added ceramide can affect ap...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:fb0d1904-0346-4b72-a98c-34be7fb729a1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e2b02228-c535-4fa5-9b2d-8f929cd9ac73&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e2b02228-c535-4fa5-9b2d-8f929cd9ac73","type":"Claim","title":"Assemblies of Aβ were found in the soluble extracellular-enriched fraction that coincide with memory loss at 6 months, and remain stable in middle-age mice.","label":"Lesné S et al.; Assemblies of Aβ were found in the solub...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Koh Ming Teng","Kotilinek Linda","Kayed Rakez","Glabe Charles G","Yang Austin","Gallagher Michela","Ashe Karen H"],"firstAuthor":"Lesné Sylvain","referenceYear":"2006","referenceDate":"2006-03-16","id":"urn:lsid:swan.org:researchstatement:e2b02228-c535-4fa5-9b2d-8f929cd9ac73"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:07d15702-ecf4-4c59-8a9a-d620a478d6f6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:07d15702-ecf4-4c59-8a9a-d620a478d6f6","type":"Question","title":"If high tau levels have direct effects on transport in this model, it would need to be shown in the absence of indirect effects on transport arising from tau-mediated neurodegeneration.","label":"If high tau levels have direct effects o...","icon":"../icons/ontological/discourse-element/research-question.png","firstAuthor":"Nixon Ralph A","id":"urn:lsid:swan.org:researchquestion:07d15702-ecf4-4c59-8a9a-d620a478d6f6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1531df65-4a30-4928-94f7-0661178a8068&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1531df65-4a30-4928-94f7-0661178a8068","type":"Claim","title":"The observation of microglia recruitment and activation after plaque formation further supports a model in which plaques act as a reservoir of bioactive molecules which subsequently lead to neuronal alterations including local loss of dendritic spines and axonal dystrophies","label":"Meyer-Luehmann M et al.; The observation of microglia recruitment...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:1531df65-4a30-4928-94f7-0661178a8068"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3c9106b2-16e8-4e2e-90ab-db319551e1c2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3c9106b2-16e8-4e2e-90ab-db319551e1c2","type":"Claim","title":"The transentorhinal area that is considered among the earliest and most severely affected regions in the human AD brain is roughly homologous to the perirhinal cortex in rat brain, which is second only to the PC/RS cortex in its sensitivity to NRHypo neurodegeneration.","label":"Olney J et al.; The transentorhinal area that is conside...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:3c9106b2-16e8-4e2e-90ab-db319551e1c2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3b6ccabc-c590-4417-a7fa-9b38f3cc15b2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3b6ccabc-c590-4417-a7fa-9b38f3cc15b2","type":"Claim","title":"The likeliness that Aβ42 monomers subserve a prosurvival function in the brain implies that therapeutic strategies aimed at targeting Aβ should spare forms endowed with physiological functions.","label":"Giuffrida M et al.; The likeliness that Aβ42 monomers subser...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Caraci Filippo","Pignataro Bruno","Cataldo Sebastiano","De Bona Paolo","Bruno Valeria","Molinaro Gemma","Pappalardo Giuseppe","Messina Angela","Palmigiano Angelo","Garozzo Domenico","Nicoletti Ferdinando","Rizzarelli Enrico","Copani Agata"],"firstAuthor":"Giuffrida Maria Laura","referenceYear":"2009","referenceDate":"2009-08-26","id":"urn:lsid:swan.org:researchstatement:3b6ccabc-c590-4417-a7fa-9b38f3cc15b2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d9a87a60-7642-4e62-bc10-3ad8c8c826b4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d9a87a60-7642-4e62-bc10-3ad8c8c826b4","type":"Claim","title":"Although dystrophic neurites were observed in plaque-free areas, they were more pronounced near plaques.","label":"Kumar-Singh S; Although dystrophic neurites were observ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Kumar-Singh Samir","id":"urn:lsid:swan.org:researchstatement:d9a87a60-7642-4e62-bc10-3ad8c8c826b4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:02a5b0f4-1476-4de9-a931-da7e418c5327&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:02a5b0f4-1476-4de9-a931-da7e418c5327","type":"Hypothesis","title":"The mitochondrial cascade hypothesis focuses on the electron transport chain as establishing basal rate of reactive oxygen species production and induction of Alzheimer disease.","label":"Swerdlow R et al.; The mitochondrial cascade hypothesis foc...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Khan Shaharyar M"],"firstAuthor":"Swerdlow Russell H","referenceYear":"2004","referenceDate":"2004","id":"urn:lsid:swan.org:researchstatement:02a5b0f4-1476-4de9-a931-da7e418c5327"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:05216206-bfb5-4634-890d-f3ad0c854e51&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:05216206-bfb5-4634-890d-f3ad0c854e51","type":"Hypothesis","title":"ApoE4 enhances amyloid deposition.","label":"Wisniewski T et al.; ApoE4 enhances amyloid deposition.","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Frangione B"],"firstAuthor":"Wisniewski T","referenceYear":"1992","referenceDate":"1992-02-03","id":"urn:lsid:swan.org:researchstatement:05216206-bfb5-4634-890d-f3ad0c854e51"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:49ef467f-32e3-4fdc-8290-b483ffc45123&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:49ef467f-32e3-4fdc-8290-b483ffc45123","type":"Claim","title":"re-use","label":"re-use","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:49ef467f-32e3-4fdc-8290-b483ffc45123"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2396c054-182b-4eee-b0a1-3a4dc30ca15e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2396c054-182b-4eee-b0a1-3a4dc30ca15e","type":"Claim","title":"It is biologically more plausible that A&#946;- or p3-like substrate products of intramembranous cleavage are efficiently released into the luminal space of vesicles.","label":"Selkoe D; It is biologically more plausible that A...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Selkoe Dennis J","id":"urn:lsid:swan.org:researchstatement:2396c054-182b-4eee-b0a1-3a4dc30ca15e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a6753eb5-b7e5-40b9-bfa7-e4f19ec7da05&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a6753eb5-b7e5-40b9-bfa7-e4f19ec7da05","type":"Claim","title":"The MT-binding domain of tau may engage with other structures and enzymes, including RNA and presenilin 1 (PS1).","label":"Ballatore C et al.; The MT-binding domain of tau may engage ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Lee Virginia M-Y","Trojanowski John Q"],"firstAuthor":"Ballatore Carlo","referenceYear":"2007","referenceDate":"2007-09","id":"urn:lsid:swan.org:researchstatement:a6753eb5-b7e5-40b9-bfa7-e4f19ec7da05"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d2b434bb-55e5-47fb-a509-1a9a51a95bb5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d2b434bb-55e5-47fb-a509-1a9a51a95bb5","type":"Claim","title":"In the presence of amyloid plaques and extracellular Aβ amounts that are similar to those seen in APP-overexpressing mouse models, deletion of the α7nAChR subtype improved many aspects of cognitive, pathological, and neurophysiological deficits.","label":"Dziewczapolski G et al.; In the presence of amyloid plaques and e...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Glogowski Carolina M","Masliah Eliezer","Heinemann Stephen F"],"firstAuthor":"Dziewczapolski Gustavo","referenceYear":"2009","referenceDate":"2009-07-08","id":"urn:lsid:swan.org:researchstatement:d2b434bb-55e5-47fb-a509-1a9a51a95bb5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:48aaca15-1d42-4b7e-89bc-bf5855ca466e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:48aaca15-1d42-4b7e-89bc-bf5855ca466e","type":"Claim","title":"Proteasome activity is decreased in the AD brain.","label":"Keck S et al.; Proteasome activity is decreased in the ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:48aaca15-1d42-4b7e-89bc-bf5855ca466e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1eb907db-c543-4752-ac53-c83477a7547e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1eb907db-c543-4752-ac53-c83477a7547e","type":"Claim","title":"Thop1 destroys antigenic peptides and limits the extent of MHC class I antigen presentation.","label":"Abraham C; Thop1 destroys antigenic peptides and li...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Abraham C R","id":"urn:lsid:swan.org:researchstatement:1eb907db-c543-4752-ac53-c83477a7547e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:aafc1ca1-08d9-4e5a-bbf1-619f283cef6c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:aafc1ca1-08d9-4e5a-bbf1-619f283cef6c","type":"Claim","title":"Aph1BC deficiency lowers amyloid burden and prevents learning and memory deficits associated with APP and PS1 overexpression.","label":"Serneels L et al.; Aph1BC deficiency lowers amyloid burden ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Van Biervliet Jérôme","Craessaerts Katleen","Dejaegere Tim","Horré Katrien","Van Houtvin Tine","Esselmann Hermann","Paul Sabine","Schäfer Martin K","Berezovska Oksana","Hyman Bradley T","Sprangers Ben","Sciot Raf","Moons Lieve","Jucker Mathias","Yang Zhixiang","May Patrick C","Karran Eric","Wiltfang Jens","D'Hooge Rudi","De Strooper Bart"],"firstAuthor":"Serneels Lutgarde","referenceYear":"2009","referenceDate":"2009-05-01","id":"urn:lsid:swan.org:researchstatement:aafc1ca1-08d9-4e5a-bbf1-619f283cef6c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:227b94f3-aeb5-482c-b353-8d55b140976f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:227b94f3-aeb5-482c-b353-8d55b140976f","type":"Claim","title":"Genome-wide significant evidence for association with AD was reached at the APOE, CLU and PICALM  loci, as well as for two novel loci on chromosomes 2 (rs744373, within 30 kb of the gene bridging integrator 1 (BIN1)) and 19 (rs597668) resulting from an international, racially restricted, 3-stage meta-analysis of several of the largest AD GWAS studies that includes CHARGE Consortium, Translational Genomics Research Institute (TGEN) public release database and the Mayo AD GWAS.","label":"Seshadri S et al.; Genome-wide significant evidence for ass...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Fitzpatrick Annette L","Ikram M Arfan","DeStefano Anita L","Gudnason Vilmundur","Boada Merce","Bis Joshua C","Smith Albert V","Carassquillo Minerva M","Lambert Jean Charles","Harold Denise","Schrijvers Elisabeth M","Ramirez-Lorca Reposo","Debette Stephanie","Longstreth W T","Janssens A Cecile","Pankratz V Shane","Dartigues Jean François","Hollingworth Paul","Aspelund Thor","Hernandez Isabel","Beiser Alexa","Kuller Lewis H","Koudstaal Peter J","Dickson Dennis W","Tzourio Christophe","Abraham Richard","Antunez Carmen","Du Yangchun","Rotter Jerome I","Aulchenko Yurii S","Harris Tamara B","Petersen Ronald C","Berr Claudine","Owen Michael J","Lopez-Arrieta Jesus","Varadarajan Badri N","Becker James T","Rivadeneira Fernando","Nalls Michael A","Graff-Radford Neill R","Campion Dominique","Auerbach Sanford","Rice Kenneth","Hofman Albert","Jonsson Palmi V","Schmidt Helena","Lathrop Mark","Mosley Thomas H","Au Rhoda","Psaty Bruce M","Uitterlinden Andre G","Farrer Lindsay A","Lumley Thomas","Ruiz Agustin","Williams Julie","Amouyel Philippe","Younkin Steve G","Wolf Philip A","Launer Lenore J","Lopez Oscar L","van Duijn Cornelia M","Breteler Monique M"],"firstAuthor":"Seshadri Sudha","referenceYear":"2010","referenceDate":"2010-05-12","id":"urn:lsid:swan.org:researchstatement:227b94f3-aeb5-482c-b353-8d55b140976f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:25e97344-3808-45d4-81bd-43e8fdcfc9e4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:25e97344-3808-45d4-81bd-43e8fdcfc9e4","type":"Claim","title":"Human erythrocytes (the cell type that most abundantly expresses CR1) is able to sequester Aβ42 and to favor its clearance via the C3b-mediated adherence to erythrocyte CR1, and this mechanism may be compromised in AD.","label":"Lambert J et al.; Human erythrocytes (the cell type that m...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Heath Simon","Even Gael","Campion Dominique","Sleegers Kristel","Hiltunen Mikko","Combarros Onofre","Zelenika Diana","Bullido Maria J","Tavernier Béatrice","Letenneur Luc","Bettens Karolien","Berr Claudine","Pasquier Florence","Fiévet Nathalie","Barberger-Gateau Pascale","Engelborghs Sebastiaan","De Deyn Peter","Mateo Ignacio","Franck Ana","Helisalmi Seppo","Porcellini Elisa","Hanon Olivier","de Pancorbo Marian M","Lendon Corinne","Dufouil Carole","Jaillard Céline","Leveillard Thierry","Alvarez Victoria","Bosco Paolo","Mancuso Michelangelo","Panza Francesco","Nacmias Benedetta","Bossù Paola","Piccardi Paola","Annoni Giorgio","Seripa Davide","Galimberti Daniela","Hannequin Didier","Licastro Federico","Soininen Hilkka","Ritchie Karen","Blanché Hélène","Dartigues Jean-François","Tzourio Christophe","Gut Ivo","Van Broeckhoven Christine","Alpérovitch Annick","Lathrop Mark","Amouyel Philippe"],"firstAuthor":"Lambert Jean-Charles","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:25e97344-3808-45d4-81bd-43e8fdcfc9e4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:534caab4-5137-46a0-ae6d-db360eda7492&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:534caab4-5137-46a0-ae6d-db360eda7492","type":"Hypothesis","title":"RAGE receptor binds Aβ peptides and mediates Aβ effects on neurons and microglia.","label":"Yan S et al.; RAGE receptor binds Aβ peptides and medi...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Chen X","Fu J","Chen M","Zhu H","Roher A","Slattery T","Zhao L","Nagashima M","Morser J","Migheli A","Nawroth P","Stern D","Schmidt A M"],"firstAuthor":"Yan S D","referenceYear":"1996","referenceDate":"1996-08-22","id":"urn:lsid:swan.org:researchstatement:534caab4-5137-46a0-ae6d-db360eda7492"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b2f727ff-3760-4c8d-9a7b-d62774efa325&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b2f727ff-3760-4c8d-9a7b-d62774efa325","type":"Claim","title":"In the AN1792 immunized participants, there was no evidence of a relation between AN1792 dose and Aβ load or plaque removal.","label":"Holmes C et al.; In the AN1792 immunized participants, th...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:b2f727ff-3760-4c8d-9a7b-d62774efa325"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0a599b29-fc07-43d0-913a-026568021ff7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0a599b29-fc07-43d0-913a-026568021ff7","type":"Claim","title":"Using small interfering RNA to disrupt nuclear import pathways, five nuclear transport factors consistently and significantly affect cytoplasmic accumulation of TDP-43 in human cells: NUPL1, NUP62, and NUP54 which are intrinsic and essential parts of the nuclear pore complex; cellular apoptosis susceptibility (CAS) and karyopherin-β1 proteins which are involved in active transport of cargo proteins into the nucleus through the nuclear pore complex.","label":"Nishimura A et al.; Using small interfering RNA to disrupt n...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zupunski Vera","Troakes Claire","Kathe Claudia","Fratta Pietro","Howell Michael","Gallo Jean-Marc","Hortobágyi Tibor","Shaw Christopher E","Rogelj Boris"],"firstAuthor":"Nishimura Agnes L","referenceYear":"2010","referenceDate":"2010-06","id":"urn:lsid:swan.org:researchstatement:0a599b29-fc07-43d0-913a-026568021ff7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9fbdf403-1d69-462f-b222-e7e554c78447&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9fbdf403-1d69-462f-b222-e7e554c78447","type":"Claim","title":"Insulin has indirect effects on vascular function via dyslipidemia, inflammation, Aβ-induced damage to vascular endothelium.","label":"Craft S; Insulin has indirect effects on vascular...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft S","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:9fbdf403-1d69-462f-b222-e7e554c78447"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3033e29e-76f0-4a49-9117-5ad353d77795&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3033e29e-76f0-4a49-9117-5ad353d77795","type":"Claim","title":"Aβ oligomer amounts are not reduced with previous trypsinization of intact cells, supporting their intracellular origin.","label":"Walsh D et al.; Aβ oligomer amounts are not reduced with...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Klyubin Igor","Fadeeva Julia V","Cullen William K","Anwyl Roger","Wolfe Michael S","Rowan Michael J","Selkoe Dennis J"],"firstAuthor":"Walsh Dominic M","referenceYear":"2002","referenceDate":"2002-04-04","id":"urn:lsid:swan.org:researchstatement:3033e29e-76f0-4a49-9117-5ad353d77795"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:46288f49-b5ef-42e6-9772-b3cfaafde033&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:46288f49-b5ef-42e6-9772-b3cfaafde033","type":"Claim","title":"The proteasome complex consists of two sets of 14 subunits, typically giving a pattern of multiple bands between 20 and 30 kDa on SDS-PAGE, arranged in a set of two or three major bands, representing several subunits.","label":"Keck S et al.; The proteasome complex consists of two s...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:46288f49-b5ef-42e6-9772-b3cfaafde033"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0917de22-562a-4d97-a738-209fb0fbc0f2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0917de22-562a-4d97-a738-209fb0fbc0f2","type":"Claim","title":"NSAIDs may affect conformation of PS1.","label":"Marchesi V; NSAIDs may affect conformation of PS1.","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:0917de22-562a-4d97-a738-209fb0fbc0f2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:335b8cc7-70f9-4f56-8dc9-471aea4515d7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:335b8cc7-70f9-4f56-8dc9-471aea4515d7","type":"Claim","title":"Chronic active immunization had beneficial effects on memory impairment in two different strains of transgenic mice as assessed using a radial-arm water maze; but notably, treatment did not affect amyloid pathology in the same way in the two strains of mice.","label":"Dodart J et al.; Chronic active immunization had benefici...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:335b8cc7-70f9-4f56-8dc9-471aea4515d7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ca33ab40-0cc9-4686-b3fc-a5cfa47105b5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ca33ab40-0cc9-4686-b3fc-a5cfa47105b5","type":"Hypothesis","title":"[ADNI]  Decreased cerebrospinal fluid (CSF) Aβ42 and positive Pittsburgh compound B amyloid imaging are early pathological changes in AD.","label":"Jack C et al.; [ADNI]  Decreased cerebrospinal fluid (C...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","id":"urn:lsid:swan.org:researchstatement:ca33ab40-0cc9-4686-b3fc-a5cfa47105b5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0f71866a-7031-41e9-9954-67dadded86d6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0f71866a-7031-41e9-9954-67dadded86d6","type":"Claim","title":"In prion disease, oligomerization occurs via a pathway distinct from fibrillogenesis.","label":"Gong Y et al.; In prion disease, oligomerization occurs...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:0f71866a-7031-41e9-9954-67dadded86d6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:18ee37cc-8dde-43cc-bc9d-c2f4ee56c04e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:18ee37cc-8dde-43cc-bc9d-c2f4ee56c04e","type":"Claim","title":"Autophagy is an effector mechanism activated during senescence, as are a subset of autophagy related genes, and inhibition of autophagy delays oncogene induced replicative senescence.","label":"Golde T et al.; Autophagy is an effector mechanism activ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:18ee37cc-8dde-43cc-bc9d-c2f4ee56c04e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7f2d2e3a-c3bd-4ab6-8932-b77ae09a6e20&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7f2d2e3a-c3bd-4ab6-8932-b77ae09a6e20","type":"Claim","title":"Protein aggregation is a central event in the initiation of cell death in neurodegenerative diseases.","label":"Keck S et al.; Protein aggregation is a central event i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:7f2d2e3a-c3bd-4ab6-8932-b77ae09a6e20"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:907d7e47-4fc8-4422-a3f2-e805518438d4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:907d7e47-4fc8-4422-a3f2-e805518438d4","type":"Claim","title":"It is a widely held belief that neurons degenerate in AD primarily by the formation of intracellular tangles, that originate from the hyperphosphorylation of the protein tau.","label":"Cotman C et al.; It is a widely held belief that neurons ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:907d7e47-4fc8-4422-a3f2-e805518438d4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e3d847d4-eb09-4348-b376-8222fe281dd9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e3d847d4-eb09-4348-b376-8222fe281dd9","type":"Claim","title":"Contradictory observations from other laboratories have previously shown decreased K  current after A&#946;1-40 treatment in human fibroblasts.","label":"Plant L et al.; Contradictory observations from other la...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:e3d847d4-eb09-4348-b376-8222fe281dd9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:85f24397-2fd0-4cea-bf23-fa0ffce366c5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:85f24397-2fd0-4cea-bf23-fa0ffce366c5","type":"Claim","title":"Cerebral Aβ accumulation is the primary influence in AD.","label":"Hardy J et al.; Cerebral Aβ accumulation is the primary ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:85f24397-2fd0-4cea-bf23-fa0ffce366c5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:31e5ec54-1878-46a3-8fc9-0150c5e75f51&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:31e5ec54-1878-46a3-8fc9-0150c5e75f51","type":"Claim","title":"The brains of many cognitively normal aged individuals show abundant Aβ containing senile plaques but no clinical signs of Alzheimer disease.","label":"Aliev G; The brains of many cognitively normal ag...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Aliev Gjumrakch","id":"urn:lsid:swan.org:researchstatement:31e5ec54-1878-46a3-8fc9-0150c5e75f51"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bfa67695-9c01-4b85-824b-1460a60cd75a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bfa67695-9c01-4b85-824b-1460a60cd75a","type":"Claim","title":"The rates of wild-type and mutant tau axonal transport in cultured cortical neurons are similar.","label":"Yuan A et al.; The rates of wild-type and mutant tau ax...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:bfa67695-9c01-4b85-824b-1460a60cd75a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7a4c4f19-7595-4e16-909f-70856e79a3f4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7a4c4f19-7595-4e16-909f-70856e79a3f4","type":"Claim","title":"A hallmark of replicatively senescent cells is a massive increase in the secretion of multiple pro-inflammatory proteins, including IL-6, IL-8 (CXCL8), IL-1α, IL-1β and monocyte chemoattractant peptide-1 (MCP-1, CCL2).","label":"Golde T et al.; A hallmark of replicatively senescent ce...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:7a4c4f19-7595-4e16-909f-70856e79a3f4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ab81d399-c764-499b-b2b5-91c825aab78f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ab81d399-c764-499b-b2b5-91c825aab78f","type":"Claim","title":"The ability of PS1 bearing the FAD-linked A246E mutation to rescue the phenotypic defects of PS1-/- mice has been taken as evidence that mutant PS possess normal biological activity, and that pathogenic PS1 mutations do not act through a loss-of-function mechanism.","label":"Shen J et al.; The ability of PS1 bearing the FAD-linke...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:ab81d399-c764-499b-b2b5-91c825aab78f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ffdc2121-2a67-490e-9c00-d616f39697cc&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ffdc2121-2a67-490e-9c00-d616f39697cc","type":"Hypothesis","title":"The accumulation of synthetic or native Alzheimer\u2019s disease (AD)-brain oligomers at synapses is regulated by synaptic activity and zinc.","label":"Deshpande A et al.; The accumulation of synthetic or native ...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Kawai Hideki","Metherate Raju","Glabe Charles G","Busciglio Jorge"],"firstAuthor":"Deshpande Atul","referenceYear":"2009","referenceDate":"2009-04-01","id":"urn:lsid:swan.org:researchstatement:ffdc2121-2a67-490e-9c00-d616f39697cc"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4e479be3-a374-4b5f-a23a-f28f1b8285c7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4e479be3-a374-4b5f-a23a-f28f1b8285c7","type":"Hypothesis","title":"A critical reappraisal of the Amyloid Hypothesis, in response to inconclusive clinical trial results.","label":"Hardy J; A critical reappraisal of the Amyloid Hy...","icon":"../icons/ontological/discourse-element/h-research-statement.png","firstAuthor":"Hardy John","referenceYear":"2009","referenceDate":"2009-05-18","id":"urn:lsid:swan.org:researchstatement:4e479be3-a374-4b5f-a23a-f28f1b8285c7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c552ae5a-ce0a-4b67-ae19-face9d5a8419&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c552ae5a-ce0a-4b67-ae19-face9d5a8419","type":"Claim","title":"Fyn, a nonreceptor protein tyrosine kinase is up-regulated in AD-afflicted neurons and belongs to the Src-family of protein tyrosine kinases, which are central to multiple cellular signals and responses.","label":"Lambert M et al.; Fyn, a nonreceptor protein tyrosine kina...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:c552ae5a-ce0a-4b67-ae19-face9d5a8419"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fc89d665-a99e-425f-88b3-855bbd09cff8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fc89d665-a99e-425f-88b3-855bbd09cff8","type":"Claim","title":"Secretase inhibitor and Aβ 1-40 concurrent treatment induced currents similar to control levels.","label":"Plant L et al.; Secretase inhibitor and Aβ 1-40 concurre...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:fc89d665-a99e-425f-88b3-855bbd09cff8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:13c6b55b-2fac-44cf-9139-d10a84aacce2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:13c6b55b-2fac-44cf-9139-d10a84aacce2","type":"Claim","title":"The first direct evidence that FAD-linked mutations impair the biological activity of PS came from genetic complementation studies in Caenorhabditis elegans in which loss-of-function mutations in SEL12, which exhibits ~50% sequence identity to PS1 and PS2, reduce LIN12 activity and confer an egg-laying defective phenotype (Egl).","label":"Shen J et al.; The first direct evidence that FAD-linke...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:13c6b55b-2fac-44cf-9139-d10a84aacce2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:90f03520-2246-49f1-9ef9-8aeab3139740&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:90f03520-2246-49f1-9ef9-8aeab3139740","type":"Claim","title":"The first genetic mutation that caused AD was discovered in APP.","label":"Hardy J et al.; The first genetic mutation that caused A...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:90f03520-2246-49f1-9ef9-8aeab3139740"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c5bd1fba-d6ed-4cfc-9904-418c24d79d9b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c5bd1fba-d6ed-4cfc-9904-418c24d79d9b","type":"Claim","title":"Aβ42 is more abundant in AD brain tissue than in age-matched controls, and production of Aβ42 in cell transfection experiments is increased by APP and presenilin mutations that cause AD.","label":"Lambert M et al.; Aβ42 is more abundant in AD brain tissue...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:c5bd1fba-d6ed-4cfc-9904-418c24d79d9b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d1cb0dcb-a222-4601-ab3d-bef14587d6ff&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d1cb0dcb-a222-4601-ab3d-bef14587d6ff","type":"Claim","title":"Support for the role of IDE in AD pathogenesis stems from recent reports of its genetic association with late-onset AD.","label":"Tanzi R et al.; Support for the role of IDE in AD pathog...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:d1cb0dcb-a222-4601-ab3d-bef14587d6ff"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d09192c9-e705-4672-b5f7-41977b167e2c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d09192c9-e705-4672-b5f7-41977b167e2c","type":"Claim","title":"Amyloid beta increases synthesis of Kv4-containing channels, resulting in larger whole-cell K+ current.","label":"Plant L et al.; Amyloid beta increases synthesis of Kv4-...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:d09192c9-e705-4672-b5f7-41977b167e2c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9777c50e-3273-4e01-a8de-e1ea9cdf6a48&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9777c50e-3273-4e01-a8de-e1ea9cdf6a48","type":"Hypothesis","title":"Borrelia burgdorferi persists in the brain in chronic lyme neuroborreliosis and may be associated with Alzheimer disease.","label":"Miklossy J et al.; Borrelia burgdorferi persists in the bra...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Khalili Kamel","Gern Lise","Ericson Rebecca L","Darekar Pushpa","Bolle Lorie","Hurlimann Jean","Paster Bruce J"],"firstAuthor":"Miklossy Judith","referenceYear":"2004","referenceDate":"2004-12","id":"urn:lsid:swan.org:researchstatement:9777c50e-3273-4e01-a8de-e1ea9cdf6a48"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:fde7ce7c-b425-40fc-8077-b8c2348c4e7c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:fde7ce7c-b425-40fc-8077-b8c2348c4e7c","type":"Question","title":"Further studies will be required to fully determine the mechanism by which m266 affects memory performance.","label":"Further studies will be required to full...","icon":"../icons/ontological/discourse-element/research-question.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","id":"urn:lsid:swan.org:researchquestion:fde7ce7c-b425-40fc-8077-b8c2348c4e7c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e30af083-44c8-415d-b7c0-58666be97dbc&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e30af083-44c8-415d-b7c0-58666be97dbc","type":"Claim","title":"APP23/Ar+/- male mice exhibit a significant reduction in BACE1 and C99 or AICD protein levels compared with age-matched APP23 mice, while APP level was unchanged, suggesting that testosterone may attenuate Aβ production by down-regulating BACE1 protein levels in the brain.","label":"McAllister C et al.; APP23/Ar+/- male mice exhibit a signific...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Long Jiangang","Bowers Adrienne","Walker Aaron","Cao Philip","Honda Shin-Ichiro","Harada Nobuhiro","Staufenbiel Matthias","Shen Yong","Li Rena"],"firstAuthor":"McAllister Carrie","referenceYear":"2010","referenceDate":"2010-05-26","id":"urn:lsid:swan.org:researchstatement:e30af083-44c8-415d-b7c0-58666be97dbc"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9a30282e-ecb5-478f-9066-aa5f0fbd3d1a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9a30282e-ecb5-478f-9066-aa5f0fbd3d1a","type":"Claim","title":"ApoE-/- decreased amyloid A (AA) deposition in human and mouse spleen.","label":"Holtzman D; ApoE-/- decreased amyloid A (AA) deposit...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:9a30282e-ecb5-478f-9066-aa5f0fbd3d1a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2826d361-5c4d-4b84-8cc6-cf41457899c9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2826d361-5c4d-4b84-8cc6-cf41457899c9","type":"Claim","title":"Mouse apoE is 70% identical to human apoE at the amino acid level.","label":"Holtzman D; Mouse apoE is 70% identical to human apo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:2826d361-5c4d-4b84-8cc6-cf41457899c9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7b85d7c2-e3d6-4ce3-8650-80aa5e01a2b8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7b85d7c2-e3d6-4ce3-8650-80aa5e01a2b8","type":"Claim","title":"Developmental axonal degeneration similarly has many hallmarks of apoptosis\u2014 including blebbing, fragmentation, and phagocytic clearing of debris by neighboring cells.","label":"Nikolaev A et al.; Developmental axonal degeneration simila...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["McLaughlin Todd","O'Leary Dennis D","Tessier-Lavigne Marc"],"firstAuthor":"Nikolaev Anatoly","referenceYear":"2009","referenceDate":"2009-02-19","id":"urn:lsid:swan.org:researchstatement:7b85d7c2-e3d6-4ce3-8650-80aa5e01a2b8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7c2fcc1c-53c3-4d8d-a317-510aa5dcaa46&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7c2fcc1c-53c3-4d8d-a317-510aa5dcaa46","type":"Claim","title":"The PS clinical mutations could cause loss of function not only by interfering with the catalytic efficiency of the protease, but also by subtly modifying the docking of substrates and/or by interfering with the mechanism that moves the substrate towards the catalytic site.  This would explain the diverse effects of PS clinical mutations on APP and other substrates.","label":"Bentahir M et al.; The PS clinical mutations could cause lo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:7c2fcc1c-53c3-4d8d-a317-510aa5dcaa46"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:64fdaf88-1ea8-4a1c-a834-7737a42fe8dd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:64fdaf88-1ea8-4a1c-a834-7737a42fe8dd","type":"Claim","title":"Apoptosis and necrosis share some common stimuli. For most of these common stimuli, if the stimulus becomes too strong or the cell becomes too weak, necrotic pathways likely prevail.","label":"Cotman C et al.; Apoptosis and necrosis share some common...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:64fdaf88-1ea8-4a1c-a834-7737a42fe8dd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:618e33a5-d797-4afb-94b5-7a51b60beb9e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:618e33a5-d797-4afb-94b5-7a51b60beb9e","type":"Claim","title":"The putative key role of Aβ in the pathogenesis of Alzheimer Disease led to immunotherapeutic strategies that aimed to reduce levels of Aβ in the brain.","label":"Holmes C et al.; The putative key role of Aβ in the patho...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:618e33a5-d797-4afb-94b5-7a51b60beb9e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:28e9a267-c39c-408f-85b0-45d6302c1508&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:28e9a267-c39c-408f-85b0-45d6302c1508","type":"Claim","title":"APOE and CLU are both are present in amyloid plaques and can bind Aβ.","label":"Lambert J et al.; APOE and CLU are both are present in amy...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Heath Simon","Even Gael","Campion Dominique","Sleegers Kristel","Hiltunen Mikko","Combarros Onofre","Zelenika Diana","Bullido Maria J","Tavernier Béatrice","Letenneur Luc","Bettens Karolien","Berr Claudine","Pasquier Florence","Fiévet Nathalie","Barberger-Gateau Pascale","Engelborghs Sebastiaan","De Deyn Peter","Mateo Ignacio","Franck Ana","Helisalmi Seppo","Porcellini Elisa","Hanon Olivier","de Pancorbo Marian M","Lendon Corinne","Dufouil Carole","Jaillard Céline","Leveillard Thierry","Alvarez Victoria","Bosco Paolo","Mancuso Michelangelo","Panza Francesco","Nacmias Benedetta","Bossù Paola","Piccardi Paola","Annoni Giorgio","Seripa Davide","Galimberti Daniela","Hannequin Didier","Licastro Federico","Soininen Hilkka","Ritchie Karen","Blanché Hélène","Dartigues Jean-François","Tzourio Christophe","Gut Ivo","Van Broeckhoven Christine","Alpérovitch Annick","Lathrop Mark","Amouyel Philippe"],"firstAuthor":"Lambert Jean-Charles","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:28e9a267-c39c-408f-85b0-45d6302c1508"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:25cff474-06de-4810-a813-612635d6fe6a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:25cff474-06de-4810-a813-612635d6fe6a","type":"Claim","title":"The direct substrate of memory impairment is hippocampal atrophy on MRI, and not Aβ deposition as measured by Pittsburgh compound B (PiB) imaging.","label":"Jack C et al.; The direct substrate of memory impairmen...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:25cff474-06de-4810-a813-612635d6fe6a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b7cce430-456a-4961-9a3e-40825d723bde&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b7cce430-456a-4961-9a3e-40825d723bde","type":"Claim","title":"CAD cells are a useful model system for studying neurite retraction and retrodifferentiation.","label":"Muresan Z et al.; CAD cells are a useful model system for ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","id":"urn:lsid:swan.org:researchstatement:b7cce430-456a-4961-9a3e-40825d723bde"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f953fabd-b9e6-4e83-a4bc-caee34472562&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f953fabd-b9e6-4e83-a4bc-caee34472562","type":"Claim","title":"The amyloid hypothesis relies on a genetic framework.","label":"Hardy J et al.; The amyloid hypothesis relies on a genet...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:f953fabd-b9e6-4e83-a4bc-caee34472562"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9634d1e2-d87e-4fb7-acd7-a46fa239f4d9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9634d1e2-d87e-4fb7-acd7-a46fa239f4d9","type":"Claim","title":"The genetic link between sorLA variance and late-onset AD (LOAD) has been replicated in most (though not all) subsequent studies with positive linkage has been found in 13 out of 20 populations.","label":"Small S et al.; The genetic link between sorLA variance ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:9634d1e2-d87e-4fb7-acd7-a46fa239f4d9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:896014e2-4cf4-42a2-9852-a8ad5dee074a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:896014e2-4cf4-42a2-9852-a8ad5dee074a","type":"Hypothesis","title":"Loss of glucose transporter at blood brain barrier, in cerebral microvessels and cortex is specific and disease-related in Alzheimer disease.","label":"Kalaria R et al.; Loss of glucose transporter at blood bra...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Harik S I"],"firstAuthor":"Kalaria R N","referenceYear":"1989","referenceDate":"1989","id":"urn:lsid:swan.org:researchstatement:896014e2-4cf4-42a2-9852-a8ad5dee074a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8800377b-2c76-420f-bd1b-4265c4310d25&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8800377b-2c76-420f-bd1b-4265c4310d25","type":"Claim","title":"The myelination process is essential for many uniquely human brain functions such as language, higher cognition, and complex behaviors that are dependent on extremely fast information processing. ","label":"Bartzokis G; The myelination process is essential for...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:8800377b-2c76-420f-bd1b-4265c4310d25"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:09cea786-b1d5-4f33-953e-7caffc5610ce&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:09cea786-b1d5-4f33-953e-7caffc5610ce","type":"Claim","title":"The hippocampus is associated with the highest cerebral Gab2 expression in the rodent brain.","label":"Reiman E et al.; The hippocampus is associated with the h...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Jennifer A","Myers Amanda J","Hardy John","Dunckley Travis","Zismann Victoria L","Joshipura Keta D","Pearson John V","Hu-Lince Diane","Huentelman Matthew J","Craig David W","Coon Keith D","Liang Winnie S","Herbert RiLee H","Beach Thomas","Rohrer Kristen C","Zhao Alice S","Leung Doris","Bryden Leslie","Marlowe Lauren","Kaleem Mona","Mastroeni Diego","Grover Andrew","Heward Christopher B","Ravid Rivka","Rogers Joseph","Hutton Michael L","Melquist Stacey","Petersen Ron C","Alexander Gene E","Caselli Richard J","Kukull Walter","Papassotiropoulos Andreas","Stephan Dietrich A"],"firstAuthor":"Reiman Eric M","referenceYear":"2007","referenceDate":"2007-06-07","id":"urn:lsid:swan.org:researchstatement:09cea786-b1d5-4f33-953e-7caffc5610ce"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3512150e-ea87-4cb8-b7ba-684ea810e197&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3512150e-ea87-4cb8-b7ba-684ea810e197","type":"Claim","title":"FAD-linked PS mutations are likely to be genetically antimorphic, causing an intrinsic loss of function as well as a gain of negative function, thereby bringing about an overall loss of PS activity.","label":"Shen J et al.; FAD-linked PS mutations are likely to be...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:3512150e-ea87-4cb8-b7ba-684ea810e197"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:134ed08c-09d8-4623-89ab-0521195905b3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:134ed08c-09d8-4623-89ab-0521195905b3","type":"Claim","title":"Tau pathology in AD involves the spread of tau deposits from the trans-entorhinal cortex to the hippocampus and cortical areas, correlated with trans-synaptic distance. ","label":"Frost B et al.; Tau pathology in AD involves the spread ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Jacks Rachel L","Diamond Marc I"],"firstAuthor":"Frost Bess","referenceYear":"2009","referenceDate":"2009-05-08","id":"urn:lsid:swan.org:researchstatement:134ed08c-09d8-4623-89ab-0521195905b3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5ef14756-982d-4f99-97d0-4f9702adbb02&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5ef14756-982d-4f99-97d0-4f9702adbb02","type":"Claim","title":"By the data censoring date, 53% of the AN1792 treated group and 50% of the placebo group had died with no evidence of differences in survival time between the treated and placebo groups, even after correction for cognitive state and age at the start of the study.","label":"Holmes C et al.; By the data censoring date, 53% of the A...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:5ef14756-982d-4f99-97d0-4f9702adbb02"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c27dcaf3-75e5-4574-afb5-f0eee0c8a0c8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c27dcaf3-75e5-4574-afb5-f0eee0c8a0c8","type":"Claim","title":"Activated microglia may clear amyloid deposits.","label":"Meyer-Luehmann M et al.; Activated microglia may clear amyloid de...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:c27dcaf3-75e5-4574-afb5-f0eee0c8a0c8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:48b6317f-8eb6-44e6-9d01-b9dc4ca2290e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:48b6317f-8eb6-44e6-9d01-b9dc4ca2290e","type":"Claim","title":"Facilitation of Aβ clearance carries the potential to be equally effective at lowering beta amyloid burden.","label":"Tanzi R et al.; Facilitation of Aβ clearance carries the...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:48b6317f-8eb6-44e6-9d01-b9dc4ca2290e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bdf578a6-4826-4d19-a564-c69e4dc8f8d9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bdf578a6-4826-4d19-a564-c69e4dc8f8d9","type":"Claim","title":"Oligomeric Aβ formation and levels in V717F APP751 transfected cell conditioned media was reduced by treating transfected cells with γ-secretase inhibitors DAPM and MWIII-20.","label":"Walsh D et al.; Oligomeric Aβ formation and levels in V7...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Klyubin Igor","Fadeeva Julia V","Cullen William K","Anwyl Roger","Wolfe Michael S","Rowan Michael J","Selkoe Dennis J"],"firstAuthor":"Walsh Dominic M","referenceYear":"2002","referenceDate":"2002-04-04","id":"urn:lsid:swan.org:researchstatement:bdf578a6-4826-4d19-a564-c69e4dc8f8d9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:59387662-b01e-4dcd-921f-f14c6a1959cf&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:59387662-b01e-4dcd-921f-f14c6a1959cf","type":"Claim","title":"Aβ isolated from AD brain stably associated with apoE protein.","label":"Holtzman D; Aβ isolated from AD brain stably associa...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:59387662-b01e-4dcd-921f-f14c6a1959cf"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e23b823e-1647-4142-9cdb-21cff8ed727f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e23b823e-1647-4142-9cdb-21cff8ed727f","type":"Claim","title":"IP3-mediated calcium release was more than threefold greater in the PS1 mutant mice relative to age matched NonTg controls.","label":"Smith I et al.; IP3-mediated calcium release was more th...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:e23b823e-1647-4142-9cdb-21cff8ed727f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:77e24b03-c9e4-4453-bd00-b46827eaabd5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:77e24b03-c9e4-4453-bd00-b46827eaabd5","type":"Claim","title":"Tau hyperphosphorylation can be induced with stress in neurons that subsequently degenerate.","label":"Cotman C et al.; Tau hyperphosphorylation can be induced ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:77e24b03-c9e4-4453-bd00-b46827eaabd5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c428b751-2244-4de1-9a46-94381703fabe&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c428b751-2244-4de1-9a46-94381703fabe","type":"Claim","title":"Recent neuropathological analysis of 180 subjects from longitudinal community based cohort with extensive medical history, pharmacy records, biannual cognitive evaluation demonstrates a role of vascular factors in neuropathology of diabetes and dementia such that diabetes reduces AD pathological markers compared to non-diabetic subjects with dementia.        ","label":"Craft S; Recent neuropathological analysis of 180...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft Suzanne","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:c428b751-2244-4de1-9a46-94381703fabe"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:458ac699-2655-4280-a36d-3300cfc2fb67&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:458ac699-2655-4280-a36d-3300cfc2fb67","type":"Claim","title":"Neuritic plaques contain at their core extracellular deposits of Aβ peptide.","label":"Neuritic plaques contain at their core e...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:458ac699-2655-4280-a36d-3300cfc2fb67"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b090c7bd-adb2-4b3b-9bea-06ae7dbb5800&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b090c7bd-adb2-4b3b-9bea-06ae7dbb5800","type":"Hypothesis","title":"Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer\u2019s disease.","label":"Meyer-Luehmann M et al.; Rapid appearance and local toxicity of a...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:b090c7bd-adb2-4b3b-9bea-06ae7dbb5800"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:107ead07-f588-4082-9868-5a57366d1a2a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:107ead07-f588-4082-9868-5a57366d1a2a","type":"Claim","title":"In the absence of Wnt, the signaling pool of β-catenin is maintained at low levels through degradation.","label":"Hooper C et al.; In the absence of Wnt, the signaling poo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:107ead07-f588-4082-9868-5a57366d1a2a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:45f48fc1-799d-44c0-9a8f-dd2f8a0ffca2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:45f48fc1-799d-44c0-9a8f-dd2f8a0ffca2","type":"Claim","title":"Presenilin mutations increase A&#946;42, accelerating aggregation.","label":"Golde T; Presenilin mutations increase A&#946;42,...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde T","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:45f48fc1-799d-44c0-9a8f-dd2f8a0ffca2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:1af29356-2ed4-4ae2-b12b-8ff6d90ce74b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:1af29356-2ed4-4ae2-b12b-8ff6d90ce74b","type":"Comment","title":"July 2008 update on Cotman hypothesis \"Apoptosis is a mechanism of neuronal death in Alzheimer disease.\"","label":"Cotman C; July 2008 update on Cotman hypothesis \"A...","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Cotman Carl W","id":"urn:lsid:swan.org:comment:1af29356-2ed4-4ae2-b12b-8ff6d90ce74b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bd9263e7-a22d-4a51-b707-fd9aa9d469e5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bd9263e7-a22d-4a51-b707-fd9aa9d469e5","type":"Claim","title":"It is not always clear how well use of cell culture to examine the issue of axonal transport recapitulates what occurs in living animals.","label":"Lee V et al.; It is not always clear how well use of c...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Trojanowski John Q"],"firstAuthor":"Lee Virginia M-Y","id":"urn:lsid:swan.org:researchstatement:bd9263e7-a22d-4a51-b707-fd9aa9d469e5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f20fe9cf-3808-4fcb-9ae9-72b4bff63d1f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f20fe9cf-3808-4fcb-9ae9-72b4bff63d1f","type":"Claim","title":"One concern about the continued development of anti-Abeta immunization is meningio-encephalitis that caused the halting of a Phase II clinical trial.","label":"Golde T; One concern about the continued developm...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde T","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:f20fe9cf-3808-4fcb-9ae9-72b4bff63d1f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1209e7e4-c2ff-447f-a05d-9dd203d63350&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1209e7e4-c2ff-447f-a05d-9dd203d63350","type":"Claim","title":"Unless further activated, microglia do not successfully clear plaques but instead may well restrict their growth, leading to the observed steady state of plaque size after initial formation.","label":"Meyer-Luehmann M et al.; Unless further activated, microglia do n...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:1209e7e4-c2ff-447f-a05d-9dd203d63350"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bfa41ff8-d31b-4b89-9d67-83cb5fda3244&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bfa41ff8-d31b-4b89-9d67-83cb5fda3244","type":"Hypothesis","title":"PS1 clinical mutations can affect γ-secretase activity by different mechanisms.","label":"Bentahir M et al.; PS1 clinical mutations can affect γ-secr...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:bfa41ff8-d31b-4b89-9d67-83cb5fda3244"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:0f844509-4a1c-4b21-985f-be92063b8656&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:0f844509-4a1c-4b21-985f-be92063b8656","type":"Question","title":"Does inhibition of presenilin make neurodegeneration worse?","label":"Does inhibition of presenilin make neuro...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:0f844509-4a1c-4b21-985f-be92063b8656"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7a61463a-f527-44d6-95fc-916bdd3fc998&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7a61463a-f527-44d6-95fc-916bdd3fc998","type":"Hypothesis","title":"Amyloid-β protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory","label":"Shankar G et al.; Amyloid-β protein dimers isolated direct...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Li Shaomin","Mehta Tapan H","Garcia-Munoz Amaya","Shepardson Nina E","Smith Imelda","Brett Francesca M","Farrell Michael A","Rowan Michael J","Lemere Cynthia A","Regan Ciaran M","Walsh Dominic M","Sabatini Bernardo L","Selkoe Dennis J"],"firstAuthor":"Shankar Ganesh M","referenceYear":"2008","referenceDate":"2008-08","id":"urn:lsid:swan.org:researchstatement:7a61463a-f527-44d6-95fc-916bdd3fc998"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b076f5a8-85c3-4d84-842d-689b63e08001&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b076f5a8-85c3-4d84-842d-689b63e08001","type":"Claim","title":"Fluorodeoxyglucose (FDG)-PET uptake, used to measure net brain glucose metabolism, is largely indicative of synaptic activity and highly correlates with post-mortem measures of the synaptic structural protein synaptophysin.","label":"Jack C et al.; Fluorodeoxyglucose (FDG)-PET uptake, use...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2003","referenceDate":"2003-11","id":"urn:lsid:swan.org:researchstatement:b076f5a8-85c3-4d84-842d-689b63e08001"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f3ed1b5e-4211-4f59-b8d1-1e9286ccd363&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f3ed1b5e-4211-4f59-b8d1-1e9286ccd363","type":"Claim","title":"In a departure from the chaperone mediated clearance mode, there is strong evidence for the direct interaction of LRP and Aβ on brain capillaries indicating that Aβ can be transported across the BBB and be cleared from the brain after directly binding to LRP.","label":"Tanzi R et al.; In a departure from the chaperone mediat...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:f3ed1b5e-4211-4f59-b8d1-1e9286ccd363"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f3501fc5-404a-45ae-86a1-088f0c6171ac&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f3501fc5-404a-45ae-86a1-088f0c6171ac","type":"Claim","title":"Aβ can alter the activity of a number calcium conducting ion channels such as voltage-gated calcium channels, NMDA receptors and nicotinic receptors.","label":"Smith I et al.; Aβ can alter the activity of a number ca...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:f3501fc5-404a-45ae-86a1-088f0c6171ac"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8e794554-1b59-4e9f-b0c8-cdf5ab2cb81c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8e794554-1b59-4e9f-b0c8-cdf5ab2cb81c","type":"Claim","title":"Neuritic Aβ accumulations co-localize with markers of late endosomes and autophagic vacuoles.","label":"Muresan Z et al.; Neuritic Aβ accumulations co-localize wi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","referenceYear":"2008","referenceDate":"2008","id":"urn:lsid:swan.org:researchstatement:8e794554-1b59-4e9f-b0c8-cdf5ab2cb81c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ffdce07b-becd-424c-af40-57719c7af821&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ffdce07b-becd-424c-af40-57719c7af821","type":"Claim","title":"Not all of the presenilin-mediated calcium signalling effects can be accounted for γ-secretase activity, because the PS1-mediated effects on capacitative calcium entry occur independently of APP.","label":"Smith I et al.; Not all of the presenilin-mediated calci...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:ffdce07b-becd-424c-af40-57719c7af821"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9fe68b71-bad4-4ed8-ae79-48df04a6277a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9fe68b71-bad4-4ed8-ae79-48df04a6277a","type":"Claim","title":"Increased Aβ catabolism in mouse models attenuates AD-like neuropathology.","label":"Hardy J et al.; Increased Aβ catabolism in mouse models ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","id":"urn:lsid:swan.org:researchstatement:9fe68b71-bad4-4ed8-ae79-48df04a6277a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2d917920-cd75-4e29-9a31-b57f0200d4c6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2d917920-cd75-4e29-9a31-b57f0200d4c6","type":"Claim","title":"The phosphorylation of APP observed under the different conditions, synchrony of cells at G2/M phase or activation of cdc2 kinase by okadaic acid, supports the contention that APP phosphorylation by cdc2 kinase occurs in intact cells.","label":"Suzuki T et al.; The phosphorylation of APP observed unde...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:2d917920-cd75-4e29-9a31-b57f0200d4c6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:96d761c6-3b96-4273-ac94-eab12f0bee79&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:96d761c6-3b96-4273-ac94-eab12f0bee79","type":"Claim","title":"CAA consists of Aβ deposited in beta-sheet conformation in leptomeningeal and cortical blood vessels.","label":"Holtzman D; CAA consists of Aβ deposited in beta-she...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:96d761c6-3b96-4273-ac94-eab12f0bee79"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:6206b67f-5fc2-4062-8c1d-a9197cfda881&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:6206b67f-5fc2-4062-8c1d-a9197cfda881","type":"Question","title":"Why does misfolded amyloid protein accumulate progressively throughout the brain in tauopathy and other neurodegenerative diseases?","label":"Why does misfolded amyloid protein accum...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:6206b67f-5fc2-4062-8c1d-a9197cfda881"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:f6c90688-8685-4b47-8884-dd29b48dcc6e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:f6c90688-8685-4b47-8884-dd29b48dcc6e","type":"Question","title":"Additional studies in AD mouse models expressing human apoE2 will be useful in determining the mechanism of this CAA-associated hemorrhage.","label":"Additional studies in AD mouse models ex...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:f6c90688-8685-4b47-8884-dd29b48dcc6e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:19dcd37f-dfbc-4672-b34b-497220d6f9e7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:19dcd37f-dfbc-4672-b34b-497220d6f9e7","type":"Hypothesis","title":"ApoJ/Clusterin contributes to chronic inflammation and neurotoxicity through direct effects on microglia.","label":"Xie Z et al.; ApoJ/Clusterin contributes to chronic in...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Harris-White M E","Wals P A","Frautschy S A","Finch C E","Morgan T E"],"firstAuthor":"Xie Z","referenceYear":"2005","referenceDate":"2005-05","id":"urn:lsid:swan.org:researchstatement:19dcd37f-dfbc-4672-b34b-497220d6f9e7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9f42eed6-3240-4248-ad13-2a54c62926ff&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9f42eed6-3240-4248-ad13-2a54c62926ff","type":"Claim","title":"In the AN1792 immunized participants, mean Aβ load was lower than in the unimmunized controls although there was considerable variation both in the Aβ load and in the degree of plaque removal among the immunized participants.","label":"Holmes C et al.; In the AN1792 immunized participants, me...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:9f42eed6-3240-4248-ad13-2a54c62926ff"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f3470fcb-9562-4db3-9bb8-8d85266608fa&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f3470fcb-9562-4db3-9bb8-8d85266608fa","type":"Claim","title":"ADDLs are oligomeric had mass between 17 and 42 kDa, with the predominant species at 27 kDa and a minor species at 17 kDa.","label":"Lambert M et al.; ADDLs are oligomeric had mass between 17...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:f3470fcb-9562-4db3-9bb8-8d85266608fa"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ce26027f-c46c-44c2-8378-62a0b60c2025&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ce26027f-c46c-44c2-8378-62a0b60c2025","type":"Claim","title":"Bath application of high concentrations of Aβ1\u201340 cause a rapid increase in intracellular calcium in human fibroblasts and GT1-7 hypothalamic neurons; both responses attributed to formation of Aβ channels.","label":"Smith I et al.; Bath application of high concentrations ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:ce26027f-c46c-44c2-8378-62a0b60c2025"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:758d21a9-1bf9-4b67-999e-1391e589c840&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:758d21a9-1bf9-4b67-999e-1391e589c840","type":"Comment","title":"Update on Holtzman hypothesis \u201cApoE interacts with Aβ peptide, influences Aβ conformation and clearance in vivo.\u201d","label":"Holtzman D; Update on Holtzman hypothesis \u201cApoE inte...","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Holtzman David M","id":"urn:lsid:swan.org:comment:758d21a9-1bf9-4b67-999e-1391e589c840"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a7ec042e-3747-48bc-8787-b36abefbbf2d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a7ec042e-3747-48bc-8787-b36abefbbf2d","type":"Claim","title":"It is possible that TdT labeling in some AD cortical or hippocampal cells represents an active process of DNA-damage/DNA repair in cells at risk.","label":"Cotman C et al.; It is possible that TdT labeling in some...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:a7ec042e-3747-48bc-8787-b36abefbbf2d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:69fd29ff-6847-45a1-a594-3b79600be670&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:69fd29ff-6847-45a1-a594-3b79600be670","type":"Claim","title":"Some PS mutations that strongly increase Aβ metabolism correlates with spastic paraparesis and large \"cotton wool\" plaques, rather than accelerated early AD onset.","label":"Hardy J et al.; Some PS mutations that strongly increase...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:69fd29ff-6847-45a1-a594-3b79600be670"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:255fe902-a472-4251-bbd0-9af4af6c5a3a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:255fe902-a472-4251-bbd0-9af4af6c5a3a","type":"Claim","title":"IL-6 and MCP-1 are markedly upregulated in AD, as are CXCR2 receptors.","label":"Golde T et al.; IL-6 and MCP-1 are markedly upregulated ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:255fe902-a472-4251-bbd0-9af4af6c5a3a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:73d6eb0b-870c-447c-941b-b86c24f7a513&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:73d6eb0b-870c-447c-941b-b86c24f7a513","type":"Claim","title":"Wild-type PS2 produced less Aβ40 and Aβ42 than wild-type PS1 in PS1 deficient fibroblasts, despite more expression of WT PS2 than PS1 and comparable incorporation of PS2 into stable γ-secretase complexes.","label":"Bentahir M et al.; Wild-type PS2 produced less Aβ40 and Aβ4...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:73d6eb0b-870c-447c-941b-b86c24f7a513"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:25ad8f75-e2b1-485a-b16c-830eb5186d2b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:25ad8f75-e2b1-485a-b16c-830eb5186d2b","type":"Comment","title":"Hasegawa comment on Hardy hypothesis  \"A critical reappraisal of the Amyloid Hypothesis, in response to inconclusive clinical trial results.\"","label":"Hasegawa T; Hasegawa comment on Hardy hypothesis  \"A...","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Hasegawa Tohru","id":"urn:lsid:swan.org:comment:25ad8f75-e2b1-485a-b16c-830eb5186d2b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7276d9a2-99cd-44ee-ac5a-e263a07114b3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7276d9a2-99cd-44ee-ac5a-e263a07114b3","type":"Claim","title":"In the forebrains of p25 transgenic mice, SIRT1 protein levels increased as early as 2 weeks after p25 induction and persisted throughout the progression of the pathology to 12 weeks.","label":"Kim D et al.; In the forebrains of p25 transgenic mice...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:7276d9a2-99cd-44ee-ac5a-e263a07114b3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b0f7ac51-dfdd-44ce-b0ef-e9197e93cf6c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b0f7ac51-dfdd-44ce-b0ef-e9197e93cf6c","type":"Claim","title":"Myelin-associated glycoprotein (MAG) has recently been suggested to interact with axonal receptors and have protective effects upon underlying axons.","label":"Bartzokis G; Myelin-associated glycoprotein (MAG) has...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:b0f7ac51-dfdd-44ce-b0ef-e9197e93cf6c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:db0f8046-58b0-4c73-992f-c16b4fd95bee&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:db0f8046-58b0-4c73-992f-c16b4fd95bee","type":"Claim","title":"Absence of the major CNS myelin protein proteolipid protein 1 (PLP1) in the overlying myelin  can result in axonal degeneration phenotype in the absence of demyelination or inflammation or axonal swelling.","label":"Bartzokis G; Absence of the major CNS myelin protein ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:db0f8046-58b0-4c73-992f-c16b4fd95bee"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:59b00b8c-b7ef-4ca6-af5d-782edbf34b82&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:59b00b8c-b7ef-4ca6-af5d-782edbf34b82","type":"Claim","title":"Intracellular stress may lead to the initiation of Aβ oligomerization and accumulation.","label":"Muresan Z et al.; Intracellular stress may lead to the ini...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","referenceYear":"2008","referenceDate":"2008","id":"urn:lsid:swan.org:researchstatement:59b00b8c-b7ef-4ca6-af5d-782edbf34b82"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ac571618-4761-4e41-94ec-882e2de78e3e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ac571618-4761-4e41-94ec-882e2de78e3e","type":"Claim","title":"Data overwhelmingly support the \u2018Aβ aggregate/amyloid cascade\u2019 hypothesis, which posits that Aβ aggregation and accumulation precedes, and therefore drives, tau accumulation.","label":"Golde T et al.; Data overwhelmingly support the \u2018Aβ aggr...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:ac571618-4761-4e41-94ec-882e2de78e3e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:858163ad-7c20-4a90-8a64-dc309ffc553d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:858163ad-7c20-4a90-8a64-dc309ffc553d","type":"Claim","title":"In vivo evidence supports the attenuation of tau aggregation by CHIP upregulation.","label":"Carrettiero D et al.; In vivo evidence supports the attenuatio...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hernandez Israel","Neveu Pierre","Papagiannakopoulos Thales","Kosik Kenneth S"],"firstAuthor":"Carrettiero Daniel C","referenceYear":"2009","referenceDate":"2009-02-18","id":"urn:lsid:swan.org:researchstatement:858163ad-7c20-4a90-8a64-dc309ffc553d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b7783f55-4466-4054-bff3-a9a0a70bb7fb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b7783f55-4466-4054-bff3-a9a0a70bb7fb","type":"Claim","title":"AD pathophysiological mechanisms may be different in mice and humans, and caution should be applied in comparisons of disease mechanisms between species.","label":"Hasegawa T; AD pathophysiological mechanisms may be ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Hasegawa Tohru","id":"urn:lsid:swan.org:researchstatement:b7783f55-4466-4054-bff3-a9a0a70bb7fb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4f4dc191-8b98-4ecb-9049-a1e0d70fc9c6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4f4dc191-8b98-4ecb-9049-a1e0d70fc9c6","type":"Claim","title":"High concentration of cholesterol in brain or cells can increase Aβ.","label":"High concentration of cholesterol in bra...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:4f4dc191-8b98-4ecb-9049-a1e0d70fc9c6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3eb62325-8446-4032-b1e4-e09558455738&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3eb62325-8446-4032-b1e4-e09558455738","type":"Claim","title":"The peak slow transport rate between 7 and 14 d was calculated as 0.14mm/d for neurofilament proteins in both tau-null and wild-type mouse optic axons.","label":"Yuan A et al.; The peak slow transport rate between 7 a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:3eb62325-8446-4032-b1e4-e09558455738"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e464f6ec-8dd2-4999-aaab-26635ef2de41&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e464f6ec-8dd2-4999-aaab-26635ef2de41","type":"Claim","title":"Aβ, tau, and α-syn can synergistically exacerbate the aggregation and deposition of each other, thereby promoting the additional acceleration of cognitive decline, although no qualitative differences between DLB-AD and 3xTg-AD mice were observed in neuronal or glial density and morphology.","label":"Clinton L et al.; Aβ, tau, and α-syn can synergistically e...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Blurton-Jones Mathew","Myczek Kristoffer","Trojanowski John Q","LaFerla Frank M"],"firstAuthor":"Clinton Lani K","referenceYear":"2010","referenceDate":"2010-05-26","id":"urn:lsid:swan.org:researchstatement:e464f6ec-8dd2-4999-aaab-26635ef2de41"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ff6ab49c-664c-40ba-9153-cf3d72f7b76c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ff6ab49c-664c-40ba-9153-cf3d72f7b76c","type":"Claim","title":"ApoE regulates extracellular Aβ metabolism and deposition in vivo.","label":"Holtzman D; ApoE regulates extracellular Aβ metaboli...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman David M","id":"urn:lsid:swan.org:researchstatement:ff6ab49c-664c-40ba-9153-cf3d72f7b76c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d285da3c-3598-4c91-bb33-62258282ec85&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d285da3c-3598-4c91-bb33-62258282ec85","type":"Claim","title":"Intranasal insulin administration increases plasma Aβ with Aβ40:Aβ42 ratio increased after 21 days treatment.","label":"Craft S; Intranasal insulin administration increa...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft Suzanne","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:d285da3c-3598-4c91-bb33-62258282ec85"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5b658835-7596-448b-aa25-20ac2fdc2ccb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5b658835-7596-448b-aa25-20ac2fdc2ccb","type":"Claim","title":"Intracellular Aβ staining of neurons from Down syndrome brain neurons could be due to increased APP expression.","label":"Selkoe D; Intracellular Aβ staining of neurons fro...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Selkoe Dennis J","id":"urn:lsid:swan.org:researchstatement:5b658835-7596-448b-aa25-20ac2fdc2ccb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4d39e0fd-05c5-4e54-be8a-ce6661a1f50a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4d39e0fd-05c5-4e54-be8a-ce6661a1f50a","type":"Claim","title":"Oligomeric Aβ intermediate assemblies are potent neurotoxins.","label":"Bitan G et al.; Oligomeric Aβ intermediate assemblies ar...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:4d39e0fd-05c5-4e54-be8a-ce6661a1f50a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:03ea9f4a-fffc-4436-9637-34620e694fc5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:03ea9f4a-fffc-4436-9637-34620e694fc5","type":"Claim","title":"The SIRT1 gene is believed to provide cell protection during times of cell stress; however, the role of SIRT1 in vivo in age-dependent chronic neurodegenerative disorders remains undefined.","label":"Kim D et al.; The SIRT1 gene is believed to provide ce...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:03ea9f4a-fffc-4436-9637-34620e694fc5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0483c961-4f2e-4acd-b565-8faa315ad34e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0483c961-4f2e-4acd-b565-8faa315ad34e","type":"Claim","title":"Accumulation of Aβ begins within neurites, prior to any major signs of neurodegeneration or cell death, although the terminals that contain accumulations appear dystrophic.","label":"Muresan Z et al.; Accumulation of Aβ begins within neurite...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","referenceYear":"2008","referenceDate":"2008","id":"urn:lsid:swan.org:researchstatement:0483c961-4f2e-4acd-b565-8faa315ad34e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5ed10ff6-f273-4a7b-9197-e7a278b554b6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5ed10ff6-f273-4a7b-9197-e7a278b554b6","type":"Claim","title":"The MT-binding ability of tau is post-translationally regulated primarily by serine/threonine-directed phosphorylation which can effectively modulate the binding affinity of tau for MTs.","label":"Ballatore C et al.; The MT-binding ability of tau is post-tr...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Lee Virginia M-Y","Trojanowski John Q"],"firstAuthor":"Ballatore Carlo","referenceYear":"2007","referenceDate":"2007-09","id":"urn:lsid:swan.org:researchstatement:5ed10ff6-f273-4a7b-9197-e7a278b554b6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6d8197ce-a526-48da-a25c-cfe60a6c242b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6d8197ce-a526-48da-a25c-cfe60a6c242b","type":"Claim","title":"Reduction of β-amyloid  peptide, a hallmark of AD, occurs in brains of calorie-restricted animals and can be reproduced in mouse neurons in vitro by manipulating cellular SIRT1 expression/ activity.","label":"Kim D et al.; Reduction of β-amyloid  peptide, a hallm...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:6d8197ce-a526-48da-a25c-cfe60a6c242b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e01e15ab-8b7a-45c1-82c7-aadc219269af&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e01e15ab-8b7a-45c1-82c7-aadc219269af","type":"Claim","title":"Nondemented older individuals with elevated PiB binding levels also demonstrate regional brain atrophy and cerebral cortical thinning as well as episodic memory deficits and longitudinal cognitive decline.","label":"Morris J et al.; Nondemented older individuals with eleva...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Roe Catherine M","Grant Elizabeth A","Head Denise","Storandt Martha","Goate Alison M","Fagan Anne M","Holtzman David M","Mintun Mark A"],"firstAuthor":"Morris John C","referenceYear":"2009","referenceDate":"2009-12","id":"urn:lsid:swan.org:researchstatement:e01e15ab-8b7a-45c1-82c7-aadc219269af"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:95dc4f1a-9396-486c-90e7-8d27fcc2f2d3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:95dc4f1a-9396-486c-90e7-8d27fcc2f2d3","type":"Question","title":"To test the myelin model of aging and AD, long lived strains of myelin deficient rodents could be examined to see if there is any difference in amyloid load with aging.","label":"To test the myelin model of aging and AD...","icon":"../icons/ontological/discourse-element/research-question.png","firstAuthor":"Barres Ben A","id":"urn:lsid:swan.org:researchquestion:95dc4f1a-9396-486c-90e7-8d27fcc2f2d3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e0865fa8-fe70-4c64-9014-23c3cd04d1de&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e0865fa8-fe70-4c64-9014-23c3cd04d1de","type":"Claim","title":"While amyloid-β (Aβ) may play a downstream role through perturbation of Ca2+ homeostasis, oxidative stress as the initiator needs to be addressed since oxidative stress affects both Aβ production and tau phosphorylation.","label":"Petersen R et al.; While amyloid-β (Aβ) may play a downstre...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Castellani Rudolph J","Nunomura Akihiko","Zhu Xiongwei","Lee Hyoung-gon","Perry George","Smith Mark A"],"firstAuthor":"Petersen R B","id":"urn:lsid:swan.org:researchstatement:e0865fa8-fe70-4c64-9014-23c3cd04d1de"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:60111c0e-526a-4449-8e29-9df84b15ad66&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:60111c0e-526a-4449-8e29-9df84b15ad66","type":"Claim","title":"ApoE4 increases Aβ amyloid production.","label":"Golde T; ApoE4 increases Aβ amyloid production.","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde Todd E","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:60111c0e-526a-4449-8e29-9df84b15ad66"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1ae8d7ae-f6c5-44ed-9702-4dac6b467711&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1ae8d7ae-f6c5-44ed-9702-4dac6b467711","type":"Claim","title":"The mean antibody response during the AN1792 treatment period showed a non-significant inverse correlation with post-mortem Aβ load.","label":"Holmes C et al.; The mean antibody response during the AN...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:1ae8d7ae-f6c5-44ed-9702-4dac6b467711"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:534ea191-013c-4c1b-8ef7-d42a4f56703f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:534ea191-013c-4c1b-8ef7-d42a4f56703f","type":"Claim","title":"Trisomy 21 increases Aβ by gene dosage of APP, increasing expression and Aβ.","label":"Golde T; Trisomy 21 increases Aβ by gene dosage o...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde T","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:534ea191-013c-4c1b-8ef7-d42a4f56703f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8db50dcd-bf60-489a-8f34-eabc727c97e7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8db50dcd-bf60-489a-8f34-eabc727c97e7","type":"Hypothesis","title":"Blood-Brain Barrier and Alzheimer Disease: Pathogenesis of Alzheimer disease begins with a leakage of a neurotoxin through a defective cortical blood brain barrier.","label":"Mann D; Blood-Brain Barrier and Alzheimer Diseas...","icon":"../icons/ontological/discourse-element/h-research-statement.png","firstAuthor":"Mann D M","referenceYear":"1985","referenceDate":"1985-09","id":"urn:lsid:swan.org:researchstatement:8db50dcd-bf60-489a-8f34-eabc727c97e7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3ed8eb43-6163-407d-b722-367ce08216d2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3ed8eb43-6163-407d-b722-367ce08216d2","type":"Claim","title":"CREB inhibition may involve displacement of Fyn which is normally tethered to PSD-95 and has been associated with neuronal death, memory deficits and AD pathology.","label":"Gong Y et al.; CREB inhibition may involve displacement...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:3ed8eb43-6163-407d-b722-367ce08216d2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:992aa7b1-203d-4b9c-9c69-1967b0fdb613&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:992aa7b1-203d-4b9c-9c69-1967b0fdb613","type":"Claim","title":"Rapid increase of Kv4.2 expression induced by amyloid beta may be due to reduced degradation of channel protein.","label":"Plant L et al.; Rapid increase of Kv4.2 expression induc...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:992aa7b1-203d-4b9c-9c69-1967b0fdb613"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3036feae-3170-44b9-b155-3d450ee59add&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3036feae-3170-44b9-b155-3d450ee59add","type":"Claim","title":"Resveratrol may also stimulate the deacetylation of forkhead FOXO3/4 transcription factors, thereby enhancing gene expression of antioxidative molecules and upregulating DNA repair.","label":"Kim D et al.; Resveratrol may also stimulate the deace...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:3036feae-3170-44b9-b155-3d450ee59add"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a19bd092-802b-47a7-8156-32baa5df9eb1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a19bd092-802b-47a7-8156-32baa5df9eb1","type":"Claim","title":"When a normal protein misfolds and aggregates, it no longer resembles a self protein but rather resemble pathogen-associated molecular patterns (PAMPs) and thymus independent type 2 (TI-2) antigens; thus, it is subject to recognition by the immune system, and like PAMPS, can activate a wide array of innate immune defenses.","label":"Golde T et al.; When a normal protein misfolds and aggre...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:a19bd092-802b-47a7-8156-32baa5df9eb1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f5a9bc13-220d-4cdb-92a3-efb058c8fc93&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f5a9bc13-220d-4cdb-92a3-efb058c8fc93","type":"Hypothesis","title":"Estrogen use in postmenopausal women may delay the onset and decrease the risk of Alzheimer disease.","label":"Tang M et al.; Estrogen use in postmenopausal women may...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Jacobs D","Stern Y","Marder K","Schofield P","Gurland B","Andrews H","Mayeux R"],"firstAuthor":"Tang M X","referenceYear":"1996","referenceDate":"1996-08-17","id":"urn:lsid:swan.org:researchstatement:f5a9bc13-220d-4cdb-92a3-efb058c8fc93"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e230b7da-0e5f-49ad-bf85-65f140fae0c7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e230b7da-0e5f-49ad-bf85-65f140fae0c7","type":"Claim","title":"Prefibrillar Aβ assemblies may be neurotoxic in vivo.","label":"Hardy J et al.; Prefibrillar Aβ assemblies may be neurot...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:e230b7da-0e5f-49ad-bf85-65f140fae0c7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:192e43be-ce5d-4108-8870-ad988ec1039a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:192e43be-ce5d-4108-8870-ad988ec1039a","type":"Claim","title":"Aβ42 is found in the CSF of nondemented individuals and has been implicated as a physiological regulator of synaptic activity.","label":"Giuffrida M et al.; Aβ42 is found in the CSF of nondemented ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Caraci Filippo","Pignataro Bruno","Cataldo Sebastiano","De Bona Paolo","Bruno Valeria","Molinaro Gemma","Pappalardo Giuseppe","Messina Angela","Palmigiano Angelo","Garozzo Domenico","Nicoletti Ferdinando","Rizzarelli Enrico","Copani Agata"],"firstAuthor":"Giuffrida Maria Laura","referenceYear":"2009","referenceDate":"2009-08-26","id":"urn:lsid:swan.org:researchstatement:192e43be-ce5d-4108-8870-ad988ec1039a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4e7995db-60c4-497c-8522-2e4d225cc720&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4e7995db-60c4-497c-8522-2e4d225cc720","type":"Claim","title":"In APP, the residues 668-671 represent a consensus sequence for phosphorylation by casein kinase II.","label":"Suzuki T et al.; In APP, the residues 668-671 represent a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:4e7995db-60c4-497c-8522-2e4d225cc720"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b6084d53-dc88-45c3-b691-f4b7c14b572a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b6084d53-dc88-45c3-b691-f4b7c14b572a","type":"Claim","title":"Tau protein and neurofilament protein are phosphorylated by cdc2 kinase in vitro.","label":"Suzuki T et al.; Tau protein and neurofilament protein ar...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:b6084d53-dc88-45c3-b691-f4b7c14b572a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5a895aff-b0a6-481a-9e1a-8bdbf8dd1c75&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5a895aff-b0a6-481a-9e1a-8bdbf8dd1c75","type":"Claim","title":"The presenilin inhibition hypothesis ignores the analogy of British dementia, another plaque and tangle disease, in which γ-secretase does not seem to be involved. ","label":"Hardy ; The presenilin inhibition hypothesis ign...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Hardy","referenceYear":"2009","referenceDate":"2009-05-18","id":"urn:lsid:swan.org:researchstatement:5a895aff-b0a6-481a-9e1a-8bdbf8dd1c75"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1b76008b-1bf0-4de3-9c6e-a046a53858ad&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1b76008b-1bf0-4de3-9c6e-a046a53858ad","type":"Claim","title":"The process of DNA degradation, characteristic of apoptosis, produces a series of oligonucleosome-length DNA fragments that have newly generated 3'-0H ends whereas normal cells have very low numbers of terminal DNA strand breaks.","label":"Cotman C et al.; The process of DNA degradation, characte...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:1b76008b-1bf0-4de3-9c6e-a046a53858ad"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9ef7f60f-a5c9-4d91-ba4f-888d23f90d9b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9ef7f60f-a5c9-4d91-ba4f-888d23f90d9b","type":"Claim","title":"The normal function of intramembranous Aβ may involve interaction with other proteins, such as parts of ion channels or pumps or receptors.","label":"Marchesi V; The normal function of intramembranous A...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:9ef7f60f-a5c9-4d91-ba4f-888d23f90d9b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4b819d76-132b-44fc-9556-fcf67a233474&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4b819d76-132b-44fc-9556-fcf67a233474","type":"Claim","title":"The Aph1A complexes are crucial for Notch signaling during embryogenesis.","label":"Serneels L et al.; The Aph1A complexes are crucial for Notc...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Van Biervliet Jérôme","Craessaerts Katleen","Dejaegere Tim","Horré Katrien","Van Houtvin Tine","Esselmann Hermann","Paul Sabine","Schäfer Martin K","Berezovska Oksana","Hyman Bradley T","Sprangers Ben","Sciot Raf","Moons Lieve","Jucker Mathias","Yang Zhixiang","May Patrick C","Karran Eric","Wiltfang Jens","D'Hooge Rudi","De Strooper Bart"],"firstAuthor":"Serneels Lutgarde","referenceYear":"2009","referenceDate":"2009-05-01","id":"urn:lsid:swan.org:researchstatement:4b819d76-132b-44fc-9556-fcf67a233474"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:68ecdd56-ceb8-4b19-a365-debabbe8ff5f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:68ecdd56-ceb8-4b19-a365-debabbe8ff5f","type":"Claim","title":"Intranasal administration of insulin is a therapeutic strategy to normalize CNS insulin signaling, delivered via bulk flow along rostral (olfactory nerves) or caudal (trigeminal nerves) perivascular channels, reaching brain in minutes, bypassing the blood brain barrier without raising peripheral levels of insulin.          ","label":"Craft S; Intranasal administration of insulin is ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft Suzanne","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:68ecdd56-ceb8-4b19-a365-debabbe8ff5f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0d2e73ea-c25e-4886-be07-e9f9b14d5408&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0d2e73ea-c25e-4886-be07-e9f9b14d5408","type":"Claim","title":"The spheroid Aβ42 structures is similar to structures observed by others.","label":"Bitan G et al.; The spheroid Aβ42 structures is similar ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:0d2e73ea-c25e-4886-be07-e9f9b14d5408"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1b0e968b-2790-4715-be16-67fe070375b7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1b0e968b-2790-4715-be16-67fe070375b7","type":"Claim","title":"Longer forms of Aβ may act as γ-secretase inhibitors by occupying the enzyme\u2019s active site nonproductively, in a manner similar to peptidomimetic active-site directed inhibitors. ","label":"Shen J et al.; Longer forms of Aβ may act as γ-secretas...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:1b0e968b-2790-4715-be16-67fe070375b7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:052b7b86-9a5e-44a5-98eb-4532902bef62&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:052b7b86-9a5e-44a5-98eb-4532902bef62","type":"Claim","title":"Memantine, a use-dependent calcium channel blocker of the glutamate NMDA receptor, was recently shown to more potently block α7nicotinic acetylcholine receptors than NMDA receptors in rat hippocampal neurons, providing some extra evidence supporting the potential beneficial effect of antagonizing α7nAChRs.","label":"Dziewczapolski G et al.; Memantine, a use-dependent calcium chann...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Glogowski Carolina M","Masliah Eliezer","Heinemann Stephen F"],"firstAuthor":"Dziewczapolski Gustavo","referenceYear":"2009","referenceDate":"2009-07-08","id":"urn:lsid:swan.org:researchstatement:052b7b86-9a5e-44a5-98eb-4532902bef62"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:743bfb30-34ea-4aad-927a-fcf0bbb3f61f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:743bfb30-34ea-4aad-927a-fcf0bbb3f61f","type":"Claim","title":"AD brains contain 3-fold higher levels of ceramide than age-matched controls.","label":"AD brains contain 3-fold higher levels o...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:743bfb30-34ea-4aad-927a-fcf0bbb3f61f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ddd9d4e3-791f-4547-b104-1d539db2c8a6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ddd9d4e3-791f-4547-b104-1d539db2c8a6","type":"Claim","title":"In the spinal cords of mutant SOD1G37R mice, SIRT1 was only slightly upregulated at 4 months, a stage with limited degeneration; however, levels of SIRT1 were significantly upregulated when severe neurodegeneration was evident at 10\u201312 months.","label":"Kim D et al.; In the spinal cords of mutant SOD1G37R m...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:ddd9d4e3-791f-4547-b104-1d539db2c8a6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:e8a4c32a-1390-4cc5-86f6-682f8d843140&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:e8a4c32a-1390-4cc5-86f6-682f8d843140","type":"Comment","title":"Computational models of aged neurons likely do not yet exist, therefore results may be different using more biologically age-relevant modeling equations.  ","label":"Stutzmann G; Computational models of aged neurons lik...","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Stutzmann Grace","id":"urn:lsid:swan.org:comment:e8a4c32a-1390-4cc5-86f6-682f8d843140"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2620d9a0-7669-4ef7-9c0d-88f7e63b1d64&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2620d9a0-7669-4ef7-9c0d-88f7e63b1d64","type":"Claim","title":"The PS1/gamma-secretase complex can generate neuronal dysfunction independently of its role in generating excess Aβ.","label":"Marchesi V; The PS1/gamma-secretase complex can gene...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:2620d9a0-7669-4ef7-9c0d-88f7e63b1d64"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0a3b5366-7cef-4be0-b474-e4f72eb1574c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0a3b5366-7cef-4be0-b474-e4f72eb1574c","type":"Claim","title":"Plaques form preferentially in specific brain regions, such as the cerebral cortex and the hippocampus.","label":"Muresan Z et al.; Plaques form preferentially in specific ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","referenceYear":"2008","referenceDate":"2008","id":"urn:lsid:swan.org:researchstatement:0a3b5366-7cef-4be0-b474-e4f72eb1574c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:dca0b98a-0951-49fd-a563-776beb9961f8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:dca0b98a-0951-49fd-a563-776beb9961f8","type":"Claim","title":"Post-mortem immunostaining suggested that both dendritic and axonal elements contribute to these dystrophic neurites.","label":"Meyer-Luehmann M et al.; Post-mortem immunostaining suggested tha...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:dca0b98a-0951-49fd-a563-776beb9961f8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:393d0393-87f6-4772-966f-d91922d1eb74&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:393d0393-87f6-4772-966f-d91922d1eb74","type":"Hypothesis","title":"ApoE scavenger receptor BI binds ApoE complexed Aβ.","label":"Srivastava R et al.; ApoE scavenger receptor BI binds ApoE co...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Jain Jinesh C"],"firstAuthor":"Srivastava Rai Ajit","referenceYear":"2002","referenceDate":"2002-04-15","id":"urn:lsid:swan.org:researchstatement:393d0393-87f6-4772-966f-d91922d1eb74"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6eee45d3-0292-4412-b597-07f0a0296104&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6eee45d3-0292-4412-b597-07f0a0296104","type":"Claim","title":"γ-secretase inhibitor development is controversial due to target-based toxicities attributable to effects on γ-secretase substrates such as Notch.","label":"Golde T; γ-secretase inhibitor development is con...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde T","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:6eee45d3-0292-4412-b597-07f0a0296104"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c16def1f-2f84-4706-9ad5-9588ad93e9b4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c16def1f-2f84-4706-9ad5-9588ad93e9b4","type":"Claim","title":"Cortical cell cycle events (CCEs) appear ~8 months before the onset of fibrillar Aβ deposition in the B6- R1.40 model suggesting that fibrillar Aβ deposits are not responsible for the induction of neuronal CCEs and instead implicates either unique soluble Aβ species or particular APP processing products. ","label":"Varvel N et al.; Cortical cell cycle events (CCEs) appear...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bhaskar Kiran","Patil Anita R","Pimplikar Sanjay W","Herrup Karl","Lamb Bruce T"],"firstAuthor":"Varvel Nicholas H","referenceYear":"2008","referenceDate":"2008-10-22","id":"urn:lsid:swan.org:researchstatement:c16def1f-2f84-4706-9ad5-9588ad93e9b4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7d2a2a9d-f886-470a-8cb0-09c35f10ff14&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7d2a2a9d-f886-470a-8cb0-09c35f10ff14","type":"Claim","title":"CAD cells are a useful model system for studying intracellular transport, including axonal transport.","label":"Muresan Z et al.; CAD cells are a useful model system for ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","id":"urn:lsid:swan.org:researchstatement:7d2a2a9d-f886-470a-8cb0-09c35f10ff14"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:18b8c1fa-aed2-4a78-8843-b33947ef6a5e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:18b8c1fa-aed2-4a78-8843-b33947ef6a5e","type":"Claim","title":"The prosurvival effect of Aβ42 monomers was mediated by the PI-3-K pathway, which required the activation of IGF-1/insulin receptors.","label":"Giuffrida M et al.; The prosurvival effect of Aβ42 monomers ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Caraci Filippo","Pignataro Bruno","Cataldo Sebastiano","De Bona Paolo","Bruno Valeria","Molinaro Gemma","Pappalardo Giuseppe","Messina Angela","Palmigiano Angelo","Garozzo Domenico","Nicoletti Ferdinando","Rizzarelli Enrico","Copani Agata"],"firstAuthor":"Giuffrida Maria Laura","referenceYear":"2009","referenceDate":"2009-08-26","id":"urn:lsid:swan.org:researchstatement:18b8c1fa-aed2-4a78-8843-b33947ef6a5e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:aa314236-9c2e-4964-97f3-4c75be374752&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:aa314236-9c2e-4964-97f3-4c75be374752","type":"Claim","title":"Calcium liberated from IP3 sensitive calcium stores can initiate a process known as calcium-induced calcium release (CICR) effectively recruiting RyR-sensitive stores.","label":"Smith I et al.; Calcium liberated from IP3 sensitive cal...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:aa314236-9c2e-4964-97f3-4c75be374752"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:414c6768-3708-4099-8130-f12183285a39&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:414c6768-3708-4099-8130-f12183285a39","type":"Claim","title":"The endoplasmic reticulum (ER) contains two main type of calcium release channels, the inositol 1,4,5-trisphosphate receptor (IP3R) and the RyR.","label":"Smith I et al.; The endoplasmic reticulum (ER) contains ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:414c6768-3708-4099-8130-f12183285a39"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:93c868dc-bdb5-404f-991a-a973c72138ec&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:93c868dc-bdb5-404f-991a-a973c72138ec","type":"Claim","title":"The slow transport rates of neurofilament proteins were similar in 8c and their wild-type controls at 15 d and 30 d after injection.","label":"Yuan A et al.; The slow transport rates of neurofilamen...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:93c868dc-bdb5-404f-991a-a973c72138ec"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fcaef644-95eb-4971-a8d5-672b1e288d8e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fcaef644-95eb-4971-a8d5-672b1e288d8e","type":"Claim","title":"Sometimes the capillary network is strangely absent where the plaque-vessel relationship has been alluded to on a small sample size.","label":"Kumar-Singh S; Sometimes the capillary network is stran...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Kumar-Singh Samir","id":"urn:lsid:swan.org:researchstatement:fcaef644-95eb-4971-a8d5-672b1e288d8e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:11f77ea3-3c7d-47f8-9f8a-54a04c14b56b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:11f77ea3-3c7d-47f8-9f8a-54a04c14b56b","type":"Claim","title":"Intramolecular cross-linking may compete with intermolecular cross-linking and slow down the oligomerization process.","label":"Hartley D et al.; Intramolecular cross-linking may compete...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:11f77ea3-3c7d-47f8-9f8a-54a04c14b56b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6b7056f2-90e4-4a6e-8bf3-4430a1b4acf3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6b7056f2-90e4-4a6e-8bf3-4430a1b4acf3","type":"Claim","title":"APP exists in neuronal plasma membranes as homodimers.","label":"Marchesi V; APP exists in neuronal plasma membranes ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:6b7056f2-90e4-4a6e-8bf3-4430a1b4acf3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:20b1a907-f47e-4c36-9992-70966b306123&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:20b1a907-f47e-4c36-9992-70966b306123","type":"Claim","title":"The deposition of protein aggregates (extracellular neuritic plaques containing Aβ and intracellular neurofibrillary tangles containing hyperphosphorylated tau) is by in large a process observed primarily in humans and is not fully replicated in non-human primates in whom amyloid deposits are less prevalent/pronounced and tau deposits are almost never observed.","label":"Bartzokis G; The deposition of protein aggregates (ex...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:20b1a907-f47e-4c36-9992-70966b306123"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4b993371-e175-47ea-910f-ab0611cbbdc8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4b993371-e175-47ea-910f-ab0611cbbdc8","type":"Claim","title":"Only a weak correlation was shown between senile plaque counts and psychological testing, but strong correlations were shown with counts of the large neocortical pyramidal cells with a continuous loss of pyramidal cells in the frontal and temporal cortex.","label":"Terry R et al.; Only a weak correlation was shown betwee...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Masliah E","Salmon D P","Butters N","DeTeresa R","Hill R","Hansen L A","Katzman R"],"firstAuthor":"Terry R D","referenceYear":"1991","referenceDate":"1991-10","id":"urn:lsid:swan.org:researchstatement:4b993371-e175-47ea-910f-ab0611cbbdc8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:07315df2-f21a-49eb-a5c0-50208c534fe6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:07315df2-f21a-49eb-a5c0-50208c534fe6","type":"Claim","title":"The erratic pattern of microtubule tortuosity and disarray together with apparent efforts at microtubule regeneration may reflect abnormal hyperactivity of this m3 -linked second messenger system and consequent disruption of its protein phosphorylation functions. ","label":"Olney J et al.; The erratic pattern of microtubule tortu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:07315df2-f21a-49eb-a5c0-50208c534fe6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5fa68c06-b471-4739-b3b7-4398888abd77&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5fa68c06-b471-4739-b3b7-4398888abd77","type":"Claim","title":"Soluble, diffusible Aβ oligomers can interrupt memory circuits in the brain.","label":"Selkoe D; Soluble, diffusible Aβ oligomers can int...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Selkoe Dennis J","id":"urn:lsid:swan.org:researchstatement:5fa68c06-b471-4739-b3b7-4398888abd77"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3651c721-8bef-462d-8326-45c420b2bbab&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3651c721-8bef-462d-8326-45c420b2bbab","type":"Claim","title":"PICALM could influence AD risk through APP processing via endocytic pathways, resulting in changes in Aβ levels.","label":"Harold D et al.; PICALM could influence AD risk through A...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Abraham Richard","Hollingworth Paul","Sims Rebecca","Gerrish Amy","Hamshere Marian L","Pahwa Jaspreet Singh","Moskvina Valentina","Dowzell Kimberley","Williams Amy","Jones Nicola","Thomas Charlene","Stretton Alexandra","Morgan Angharad R","Lovestone Simon","Powell John","Proitsi Petroula","Lupton Michelle K","Brayne Carol","Rubinsztein David C","Gill Michael","Lawlor Brian","Lynch Aoibhinn","Morgan Kevin","Brown Kristelle S","Passmore Peter A","Craig David","McGuinness Bernadette","Todd Stephen","Holmes Clive","Mann David","Smith A David","Love Seth","Kehoe Patrick G","Hardy John","Mead Simon","Fox Nick","Rossor Martin","Collinge John","Maier Wolfgang","Jessen Frank","Schürmann Britta","van den Bussche Hendrik","Heuser Isabella","Kornhuber Johannes","Wiltfang Jens","Dichgans Martin","Frölich Lutz","Hampel Harald","Hüll Michael","Rujescu Dan","Goate Alison M","Kauwe John S","Cruchaga Carlos","Nowotny Petra","Morris John C","Mayo Kevin","Sleegers Kristel","Bettens Karolien","Engelborghs Sebastiaan","De Deyn Peter P","Van Broeckhoven Christine","Livingston Gill","Bass Nicholas J","Gurling Hugh","McQuillin Andrew","Gwilliam Rhian","Deloukas Panagiotis","Al-Chalabi Ammar","Shaw Christopher E","Tsolaki Magda","Singleton Andrew B","Guerreiro Rita","Mühleisen Thomas W","Nöthen Markus M","Moebus Susanne","Jöckel Karl-Heinz","Klopp Norman","Wichmann H-Erich","Carrasquillo Minerva M","Pankratz V Shane","Younkin Steven G","Holmans Peter A","O'Donovan Michael","Owen Michael J","Williams Julie"],"firstAuthor":"Harold Denise","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:3651c721-8bef-462d-8326-45c420b2bbab"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d9ac7aed-c395-4775-b38f-282afc8ac64a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d9ac7aed-c395-4775-b38f-282afc8ac64a","type":"Hypothesis","title":"MHC-I signaling is important in the development, function, and diseases of both immune and nervous systems.","label":"Boulanger L et al.; MHC-I signaling is important in the deve...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Huh G S","Shatz C J"],"firstAuthor":"Boulanger L M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:d9ac7aed-c395-4775-b38f-282afc8ac64a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ddfc4a6b-d6d8-4d73-991e-6c9b53bf58de&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ddfc4a6b-d6d8-4d73-991e-6c9b53bf58de","type":"Hypothesis","title":"Neuroplasticity failure is the core of a unifying theory that can account for all the clinical and neuropathological features of Alzheimer disease.","label":"Mesulam M; Neuroplasticity failure is the core of a...","icon":"../icons/ontological/discourse-element/h-research-statement.png","firstAuthor":"Mesulam M M","referenceYear":"1999","referenceDate":"1999-11","id":"urn:lsid:swan.org:researchstatement:ddfc4a6b-d6d8-4d73-991e-6c9b53bf58de"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:beab2259-90d6-41a4-b49a-6a6a11c381e4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:beab2259-90d6-41a4-b49a-6a6a11c381e4","type":"Hypothesis","title":"Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down's syndrome patients.","label":"van Leeuwen F; Frameshift mutants of beta amyloid precu...","icon":"../icons/ontological/discourse-element/h-research-statement.png","firstAuthor":"van Leeuwen F W","id":"urn:lsid:swan.org:researchstatement:beab2259-90d6-41a4-b49a-6a6a11c381e4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e9499c06-253c-410e-bbaa-20545acc3104&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e9499c06-253c-410e-bbaa-20545acc3104","type":"Claim","title":"Genetic ablation of the presenilins attenuates IP3-mediated calcium signalling.","label":"Smith I et al.; Genetic ablation of the presenilins atte...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:e9499c06-253c-410e-bbaa-20545acc3104"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:aba7022a-f311-45dc-96eb-df31f160ddee&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:aba7022a-f311-45dc-96eb-df31f160ddee","type":"Claim","title":"Back-propagating action potentials are known to influence pyramidal neuronal LTP and LTD, and this is critical for information processing and memory storage by these neurons.","label":"Morse T et al.; Back-propagating action potentials are k...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Mutalik Pradeep","Cheung Kei","Miller Perry L","Shepherd Gordon"],"firstAuthor":"Morse Thomas M","id":"urn:lsid:swan.org:researchstatement:aba7022a-f311-45dc-96eb-df31f160ddee"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:34bd8437-9db1-4c02-a557-b175aa37351f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:34bd8437-9db1-4c02-a557-b175aa37351f","type":"Claim","title":"Huntington Disease shows evidence for the presence of DNA damage and apoptosis in affected brain areas.","label":"Cotman C et al.; Huntington Disease shows evidence for th...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:34bd8437-9db1-4c02-a557-b175aa37351f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:61d31cbc-e04f-491d-8a03-b5819f75e321&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:61d31cbc-e04f-491d-8a03-b5819f75e321","type":"Claim","title":"Additional studies have confirmed that conditioned media from V717F APP751 transfected cells does not alter baseline transmission, using mouse hippocampal slice cultures in vitro.","label":"Walsh D; Additional studies have confirmed that c...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Walsh Dominic M","id":"urn:lsid:swan.org:researchstatement:61d31cbc-e04f-491d-8a03-b5819f75e321"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a8fee6b5-a1f9-40a3-a4ab-5d5dfaea7b0e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a8fee6b5-a1f9-40a3-a4ab-5d5dfaea7b0e","type":"Claim","title":"Disturbances of intracellular calcium homeostasis have been shown to reliably predict the development of AD years prior to the development of an overt clinical phenotype.","label":"Smith I et al.; Disturbances of intracellular calcium ho...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:a8fee6b5-a1f9-40a3-a4ab-5d5dfaea7b0e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:85777570-ebcf-42eb-8a44-e37663990d87&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:85777570-ebcf-42eb-8a44-e37663990d87","type":"Claim","title":"The PI-3-K inhibitor LY294002 reduced the neuroprotective effect of Aβ42 and Aβ40 monomers against NMDA toxicity whereas the ERK kinase inhibitor, UO126 had no effect.","label":"Giuffrida M et al.; The PI-3-K inhibitor LY294002 reduced th...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Caraci Filippo","Pignataro Bruno","Cataldo Sebastiano","De Bona Paolo","Bruno Valeria","Molinaro Gemma","Pappalardo Giuseppe","Messina Angela","Palmigiano Angelo","Garozzo Domenico","Nicoletti Ferdinando","Rizzarelli Enrico","Copani Agata"],"firstAuthor":"Giuffrida Maria Laura","referenceYear":"2009","referenceDate":"2009-08-26","id":"urn:lsid:swan.org:researchstatement:85777570-ebcf-42eb-8a44-e37663990d87"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ebc6c139-32be-4a8e-ab3b-556eebc27294&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ebc6c139-32be-4a8e-ab3b-556eebc27294","type":"Claim","title":"Three \u201camyloid\u201d hypothesis clinical trials including the active immunization trial, the passive immunization trial and γ-secretase modulator R-flurbuprofen (Tarenflurbil) trial, leave little certainty of clinical benefit, and that massively reducing amyloid burden late in the disease, is not a miracle cure.","label":"Three \u201camyloid\u201d hypothesis clinical tria...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:ebc6c139-32be-4a8e-ab3b-556eebc27294"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a86b8a31-d15d-40e1-ade2-931ca4d4d8f8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a86b8a31-d15d-40e1-ade2-931ca4d4d8f8","type":"Claim","title":"The polymerization of soluble Aβ, which leads to plaque formation, is nucleated by \u201cseeds\u201d of oligomeric Aβ, but it remains unclear where seeds of polymerized Aβ originate or how they are formed.","label":"Muresan Z et al.; The polymerization of soluble Aβ, which ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","referenceYear":"2008","referenceDate":"2008","id":"urn:lsid:swan.org:researchstatement:a86b8a31-d15d-40e1-ade2-931ca4d4d8f8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c3e4de07-9ea4-402d-b0f9-148009fd6e50&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c3e4de07-9ea4-402d-b0f9-148009fd6e50","type":"Claim","title":"Rapid autopsy tissues (average delay of 55 minutes) also showed a similar extent and pattern of cells with DNA damage to conventional postmortem tissues.  Description:  Accordingly studies have been restricted to cases with an average postmortem delay of 4.5 hours.","label":"Cotman C et al.; Rapid autopsy tissues (average delay of ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:c3e4de07-9ea4-402d-b0f9-148009fd6e50"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:14629920-22bf-4029-8efe-4d20f05f7c6a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:14629920-22bf-4029-8efe-4d20f05f7c6a","type":"Claim","title":"Ceramide can promote outgrowth and survival of cultured neurons under senescence-like conditions.","label":"Ceramide can promote outgrowth and survi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:14629920-22bf-4029-8efe-4d20f05f7c6a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c38f0b6b-2328-4545-bf2d-6dff5309aeb2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c38f0b6b-2328-4545-bf2d-6dff5309aeb2","type":"Hypothesis","title":"Clusterin (ApoJ) and phosphatidylinositol binding clathrin assembly protein gene (PICALM) genes are associated with Late Onset AD.","label":"Harold D et al.; Clusterin (ApoJ) and phosphatidylinosito...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Abraham Richard","Hollingworth Paul","Sims Rebecca","Gerrish Amy","Hamshere Marian L","Pahwa Jaspreet Singh","Moskvina Valentina","Dowzell Kimberley","Williams Amy","Jones Nicola","Thomas Charlene","Stretton Alexandra","Morgan Angharad R","Lovestone Simon","Powell John","Proitsi Petroula","Lupton Michelle K","Brayne Carol","Rubinsztein David C","Gill Michael","Lawlor Brian","Lynch Aoibhinn","Morgan Kevin","Brown Kristelle S","Passmore Peter A","Craig David","McGuinness Bernadette","Todd Stephen","Holmes Clive","Mann David","Smith A David","Love Seth","Kehoe Patrick G","Hardy John","Mead Simon","Fox Nick","Rossor Martin","Collinge John","Maier Wolfgang","Jessen Frank","Schürmann Britta","van den Bussche Hendrik","Heuser Isabella","Kornhuber Johannes","Wiltfang Jens","Dichgans Martin","Frölich Lutz","Hampel Harald","Hüll Michael","Rujescu Dan","Goate Alison M","Kauwe John S","Cruchaga Carlos","Nowotny Petra","Morris John C","Mayo Kevin","Sleegers Kristel","Bettens Karolien","Engelborghs Sebastiaan","De Deyn Peter P","Van Broeckhoven Christine","Livingston Gill","Bass Nicholas J","Gurling Hugh","McQuillin Andrew","Gwilliam Rhian","Deloukas Panagiotis","Al-Chalabi Ammar","Shaw Christopher E","Tsolaki Magda","Singleton Andrew B","Guerreiro Rita","Mühleisen Thomas W","Nöthen Markus M","Moebus Susanne","Jöckel Karl-Heinz","Klopp Norman","Wichmann H-Erich","Carrasquillo Minerva M","Pankratz V Shane","Younkin Steven G","Holmans Peter A","O'Donovan Michael","Owen Michael J","Williams Julie"],"firstAuthor":"Harold Denise","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:c38f0b6b-2328-4545-bf2d-6dff5309aeb2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:048b65e0-f629-467d-ad93-21d02618a69c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:048b65e0-f629-467d-ad93-21d02618a69c","type":"Claim","title":"Steinlein and colleagues screened nine AD cases for mutations in the coding regions of CHRNΑ4 and CHRNΒ2 by single strand conformation polymorphisms (SSCP) and heteroduplex analyses.","label":"Cook L et al.; Steinlein and colleagues screened nine A...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Ho Luk W","Taylor Alison E","Brayne Carol","Evans John Grimley","Xuereb John","Cairns Nigel J","Pritchard Antonia","Lemmon Helen","Mann David","St Clair David","Turic Dragana","Hollingworth Paul","Moore Pamela J","Jehu Luke","Archer Nicola","Walter Sarah","Foy Catherine","Edmondson Amanda","Powell John","Lovestone Simon","Owen Michael J","Williams Julie","Lendon Corinne","Rubinsztein David C"],"firstAuthor":"Cook Lynnette J","referenceYear":"2004","referenceDate":"2004-03-25","id":"urn:lsid:swan.org:researchstatement:048b65e0-f629-467d-ad93-21d02618a69c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7012c70f-538a-4127-bf6f-33658ef3a8c2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7012c70f-538a-4127-bf6f-33658ef3a8c2","type":"Claim","title":"Alzheimer Aβ amyloid precursor protein (APP) is an integral membrane glycoprotein, existing as several distinct isoforms arising by alternative splicing of a single gene.","label":"Suzuki T et al.; Alzheimer Aβ amyloid precursor protein (...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:7012c70f-538a-4127-bf6f-33658ef3a8c2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b1328174-3135-4300-9b7b-4e9f9054d325&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b1328174-3135-4300-9b7b-4e9f9054d325","type":"Claim","title":"If tau overexpression induces impairment of axonal transport, tau Tg mice must show neuronal dysfunction in the entire brain from a young age on.","label":"Takashima A; If tau overexpression induces impairment...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Takashima Akihiko","id":"urn:lsid:swan.org:researchstatement:b1328174-3135-4300-9b7b-4e9f9054d325"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3818e975-33dc-43c8-b0a2-503da681dd32&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3818e975-33dc-43c8-b0a2-503da681dd32","type":"Claim","title":"The treatment of PS1 mutant cells with ER calcium channel inhibitors such as dantrolene or xestospongin, which inhibits the IP3 or the ryanodine receptor respectively, protects cells from toxic insults, including Aβ.","label":"Smith I et al.; The treatment of PS1 mutant cells with E...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:3818e975-33dc-43c8-b0a2-503da681dd32"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:508a1072-ad36-4bfb-a50b-67b40ad02732&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:508a1072-ad36-4bfb-a50b-67b40ad02732","type":"Claim","title":"The Aβ peptide is not metabolically inert, but rather possesses biological activity.","label":"Cotman C et al.; The Aβ peptide is not metabolically iner...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:508a1072-ad36-4bfb-a50b-67b40ad02732"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2b5d8234-8eeb-4214-8804-c37b14c8bd11&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2b5d8234-8eeb-4214-8804-c37b14c8bd11","type":"Claim","title":"Expression of a C3 convertase inhibitor such as the rodent complement receptor 1-related gene/protein y (Crry) results in increased Aβ deposition and neurodegeneration.","label":"Lambert J et al.; Expression of a C3 convertase inhibitor ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Heath Simon","Even Gael","Campion Dominique","Sleegers Kristel","Hiltunen Mikko","Combarros Onofre","Zelenika Diana","Bullido Maria J","Tavernier Béatrice","Letenneur Luc","Bettens Karolien","Berr Claudine","Pasquier Florence","Fiévet Nathalie","Barberger-Gateau Pascale","Engelborghs Sebastiaan","De Deyn Peter","Mateo Ignacio","Franck Ana","Helisalmi Seppo","Porcellini Elisa","Hanon Olivier","de Pancorbo Marian M","Lendon Corinne","Dufouil Carole","Jaillard Céline","Leveillard Thierry","Alvarez Victoria","Bosco Paolo","Mancuso Michelangelo","Panza Francesco","Nacmias Benedetta","Bossù Paola","Piccardi Paola","Annoni Giorgio","Seripa Davide","Galimberti Daniela","Hannequin Didier","Licastro Federico","Soininen Hilkka","Ritchie Karen","Blanché Hélène","Dartigues Jean-François","Tzourio Christophe","Gut Ivo","Van Broeckhoven Christine","Alpérovitch Annick","Lathrop Mark","Amouyel Philippe"],"firstAuthor":"Lambert Jean-Charles","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:2b5d8234-8eeb-4214-8804-c37b14c8bd11"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:032da423-4abc-41d7-8be1-cdb474023591&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:032da423-4abc-41d7-8be1-cdb474023591","type":"Claim","title":"The proteasome activity in the temporal lobe, occipital lobe and striatum was lower in AD brain than in controls but did not reach significant levels, owing to large intraregional differences in individual patients.","label":"Keck S et al.; The proteasome activity in the temporal ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:032da423-4abc-41d7-8be1-cdb474023591"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2794bd21-53c9-4411-8f75-9581988aee47&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2794bd21-53c9-4411-8f75-9581988aee47","type":"Claim","title":"Aβ oligomers potentially could attach to neurons nonspecifically by insertion into lipid bilayers, or, alternatively, by acting as specific ligands for particular\nsurface binding sites.","label":"Gong Y et al.; Aβ oligomers potentially could attach to...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:2794bd21-53c9-4411-8f75-9581988aee47"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:deb16495-8354-4589-8710-8fbd3d3db94b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:deb16495-8354-4589-8710-8fbd3d3db94b","type":"Claim","title":"Abnormality in Aβ-plaque deposition biomarkers is an early event that nears a plateau before the appearance of both atrophy on MRI and cognitive symptoms, and remains relatively static thereafter.","label":"Jack C et al.; Abnormality in Aβ-plaque deposition biom...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:deb16495-8354-4589-8710-8fbd3d3db94b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:53818d4e-97d2-4c2f-a728-496e839d4475&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:53818d4e-97d2-4c2f-a728-496e839d4475","type":"Claim","title":"Tau inclusions are ubiquitinated, both in poly-ubiquitinated and mono-ubiquitinated linkages.","label":"Carrettiero D et al.; Tau inclusions are ubiquitinated, both i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hernandez Israel","Neveu Pierre","Papagiannakopoulos Thales","Kosik Kenneth S"],"firstAuthor":"Carrettiero Daniel C","referenceYear":"2009","referenceDate":"2009-02-18","id":"urn:lsid:swan.org:researchstatement:53818d4e-97d2-4c2f-a728-496e839d4475"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3adf9c66-2ecb-41f4-8e54-271d87f4cbdd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3adf9c66-2ecb-41f4-8e54-271d87f4cbdd","type":"Claim","title":"GSK3β has been shown to co-localize with dystrophic neurites and NFTs and active GSK3 appears in neurons with pre-tangle changes.","label":"Hooper C et al.; GSK3β has been shown to co-localize with...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:3adf9c66-2ecb-41f4-8e54-271d87f4cbdd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4dcccde2-eb0a-441e-8f62-36e7f2d93bbd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4dcccde2-eb0a-441e-8f62-36e7f2d93bbd","type":"Claim","title":"APOE and CLU are the most abundantly expressed apolipoproteins in the central nervous system.","label":"Lambert J et al.; APOE and CLU are the most abundantly exp...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Heath Simon","Even Gael","Campion Dominique","Sleegers Kristel","Hiltunen Mikko","Combarros Onofre","Zelenika Diana","Bullido Maria J","Tavernier Béatrice","Letenneur Luc","Bettens Karolien","Berr Claudine","Pasquier Florence","Fiévet Nathalie","Barberger-Gateau Pascale","Engelborghs Sebastiaan","De Deyn Peter","Mateo Ignacio","Franck Ana","Helisalmi Seppo","Porcellini Elisa","Hanon Olivier","de Pancorbo Marian M","Lendon Corinne","Dufouil Carole","Jaillard Céline","Leveillard Thierry","Alvarez Victoria","Bosco Paolo","Mancuso Michelangelo","Panza Francesco","Nacmias Benedetta","Bossù Paola","Piccardi Paola","Annoni Giorgio","Seripa Davide","Galimberti Daniela","Hannequin Didier","Licastro Federico","Soininen Hilkka","Ritchie Karen","Blanché Hélène","Dartigues Jean-François","Tzourio Christophe","Gut Ivo","Van Broeckhoven Christine","Alpérovitch Annick","Lathrop Mark","Amouyel Philippe"],"firstAuthor":"Lambert Jean-Charles","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:4dcccde2-eb0a-441e-8f62-36e7f2d93bbd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9c51a6ad-4308-492e-a86b-59c5224fe446&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9c51a6ad-4308-492e-a86b-59c5224fe446","type":"Claim","title":"One possible reason for discrepancies in findings is the nature of the cargos under investigation, as the 8c tau transgenic mice study focused primarily on cargos undergoing slow transport along the axon.","label":"Holzbaur E; One possible reason for discrepancies in...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holzbaur Erika L F","id":"urn:lsid:swan.org:researchstatement:9c51a6ad-4308-492e-a86b-59c5224fe446"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:42003699-3995-41f3-95e0-daed3aa99acd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:42003699-3995-41f3-95e0-daed3aa99acd","type":"Claim","title":"Biosynthesis of nonsterol isoprenoids also affect Aβ accumulation.","label":"Biosynthesis of nonsterol isoprenoids al...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:42003699-3995-41f3-95e0-daed3aa99acd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8343605c-ee09-47ff-a312-d8de5ace82ed&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8343605c-ee09-47ff-a312-d8de5ace82ed","type":"Claim","title":"Hyperinsulinemia strongly increases CSF Aβ42 in normal older adults, in a hyperinsulinemic-euglycemic clamp study.","label":"Craft S; Hyperinsulinemia strongly increases CSF ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft Suzanne","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:8343605c-ee09-47ff-a312-d8de5ace82ed"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bb2a9825-9d0d-4d53-923e-ca751187c084&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bb2a9825-9d0d-4d53-923e-ca751187c084","type":"Claim","title":"Myelination of smaller and more thinly-myelinated fibers may be disproportionately dependent on IGF-1 signaling compared to larger and more thickly-myelinated fibers.","label":"Bartzokis G; Myelination of smaller and more thinly-m...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:bb2a9825-9d0d-4d53-923e-ca751187c084"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fc0361c5-4c20-48f7-9cbe-634422e6a027&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fc0361c5-4c20-48f7-9cbe-634422e6a027","type":"Claim","title":"Reduced levels of CSF Aβ42 in cognitively normal older adults are associated with whole brain atrophy and with hypometabolism in the medial temporal lobe.","label":"Morris J et al.; Reduced levels of CSF Aβ42 in cognitivel...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Roe Catherine M","Grant Elizabeth A","Head Denise","Storandt Martha","Goate Alison M","Fagan Anne M","Holtzman David M","Mintun Mark A"],"firstAuthor":"Morris John C","referenceYear":"2009","referenceDate":"2009-12","id":"urn:lsid:swan.org:researchstatement:fc0361c5-4c20-48f7-9cbe-634422e6a027"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d5cd4fdd-89af-404e-b96a-a247c698b500&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d5cd4fdd-89af-404e-b96a-a247c698b500","type":"Claim","title":"The SIRT1 gene resides in a locus on chromosome 10 that is associated with familial AD.","label":"Kim D et al.; The SIRT1 gene resides in a locus on chr...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:d5cd4fdd-89af-404e-b96a-a247c698b500"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ae63fdea-5d07-4998-87b9-91106c2acaaa&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ae63fdea-5d07-4998-87b9-91106c2acaaa","type":"Claim","title":"Tissue-transglutaminase occurs abundantly in the brain and has been implicated in neurodegeneration.","label":"Hartley D et al.; Tissue-transglutaminase occurs abundantl...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:ae63fdea-5d07-4998-87b9-91106c2acaaa"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bd816262-3d5a-42f5-92ea-cb40cece90b9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bd816262-3d5a-42f5-92ea-cb40cece90b9","type":"Claim","title":"Cultured neuronal cells originating from the brainstem - but not neurons derived from the cerebral cortex or hippocampus - accumulate oligomerized Aβ at the terminals of their processes.","label":"Muresan Z et al.; Cultured neuronal cells originating from...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","referenceYear":"2008","referenceDate":"2008","id":"urn:lsid:swan.org:researchstatement:bd816262-3d5a-42f5-92ea-cb40cece90b9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7b82fe33-d3c9-4e08-9d32-049eb19399a6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7b82fe33-d3c9-4e08-9d32-049eb19399a6","type":"Claim","title":"Deficiencies in elements related to the retromer sorting pathways will elevate Aβ.","label":"Small S et al.; Deficiencies in elements related to the ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:7b82fe33-d3c9-4e08-9d32-049eb19399a6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5826638d-4fa7-4a14-afbc-4c6fb81ff0ef&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5826638d-4fa7-4a14-afbc-4c6fb81ff0ef","type":"Claim","title":"Failure of glutamate to maintain inhibition is the basic principle underlying NRHypo neurodegeneration.","label":"Olney J et al.; Failure of glutamate to maintain inhibit...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:5826638d-4fa7-4a14-afbc-4c6fb81ff0ef"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:18eccf3e-9ac9-40f2-bdde-9910cb3463e2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:18eccf3e-9ac9-40f2-bdde-9910cb3463e2","type":"Claim","title":"Tau knock-out mice lack tau in their optic axons and retinas. In contrast, tau overexpressing 8c mice expressed approximately fourfold more tau in optic axons than did nontransgenic mice consistent with previous findings in brain.","label":"Yuan A et al.; Tau knock-out mice lack tau in their opt...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:18eccf3e-9ac9-40f2-bdde-9910cb3463e2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:89adbdfa-1cb4-471e-948f-949deb4697c4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:89adbdfa-1cb4-471e-948f-949deb4697c4","type":"Claim","title":"Inhibitors of GSK3β have also been shown to block long-term depression (LTD) and GSK3β activity is enhanced during LTD.","label":"Hooper C et al.; Inhibitors of GSK3β have also been shown...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:89adbdfa-1cb4-471e-948f-949deb4697c4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2ffa966b-e3b2-4a90-96f6-283ce5e75e82&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2ffa966b-e3b2-4a90-96f6-283ce5e75e82","type":"Claim","title":"CAD cells are a useful model system for studying a variety of neurodegenerative diseases and neurological disorders.  ","label":"Muresan Z et al.; CAD cells are a useful model system for ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","id":"urn:lsid:swan.org:researchstatement:2ffa966b-e3b2-4a90-96f6-283ce5e75e82"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f4a5d3cd-fe0a-4d2f-b44a-028035db01de&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f4a5d3cd-fe0a-4d2f-b44a-028035db01de","type":"Claim","title":"L-, P- and N-type calcium channel activity can be modulated by Aβ application which appears to be mediated primarily by Aβ-induced production of ROS.","label":"Smith I et al.; L-, P- and N-type calcium channel activi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:f4a5d3cd-fe0a-4d2f-b44a-028035db01de"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e52f3984-d94a-475e-b96a-08721ed7594f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e52f3984-d94a-475e-b96a-08721ed7594f","type":"Claim","title":"Increased CSF tau is not specific for AD, but does correlate with clinical disease severity, with higher concentrations associated with greater cognitive impairment in individuals on the normal\u2013MCI\u2013AD cognitive spectrum.","label":"Jack C et al.; Increased CSF tau is not specific for AD...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:e52f3984-d94a-475e-b96a-08721ed7594f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:50651196-c7ba-4b41-9956-75a88a9bb441&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:50651196-c7ba-4b41-9956-75a88a9bb441","type":"Claim","title":"PS clinical mutations have different effects on γ-secretase activity, and do not have the same effect on different substrates.","label":"Bentahir M et al.; PS clinical mutations have different eff...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:50651196-c7ba-4b41-9956-75a88a9bb441"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ba85352a-6286-4cb0-b022-4a766d38eb6c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ba85352a-6286-4cb0-b022-4a766d38eb6c","type":"Claim","title":"The structural and thermodynamic meaning of the difference between Aβ42 vs Aβ40 amyloidogenesis is unclear.","label":"Bitan G et al.; The structural and thermodynamic meaning...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:ba85352a-6286-4cb0-b022-4a766d38eb6c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:efd66e96-8311-447e-af08-659993dc04fe&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:efd66e96-8311-447e-af08-659993dc04fe","type":"Claim","title":"Aging is a product of biochemical-molecular changes that occur during life.","label":"Aging is a product of biochemical-molecu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:efd66e96-8311-447e-af08-659993dc04fe"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7f50a19e-2a51-4883-81fc-2f6979bdaaf7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7f50a19e-2a51-4883-81fc-2f6979bdaaf7","type":"Claim","title":"TDP-43 immunoreactive histopathology, seen in both glia and neurons, has since been reported in a variety of neurodegenerative diseases including Alzhemier\u2019s disease, hippocampal sclerosis, Picks disease, Parkinson\u2019s disease, and in a small proportion of cases with agryrophilic grain and Huntington\u2019s disease. ","label":"Warraich S et al.; TDP-43 immunoreactive histopathology, se...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Yang Shu","Nicholson Garth A","Blair Ian P"],"firstAuthor":"Warraich Sadaf T","referenceYear":"2010","referenceDate":"2010-06-25","id":"urn:lsid:swan.org:researchstatement:7f50a19e-2a51-4883-81fc-2f6979bdaaf7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7957ca36-f96b-44e6-b95c-d7ea89d7ce98&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7957ca36-f96b-44e6-b95c-d7ea89d7ce98","type":"Claim","title":"The results from Bitan et al suggest that even before oligomers or fibrils form, Aβ42 molecules can closely associate with each other (which the authors termed \"paranuclei\") and, because of this, may be more likely to aggregate than Aβ40.","label":"Holtzman D; The results from Bitan et al suggest tha...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman David M","id":"urn:lsid:swan.org:researchstatement:7957ca36-f96b-44e6-b95c-d7ea89d7ce98"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9720c197-cb08-420d-8ffe-8c884d646680&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9720c197-cb08-420d-8ffe-8c884d646680","type":"Claim","title":"One genetic variant of familial AD demonstrated that APP processing predates tau changes and neuronal injury.","label":"Hardy J et al.; One genetic variant of familial AD demon...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:9720c197-cb08-420d-8ffe-8c884d646680"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f002678d-f853-4b21-af5e-fa09ef29f212&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f002678d-f853-4b21-af5e-fa09ef29f212","type":"Claim","title":"A dose-dependent effect of m266 was observed on the object recognition index.","label":"Dodart J et al.; A dose-dependent effect of m266 was obse...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:f002678d-f853-4b21-af5e-fa09ef29f212"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a7bc649d-2e5f-47cc-83cd-4aee7c3a3745&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a7bc649d-2e5f-47cc-83cd-4aee7c3a3745","type":"Claim","title":"In vitro studies have suggested that tau overexpression inhibits anterograde transport in cultured cells and neurons.","label":"Takashima A; In vitro studies have suggested that tau...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Takashima Akihiko","id":"urn:lsid:swan.org:researchstatement:a7bc649d-2e5f-47cc-83cd-4aee7c3a3745"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4f175542-9785-48d9-887a-2001e4420cda&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4f175542-9785-48d9-887a-2001e4420cda","type":"Hypothesis","title":"Cholesterol transport alters PS1 localization and APP processing.","label":"Runz H et al.; Cholesterol transport alters PS1 localiz...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Rietdorf Jens","Tomic Inge","de Bernard Marina","Beyreuther Konrad","Pepperkok Rainer","Hartmann Tobias"],"firstAuthor":"Runz Heiko","referenceYear":"2002","referenceDate":"2002-03-01","id":"urn:lsid:swan.org:researchstatement:4f175542-9785-48d9-887a-2001e4420cda"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:722e3a4a-f892-423e-9af7-e3621d7a66fd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:722e3a4a-f892-423e-9af7-e3621d7a66fd","type":"Claim","title":"Immature APP was found to be phosphorylated to a greater extent than mAPP in okadaic acid treated PC12 cells, consistent with the results observed at G2/M phase in both HeLa and PC12 cells.","label":"Suzuki T et al.; Immature APP was found to be phosphoryla...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:722e3a4a-f892-423e-9af7-e3621d7a66fd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c7efd7ce-48e3-4531-8afb-154f31cd6d07&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c7efd7ce-48e3-4531-8afb-154f31cd6d07","type":"Claim","title":"There is general agreement that neurofibrillary tangles containing tau and senile plaques containing Aβ are the products of degenerating neurons, and therefore they can not be the cause, since it is axiomatic that a product is the result not the cause of some activity.","label":"Aliev G; There is general agreement that neurofib...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Aliev Gjumrakch","id":"urn:lsid:swan.org:researchstatement:c7efd7ce-48e3-4531-8afb-154f31cd6d07"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bacf565f-b2d4-427f-a989-4c09133f049f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bacf565f-b2d4-427f-a989-4c09133f049f","type":"Claim","title":"Other diagnostic modalities (eg, functional MRI connectivity) will be added to this biomarker staging model as they mature.","label":"Jack C et al.; Other diagnostic modalities (eg, functio...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner Michael W","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:bacf565f-b2d4-427f-a989-4c09133f049f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f2d9af0d-3482-434c-9d96-04990981eeba&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f2d9af0d-3482-434c-9d96-04990981eeba","type":"Claim","title":"Alzheimer&#8217;s Disease can be divided into early onset and late onset disease.","label":"Alzheimer&#8217;s Disease can be divided...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:f2d9af0d-3482-434c-9d96-04990981eeba"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:6cad946b-90bc-4169-8c59-63c8743128c9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:6cad946b-90bc-4169-8c59-63c8743128c9","type":"Comment","title":"Lee and Trojanowski comment on Yuan hypothesis \"Axonal transport is not impaired by changes in tau gene expression levels.\"","label":"Lee V et al.; Lee and Trojanowski comment on Yuan hypo...","icon":"../icons/ontological/discourse-element/comment.png","otherAuthors":["Trojanowski John"],"firstAuthor":"Lee Virginia M-Y","referenceYear":"2008","referenceDate":"2008-02-14","id":"urn:lsid:swan.org:comment:6cad946b-90bc-4169-8c59-63c8743128c9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:aa655524-3695-40cf-818c-80fc3955635f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:aa655524-3695-40cf-818c-80fc3955635f","type":"Claim","title":"SIRT1 is thought to be a key regulator of an evolutionarily conserved pathway that allows organisms to cope with adversity.","label":"Kim D et al.; SIRT1 is thought to be a key regulator o...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:aa655524-3695-40cf-818c-80fc3955635f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c14395c7-61ff-403e-8bf9-35457a1e8344&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c14395c7-61ff-403e-8bf9-35457a1e8344","type":"Claim","title":"Normal proteolytic processing of APP generates two fragments, a large extracellular N-terminal domain (APPs) which is cleaved within the Aβ domain and secreted, and a truncated C-terminal domain (APPCOOH) which remains cell-associated and is degraded by lysosomes.","label":"Suzuki T et al.; Normal proteolytic processing of APP gen...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:c14395c7-61ff-403e-8bf9-35457a1e8344"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5a6f74eb-4c2c-4c93-9111-64175449769d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5a6f74eb-4c2c-4c93-9111-64175449769d","type":"Claim","title":"Monitoring DNA damage revealed a potential involvement of nonstriatal regions in Huntington Disease progression and the possible degeneration of astrocytes at specific stages of the disease.","label":"Cotman C et al.; Monitoring DNA damage revealed a potenti...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:5a6f74eb-4c2c-4c93-9111-64175449769d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:37cc26c1-e2eb-4896-a95f-3f2847744bec&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:37cc26c1-e2eb-4896-a95f-3f2847744bec","type":"Comment","title":"April 2008 Update of the hypothesis \"Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo.\" contributed by Dominic Walsh.","label":"Walsh D; April 2008 Update of the hypothesis \"Nat...","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Walsh Dominic M","id":"urn:lsid:swan.org:comment:37cc26c1-e2eb-4896-a95f-3f2847744bec"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e0299fa9-1a21-41bf-ac85-3cb8f329c165&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e0299fa9-1a21-41bf-ac85-3cb8f329c165","type":"Claim","title":"Treatment of rat cortical neuron cultures with Aβ25\u201335 for 48 h induced an about 40% reduction of total neurite outgrowth which could be rescued nearly completely by overexpression of THOP1.","label":"Pollio G et al.; Treatment of rat cortical neuron culture...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hoozemans Jeroen J","Andersen Claus A","Roncarati Renza","Rosi Maria Cristina","van Haastert Elise S","Seredenina Tamara","Diamanti Daniela","Gotta Stefano","Fiorentini Anna","Magnoni Letizia","Raggiaschi Roberto","Rozemuller Annemieke J","Casamenti Fiorella","Caricasole Andrea","Terstappen Georg C"],"firstAuthor":"Pollio Giuseppe","referenceYear":"2008","referenceDate":"2008-07","id":"urn:lsid:swan.org:researchstatement:e0299fa9-1a21-41bf-ac85-3cb8f329c165"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:95d12970-ac30-4c8c-9adf-c9ea99359569&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:95d12970-ac30-4c8c-9adf-c9ea99359569","type":"Claim","title":"Many protein aggregates in neurodegenerative diseases show the characteristic features of amyloid and accumulate in an \u2018abnormal\u2019 fibrillar β-pleated sheet structure.","label":"Golde T et al.; Many protein aggregates in neurodegenera...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:95d12970-ac30-4c8c-9adf-c9ea99359569"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c1f8c581-0734-4e44-95bc-ab5a478003a3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c1f8c581-0734-4e44-95bc-ab5a478003a3","type":"Claim","title":"The debate regarding whether PS clinical mutations cause a gain of \u201cabnormal\u201d function or loss of \u201cnormal\u201d (wildtype) function persists.","label":"Bentahir M et al.; The debate regarding whether PS clinical...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:c1f8c581-0734-4e44-95bc-ab5a478003a3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3d769240-e2f0-4955-b0b3-f3967c876a9c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3d769240-e2f0-4955-b0b3-f3967c876a9c","type":"Claim","title":"Age-related increases in brain iron levels, promoted in part by myelin repair/remyelination processes, may drive the age-related risk for the major degenerative diseases (AD, PD, and DLB) as well as earlier manifestation of these diseases in men compared to women.","label":"Bartzokis G; Age-related increases in brain iron leve...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:3d769240-e2f0-4955-b0b3-f3967c876a9c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fa66c263-f6b8-41bc-9ba4-6b0d01aa84ab&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fa66c263-f6b8-41bc-9ba4-6b0d01aa84ab","type":"Claim","title":"The explicit prediction that causes of Alzheimer Disease would relate to amyloid production and clearance was fulfilled when presenilins were cloned and shown to directly relate to amyloid production, with presenilin mutations increasing the production of Aβ42 in people with mutations and in cells and transgenic mice.","label":"Hardy ; The explicit prediction that causes of A...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Hardy","referenceYear":"2009","referenceDate":"2009-05-18","id":"urn:lsid:swan.org:researchstatement:fa66c263-f6b8-41bc-9ba4-6b0d01aa84ab"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6f8871ee-982e-4d26-a0f7-052d3367732c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6f8871ee-982e-4d26-a0f7-052d3367732c","type":"Hypothesis","title":"Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo.","label":"Walsh D et al.; Naturally secreted oligomers of amyloid ...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Klyubin Igor","Fadeeva Julia V","Cullen William K","Anwyl Roger","Wolfe Michael S","Rowan Michael J","Selkoe Dennis J"],"firstAuthor":"Walsh Dominic M","referenceYear":"2002","referenceDate":"2002-04-04","id":"urn:lsid:swan.org:researchstatement:6f8871ee-982e-4d26-a0f7-052d3367732c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b3a4a719-0471-4441-aeb6-695f96a48757&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b3a4a719-0471-4441-aeb6-695f96a48757","type":"Claim","title":"TgCNRD8 mice represent an \u2018aggressive\u2019 transgenic animal model of Aβ plaque deposition and in human AD brain tissue, with plaques developing as early as 3 months of age.","label":"Pollio G et al.; TgCNRD8 mice represent an \u2018aggressive\u2019 t...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hoozemans Jeroen J","Andersen Claus A","Roncarati Renza","Rosi Maria Cristina","van Haastert Elise S","Seredenina Tamara","Diamanti Daniela","Gotta Stefano","Fiorentini Anna","Magnoni Letizia","Raggiaschi Roberto","Rozemuller Annemieke J","Casamenti Fiorella","Caricasole Andrea","Terstappen Georg C"],"firstAuthor":"Pollio Giuseppe","referenceYear":"2008","referenceDate":"2008-07","id":"urn:lsid:swan.org:researchstatement:b3a4a719-0471-4441-aeb6-695f96a48757"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:43030a6c-4a8b-4cd0-abba-47c91e92c4a4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:43030a6c-4a8b-4cd0-abba-47c91e92c4a4","type":"Claim","title":"cdc2 kinase is able to phosphorylate APP at Thr668 in vitro.","label":"Suzuki T et al.; cdc2 kinase is able to phosphorylate APP...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:43030a6c-4a8b-4cd0-abba-47c91e92c4a4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:25796c2e-fa9e-4913-a6a8-c1f714f2f251&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:25796c2e-fa9e-4913-a6a8-c1f714f2f251","type":"Claim","title":"Despite the evidence of disease modification, there is no evidence of any major effect on cognitive function, since all but one of the individuals who died during the follow-up phase had clear end stage dementia before death, including the two individuals with the highest mean anti-Aβ antibodies and almost complete elimination of plaques.","label":"Holmes C et al.; Despite the evidence of disease modifica...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:25796c2e-fa9e-4913-a6a8-c1f714f2f251"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1e243257-5074-4888-a9ee-ca0883bd7e91&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1e243257-5074-4888-a9ee-ca0883bd7e91","type":"Claim","title":"Insulin reduced tau phosphorylation through phosphatidylinositol 3-kinase (PI3K) dependent inhibition of GSK3 in human NT2N neurons. ","label":"Craft S; Insulin reduced tau phosphorylation thro...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft Suzanne","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:1e243257-5074-4888-a9ee-ca0883bd7e91"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d67cc389-40e4-4ac0-b291-2480f6cd6d89&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d67cc389-40e4-4ac0-b291-2480f6cd6d89","type":"Claim","title":"Endogenous anti-Aβ autoantibodies in human plasma may operate naturally to facilitate clearance of Aβ in normal subjects.","label":"Tanzi R et al.; Endogenous anti-Aβ autoantibodies in hum...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:d67cc389-40e4-4ac0-b291-2480f6cd6d89"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:46e8a7aa-fa97-4943-b2eb-4e394d0040c2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:46e8a7aa-fa97-4943-b2eb-4e394d0040c2","type":"Claim","title":"GSK3 activity might be increased in AD, through changes in its phosphorylation state as well as expression levels, although direct evidence for this is limited and some studies find no change in GSK3 activity or reduced GSK3 activity in AD.","label":"Hooper C et al.; GSK3 activity might be increased in AD, ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:46e8a7aa-fa97-4943-b2eb-4e394d0040c2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e767f156-f76c-4296-ba0a-4e1f05e27006&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e767f156-f76c-4296-ba0a-4e1f05e27006","type":"Claim","title":"Recent analysis of a series of FAD-linked PS mutations in cultured human cells and Drosophila has further shown that the degree of reduction in PS-dependent activity correlates well with the corresponding clinical severity, as indicated by age of disease onset.","label":"Shen J et al.; Recent analysis of a series of FAD-linke...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:e767f156-f76c-4296-ba0a-4e1f05e27006"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:58db68a6-5086-4fc6-ba6e-2f3a8e2b0adc&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:58db68a6-5086-4fc6-ba6e-2f3a8e2b0adc","type":"Claim","title":"In the brain CDK5 can phosphorylate APP.","label":"Suzuki T; In the brain CDK5 can phosphorylate APP.","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Suzuki Toshiharu","id":"urn:lsid:swan.org:researchstatement:58db68a6-5086-4fc6-ba6e-2f3a8e2b0adc"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d0a40869-e4ab-4df1-befe-75e3456a8b31&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d0a40869-e4ab-4df1-befe-75e3456a8b31","type":"Claim","title":"Inflammation is a hallmark of other CNS proteinopathies and is often seen as an early change in mouse models of these diseases.","label":"Golde T et al.; Inflammation is a hallmark of other CNS ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:d0a40869-e4ab-4df1-befe-75e3456a8b31"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:84d88107-4ec6-4d12-b1d6-353778570353&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:84d88107-4ec6-4d12-b1d6-353778570353","type":"Claim","title":"A splice variant of tissue-transglutaminase found only in AD tissue produces a truncated form of the enzyme, which lacks the calcium regulatory domain of the full-length enzyme.","label":"Hartley D et al.; A splice variant of tissue-transglutamin...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:84d88107-4ec6-4d12-b1d6-353778570353"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e5b4d263-e94f-4068-b29b-2038ff77038a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e5b4d263-e94f-4068-b29b-2038ff77038a","type":"Claim","title":"Processes containing Aβ accumulations contain fewer mitochondria than processes lacking Aβ accumulations.","label":"Muresan Z et al.; Processes containing Aβ accumulations co...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","referenceYear":"2008","referenceDate":"2008","id":"urn:lsid:swan.org:researchstatement:e5b4d263-e94f-4068-b29b-2038ff77038a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:54e7527a-e292-4e83-bcb4-495409624bf8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:54e7527a-e292-4e83-bcb4-495409624bf8","type":"Claim","title":"Extracts of AD brain contain a prominent oligomer at 56 kDa and pI 5.6, absent in control brain extracts.","label":"Gong Y et al.; Extracts of AD brain contain a prominent...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:54e7527a-e292-4e83-bcb4-495409624bf8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:47372912-6bda-489b-827a-c2435ee4b1ed&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:47372912-6bda-489b-827a-c2435ee4b1ed","type":"Claim","title":"p140 and p260 but not p100 were enriched in raft preparations of brain extracts.","label":"Gong Y et al.; p140 and p260 but not p100 were enriched...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:47372912-6bda-489b-827a-c2435ee4b1ed"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:008257fc-6582-4534-ba60-1bf5196baea0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:008257fc-6582-4534-ba60-1bf5196baea0","type":"Claim","title":"Presenilins also possess γ-secretase-independent activities, such as down-regulation of Wnt signaling through destabilization of β-catenin.","label":"Shen J et al.; Presenilins also possess γ-secretase-ind...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:008257fc-6582-4534-ba60-1bf5196baea0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:05161137-2b5c-4bcc-ba09-e169b1f8f46a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:05161137-2b5c-4bcc-ba09-e169b1f8f46a","type":"Claim","title":"In individuals with Alzheimer\u2019s disease, CLU expression is reported to be increased in affected cortical areas of the brain and to be present in amyloid plaques and in the cerebrospinal fluid.","label":"Harold D et al.; In individuals with Alzheimer\u2019s disease,...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Abraham Richard","Hollingworth Paul","Sims Rebecca","Gerrish Amy","Hamshere Marian L","Pahwa Jaspreet Singh","Moskvina Valentina","Dowzell Kimberley","Williams Amy","Jones Nicola","Thomas Charlene","Stretton Alexandra","Morgan Angharad R","Lovestone Simon","Powell John","Proitsi Petroula","Lupton Michelle K","Brayne Carol","Rubinsztein David C","Gill Michael","Lawlor Brian","Lynch Aoibhinn","Morgan Kevin","Brown Kristelle S","Passmore Peter A","Craig David","McGuinness Bernadette","Todd Stephen","Holmes Clive","Mann David","Smith A David","Love Seth","Kehoe Patrick G","Hardy John","Mead Simon","Fox Nick","Rossor Martin","Collinge John","Maier Wolfgang","Jessen Frank","Schürmann Britta","van den Bussche Hendrik","Heuser Isabella","Kornhuber Johannes","Wiltfang Jens","Dichgans Martin","Frölich Lutz","Hampel Harald","Hüll Michael","Rujescu Dan","Goate Alison M","Kauwe John S","Cruchaga Carlos","Nowotny Petra","Morris John C","Mayo Kevin","Sleegers Kristel","Bettens Karolien","Engelborghs Sebastiaan","De Deyn Peter P","Van Broeckhoven Christine","Livingston Gill","Bass Nicholas J","Gurling Hugh","McQuillin Andrew","Gwilliam Rhian","Deloukas Panagiotis","Al-Chalabi Ammar","Shaw Christopher E","Tsolaki Magda","Singleton Andrew B","Guerreiro Rita","Mühleisen Thomas W","Nöthen Markus M","Moebus Susanne","Jöckel Karl-Heinz","Klopp Norman","Wichmann H-Erich","Carrasquillo Minerva M","Pankratz V Shane","Younkin Steven G","Holmans Peter A","O'Donovan Michael","Owen Michael J","Williams Julie"],"firstAuthor":"Harold Denise","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:05161137-2b5c-4bcc-ba09-e169b1f8f46a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a9f4939d-78be-4587-953d-8e48be18a919&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a9f4939d-78be-4587-953d-8e48be18a919","type":"Claim","title":"Autophagocytosis in CAD cells may also target dense-core vesicles.","label":"Muresan Z et al.; Autophagocytosis in CAD cells may also t...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","referenceYear":"2008","referenceDate":"2008","id":"urn:lsid:swan.org:researchstatement:a9f4939d-78be-4587-953d-8e48be18a919"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:245d9c42-0a04-4d4e-b2b8-51d506079e4d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:245d9c42-0a04-4d4e-b2b8-51d506079e4d","type":"Hypothesis","title":"ApoE aggregates have isoform-specific neurotoxicity.","label":"Hatters D et al.; ApoE aggregates have isoform-specific ne...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Zhong Ning","Rutenber Earl","Weisgraber Karl H"],"firstAuthor":"Hatters Danny M","referenceYear":"2006","referenceDate":"2006-09-01","id":"urn:lsid:swan.org:researchstatement:245d9c42-0a04-4d4e-b2b8-51d506079e4d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:598ec791-e003-4809-8859-d1c6aa2d68e4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:598ec791-e003-4809-8859-d1c6aa2d68e4","type":"Claim","title":"The proteasome activity was significantly reduced almost directly together with a slight appearance of co-precipitated PHF-tau bound to the proteasome.","label":"Keck S et al.; The proteasome activity was significantl...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:598ec791-e003-4809-8859-d1c6aa2d68e4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e6c5d52d-2efa-497c-8165-f83c0363bb15&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e6c5d52d-2efa-497c-8165-f83c0363bb15","type":"Claim","title":"Native Aβ dimers significantly inhibited LTP.","label":"Shankar G et al.; Native Aβ dimers significantly inhibited...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Li Shaomin","Mehta Tapan H","Garcia-Munoz Amaya","Shepardson Nina E","Smith Imelda","Brett Francesca M","Farrell Michael A","Rowan Michael J","Lemere Cynthia A","Regan Ciaran M","Walsh Dominic M","Sabatini Bernardo L","Selkoe Dennis J"],"firstAuthor":"Shankar Ganesh M","referenceYear":"2008","referenceDate":"2008-08","id":"urn:lsid:swan.org:researchstatement:e6c5d52d-2efa-497c-8165-f83c0363bb15"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:64401bc5-1df1-4126-8c22-b08a3489d6c2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:64401bc5-1df1-4126-8c22-b08a3489d6c2","type":"Claim","title":"PS1 plays a critical role in embryonic and adult neurogenesis, demonstrated by massive depletion of adult brain neural progenitors (NPCs) in the developing ventricular zone of the telencephalon due to conditional deletion of both PSEN1 and PSEN2 genes.  ","label":"Veeraraghavalu K et al.; PS1 plays a critical role in embryonic a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Choi Se Hoon","Zhang Xiaoqiong","Sisodia Sangram S"],"firstAuthor":"Veeraraghavalu Karthikeyan","referenceYear":"2010","referenceDate":"2010-05-19","id":"urn:lsid:swan.org:researchstatement:64401bc5-1df1-4126-8c22-b08a3489d6c2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c760ec3e-66af-4529-9b8a-17dffc9cd119&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c760ec3e-66af-4529-9b8a-17dffc9cd119","type":"Claim","title":"In several cases, BACE1-null mice younger than 3 weeks of age died immediately after seizures, and approximately 30% of BACE1-null mice die shortly after birth.","label":"Hu X et al.; In several cases, BACE1-null mice younge...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhou Xiangdong","He Wanxia","Yang Jun","Xiong Wencheng","Wong Philip","Wilson Christopher G","Yan Riqiang"],"firstAuthor":"Hu Xiangyou","referenceYear":"2010","referenceDate":"2010-06-30","id":"urn:lsid:swan.org:researchstatement:c760ec3e-66af-4529-9b8a-17dffc9cd119"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ddacc8c3-f83d-4137-b384-b145520eb2fb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ddacc8c3-f83d-4137-b384-b145520eb2fb","type":"Claim","title":"Mutant forms of PS1 might cause APP cleavage products being left embedded in membrane.","label":"Marchesi V; Mutant forms of PS1 might cause APP clea...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:ddacc8c3-f83d-4137-b384-b145520eb2fb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bbcd0139-ca6d-4338-a430-53f62a0af5c7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bbcd0139-ca6d-4338-a430-53f62a0af5c7","type":"Claim","title":"THOP1 (Thimet, EC 3.4.24.15; EP24.15) is a thiol-sensitive metalloprotease with Zn2+, Mn2+ and Co2+ as cofactors, that cleaves peptide substrates of b18 amino acids.  ","label":"Pollio G et al.; THOP1 (Thimet, EC 3.4.24.15; EP24.15) is...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hoozemans Jeroen J","Andersen Claus A","Roncarati Renza","Rosi Maria Cristina","van Haastert Elise S","Seredenina Tamara","Diamanti Daniela","Gotta Stefano","Fiorentini Anna","Magnoni Letizia","Raggiaschi Roberto","Rozemuller Annemieke J","Casamenti Fiorella","Caricasole Andrea","Terstappen Georg C"],"firstAuthor":"Pollio Giuseppe","referenceYear":"2008","referenceDate":"2008-07","id":"urn:lsid:swan.org:researchstatement:bbcd0139-ca6d-4338-a430-53f62a0af5c7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6c8fc058-fe33-48bb-8b97-657d599ba33b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6c8fc058-fe33-48bb-8b97-657d599ba33b","type":"Claim","title":"Hippocampal sclerosis (HS) was significantly more frequent in TDP-43-positive than TDP-43 negative progressive supranuclear palsy (PSP) cases. ","label":"Yokota O et al.; Hippocampal sclerosis (HS) was significa...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Davidson Yvonne","Bigio Eileen H","Ishizu Hideki","Terada Seishi","Arai Tetsuaki","Hasegawa Masato","Akiyama Haruhiko","Sikkink Stephen","Pickering-Brown Stuart","Mann David M"],"firstAuthor":"Yokota Osamu","referenceYear":"2010","referenceDate":"2010-07","id":"urn:lsid:swan.org:researchstatement:6c8fc058-fe33-48bb-8b97-657d599ba33b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4593dd4a-b1e0-48c6-ad41-36d70cd7525b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4593dd4a-b1e0-48c6-ad41-36d70cd7525b","type":"Claim","title":"HEK293 cells stably transfected with Kv4.2 demonstrated increased Kv current in response to amyloid beta but no change in channel protein levels.","label":"Plant L et al.; HEK293 cells stably transfected with Kv4...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:4593dd4a-b1e0-48c6-ad41-36d70cd7525b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9685ec84-1630-41b4-9b77-c872f595fba0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9685ec84-1630-41b4-9b77-c872f595fba0","type":"Claim","title":"Oligomeric Aβ levels are increased by expressing AD-causing mutations of APP or presenilins.","label":"Walsh D et al.; Oligomeric Aβ levels are increased by ex...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Klyubin Igor","Fadeeva Julia V","Cullen William K","Anwyl Roger","Wolfe Michael S","Rowan Michael J","Selkoe Dennis J"],"firstAuthor":"Walsh Dominic M","referenceYear":"2002","referenceDate":"2002-04-04","id":"urn:lsid:swan.org:researchstatement:9685ec84-1630-41b4-9b77-c872f595fba0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:86c7d1e7-9510-4a61-8a12-018d202ac2c6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:86c7d1e7-9510-4a61-8a12-018d202ac2c6","type":"Claim","title":"4.\tGSK3 activity is modulated by insulin and Wnt signaling, both pathways act in a negative regulatory manner.","label":"Hooper C et al.; 4.\tGSK3 activity is modulated by insulin...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:86c7d1e7-9510-4a61-8a12-018d202ac2c6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:54522209-f204-425a-9dbd-b6b60790e164&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:54522209-f204-425a-9dbd-b6b60790e164","type":"Claim","title":"Based on the NRHypo neurodegeneration hypothesis, excessive activation of muscarinic receptors may be a key feature of the pathological mechanism, and decreasing such activation should be neuroprotective.","label":"Olney J et al.; Based on the NRHypo neurodegeneration hy...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:54522209-f204-425a-9dbd-b6b60790e164"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9baeb64c-8b16-4410-bfc5-d3e339a4e5f5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9baeb64c-8b16-4410-bfc5-d3e339a4e5f5","type":"Claim","title":"PS1<sub>M146V<\/sub> knock-in mice were used to study the in vivo effects of mutant PS1 on calcium homeostasis and the data are remarkably consistent with earlier expression studies in a diverse range of cell lines.","label":"Smith I et al.; PS1<sub>M146V<\/sub> knock-in mice were u...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:9baeb64c-8b16-4410-bfc5-d3e339a4e5f5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ad612812-dd66-4d65-8314-8ae84d62f9cf&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ad612812-dd66-4d65-8314-8ae84d62f9cf","type":"Claim","title":"Three PS1 mutations (L113P, G183V, and insR352) have been identified in families with FTD, a common neurodegenerative dementia that lacks amyloid pathology, implying that these PS1 mutations may confer a stronger loss of function than those causing familial AD, equivalent to high doses of γ-secretase inhibitor.","label":"Shen J et al.; Three PS1 mutations (L113P, G183V, and i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:ad612812-dd66-4d65-8314-8ae84d62f9cf"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f19c9b3a-36b6-4f47-a870-04283f7899c5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f19c9b3a-36b6-4f47-a870-04283f7899c5","type":"Hypothesis","title":"Aging-related changes in metabolism lead to neurodegeneration.","label":"Finch C et al.; Aging-related changes in metabolism lead...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Cohen D M"],"firstAuthor":"Finch C E","referenceYear":"1997","referenceDate":"1997-01","id":"urn:lsid:swan.org:researchstatement:f19c9b3a-36b6-4f47-a870-04283f7899c5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ca6c8b62-133b-4e66-9d26-a8e70f0635ec&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ca6c8b62-133b-4e66-9d26-a8e70f0635ec","type":"Claim","title":"Though replicative senescence has been postulated to be a key driver of human aging, it is more likely that replicative senescence is simply one of many factors that contribute to the aging process.","label":"Golde T et al.; Though replicative senescence has been p...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:ca6c8b62-133b-4e66-9d26-a8e70f0635ec"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6d7f9892-54bb-4ae1-abb9-c74fe6891030&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6d7f9892-54bb-4ae1-abb9-c74fe6891030","type":"Claim","title":"Some of the punctate blue staining might potentially be \u201csub-microscopic\u201d dense plaques.","label":"Kumar-Singh S; Some of the punctate blue staining might...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Kumar-Singh Samir","id":"urn:lsid:swan.org:researchstatement:6d7f9892-54bb-4ae1-abb9-c74fe6891030"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:89585d70-7a66-4b8d-91ee-16cdd81450e4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:89585d70-7a66-4b8d-91ee-16cdd81450e4","type":"Hypothesis","title":"The combination of nicotine with galantamine is expected to have enhanced therapeutic effects in patients with Alzheimer's disease.","label":"Petrova S; The combination of nicotine with galanta...","icon":"../icons/ontological/discourse-element/h-research-statement.png","firstAuthor":"Petrova Silvia","id":"urn:lsid:swan.org:researchstatement:89585d70-7a66-4b8d-91ee-16cdd81450e4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:54d1e152-57a6-466a-90b4-8b25f6ab013a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:54d1e152-57a6-466a-90b4-8b25f6ab013a","type":"Claim","title":"It is possible that LC neurons that show CCEs have their projections in the hippocampus and cortex, where plaques are regularly found.  ","label":"Muresan Z et al.; It is possible that LC neurons that show...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","id":"urn:lsid:swan.org:researchstatement:54d1e152-57a6-466a-90b4-8b25f6ab013a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6990538f-c2e0-408b-8cf2-c913cfc30fd9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6990538f-c2e0-408b-8cf2-c913cfc30fd9","type":"Claim","title":"Aβ40 monomers are depleted in AD, suggested by the lower CSF levels of Aβ40 in mild cognitive impairment patients with a more rapid cognitive decline.","label":"Giuffrida M et al.; Aβ40 monomers are depleted in AD, sugges...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Caraci Filippo","Pignataro Bruno","Cataldo Sebastiano","De Bona Paolo","Bruno Valeria","Molinaro Gemma","Pappalardo Giuseppe","Messina Angela","Palmigiano Angelo","Garozzo Domenico","Nicoletti Ferdinando","Rizzarelli Enrico","Copani Agata"],"firstAuthor":"Giuffrida Maria Laura","referenceYear":"2009","referenceDate":"2009-08-26","id":"urn:lsid:swan.org:researchstatement:6990538f-c2e0-408b-8cf2-c913cfc30fd9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c14b09f9-6823-40ac-b00e-423c5c8622da&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c14b09f9-6823-40ac-b00e-423c5c8622da","type":"Claim","title":"Deficits in LTP observed in the 3xTg-AD mice are most likely due to the overexpression of APP, being either as a result of APP expression itself or more likely due to the intraneuronal accumulation of Aβ.","label":"Smith I et al.; Deficits in LTP observed in the 3xTg-AD ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:c14b09f9-6823-40ac-b00e-423c5c8622da"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a0c992a2-e031-4d78-91a2-be3cec8ca987&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a0c992a2-e031-4d78-91a2-be3cec8ca987","type":"Claim","title":"It is conceivable that at the doses tested, m266 may enter the central compartment and sequester soluble Aβ.","label":"Dodart J et al.; It is conceivable that at the doses test...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:a0c992a2-e031-4d78-91a2-be3cec8ca987"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:211332aa-42d1-4347-8941-50276ec9d524&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:211332aa-42d1-4347-8941-50276ec9d524","type":"Claim","title":"The NRHypo model dendritic tortuosity is accompanied by tortuosity of the microtubular cytoskeleton within the distorted dendrite, suggesting that changes in the external configuration of the dendrite are due to cytoskeletal changes within the dendrite.","label":"Olney J et al.; The NRHypo model dendritic tortuosity is...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:211332aa-42d1-4347-8941-50276ec9d524"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:402ba2f6-690e-4f92-8028-d45ee5690938&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:402ba2f6-690e-4f92-8028-d45ee5690938","type":"Claim","title":"Should Aβ assemblies be physiologically active, their persistence could increase their contribution to the progressive neurodegeneration process observed in AD.","label":"Hartley D et al.; Should Aβ assemblies be physiologically ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:402ba2f6-690e-4f92-8028-d45ee5690938"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:03e61a40-bb38-4484-b2f6-d7ef81de98b1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:03e61a40-bb38-4484-b2f6-d7ef81de98b1","type":"Claim","title":"A preponderance of current evidence suggests that the effect of apoE on Aβ metabolism, including the 40:42 ratio, is via apoE acting as an Aβ chaperone and not by affecting Aβ production from APP.","label":"Fryer J et al.; A preponderance of current evidence sugg...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:03e61a40-bb38-4484-b2f6-d7ef81de98b1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:508a1dce-94ac-4dda-8e04-b231974a74f8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:508a1dce-94ac-4dda-8e04-b231974a74f8","type":"Claim","title":"In the periphery, the regulation of GSK3 activity is critical for inflammatory cell differentiation, inflammatory cell migration and the secretion of pro-inflammatory cytokines.","label":"Hooper C et al.; In the periphery, the regulation of GSK3...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:508a1dce-94ac-4dda-8e04-b231974a74f8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ebabaad9-c697-4527-b159-c6c43fb3540d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ebabaad9-c697-4527-b159-c6c43fb3540d","type":"Claim","title":"The primary pathological hallmark of Alzheimer's disease (AD) is the loss of neurons.","label":"Cotman C et al.; The primary pathological hallmark of Alz...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:ebabaad9-c697-4527-b159-c6c43fb3540d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f55ee608-4ea1-4bdf-95b7-3c59b42229e2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f55ee608-4ea1-4bdf-95b7-3c59b42229e2","type":"Hypothesis","title":"Genetic depletion of aromatase in male APP transgenic mice down-regulates beta-secretase (BACE1) and prevents Alzheimer-like pathology and cognitive impairment. ","label":"McAllister C et al.; Genetic depletion of aromatase in male A...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Long Jiangang","Bowers Adrienne","Walker Aaron","Cao Philip","Honda Shin-Ichiro","Harada Nobuhiro","Staufenbiel Matthias","Shen Yong","Li Rena"],"firstAuthor":"McAllister Carrie","referenceYear":"2010","referenceDate":"2010-05-26","id":"urn:lsid:swan.org:researchstatement:f55ee608-4ea1-4bdf-95b7-3c59b42229e2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:14ba47ac-f1e8-4e5f-8d58-682d52478d8b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:14ba47ac-f1e8-4e5f-8d58-682d52478d8b","type":"Claim","title":"Autophagy plays a key role in organismal aging and lifespan.","label":"Golde T et al.; Autophagy plays a key role in organismal...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:14ba47ac-f1e8-4e5f-8d58-682d52478d8b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9bedc1f8-c11e-48e7-a34e-c4bc60a46cbc&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9bedc1f8-c11e-48e7-a34e-c4bc60a46cbc","type":"Claim","title":"Abnormal intraneuronal accumulation of alpha-synuclein in Lewy bodies and Lewy neurites caused by familial Parkinson\u2019s Disease-linked mutations has suggested a defect in axonal transport of alpha-synuclein.","label":"Yuan A et al.; Abnormal intraneuronal accumulation of a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:9bedc1f8-c11e-48e7-a34e-c4bc60a46cbc"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1effb5d0-b956-4547-af8d-da88c4c1c93c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1effb5d0-b956-4547-af8d-da88c4c1c93c","type":"Claim","title":"The generation of ER calcium elevations may have a direct role in the induction of synaptic plasticity.","label":"Smith I et al.; The generation of ER calcium elevations ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:1effb5d0-b956-4547-af8d-da88c4c1c93c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ae8b2f98-9971-4b84-874d-a980a37eea59&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ae8b2f98-9971-4b84-874d-a980a37eea59","type":"Claim","title":"Data supporting the prediction that amyloid/Aβ should initiate tangle dysfunction are disappointing. ","label":"Hardy ; Data supporting the prediction that amyl...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Hardy","referenceYear":"2009","referenceDate":"2009-05-18","id":"urn:lsid:swan.org:researchstatement:ae8b2f98-9971-4b84-874d-a980a37eea59"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e08dbb93-84cb-4d69-8d19-be6c91b36bc5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e08dbb93-84cb-4d69-8d19-be6c91b36bc5","type":"Claim","title":"Neuronal cell body degeneration requires the apoptotic effectors BAX and caspase 3.","label":"Nikolaev A et al.; Neuronal cell body degeneration requires...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["McLaughlin Todd","O'Leary Dennis D","Tessier-Lavigne Marc"],"firstAuthor":"Nikolaev Anatoly","referenceYear":"2009","referenceDate":"2009-02-19","id":"urn:lsid:swan.org:researchstatement:e08dbb93-84cb-4d69-8d19-be6c91b36bc5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:529a62d8-8989-4c01-97eb-d087a7f90d1c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:529a62d8-8989-4c01-97eb-d087a7f90d1c","type":"Claim","title":"Three global cognitive tests (Blessed IMC, MMSE and Total DRS) demonstrated by far the closest correlation to the density of mid-frontal (MF) presynaptic boutons, and to inferior parietal (IP) synapse density to a lesser extent.","label":"Terry R et al.; Three global cognitive tests (Blessed IM...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Masliah E","Salmon D P","Butters N","DeTeresa R","Hill R","Hansen L A","Katzman R"],"firstAuthor":"Terry R D","referenceYear":"1991","referenceDate":"1991-10","id":"urn:lsid:swan.org:researchstatement:529a62d8-8989-4c01-97eb-d087a7f90d1c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d9d73ae1-52f3-4eb6-ac74-c9be21ad8ce9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d9d73ae1-52f3-4eb6-ac74-c9be21ad8ce9","type":"Claim","title":"Non-genetic AD is a vascular disorder whose underlying cause is impaired blood flow to the brain during advanced aging.  ","label":"Aliev G; Non-genetic AD is a vascular disorder wh...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Aliev Gjumrakch","id":"urn:lsid:swan.org:researchstatement:d9d73ae1-52f3-4eb6-ac74-c9be21ad8ce9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a567d6a5-4764-4445-9804-88e648ed975b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a567d6a5-4764-4445-9804-88e648ed975b","type":"Claim","title":"A distinct proteasome activity was co-isolated even in the purified PHF-tau isolates, indicating a strong interaction between proteasome subunits and PHF-tau.","label":"Keck S et al.; A distinct proteasome activity was co-is...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:a567d6a5-4764-4445-9804-88e648ed975b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:44424be3-481a-42f8-ac79-3a218fb8aa5c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:44424be3-481a-42f8-ac79-3a218fb8aa5c","type":"Claim","title":"Production of HNE is markedly increased in the AD brain.  When cultured neurons are incubated with Aβ, both ROS and HNE levels increase.","label":"Smith I et al.; Production of HNE is markedly increased ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:44424be3-481a-42f8-ac79-3a218fb8aa5c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8cc1cd87-e638-44e5-a39d-280c8bd17b12&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8cc1cd87-e638-44e5-a39d-280c8bd17b12","type":"Claim","title":"Aβ is first detected intraneuronally.","label":"Marchesi V; Aβ is first detected intraneuronally.","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:8cc1cd87-e638-44e5-a39d-280c8bd17b12"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:028e69e8-4439-4b79-a3e7-18391cf6e4aa&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:028e69e8-4439-4b79-a3e7-18391cf6e4aa","type":"Hypothesis","title":"The decreased antioxidant activity of ApoE4 could contribute to Alzheimer disease, cardiovascular disease and decreased longevity.","label":"Miyata M et al.; The decreased antioxidant activity of Ap...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Smith J D"],"firstAuthor":"Miyata M","referenceYear":"1996","referenceDate":"1996-09","id":"urn:lsid:swan.org:researchstatement:028e69e8-4439-4b79-a3e7-18391cf6e4aa"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b44f501c-cc62-47e8-9744-2071110a4d3c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b44f501c-cc62-47e8-9744-2071110a4d3c","type":"Claim","title":"The onset of the neuronal cell cycle events (CCEs) in cortical layers II/III in genomic APP(Swe) transgenic mice is rapid and nearly synchronous.","label":"Varvel N et al.; The onset of the neuronal cell cycle eve...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bhaskar Kiran","Patil Anita R","Pimplikar Sanjay W","Herrup Karl","Lamb Bruce T"],"firstAuthor":"Varvel Nicholas H","referenceYear":"2008","referenceDate":"2008-10-22","id":"urn:lsid:swan.org:researchstatement:b44f501c-cc62-47e8-9744-2071110a4d3c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5a82ddae-fa3b-42cb-bc3b-51d73c4916e8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5a82ddae-fa3b-42cb-bc3b-51d73c4916e8","type":"Claim","title":"Addition of Aβ42 to cultured neurons enhances glucose uptake and metabolism via the induction of hypoxia-inducible factor-1α.","label":"Giuffrida M et al.; Addition of Aβ42 to cultured neurons enh...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Caraci Filippo","Pignataro Bruno","Cataldo Sebastiano","De Bona Paolo","Bruno Valeria","Molinaro Gemma","Pappalardo Giuseppe","Messina Angela","Palmigiano Angelo","Garozzo Domenico","Nicoletti Ferdinando","Rizzarelli Enrico","Copani Agata"],"firstAuthor":"Giuffrida Maria Laura","referenceYear":"2009","referenceDate":"2009-08-26","id":"urn:lsid:swan.org:researchstatement:5a82ddae-fa3b-42cb-bc3b-51d73c4916e8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7b436e9d-00f0-44a6-8d27-c86c480a724a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7b436e9d-00f0-44a6-8d27-c86c480a724a","type":"Claim","title":"Aβ fibril and protofibril assembly involves significant conformational rearrangement to result in β-sheets.","label":"Bitan G et al.; Aβ fibril and protofibril assembly invol...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:7b436e9d-00f0-44a6-8d27-c86c480a724a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b3560aaa-1124-405f-bf5d-33b9dac4aae5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b3560aaa-1124-405f-bf5d-33b9dac4aae5","type":"Claim","title":"Therapy for the first neurodegenerative stage of AD, if asymptomatic patients could be identified, might correct or prevent beta-amyloid excesses, energy deficits, or oxidative stress or to block NMDA receptors, which runs the risk of pharmacologically producing pathogenic NRHypo condition.","label":"Olney J et al.; Therapy for the first neurodegenerative ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:b3560aaa-1124-405f-bf5d-33b9dac4aae5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:70ef9815-d6c6-466c-bb89-cade862f558e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:70ef9815-d6c6-466c-bb89-cade862f558e","type":"Claim","title":"In transgenic mice which reversibly express P301L tau, tangle bearing neurons show activated caspases, develop tangles and show neuronal loss. While caspases are activated apoptosis related pathway markers are less severe in the Tg4510 mouse model which may delay degeneration.","label":"Cotman C; In transgenic mice which reversibly expr...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Cotman Carl W","id":"urn:lsid:swan.org:researchstatement:70ef9815-d6c6-466c-bb89-cade862f558e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d1daa2ab-14b3-4281-9a2e-1314430a6df2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d1daa2ab-14b3-4281-9a2e-1314430a6df2","type":"Claim","title":"Later-differentiating oligodendrocytes have reduced capacity for myelin repair than earlier differentiating cells and thus, may be more susceptible to myelin breakdown. ","label":"Bartzokis G; Later-differentiating oligodendrocytes h...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:d1daa2ab-14b3-4281-9a2e-1314430a6df2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:69aaae05-4751-4a45-81fe-ec421ac75697&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:69aaae05-4751-4a45-81fe-ec421ac75697","type":"Claim","title":"HNE has been shown to specifically enhance L-type VGCC currents through a mechanism involving increased tyrosine phosphorylation.","label":"Smith I et al.; HNE has been shown to specifically enhan...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:69aaae05-4751-4a45-81fe-ec421ac75697"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a71a3421-e1dd-4a49-bb77-0129678aa814&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a71a3421-e1dd-4a49-bb77-0129678aa814","type":"Claim","title":"Recent recommendations have suggested redefining research criteria for AD by labeling individuals with memory impairment plus accompanying biomarker evidence of AD as having early AD.","label":"Jack C et al.; Recent recommendations have suggested re...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner Michael W","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:a71a3421-e1dd-4a49-bb77-0129678aa814"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0bbae21b-ec58-4aba-bef9-22427e576e6e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0bbae21b-ec58-4aba-bef9-22427e576e6e","type":"Claim","title":"Highest levels of ApoE are expressed in liver and secondly in brain, primarily by astrocytes and microglia","label":"Holtzman D; Highest levels of ApoE are expressed in ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:0bbae21b-ec58-4aba-bef9-22427e576e6e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:de03513c-e2b5-40c2-871c-d1d58cf53b36&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:de03513c-e2b5-40c2-871c-d1d58cf53b36","type":"Claim","title":"In the NRHypo neurodegenerative syndrome the most prominently affected neurons are medium-sized pyramidal or multipolar neurons in each region, fitting the description of neurons primarily involved in the formation of neurofibrillary tangles (NFTs) in the AD brain.","label":"Olney J et al.; In the NRHypo neurodegenerative syndrome...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:de03513c-e2b5-40c2-871c-d1d58cf53b36"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:913f6807-da48-4c8e-920b-703611aebcd8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:913f6807-da48-4c8e-920b-703611aebcd8","type":"Claim","title":"A polymorphism in the GSK3β promoter is a risk factor for late onset AD, which might account for alterations in GSK3 expression in disease.","label":"Hooper C et al.; A polymorphism in the GSK3β promoter is ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:913f6807-da48-4c8e-920b-703611aebcd8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:b02bfdb0-17b3-415f-abb7-37c715f64499&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:b02bfdb0-17b3-415f-abb7-37c715f64499","type":"Question","title":"Understanding differences between replicative senescence and the physiological senescence of neuronal or glial cells may reveal new therapeutic approaches to treat many neurodegenerative diseases.","label":"Understanding differences between replic...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:b02bfdb0-17b3-415f-abb7-37c715f64499"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a22134f6-5abf-458c-85ea-00e01f1a157a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a22134f6-5abf-458c-85ea-00e01f1a157a","type":"Claim","title":"CSF abnormalities (low CSF Aβ42 and elevated CSF tau levels) indicative of AD may precede, in some individuals, the detection of fibrillar Aβ by amyloid imaging.","label":"Morris J et al.; CSF abnormalities (low CSF Aβ42 and elev...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Roe Catherine M","Grant Elizabeth A","Head Denise","Storandt Martha","Goate Alison M","Fagan Anne M","Holtzman David M","Mintun Mark A"],"firstAuthor":"Morris John C","referenceYear":"2009","referenceDate":"2009-12","id":"urn:lsid:swan.org:researchstatement:a22134f6-5abf-458c-85ea-00e01f1a157a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fbb41272-e517-49af-9654-1a0cb21ec610&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fbb41272-e517-49af-9654-1a0cb21ec610","type":"Claim","title":"There are unresolved differences regarding the precise biochemical nature of synaptotoxic Aβ species.","label":"Shankar G et al.; There are unresolved differences regardi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Li Shaomin","Mehta Tapan H","Garcia-Munoz Amaya","Shepardson Nina E","Smith Imelda","Brett Francesca M","Farrell Michael A","Rowan Michael J","Lemere Cynthia A","Regan Ciaran M","Walsh Dominic M","Sabatini Bernardo L","Selkoe Dennis J"],"firstAuthor":"Shankar Ganesh M","referenceYear":"2008","referenceDate":"2008-08","id":"urn:lsid:swan.org:researchstatement:fbb41272-e517-49af-9654-1a0cb21ec610"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5334f4a8-ebcc-4529-bccc-a6b398862513&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5334f4a8-ebcc-4529-bccc-a6b398862513","type":"Claim","title":"Neither plaques nor tangles correlated with mental status.  Neither ChAT nor somatostatin assays correlated with mental status.","label":"Terry R et al.; Neither plaques nor tangles correlated w...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Masliah E","Salmon D P","Butters N","DeTeresa R","Hill R","Hansen L A","Katzman R"],"firstAuthor":"Terry R D","referenceYear":"1991","referenceDate":"1991-10","id":"urn:lsid:swan.org:researchstatement:5334f4a8-ebcc-4529-bccc-a6b398862513"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1be9ba38-4c8b-46e8-b6e1-9431f97e6a65&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1be9ba38-4c8b-46e8-b6e1-9431f97e6a65","type":"Claim","title":"A link between NRHypo and neurodegeneration was first established in experiments in which NMDA antagonist drugs, which cause a profound NRHypo state, were administered to adult rats, and it was observed that this treatment consistently induced injury of cerebrocortical neurons.","label":"Olney J et al.; A link between NRHypo and neurodegenerat...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:1be9ba38-4c8b-46e8-b6e1-9431f97e6a65"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:48f5ca4d-d710-4d09-8be5-8f2c4fa5e79c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:48f5ca4d-d710-4d09-8be5-8f2c4fa5e79c","type":"Claim","title":"The inhibition of LTP by ADDLs is not caused by cell death, because at 45 min there are no signs of overt cytodegeneration; moreover, cells are electrophysiologically active, albeit lacking in LTP.","label":"Lambert M et al.; The inhibition of LTP by ADDLs is not ca...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:48f5ca4d-d710-4d09-8be5-8f2c4fa5e79c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d84bbf29-7302-484b-90eb-77e184a58edc&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d84bbf29-7302-484b-90eb-77e184a58edc","type":"Claim","title":"Novel anti-inflammatory approaches designed to reduce the paracrine effects of the SASP/SMS may limit the spread of a neurodegenerative process, and thereby limit the collateral damage caused by a proteinopathy.","label":"Golde T et al.; Novel anti-inflammatory approaches desig...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:d84bbf29-7302-484b-90eb-77e184a58edc"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f1632976-dc86-414e-9450-8dfdf07bd63e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f1632976-dc86-414e-9450-8dfdf07bd63e","type":"Hypothesis","title":"Oxidative stress is central to the pathogenesis of Alzheimer's disease.","label":"Smith M et al.; Oxidative stress is central to the patho...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Perry George"],"firstAuthor":"Smith Mark A","id":"urn:lsid:swan.org:researchstatement:f1632976-dc86-414e-9450-8dfdf07bd63e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1b36a44c-c582-4a80-b256-454689ffed13&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1b36a44c-c582-4a80-b256-454689ffed13","type":"Claim","title":"Aβ42 immunization is perhaps the most exciting pharmacological development to decrease Aβ production or increase its clearance.","label":"Small S et al.; Aβ42 immunization is perhaps the most ex...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:1b36a44c-c582-4a80-b256-454689ffed13"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7c966898-0eb1-4ede-8621-59cbefe48160&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7c966898-0eb1-4ede-8621-59cbefe48160","type":"Claim","title":"By 12 months of age, DLB-AD mice demonstrate a significant decrease in detergent-soluble tau and a corresponding increase in detergent-insoluble tau with a dramatic increase in phospho-tau (AT8) immunoreactivity.","label":"Clinton L et al.; By 12 months of age, DLB-AD mice demonst...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Blurton-Jones Mathew","Myczek Kristoffer","Trojanowski John Q","LaFerla Frank M"],"firstAuthor":"Clinton Lani K","referenceYear":"2010","referenceDate":"2010-05-26","id":"urn:lsid:swan.org:researchstatement:7c966898-0eb1-4ede-8621-59cbefe48160"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f0d950f8-8ada-47f1-b1b6-60831d1d7384&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f0d950f8-8ada-47f1-b1b6-60831d1d7384","type":"Claim","title":"Under pathological conditions, the equilibrium of tau binding to the MTs is perturbed, resulting in an abnormal increase in the levels of the free (unbound) tau fraction and it is likely that the higher cytosolic concentrations of tau increase the chances of pathogenic conformational changes that in turn lead to the aggregation and fibrillization of tau.","label":"Ballatore C et al.; Under pathological conditions, the equil...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Lee Virginia M-Y","Trojanowski John Q"],"firstAuthor":"Ballatore Carlo","referenceYear":"2007","referenceDate":"2007-09","id":"urn:lsid:swan.org:researchstatement:f0d950f8-8ada-47f1-b1b6-60831d1d7384"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fb737958-590c-4234-80eb-9a603527ab5e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fb737958-590c-4234-80eb-9a603527ab5e","type":"Claim","title":"As Aβ peptide length increases, the distribution of oligomers shifts to favor the formation of paranuclei.","label":"Bitan G et al.; As Aβ peptide length increases, the dist...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:fb737958-590c-4234-80eb-9a603527ab5e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:13b66b42-ae10-4e06-8f85-1ef91682d054&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:13b66b42-ae10-4e06-8f85-1ef91682d054","type":"Claim","title":"Aβ accumulation in the membrane may impair any normal function of APP dimers.","label":"Marchesi V; Aβ accumulation in the membrane may impa...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:13b66b42-ae10-4e06-8f85-1ef91682d054"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bf14feb3-0b2d-4339-b5cb-3a65ffe6f7e6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bf14feb3-0b2d-4339-b5cb-3a65ffe6f7e6","type":"Claim","title":"Aggregated Aβ in the form of plaques may be harmless, or could even be protective, and therefore the process of removing them might be counterproductive, by generating an increased concentration of toxic oligomeric Aβ.","label":"Holmes C et al.; Aggregated Aβ in the form of plaques may...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:bf14feb3-0b2d-4339-b5cb-3a65ffe6f7e6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ba71aff9-a6c6-4bf2-bd7c-b774f6ecf9f8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ba71aff9-a6c6-4bf2-bd7c-b774f6ecf9f8","type":"Claim","title":"The diffuse distribution of PS mutations is most compatible with a loss of function.","label":"Shen J et al.; The diffuse distribution of PS mutations...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:ba71aff9-a6c6-4bf2-bd7c-b774f6ecf9f8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5ccaac4a-0852-4248-add1-fbe1cfdbfa78&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5ccaac4a-0852-4248-add1-fbe1cfdbfa78","type":"Claim","title":"In human AD, neuronal cell cycle events (CCEs) are observed in neurons subject to neurodegeneration in patients early in the disease process as indicated by their presence in patients with mild cognitive impairment suggesting that neuronal CCEs represent an early marker of neuronal distress and disease pathogenesis.","label":"Varvel N et al.; In human AD, neuronal cell cycle events ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bhaskar Kiran","Patil Anita R","Pimplikar Sanjay W","Herrup Karl","Lamb Bruce T"],"firstAuthor":"Varvel Nicholas H","referenceYear":"2008","referenceDate":"2008-10-22","id":"urn:lsid:swan.org:researchstatement:5ccaac4a-0852-4248-add1-fbe1cfdbfa78"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:77836612-c59a-4ecc-8c70-f5b3945d6a1c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:77836612-c59a-4ecc-8c70-f5b3945d6a1c","type":"Comment","title":"Neither β-amyloid (since levels are not correlated with cognitive deficits) nor cell death (extreme late stage pathology) are likely candidate biochemical or pathological abnormalities that are directly triggering the pathological electrical deficits.","label":"Stutzmann G; Neither β-amyloid (since levels are not ...","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Stutzmann Grace","id":"urn:lsid:swan.org:comment:77836612-c59a-4ecc-8c70-f5b3945d6a1c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e11b2725-d0d9-4b68-8ab2-b814d478f609&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e11b2725-d0d9-4b68-8ab2-b814d478f609","type":"Claim","title":"Caspases are activated in AD brain and the caspase cleavage of tau can catalyze tangle formation.","label":"Cotman C; Caspases are activated in AD brain and t...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Cotman Carl W","id":"urn:lsid:swan.org:researchstatement:e11b2725-d0d9-4b68-8ab2-b814d478f609"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6fa8f6fc-a738-48d8-a4d1-dc6ef20fe4c0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6fa8f6fc-a738-48d8-a4d1-dc6ef20fe4c0","type":"Claim","title":"APP is a phosphoprotein and contains several putative phosphorylation sites in its cytoplasmic domain.","label":"Suzuki T et al.; APP is a phosphoprotein and contains sev...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:6fa8f6fc-a738-48d8-a4d1-dc6ef20fe4c0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e2de65ae-05fa-4523-8703-a9aa3a48c271&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e2de65ae-05fa-4523-8703-a9aa3a48c271","type":"Claim","title":"The local environment along periarterial interstitial fluid drainage pathways has abundant molecules known to bind apoE, such as heparan sulfate proteoglycans and low-density lipoprotein receptor family members.","label":"Fryer J et al.; The local environment along periarterial...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:e2de65ae-05fa-4523-8703-a9aa3a48c271"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e27abb02-ffa6-4965-9bb2-c5c5fc0112f9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e27abb02-ffa6-4965-9bb2-c5c5fc0112f9","type":"Claim","title":"A chromosome 10 locus has been implicated in both increased risk of AD and regulating Abeta42 levels.","label":"Golde T; A chromosome 10 locus has been implicate...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde Todd E","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:e27abb02-ffa6-4965-9bb2-c5c5fc0112f9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ba5a688b-0b3d-4b2d-adf8-a11855e0291b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ba5a688b-0b3d-4b2d-adf8-a11855e0291b","type":"Claim","title":"ADDLs-specific antibodies may safely preserve or restore memory functions in human AD.","label":"Gong Y et al.; ADDLs-specific antibodies may safely pre...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:ba5a688b-0b3d-4b2d-adf8-a11855e0291b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:95341e28-d864-4c32-a63f-963c10be7903&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:95341e28-d864-4c32-a63f-963c10be7903","type":"Claim","title":"Manipulation of the molecular mechanisms of PHF-tau formation might represent a potential target for therapeutic intervention in AD.","label":"Keck S et al.; Manipulation of the molecular mechanisms...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:95341e28-d864-4c32-a63f-963c10be7903"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d1338a87-df44-4bbb-9700-8c070a023f88&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d1338a87-df44-4bbb-9700-8c070a023f88","type":"Claim","title":"Neurotoxic Aβ is known to be generated from mature APP isoform alone.","label":"Suzuki T; Neurotoxic Aβ is known to be generated f...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Suzuki Toshiharu","id":"urn:lsid:swan.org:researchstatement:d1338a87-df44-4bbb-9700-8c070a023f88"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:67ed2f57-11fa-47b6-92e3-27607d3b5cf2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:67ed2f57-11fa-47b6-92e3-27607d3b5cf2","type":"Claim","title":"Intracellular injection of the calcium chelator EGTA reversed the enhancement of LTP reported in hippocampal neurons.","label":"Smith I et al.; Intracellular injection of the calcium c...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:67ed2f57-11fa-47b6-92e3-27607d3b5cf2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:781c7281-4d84-497f-8c06-bceb0cb1c584&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:781c7281-4d84-497f-8c06-bceb0cb1c584","type":"Claim","title":"A greater than two-fold increase in DNA strand breaks has been reported in AD versus control cerebral cortex using biochemical techniques.","label":"Cotman C et al.; A greater than two-fold increase in DNA ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:781c7281-4d84-497f-8c06-bceb0cb1c584"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d8ac7231-3222-4c48-bef4-2d41e01abf34&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d8ac7231-3222-4c48-bef4-2d41e01abf34","type":"Claim","title":"Axonal transport is not necessarily dependent on the presence of tau and is not significantly inhibited by moderately elevated levels of tau.","label":"Yuan A et al.; Axonal transport is not necessarily depe...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:d8ac7231-3222-4c48-bef4-2d41e01abf34"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b6936d62-f8e9-460e-9bd6-b99c676258ae&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b6936d62-f8e9-460e-9bd6-b99c676258ae","type":"Claim","title":"Experimental analysis of normal dendrites shows that they constitute highly elaborated systems for information processing.","label":"Morse T et al.; Experimental analysis of normal dendrite...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Mutalik Pradeep","Cheung Kei","Miller Perry L","Shepherd Gordon"],"firstAuthor":"Morse Thomas M","id":"urn:lsid:swan.org:researchstatement:b6936d62-f8e9-460e-9bd6-b99c676258ae"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:577c8215-9d25-41b2-81d3-f0d7dd90784b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:577c8215-9d25-41b2-81d3-f0d7dd90784b","type":"Claim","title":"Tissue-transglutaminase-induced Aβ assemblies attenuate long-term potentiation (LTP).","label":"Hartley D et al.; Tissue-transglutaminase-induced Aβ assem...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:577c8215-9d25-41b2-81d3-f0d7dd90784b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1a1fa9c0-1780-448e-bf22-3cb32ec1188c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1a1fa9c0-1780-448e-bf22-3cb32ec1188c","type":"Claim","title":"NSAIDS block production of Aβ peptides in animal models.","label":"Marchesi V; NSAIDS block production of Aβ peptides i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:1a1fa9c0-1780-448e-bf22-3cb32ec1188c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:febcb3da-7ccd-48b1-a993-60e87cba48d7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:febcb3da-7ccd-48b1-a993-60e87cba48d7","type":"Claim","title":"Oxidatively damaged proteins are increased in the neuronal cytoplasm and nuclei of hippocampal brain tissue from patients with AD in comparison to age-matched controls.","label":"Keck S et al.; Oxidatively damaged proteins are increas...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:febcb3da-7ccd-48b1-a993-60e87cba48d7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:721264fd-8e39-4f5a-95a7-c7fb7f5ecb59&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:721264fd-8e39-4f5a-95a7-c7fb7f5ecb59","type":"Claim","title":"Biochemical analyses of TDP-43 in the brain and spinal cord of FTLD and ALS patients revealed that TDP-43 is pathologically modified, including abnormal hyperphosphorylation, ubiquitination and N-terminal cleavage. ","label":"Warraich S et al.; Biochemical analyses of TDP-43 in the br...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Yang Shu","Nicholson Garth A","Blair Ian P"],"firstAuthor":"Warraich Sadaf T","referenceYear":"2010","referenceDate":"2010-06-25","id":"urn:lsid:swan.org:researchstatement:721264fd-8e39-4f5a-95a7-c7fb7f5ecb59"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:078f8d5f-ea66-4b09-b6b1-23289ca7cbfa&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:078f8d5f-ea66-4b09-b6b1-23289ca7cbfa","type":"Claim","title":"Immunodepletion-induced prevention of LTP blockage was not due to a non-specific effect of R1282 present in the V717F APP751 conditioned media, since R1282 added to untransfected cell conditioned media had no effect on LTP.","label":"Walsh D et al.; Immunodepletion-induced prevention of LT...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Klyubin Igor","Fadeeva Julia V","Cullen William K","Anwyl Roger","Wolfe Michael S","Rowan Michael J","Selkoe Dennis J"],"firstAuthor":"Walsh Dominic M","referenceYear":"2002","referenceDate":"2002-04-04","id":"urn:lsid:swan.org:researchstatement:078f8d5f-ea66-4b09-b6b1-23289ca7cbfa"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:53ab9a68-8392-4c7c-99eb-646b5441e387&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:53ab9a68-8392-4c7c-99eb-646b5441e387","type":"Claim","title":"Bcl-2 can reduce plaque and tangle pathology in AD mice with overexpressed Bcl-2.","label":"Cotman C; Bcl-2 can reduce plaque and tangle patho...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Cotman Carl W","id":"urn:lsid:swan.org:researchstatement:53ab9a68-8392-4c7c-99eb-646b5441e387"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bd5b25a1-dd73-4ecb-8a8a-c50d3ad8ca5b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bd5b25a1-dd73-4ecb-8a8a-c50d3ad8ca5b","type":"Hypothesis","title":"Cholesterol homeostasis failure as a unifying cause of synaptic degeneration.","label":"Koudinov A et al.; Cholesterol homeostasis failure as a uni...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Koudinova Natalia V"],"firstAuthor":"Koudinov Alexei R","referenceYear":"2005","referenceDate":"2005-03-15","id":"urn:lsid:swan.org:researchstatement:bd5b25a1-dd73-4ecb-8a8a-c50d3ad8ca5b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c5ff614a-1bde-4208-8c01-895fef545596&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c5ff614a-1bde-4208-8c01-895fef545596","type":"Claim","title":"Streptozotocin-induced insulin-receptor dysfunction increases tau phosphorylation at multiple isotopes in mouse cortex and hippocampus, reversible by insulin treatment.","label":"Craft S; Streptozotocin-induced insulin-receptor ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft S","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:c5ff614a-1bde-4208-8c01-895fef545596"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3e7efa78-e870-4c9e-aa3f-44f2d7f26202&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3e7efa78-e870-4c9e-aa3f-44f2d7f26202","type":"Claim","title":"In the brain in vivo, CDK5 and/or JNK phosphorylates mAPP at Thr668.","label":"Suzuki T; In the brain in vivo, CDK5 and/or JNK ph...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Suzuki Toshiharu","id":"urn:lsid:swan.org:researchstatement:3e7efa78-e870-4c9e-aa3f-44f2d7f26202"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1bd38a15-4451-4976-94a9-cf06a3a67680&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1bd38a15-4451-4976-94a9-cf06a3a67680","type":"Claim","title":"Inactivation of a single PS1 allele in mice, whether germ-line or conditional, is insufficient to cause neurodegeneration, whereas the inheritance of a single mutant PS allele is sufficient to cause AD, despite the presence of three remaining intact PS alleles.","label":"Shen J et al.; Inactivation of a single PS1 allele in m...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:1bd38a15-4451-4976-94a9-cf06a3a67680"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d6927812-f9fc-429b-99d4-31fd468fa872&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d6927812-f9fc-429b-99d4-31fd468fa872","type":"Claim","title":"The progression of apoptotic events postmortem was suggested by the observation that at 24 hours as compared with 8.5 hours, there appeared to be more cells with a more granular and classically apoptotic appearance.","label":"Cotman C et al.; The progression of apoptotic events post...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:d6927812-f9fc-429b-99d4-31fd468fa872"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:28ce0cb3-e084-4492-a618-8501b3e5054c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:28ce0cb3-e084-4492-a618-8501b3e5054c","type":"Claim","title":"Aβ oligomers bind with nanomolar affinity to cellular prion protein (PrPC). The interaction does not require the infectious PrPSc conformation.","label":"Laurén J et al.; Aβ oligomers bind with nanomolar affinit...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Gimbel David A","Nygaard Haakon B","Gilbert John W","Strittmatter Stephen M"],"firstAuthor":"Laurén Juha","referenceYear":"2009","referenceDate":"2009-02-26","id":"urn:lsid:swan.org:researchstatement:28ce0cb3-e084-4492-a618-8501b3e5054c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:71c9a94c-6432-4f99-8a34-39421ee47f2e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:71c9a94c-6432-4f99-8a34-39421ee47f2e","type":"Claim","title":"Adenomatous polyposis coli, a synaptic scaffolding protein and collapsin response mediator proteins (CRMPs) are known to influence growth cone dynamics and are hyper-phosphorylated in Aβ plaques. ","label":"Hooper C et al.; Adenomatous polyposis coli, a synaptic s...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:71c9a94c-6432-4f99-8a34-39421ee47f2e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:fc5f22b2-d975-421d-a787-c5bae105b3eb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:fc5f22b2-d975-421d-a787-c5bae105b3eb","type":"Comment","title":"The factors considered by Morse et al. to be causes of electrical activity (which in turn causes cognitive deficits in AD), are not considered to be linked to cognitive deficits.  ","label":"Stutzmann G; The factors considered by Morse et al. t...","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Stutzmann Grace","id":"urn:lsid:swan.org:comment:fc5f22b2-d975-421d-a787-c5bae105b3eb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b57b0863-0c01-4308-b7fa-f4c1c62b8b5c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b57b0863-0c01-4308-b7fa-f4c1c62b8b5c","type":"Claim","title":"The five most widely studied biomarkers of AD pathology, based on the current literature are decreased CSF Aβ42, increased CSF tau, decreased fluorodeoxyglucose uptake measured by positron emission tomography (FDG-PET), PET amyloid imaging, and structural magnetic resonance imaging (MRI) measures of cerebral atrophy.","label":"Jack C et al.; The five most widely studied biomarkers ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner Michael W","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:b57b0863-0c01-4308-b7fa-f4c1c62b8b5c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:22de6638-e2e0-4930-8ca4-d4fc2661d125&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:22de6638-e2e0-4930-8ca4-d4fc2661d125","type":"Claim","title":"There are a number of previous studies (cited in Stokin et al., 2005) that find significant axonal dystrophies, which may be indicative of defects in axonal transport, prior to amyloid deposition as well as in regions of the brain that lack amyloid deposition.","label":"Goldstein L; There are a number of previous studies (...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Goldstein Lawrence S B","id":"urn:lsid:swan.org:researchstatement:22de6638-e2e0-4930-8ca4-d4fc2661d125"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5803fad2-5145-4abe-a424-051d621dfa22&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5803fad2-5145-4abe-a424-051d621dfa22","type":"Claim","title":"The onset and progression of AD may not necessarily be best represented by an unequivocal linear sequence of causes and effects, where one single \u2018root\u2019 cause is responsible for the entire cascade of events.  ","label":"Ballatore C et al.; The onset and progression of AD may not ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Lee Virginia M-Y","Trojanowski John Q"],"firstAuthor":"Ballatore Carlo","referenceYear":"2007","referenceDate":"2007-09","id":"urn:lsid:swan.org:researchstatement:5803fad2-5145-4abe-a424-051d621dfa22"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:c73977de-a051-4d86-b90f-66cf744ad044&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:c73977de-a051-4d86-b90f-66cf744ad044","type":"Question","title":"Why are discrete neuronal populations impacted differently (in timing of cell cycle event onset) with age in the R1.40 mouse model and in AD?","label":"Why are discrete neuronal populations im...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:c73977de-a051-4d86-b90f-66cf744ad044"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fedc88b2-1aad-4aad-a8bb-f5ff6ecc0bde&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fedc88b2-1aad-4aad-a8bb-f5ff6ecc0bde","type":"Claim","title":"The transport wave peak of snap25 in cytoskeleton fractions indicating a peak rate of >38.4 mm/d in both the tau deletion mutant and tau wild-type mice.","label":"Yuan A et al.; The transport wave peak of snap25 in cyt...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:fedc88b2-1aad-4aad-a8bb-f5ff6ecc0bde"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7bbfc875-b422-49a4-a85e-33d6be64c42c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7bbfc875-b422-49a4-a85e-33d6be64c42c","type":"Claim","title":"Tau turnover is dependent on degradation by the proteasome (inhibited by MG132) in HT22 neuronal cells.","label":"Grune T; Tau turnover is dependent on degradation...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Grune Tilman","id":"urn:lsid:swan.org:researchstatement:7bbfc875-b422-49a4-a85e-33d6be64c42c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b47097c7-7243-409c-9efd-e75a00ebf685&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b47097c7-7243-409c-9efd-e75a00ebf685","type":"Claim","title":"LAG-1 deletion in yeast increases yeast cell lifespan.","label":"LAG-1 deletion in yeast increases yeast ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:b47097c7-7243-409c-9efd-e75a00ebf685"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:48d69581-00c4-447b-aa34-0ce88da3b34a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:48d69581-00c4-447b-aa34-0ce88da3b34a","type":"Claim","title":"A recent study suggests that SIRT1 is not required for NAD-dependent protection, rendering the role of SIRT1 in peripheral axotomy unclear.","label":"Kim D et al.; A recent study suggests that SIRT1 is no...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:48d69581-00c4-447b-aa34-0ce88da3b34a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4931c345-904a-486d-ae57-adc2069e800f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4931c345-904a-486d-ae57-adc2069e800f","type":"Claim","title":"CAD cells are a useful model system for studying cellular processes related Alzheimer\u2019s disease pathology, including post-translational processing of APP and intraneuronal oligomerization of Aβ.","label":"Muresan Z et al.; CAD cells are a useful model system for ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","id":"urn:lsid:swan.org:researchstatement:4931c345-904a-486d-ae57-adc2069e800f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e11f4ac7-8080-418d-b29d-f240a2f1dae0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e11f4ac7-8080-418d-b29d-f240a2f1dae0","type":"Claim","title":"Given potential difficulties with the active immunization model, a passive immunization model takes on increased importance.","label":"Wolozin B; Given potential difficulties with the ac...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Wolozin B L","id":"urn:lsid:swan.org:researchstatement:e11f4ac7-8080-418d-b29d-f240a2f1dae0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8da2e297-f469-4c6d-b81b-032be09629e4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8da2e297-f469-4c6d-b81b-032be09629e4","type":"Claim","title":"Selective agonists for 5HT2A serotonergic receptors and selective antagonists for the m3 muscarinic receptor or for sigma receptors are not available. ","label":"Olney J et al.; Selective agonists for 5HT2A serotonergi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:8da2e297-f469-4c6d-b81b-032be09629e4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:138bc99b-aa44-4559-a5da-18ee5a3a2e12&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:138bc99b-aa44-4559-a5da-18ee5a3a2e12","type":"Claim","title":"Protein aggregates are considered to be strong inhibitors of proteasome activity.","label":"Keck S et al.; Protein aggregates are considered to be ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:138bc99b-aa44-4559-a5da-18ee5a3a2e12"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:303e3c7b-7688-4c21-975c-33bb82c6f532&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:303e3c7b-7688-4c21-975c-33bb82c6f532","type":"Claim","title":"Insulin resistance, the tissue-specific inability of insulin to invoke normal signaling, accompanied by peripheral hyperinsulinemia, is the underlying pathophysiology for impaired glucose tolerance (IGT) / T2DM, hypertension (HTN) and cardiovascular disease (CVD) which are all associated with increased AD and Vascular Dementia risk in epidemiologic studies. ","label":"Craft S; Insulin resistance, the tissue-specific ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft Suzanne","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:303e3c7b-7688-4c21-975c-33bb82c6f532"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:acba038a-193a-435f-8bd9-e712f4b6a03e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:acba038a-193a-435f-8bd9-e712f4b6a03e","type":"Claim","title":"In contrast to amyloid, the stability and \u2018seeding\u2019 or nucleating potential of other potentially pathogenic oligomeric structures formed by misfolded proteins has not been studied in detail. ","label":"Golde T et al.; In contrast to amyloid, the stability an...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:acba038a-193a-435f-8bd9-e712f4b6a03e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:327f52aa-f993-4240-94ad-07d1ec38c276&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:327f52aa-f993-4240-94ad-07d1ec38c276","type":"Claim","title":"Presenilin mutations have profound effects on cellular calcium homeostasis, in addition to direct effects on Aβ formation.  It is notable that every presenilin clinical mutation investigated appears to disrupt calcium signalling.","label":"Smith I et al.; Presenilin mutations have profound effec...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:327f52aa-f993-4240-94ad-07d1ec38c276"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b41d5eb0-d713-41ea-8d6a-d964de81c7ba&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b41d5eb0-d713-41ea-8d6a-d964de81c7ba","type":"Claim","title":"Control and AD tissues fixed in 10% formalin show more robust TdT labeling than those fixed in 4% buffered paraformaldehyde.","label":"Cotman C et al.; Control and AD tissues fixed in 10% form...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:b41d5eb0-d713-41ea-8d6a-d964de81c7ba"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:50571864-7095-4494-87de-3815569bbea8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:50571864-7095-4494-87de-3815569bbea8","type":"Claim","title":"Aβ is readily taken up into cells and synaptosomes within minutes of application in external media.","label":"Plant L et al.; Aβ is readily taken up into cells and sy...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:50571864-7095-4494-87de-3815569bbea8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f8151624-988e-46d8-854b-70b1bb128768&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f8151624-988e-46d8-854b-70b1bb128768","type":"Claim","title":"Aβ is generated in very small quantities in normal healthy individuals and does not typically build up to very high levels.","label":"Smith I et al.; Aβ is generated in very small quantities...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:f8151624-988e-46d8-854b-70b1bb128768"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:28e2dba6-1ca7-4b31-8608-b3d9d1feb25d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:28e2dba6-1ca7-4b31-8608-b3d9d1feb25d","type":"Claim","title":"The major age-related degenerative brain disorders represent co-deposition of several proteins such as Aβ, tau, αSyn, TDP43.  ","label":"Bartzokis G; The major age-related degenerative brain...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:28e2dba6-1ca7-4b31-8608-b3d9d1feb25d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:94228aa6-3db2-4f34-9410-315e344d2906&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:94228aa6-3db2-4f34-9410-315e344d2906","type":"Claim","title":"Cloning and characterization of PS1 and PS2 AD-causing mutations revealed that these enhance APP processing to generate amyloidogenic Aβ.","label":"Hardy J et al.; Cloning and characterization of PS1 and ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:94228aa6-3db2-4f34-9410-315e344d2906"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4d02c01e-42a8-4b64-b6ac-d6489358b047&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4d02c01e-42a8-4b64-b6ac-d6489358b047","type":"Claim","title":"PICUP demonstrates that oligomer size of A&#946;40 ranges as monomer to tetramer forms.","label":"Bitan G et al.; PICUP demonstrates that oligomer size of...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:4d02c01e-42a8-4b64-b6ac-d6489358b047"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6cf1634a-a9ba-4ffd-96da-4376c61d59de&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6cf1634a-a9ba-4ffd-96da-4376c61d59de","type":"Claim","title":"Aβ can interact with other cellular insults or risk factors to exacerbate pathological mechanisms in AD or act directly to induce damage.","label":"Cotman C et al.; Aβ can interact with other cellular insu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:6cf1634a-a9ba-4ffd-96da-4376c61d59de"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bc464266-85fa-429b-809d-898625416d80&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bc464266-85fa-429b-809d-898625416d80","type":"Claim","title":"Tau may interfere with axonal transport when overexpressed at extremely high levels or when its isoform composition or phosphorylation state is altered significantly.","label":"Yuan A et al.; Tau may interfere with axonal transport ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:bc464266-85fa-429b-809d-898625416d80"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e79ae8a3-8511-46d9-ac04-14c33f90949a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e79ae8a3-8511-46d9-ac04-14c33f90949a","type":"Claim","title":"Tissue-transglutaminase appears to favor catalyzing intermolecular crosslinks, inducing the formation of Aβ oligomers, but we cannot rule out the possibility that intramolecular cross-linking is also occurring.","label":"Hartley D et al.; Tissue-transglutaminase appears to favor...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:e79ae8a3-8511-46d9-ac04-14c33f90949a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4fb01eeb-a982-428b-92ea-757c05aca4d5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4fb01eeb-a982-428b-92ea-757c05aca4d5","type":"Claim","title":"Aβ can promote the proteasome-dependent degradation of LRP.","label":"Tanzi R et al.; Aβ can promote the proteasome-dependent ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:4fb01eeb-a982-428b-92ea-757c05aca4d5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:59fcbc13-bb81-4278-83da-e2e56d6792e4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:59fcbc13-bb81-4278-83da-e2e56d6792e4","type":"Claim","title":"Aβ42 binds to the α7nicotinic acetylcholine receptor with picomolar affinity.","label":"Dziewczapolski G et al.; Aβ42 binds to the α7nicotinic acetylchol...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Glogowski Carolina M","Masliah Eliezer","Heinemann Stephen F"],"firstAuthor":"Dziewczapolski Gustavo","referenceYear":"2009","referenceDate":"2009-07-08","id":"urn:lsid:swan.org:researchstatement:59fcbc13-bb81-4278-83da-e2e56d6792e4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2ac1e181-d3f7-429f-a06a-33d74e5e98ba&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2ac1e181-d3f7-429f-a06a-33d74e5e98ba","type":"Claim","title":"APP V717F and APPSw transgenic mice develop neuritic plaque in the presence of mouse ApoE, but no neuritic dystrophy developed in the absence of ApoE.","label":"Holtzman D; APP V717F and APPSw transgenic mice deve...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:2ac1e181-d3f7-429f-a06a-33d74e5e98ba"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cf553406-4008-4dde-b1b5-644ece3900ca&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cf553406-4008-4dde-b1b5-644ece3900ca","type":"Claim","title":"Microglia are also found on the surface of some neurons and may place these cells at risk by generating proteases and oxidative radicals.","label":"Cotman C et al.; Microglia are also found on the surface ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:cf553406-4008-4dde-b1b5-644ece3900ca"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cc9e4a2f-490f-4870-a649-265fcde91823&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cc9e4a2f-490f-4870-a649-265fcde91823","type":"Hypothesis","title":"The role of the carboxyl-terminal fragment of APP in the neurodegeneration and cognitive loss in Alzheimer disease.","label":"The role of the carboxyl-terminal fragme...","icon":"../icons/ontological/discourse-element/h-research-statement.png","id":"urn:lsid:swan.org:researchstatement:cc9e4a2f-490f-4870-a649-265fcde91823"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e0327947-a34e-4eb5-8549-ff7a21bc46c7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e0327947-a34e-4eb5-8549-ff7a21bc46c7","type":"Claim","title":"In transgenic mouse and rat models with Aβ deposition, synaptic changes occur before plaque accumulation, evidence that gives strength to the idea that the soluble nonfibrillary species of Aβ plays a crucial role in AD pathogenesis.","label":"Dziewczapolski G et al.; In transgenic mouse and rat models with ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Glogowski Carolina M","Masliah Eliezer","Heinemann Stephen F"],"firstAuthor":"Dziewczapolski Gustavo","referenceYear":"2009","referenceDate":"2009-07-08","id":"urn:lsid:swan.org:researchstatement:e0327947-a34e-4eb5-8549-ff7a21bc46c7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:62aa46bc-e2e7-4eeb-b3a5-e4ddd619d251&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:62aa46bc-e2e7-4eeb-b3a5-e4ddd619d251","type":"Claim","title":"Longitudinal in vivo multiphoton microscopy has been developed to explore the formation of amyloid plaques and to determine the effects of newly formed dense-cored plaques on the microarchitecture of the brain.","label":"Meyer-Luehmann M et al.; Longitudinal in vivo multiphoton microsc...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:62aa46bc-e2e7-4eeb-b3a5-e4ddd619d251"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:36d0171a-e7cf-4ee2-b9ca-8b41273fb845&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:36d0171a-e7cf-4ee2-b9ca-8b41273fb845","type":"Claim","title":"Compounds to neutralize Aβ toxicity reverse AD phenotype in mouse models.","label":"Hardy J et al.; Compounds to neutralize Aβ toxicity reve...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","id":"urn:lsid:swan.org:researchstatement:36d0171a-e7cf-4ee2-b9ca-8b41273fb845"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9e325337-22f0-4ef4-9036-395428c861e7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9e325337-22f0-4ef4-9036-395428c861e7","type":"Claim","title":"Notch is a key physiological substrate of γ-secretase, as evidenced by similar developmental phenotypes exhibited by PS and Notch mutant mice, and the dependence of Notch signaling on the γ-secretase-mediated release of its intracellular domain (NICD).","label":"Shen J et al.; Notch is a key physiological substrate o...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:9e325337-22f0-4ef4-9036-395428c861e7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e31ead25-78fc-4030-84c7-daa95c9a33fa&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e31ead25-78fc-4030-84c7-daa95c9a33fa","type":"Claim","title":"THOP1 expression was significantly increased in AD temporal cortex and CA1 hippocampus as compared to non-demented control cases.","label":"Pollio G et al.; THOP1 expression was significantly incre...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hoozemans Jeroen J","Andersen Claus A","Roncarati Renza","Rosi Maria Cristina","van Haastert Elise S","Seredenina Tamara","Diamanti Daniela","Gotta Stefano","Fiorentini Anna","Magnoni Letizia","Raggiaschi Roberto","Rozemuller Annemieke J","Casamenti Fiorella","Caricasole Andrea","Terstappen Georg C"],"firstAuthor":"Pollio Giuseppe","referenceYear":"2008","referenceDate":"2008-07","id":"urn:lsid:swan.org:researchstatement:e31ead25-78fc-4030-84c7-daa95c9a33fa"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fa3f7be9-1c45-4ed0-bfd7-fcf5d6bdec2d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fa3f7be9-1c45-4ed0-bfd7-fcf5d6bdec2d","type":"Claim","title":"The inflammatory changes noted in the earliest stages of the AD process have also been shown to be early events in some of the AD mouse models of amyloid and tau pathology, including microglial activation and increased levels of select cytokines.","label":"Golde T et al.; The inflammatory changes noted in the ea...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:fa3f7be9-1c45-4ed0-bfd7-fcf5d6bdec2d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b06e73af-6bf9-4baa-af8c-fe689d5fef6f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b06e73af-6bf9-4baa-af8c-fe689d5fef6f","type":"Claim","title":"Agents that prevent NMDA antagonist drug-induced damage should prevent damage induced by the second neurodegenerative stage of AD. ","label":"Olney J et al.; Agents that prevent NMDA antagonist drug...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:b06e73af-6bf9-4baa-af8c-fe689d5fef6f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3be4ddbd-7811-4830-bc66-32965ae526fe&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3be4ddbd-7811-4830-bc66-32965ae526fe","type":"Claim","title":"Although there are no known mutations of tau in AD, tau mutations cause FTDP-17 (frontotemporal dementia with parkinsonism linked to chromosome 17) and are associated with the development of corticobasal degeneration, progressive supranuclear palsy, and Pick\u2019s disease.","label":"Yuan A et al.; Although there are no known mutations of...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:3be4ddbd-7811-4830-bc66-32965ae526fe"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:de0c0b08-0ff4-4495-8dd1-4088c0b55510&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:de0c0b08-0ff4-4495-8dd1-4088c0b55510","type":"Question","title":"It will be critical to determine whether neuronal cell cycle events (CCEs) represent an upstream or downstream consequence of Aβ oligomer exposure.","label":"It will be critical to determine whether...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:de0c0b08-0ff4-4495-8dd1-4088c0b55510"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4fcced46-1880-4855-ba5d-aa0b25c42da7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4fcced46-1880-4855-ba5d-aa0b25c42da7","type":"Claim","title":"IGF-1 is a powerful promoter of myelination and inhibitor of oligodendrocyte apoptosis during primary demyelination, and IGF-1 receptor triggered mechanisms are essential for myelination, remyelination, and their timing.","label":"Bartzokis G; IGF-1 is a powerful promoter of myelinat...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:4fcced46-1880-4855-ba5d-aa0b25c42da7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8d94c2e4-f11b-4760-abbe-e664bb8c4727&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8d94c2e4-f11b-4760-abbe-e664bb8c4727","type":"Claim","title":"As demonstrated by scanning and transmission electron micrographs, Aβ-treated neurons exhibit the classic ultrastructural changes of apoptotic degeneration.","label":"Cotman C et al.; As demonstrated by scanning and transmis...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:8d94c2e4-f11b-4760-abbe-e664bb8c4727"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8f63f6ac-9eda-428c-9817-f518587ffe88&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8f63f6ac-9eda-428c-9817-f518587ffe88","type":"Claim","title":"Axonal dystrophies can be observed both near plaques and in the neuropil without a plaque and have been hypothesized to anticipate the location of plaques.","label":"Meyer-Luehmann M et al.; Axonal dystrophies can be observed both ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:8f63f6ac-9eda-428c-9817-f518587ffe88"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:42f201f3-b475-43b2-ae77-bb1a57272f4e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:42f201f3-b475-43b2-ae77-bb1a57272f4e","type":"Claim","title":"Hyperinsulinemia increases CNS inflammation in an age-dependent manner, as evidenced by IL-1α, TNFα, IL-6, and lipid peroxidation F2-isoprostane markers all significantly increased in CSF after insulin infusion.","label":"Craft S; Hyperinsulinemia increases CNS inflammat...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft Suzanne","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:42f201f3-b475-43b2-ae77-bb1a57272f4e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6df6eea2-71b0-428b-9272-aac29f278044&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6df6eea2-71b0-428b-9272-aac29f278044","type":"Claim","title":"GSK3β reduces acetylcholine synthesis, which is in accordance with the cholinergic deficit present in AD.","label":"Hooper C et al.; GSK3β reduces acetylcholine synthesis, w...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:6df6eea2-71b0-428b-9272-aac29f278044"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4066edc2-46a4-40f8-85ec-3d5a2d36dfec&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4066edc2-46a4-40f8-85ec-3d5a2d36dfec","type":"Claim","title":"AD should be re-classified as an oxidative stress induced vascular disorder and described as a \u201cvasocognopathy\u201d with mitochondrial failure.","label":"Aliev G; AD should be re-classified as an oxidati...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Aliev Gjumrakch","id":"urn:lsid:swan.org:researchstatement:4066edc2-46a4-40f8-85ec-3d5a2d36dfec"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:64486629-deb2-4175-83aa-c054dd300576&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:64486629-deb2-4175-83aa-c054dd300576","type":"Hypothesis","title":"DNA damage may reduce the expression of genes involved in learning, memory and neuronal survival, initiating brain aging, the major risk factor for Alzheimer disease.","label":"Lu T et al.; DNA damage may reduce the expression of ...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Pan Ying","Kao Shyan-Yuan","Li Cheng","Kohane Isaac","Chan Jennifer","Yankner Bruce A"],"firstAuthor":"Lu Tao","referenceYear":"2004","referenceDate":"2004-06-24","id":"urn:lsid:swan.org:researchstatement:64486629-deb2-4175-83aa-c054dd300576"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:67f31d04-e1ab-4e25-ab63-ac065085c546&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:67f31d04-e1ab-4e25-ab63-ac065085c546","type":"Claim","title":"AG1024, which inhibits all members of the insulin receptor superfamily, antagonized the phosphorylation of AKT and IRS1 (insulin receptor substrate 1) promoted by monomeric Aβ42, further indicating that the peptide effect involved the activation of IGF-1/insulin receptors.","label":"Giuffrida M et al.; AG1024, which inhibits all members of th...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Caraci Filippo","Pignataro Bruno","Cataldo Sebastiano","De Bona Paolo","Bruno Valeria","Molinaro Gemma","Pappalardo Giuseppe","Messina Angela","Palmigiano Angelo","Garozzo Domenico","Nicoletti Ferdinando","Rizzarelli Enrico","Copani Agata"],"firstAuthor":"Giuffrida Maria Laura","referenceYear":"2009","referenceDate":"2009-08-26","id":"urn:lsid:swan.org:researchstatement:67f31d04-e1ab-4e25-ab63-ac065085c546"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9ac0e05f-71d2-475a-b046-a0d095204e91&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9ac0e05f-71d2-475a-b046-a0d095204e91","type":"Claim","title":"Some types of microglia degenerate in the presence of Aβ.","label":"Cotman C et al.; Some types of microglia degenerate in th...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:9ac0e05f-71d2-475a-b046-a0d095204e91"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9d7356fa-9aa0-4a4f-ad5d-d23cee077ec6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9d7356fa-9aa0-4a4f-ad5d-d23cee077ec6","type":"Claim","title":"APPsw mice expressing human apoE3 or apoE4 under the control of endogenous apoE regulatory elements (\u201cknock-in\u201d mice) demonstrate that, once Aβ fibrillogenesis occurs, apoE4 results in a shift of Aβ deposition from brain parenchyma to the vasculature compared to murine apoE and human apoE3.","label":"Fryer J et al.; APPsw mice expressing human apoE3 or apo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:9d7356fa-9aa0-4a4f-ad5d-d23cee077ec6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5f9c26d1-7ca6-42ea-beeb-f5fa133e7ffb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5f9c26d1-7ca6-42ea-beeb-f5fa133e7ffb","type":"Claim","title":"Marchesi's hypothesis could illuminate why A&#946;42 prefers to be retained in cells upon exocytosis of more soluble A&#946;40 peptides.","label":"Gouras G; Marchesi's hypothesis could illuminate w...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Gouras Gunnar K","id":"urn:lsid:swan.org:researchstatement:5f9c26d1-7ca6-42ea-beeb-f5fa133e7ffb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f8c8e0dd-cd12-41d4-9326-7316632e0095&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f8c8e0dd-cd12-41d4-9326-7316632e0095","type":"Claim","title":"Mouse models overexpressing mutant human APP have reproduced overproduction of Aβ peptides and progressive amyloid deposition, but they have largely failed to reproduce neurodegeneration.","label":"Shen J et al.; Mouse models overexpressing mutant human...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:f8c8e0dd-cd12-41d4-9326-7316632e0095"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:875c1b82-af7a-40f6-9b9d-d806407b5f99&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:875c1b82-af7a-40f6-9b9d-d806407b5f99","type":"Comment","title":"Holtzman comment on Bitan hypothesis \u201cOligomerization of Aβ 40 and 42 occurs via distinct pathways.\u201d","label":"Holtzman D; Holtzman comment on Bitan hypothesis \u201cOl...","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Holtzman David M","referenceYear":"2002","referenceDate":"2002-12-19","id":"urn:lsid:swan.org:comment:875c1b82-af7a-40f6-9b9d-d806407b5f99"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b1683893-4426-437f-94b9-8b9d5e4faf11&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b1683893-4426-437f-94b9-8b9d5e4faf11","type":"Claim","title":"Soluble Aβ oligomers have been implicated in physical degeneration of synapses.","label":"Gong Y et al.; Soluble Aβ oligomers have been implicate...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:b1683893-4426-437f-94b9-8b9d5e4faf11"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ed4ccd0e-c41d-4f52-bc1c-9f8b974fd68e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ed4ccd0e-c41d-4f52-bc1c-9f8b974fd68e","type":"Claim","title":"Dysregulated intracellular calcium stores have been shown to play a role in Abeta-induced toxicity in mutant PS1-expressing neurons.","label":"Smith I et al.; Dysregulated intracellular calcium store...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:ed4ccd0e-c41d-4f52-bc1c-9f8b974fd68e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e416a178-5e98-480b-ad3a-364f1423b291&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e416a178-5e98-480b-ad3a-364f1423b291","type":"Claim","title":"The data leaves open the possibility that diffuse or pre-diffuse plaques are formed but are quickly turned over.","label":"Kumar-Singh S; The data leaves open the possibility tha...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Kumar-Singh Samir","id":"urn:lsid:swan.org:researchstatement:e416a178-5e98-480b-ad3a-364f1423b291"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:da783cdf-ce79-470a-8daf-a9bc34dc1b42&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:da783cdf-ce79-470a-8daf-a9bc34dc1b42","type":"Claim","title":"Observing the \u2018birthday\u2019 of new plaques strongly argue in favour of the hypothesis that dystrophic neurites near amyloid deposits follow amyloid deposition and suggest a period of several days after plaque formation during which progressive cytoskeletal derangements occur in neurites near a plaque.","label":"Meyer-Luehmann M et al.; Observing the \u2018birthday\u2019 of new plaques ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:da783cdf-ce79-470a-8daf-a9bc34dc1b42"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f2b4375d-0944-4d24-a531-3be22b379536&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f2b4375d-0944-4d24-a531-3be22b379536","type":"Claim","title":"Molecular understanding of AD pathogenesis has resulted in new therapeutic targets.","label":"Hardy J et al.; Molecular understanding of AD pathogenes...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","id":"urn:lsid:swan.org:researchstatement:f2b4375d-0944-4d24-a531-3be22b379536"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0ee9b2c6-2de7-4e7c-af10-ace503bf6fae&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0ee9b2c6-2de7-4e7c-af10-ace503bf6fae","type":"Hypothesis","title":"Human Apolipoprotein E4 alters the amyloid-β 40:42 ratio and promotes the formation of Cerebral Amyloid Angiopathy in an Amyloid Precursor Protein transgenic mouse.","label":"Fryer J et al.; Human Apolipoprotein E4 alters the amylo...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:0ee9b2c6-2de7-4e7c-af10-ace503bf6fae"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:48689183-ca6c-4459-bfa8-17aae929ac62&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:48689183-ca6c-4459-bfa8-17aae929ac62","type":"Hypothesis","title":"The underlying mechanistic link between statin treatment and a reduced prevalence for Alzheimer disease may involve vascular or inflammatory pathways.","label":"Höglund K et al.; The underlying mechanistic link between ...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Blennow Kaj"],"firstAuthor":"Höglund Kina","referenceYear":"2007","referenceDate":"2007","id":"urn:lsid:swan.org:researchstatement:48689183-ca6c-4459-bfa8-17aae929ac62"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2b578ad0-af45-4d72-85a5-a373b6ee0b50&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2b578ad0-af45-4d72-85a5-a373b6ee0b50","type":"Hypothesis","title":"Aluminosilicate precipitations and Alzheimer's disease.","label":"Meyer C; Aluminosilicate precipitations and Alzhe...","icon":"../icons/ontological/discourse-element/h-research-statement.png","firstAuthor":"Meyer Colin","id":"urn:lsid:swan.org:researchstatement:2b578ad0-af45-4d72-85a5-a373b6ee0b50"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ef0c03e6-0343-44d1-8b19-c53787da6a87&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ef0c03e6-0343-44d1-8b19-c53787da6a87","type":"Claim","title":"Cell cycle-dependent phosphorylation of APP at Thr668 is associated with altered APP metabolism.","label":"Suzuki T et al.; Cell cycle-dependent phosphorylation of ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:ef0c03e6-0343-44d1-8b19-c53787da6a87"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9daee7d2-2219-4fb8-8dcd-7b5cd979c9f0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9daee7d2-2219-4fb8-8dcd-7b5cd979c9f0","type":"Claim","title":"Therapeutic strategies are in progress based on Aβ biology.","label":"Hardy J et al.; Therapeutic strategies are in progress b...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:9daee7d2-2219-4fb8-8dcd-7b5cd979c9f0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:8ccebb7d-7c9a-4803-a405-01cd4f3c45ab&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:8ccebb7d-7c9a-4803-a405-01cd4f3c45ab","type":"Question","title":"These unexpected results led us to further investigate whether acute treatment with m266 could reverse object recognition memory deficits in relatively old PDAPP mice.","label":"These unexpected results led us to furth...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:8ccebb7d-7c9a-4803-a405-01cd4f3c45ab"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9c3dab11-05c1-4c54-b07d-a5effb5aa8a7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9c3dab11-05c1-4c54-b07d-a5effb5aa8a7","type":"Claim","title":"Like dendrites and axons, a large number of dendritic spines in transgenic animals have a markedly elevated calcium concentration.","label":"Kuchibhotla K et al.; Like dendrites and axons, a large number...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Goldman Samuel T","Lattarulo Carli R","Wu Hai-Yan","Hyman Bradley T","Bacskai Brian J"],"firstAuthor":"Kuchibhotla Kishore V","referenceYear":"2008","referenceDate":"2008-07-31","id":"urn:lsid:swan.org:researchstatement:9c3dab11-05c1-4c54-b07d-a5effb5aa8a7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a1c8abed-657b-472f-b7dc-3c277ccd058d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a1c8abed-657b-472f-b7dc-3c277ccd058d","type":"Claim","title":"Aβ dimer-enriched membrane fragments were detected in brain samples from AD patients.","label":"Marchesi V; Aβ dimer-enriched membrane fragments wer...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:a1c8abed-657b-472f-b7dc-3c277ccd058d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cff14176-4d91-40ec-9505-eb51773d75f1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cff14176-4d91-40ec-9505-eb51773d75f1","type":"Claim","title":"The half-life of cholesterol metabolism in the brain is in the range of several months, compared to approximately 1 day in the liver.","label":"The half-life of cholesterol metabolism ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:cff14176-4d91-40ec-9505-eb51773d75f1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6fc38975-e69d-46c2-8132-80a7d53f7f6d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6fc38975-e69d-46c2-8132-80a7d53f7f6d","type":"Claim","title":"DNA damage is active and ongoing relatively early in the disease.","label":"Cotman C et al.; DNA damage is active and ongoing relativ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:6fc38975-e69d-46c2-8132-80a7d53f7f6d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b6a19daf-de15-4055-b108-cba10fd724e9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b6a19daf-de15-4055-b108-cba10fd724e9","type":"Claim","title":"No differences in the levels of Aβ and APP expression were observed between APP and APP α7KO mice using immunohistochemistry, Western blot, and ELISA methods.","label":"Dziewczapolski G et al.; No differences in the levels of Aβ and A...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Glogowski Carolina M","Masliah Eliezer","Heinemann Stephen F"],"firstAuthor":"Dziewczapolski Gustavo","referenceYear":"2009","referenceDate":"2009-07-08","id":"urn:lsid:swan.org:researchstatement:b6a19daf-de15-4055-b108-cba10fd724e9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0eca6284-ab89-4460-97f6-40d92e3b9a75&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0eca6284-ab89-4460-97f6-40d92e3b9a75","type":"Claim","title":"Tissue-transglutaminase occurs abundantly in the brain, especially in areas thought to be affected by AD.","label":"Hartley D et al.; Tissue-transglutaminase occurs abundantl...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:0eca6284-ab89-4460-97f6-40d92e3b9a75"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a6b83e2e-f43a-4068-9dd3-25df849723e3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a6b83e2e-f43a-4068-9dd3-25df849723e3","type":"Claim","title":"Given that the mutations consistently decrease the processing of other substrates, Aβ42 is proposed to be an incompletely digested form of the Aβ peptide.","label":"Bentahir M et al.; Given that the mutations consistently de...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:a6b83e2e-f43a-4068-9dd3-25df849723e3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3f37cc69-79cd-4f3a-825c-bafb7bb27540&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3f37cc69-79cd-4f3a-825c-bafb7bb27540","type":"Claim","title":"NSAIDs have demonstrated efficacy in animal models and are in Phase II clinical trial.","label":"Golde T; NSAIDs have demonstrated efficacy in ani...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde T","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:3f37cc69-79cd-4f3a-825c-bafb7bb27540"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c9b26b9f-7f0b-490d-91de-9cf62c431101&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c9b26b9f-7f0b-490d-91de-9cf62c431101","type":"Claim","title":"The molecular pathways responsible for efflux and influx of Aβ across the BBB, between plasma and brain, suggest an array of potential therapeutic strategies that could be aimed at reducing the accumulation of cerebral Aβ.","label":"Tanzi R et al.; The molecular pathways responsible for e...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:c9b26b9f-7f0b-490d-91de-9cf62c431101"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:53661b31-c094-4992-a241-ffcd1343532b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:53661b31-c094-4992-a241-ffcd1343532b","type":"Claim","title":"The acetylation status and overall p53 levels of K382-p53 was lower in resveratrol-treated hippocampal tissue of p25 transgenic mice, relative to vehicle.  This is consistent with the deacetylated form being less stable. Thus the neuroprotective effect of resveratrol is due, at least in part, to deacetylation of K382-p53.","label":"Kim D et al.; The acetylation status and overall p53 l...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:53661b31-c094-4992-a241-ffcd1343532b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5cd3c9d7-3164-428e-9e16-176dff56a493&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5cd3c9d7-3164-428e-9e16-176dff56a493","type":"Claim","title":"Increased production of wild type APP (in Trisomy 21 and other genetic triplications) and increased intracellular oligomeric Aβ can degrade axonal transport, and cause deficits in myelin development and cognition in several animal models.","label":"Bartzokis G; Increased production of wild type APP (i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:5cd3c9d7-3164-428e-9e16-176dff56a493"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:12b4649e-6444-4852-8d83-6d0fcd6f73c1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:12b4649e-6444-4852-8d83-6d0fcd6f73c1","type":"Claim","title":"Conditional null mice that lack Nrg-1 expression maintain similar densities of Olig2+ and MBP+ oligodendrocytes as compared to controls, providing evidence that myelinating glial cells develop in the absence of NRG-1. ","label":"Barres B; Conditional null mice that lack Nrg-1 ex...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Barres Ben A","id":"urn:lsid:swan.org:researchstatement:12b4649e-6444-4852-8d83-6d0fcd6f73c1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8114ae89-b754-42dc-b628-8ce0e6005d91&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8114ae89-b754-42dc-b628-8ce0e6005d91","type":"Claim","title":"Disease-causing mutations of EOAD in presenilin1 and 2 have a primary effect on Aβ processing and plaque formation.","label":"Small S et al.; Disease-causing mutations of EOAD in pre...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:8114ae89-b754-42dc-b628-8ce0e6005d91"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ad816b8b-92a7-4f89-af3f-109e067ea1dd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ad816b8b-92a7-4f89-af3f-109e067ea1dd","type":"Hypothesis","title":"[ADNI]  Increased cerebrospinal fluid (CSF) tau is a biomarker of AD pathology that correlates with clinical severity of Alzheimer Disease.","label":"Jack C et al.; [ADNI]  Increased cerebrospinal fluid (C...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","id":"urn:lsid:swan.org:researchstatement:ad816b8b-92a7-4f89-af3f-109e067ea1dd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fc5e1a17-7518-4a7c-91d9-c1c1047e7d7c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fc5e1a17-7518-4a7c-91d9-c1c1047e7d7c","type":"Claim","title":"Large amounts of covalent high molecular weight PHF-tau aggregates were detected in the samples with very little proteasome activity, indicating that such aggregates most strongly inhibited proteasome function.","label":"Keck S et al.; Large amounts of covalent high molecular...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:fc5e1a17-7518-4a7c-91d9-c1c1047e7d7c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:11cf5799-10f6-4774-b0cd-615a5fccbd5b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:11cf5799-10f6-4774-b0cd-615a5fccbd5b","type":"Claim","title":"Biochemical pathways that affect both Aβ biogenesis and synaptogenesis interact with each other and are affected by aging.","label":"Biochemical pathways that affect both Aβ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:11cf5799-10f6-4774-b0cd-615a5fccbd5b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4437906a-cf6b-4f4d-a721-5f0f24e2526f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4437906a-cf6b-4f4d-a721-5f0f24e2526f","type":"Claim","title":"Animal models based on genetic evidence recapitulate disease pathology and promotion of Aβ deposition, but not neuronal cell death.","label":"Golde T; Animal models based on genetic evidence ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde T","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:4437906a-cf6b-4f4d-a721-5f0f24e2526f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e33deef1-838e-43e6-9e7b-ec6c580d717f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e33deef1-838e-43e6-9e7b-ec6c580d717f","type":"Claim","title":"TdT labeling was regionally specific and absent or present at very low levels in the cerebellum as compared to the entorhinal cortex of the AD cases examined. These findings are consistent with previous results regarding ultrastructural neuronal injury and the formation of AD pathology.","label":"Cotman C et al.; TdT labeling was regionally specific and...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:e33deef1-838e-43e6-9e7b-ec6c580d717f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e4484218-d12a-4029-b8ed-ca0d1e5d88d4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e4484218-d12a-4029-b8ed-ca0d1e5d88d4","type":"Claim","title":"APP23/Ar+/- male mice exhibit a great increase in protein expression of neprilysin (NEP), enhancement of NEP activity and elevated insulin-degrading enzyme (IDE) protein and activity levels suggesting that suggest that the testosterone-induced increase in NEP activity might enhance Aβ clearance in male APP23/Ar+/- mice.","label":"McAllister C et al.; APP23/Ar+/- male mice exhibit a great in...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Long Jiangang","Bowers Adrienne","Walker Aaron","Cao Philip","Honda Shin-Ichiro","Harada Nobuhiro","Staufenbiel Matthias","Shen Yong","Li Rena"],"firstAuthor":"McAllister Carrie","referenceYear":"2010","referenceDate":"2010-05-26","id":"urn:lsid:swan.org:researchstatement:e4484218-d12a-4029-b8ed-ca0d1e5d88d4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1a2cebc5-19a7-416f-8da3-18aead64245c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1a2cebc5-19a7-416f-8da3-18aead64245c","type":"Claim","title":"Cognitive decline curve might shift closer to the Aβ curve (to the left) in individuals with comorbidities (eg, vascular disease), whereas the cognitive decline curve would shift away from the amyloid curve (to the right) in individuals with enhanced cognitive reserve.","label":"Jack C et al.; Cognitive decline curve might shift clos...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:1a2cebc5-19a7-416f-8da3-18aead64245c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4e915df7-2412-4157-9422-772b4abb8e14&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4e915df7-2412-4157-9422-772b4abb8e14","type":"Claim","title":"Numerous mutations in PS1 and PS2 can cause significant reductions in the production of Aβ40, often despite a concomitant increase in the production of Aβ42.","label":"Shen J et al.; Numerous mutations in PS1 and PS2 can ca...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:4e915df7-2412-4157-9422-772b4abb8e14"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8fb18d3a-af12-456a-97da-0d080319b4ae&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8fb18d3a-af12-456a-97da-0d080319b4ae","type":"Claim","title":"Tau amyloidosis leaves less normal tau protein available to stabilize MTs, and, when MTs are destabilized, this compromises intraneuronal transport leading to neurodegeneration.","label":"Lee V et al.; Tau amyloidosis leaves less normal tau p...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Trojanowski John Q"],"firstAuthor":"Lee Virginia M-Y","id":"urn:lsid:swan.org:researchstatement:8fb18d3a-af12-456a-97da-0d080319b4ae"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:dd5dd974-b9c1-4379-b1c0-7882a0cc87be&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:dd5dd974-b9c1-4379-b1c0-7882a0cc87be","type":"Claim","title":"Variable but significant numbers of BACE1-null mice spontaneously develop epileptic seizures occurring in BACE1-null mice, increasingly with age.","label":"Hu X et al.; Variable but significant numbers of BACE...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhou Xiangdong","He Wanxia","Yang Jun","Xiong Wencheng","Wong Philip","Wilson Christopher G","Yan Riqiang"],"firstAuthor":"Hu Xiangyou","referenceYear":"2010","referenceDate":"2010-06-30","id":"urn:lsid:swan.org:researchstatement:dd5dd974-b9c1-4379-b1c0-7882a0cc87be"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b95591ee-20f1-4160-a4a5-a70ccd0dae44&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b95591ee-20f1-4160-a4a5-a70ccd0dae44","type":"Claim","title":"Amyloid beta 1-40 is important in regulating K channel activity.","label":"Plant L et al.; Amyloid beta 1-40 is important in regula...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:b95591ee-20f1-4160-a4a5-a70ccd0dae44"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:275bf034-cf84-4745-82e6-69d409cacdcb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:275bf034-cf84-4745-82e6-69d409cacdcb","type":"Claim","title":"I<sub>KA<\/sub> current in cerebellar granule neurons is mediated by Kv4.2 and Kv4.3 expression.","label":"Plant L et al.; I<sub>KA<\/sub> current in cerebellar gra...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:275bf034-cf84-4745-82e6-69d409cacdcb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0e25b9f5-d8e7-42e5-a948-512d6afcdaf3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0e25b9f5-d8e7-42e5-a948-512d6afcdaf3","type":"Claim","title":"p25 transgenic mice, subjected to a single injection of control or SIRT1 expressing lentivirus in each side of the brain showed that the SIRT1 virus-treated side exhibited 38 ± 13% higher number of neurons than the control virus-treated side, and the neurons were morphologically healthier.","label":"Kim D et al.; p25 transgenic mice, subjected to a sing...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:0e25b9f5-d8e7-42e5-a948-512d6afcdaf3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:468d91d3-8089-4509-9cd2-6cbc8c189641&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:468d91d3-8089-4509-9cd2-6cbc8c189641","type":"Claim","title":"In mutant mice lacking SIRT1 catalytic activity in a brain-specific manner (SIRT1Δ), SIRT1 loss-of-function impairs memory and synaptic plasticity, evidenced by contextual fear conditioning, novel object recognition, water maze hidden platform escape time, LTP measurements, reduced synaptophysin protein expression and density of hippocampal neuronal dendritic spines.","label":"Gao J et al.; In mutant mice lacking SIRT1 catalytic a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wang Wen-Yuan","Mao Ying-Wei","Gräff Johannes","Guan Ji-Song","Pan Ling","Mak Gloria","Kim Dohoon","Su Susan C","Tsai Li-Huei"],"firstAuthor":"Gao Jun","referenceYear":"2010","referenceDate":"2010-07-11","id":"urn:lsid:swan.org:researchstatement:468d91d3-8089-4509-9cd2-6cbc8c189641"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b1d6b8d7-19f3-4374-96d5-e5a4146957c4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b1d6b8d7-19f3-4374-96d5-e5a4146957c4","type":"Claim","title":"Iron responsive elements (IREs) on transferrin, ferritin, APP and αSyn mRNAs that respond to intracellular iron levels suggests that levels of ferritin as well as APP and αSyn may respond to age related increases in brain iron to promote protein oligomerization and may partially explain the highly prevalent co-occurrence of Aβ and αSyn deposits in FAD, LOAD, PD and DLB.","label":"Bartzokis G; Iron responsive elements (IREs) on trans...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:b1d6b8d7-19f3-4374-96d5-e5a4146957c4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cb389a75-e99e-4883-9655-97444c75d9d4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cb389a75-e99e-4883-9655-97444c75d9d4","type":"Claim","title":"Aβ oligomers are composed of Aβ40 and Aβ42.","label":"Walsh D et al.; Aβ oligomers are composed of Aβ40 and Aβ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Klyubin Igor","Fadeeva Julia V","Cullen William K","Anwyl Roger","Wolfe Michael S","Rowan Michael J","Selkoe Dennis J"],"firstAuthor":"Walsh Dominic M","referenceYear":"2002","referenceDate":"2002-04-04","id":"urn:lsid:swan.org:researchstatement:cb389a75-e99e-4883-9655-97444c75d9d4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f61e9a0e-8127-4f00-b413-3e94b8c83fa9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f61e9a0e-8127-4f00-b413-3e94b8c83fa9","type":"Claim","title":"The Phase 3 trials of Alzhemed in the U.S. and Europe have been discontinued.","label":"The Phase 3 trials of Alzhemed in the U....","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:f61e9a0e-8127-4f00-b413-3e94b8c83fa9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:575a3846-113f-4641-9e23-b9ce19fb8570&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:575a3846-113f-4641-9e23-b9ce19fb8570","type":"Claim","title":"It is increasingly apparent that apoptosis and necrosis are not mutually exclusive processes; there may be a continuum between these pathways.","label":"Cotman C et al.; It is increasingly apparent that apoptos...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:575a3846-113f-4641-9e23-b9ce19fb8570"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3695e1f6-b4ed-4f21-a889-b915816e2a4a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3695e1f6-b4ed-4f21-a889-b915816e2a4a","type":"Claim","title":"Deep microvascular lesions, which are markers of vascular pathology with unknown etiology and significance, increase in non-diabetic dementia, and further increased in diabetic + dementia adults. ","label":"Craft S; Deep microvascular lesions, which are ma...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft Suzanne","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:3695e1f6-b4ed-4f21-a889-b915816e2a4a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5a992609-a7ce-44d9-b029-d1eff29ef442&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5a992609-a7ce-44d9-b029-d1eff29ef442","type":"Claim","title":"PS1-A246E clinical mutant displays good activity in Notch NICD production but not in APP epsilon cleavage.","label":"Bentahir M et al.; PS1-A246E clinical mutant displays good ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:5a992609-a7ce-44d9-b029-d1eff29ef442"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:456fb6e2-cd98-44aa-854d-2f1569585349&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:456fb6e2-cd98-44aa-854d-2f1569585349","type":"Claim","title":"ApoE protein associated with soluble Aβ in CSF, plasma, brain homogenates from both control and AD patients.","label":"Holtzman D; ApoE protein associated with soluble Aβ ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:456fb6e2-cd98-44aa-854d-2f1569585349"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:38eae7c0-8f02-4e07-88ca-43a6361e7a86&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:38eae7c0-8f02-4e07-88ca-43a6361e7a86","type":"Claim","title":"ApoE is encoded by a single gene, with 3 common isoform alleles in human, ApoE2, ApoE3, and ApoE4, products of alleles at a single locus on chromosome 19.","label":"Holtzman D; ApoE is encoded by a single gene, with 3...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:38eae7c0-8f02-4e07-88ca-43a6361e7a86"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:04908112-b9bc-4d35-b300-88427dbc15b3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:04908112-b9bc-4d35-b300-88427dbc15b3","type":"Claim","title":"APEH is an Aβ degrading protease of particular interest in AD because it preferentially cleaves Aβ dimers and trimers. ","label":"Abraham C; APEH is an Aβ degrading protease of part...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Abraham Carmela R","id":"urn:lsid:swan.org:researchstatement:04908112-b9bc-4d35-b300-88427dbc15b3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:9dc876fc-7fbe-4d02-ba8d-cd320466e8f2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:9dc876fc-7fbe-4d02-ba8d-cd320466e8f2","type":"Question","title":"Will the upregulation of GSK3 activity caused by retromer deficiency result in tau hyperphosphorylation, independent and in parallel of its established effects on APP processing?","label":"Will the upregulation of GSK3 activity c...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:9dc876fc-7fbe-4d02-ba8d-cd320466e8f2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e54b0a35-286e-4aa5-8528-834e13bbaf1e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e54b0a35-286e-4aa5-8528-834e13bbaf1e","type":"Claim","title":"Fucoidin, an antagonist for scavenger receptors, blocks ADDL binding to rat neuroblastoma B103 cells.","label":"Lambert M et al.; Fucoidin, an antagonist for scavenger re...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:e54b0a35-286e-4aa5-8528-834e13bbaf1e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5b24b7b6-898b-4063-9fbf-e8125ced1a9d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5b24b7b6-898b-4063-9fbf-e8125ced1a9d","type":"Claim","title":"Insulin modulates neurotransmitter levels such as dopamine and acetylcholine, glucose utilization, LTP/LTD, and enhances memory at optimal dose particularly within the hippocampus at insulin-sensitive glucose transporters. ","label":"Craft S; Insulin modulates neurotransmitter level...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft Suzanne","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:5b24b7b6-898b-4063-9fbf-e8125ced1a9d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:994c24e7-9166-4112-9088-2c1c0097ba41&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:994c24e7-9166-4112-9088-2c1c0097ba41","type":"Question","title":"There is a pressing need to keep examining in vivo biology in concert with higher-resolution studies that offer more mechanistic insights into the role of tau expression in axonal transport.","label":"There is a pressing need to keep examini...","icon":"../icons/ontological/discourse-element/research-question.png","firstAuthor":"Holzbaur Erika L F","id":"urn:lsid:swan.org:researchquestion:994c24e7-9166-4112-9088-2c1c0097ba41"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:be9b1ff7-e735-476f-9bf4-bffcb61578f9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:be9b1ff7-e735-476f-9bf4-bffcb61578f9","type":"Claim","title":"Human tau overexpression that results in the development of neurofibrillary tau pathology can model authentic human neurodegenerative tauopathies, whereas there is no clear human counterpart, disease or otherwise, of tau overexpression alone.","label":"Lee V et al.; Human tau overexpression that results in...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Trojanowski John Q"],"firstAuthor":"Lee Virginia M-Y","id":"urn:lsid:swan.org:researchstatement:be9b1ff7-e735-476f-9bf4-bffcb61578f9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cb71a62f-0fd8-46ad-8dec-f9b933f2983e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cb71a62f-0fd8-46ad-8dec-f9b933f2983e","type":"Hypothesis","title":"Dendritic changes play a role in the malfunctioning of the brain and may be a forerunner to the neuronal loss.","label":"Anderton B et al.; Dendritic changes play a role in the mal...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Callahan L","Coleman P","Flood D","Jicha G A","Ohm T","Weaver C"],"firstAuthor":"Anderton B H","referenceYear":"1998","referenceDate":"1998-08","id":"urn:lsid:swan.org:researchstatement:cb71a62f-0fd8-46ad-8dec-f9b933f2983e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:367f21a7-e967-4119-b177-be2464b1aae6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:367f21a7-e967-4119-b177-be2464b1aae6","type":"Claim","title":"Thop1 is a neuropeptidase that degrades a number of neuropeptides including neurotensin, somatostatin and as such participates in the neuropeptide homeostasis of the brain.","label":"Abraham C; Thop1 is a neuropeptidase that degrades ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Abraham Carmela R","id":"urn:lsid:swan.org:researchstatement:367f21a7-e967-4119-b177-be2464b1aae6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:66dc97ce-68a5-43d7-acf6-155f36b6efd9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:66dc97ce-68a5-43d7-acf6-155f36b6efd9","type":"Claim","title":"The first neurodegenerative stage of AD occurs when low concentrations of amyloid are deposited in the brain and interacts with certain NMDA receptors to increase the glutamate sensitivity of these receptors to cause hyperstimulation and destruction by endogenous glutamate. ","label":"Olney J et al.; The first neurodegenerative stage of AD ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:66dc97ce-68a5-43d7-acf6-155f36b6efd9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3d480935-afb9-459d-91d6-8a82c5963fe0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3d480935-afb9-459d-91d6-8a82c5963fe0","type":"Claim","title":"APPsw mice expressing human apoE3 or apoE4 under the control of endogenous apoE regulatory elements (\u201cknock-in\u201d mice) demonstrate early effects of apoE4 on increasing the Aβ40:42 ratio.","label":"Fryer J et al.; APPsw mice expressing human apoE3 or apo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:3d480935-afb9-459d-91d6-8a82c5963fe0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3765e02e-b388-45ea-8f34-c633fd40f1f7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3765e02e-b388-45ea-8f34-c633fd40f1f7","type":"Claim","title":"Fast transport in 8c tau overexpressing mice was not significantly different from that in wild-type. The transport rates of two different fast transport cargoes (represented by protein p135 and snap25) were not significantly impaired in 8c tau overexpressing mice.","label":"Yuan A et al.; Fast transport in 8c tau overexpressing ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:3765e02e-b388-45ea-8f34-c633fd40f1f7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2cd8ceaa-c811-459a-b11f-84e94864ac9e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2cd8ceaa-c811-459a-b11f-84e94864ac9e","type":"Claim","title":"A chemical compound that inhibits the production of Aβ is used to lower the oligomers enough to completely prevent the synaptic interruption, while still leaving appreciable monomer levels (60 percent of normal).","label":"Selkoe D; A chemical compound that inhibits the pr...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Selkoe Dennis J","id":"urn:lsid:swan.org:researchstatement:2cd8ceaa-c811-459a-b11f-84e94864ac9e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:a331aea3-f3ac-4026-9c70-0f6cefef469d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:a331aea3-f3ac-4026-9c70-0f6cefef469d","type":"Comment","title":"LaDu comment on Bitan hypothesis \u201cOligomerization of Aβ 40 and 42 occurs via distinct pathways.\u201d","label":"LaDu M; LaDu comment on Bitan hypothesis \u201cOligom...","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"LaDu Mary Jo","referenceYear":"2002","referenceDate":"2002-12-18","id":"urn:lsid:swan.org:comment:a331aea3-f3ac-4026-9c70-0f6cefef469d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:222b853d-4bf4-464d-a163-05952cdda2c6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:222b853d-4bf4-464d-a163-05952cdda2c6","type":"Claim","title":"The results of in vivo studies of tau-null and tau overexpressing mice are consistent with a report that monomeric tau at levels even 20-fold higher than physiological ones did not affect in vitro axonal transport rates in squid axoplasm.","label":"Yuan A et al.; The results of in vivo studies of tau-nu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:222b853d-4bf4-464d-a163-05952cdda2c6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:515b5a05-e0b7-4722-aac6-b98715dff4a7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:515b5a05-e0b7-4722-aac6-b98715dff4a7","type":"Hypothesis","title":"ApoE exhibits isoform-specific neurotoxicity.","label":"Marques M et al.; ApoE exhibits isoform-specific neurotoxi...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Tolar M","Harmony J A","Crutcher K A"],"firstAuthor":"Marques M A","referenceYear":"1996","referenceDate":"1996-11-04","id":"urn:lsid:swan.org:researchstatement:515b5a05-e0b7-4722-aac6-b98715dff4a7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:efb4fbf0-ec20-4234-a21b-fa7735e2d023&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:efb4fbf0-ec20-4234-a21b-fa7735e2d023","type":"Claim","title":"Biochemical analyses of the brains of AD patients have revealed deficits in the neuronal nicotinic acetylcholine receptors (nAChRs) and a consistent reduction in activity of acetylcholine, acetylcholinesterase and choline acetyltransferase.","label":"Biochemical analyses of the brains of AD...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:efb4fbf0-ec20-4234-a21b-fa7735e2d023"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a01a859e-9474-444a-b5c4-74af36a99960&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a01a859e-9474-444a-b5c4-74af36a99960","type":"Claim","title":"Filamentous Aβ oligomers are not detected in conditioned media of transfected V717F APP751 cells.","label":"Walsh D et al.; Filamentous Aβ oligomers are not detecte...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Klyubin Igor","Fadeeva Julia V","Cullen William K","Anwyl Roger","Wolfe Michael S","Rowan Michael J","Selkoe Dennis J"],"firstAuthor":"Walsh Dominic M","referenceYear":"2002","referenceDate":"2002-04-04","id":"urn:lsid:swan.org:researchstatement:a01a859e-9474-444a-b5c4-74af36a99960"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b9031550-8834-4e05-ae3c-971beac34574&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b9031550-8834-4e05-ae3c-971beac34574","type":"Claim","title":"PICALM appears to be involved in directing the trafficking of VAMP2, a soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) protein that has a prominent role in the fusion of synaptic vesicles to the presynaptic membrane in neurotransmitter release, a process that is crucial to neuronal function.","label":"Harold D et al.; PICALM appears to be involved in directi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Abraham Richard","Hollingworth Paul","Sims Rebecca","Gerrish Amy","Hamshere Marian L","Pahwa Jaspreet Singh","Moskvina Valentina","Dowzell Kimberley","Williams Amy","Jones Nicola","Thomas Charlene","Stretton Alexandra","Morgan Angharad R","Lovestone Simon","Powell John","Proitsi Petroula","Lupton Michelle K","Brayne Carol","Rubinsztein David C","Gill Michael","Lawlor Brian","Lynch Aoibhinn","Morgan Kevin","Brown Kristelle S","Passmore Peter A","Craig David","McGuinness Bernadette","Todd Stephen","Holmes Clive","Mann David","Smith A David","Love Seth","Kehoe Patrick G","Hardy John","Mead Simon","Fox Nick","Rossor Martin","Collinge John","Maier Wolfgang","Jessen Frank","Schürmann Britta","van den Bussche Hendrik","Heuser Isabella","Kornhuber Johannes","Wiltfang Jens","Dichgans Martin","Frölich Lutz","Hampel Harald","Hüll Michael","Rujescu Dan","Goate Alison M","Kauwe John S","Cruchaga Carlos","Nowotny Petra","Morris John C","Mayo Kevin","Sleegers Kristel","Bettens Karolien","Engelborghs Sebastiaan","De Deyn Peter P","Van Broeckhoven Christine","Livingston Gill","Bass Nicholas J","Gurling Hugh","McQuillin Andrew","Gwilliam Rhian","Deloukas Panagiotis","Al-Chalabi Ammar","Shaw Christopher E","Tsolaki Magda","Singleton Andrew B","Guerreiro Rita","Mühleisen Thomas W","Nöthen Markus M","Moebus Susanne","Jöckel Karl-Heinz","Klopp Norman","Wichmann H-Erich","Carrasquillo Minerva M","Pankratz V Shane","Younkin Steven G","Holmans Peter A","O'Donovan Michael","Owen Michael J","Williams Julie"],"firstAuthor":"Harold Denise","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:b9031550-8834-4e05-ae3c-971beac34574"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:019cd485-9298-45ec-b89a-fd6659b23d1f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:019cd485-9298-45ec-b89a-fd6659b23d1f","type":"Claim","title":"Extracellular determinants may confer the Aβ phenotype of CAD cells.","label":"Muresan Z et al.; Extracellular determinants may confer th...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","referenceYear":"2008","referenceDate":"2008","id":"urn:lsid:swan.org:researchstatement:019cd485-9298-45ec-b89a-fd6659b23d1f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7f5414ca-53de-427f-bd11-d8677df84dd1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7f5414ca-53de-427f-bd11-d8677df84dd1","type":"Claim","title":"Recent studies of the senescence-associated secretory phenotype (SASP) have identified a number of consistently upregulated secreted biomarkers during replicative senescence that are inflammatory mediators, including IL-6, IL-8 and other chemokines and cytokines.","label":"Golde T et al.; Recent studies of the senescence-associa...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:7f5414ca-53de-427f-bd11-d8677df84dd1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:450e6534-2081-40af-b828-d94d3d3262a5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:450e6534-2081-40af-b828-d94d3d3262a5","type":"Claim","title":"Immediate early genes have been suggested to participate in apoptosis, such as c-Jun, which has been shown to be induced during and involved in apoptosis in both neuronal and non-neuronal systems.","label":"Cotman C et al.; Immediate early genes have been suggeste...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:450e6534-2081-40af-b828-d94d3d3262a5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7d7bc595-fb53-4cd4-ae27-1df75187b526&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7d7bc595-fb53-4cd4-ae27-1df75187b526","type":"Claim","title":"Multiple disease-associated substrates have been shown to be cross-linked by Tissue-transglutaminase: huntingtin in Huntington\u2019s disease, ataxin-1 in spinocerebellar ataxia-1, and tau and Aβ in Alzheimer\u2019s disease.","label":"Hartley D et al.; Multiple disease-associated substrates h...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:7d7bc595-fb53-4cd4-ae27-1df75187b526"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e327ae26-c10d-4a5a-b1d1-f48165861b7c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e327ae26-c10d-4a5a-b1d1-f48165861b7c","type":"Hypothesis","title":"The combination of HSV1 in brain and carriage of an APOE-epsilon 4 allele is a strong risk factor for Alzheimer disease, whereas either of these features alone does not increase the risk of Alzheimer disease.","label":"Itzhaki R et al.; The combination of HSV1 in brain and car...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Lin W R","Shang D","Wilcock G K","Faragher B","Jamieson G A"],"firstAuthor":"Itzhaki R F","referenceYear":"1997","referenceDate":"1997-01-25","id":"urn:lsid:swan.org:researchstatement:e327ae26-c10d-4a5a-b1d1-f48165861b7c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:570d0edd-daa2-485e-9c5e-bc78e7e111d6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:570d0edd-daa2-485e-9c5e-bc78e7e111d6","type":"Claim","title":"Early onset AD is linked to mutations in APP, PS1 and PS2 genes and accounts for 3% of all AD cases.","label":"Early onset AD is linked to mutations in...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:570d0edd-daa2-485e-9c5e-bc78e7e111d6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6ab02e70-3e34-4db6-b64a-a933f240e33e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6ab02e70-3e34-4db6-b64a-a933f240e33e","type":"Claim","title":"From yeast species Saccharomyces, LAG-1 (longevity assurance gene 1) is a C26 ceramide synthase.","label":"From yeast species Saccharomyces, LAG-1 ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:6ab02e70-3e34-4db6-b64a-a933f240e33e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ca9f0759-5e90-4e72-94e6-f0ae5f93ac3f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ca9f0759-5e90-4e72-94e6-f0ae5f93ac3f","type":"Claim","title":"The enhanced response to caffeine observed in both the PS1KI and 3xTg-AD neurons may be attributable to increased levels of the RyR facilitating the release of stored Ca<sup>2+<\/sup>.","label":"Smith I et al.; The enhanced response to caffeine observ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:ca9f0759-5e90-4e72-94e6-f0ae5f93ac3f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a934889c-702a-4dd2-937f-2b5d507fc70c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a934889c-702a-4dd2-937f-2b5d507fc70c","type":"Claim","title":"The production and maintenance of the myelin sheath(s) that is up to 600× the surface area of oligodendrocyte soma membrane and 100× the weight of the soma makes the energy requirements of oligodendrocytes 2\u20133 fold higher than other brain cells.","label":"Bartzokis G; The production and maintenance of the my...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:a934889c-702a-4dd2-937f-2b5d507fc70c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:dbd5dcda-c003-4e49-9bf5-59e099e1ae2e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:dbd5dcda-c003-4e49-9bf5-59e099e1ae2e","type":"Claim","title":"CNS cells will display a senescent phenotype that is physiologically similar to cells that have undergone replicative senescence, and be functionally impaired in a way that leads to neuronal dysfunction and degeneration; ultimately, leading to either widespread brain \u2018organ failure\u2019 as exhibited in AD, or more or less regional brain organ failure as seen in other neurodegenerative proteinopathies.","label":"Golde T et al.; CNS cells will display a senescent pheno...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:dbd5dcda-c003-4e49-9bf5-59e099e1ae2e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1d5f38e6-70b5-46da-9d53-84b8d29c5d1c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1d5f38e6-70b5-46da-9d53-84b8d29c5d1c","type":"Claim","title":"Aβ-initiated apoptosis may be another example of activation-induced PCD.","label":"Cotman C et al.; Aβ-initiated apoptosis may be another ex...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:1d5f38e6-70b5-46da-9d53-84b8d29c5d1c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2239449b-625b-432f-8767-f8394e046f7c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2239449b-625b-432f-8767-f8394e046f7c","type":"Claim","title":"TdT labeling of AD brain did not show detectable changes at delays of up to 6.5 hours postmortem.","label":"Cotman C et al.; TdT labeling of AD brain did not show de...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:2239449b-625b-432f-8767-f8394e046f7c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3f0a3933-8819-4b03-b71f-c56d875e1fa6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3f0a3933-8819-4b03-b71f-c56d875e1fa6","type":"Claim","title":"More than 550 other genes have been proposed as candidates for Alzheimer\u2019s disease susceptibility, but thus far none have been confirmed to have a role in Alzheimer\u2019s disease pathogenesis.","label":"Lambert J et al.; More than 550 other genes have been prop...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Heath Simon","Even Gael","Campion Dominique","Sleegers Kristel","Hiltunen Mikko","Combarros Onofre","Zelenika Diana","Bullido Maria J","Tavernier Béatrice","Letenneur Luc","Bettens Karolien","Berr Claudine","Pasquier Florence","Fiévet Nathalie","Barberger-Gateau Pascale","Engelborghs Sebastiaan","De Deyn Peter","Mateo Ignacio","Franck Ana","Helisalmi Seppo","Porcellini Elisa","Hanon Olivier","de Pancorbo Marian M","Lendon Corinne","Dufouil Carole","Jaillard Céline","Leveillard Thierry","Alvarez Victoria","Bosco Paolo","Mancuso Michelangelo","Panza Francesco","Nacmias Benedetta","Bossù Paola","Piccardi Paola","Annoni Giorgio","Seripa Davide","Galimberti Daniela","Hannequin Didier","Licastro Federico","Soininen Hilkka","Ritchie Karen","Blanché Hélène","Dartigues Jean-François","Tzourio Christophe","Gut Ivo","Van Broeckhoven Christine","Alpérovitch Annick","Lathrop Mark","Amouyel Philippe"],"firstAuthor":"Lambert Jean-Charles","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:3f0a3933-8819-4b03-b71f-c56d875e1fa6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:46f21570-2957-4d65-89f6-d1c97f818be4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:46f21570-2957-4d65-89f6-d1c97f818be4","type":"Hypothesis","title":"Proteasomal system dysfunction causes neurodegeneration in Alzheimer disease.","label":"Keck S et al.; Proteasomal system dysfunction causes ne...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:46f21570-2957-4d65-89f6-d1c97f818be4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:acb0cb5b-34f1-4cd5-84b3-6b9a373a8044&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:acb0cb5b-34f1-4cd5-84b3-6b9a373a8044","type":"Claim","title":"Binding of ADDLs was robust in hippocampal and cortical cultures, but not in cerebellar cultures.","label":"Gong Y et al.; Binding of ADDLs was robust in hippocamp...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:acb0cb5b-34f1-4cd5-84b3-6b9a373a8044"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:e11f45bb-d3c4-4b79-9bf4-50aa5eeb727b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:e11f45bb-d3c4-4b79-9bf4-50aa5eeb727b","type":"Question","title":"What is the precise mechanism underlying modulation of THOP1 protein by Aβ?","label":"What is the precise mechanism underlying...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:e11f45bb-d3c4-4b79-9bf4-50aa5eeb727b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5ed30b59-b747-483c-b4f1-b366efc685af&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5ed30b59-b747-483c-b4f1-b366efc685af","type":"Claim","title":"Structural MRI measures of atrophy correlates well with Braak staging at autopsy as distribution of atrophy on MRI maps well onto Braak\u2019s staging of NFT pathology in patients who have undergone ante-mortem MRI and post-mortem AD staging.","label":"Jack C et al.; Structural MRI measures of atrophy corre...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:5ed30b59-b747-483c-b4f1-b366efc685af"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2a87ca3d-6420-446f-9ad9-45ed66e6142d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2a87ca3d-6420-446f-9ad9-45ed66e6142d","type":"Claim","title":"CAD cell are a useful model for studying a potential role of brainstem neurons in the initiation of neuritic plaques in Alzheimer\u2019s disease.","label":"Muresan Z et al.; CAD cell are a useful model for studying...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","id":"urn:lsid:swan.org:researchstatement:2a87ca3d-6420-446f-9ad9-45ed66e6142d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:543f3e96-f059-48d8-8b0d-99cdd6790dc7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:543f3e96-f059-48d8-8b0d-99cdd6790dc7","type":"Claim","title":"Pentamer or hexamer forms of Aβ42 are termed \"paranuclei\" because they represent an initial and minimal structural unit from which Aβ assemblies evolve.","label":"Bitan G et al.; Pentamer or hexamer forms of Aβ42 are te...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:543f3e96-f059-48d8-8b0d-99cdd6790dc7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:73a8a75b-3e43-4238-a3cd-38d9ae172510&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:73a8a75b-3e43-4238-a3cd-38d9ae172510","type":"Claim","title":"α7Nicotinic acetylcholine receptor activation mediates Aβ-induced tau protein phosphorylation in hippocampal synaptosomes and human neuroblastoma cells.","label":"Dziewczapolski G et al.; α7Nicotinic acetylcholine receptor activ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Glogowski Carolina M","Masliah Eliezer","Heinemann Stephen F"],"firstAuthor":"Dziewczapolski Gustavo","referenceYear":"2009","referenceDate":"2009-07-08","id":"urn:lsid:swan.org:researchstatement:73a8a75b-3e43-4238-a3cd-38d9ae172510"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:66e75ff2-fb84-46fc-9c81-f10f30a4a0c2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:66e75ff2-fb84-46fc-9c81-f10f30a4a0c2","type":"Hypothesis","title":"APP Intracellular Domain (AICD) is a positive regulator of apoptosis, may add to the toxic effect of A&#946;42 aggregates and further accelerate neurodegeneration.","label":"Passer B et al.; APP Intracellular Domain (AICD) is a pos...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Pellegrini L","Russo C","Siegel R M","Lenardo M J","Schettini G","Bachmann M","Tabaton M","D'Adamio L"],"firstAuthor":"Passer B","referenceYear":"2000","referenceDate":"2000-11","id":"urn:lsid:swan.org:researchstatement:66e75ff2-fb84-46fc-9c81-f10f30a4a0c2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1c9816e6-a9da-4927-bb8b-4f197a270bb0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1c9816e6-a9da-4927-bb8b-4f197a270bb0","type":"Claim","title":"Many studies have raised concerns about the long-term safety of the active Aβ42 immunization approach, despite a lack of long-term data on the survival rates or the cause of death in study populations","label":"Holmes C et al.; Many studies have raised concerns about ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:1c9816e6-a9da-4927-bb8b-4f197a270bb0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:416e2719-aaf1-40ef-b500-0d80131bcc89&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:416e2719-aaf1-40ef-b500-0d80131bcc89","type":"Claim","title":"Intracellular tau fibrils are competent to seed fibril formation of recombinant tau monomer in vitro.","label":"Frost B et al.; Intracellular tau fibrils are competent ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Jacks Rachel L","Diamond Marc I"],"firstAuthor":"Frost Bess","referenceYear":"2009","referenceDate":"2009-05-08","id":"urn:lsid:swan.org:researchstatement:416e2719-aaf1-40ef-b500-0d80131bcc89"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:57c5162a-ae9c-4573-8eb7-ff99f638fb7f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:57c5162a-ae9c-4573-8eb7-ff99f638fb7f","type":"Claim","title":"In both aged TgCRND8 and human AD brain an intense glia reaction occurs in close proximity to Aβ deposits, with the activated MHC-II positive microglial cells infiltrating the plaques, while the hyperthrophic astrocytes surround Aβ deposits demonstrating that both oxidative stress and inflammatory reaction contribute to the pathogenic cascade leading to neurodegeneration.","label":"Pollio G et al.; In both aged TgCRND8 and human AD brain ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hoozemans Jeroen J","Andersen Claus A","Roncarati Renza","Rosi Maria Cristina","van Haastert Elise S","Seredenina Tamara","Diamanti Daniela","Gotta Stefano","Fiorentini Anna","Magnoni Letizia","Raggiaschi Roberto","Rozemuller Annemieke J","Casamenti Fiorella","Caricasole Andrea","Terstappen Georg C"],"firstAuthor":"Pollio Giuseppe","referenceYear":"2008","referenceDate":"2008-07","id":"urn:lsid:swan.org:researchstatement:57c5162a-ae9c-4573-8eb7-ff99f638fb7f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c6ddf270-8349-4cd0-a095-a0b77fe0b9c3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c6ddf270-8349-4cd0-a095-a0b77fe0b9c3","type":"Claim","title":"Despite THOP1 being capable of generating amyloidogenic peptides from APP by virtue of its capacity to cleave at β-secretase sites, modulation of THOP1 expression in a neuroblastoma cell line supports a role for this enzyme in the degradation of soluble Aβ.","label":"Pollio G et al.; Despite THOP1 being capable of generatin...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hoozemans Jeroen J","Andersen Claus A","Roncarati Renza","Rosi Maria Cristina","van Haastert Elise S","Seredenina Tamara","Diamanti Daniela","Gotta Stefano","Fiorentini Anna","Magnoni Letizia","Raggiaschi Roberto","Rozemuller Annemieke J","Casamenti Fiorella","Caricasole Andrea","Terstappen Georg C"],"firstAuthor":"Pollio Giuseppe","referenceYear":"2008","referenceDate":"2008-07","id":"urn:lsid:swan.org:researchstatement:c6ddf270-8349-4cd0-a095-a0b77fe0b9c3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0cc36913-2d22-432d-b76a-6860a4bed641&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0cc36913-2d22-432d-b76a-6860a4bed641","type":"Hypothesis","title":"Apoptosis is a mechanism of neuronal death in Alzheimer disease.","label":"Cotman C et al.; Apoptosis is a mechanism of neuronal dea...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:0cc36913-2d22-432d-b76a-6860a4bed641"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9586a0fc-1801-4702-aedd-83ee09e30a1c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9586a0fc-1801-4702-aedd-83ee09e30a1c","type":"Claim","title":"It is unlikely that membrane-bound Aβ42 oligomers contribute to neuroprotection because concentrations of oligomers as low as 10 nM did not attenuate but rather amplified excitotoxic death.","label":"Giuffrida M et al.; It is unlikely that membrane-bound Aβ42 ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Caraci Filippo","Pignataro Bruno","Cataldo Sebastiano","De Bona Paolo","Bruno Valeria","Molinaro Gemma","Pappalardo Giuseppe","Messina Angela","Palmigiano Angelo","Garozzo Domenico","Nicoletti Ferdinando","Rizzarelli Enrico","Copani Agata"],"firstAuthor":"Giuffrida Maria Laura","referenceYear":"2009","referenceDate":"2009-08-26","id":"urn:lsid:swan.org:researchstatement:9586a0fc-1801-4702-aedd-83ee09e30a1c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9ed6f454-cfef-4020-bca9-eb80614adcf0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9ed6f454-cfef-4020-bca9-eb80614adcf0","type":"Claim","title":"Both AN1792 and its adjuvant QS-21 have been shown to elicit a pro-inflammatory Th1 response.","label":"Holmes C et al.; Both AN1792 and its adjuvant QS-21 have ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:9ed6f454-cfef-4020-bca9-eb80614adcf0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7734ef41-3386-4fa9-9451-76d83e5a756a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7734ef41-3386-4fa9-9451-76d83e5a756a","type":"Claim","title":"Shaker channel protein maturation and insertion can occur within 2 h","label":"Plant L et al.; Shaker channel protein maturation and in...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:7734ef41-3386-4fa9-9451-76d83e5a756a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:488bc6da-2fbb-46e3-a5c7-ee677f9ccdd7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:488bc6da-2fbb-46e3-a5c7-ee677f9ccdd7","type":"Claim","title":"An important therapeutic implication of the dual pathway model is that the findings upon which it is based suggest that it might be plausible to develop drugs that simultaneously target both Aβ and tau.","label":"Small S et al.; An important therapeutic implication of ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:488bc6da-2fbb-46e3-a5c7-ee677f9ccdd7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a3d3f7f0-298e-4bdf-bcd0-cd63f8ffbce7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a3d3f7f0-298e-4bdf-bcd0-cd63f8ffbce7","type":"Claim","title":"cdc2 kinase, activated at the G2/M phase of the cell cycle, phosphorylates APP at Thr668.","label":"Suzuki T et al.; cdc2 kinase, activated at the G2/M phase...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:a3d3f7f0-298e-4bdf-bcd0-cd63f8ffbce7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:14f868fa-b509-4214-9f65-fd7cec1213ff&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:14f868fa-b509-4214-9f65-fd7cec1213ff","type":"Hypothesis","title":"Calcium signaling deficit hypothesis for Alzheimer's disease.","label":"Chen M; Calcium signaling deficit hypothesis for...","icon":"../icons/ontological/discourse-element/h-research-statement.png","firstAuthor":"Chen Ming","id":"urn:lsid:swan.org:researchstatement:14f868fa-b509-4214-9f65-fd7cec1213ff"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4538395b-f97e-4324-89a9-0f0d6aab15ff&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4538395b-f97e-4324-89a9-0f0d6aab15ff","type":"Hypothesis","title":"ACAT inhibition reduces Aβ production.","label":"Hutter-Paier B et al.; ACAT inhibition reduces Aβ production.","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Huttunen Henri J","Puglielli Luigi","Eckman Christopher B","Kim Doo Yeon","Hofmeister Alexander","Moir Robert D","Domnitz Sarah B","Frosch Matthew P","Windisch Manfred","Kovacs Dora M"],"firstAuthor":"Hutter-Paier Birgit","referenceYear":"2004","referenceDate":"2004-10-14","id":"urn:lsid:swan.org:researchstatement:4538395b-f97e-4324-89a9-0f0d6aab15ff"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:641b1e60-2390-44b9-90fc-22abe0520873&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:641b1e60-2390-44b9-90fc-22abe0520873","type":"Claim","title":"Addition of Aβ42 monomers completely rescued neurons from death induced by trophic deprivation due to insulin excluded from the growth medium.","label":"Giuffrida M et al.; Addition of Aβ42 monomers completely res...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Caraci Filippo","Pignataro Bruno","Cataldo Sebastiano","De Bona Paolo","Bruno Valeria","Molinaro Gemma","Pappalardo Giuseppe","Messina Angela","Palmigiano Angelo","Garozzo Domenico","Nicoletti Ferdinando","Rizzarelli Enrico","Copani Agata"],"firstAuthor":"Giuffrida Maria Laura","referenceYear":"2009","referenceDate":"2009-08-26","id":"urn:lsid:swan.org:researchstatement:641b1e60-2390-44b9-90fc-22abe0520873"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5f2c793e-eed0-4066-a555-940abf3c9db0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5f2c793e-eed0-4066-a555-940abf3c9db0","type":"Claim","title":"Five months duration of passive immunization of PDAPP mice (four months of age at the beginning of treatment) with anti-Aβ antibody markedly reduces cortical Aβ burden.","label":"Dodart J et al.; Five months duration of passive immuniza...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:5f2c793e-eed0-4066-a555-940abf3c9db0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:38d2f8df-2a67-49f4-af7a-10bc9011c8e7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:38d2f8df-2a67-49f4-af7a-10bc9011c8e7","type":"Claim","title":"Oligomeric assemblies of amyloidogenic proteins have not been studied as intensively with respect to PRR activation, but in the cases that they have they can be shown to elicit effects similar to amyloid fibrils.","label":"Golde T et al.; Oligomeric assemblies of amyloidogenic p...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:38d2f8df-2a67-49f4-af7a-10bc9011c8e7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cbef0db7-da0e-4efb-9098-05be68ce803c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cbef0db7-da0e-4efb-9098-05be68ce803c","type":"Claim","title":"Neuregulin signaling and BACE1 activation may be important in repair of later- more thinly myelinated regions where age-related myelin breakdown is most pronounced.","label":"Bartzokis G; Neuregulin signaling and BACE1 activatio...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:cbef0db7-da0e-4efb-9098-05be68ce803c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2709c7ff-be0a-4dcc-9a09-3942d87cd758&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2709c7ff-be0a-4dcc-9a09-3942d87cd758","type":"Claim","title":"Protofibrils, which can be neurologically active, have been reported to occur in cerebrospinal fluid.","label":"Gong Y et al.; Protofibrils, which can be neurologicall...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:2709c7ff-be0a-4dcc-9a09-3942d87cd758"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:499dd65b-abe1-40bf-8bbe-130af277f8f7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:499dd65b-abe1-40bf-8bbe-130af277f8f7","type":"Claim","title":"Ceramide may regulate molecular events linked to AD pathogenesis in an age-dependent fashion.","label":"Ceramide may regulate molecular events l...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:499dd65b-abe1-40bf-8bbe-130af277f8f7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2becc0ad-63e1-4a59-b1bf-8497c4f928ad&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2becc0ad-63e1-4a59-b1bf-8497c4f928ad","type":"Hypothesis","title":"Aluminum is important in the pathogenesis of Alzheimer disease neurodegenerative process.","label":"McLachlan D; Aluminum is important in the pathogenesi...","icon":"../icons/ontological/discourse-element/h-research-statement.png","firstAuthor":"McLachlan D R","referenceYear":"1986","referenceDate":"1986","id":"urn:lsid:swan.org:researchstatement:2becc0ad-63e1-4a59-b1bf-8497c4f928ad"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:382a60ed-d0e3-4131-9db1-6de2c205a9ef&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:382a60ed-d0e3-4131-9db1-6de2c205a9ef","type":"Claim","title":"FAD PS1 and PS2 mutant proteins are incorporated into 440-kDa γ-secretase complexes.","label":"Bentahir M et al.; FAD PS1 and PS2 mutant proteins are inco...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:382a60ed-d0e3-4131-9db1-6de2c205a9ef"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:94f795c8-521d-4354-8c43-240812d95c15&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:94f795c8-521d-4354-8c43-240812d95c15","type":"Claim","title":"Differential activation of the innate immune system by different protein aggregates and variable clearance of the aggregates following immune activation probably contribute to the imperfect correlations between the amounts and regional distribution of protein aggregates with clinical and neuropathological phenotypes.","label":"Golde T et al.; Differential activation of the innate im...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:94f795c8-521d-4354-8c43-240812d95c15"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d1fc5e21-3233-4ba7-94c6-46675af55a6b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d1fc5e21-3233-4ba7-94c6-46675af55a6b","type":"Hypothesis","title":"Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.","label":"Laurén J et al.; Cellular prion protein mediates impairme...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Gimbel David A","Nygaard Haakon B","Gilbert John W","Strittmatter Stephen M"],"firstAuthor":"Laurén Juha","referenceYear":"2009","referenceDate":"2009-02-26","id":"urn:lsid:swan.org:researchstatement:d1fc5e21-3233-4ba7-94c6-46675af55a6b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:96da4aab-d75e-4367-a18b-928ee5c10cc8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:96da4aab-d75e-4367-a18b-928ee5c10cc8","type":"Claim","title":"Brain Alzheimerization is not fully replicated in rodents even when multiple genetic risk factors are introduced in transgenic models.","label":"Bartzokis G; Brain Alzheimerization is not fully repl...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","id":"urn:lsid:swan.org:researchstatement:96da4aab-d75e-4367-a18b-928ee5c10cc8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0b0f5393-a267-4255-b805-9e0676a63f6b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0b0f5393-a267-4255-b805-9e0676a63f6b","type":"Claim","title":"Jun B or Jun D are not induced in AD brain tissue.","label":"Cotman C et al.; Jun B or Jun D are not induced in AD bra...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:0b0f5393-a267-4255-b805-9e0676a63f6b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:395cf78b-1605-4f8d-8393-d667916da78b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:395cf78b-1605-4f8d-8393-d667916da78b","type":"Claim","title":"Abnormal tau phosphorylation is not necessary for proteasome inhibition in AD.","label":"Keck S et al.; Abnormal tau phosphorylation is not nece...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:395cf78b-1605-4f8d-8393-d667916da78b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:20c43e5c-092a-4cb6-812d-dead4ec418d4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:20c43e5c-092a-4cb6-812d-dead4ec418d4","type":"Claim","title":"Cell cycle-regulated phosphorylation of APP isoforms may be important in modulating their normal physiological functions, since APP isoforms are ubiquitously expressed in cells.","label":"Suzuki T et al.; Cell cycle-regulated phosphorylation of ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:20c43e5c-092a-4cb6-812d-dead4ec418d4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1d178639-6537-4211-a977-b100a5949b9c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1d178639-6537-4211-a977-b100a5949b9c","type":"Claim","title":"APOE may account for as much as 50% of genetic susceptibility of late onset AD.","label":"Lambert J et al.; APOE may account for as much as 50% of g...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Heath Simon","Even Gael","Campion Dominique","Sleegers Kristel","Hiltunen Mikko","Combarros Onofre","Zelenika Diana","Bullido Maria J","Tavernier Béatrice","Letenneur Luc","Bettens Karolien","Berr Claudine","Pasquier Florence","Fiévet Nathalie","Barberger-Gateau Pascale","Engelborghs Sebastiaan","De Deyn Peter","Mateo Ignacio","Franck Ana","Helisalmi Seppo","Porcellini Elisa","Hanon Olivier","de Pancorbo Marian M","Lendon Corinne","Dufouil Carole","Jaillard Céline","Leveillard Thierry","Alvarez Victoria","Bosco Paolo","Mancuso Michelangelo","Panza Francesco","Nacmias Benedetta","Bossù Paola","Piccardi Paola","Annoni Giorgio","Seripa Davide","Galimberti Daniela","Hannequin Didier","Licastro Federico","Soininen Hilkka","Ritchie Karen","Blanché Hélène","Dartigues Jean-François","Tzourio Christophe","Gut Ivo","Van Broeckhoven Christine","Alpérovitch Annick","Lathrop Mark","Amouyel Philippe"],"firstAuthor":"Lambert Jean-Charles","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:1d178639-6537-4211-a977-b100a5949b9c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d1099f6e-d228-4d4b-bab2-16b409fc3758&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d1099f6e-d228-4d4b-bab2-16b409fc3758","type":"Claim","title":"Derangement of hippocampus signal transduction cascades in AD arises when increased Aβ burden chronically activates the ERK MAPK cascade in an α7nicotinic acetylcholine receptor-dependent manner.","label":"Dziewczapolski G et al.; Derangement of hippocampus signal transd...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Glogowski Carolina M","Masliah Eliezer","Heinemann Stephen F"],"firstAuthor":"Dziewczapolski Gustavo","referenceYear":"2009","referenceDate":"2009-07-08","id":"urn:lsid:swan.org:researchstatement:d1099f6e-d228-4d4b-bab2-16b409fc3758"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f7fbba49-d013-428c-8d2b-b948e91eb95c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f7fbba49-d013-428c-8d2b-b948e91eb95c","type":"Claim","title":"Aβ toxicity is tau dependent.","label":"Hardy J et al.; Aβ toxicity is tau dependent.","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:f7fbba49-d013-428c-8d2b-b948e91eb95c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ccf03552-94f7-49f5-ad94-041891d85eb1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ccf03552-94f7-49f5-ad94-041891d85eb1","type":"Claim","title":"Although amyloid-reducing pharmacological agents have been successfully developed, and tested in late-onset AD (LOAD) patients, the results of clinical studies have been largely disappointing.","label":"Small S et al.; Although amyloid-reducing pharmacologica...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:ccf03552-94f7-49f5-ad94-041891d85eb1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e508c3a8-1528-42a6-b334-7eeffd0f656a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e508c3a8-1528-42a6-b334-7eeffd0f656a","type":"Claim","title":"BACE1 cleaves neuregulin, a critical substrate involved in myelination signaling and possibly cholesterol synthesis. ","label":"Bartzokis G; BACE1 cleaves neuregulin, a critical sub...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:e508c3a8-1528-42a6-b334-7eeffd0f656a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:27763c7d-62be-4802-9709-0a417b20702a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:27763c7d-62be-4802-9709-0a417b20702a","type":"Claim","title":"A wide range of animal models partially recapitulate the key phenotypic features of AD and related tauopathies.  ","label":"Ballatore C et al.; A wide range of animal models partially ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Lee Virginia M-Y","Trojanowski John Q"],"firstAuthor":"Ballatore Carlo","referenceYear":"2007","referenceDate":"2007-09","id":"urn:lsid:swan.org:researchstatement:27763c7d-62be-4802-9709-0a417b20702a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c4145540-11f1-4b5b-b26e-1cbaa8fa3dc1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c4145540-11f1-4b5b-b26e-1cbaa8fa3dc1","type":"Claim","title":"The drug Dimebon has been shown to improve the cognitive impairment of AD patients, but has been reported to increase beta-amyloid protein in AD model mice.","label":"Hasegawa T; The drug Dimebon has been shown to impro...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Hasegawa Tohru","id":"urn:lsid:swan.org:researchstatement:c4145540-11f1-4b5b-b26e-1cbaa8fa3dc1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1d0c53c3-f93d-4ace-8724-9c701901f17f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1d0c53c3-f93d-4ace-8724-9c701901f17f","type":"Claim","title":"The THOP1 enzyme has been associated with the processing of APP at a β-secretase site and with degradation of Aβ peptide prior to the discovery of the aspartic protease BACE.  ","label":"Pollio G et al.; The THOP1 enzyme has been associated wit...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hoozemans Jeroen J","Andersen Claus A","Roncarati Renza","Rosi Maria Cristina","van Haastert Elise S","Seredenina Tamara","Diamanti Daniela","Gotta Stefano","Fiorentini Anna","Magnoni Letizia","Raggiaschi Roberto","Rozemuller Annemieke J","Casamenti Fiorella","Caricasole Andrea","Terstappen Georg C"],"firstAuthor":"Pollio Giuseppe","referenceYear":"2008","referenceDate":"2008-07","id":"urn:lsid:swan.org:researchstatement:1d0c53c3-f93d-4ace-8724-9c701901f17f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4feb2a11-1b1c-4d64-83c7-e962dcbf01ac&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4feb2a11-1b1c-4d64-83c7-e962dcbf01ac","type":"Claim","title":"Mice expressing human apoE3 or apoE4 develop diffuse and neuritic Aβ deposits that are similar to those seen in the presence of mouse apoE.","label":"Holtzman D; Mice expressing human apoE3 or apoE4 dev...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:4feb2a11-1b1c-4d64-83c7-e962dcbf01ac"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0fff4ac3-b675-4690-82d2-675985fe7ec9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0fff4ac3-b675-4690-82d2-675985fe7ec9","type":"Claim","title":"Humans with no AD symptoms may have numerous Aβ deposits that are almost exclusively diffuse plaques.","label":"Hardy J et al.; Humans with no AD symptoms may have nume...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:0fff4ac3-b675-4690-82d2-675985fe7ec9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0da08125-3192-44e2-9a1e-8832cef489d9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0da08125-3192-44e2-9a1e-8832cef489d9","type":"Claim","title":"Aβ and tau can both be influenced by calcium dysregulation, and the accumulation of these lesions can perturb calcium regulation.","label":"Smith I et al.; Aβ and tau can both be influenced by cal...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:0da08125-3192-44e2-9a1e-8832cef489d9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3ae6c024-c63b-4836-83c6-f79387db50e7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3ae6c024-c63b-4836-83c6-f79387db50e7","type":"Claim","title":"AD biomarkers can be used to predict conversion from mild cognitive impairment (MCI) to AD, demonstrated by prediction studies that show that individuals destined to develop AD can be identified earlier in the disease course by use of the MCI designation with the addition of imaging and CSF biomarkers to enhance diagnostic specificity.","label":"Jack C et al.; AD biomarkers can be used to predict con...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner Michael W","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:3ae6c024-c63b-4836-83c6-f79387db50e7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3047b2a6-8ddc-401b-96b8-9a861a0c2f8c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3047b2a6-8ddc-401b-96b8-9a861a0c2f8c","type":"Claim","title":"Known mutations of APP, PS-1 and PS-2 result in overproduction of Aβ42 or the Aβ42/40 ratio. Aβ42 is the predominant Aβ species initially deposited in the AD brain.","label":"Holtzman D; Known mutations of APP, PS-1 and PS-2 re...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:3047b2a6-8ddc-401b-96b8-9a861a0c2f8c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0533057f-97ac-4333-b6eb-8d5cd50f51fd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0533057f-97ac-4333-b6eb-8d5cd50f51fd","type":"Claim","title":"Cross-linking with 4-hydroxynoneal enhances oligomerization but blocks fibrillogenesis.","label":"Hartley D et al.; Cross-linking with 4-hydroxynoneal enhan...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:0533057f-97ac-4333-b6eb-8d5cd50f51fd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:85e9ecec-ac8a-414a-84c5-99025bcbd261&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:85e9ecec-ac8a-414a-84c5-99025bcbd261","type":"Claim","title":"Among patients with MCI or AD alone, correlations with measures of general cognition are strong with structural MRI, but are not significant with CSF tau because CSF tau does not change appreciably over time in cognitively impaired patients and therefore correlations between cognition and CSF tau weaken as patients progress into the mid and late stages of the clinical AD spectrum.","label":"Jack C et al.; Among patients with MCI or AD alone, cor...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:85e9ecec-ac8a-414a-84c5-99025bcbd261"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3a4c0655-fd49-42a8-8638-390223eebe4c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3a4c0655-fd49-42a8-8638-390223eebe4c","type":"Claim","title":"The DNA repair enzyme Ref-1 is elevated in AD neurons, consistent with the hypothesis that there may be an extended process of DNA-damage/DNA-repair and cell death in AD. Description:  This increase of Ref-1 is particuIarly apparent in mild to moderate AD cases.","label":"Cotman C et al.; The DNA repair enzyme Ref-1 is elevated ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:3a4c0655-fd49-42a8-8638-390223eebe4c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:68b26036-7f22-420c-831c-4350b0ea2271&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:68b26036-7f22-420c-831c-4350b0ea2271","type":"Claim","title":"Soluble Aβ dimers and trimers have been detected inside APP-expressing cells, leading to the proposal that Aβ dimerization may begin within the vesicles in which it is generated.","label":"Selkoe D; Soluble Aβ dimers and trimers have been ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Selkoe Dennis J","id":"urn:lsid:swan.org:researchstatement:68b26036-7f22-420c-831c-4350b0ea2271"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:210b9d98-051a-478a-ad45-641e28357d08&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:210b9d98-051a-478a-ad45-641e28357d08","type":"Claim","title":"Secretase inhibitor and Aβ 1-42 or Aβ 25-35 concurrent treatment decreased I<sub>KA<\/sub> and I<sub>KV<\/sub> currents to levels similar to secretase inhibitor treatment alone.","label":"Plant L et al.; Secretase inhibitor and Aβ 1-42 or Aβ 25...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:210b9d98-051a-478a-ad45-641e28357d08"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:876b80ae-0c05-4b87-b293-78da3df79158&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:876b80ae-0c05-4b87-b293-78da3df79158","type":"Claim","title":"Treatment for diabetes (with insulin) elevates deep microvascular lesions in treated diabetic + dementia patients.","label":"Craft S; Treatment for diabetes (with insulin) el...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft Suzanne","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:876b80ae-0c05-4b87-b293-78da3df79158"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c10b99cf-4b38-4cb2-a241-0c973e7a8c7e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c10b99cf-4b38-4cb2-a241-0c973e7a8c7e","type":"Claim","title":"The presenilin inhibition hypothesis is consistent with AD genetic data, but suffers from lack of experimental data to support it.","label":"Hardy ; The presenilin inhibition hypothesis is ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Hardy","referenceYear":"2009","referenceDate":"2009-05-18","id":"urn:lsid:swan.org:researchstatement:c10b99cf-4b38-4cb2-a241-0c973e7a8c7e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:367d4a4f-44a1-4e88-93fd-12de13d2def9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:367d4a4f-44a1-4e88-93fd-12de13d2def9","type":"Question","title":"Do Aβ oligomers exert their mitogenic effects through any of the pathways thus far identified underlying Aβ oligomer-based neurotoxicity, such as interactions with NMDA receptors, insulin signaling, as well as calcium dysregulation?","label":"Do Aβ oligomers exert their mitogenic ef...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:367d4a4f-44a1-4e88-93fd-12de13d2def9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:770b5086-8e4d-43a0-b71e-9fa810054575&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:770b5086-8e4d-43a0-b71e-9fa810054575","type":"Claim","title":"Both PS inactivation and increased Aβ lead to reductions in synaptic NMDA receptors and cAMP-response element (CRE)-dependent gene expression, supporting the notion that these pathogenic events may converge at common downstream signaling pathways that are required for synaptic plasticity and neuronal survival.","label":"Shen J et al.; Both PS inactivation and increased Aβ le...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:770b5086-8e4d-43a0-b71e-9fa810054575"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:81fbd53d-d89d-4358-851b-e880a2493ef6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:81fbd53d-d89d-4358-851b-e880a2493ef6","type":"Claim","title":"Redox factor-1 (Ref-1) is upregulated in AD hippocampus, in regions of neuronal injury.","label":"Cotman C; Redox factor-1 (Ref-1) is upregulated in...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Cotman Carl W","id":"urn:lsid:swan.org:researchstatement:81fbd53d-d89d-4358-851b-e880a2493ef6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f7f7b437-f7b6-461d-a6b8-8e89c79494d0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f7f7b437-f7b6-461d-a6b8-8e89c79494d0","type":"Hypothesis","title":"[ADNI]  Decreased fluorodeoxyglucose uptake on PET (FDG-PET) is a biomarker of reduced brain glucose metabolism and synaptic activity in AD.","label":"Jack C et al.; [ADNI]  Decreased fluorodeoxyglucose upt...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","id":"urn:lsid:swan.org:researchstatement:f7f7b437-f7b6-461d-a6b8-8e89c79494d0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c2442dc7-2506-4b06-90cd-89b1b3417a1e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c2442dc7-2506-4b06-90cd-89b1b3417a1e","type":"Claim","title":"No significant changes of phosphorylated tau proteins were observed in 8c mice compared with those in wild-type using phosphospecific tau antibody AT8 in retinas by quantitative Western blotting and in RGCs by immunofluorescence staining.","label":"Yuan A et al.; No significant changes of phosphorylated...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:c2442dc7-2506-4b06-90cd-89b1b3417a1e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f7bdf213-70e7-40fc-b122-b12f4b307b2b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f7bdf213-70e7-40fc-b122-b12f4b307b2b","type":"Claim","title":"The APP intracellular domain (AICD), which is similarly released by γ-secretase-mediated cleavage, has been implicated in transcriptional regulation.","label":"Shen J et al.; The APP intracellular domain (AICD), whi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:f7bdf213-70e7-40fc-b122-b12f4b307b2b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:92a22fc2-ce10-4817-920f-26213e6dc367&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:92a22fc2-ce10-4817-920f-26213e6dc367","type":"Claim","title":"H<sub>2<\/sub>O<sub>2<\/sub>, a bioproduct of sterol oxidation is a powerful inducer of apoptosis.","label":"H<sub>2<\/sub>O<sub>2<\/sub>, a bioproduct...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:92a22fc2-ce10-4817-920f-26213e6dc367"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d04b3cbe-b914-49cc-a65f-0f56d1154f2e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d04b3cbe-b914-49cc-a65f-0f56d1154f2e","type":"Claim","title":"Compared with PS1hWT, expression of PS1delE9 or PS1C410Y mutants resulted in enhanced commitment of adult brain neural progenitors (NPCs) toward the neuronal lineage as evidenced by increased staining for neuronal antigens, MAP2 or βIII-tubulin or while not affecting astrocyte markers GFAP and s100β.  ","label":"Veeraraghavalu K et al.; Compared with PS1hWT, expression of PS1d...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Choi Se Hoon","Zhang Xiaoqiong","Sisodia Sangram S"],"firstAuthor":"Veeraraghavalu Karthikeyan","referenceYear":"2010","referenceDate":"2010-05-19","id":"urn:lsid:swan.org:researchstatement:d04b3cbe-b914-49cc-a65f-0f56d1154f2e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:21e38434-7803-4c71-9175-de5685eb5df5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:21e38434-7803-4c71-9175-de5685eb5df5","type":"Comment","title":"It is well-documented that beta amyloid pathology does not correlate with the degree of cognitive deficits in AD or MCI patients so it is unclear how/why a meager level of β-amyloid could cause devastating alterations in neuronal excitability resulting in cognitive deficits in one brain, while buckets of β-amyloid are seemingly benign in another.","label":"Stutzmann G; It is well-documented that beta amyloid ...","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Stutzmann Grace","id":"urn:lsid:swan.org:comment:21e38434-7803-4c71-9175-de5685eb5df5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:37c24c95-96d8-4ea6-b866-d7e8957aac55&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:37c24c95-96d8-4ea6-b866-d7e8957aac55","type":"Claim","title":"Learning performance improved markedly in PDAPP mice, 4-5 days after a single dose of m266 (360 µg, i.p.) as compared to those treated with PBS.","label":"Dodart J et al.; Learning performance improved markedly i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:37c24c95-96d8-4ea6-b866-d7e8957aac55"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:45b4dcf0-9aac-4945-a799-a44bdd7e35e4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:45b4dcf0-9aac-4945-a799-a44bdd7e35e4","type":"Claim","title":"Mediation of the Aβ effect through the cellular prion protein has recently been proposed; in prion null animals, blockade of LTP by Aβ is absent.","label":"Petersen R et al.; Mediation of the Aβ effect through the c...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Castellani Rudolph J","Nunomura Akihiko","Zhu Xiongwei","Lee Hyoung-gon","Perry George","Smith Mark A"],"firstAuthor":"Petersen R B","id":"urn:lsid:swan.org:researchstatement:45b4dcf0-9aac-4945-a799-a44bdd7e35e4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e486f2f3-ba85-4f4a-984c-18149ca7d179&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e486f2f3-ba85-4f4a-984c-18149ca7d179","type":"Claim","title":"Robust release of Aβ monomer following γ-secretase processing of endogenous APP has also been shown in primary human neurons and healthy cultured cells expressing APP.","label":"Selkoe D; Robust release of Aβ monomer following γ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Selkoe Dennis J","id":"urn:lsid:swan.org:researchstatement:e486f2f3-ba85-4f4a-984c-18149ca7d179"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:34f806b8-58c5-4a7b-8f7f-66521550e62d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:34f806b8-58c5-4a7b-8f7f-66521550e62d","type":"Hypothesis","title":"Loss of essential functions of presenilin can explain dementia and neurodegeneration in Alzheimer disease.","label":"Shen J et al.; Loss of essential functions of presenili...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:34f806b8-58c5-4a7b-8f7f-66521550e62d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:11f9c5f1-937f-4134-8ab7-d50731d7267a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:11f9c5f1-937f-4134-8ab7-d50731d7267a","type":"Claim","title":"APP mice with cortical plaques exhibit a two-stage calcium pathology:  1), the immediate micro-environment of an Aβ plaque focally disrupts neuronal [Ca2+]i handling and function, and 2) calcium overload can be detected (although in a lower percentage of neurites) even at distances farther from a plaque.","label":"Kuchibhotla K et al.; APP mice with cortical plaques exhibit a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Goldman Samuel T","Lattarulo Carli R","Wu Hai-Yan","Hyman Bradley T","Bacskai Brian J"],"firstAuthor":"Kuchibhotla Kishore V","referenceYear":"2008","referenceDate":"2008-07-31","id":"urn:lsid:swan.org:researchstatement:11f9c5f1-937f-4134-8ab7-d50731d7267a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9ef16203-d05b-41b5-afca-3d96e090fc2e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9ef16203-d05b-41b5-afca-3d96e090fc2e","type":"Claim","title":"The levels of apoE in apoE3- and apoE4-expressing mice are not significantly different in either cortex or CSF, indicating that differences in the level of apoE do not account for the pathological differences observed between APOE3 and APOE4 knock-in mice.","label":"Fryer J et al.; The levels of apoE in apoE3- and apoE4-e...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:9ef16203-d05b-41b5-afca-3d96e090fc2e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:25fc2761-87ac-429f-b18b-412029d4c0e4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:25fc2761-87ac-429f-b18b-412029d4c0e4","type":"Claim","title":"AD brains have a reduced number of syn¬apses that may be dysfunctional even before they visibly degenerate and the reduction in synaptic density correlates better with cognitive decline than with the accumulation of plaques.","label":"Harold D et al.; AD brains have a reduced number of syn¬a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Abraham Richard","Hollingworth Paul","Sims Rebecca","Gerrish Amy","Hamshere Marian L","Pahwa Jaspreet Singh","Moskvina Valentina","Dowzell Kimberley","Williams Amy","Jones Nicola","Thomas Charlene","Stretton Alexandra","Morgan Angharad R","Lovestone Simon","Powell John","Proitsi Petroula","Lupton Michelle K","Brayne Carol","Rubinsztein David C","Gill Michael","Lawlor Brian","Lynch Aoibhinn","Morgan Kevin","Brown Kristelle S","Passmore Peter A","Craig David","McGuinness Bernadette","Todd Stephen","Holmes Clive","Mann David","Smith A David","Love Seth","Kehoe Patrick G","Hardy John","Mead Simon","Fox Nick","Rossor Martin","Collinge John","Maier Wolfgang","Jessen Frank","Schürmann Britta","van den Bussche Hendrik","Heuser Isabella","Kornhuber Johannes","Wiltfang Jens","Dichgans Martin","Frölich Lutz","Hampel Harald","Hüll Michael","Rujescu Dan","Goate Alison M","Kauwe John S","Cruchaga Carlos","Nowotny Petra","Morris John C","Mayo Kevin","Sleegers Kristel","Bettens Karolien","Engelborghs Sebastiaan","De Deyn Peter P","Van Broeckhoven Christine","Livingston Gill","Bass Nicholas J","Gurling Hugh","McQuillin Andrew","Gwilliam Rhian","Deloukas Panagiotis","Al-Chalabi Ammar","Shaw Christopher E","Tsolaki Magda","Singleton Andrew B","Guerreiro Rita","Mühleisen Thomas W","Nöthen Markus M","Moebus Susanne","Jöckel Karl-Heinz","Klopp Norman","Wichmann H-Erich","Carrasquillo Minerva M","Pankratz V Shane","Younkin Steven G","Holmans Peter A","O'Donovan Michael","Owen Michael J","Williams Julie"],"firstAuthor":"Harold Denise","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:25fc2761-87ac-429f-b18b-412029d4c0e4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:61ed9bc2-484c-4fe8-8094-912fd9bc3582&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:61ed9bc2-484c-4fe8-8094-912fd9bc3582","type":"Claim","title":"Abeta\u2019s influence on LTP and hence learning and memory may involve disruption of intracellular calcium homeostasis.","label":"Smith I et al.; Abeta\u2019s influence on LTP and hence learn...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:61ed9bc2-484c-4fe8-8094-912fd9bc3582"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:02434d5b-bc2f-45fa-8e1f-93d82f6699f6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:02434d5b-bc2f-45fa-8e1f-93d82f6699f6","type":"Claim","title":"Membrane phospholipids in the brain are composed of polyunsaturated fatty acids that are susceptible to free radical attack.  When oxidized, these polyunsaturated fatty acids form aldehydes, particularly 4-hydroxynonenal (HNE), a highly cytotoxic aldehyde which inhibits glycolysis, protein and nucleic acid synthesis leading to apoptosis.","label":"Smith I et al.; Membrane phospholipids in the brain are ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:02434d5b-bc2f-45fa-8e1f-93d82f6699f6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6907fd29-041a-41d6-a70e-2b2c9605c0c0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6907fd29-041a-41d6-a70e-2b2c9605c0c0","type":"Claim","title":"Full-length tau does not aggregate spontaneously in cells, but rather, truncated tau forms intracellular inclusions.","label":"Frost B et al.; Full-length tau does not aggregate spont...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Jacks Rachel L","Diamond Marc I"],"firstAuthor":"Frost Bess","referenceYear":"2009","referenceDate":"2009-05-08","id":"urn:lsid:swan.org:researchstatement:6907fd29-041a-41d6-a70e-2b2c9605c0c0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0b41f17b-d221-4316-b643-a06a2730908f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0b41f17b-d221-4316-b643-a06a2730908f","type":"Claim","title":"Like familial AD, mutations in a number of genes result in accumulation of protein aggregates (for example, ABri, ADan, superoxide dismutase, α-synuclein, huntingtin, ataxins, and neuroserpin), triggering the pathological cascade that leads to many phenotypically distinct neurodegenerative diseases.","label":"Golde T et al.; Like familial AD, mutations in a number ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:0b41f17b-d221-4316-b643-a06a2730908f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:66872abd-06f1-4c17-b061-ef79e60ee28c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:66872abd-06f1-4c17-b061-ef79e60ee28c","type":"Claim","title":"Quick recruitment of macrophages at sites of dense plaque formation could be one mechanism for plaque growth inhibition.","label":"Kumar-Singh S; Quick recruitment of macrophages at site...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Kumar-Singh Samir","id":"urn:lsid:swan.org:researchstatement:66872abd-06f1-4c17-b061-ef79e60ee28c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b7b22984-8b58-4182-8716-e7e23aa9cc80&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b7b22984-8b58-4182-8716-e7e23aa9cc80","type":"Claim","title":"Increased Ca++ influx is caused by activation of L-type calcium channels, and these channels have been shown to be affected both by Aβ as well as by mitogen-activated protein kinase (MAPK).","label":"Morse T et al.; Increased Ca++ influx is caused by activ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Mutalik Pradeep","Cheung Kei","Miller Perry L","Shepherd Gordon"],"firstAuthor":"Morse Thomas M","id":"urn:lsid:swan.org:researchstatement:b7b22984-8b58-4182-8716-e7e23aa9cc80"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9beef97c-2189-4087-a13c-4afae6578528&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9beef97c-2189-4087-a13c-4afae6578528","type":"Claim","title":"IDE knockout mice reveal increased endogenous levels of Aβ and AICD in the brain. Additionally, heterozygous IDE +/- mice exhibit Aβ levels that are intermediate between wild-type controls and IDE-/- mice.","label":"Tanzi R et al.; IDE knockout mice reveal increased endog...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:9beef97c-2189-4087-a13c-4afae6578528"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:5c184d24-8a95-452e-9647-1c6a52c92d88&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:5c184d24-8a95-452e-9647-1c6a52c92d88","type":"Question","title":"To be beneficial therapeutically, how much does Aβ needs to be lowered?","label":"To be beneficial therapeutically, how mu...","icon":"../icons/ontological/discourse-element/research-question.png","firstAuthor":"Golde T","id":"urn:lsid:swan.org:researchquestion:5c184d24-8a95-452e-9647-1c6a52c92d88"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7a1f7c5d-b42c-48b1-a6a3-c6bdbff1d1a1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7a1f7c5d-b42c-48b1-a6a3-c6bdbff1d1a1","type":"Hypothesis","title":"Reactivation of dormant HSV1 might be the cause of Alzheimer disease.","label":"Ball M; Reactivation of dormant HSV1 might be th...","icon":"../icons/ontological/discourse-element/h-research-statement.png","firstAuthor":"Ball M J","referenceYear":"1982","referenceDate":"1982-08","id":"urn:lsid:swan.org:researchstatement:7a1f7c5d-b42c-48b1-a6a3-c6bdbff1d1a1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:72f7de10-22af-4e88-ab88-c20d9a2568b8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:72f7de10-22af-4e88-ab88-c20d9a2568b8","type":"Claim","title":"Therapeutics to prevent Aβ oligomerization are in development.","label":"Hardy J et al.; Therapeutics to prevent Aβ oligomerizati...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:72f7de10-22af-4e88-ab88-c20d9a2568b8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:256a6371-807f-440d-b115-a813dcf58ab5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:256a6371-807f-440d-b115-a813dcf58ab5","type":"Claim","title":"A triple-transgenic mouse model (3xTg-AD) was developed by introducing two transgenes (APPswe and tauP301L) into the germline of the PS1 mutant knock-in mouse.","label":"Smith I et al.; A triple-transgenic mouse model (3xTg-AD...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:256a6371-807f-440d-b115-a813dcf58ab5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:01feade7-2f67-4609-b1b1-1064658bfd3e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:01feade7-2f67-4609-b1b1-1064658bfd3e","type":"Comment","title":"Prado comment on Laurén et al hypothesis \"Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.\"","label":"Prado M; Prado comment on Laurén et al hypothesis...","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Prado Marco","referenceYear":"2009","referenceDate":"2009-03-24","id":"urn:lsid:swan.org:comment:01feade7-2f67-4609-b1b1-1064658bfd3e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4fa02ff7-e88e-4360-a8db-78c4660043f8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4fa02ff7-e88e-4360-a8db-78c4660043f8","type":"Claim","title":"GSK3 is intimately involved in the hyperphosphorylation of tau, memory impairment, the increased production of Aβ and in inflammatory responses.","label":"Hooper C et al.; GSK3 is intimately involved in the hyper...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:4fa02ff7-e88e-4360-a8db-78c4660043f8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1099d048-9da4-4b35-adcc-6e6e0788a4e0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1099d048-9da4-4b35-adcc-6e6e0788a4e0","type":"Claim","title":"ApoE4 is a risk factor for the development of CAA.","label":"Holtzman D; ApoE4 is a risk factor for the developme...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:1099d048-9da4-4b35-adcc-6e6e0788a4e0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f7dd1483-be66-4eab-8139-654501cbfe6a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f7dd1483-be66-4eab-8139-654501cbfe6a","type":"Claim","title":"A novel and highly efficient pathway of tau degradation that is mediated by the cochaperone BAG2, is ubiquitin-independent, operates in proximity to the microtubule, and this pathway is regulated by miR-128, a microRNA that is increased in Alzheimer\u2019s disease.","label":"Carrettiero D et al.; A novel and highly efficient pathway of ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hernandez Israel","Neveu Pierre","Papagiannakopoulos Thales","Kosik Kenneth S"],"firstAuthor":"Carrettiero Daniel C","referenceYear":"2009","referenceDate":"2009-02-18","id":"urn:lsid:swan.org:researchstatement:f7dd1483-be66-4eab-8139-654501cbfe6a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:92b81481-6571-46a8-982b-1f66b36676a4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:92b81481-6571-46a8-982b-1f66b36676a4","type":"Hypothesis","title":"Towards an animal model of Alzheimer's disease. Can phorbol esters fan the flames?","label":"Smalheiser N; Towards an animal model of Alzheimer's d...","icon":"../icons/ontological/discourse-element/h-research-statement.png","firstAuthor":"Smalheiser Neil R.","id":"urn:lsid:swan.org:researchstatement:92b81481-6571-46a8-982b-1f66b36676a4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b667b04c-41ca-46eb-a4db-9ff0310ad943&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b667b04c-41ca-46eb-a4db-9ff0310ad943","type":"Hypothesis","title":"The process of memory consolidation involves the synthesis of novel macromolecules recognized by the immune system as \"non-self\" antigens.","label":"Arshavsky Y; The process of memory consolidation invo...","icon":"../icons/ontological/discourse-element/h-research-statement.png","firstAuthor":"Arshavsky Y I","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:b667b04c-41ca-46eb-a4db-9ff0310ad943"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:8179cb06-65b8-449c-b3b3-97bf3a889073&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:8179cb06-65b8-449c-b3b3-97bf3a889073","type":"Question","title":"Which form of Aβ is toxic?","label":"Which form of Aβ is toxic?","icon":"../icons/ontological/discourse-element/research-question.png","firstAuthor":"Golde T","id":"urn:lsid:swan.org:researchquestion:8179cb06-65b8-449c-b3b3-97bf3a889073"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e99a707f-7002-4f8e-9c5d-7cc3ee4587cd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e99a707f-7002-4f8e-9c5d-7cc3ee4587cd","type":"Claim","title":"Neurotoxins that do not behave as sedimentable fibrils will form when Aβ42 is incubated with clusterin, fibril-free Aβ derivatives are referred to as ADDLs.","label":"Lambert M et al.; Neurotoxins that do not behave as sedime...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:e99a707f-7002-4f8e-9c5d-7cc3ee4587cd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:10b889eb-10fd-411e-b0df-9ba16d555dad&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:10b889eb-10fd-411e-b0df-9ba16d555dad","type":"Hypothesis","title":"A downregulation of calcineurin may contribute to the dysregulation of glutamate release that is considered a hallmark of Alzheimer disease.","label":"Celsi F et al.; A downregulation of calcineurin may cont...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Svedberg M","Unger C","Cotman C W","Carrì M T","Ottersen O P","Nordberg A","Torp R"],"firstAuthor":"Celsi F","referenceYear":"2007","referenceDate":"2007-05","id":"urn:lsid:swan.org:researchstatement:10b889eb-10fd-411e-b0df-9ba16d555dad"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:da98cb47-9532-456e-927a-a4de68efb790&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:da98cb47-9532-456e-927a-a4de68efb790","type":"Claim","title":"Persistence of Aβ dimers in the membrane could influence the behavior of receptors or channels.","label":"Marchesi V; Persistence of Aβ dimers in the membrane...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:da98cb47-9532-456e-927a-a4de68efb790"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:66ccdfac-3be2-4a36-af30-0cb6f705d812&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:66ccdfac-3be2-4a36-af30-0cb6f705d812","type":"Claim","title":"Tau degradation pathways have been described including ubiquitin-independent tau degradation and caspase-mediated degradation.","label":"Carrettiero D et al.; Tau degradation pathways have been descr...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hernandez Israel","Neveu Pierre","Papagiannakopoulos Thales","Kosik Kenneth S"],"firstAuthor":"Carrettiero Daniel C","referenceYear":"2009","referenceDate":"2009-02-18","id":"urn:lsid:swan.org:researchstatement:66ccdfac-3be2-4a36-af30-0cb6f705d812"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6ed9e244-4691-4380-8525-24f0310ac6f8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6ed9e244-4691-4380-8525-24f0310ac6f8","type":"Claim","title":"From SDS-PAGE analyses on optic axons and retinas from tau 8c mice and nontransgenic controls, the apparent molecular masses of several heat-stable tau isoforms in the 50\u201360 kDa [low molecular weight (LMW) tau] species were similar, indicating no evidence for changes in the state of phosphorylation of tau in 8c.","label":"Yuan A et al.; From SDS-PAGE analyses on optic axons an...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:6ed9e244-4691-4380-8525-24f0310ac6f8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8fe63be7-847e-4776-84ec-6e61f4607c8f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8fe63be7-847e-4776-84ec-6e61f4607c8f","type":"Claim","title":"In one study of 12-month-old T44 tau transgenic mice that overexpress the shortest human tau isoform, fast transport rates were slowed in the L5 ventral roots of the spinal cord.","label":"Yuan A et al.; In one study of 12-month-old T44 tau tra...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:8fe63be7-847e-4776-84ec-6e61f4607c8f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:008c20f8-2e58-4e33-8e73-0b79f357f5af&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:008c20f8-2e58-4e33-8e73-0b79f357f5af","type":"Claim","title":"Low levels of brain blood flow in aged humans and animals can lead to abnormal cell metabolism, tissue damage and memory problems independent of Aβ.","label":"Aliev G; Low levels of brain blood flow in aged h...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Aliev Gjumrakch","id":"urn:lsid:swan.org:researchstatement:008c20f8-2e58-4e33-8e73-0b79f357f5af"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9ee666b9-bcf9-4365-b284-30705ed85bda&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9ee666b9-bcf9-4365-b284-30705ed85bda","type":"Claim","title":"Nondemented older adults with preclinical AD who have high occupational status have accelerated rates of brain atrophy.","label":"Morris J et al.; Nondemented older adults with preclinica...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Roe Catherine M","Grant Elizabeth A","Head Denise","Storandt Martha","Goate Alison M","Fagan Anne M","Holtzman David M","Mintun Mark A"],"firstAuthor":"Morris John C","referenceYear":"2009","referenceDate":"2009-12","id":"urn:lsid:swan.org:researchstatement:9ee666b9-bcf9-4365-b284-30705ed85bda"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:90568ec4-1a8f-4b63-9a49-da78f0a0a81b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:90568ec4-1a8f-4b63-9a49-da78f0a0a81b","type":"Claim","title":"The maturation of protofibrils to form fibrils is largely irreversible kinetically.","label":"Bitan G et al.; The maturation of protofibrils to form f...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:90568ec4-1a8f-4b63-9a49-da78f0a0a81b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c52ac99f-c97a-4a88-b97d-16759229ba7c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c52ac99f-c97a-4a88-b97d-16759229ba7c","type":"Claim","title":"Small vessel damage (including the subcellular organelles such as mitochondria) is present in the majority of AD brains after death.","label":"Aliev G; Small vessel damage (including the subce...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Aliev Gjumrakch","id":"urn:lsid:swan.org:researchstatement:c52ac99f-c97a-4a88-b97d-16759229ba7c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:95667f38-7b05-4272-b214-2c3a6b1a0635&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:95667f38-7b05-4272-b214-2c3a6b1a0635","type":"Hypothesis","title":"Pathological changes in both L-type Ca2+ channels and RyRs accelerate functional decline during aging and Alzheimer disease.","label":"Thibault O et al.; Pathological changes in both L-type Ca2+...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Gant John C","Landfield Philip W"],"firstAuthor":"Thibault Olivier","referenceYear":"2007","referenceDate":"2007-06","id":"urn:lsid:swan.org:researchstatement:95667f38-7b05-4272-b214-2c3a6b1a0635"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4fecfd72-888d-4d3f-84cc-95fe3af0ddef&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4fecfd72-888d-4d3f-84cc-95fe3af0ddef","type":"Claim","title":"Contradictory observations from other laboratories have previously shown increase in non-inactivation K  current after high concentration aggregated Aβ treatment.","label":"Plant L et al.; Contradictory observations from other la...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:4fecfd72-888d-4d3f-84cc-95fe3af0ddef"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:55809a1c-68bc-4cb9-996c-256aa3b73d12&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:55809a1c-68bc-4cb9-996c-256aa3b73d12","type":"Claim","title":"PS mutations also occur in families in which early-onset AD is associated with cortical Lewy bodies, which contain α-synuclein aggregates.","label":"Shen J et al.; PS mutations also occur in families in w...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:55809a1c-68bc-4cb9-996c-256aa3b73d12"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:532449fe-6f86-454e-b4ff-9b6623cc3e99&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:532449fe-6f86-454e-b4ff-9b6623cc3e99","type":"Claim","title":"Active immunization can prevent the development of AD-like neuropathology as well as preventing memory impairment in several mouse models of AD.","label":"Dodart J et al.; Active immunization can prevent the deve...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:532449fe-6f86-454e-b4ff-9b6623cc3e99"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:360b536e-95f7-4cf9-900e-681a81f81362&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:360b536e-95f7-4cf9-900e-681a81f81362","type":"Claim","title":"APOE is linked with tau hyperphosphorylation through a separate and distinct group of mechanisms.","label":"Small S et al.; APOE is linked with tau hyperphosphoryla...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:360b536e-95f7-4cf9-900e-681a81f81362"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5a44ce10-e769-4541-b6dc-026be9a66625&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5a44ce10-e769-4541-b6dc-026be9a66625","type":"Claim","title":"What does this data (from Meyer-Luehmann, et al., 2008) suggest in terms of AD patients being treated with drugs to lower Aβ and to inhibit plaque formation?","label":"What does this data (from Meyer-Luehmann...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:5a44ce10-e769-4541-b6dc-026be9a66625"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a3d02eb6-2208-476d-a872-ade7f5bc25df&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a3d02eb6-2208-476d-a872-ade7f5bc25df","type":"Claim","title":"Experimental manipulation of CAD cells is easier, compared to primary neurons. ","label":"Muresan Z et al.; Experimental manipulation of CAD cells i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","id":"urn:lsid:swan.org:researchstatement:a3d02eb6-2208-476d-a872-ade7f5bc25df"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:286d4645-67ca-40c5-a5db-1fa18cd10414&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:286d4645-67ca-40c5-a5db-1fa18cd10414","type":"Hypothesis","title":"SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer\u2019s disease and amyotrophic lateral sclerosis.","label":"Kim D et al.; SIRT1 deacetylase protects against neuro...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:286d4645-67ca-40c5-a5db-1fa18cd10414"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d79a940d-7dbc-4b98-a207-c25cf129ace1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d79a940d-7dbc-4b98-a207-c25cf129ace1","type":"Claim","title":"LTP is enhanced and medium and late after hyperpolarizations (which are mediated by calcium sensitive potassium channels) are increased in mutant PS1 mice.","label":"Smith I et al.; LTP is enhanced and medium and late afte...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:d79a940d-7dbc-4b98-a207-c25cf129ace1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1ac7dfd2-c95c-4eb7-9d16-987f067204eb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1ac7dfd2-c95c-4eb7-9d16-987f067204eb","type":"Hypothesis","title":"Toxic C100 Hypothesis: Abnormal carboxyl-terminal subfragments of &#946; APP in vivo may cause amyloidogenesis and specific neuropathology.","label":"Kammesheidt A et al.; Toxic C100 Hypothesis: Abnormal carboxyl...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Boyce F M","Spanoyannis A F","Cummings B J","Ortegón M","Cotman C","Vaught J L","Neve R L"],"firstAuthor":"Kammesheidt A","referenceYear":"1992","referenceDate":"1992-11-15","id":"urn:lsid:swan.org:researchstatement:1ac7dfd2-c95c-4eb7-9d16-987f067204eb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7f3c78b8-1b52-4c69-97b4-e5531dcb84e6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7f3c78b8-1b52-4c69-97b4-e5531dcb84e6","type":"Claim","title":"Mutations in APP cause familial AD and cause increased accumulation in Aβ42.","label":"Gong Y et al.; Mutations in APP cause familial AD and c...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:7f3c78b8-1b52-4c69-97b4-e5531dcb84e6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5979be7b-f4e8-4359-85f4-f68dc5510c47&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5979be7b-f4e8-4359-85f4-f68dc5510c47","type":"Claim","title":"Alzheimer disease (AD) is characterized by the extracellular aggregation and deposition of amyloid-beta (Aβ) peptide in the form of diffuse and fibrillar plaques. Aβ can also deposit in the walls of cerebral vessels, specifically arteries and arterioles, which is known as cerebral amyloid angiopathy (CAA).","label":"Fryer J et al.; Alzheimer disease (AD) is characterized ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:5979be7b-f4e8-4359-85f4-f68dc5510c47"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9ddbe978-3ff6-4c6a-91b8-fad951154127&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9ddbe978-3ff6-4c6a-91b8-fad951154127","type":"Claim","title":"ApoE pathogenesis in AD involves Aβ metabolism.","label":"Hardy J et al.; ApoE pathogenesis in AD involves Aβ meta...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:9ddbe978-3ff6-4c6a-91b8-fad951154127"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:20de59b7-b900-402b-9067-a2bae0802cb8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:20de59b7-b900-402b-9067-a2bae0802cb8","type":"Claim","title":"PS1-A246E is a mild mutation reducing S3 cleavage of Notch only by 20%, resolving a discrepancy that this mutation is not able to rescue Notch deficiency in C. elegans, but is at least partially able to rescue Notch-deficient phenotypes in PS1 knockout mice.","label":"Bentahir M et al.; PS1-A246E is a mild mutation reducing S3...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:20de59b7-b900-402b-9067-a2bae0802cb8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2b3b2d30-fe97-475e-8688-ae162a3ffd93&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2b3b2d30-fe97-475e-8688-ae162a3ffd93","type":"Claim","title":"Double-transgenic Drosophila over-expressing tau and shaggy, the Drosophila form of GSK3, exhibit neuronal impairment and tau pathology.","label":"Hooper C et al.; Double-transgenic Drosophila over-expres...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:2b3b2d30-fe97-475e-8688-ae162a3ffd93"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e2365de9-8def-4a1d-8806-685f79f7e13b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e2365de9-8def-4a1d-8806-685f79f7e13b","type":"Claim","title":"Decreased fluorodeoxyglucose uptake measured by positron emission tomography (FDG-PET) and atrophy rate abnormalities, as measured by magnetic resonance imaging (MRI), precede any cognitive symptoms in individuals who later progress to AD; in patients who are in the mild cognitive impairment (MCI) phase of AD, MRI, FDG-PET, and CSF tau biomarkers are already abnormal.","label":"Jack C et al.; Decreased fluorodeoxyglucose uptake meas...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner Michael W","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:e2365de9-8def-4a1d-8806-685f79f7e13b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6361534e-87fb-42ff-a6a8-3a982fcea4a1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6361534e-87fb-42ff-a6a8-3a982fcea4a1","type":"Claim","title":"Aβ can form a novel a calcium-conducting pore in lipid bilayers providing a route through which uncontrolled calcium entry may perturb the tightly regulated intracellular calcium environment.","label":"Smith I et al.; Aβ can form a novel a calcium-conducting...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:6361534e-87fb-42ff-a6a8-3a982fcea4a1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cbd5c892-26c1-43a6-9a58-41b92468fb44&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cbd5c892-26c1-43a6-9a58-41b92468fb44","type":"Claim","title":"The striking results for IDE knockout and transgenic mice would imply that even affecting the metabolism of soluble Aβ monomer could have profound effects on Aβ accumulation.","label":"Tanzi R et al.; The striking results for IDE knockout an...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:cbd5c892-26c1-43a6-9a58-41b92468fb44"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8794326e-5e6f-4573-9a8c-0a59d6d347b8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8794326e-5e6f-4573-9a8c-0a59d6d347b8","type":"Claim","title":"The mechanism of NRHypo neuronal injury involves simultaneous hyperactivation of the neuron through several excitatory receptors, including a muscarinic (m3) cholinergic receptor and a glutamatergic (kainic acid) receptor. ","label":"Olney J et al.; The mechanism of NRHypo neuronal injury ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:8794326e-5e6f-4573-9a8c-0a59d6d347b8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:90c57cd2-cfbc-4d63-adef-535b53589c8b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:90c57cd2-cfbc-4d63-adef-535b53589c8b","type":"Claim","title":"CAD cells are a useful model system for studying interneuronal transport through tunneling nanotubes.","label":"Muresan Z et al.; CAD cells are a useful model system for ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","id":"urn:lsid:swan.org:researchstatement:90c57cd2-cfbc-4d63-adef-535b53589c8b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:79a58b65-a21b-41a2-8964-049488adcfdc&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:79a58b65-a21b-41a2-8964-049488adcfdc","type":"Claim","title":"Ectopic stimulation of Fyn activity, which can be mitogenic, potentially could lead to nerve cell death via mitotic catastrophe to trigger cell death, an idea supported by findings that the AD brain has ectopically expressed cell cycle proteins.","label":"Lambert M et al.; Ectopic stimulation of Fyn activity, whi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:79a58b65-a21b-41a2-8964-049488adcfdc"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0af9cbf9-bdbc-4bde-b93a-5c9459716f2d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0af9cbf9-bdbc-4bde-b93a-5c9459716f2d","type":"Claim","title":"Because aging is the most important risk factor for late onset AD, it is likely that specific biochemical pathways are activated or inhibited in an age-dependent fashion and these changes are linked to AD neuropathology.","label":"Because aging is the most important risk...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:0af9cbf9-bdbc-4bde-b93a-5c9459716f2d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:589c1a19-6d68-410c-88fe-41883351d661&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:589c1a19-6d68-410c-88fe-41883351d661","type":"Claim","title":"Resveratrol treatment significantly reduces the extent of cell death caused by p25.","label":"Kim D et al.; Resveratrol treatment significantly redu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:589c1a19-6d68-410c-88fe-41883351d661"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a18adf26-f223-4ca2-b8f1-8018e82a1b2c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a18adf26-f223-4ca2-b8f1-8018e82a1b2c","type":"Claim","title":"Soluble Aβ in Alzheimer\u2019s disease brain contributes directly to synapse loss, a decrease in dendritic spine density, and this spine loss is dependent on NMDAR activation.","label":"Shankar G et al.; Soluble Aβ in Alzheimer\u2019s disease brain ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Li Shaomin","Mehta Tapan H","Garcia-Munoz Amaya","Shepardson Nina E","Smith Imelda","Brett Francesca M","Farrell Michael A","Rowan Michael J","Lemere Cynthia A","Regan Ciaran M","Walsh Dominic M","Sabatini Bernardo L","Selkoe Dennis J"],"firstAuthor":"Shankar Ganesh M","referenceYear":"2008","referenceDate":"2008-08","id":"urn:lsid:swan.org:researchstatement:a18adf26-f223-4ca2-b8f1-8018e82a1b2c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:727cd164-9451-4ca5-b830-a230584e59e0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:727cd164-9451-4ca5-b830-a230584e59e0","type":"Claim","title":"Low amounts of clusterin (Apo J), a senile plaque protein, give rise to slowly sedimenting Aβ derivatives with enhanced mitochondrial toxicity in neuron-like PC12 cells.","label":"Lambert M et al.; Low amounts of clusterin (Apo J), a seni...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:727cd164-9451-4ca5-b830-a230584e59e0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a1fa4635-47c6-4927-a7d0-f301a9e373af&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a1fa4635-47c6-4927-a7d0-f301a9e373af","type":"Claim","title":"Apoptosis operates as a mechanism of cell death for at least some neurons in AD.","label":"Cotman C et al.; Apoptosis operates as a mechanism of cel...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:a1fa4635-47c6-4927-a7d0-f301a9e373af"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8a64cebb-ee5c-47f6-a094-3e3478db480c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8a64cebb-ee5c-47f6-a094-3e3478db480c","type":"Claim","title":"Individuals with early onset autosomal dominant familial AD account for less than 1% overall number of AD cases.","label":"Holtzman D; Individuals with early onset autosomal d...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:8a64cebb-ee5c-47f6-a094-3e3478db480c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0f84f9e5-eed3-4e1e-bc2f-69954d229b31&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0f84f9e5-eed3-4e1e-bc2f-69954d229b31","type":"Claim","title":"The ability of PS1 to regulate Aβ production may be compromised by excessive intramembranous Aβ.","label":"Marchesi V; The ability of PS1 to regulate Aβ produc...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:0f84f9e5-eed3-4e1e-bc2f-69954d229b31"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:49596fd0-d84c-4d01-867f-ab665e63ab57&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:49596fd0-d84c-4d01-867f-ab665e63ab57","type":"Claim","title":"APP dimers are cleaved by the secretases as dimers.","label":"Marchesi V; APP dimers are cleaved by the secretases...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:49596fd0-d84c-4d01-867f-ab665e63ab57"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a6f60f64-f77c-4928-a658-6cde3b0061e5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a6f60f64-f77c-4928-a658-6cde3b0061e5","type":"Claim","title":"Soluble oligomers of Aβ are neurotoxic in vitro and in vivo.","label":"Bitan G et al.; Soluble oligomers of Aβ are neurotoxic i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:a6f60f64-f77c-4928-a658-6cde3b0061e5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:27ef2700-4b64-4e8d-a9ba-305ea220db80&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:27ef2700-4b64-4e8d-a9ba-305ea220db80","type":"Claim","title":"Activated microglia may restrict plaque growth.","label":"Meyer-Luehmann M et al.; Activated microglia may restrict plaque ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:27ef2700-4b64-4e8d-a9ba-305ea220db80"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:79e15014-67ad-42ec-8b92-2341392b2f58&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:79e15014-67ad-42ec-8b92-2341392b2f58","type":"Claim","title":"When tau becomes hyperphosphorylated or disengages from MTs as a result of other mechanisms, higher concentrations of cytosolic tau lead to tau fibrillization and the formation amyloid-like paired helical filaments that aggregate to form neurofibrillary tangles (NFTs).","label":"Lee V et al.; When tau becomes hyperphosphorylated or ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Trojanowski John Q"],"firstAuthor":"Lee Virginia M-Y","id":"urn:lsid:swan.org:researchstatement:79e15014-67ad-42ec-8b92-2341392b2f58"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4bcb253f-293c-4b89-ac01-70bbc3e2ccc9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4bcb253f-293c-4b89-ac01-70bbc3e2ccc9","type":"Claim","title":"Observation of this phenomenon (i.e., increase Aβ42 production while inhibiting other γ-secretase activities) in both cell culture systems and partially purified membrane preparations makes it unlikely that increased Aβ42 production is a result of inhibitory effects on other intracellular processes.","label":"Shen J et al.; Observation of this phenomenon (i.e., in...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:4bcb253f-293c-4b89-ac01-70bbc3e2ccc9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ac8240d1-0370-4792-a9e6-54b12d54054f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ac8240d1-0370-4792-a9e6-54b12d54054f","type":"Claim","title":"In early AD, neuronal excitability is influenced by the direct effects of Aβ, and other products of disordered Alzheimer biochemistry, on ion channels in dendrites.","label":"Morse T et al.; In early AD, neuronal excitability is in...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Mutalik Pradeep","Cheung Kei","Miller Perry L","Shepherd Gordon"],"firstAuthor":"Morse Thomas M","id":"urn:lsid:swan.org:researchstatement:ac8240d1-0370-4792-a9e6-54b12d54054f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:739a0655-74a3-4446-b6c7-ff4360e71b47&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:739a0655-74a3-4446-b6c7-ff4360e71b47","type":"Claim","title":"Rational therapies based on reducing Aβ production or deposition are succeeding.","label":"Golde T; Rational therapies based on reducing Aβ ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde T","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:739a0655-74a3-4446-b6c7-ff4360e71b47"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:488cf0cc-f99c-4d9b-baf0-f1860259d604&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:488cf0cc-f99c-4d9b-baf0-f1860259d604","type":"Claim","title":"PS2 mutations, like PS1, also resulted in a similar enhanced release of calcium from intracellular stores.","label":"Smith I et al.; PS2 mutations, like PS1, also resulted i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:488cf0cc-f99c-4d9b-baf0-f1860259d604"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7ae2d5ae-2e49-49c7-8ccb-716621659591&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7ae2d5ae-2e49-49c7-8ccb-716621659591","type":"Claim","title":"IKV increases observed by others could be due to incomplete aggregation allowing reduced levels of soluble Aβ to affect IKV.","label":"Plant L et al.; IKV increases observed by others could b...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:7ae2d5ae-2e49-49c7-8ccb-716621659591"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:999ff7a7-f0eb-4660-9995-af719648abf8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:999ff7a7-f0eb-4660-9995-af719648abf8","type":"Claim","title":"Within the amino acid sequences surrounding the three threonyl residues in APP, Thr668 is a potential site for phosphorylation by cdc2 kinase, a proline-directed protein kinase.","label":"Suzuki T et al.; Within the amino acid sequences surround...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:999ff7a7-f0eb-4660-9995-af719648abf8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9cb6d09a-b527-46be-99c6-3403e0d01464&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9cb6d09a-b527-46be-99c6-3403e0d01464","type":"Claim","title":"In vivo, DR6 regulates lymphocyte development.","label":"Nikolaev A et al.; In vivo, DR6 regulates lymphocyte develo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["McLaughlin Todd","O'Leary Dennis D","Tessier-Lavigne Marc"],"firstAuthor":"Nikolaev Anatoly","referenceYear":"2009","referenceDate":"2009-02-19","id":"urn:lsid:swan.org:researchstatement:9cb6d09a-b527-46be-99c6-3403e0d01464"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b672b330-13e7-4b8d-9ddb-423a5779e965&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b672b330-13e7-4b8d-9ddb-423a5779e965","type":"Claim","title":"Disruption in electrical activity and synaptic transmission precedes beta amyloid formation and cognitive deficits by months.  ","label":"Stutzmann G; Disruption in electrical activity and sy...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Stutzmann Grace E","id":"urn:lsid:swan.org:researchstatement:b672b330-13e7-4b8d-9ddb-423a5779e965"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:52afbca4-6916-4e39-bbe4-7fd163f6af46&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:52afbca4-6916-4e39-bbe4-7fd163f6af46","type":"Claim","title":"Apoptosis is a natural process that occurs during development to eliminate excess neurons, but during aging it can be reinitiated by certain stimuli and cause the loss of significant numbers of neurons, which can lead to dementia.","label":"Cotman C et al.; Apoptosis is a natural process that occu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:52afbca4-6916-4e39-bbe4-7fd163f6af46"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4adaf896-d4a2-47cf-89d8-bb20c0cfa2f4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4adaf896-d4a2-47cf-89d8-bb20c0cfa2f4","type":"Claim","title":"Extracellular tau aggregates, but not monomer, are taken up by cultured cells.","label":"Frost B et al.; Extracellular tau aggregates, but not mo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Jacks Rachel L","Diamond Marc I"],"firstAuthor":"Frost Bess","referenceYear":"2009","referenceDate":"2009-05-08","id":"urn:lsid:swan.org:researchstatement:4adaf896-d4a2-47cf-89d8-bb20c0cfa2f4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cd2b5fa4-89d5-48fc-9834-7ee7161d7fc7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cd2b5fa4-89d5-48fc-9834-7ee7161d7fc7","type":"Claim","title":"Dynamic light scattering methods to resolve the physical size of A&#946;aggregates show that A&#946;40 exists mainly in 1-2 nm hydrodynamic radius particles (monomers to tetramers in equilibrium).","label":"Bitan G et al.; Dynamic light scattering methods to reso...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:cd2b5fa4-89d5-48fc-9834-7ee7161d7fc7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1d8e5bb6-5358-4ccf-9610-dd3e5157ad2b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1d8e5bb6-5358-4ccf-9610-dd3e5157ad2b","type":"Claim","title":"Expressing the shortest human tau fivefold to 10-fold over endogenous tau inhibited axonal transport, although Nixon\u2019s group reports no inhibition of axonal transport in fourfold overexpression of human tau. Therefore, it is possible that the effect of tau on axonal transport in vivo may be dependent on the level of tau overexpression.","label":"Takashima A; Expressing the shortest human tau fivefo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Takashima Akihiko","id":"urn:lsid:swan.org:researchstatement:1d8e5bb6-5358-4ccf-9610-dd3e5157ad2b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:dc8f813f-4aba-4def-803a-f083e265e904&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:dc8f813f-4aba-4def-803a-f083e265e904","type":"Claim","title":"Patients with mild AD who carry at least one APOE ε4 allele (\u201ccarriers\u201d) were impaired to a greater extent than noncarriers on specific episodic memory measures such as 30-min delayed recall as well as two measures thought to be particularly specific to temporo-limbic memory dysfunction, recognition memory and memory retention, considered to be dependent on the medial temporal lobe memory system.","label":"Wolk D et al.; Patients with mild AD who carry at least...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Dickerson Bradford C","Weiner Michael","Aiello Marilyn","Aisen Paul","Albert Marilyn S","Alexander Gene","Anderson Heather S","Anderson Karen","Apostolova Liana","Arnold Steve","Ashford Wes","Assaly Michele","Asthana Sanjay","Bandy Dan","Bartha Rob","Bates Vernice","Beckett Laurel","Bell Karen L","Benincasa Amanda L","Bergman Howard","Bernick Charles","Bernstein Matthew","Black Sandra","Blank Karen","Borrie Michael","Brand Connie","Brewer James","Brown Alice D","Burns Jeffrey M","Cairns Nigel J","Caldwell Curtis","Capote Horacio","Carlsson Cynthia M","Carmichael Owen","Cellar Janet S","Celmins Dzintra","Chen Kewei","Chertkow Howard","Chowdhury Munir","Clark David","Connor Donald","Correia Stephen","Crawford Karen","Dale Anders","de Leon Mony J","De Santi Susan M","Decarli Charles","Detoledo-Morrell Leyla","Devous Michael","Diaz-Arrastia Ramon","Dolen Sara","Donohue Michael","Doody Rachelle S","Doraiswamy P Murali","Duara Ranjan","Englert Jessica","Farlow Martin","Feldman Howard","Felmlee Joel","Fleisher Adam","Fletcher Evan","Foroud Tatiana M","Foster Norm","Fox Nick","Frank Richard","Gamst Anthony","Given Curtis A","Graff-Radford Neill R","Green Robert C","Griffith Randall","Grossman Hillel","Hake Ann M","Hardy Peter","Harvey Danielle","Heidebrink Judith L","Hendin Barry A","Herring Scott","Honig Lawrence S","Hosein Chris","Robin Hsiung Ging-Yuek","Hudson Leon","Ismail M Saleem","Jack Clifford R","Jacobson Sandra","Jagust William","Jayam-Trouth Annapurni","Johnson Kris","Johnson Heather","Johnson Nancy","Johnson Kathleen","Johnson Keith A","Johnson Sterling","Kachaturian Zaven","Karlawish Jason H","Kataki Maria","Kaye Jeffrey","Kertesz Andrew","Killiany Ronald","Kittur Smita","Koeppe Robert A","Korecka Magdalena","Kornak John","Kozauer Nicholas","Lah James J","Laubinger Mary M","Lee Virginia M-Y","Lee T-Y","Lerner Alan","Levey Allan I","Longmire Crystal Flynn","Lopez Oscar L","Lord Joanne L","Lu Po H","Macavoy Martha G","Malloy Paul","Marson Daniel","Martin-Cook Kristen","Martinez Walter","Marzloff George","Mathis Chet","Mc-Adams-Ortiz Catherine","Mesulam Marsel","Miller Bruce L","Mintun Mark A","Mintzer Jacobo","Molchan Susan","Montine Tom","Morris John","Mulnard Ruth A","Munic Donna","Nair Anil","Neu Scott","Nguyen Dana","Norbash Alexander","Oakley Maryann","Obisesan Thomas O","Ogrocki Paula","Ott Brian R","Parfitt Francine","Pawluczyk Sonia","Pearlson Godfrey","Petersen Ronald","Petrella Jeffrey R","Potkin Steven","Potter William Z","Preda Adrian","Quinn Joseph","Rainka Michelle","Reeder Stephanie","Reiman Eric M","Rentz Dorene M","Reynolds Brigid","Richard Jennifer","Roberts Peggy","Rogers John","Rosen Allyson","Rosen Howard J","Rusinek Henry","Sabbagh Marwan","Sadowsky Carl","Salloway Stephen","Santulli Robert B","Saykin Andrew J","Scharre Douglas W","Schneider Lon","Schneider Stacy","Schuff Norbert","Shah Raj C","Shaw Les","Shen Li","Silverman Daniel H","Simpson Donna M","Sink Kaycee M","Smith Charles D","Snyder Peter J","Spann Bryan M","Sperling Reisa A","Spicer Kenneth","Stefanovic Bojana","Stern Yaakov","Stopa Edward","Tang Cheuk","Tariot Pierre","Taylor-Reinwald Lisa","Thai Gaby","Thomas Ronald G","Thompson Paul","Tinklenberg Jared","Toga Arthur W","Tremont Geoffrey","Trojanowki J Q","Trost Dick","Turner Raymond Scott","van Dyck Christopher H","Vanderswag Helen","Varon Daniel","Villanueva-Meyer Javier","Villena Teresa","Walter Sarah","Wang Paul","Watkins Franklin","Weiner Michael","Williamson Jeff D","Wolk David","Wu Chuang-Kuo","Zerrate Maria","Zimmerman Earl A"],"firstAuthor":"Wolk David A","referenceYear":"2010","referenceDate":"2010-05-17","id":"urn:lsid:swan.org:researchstatement:dc8f813f-4aba-4def-803a-f083e265e904"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:333479d7-fb0d-46aa-b0a6-e837e232c2c8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:333479d7-fb0d-46aa-b0a6-e837e232c2c8","type":"Hypothesis","title":"APP binds DR6 to trigger axon pruning and neuron death via distinct caspases.","label":"Nikolaev A et al.; APP binds DR6 to trigger axon pruning an...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["McLaughlin Todd","O'Leary Dennis D","Tessier-Lavigne Marc"],"firstAuthor":"Nikolaev Anatoly","referenceYear":"2009","referenceDate":"2009-02-19","id":"urn:lsid:swan.org:researchstatement:333479d7-fb0d-46aa-b0a6-e837e232c2c8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8bced31e-7b70-4336-9dd9-e1cf86d6ef6e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8bced31e-7b70-4336-9dd9-e1cf86d6ef6e","type":"Claim","title":"The only time that substantial Aβ induced degeneration has been seen is in the context of additional MAPT mutations that by themselves lead to cell death so this is an experiment where neurons are very severely compromised before toxicity is seen.","label":"Hardy ; The only time that substantial Aβ induce...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Hardy","referenceYear":"2009","referenceDate":"2009-05-18","id":"urn:lsid:swan.org:researchstatement:8bced31e-7b70-4336-9dd9-e1cf86d6ef6e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4d19b0bb-b28a-4b17-b53e-380769668c84&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4d19b0bb-b28a-4b17-b53e-380769668c84","type":"Claim","title":"Wild-type Tau is capable of conformational diversity that depends on templated conformation change and suggests a general pathogenic mechanism for other neurodegenerative diseases linked to amyloid protein aggregation.","label":"Wild-type Tau is capable of conformation...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:4d19b0bb-b28a-4b17-b53e-380769668c84"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f6a0c6d6-c864-4f96-8d03-c509d118abce&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f6a0c6d6-c864-4f96-8d03-c509d118abce","type":"Claim","title":"Involvement of astrocytes in HD is interesting, because astrocytes have a role in the removal of glutamate and related agonists, and there is evidence for excitotoxic-related injury in the disease.","label":"Cotman C et al.; Involvement of astrocytes in HD is inter...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:f6a0c6d6-c864-4f96-8d03-c509d118abce"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:69aac911-7335-4ec4-85b4-a603a9de5a86&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:69aac911-7335-4ec4-85b4-a603a9de5a86","type":"Claim","title":"In the context of neurodegenerative diseases, the operative mechanism in the early stages of the disease may be distinct from that in the late or terminal stages.","label":"Cotman C et al.; In the context of neurodegenerative dise...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:69aac911-7335-4ec4-85b4-a603a9de5a86"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:23cdd662-ba3e-4760-8b13-6889e80098e4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:23cdd662-ba3e-4760-8b13-6889e80098e4","type":"Claim","title":"Intraneuronal deposits of aggregated proteins are common in neurodegenerative diseases.","label":"Keck S et al.; Intraneuronal deposits of aggregated pro...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:23cdd662-ba3e-4760-8b13-6889e80098e4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5dc717b7-a38e-43e4-8ddc-d1e5d5e6eb7f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5dc717b7-a38e-43e4-8ddc-d1e5d5e6eb7f","type":"Claim","title":"Aβ oligomers applied to brain slices or injected in vivo cause failure of hippocampal LTP.","label":"Gong Y et al.; Aβ oligomers applied to brain slices or ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:5dc717b7-a38e-43e4-8ddc-d1e5d5e6eb7f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7aa1e4ac-a76f-4bf2-b8ed-71b7ec90c3de&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7aa1e4ac-a76f-4bf2-b8ed-71b7ec90c3de","type":"Claim","title":"No APP phosphorylation has been detected in brain glial cells or primary cultured glia.","label":"Suzuki T; No APP phosphorylation has been detected...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Suzuki Toshiharu","id":"urn:lsid:swan.org:researchstatement:7aa1e4ac-a76f-4bf2-b8ed-71b7ec90c3de"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:19a033d2-adab-42a7-9e09-e4b60dce46ad&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:19a033d2-adab-42a7-9e09-e4b60dce46ad","type":"Claim","title":"Insulin and Aβ may exert reciprocal effects because insulin regulates Aβ levels by promoting its intracellular release from neurons, and regulates degradation and clearance of Aβ by insulin degrading enzyme (IDE); while Aβ impairs insulin signaling.","label":"Craft S; Insulin and Aβ may exert reciprocal effe...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft S","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:19a033d2-adab-42a7-9e09-e4b60dce46ad"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:293c1903-e8cd-456d-a8aa-57398e50a845&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:293c1903-e8cd-456d-a8aa-57398e50a845","type":"Hypothesis","title":"The Amyloid Hypothesis of Alzheimer Disease.","label":"Hardy J et al.; The Amyloid Hypothesis of Alzheimer Dise...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:293c1903-e8cd-456d-a8aa-57398e50a845"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0cec37ae-50a7-4558-956b-343e7681c431&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0cec37ae-50a7-4558-956b-343e7681c431","type":"Claim","title":"One AD causing intra-Aβ APP mutation (\"Dutch\") accelerates self-aggregation of Aβ into amyloid fibrils.","label":"Hardy J et al.; One AD causing intra-Aβ APP mutation (\"D...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:0cec37ae-50a7-4558-956b-343e7681c431"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:387c4c59-57b9-4de2-9bf8-70b6127e1a72&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:387c4c59-57b9-4de2-9bf8-70b6127e1a72","type":"Claim","title":"Attempts to clear the aggregates may result in direct impairment of the protein quality control machinery.","label":"Golde T et al.; Attempts to clear the aggregates may res...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:387c4c59-57b9-4de2-9bf8-70b6127e1a72"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a22ba8e1-14fd-4a37-acba-caf1735cb829&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a22ba8e1-14fd-4a37-acba-caf1735cb829","type":"Claim","title":"Aging is the single most important risk factor for late-onset AD (LOAD).","label":"Aging is the single most important risk ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:a22ba8e1-14fd-4a37-acba-caf1735cb829"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6f36826c-638d-445b-8c08-19ea3dd7545d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6f36826c-638d-445b-8c08-19ea3dd7545d","type":"Claim","title":"Cells dying by apoptosis almost never give rise to an inflammatory response in contrast with cells dying by necrosis, which almost always do.","label":"Cotman C et al.; Cells dying by apoptosis almost never gi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:6f36826c-638d-445b-8c08-19ea3dd7545d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:251b75ad-7b0b-4026-a755-dcb4c510415a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:251b75ad-7b0b-4026-a755-dcb4c510415a","type":"Claim","title":"The transition from \"normal\" to \"pathologic\" aging will be modified by environmental and genetic risk factors.","label":"The transition from \"normal\" to \"patholo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:251b75ad-7b0b-4026-a755-dcb4c510415a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9940108f-ffa9-4dfe-abe5-a65aa9dff969&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9940108f-ffa9-4dfe-abe5-a65aa9dff969","type":"Claim","title":"Purified casein kinase II does not phosphorylate APP645-694 and the activity of casein kinase II is highest in the G1 phase of the cell cycle.","label":"Suzuki T et al.; Purified casein kinase II does not phosp...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:9940108f-ffa9-4dfe-abe5-a65aa9dff969"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2cd684dd-db19-4e3e-93ef-bf58d31a64d0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2cd684dd-db19-4e3e-93ef-bf58d31a64d0","type":"Claim","title":"Deficits in learning and memory in APP mice are improved in APP α7KO mice.","label":"Dziewczapolski G et al.; Deficits in learning and memory in APP m...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Glogowski Carolina M","Masliah Eliezer","Heinemann Stephen F"],"firstAuthor":"Dziewczapolski Gustavo","referenceYear":"2009","referenceDate":"2009-07-08","id":"urn:lsid:swan.org:researchstatement:2cd684dd-db19-4e3e-93ef-bf58d31a64d0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:886e88d2-7a38-4460-b10b-9424bbc7c4af&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:886e88d2-7a38-4460-b10b-9424bbc7c4af","type":"Claim","title":"A&#946;42 self-associates readily, giving rise to large, insoluble amyloid fibrils","label":"Gong Y et al.; A&#946;42 self-associates readily, givin...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:886e88d2-7a38-4460-b10b-9424bbc7c4af"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:66a3fad0-c1aa-4f7d-b4aa-22fccbab0c17&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:66a3fad0-c1aa-4f7d-b4aa-22fccbab0c17","type":"Question","title":"Does forced expression of classic inducers of senescence, such as p53 or INK4A, in adult neurons drive senescence and inflammation?","label":"Does forced expression of classic induce...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:66a3fad0-c1aa-4f7d-b4aa-22fccbab0c17"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:66e4dc15-3c87-4171-83ab-18b7c173acd7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:66e4dc15-3c87-4171-83ab-18b7c173acd7","type":"Claim","title":"APP undergoes several specific endoproteolytic cleavage events: beta-cleavage and gamma-cleavage to form Aβ and an active signaling intracellular domain, or alpha cleavage to form a non-aggregating form of Aβ.","label":"APP undergoes several specific endoprote...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:66e4dc15-3c87-4171-83ab-18b7c173acd7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:f704f166-ffd0-4e43-9438-d89b72c6a614&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:f704f166-ffd0-4e43-9438-d89b72c6a614","type":"Question","title":"Is AD reversible?","label":"Is AD reversible?","icon":"../icons/ontological/discourse-element/research-question.png","firstAuthor":"Golde Todd E","id":"urn:lsid:swan.org:researchquestion:f704f166-ffd0-4e43-9438-d89b72c6a614"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e745f5f6-c8d6-411c-b558-0b638558cdd2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e745f5f6-c8d6-411c-b558-0b638558cdd2","type":"Claim","title":"The phase IIa AN1792 clinical study showed no major differences in cognitive performance when antibody responders were compared with the placebo group at 1 year, despite evidence of high serum antibodies to Aβ42 in a subset of those who received active treatment.","label":"Holmes C et al.; The phase IIa AN1792 clinical study show...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:e745f5f6-c8d6-411c-b558-0b638558cdd2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:82f1cebd-15c2-4d39-8b30-98b7588b2257&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:82f1cebd-15c2-4d39-8b30-98b7588b2257","type":"Claim","title":"AD Clinical trials need to be fully reported so that definitive conclusions can be reached.","label":"Hardy ; AD Clinical trials need to be fully repo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Hardy","referenceYear":"2009","referenceDate":"2009-05-18","id":"urn:lsid:swan.org:researchstatement:82f1cebd-15c2-4d39-8b30-98b7588b2257"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fbce44d3-7836-4592-9949-c5085d87c99f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fbce44d3-7836-4592-9949-c5085d87c99f","type":"Claim","title":"It is probable that different gamma-secretase complexes exert different biological and biochemical activities.","label":"Bentahir M et al.; It is probable that different gamma-secr...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:fbce44d3-7836-4592-9949-c5085d87c99f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a4d16742-5881-4729-9328-7d6bc256b745&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a4d16742-5881-4729-9328-7d6bc256b745","type":"Claim","title":"Intranasal insulin increases CSF insulin and improves memory within 30 min in young, healthy adults without changing plasma glucose or insulin. ","label":"Craft S; Intranasal insulin increases CSF insulin...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft Suzanne","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:a4d16742-5881-4729-9328-7d6bc256b745"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ddc38f6e-0988-41eb-8261-7f4a8faf82a0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ddc38f6e-0988-41eb-8261-7f4a8faf82a0","type":"Claim","title":"Exogenous Abeta40 is rapidly transported from the CNS to plasma with an elimination half-life from the brain of ≤ 30 minutes.","label":"Holtzman D; Exogenous Abeta40 is rapidly transported...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:ddc38f6e-0988-41eb-8261-7f4a8faf82a0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:88e4a941-f17b-412f-9623-1ca3839ca37e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:88e4a941-f17b-412f-9623-1ca3839ca37e","type":"Claim","title":"Amyloidosis increases the sensitivity of NMDA receptors so that even normal concentrations of glutamate can trigger abnormal currents, which on a long-term low-grade basis can destroy NMDA receptor-bearing neurons and promote the NRHypo state.","label":"Olney J et al.; Amyloidosis increases the sensitivity of...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:88e4a941-f17b-412f-9623-1ca3839ca37e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7d2c0e3d-9057-49eb-bf0f-096026a58ad8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7d2c0e3d-9057-49eb-bf0f-096026a58ad8","type":"Claim","title":"The degree of phenotypic rescue of PS1-/- mice correlated with the extent of overexpression of mutant PS1-A246E.","label":"Shen J et al.; The degree of phenotypic rescue of PS1-/...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:7d2c0e3d-9057-49eb-bf0f-096026a58ad8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5523efc9-411c-4f80-8302-e1cb409fbfd9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5523efc9-411c-4f80-8302-e1cb409fbfd9","type":"Claim","title":"The amyloidogenic pathway involves the recruitment of BACE1 and gamma-secretase, a multimeric protein complex containing presenilin, nicastrin, Aph-1 and Pen-2.","label":"The amyloidogenic pathway involves the r...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:5523efc9-411c-4f80-8302-e1cb409fbfd9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:08b43374-1013-46bd-b9de-d5e177087288&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:08b43374-1013-46bd-b9de-d5e177087288","type":"Claim","title":"There is growing evidence that failed axonal transport might be the underlying basis for several neurodegenerative diseases in addition to tauopathies.","label":"Lee V et al.; There is growing evidence that failed ax...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Trojanowski John Q"],"firstAuthor":"Lee Virginia M-Y","id":"urn:lsid:swan.org:researchstatement:08b43374-1013-46bd-b9de-d5e177087288"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ce2115d7-4adb-4e0b-8659-eb32fafc92c9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ce2115d7-4adb-4e0b-8659-eb32fafc92c9","type":"Claim","title":"Treatment of cells with phorbol ester, which activates PKC, and/or okadaic acid, which inhibits protein phosphatases 1 and 2A, increases the production of APP<sub>COOH<\/sub> and APP<sub>s<\/sub>  by a mechanism which may involve either direct phosphorylation of APP and/or activation of the alpha-secretase pathway.","label":"Suzuki T et al.; Treatment of cells with phorbol ester, w...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:ce2115d7-4adb-4e0b-8659-eb32fafc92c9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8b3ebaaf-ec36-4c10-87d7-b2c038e0e519&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8b3ebaaf-ec36-4c10-87d7-b2c038e0e519","type":"Claim","title":"LTP of excitatory synaptic transmission in the CA1 region is induced by high-frequency stimulation.","label":"Walsh D et al.; LTP of excitatory synaptic transmission ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Klyubin Igor","Fadeeva Julia V","Cullen William K","Anwyl Roger","Wolfe Michael S","Rowan Michael J","Selkoe Dennis J"],"firstAuthor":"Walsh Dominic M","referenceYear":"2002","referenceDate":"2002-04-04","id":"urn:lsid:swan.org:researchstatement:8b3ebaaf-ec36-4c10-87d7-b2c038e0e519"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7ccc5941-1ef6-4d96-9f69-d3a54053bc4a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7ccc5941-1ef6-4d96-9f69-d3a54053bc4a","type":"Claim","title":"The underlying molecular mechanisms responsible for enhancement in calcium release from the ER may be due to a combination of an enhanced intracellular calcium store and/or a failure by the cell, caused by the pathogenic actions of Aβ, to regulate calcium elevations.","label":"Smith I et al.; The underlying molecular mechanisms resp...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:7ccc5941-1ef6-4d96-9f69-d3a54053bc4a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5b4dd01f-94fc-488a-b094-3b40909aa6ba&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5b4dd01f-94fc-488a-b094-3b40909aa6ba","type":"Claim","title":"Many natural extracellular activators of apoptosis interact with membrane proteins, and disrupt a constitutive cellular survival signal required to suppress an intrinsic cell suicide program.  Examples include reduction in trophic factors and reduction of cell-cell or cell-extracellular matrix interactions.","label":"Cotman C et al.; Many natural extracellular activators of...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:5b4dd01f-94fc-488a-b094-3b40909aa6ba"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0f90db7e-06bc-4776-9b06-c28c92898e2e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0f90db7e-06bc-4776-9b06-c28c92898e2e","type":"Claim","title":"Aβ associates physically with the ion channel, supporting a physiological role for Aβ in ion channel regulation.","label":"Smith I et al.; Aβ associates physically with the ion ch...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:0f90db7e-06bc-4776-9b06-c28c92898e2e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:97664d9d-943b-4b96-8f88-3033bee24a8a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:97664d9d-943b-4b96-8f88-3033bee24a8a","type":"Claim","title":"In vitro studies indicate that tau phosphorylation can be mediated by GSK3 in the wnt signaling pathway.","label":"Small S et al.; In vitro studies indicate that tau phosp...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:97664d9d-943b-4b96-8f88-3033bee24a8a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:283cca9a-3f33-4790-997a-b44135f4aca4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:283cca9a-3f33-4790-997a-b44135f4aca4","type":"Claim","title":"α7Nicotinic acetylcholine receptors mediate an Aβ42-induced increase in the level of acetylcholinesterase in primary cortical neurons, an effect opposite to the current rationale for the use of the first class of drugs.","label":"Dziewczapolski G et al.; α7Nicotinic acetylcholine receptors medi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Glogowski Carolina M","Masliah Eliezer","Heinemann Stephen F"],"firstAuthor":"Dziewczapolski Gustavo","referenceYear":"2009","referenceDate":"2009-07-08","id":"urn:lsid:swan.org:researchstatement:283cca9a-3f33-4790-997a-b44135f4aca4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:52d46bb6-8b6d-4d5b-a80a-0414781ab99a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:52d46bb6-8b6d-4d5b-a80a-0414781ab99a","type":"Claim","title":"Photo-induced cross-linking of unmodified proteins (PICUP) rapidly cross-links native proteins and has been used to study Aβ.","label":"Bitan G et al.; Photo-induced cross-linking of unmodifie...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:52d46bb6-8b6d-4d5b-a80a-0414781ab99a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:57962f8e-c421-408f-8acb-8bf3ab23d39d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:57962f8e-c421-408f-8acb-8bf3ab23d39d","type":"Claim","title":"BDNF and CREB, which have critical roles in synaptic plasticity and modulating synapse formation, are downregulated, whereas miRNA-134 is upregulated in a brain-specific manner, in mutant mice lacking SIRT1 catalytic activity (SIRT1Δ).","label":"Gao J et al.; BDNF and CREB, which have critical roles...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wang Wen-Yuan","Mao Ying-Wei","Gräff Johannes","Guan Ji-Song","Pan Ling","Mak Gloria","Kim Dohoon","Su Susan C","Tsai Li-Huei"],"firstAuthor":"Gao Jun","referenceYear":"2010","referenceDate":"2010-07-11","id":"urn:lsid:swan.org:researchstatement:57962f8e-c421-408f-8acb-8bf3ab23d39d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1ba927bc-4f3e-4f0d-b8e4-28f765f80c02&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1ba927bc-4f3e-4f0d-b8e4-28f765f80c02","type":"Claim","title":"Biomarker studies should be included in trial designs so that the researchers can form, as clearly as possible, informed opinions as to whether the drug has hit the proposed target.","label":"Hardy ; Biomarker studies should be included in ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Hardy","referenceYear":"2009","referenceDate":"2009-05-18","id":"urn:lsid:swan.org:researchstatement:1ba927bc-4f3e-4f0d-b8e4-28f765f80c02"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:9a5c06a0-7985-437e-a9ea-ba4061b5d5b7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:9a5c06a0-7985-437e-a9ea-ba4061b5d5b7","type":"Question","title":"The double hit hypothesis leaves unanswered the same major question left unanswered by the amyloid hypothesis: What is the relationship between APP/Aβ and tau?","label":"The double hit hypothesis leaves unanswe...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:9a5c06a0-7985-437e-a9ea-ba4061b5d5b7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d4ec376c-7b8e-4881-9fa5-27c3a75f1e59&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d4ec376c-7b8e-4881-9fa5-27c3a75f1e59","type":"Claim","title":"Microsomes isolated from cells expressing V717F mutant APP751 contain Aβ monomers and oligomers.","label":"Walsh D et al.; Microsomes isolated from cells expressin...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Klyubin Igor","Fadeeva Julia V","Cullen William K","Anwyl Roger","Wolfe Michael S","Rowan Michael J","Selkoe Dennis J"],"firstAuthor":"Walsh Dominic M","referenceYear":"2002","referenceDate":"2002-04-04","id":"urn:lsid:swan.org:researchstatement:d4ec376c-7b8e-4881-9fa5-27c3a75f1e59"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a47c23c3-a44a-4b95-8e56-98220c6b2253&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a47c23c3-a44a-4b95-8e56-98220c6b2253","type":"Claim","title":"It is possible that submicroscopic nuclei may be present in the cortex perhaps related to the recently reported amyloid-beta oligomeric forms, as precursors to this sudden growth.","label":"Meyer-Luehmann M et al.; It is possible that submicroscopic nucle...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:a47c23c3-a44a-4b95-8e56-98220c6b2253"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:0f59a467-9c5d-45a3-b167-8b6182fdf00c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:0f59a467-9c5d-45a3-b167-8b6182fdf00c","type":"Question","title":"The key question that remains to be resolved is the pathophysiological relevance of these findings and how they affect the onset and progression of neurodegeneration in AD.","label":"The key question that remains to be reso...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:0f59a467-9c5d-45a3-b167-8b6182fdf00c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7ccaa07c-28ef-4fee-9511-4b9f73834b07&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7ccaa07c-28ef-4fee-9511-4b9f73834b07","type":"Claim","title":"Amyloid deposit in the brain of Alzheimer patients has nothing to do with the treatment or benefit of AD patients.","label":"Aliev G; Amyloid deposit in the brain of Alzheime...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Aliev Gjumrakch","id":"urn:lsid:swan.org:researchstatement:7ccaa07c-28ef-4fee-9511-4b9f73834b07"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1e0c963d-456a-4011-a9b0-374b1f6b03e7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1e0c963d-456a-4011-a9b0-374b1f6b03e7","type":"Claim","title":"Thr668 is located within the TPXXR motif, which is a modified version of consensus sequence (T/SPR/K or T/SPXr/K) recognized by cdc2 kinase.  The kinetic analysis demonstrated that APP is a substrate of cdc2 kinase and perhaps other proline-directed protein kinases.","label":"Suzuki T; Thr668 is located within the TPXXR motif...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Suzuki Toshiharu","id":"urn:lsid:swan.org:researchstatement:1e0c963d-456a-4011-a9b0-374b1f6b03e7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f69338d5-f92e-4d90-b246-5a7d9ee9a77c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f69338d5-f92e-4d90-b246-5a7d9ee9a77c","type":"Hypothesis","title":"Polymorphisms in inflammatory genes enhance the risk of Alzheimer disease.","label":"McGeer P et al.; Polymorphisms in inflammatory genes enha...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["McGeer E G"],"firstAuthor":"McGeer P L","referenceYear":"2001","referenceDate":"2001-11","id":"urn:lsid:swan.org:researchstatement:f69338d5-f92e-4d90-b246-5a7d9ee9a77c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0d48b242-5903-42b5-af1e-0dfb227f8f5e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0d48b242-5903-42b5-af1e-0dfb227f8f5e","type":"Claim","title":"In vivo imaging experiments with APPsw mice, show that all CAA is present only in arterioles and not venules.","label":"Fryer J et al.; In vivo imaging experiments with APPsw m...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:0d48b242-5903-42b5-af1e-0dfb227f8f5e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c440aa6f-5186-4af8-927c-19321566e1d6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c440aa6f-5186-4af8-927c-19321566e1d6","type":"Claim","title":"The hippocampal and cortical Aβ burden measured in 24 month old m266-treated PDAPP mice was substantially greater than that in 8-month old untreated PDAPP mice that were completely unable to discriminate novel and familiar objects in the object recognition task.","label":"Dodart J et al.; The hippocampal and cortical Aβ burden m...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:c440aa6f-5186-4af8-927c-19321566e1d6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:781962e9-02ac-4032-ba8b-3f6918b6df90&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:781962e9-02ac-4032-ba8b-3f6918b6df90","type":"Claim","title":"Independent GWAS of late-onset Alzheimer\u2019s disease also reported association with markers at CLU and CR1.","label":"Lambert J et al.; Independent GWAS of late-onset Alzheimer...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Heath Simon","Even Gael","Campion Dominique","Sleegers Kristel","Hiltunen Mikko","Combarros Onofre","Zelenika Diana","Bullido Maria J","Tavernier Béatrice","Letenneur Luc","Bettens Karolien","Berr Claudine","Pasquier Florence","Fiévet Nathalie","Barberger-Gateau Pascale","Engelborghs Sebastiaan","De Deyn Peter","Mateo Ignacio","Franck Ana","Helisalmi Seppo","Porcellini Elisa","Hanon Olivier","de Pancorbo Marian M","Lendon Corinne","Dufouil Carole","Jaillard Céline","Leveillard Thierry","Alvarez Victoria","Bosco Paolo","Mancuso Michelangelo","Panza Francesco","Nacmias Benedetta","Bossù Paola","Piccardi Paola","Annoni Giorgio","Seripa Davide","Galimberti Daniela","Hannequin Didier","Licastro Federico","Soininen Hilkka","Ritchie Karen","Blanché Hélène","Dartigues Jean-François","Tzourio Christophe","Gut Ivo","Van Broeckhoven Christine","Alpérovitch Annick","Lathrop Mark","Amouyel Philippe"],"firstAuthor":"Lambert Jean-Charles","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:781962e9-02ac-4032-ba8b-3f6918b6df90"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4926dc55-4f6d-4056-96a5-a0747b91841d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4926dc55-4f6d-4056-96a5-a0747b91841d","type":"Claim","title":"An increase in APP<sub>COOH<\/sub>, observed at the G2/M phase, suggests that phosphorylation of APP<sub>COOH<\/sub> by cdc2 kinase may inhibit the movement of the C-terminal fragment through the endosomal/lysosomal pathway or inhibit its degradation within this pathway.","label":"Suzuki T et al.; An increase in APP<sub>COOH<\/sub>, obser...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:4926dc55-4f6d-4056-96a5-a0747b91841d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:288c8b01-7317-4226-be47-49d72b09c2dd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:288c8b01-7317-4226-be47-49d72b09c2dd","type":"Claim","title":"Hyperphosphorylated and nitrosylated tau proteins have been observed in the neurons around core plaques in the cortical and hippocampal areas of 7- and 12-month-old TgCRND8 mice.","label":"Pollio G et al.; Hyperphosphorylated and nitrosylated tau...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hoozemans Jeroen J","Andersen Claus A","Roncarati Renza","Rosi Maria Cristina","van Haastert Elise S","Seredenina Tamara","Diamanti Daniela","Gotta Stefano","Fiorentini Anna","Magnoni Letizia","Raggiaschi Roberto","Rozemuller Annemieke J","Casamenti Fiorella","Caricasole Andrea","Terstappen Georg C"],"firstAuthor":"Pollio Giuseppe","referenceYear":"2008","referenceDate":"2008-07","id":"urn:lsid:swan.org:researchstatement:288c8b01-7317-4226-be47-49d72b09c2dd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:11c438fe-f8f0-475b-9553-b0ce88d3565f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:11c438fe-f8f0-475b-9553-b0ce88d3565f","type":"Claim","title":"Micromolar concentrations of Aβ fragments induce a rapid increase in intracellular calcium levels that can be attenuated by the addition of L-type VGCC antagonists.","label":"Smith I et al.; Micromolar concentrations of Aβ fragment...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:11c438fe-f8f0-475b-9553-b0ce88d3565f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:582bd4fb-83de-4a97-afe9-274842af4b1e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:582bd4fb-83de-4a97-afe9-274842af4b1e","type":"Claim","title":"The observation that Aβ in oligomeric form modulates PKAα in neurons, along with the earlier finding that PKA-mediated Ser-phosphorylation influences THOP1 activity, may provide a modulatory hypothesis for THOP1 by Aβ.","label":"Pollio G et al.; The observation that Aβ in oligomeric fo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hoozemans Jeroen J","Andersen Claus A","Roncarati Renza","Rosi Maria Cristina","van Haastert Elise S","Seredenina Tamara","Diamanti Daniela","Gotta Stefano","Fiorentini Anna","Magnoni Letizia","Raggiaschi Roberto","Rozemuller Annemieke J","Casamenti Fiorella","Caricasole Andrea","Terstappen Georg C"],"firstAuthor":"Pollio Giuseppe","referenceYear":"2008","referenceDate":"2008-07","id":"urn:lsid:swan.org:researchstatement:582bd4fb-83de-4a97-afe9-274842af4b1e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7d9e722c-efbd-4807-a547-6e692199ffa1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7d9e722c-efbd-4807-a547-6e692199ffa1","type":"Claim","title":"p25 and mutant SOD1 trigger disruption of calcium homeostasis and generate oxidative stress.","label":"Kim D et al.; p25 and mutant SOD1 trigger disruption o...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:7d9e722c-efbd-4807-a547-6e692199ffa1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d05443e7-a3eb-4394-ae07-380e9552db8b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d05443e7-a3eb-4394-ae07-380e9552db8b","type":"Claim","title":"Endoproteolysis of APP is achieved by the sequential cleavage by groups of enzymes or enzyme complexes termed alpha-, beta-, and gamma-secretases.","label":"Smith I et al.; Endoproteolysis of APP is achieved by th...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:d05443e7-a3eb-4394-ae07-380e9552db8b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:95ee9dcd-32cf-4128-b7cc-18af1fa1abb4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:95ee9dcd-32cf-4128-b7cc-18af1fa1abb4","type":"Claim","title":"Late onset AD (LOAD) accounts for 97% of AD cases.","label":"Late onset AD (LOAD) accounts for 97% of...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:95ee9dcd-32cf-4128-b7cc-18af1fa1abb4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:27274f62-d374-4e06-9c46-b8f0b749fe69&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:27274f62-d374-4e06-9c46-b8f0b749fe69","type":"Claim","title":"Aberrantly phosphorylated tau is a major constituent of the paired helical filaments (PHF) observed in the brains of AD patients.","label":"Suzuki T et al.; Aberrantly phosphorylated tau is a major...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:27274f62-d374-4e06-9c46-b8f0b749fe69"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:f0e334ef-bc07-4e9f-9174-cfa168c26852&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:f0e334ef-bc07-4e9f-9174-cfa168c26852","type":"Comment","title":"Stutzmann comment on Morse hypothesis  \"The cognitive deficits of early Alzheimer Disease are caused by the disruption of electrical activity and information processing in dendrites of cortical pyramidal neurons.\"","label":"Stutzmann G; Stutzmann comment on Morse hypothesis  \"...","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Stutzmann Grace","id":"urn:lsid:swan.org:comment:f0e334ef-bc07-4e9f-9174-cfa168c26852"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:89e942a6-fca8-4ee0-820e-455dab59012a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:89e942a6-fca8-4ee0-820e-455dab59012a","type":"Claim","title":"The PCDH11X gene was previously found to be a genetic determinant of AD in GWAS; however, none of the SNPs in the PCDH11X locus reached a suggestive level of significance in the French cohort, suggesting that this locus may also contribute to the Alzheimer\u2019s disease risk but not as significantly as CLU or CR1.","label":"Lambert J et al.; The PCDH11X gene was previously found to...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Heath Simon","Even Gael","Campion Dominique","Sleegers Kristel","Hiltunen Mikko","Combarros Onofre","Zelenika Diana","Bullido Maria J","Tavernier Béatrice","Letenneur Luc","Bettens Karolien","Berr Claudine","Pasquier Florence","Fiévet Nathalie","Barberger-Gateau Pascale","Engelborghs Sebastiaan","De Deyn Peter","Mateo Ignacio","Franck Ana","Helisalmi Seppo","Porcellini Elisa","Hanon Olivier","de Pancorbo Marian M","Lendon Corinne","Dufouil Carole","Jaillard Céline","Leveillard Thierry","Alvarez Victoria","Bosco Paolo","Mancuso Michelangelo","Panza Francesco","Nacmias Benedetta","Bossù Paola","Piccardi Paola","Annoni Giorgio","Seripa Davide","Galimberti Daniela","Hannequin Didier","Licastro Federico","Soininen Hilkka","Ritchie Karen","Blanché Hélène","Dartigues Jean-François","Tzourio Christophe","Gut Ivo","Van Broeckhoven Christine","Alpérovitch Annick","Lathrop Mark","Amouyel Philippe"],"firstAuthor":"Lambert Jean-Charles","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:89e942a6-fca8-4ee0-820e-455dab59012a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3bb6abda-09de-4806-a883-046666623e78&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3bb6abda-09de-4806-a883-046666623e78","type":"Claim","title":"It has previously been suggested that cdc2 kinase activity is involved in the inhibition of vesicle fusion during membrane trafficking, thereby potentially affecting APP processing indirectly by cdc2 kinase-dependent phosphorylation of other interacting components.","label":"Suzuki T et al.; It has previously been suggested that cd...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:3bb6abda-09de-4806-a883-046666623e78"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f2498967-4566-46db-803c-b6a142883b0c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f2498967-4566-46db-803c-b6a142883b0c","type":"Claim","title":"Neurons that initiate apoptosis in response to Aβ treatment in vitro also exhibit a selective and prolonged expression of c-Jun.","label":"Cotman C et al.; Neurons that initiate apoptosis in respo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:f2498967-4566-46db-803c-b6a142883b0c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7470d861-f6fc-492e-a1ed-8f23e5ff3109&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7470d861-f6fc-492e-a1ed-8f23e5ff3109","type":"Claim","title":"Coexpression of α-syn, Aβ, and tau accelerates cognitive decline in DLB-AD mice, evidenced by significantly longer escape latencies in Barnes circular maze acquisition, a measure of spatial recognition memory.","label":"Clinton L et al.; Coexpression of α-syn, Aβ, and tau accel...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Blurton-Jones Mathew","Myczek Kristoffer","Trojanowski John Q","LaFerla Frank M"],"firstAuthor":"Clinton Lani K","referenceYear":"2010","referenceDate":"2010-05-26","id":"urn:lsid:swan.org:researchstatement:7470d861-f6fc-492e-a1ed-8f23e5ff3109"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c5b0cc30-c114-4ac4-9921-888f7f3a3395&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c5b0cc30-c114-4ac4-9921-888f7f3a3395","type":"Claim","title":"Contrary to in vitro results, prelabeled APP in cells has identified the phosphorylation of Thr668 in the cytoplasmic domain, differing from the site that PKC phosphorylates APP in vitro.","label":"Suzuki T; Contrary to in vitro results, prelabeled...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Suzuki Toshiharu","id":"urn:lsid:swan.org:researchstatement:c5b0cc30-c114-4ac4-9921-888f7f3a3395"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:53a70747-2309-43b4-aaa1-241837d28cdf&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:53a70747-2309-43b4-aaa1-241837d28cdf","type":"Claim","title":"Phospholipids and the myelin-specific lipid sulfatide have been observed to stimulate autophosphorylation of GSK-3β as well as the GSK-3β phosphorylation of both MBP and tau.","label":"Bartzokis G; Phospholipids and the myelin-specific li...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:53a70747-2309-43b4-aaa1-241837d28cdf"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3cca1347-59f8-4281-a896-85c078d45c5b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3cca1347-59f8-4281-a896-85c078d45c5b","type":"Claim","title":"The transgenic T44 mouse line recapitulates features of authentic human neurodegenerative tauopathies, with the overall phenotype most similar to Guam amyotrophic lateral sclerosis/Parkinson\u2019s dementia complex (ALS/PDC).","label":"Lee V et al.; The transgenic T44 mouse line recapitula...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Trojanowski John Q"],"firstAuthor":"Lee Virginia M-Y","id":"urn:lsid:swan.org:researchstatement:3cca1347-59f8-4281-a896-85c078d45c5b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7b1d1a6e-da19-402b-8d5a-c505500ba099&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7b1d1a6e-da19-402b-8d5a-c505500ba099","type":"Claim","title":"TdT labeling could reflect an accumulation of cells undergoing cell death that are not effectively cleared by normal phagocytic processes.","label":"Cotman C et al.; TdT labeling could reflect an accumulati...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:7b1d1a6e-da19-402b-8d5a-c505500ba099"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:b112be18-649c-46c9-88d2-c0f112d1fef1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:b112be18-649c-46c9-88d2-c0f112d1fef1","type":"Question","title":"How do we discriminate between \u2018classic\u2019 reactive neuroinflammation and senescence in the diseased brain?","label":"How do we discriminate between \u2018classic\u2019...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:b112be18-649c-46c9-88d2-c0f112d1fef1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9cb98bbd-58fb-4c84-991c-f3a5710655db&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9cb98bbd-58fb-4c84-991c-f3a5710655db","type":"Claim","title":"Tissue-transglutaminase recognizes both Aβ42 and Aβ40 as substrates.","label":"Hartley D et al.; Tissue-transglutaminase recognizes both ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:9cb98bbd-58fb-4c84-991c-f3a5710655db"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c5b185fd-2c93-4dda-b3dc-2dda1f1ce969&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c5b185fd-2c93-4dda-b3dc-2dda1f1ce969","type":"Claim","title":"Inhibition of Aβ fibrillogenesis due to absence of endogenous ApoE was not due to a change in ratio of Aβ42:total Aβ.","label":"Holtzman D; Inhibition of Aβ fibrillogenesis due to ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:c5b185fd-2c93-4dda-b3dc-2dda1f1ce969"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fff7c355-fc6f-457e-a005-3f444238e18c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fff7c355-fc6f-457e-a005-3f444238e18c","type":"Claim","title":"FAD-linked PS1 variants significantly reduce endogenous Notch/CBF-1- signaling in both single cell suspensions of cultured adult brain neural progenitors (NPCs) as well as in adult subventricular zone (SVZ) NPCs derived from PS1delE9 transgenic mice, strongly suggesting that expression of the PS1 variants leads to partial reduction or loss in PS-dependent γ-secretase processing of the Notch substrate.","label":"Veeraraghavalu K et al.; FAD-linked PS1 variants significantly re...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Choi Se Hoon","Zhang Xiaoqiong","Sisodia Sangram S"],"firstAuthor":"Veeraraghavalu Karthikeyan","referenceYear":"2010","referenceDate":"2010-05-19","id":"urn:lsid:swan.org:researchstatement:fff7c355-fc6f-457e-a005-3f444238e18c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:2e17c1e0-89f5-46d9-a5a1-761b2e45307b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:2e17c1e0-89f5-46d9-a5a1-761b2e45307b","type":"Question","title":"Mechanisms that decrease SIRT1 activity or levels may result in enhanced susceptibility to age-dependent neurodegeneration.","label":"Mechanisms that decrease SIRT1 activity ...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:2e17c1e0-89f5-46d9-a5a1-761b2e45307b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0288cc4e-16d5-457a-b59d-f178d1d66281&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0288cc4e-16d5-457a-b59d-f178d1d66281","type":"Claim","title":"The level of phosphorylation of APPCOOH in HeLa cells is relatively low at the G2/M phase compared with that observed in PC12 cells.","label":"Suzuki T et al.; The level of phosphorylation of APPCOOH ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:0288cc4e-16d5-457a-b59d-f178d1d66281"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8e3f9f54-f046-46f5-9445-e078d4e70534&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8e3f9f54-f046-46f5-9445-e078d4e70534","type":"Claim","title":"Two FTD-associated PS1 mutations occur at exon-intron boundaries, probably giving rise to both full-length transcripts encoding PS1 bearing the identified missense mutation as well as aberrantly spliced transcripts encoding markedly truncated PS fragments.","label":"Shen J et al.; Two FTD-associated PS1 mutations occur a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:8e3f9f54-f046-46f5-9445-e078d4e70534"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7956b6e4-4287-48fd-9016-9c855de164e5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7956b6e4-4287-48fd-9016-9c855de164e5","type":"Claim","title":"Fyn could be a downstream effector of either Ca2+ or reactive oxygen species (ROS), which have been implicated in cell death caused by conventional Aβ preparations.","label":"Lambert M et al.; Fyn could be a downstream effector of ei...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:7956b6e4-4287-48fd-9016-9c855de164e5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0a26fa03-7302-4d6c-aaf6-99156c9e4695&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0a26fa03-7302-4d6c-aaf6-99156c9e4695","type":"Claim","title":"Ozonolysis of cholesterol generates peroxi-derivatives of cholesterol, which in turn accelerates Aβ monomer aggregation.","label":"Ozonolysis of cholesterol generates pero...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:0a26fa03-7302-4d6c-aaf6-99156c9e4695"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9a6f82bb-c0db-42e2-9d7a-2399e376c729&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9a6f82bb-c0db-42e2-9d7a-2399e376c729","type":"Claim","title":"The 3xTg-AD mice show deficits in LTP, a form of plasticity thought to underlie learning and memory.","label":"Smith I et al.; The 3xTg-AD mice show deficits in LTP, a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:9a6f82bb-c0db-42e2-9d7a-2399e376c729"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b72e53e1-6944-4e15-a3ed-66ecafd48831&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b72e53e1-6944-4e15-a3ed-66ecafd48831","type":"Hypothesis","title":"Inert amyloid plaques are potentially major sources of neurotoxic soluble protofibrillar Abeta-aggregates by exposure to biological lipids.","label":"Martins I et al.; Inert amyloid plaques are potentially ma...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Kuperstein Inna","Wilkinson Hannah","Maes Elke","Vanbrabant Mieke","Jonckheere Wim","Van Gelder Patrick","Hartmann Dieter","D'Hooge Rudi","De Strooper Bart","Schymkowitz Joost","Rousseau Frederic"],"firstAuthor":"Martins Ivo Cristiano","referenceYear":"2008","referenceDate":"2008-01-09","id":"urn:lsid:swan.org:researchstatement:b72e53e1-6944-4e15-a3ed-66ecafd48831"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9ece622a-212f-4e2c-9f92-57bf22c28083&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9ece622a-212f-4e2c-9f92-57bf22c28083","type":"Claim","title":"In homozygous Ps -/- mouse embryonic fibroblasts, FAD PS1 and PS2 mutant proteins are expressed and processed like wild type presenilins, and are able to rescue nicastrin glycosylation and Pen-2 expression deficiency to a similar extent as wild type presenilins.","label":"Bentahir M et al.; In homozygous Ps -/- mouse embryonic fib...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:9ece622a-212f-4e2c-9f92-57bf22c28083"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:41e4c873-75a8-4183-b3fc-1cfe721f8e68&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:41e4c873-75a8-4183-b3fc-1cfe721f8e68","type":"Claim","title":"Aβ deposition is promoted by increased concentration of Aβ or increased rate of seeding.","label":"Golde T; Aβ deposition is promoted by increased c...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde T","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:41e4c873-75a8-4183-b3fc-1cfe721f8e68"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c64f5d64-3b6e-4408-8864-1d5c2793015f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c64f5d64-3b6e-4408-8864-1d5c2793015f","type":"Claim","title":"AD is an Aβ oligomer-induced synaptic failure.","label":"Gong Y et al.; AD is an Aβ oligomer-induced synaptic fa...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:c64f5d64-3b6e-4408-8864-1d5c2793015f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:86250a10-e78c-4ee2-8eaa-ff75046cf5a5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:86250a10-e78c-4ee2-8eaa-ff75046cf5a5","type":"Claim","title":"Aβ42 monomers enhanced Ser9 phosphorylation (inhibition) of the Akt substrate, glycogen-synthase kinase-3β (GSK- 3β).","label":"Giuffrida M et al.; Aβ42 monomers enhanced Ser9 phosphorylat...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Caraci Filippo","Pignataro Bruno","Cataldo Sebastiano","De Bona Paolo","Bruno Valeria","Molinaro Gemma","Pappalardo Giuseppe","Messina Angela","Palmigiano Angelo","Garozzo Domenico","Nicoletti Ferdinando","Rizzarelli Enrico","Copani Agata"],"firstAuthor":"Giuffrida Maria Laura","referenceYear":"2009","referenceDate":"2009-08-26","id":"urn:lsid:swan.org:researchstatement:86250a10-e78c-4ee2-8eaa-ff75046cf5a5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ddfd5a31-a765-4d40-9a1e-2aa396265db2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ddfd5a31-a765-4d40-9a1e-2aa396265db2","type":"Claim","title":"This study (Meyer-Luehmann et al., 2008) is not in conflict with the idea that early transport defects may play a role in neuronal dysfunction and in the enhancement of amyloid formation in Alzheimer disease.","label":"Goldstein L; This study (Meyer-Luehmann et al., 2008)...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Goldstein Lawrence S B","id":"urn:lsid:swan.org:researchstatement:ddfd5a31-a765-4d40-9a1e-2aa396265db2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3757cfb5-4289-411d-95c1-e0c19516f129&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3757cfb5-4289-411d-95c1-e0c19516f129","type":"Claim","title":"By treatment group, 36% of the AN1792 treated group and 31% of the placebo group had progressed to severe dementia by the end of the follow-up period, demonstrating no difference in the time to severe dementia between the treated and placebo groups even after correction for cognitive state and age at the start of the study.","label":"Holmes C et al.; By treatment group, 36% of the AN1792 tr...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:3757cfb5-4289-411d-95c1-e0c19516f129"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bd4940ff-9b59-4e70-92d8-3580a55b6cbf&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bd4940ff-9b59-4e70-92d8-3580a55b6cbf","type":"Claim","title":"Intracellular, neuritic Aβ accumulations occasionally become extracellular either by cell death or via exosomes.","label":"Muresan Z et al.; Intracellular, neuritic Aβ accumulations...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","referenceYear":"2008","referenceDate":"2008","id":"urn:lsid:swan.org:researchstatement:bd4940ff-9b59-4e70-92d8-3580a55b6cbf"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6a93e09f-d278-417b-9b06-47907b4eff15&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6a93e09f-d278-417b-9b06-47907b4eff15","type":"Claim","title":"In \u2018sporadic\u2019 cases it is also possible that the two pathologies may arise, at least in part, through independent pathways.","label":"Golde T et al.; In \u2018sporadic\u2019 cases it is also possible ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:6a93e09f-d278-417b-9b06-47907b4eff15"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9d11160e-94ad-4760-92a9-591e1d221769&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9d11160e-94ad-4760-92a9-591e1d221769","type":"Hypothesis","title":"The Aβ hypothesis will lead to rationally-designed therapeutic strategies for the treatment or prevention of Alzheimer disease.","label":"Golde T; The Aβ hypothesis will lead to rationall...","icon":"../icons/ontological/discourse-element/h-research-statement.png","firstAuthor":"Golde T","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:9d11160e-94ad-4760-92a9-591e1d221769"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e2708b9c-f8c7-45ed-b0d9-983f2d751015&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e2708b9c-f8c7-45ed-b0d9-983f2d751015","type":"Claim","title":"Oxidative stress and disturbances in energy metabolism, may contribute to the NRHyper that devolves into NRHypo in the aging brain.","label":"Olney J et al.; Oxidative stress and disturbances in ene...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:e2708b9c-f8c7-45ed-b0d9-983f2d751015"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4b0e28c3-a58d-4bca-8f9f-36e3e74b0cd9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4b0e28c3-a58d-4bca-8f9f-36e3e74b0cd9","type":"Claim","title":"Aberrant metabolism of ceramide is associated with inflammation, tumorigenesis, diabetes and neurodegeneration.","label":"Aberrant metabolism of ceramide is assoc...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:4b0e28c3-a58d-4bca-8f9f-36e3e74b0cd9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c78f5bff-d5c9-4920-9c36-0a82749c43e1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c78f5bff-d5c9-4920-9c36-0a82749c43e1","type":"Claim","title":"The retromer sorting pathway plays a role in the wnt signaling pathway.","label":"Small S et al.; The retromer sorting pathway plays a rol...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:c78f5bff-d5c9-4920-9c36-0a82749c43e1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:973cd5c5-a45f-44b5-a2c8-469e48f4c4b1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:973cd5c5-a45f-44b5-a2c8-469e48f4c4b1","type":"Claim","title":"The earliest association between cerebral plaques and tangles with presenile dementia, was first suggested by Alzheimer.","label":"Terry R et al.; The earliest association between cerebra...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Masliah E","Salmon D P","Butters N","DeTeresa R","Hill R","Hansen L A","Katzman R"],"firstAuthor":"Terry R D","referenceYear":"1991","referenceDate":"1991-10","id":"urn:lsid:swan.org:researchstatement:973cd5c5-a45f-44b5-a2c8-469e48f4c4b1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:be5abd2d-4dec-4fd2-a7c2-3e8b17c3f9ee&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:be5abd2d-4dec-4fd2-a7c2-3e8b17c3f9ee","type":"Claim","title":"The endogenous proteasome activity in the straight gyrus of AD brains was reduced to 56% of that in aged matched controls.","label":"Keck S et al.; The endogenous proteasome activity in th...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:be5abd2d-4dec-4fd2-a7c2-3e8b17c3f9ee"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8619efb4-254e-4804-8287-c772713b746e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8619efb4-254e-4804-8287-c772713b746e","type":"Claim","title":"An increased Aβ42:Aβ40 concentration ratio is associated with familial early onset AD.","label":"Bitan G et al.; An increased Aβ42:Aβ40 concentration rat...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:8619efb4-254e-4804-8287-c772713b746e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0315736e-f6a7-4095-8ee3-8cb8fda1744f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0315736e-f6a7-4095-8ee3-8cb8fda1744f","type":"Hypothesis","title":"Presenilin is a component of synaptic junctions.","label":"Georgakopoulos A et al.; Presenilin is a component of synaptic ju...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Marambaud P","Friedrich V L","Shioi J","Efthimiopoulos S","Robakis N K"],"firstAuthor":"Georgakopoulos A","referenceYear":"2000","referenceDate":"2000","id":"urn:lsid:swan.org:researchstatement:0315736e-f6a7-4095-8ee3-8cb8fda1744f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cf2d1da4-5f08-430c-a2fa-35f62c05beb2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cf2d1da4-5f08-430c-a2fa-35f62c05beb2","type":"Claim","title":"Extracellular and intracellular protein aggregates act like pathogen-associated molecular patterns (PAMPs) and result in chronic activation of the innate immune systems through pattern recognition receptors (PRRs), a concept that is supported by a plethora of experimental data.","label":"Golde T et al.; Extracellular and intracellular protein ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:cf2d1da4-5f08-430c-a2fa-35f62c05beb2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:828e8ee9-2523-4782-ab69-3ba1163c2093&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:828e8ee9-2523-4782-ab69-3ba1163c2093","type":"Claim","title":"Previous studies have demonstrated that a soluble non-fibrillar form of Aβ could alter LTP.","label":"Walsh D; Previous studies have demonstrated that ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Walsh Dominic M","id":"urn:lsid:swan.org:researchstatement:828e8ee9-2523-4782-ab69-3ba1163c2093"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3fef8563-e3cd-470a-81b7-5641977ceeef&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3fef8563-e3cd-470a-81b7-5641977ceeef","type":"Claim","title":"Aβ catabolism and clearance contributes to risk of late onset AD.","label":"Hardy J et al.; Aβ catabolism and clearance contributes ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:3fef8563-e3cd-470a-81b7-5641977ceeef"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:964300ab-557d-4f42-b03d-94d0160713fa&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:964300ab-557d-4f42-b03d-94d0160713fa","type":"Claim","title":"Bcl-2 is regulated by other proteins, such as Bax, which is also increased in AD relative to control brains.","label":"Cotman C et al.; Bcl-2 is regulated by other proteins, su...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:964300ab-557d-4f42-b03d-94d0160713fa"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b0741af6-3062-4aa3-9fb5-09082ce8956b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b0741af6-3062-4aa3-9fb5-09082ce8956b","type":"Claim","title":"FAD-linked PS1 mutants impair the self-renewal potential of cultured adult subventricular zone (SVZ) brain neural progenitors (NPCs) as well as reducing steady-state level of the progenitor pool in postnatal SVZ of transgenic mice expressing PS1delE9 variant compared to PS1hWT littermates.","label":"Veeraraghavalu K et al.; FAD-linked PS1 mutants impair the self-r...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Choi Se Hoon","Zhang Xiaoqiong","Sisodia Sangram S"],"firstAuthor":"Veeraraghavalu Karthikeyan","referenceYear":"2010","referenceDate":"2010-05-19","id":"urn:lsid:swan.org:researchstatement:b0741af6-3062-4aa3-9fb5-09082ce8956b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1d082e65-72a9-40f3-bad6-4e91a692953c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1d082e65-72a9-40f3-bad6-4e91a692953c","type":"Claim","title":"Both AG1024, which inhibits all members of the insulin receptor superfamily, including the type-1 receptor for insulin-like growth factor-1 (IGF-1), and picropodophyllin (PPP), which is a selective cyclolignan inhibitor of the IGF-1 receptor mimicked the action of LY294002 in reducing neuroprotection by monomeric Aβ42 and Aβ42-1.","label":"Giuffrida M et al.; Both AG1024, which inhibits all members ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Caraci Filippo","Pignataro Bruno","Cataldo Sebastiano","De Bona Paolo","Bruno Valeria","Molinaro Gemma","Pappalardo Giuseppe","Messina Angela","Palmigiano Angelo","Garozzo Domenico","Nicoletti Ferdinando","Rizzarelli Enrico","Copani Agata"],"firstAuthor":"Giuffrida Maria Laura","referenceYear":"2009","referenceDate":"2009-08-26","id":"urn:lsid:swan.org:researchstatement:1d082e65-72a9-40f3-bad6-4e91a692953c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:43a96c58-1757-446a-a083-bcc399305eb1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:43a96c58-1757-446a-a083-bcc399305eb1","type":"Hypothesis","title":"Cholesterol and ceramide are molecular connections between normal aging of the brain and Alzheimer's Disease.","label":"Costantini C et al.; Cholesterol and ceramide are molecular c...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Kolasani Rekha M.K.","Puglielli Luigi"],"firstAuthor":"Costantini Claudio","id":"urn:lsid:swan.org:researchstatement:43a96c58-1757-446a-a083-bcc399305eb1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:98925454-4384-428d-979c-3f85f5ba4acd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:98925454-4384-428d-979c-3f85f5ba4acd","type":"Hypothesis","title":"Clusterin (ApoJ) and Complement component receptor CR1 genes are associated with Late Onset AD.","label":"Lambert J et al.; Clusterin (ApoJ) and Complement componen...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Heath Simon","Even Gael","Campion Dominique","Sleegers Kristel","Hiltunen Mikko","Combarros Onofre","Zelenika Diana","Bullido Maria J","Tavernier Béatrice","Letenneur Luc","Bettens Karolien","Berr Claudine","Pasquier Florence","Fiévet Nathalie","Barberger-Gateau Pascale","Engelborghs Sebastiaan","De Deyn Peter","Mateo Ignacio","Franck Ana","Helisalmi Seppo","Porcellini Elisa","Hanon Olivier","de Pancorbo Marian M","Lendon Corinne","Dufouil Carole","Jaillard Céline","Leveillard Thierry","Alvarez Victoria","Bosco Paolo","Mancuso Michelangelo","Panza Francesco","Nacmias Benedetta","Bossù Paola","Piccardi Paola","Annoni Giorgio","Seripa Davide","Galimberti Daniela","Hannequin Didier","Licastro Federico","Soininen Hilkka","Ritchie Karen","Blanché Hélène","Dartigues Jean-François","Tzourio Christophe","Gut Ivo","Van Broeckhoven Christine","Alpérovitch Annick","Lathrop Mark","Amouyel Philippe"],"firstAuthor":"Lambert Jean-Charles","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:98925454-4384-428d-979c-3f85f5ba4acd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:824adadd-a5c4-4fa7-aaa7-26857a6e0b5e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:824adadd-a5c4-4fa7-aaa7-26857a6e0b5e","type":"Comment","title":"Selkoe comment on Walsh hypothesis \u201cNaturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo.\u201d","label":"Selkoe D; Selkoe comment on Walsh hypothesis \u201cNatu...","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Selkoe Dennis J","referenceYear":"2002","referenceDate":"2002-04-07","id":"urn:lsid:swan.org:comment:824adadd-a5c4-4fa7-aaa7-26857a6e0b5e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e4fe7598-cb1b-4f61-926e-f89c5bff75a7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e4fe7598-cb1b-4f61-926e-f89c5bff75a7","type":"Claim","title":"Although both MRI and CSF tau are predictive of future conversion from mild cognitive impairment (MCI) to AD, the predictive power of structural MRI is greater.","label":"Jack C et al.; Although both MRI and CSF tau are predic...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:e4fe7598-cb1b-4f61-926e-f89c5bff75a7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:480ce403-04a1-4cf4-8cc7-cfbd8437e233&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:480ce403-04a1-4cf4-8cc7-cfbd8437e233","type":"Claim","title":"A therapeutic opportunity for clearing cerebral Aβ may include enhancing the binding of Aβ either directly to LRP or to the LRP ligands/Aβ chaperones apoE and alpha2M as a therapeutic strategy for promoting efflux of the peptide out of the brain.","label":"Tanzi R et al.; A therapeutic opportunity for clearing c...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:480ce403-04a1-4cf4-8cc7-cfbd8437e233"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:f2dd1c52-1183-4d67-88df-60bc36652554&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:f2dd1c52-1183-4d67-88df-60bc36652554","type":"Comment","title":"March 2010 Update of the hypothesis \"The human brain\u2019s myelin sheaths underlie a unique vulnerability to Alzheimer Disease (AD).\"","label":"Bartzokis G; March 2010 Update of the hypothesis \"The...","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Bartzokis George","id":"urn:lsid:swan.org:comment:f2dd1c52-1183-4d67-88df-60bc36652554"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:97e68e4c-f6f5-4716-9e2c-72479d4816b8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:97e68e4c-f6f5-4716-9e2c-72479d4816b8","type":"Claim","title":"Fast transport rates of two cargoes (p135 and snap25), analyzed at 5 hours after injection in tau-null mice were not significantly different from those in wild-type.","label":"Yuan A et al.; Fast transport rates of two cargoes (p13...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:97e68e4c-f6f5-4716-9e2c-72479d4816b8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:14034f75-bce1-47ff-b61d-e26b9e911348&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:14034f75-bce1-47ff-b61d-e26b9e911348","type":"Claim","title":"Preliminary data suggest that much of the intracellular Aβ appears to be oligomeric.","label":"Smith I et al.; Preliminary data suggest that much of th...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:14034f75-bce1-47ff-b61d-e26b9e911348"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b9219bec-a040-474b-9dfc-651fee33b834&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b9219bec-a040-474b-9dfc-651fee33b834","type":"Claim","title":"Rapid increase of Kv4.2 expression induced by Aβ within 2 h suggests a rapid mechanism of action.","label":"Plant L et al.; Rapid increase of Kv4.2 expression induc...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:b9219bec-a040-474b-9dfc-651fee33b834"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:8e25a0e2-ad92-48f1-9209-b51e1a531f16&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:8e25a0e2-ad92-48f1-9209-b51e1a531f16","type":"Comment","title":"The statement that neuron electrophysiology can be altered even when they are morphologically normal is an important point that is often overlooked due to its subtlety and means to properly analyze.","label":"Stutzmann G; The statement that neuron electrophysiol...","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Stutzmann Grace E","id":"urn:lsid:swan.org:comment:8e25a0e2-ad92-48f1-9209-b51e1a531f16"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1fb52998-f8de-48ff-9299-0d2851256ef0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1fb52998-f8de-48ff-9299-0d2851256ef0","type":"Claim","title":"Cerebral amyloid load was observed to be doubled in AD animal models that were engineered to possess low levels of LRP at the BBB, owing to knock out of the critical LRP chaperone, receptor-associated protein (RAP).","label":"Tanzi R et al.; Cerebral amyloid load was observed to be...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:1fb52998-f8de-48ff-9299-0d2851256ef0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:99b4d7de-e152-425e-a862-d6cc84a9c1ad&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:99b4d7de-e152-425e-a862-d6cc84a9c1ad","type":"Claim","title":"Aβ oligomers inhibit long term potentiation in the hippocampus.","label":"Hardy J et al.; Aβ oligomers inhibit long term potentiat...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:99b4d7de-e152-425e-a862-d6cc84a9c1ad"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:0620c834-fb4d-47cb-853f-b8c6e2e123d2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:0620c834-fb4d-47cb-853f-b8c6e2e123d2","type":"Comment","title":"Lansbury on Meyer-Luehmann","label":"Lansbury P; Lansbury on Meyer-Luehmann","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Lansbury Peter T","id":"urn:lsid:swan.org:comment:0620c834-fb4d-47cb-853f-b8c6e2e123d2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:003b716f-b855-4dff-9181-e9f82378c3d6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:003b716f-b855-4dff-9181-e9f82378c3d6","type":"Claim","title":"In the one context where axonal transport was measured directly, overexpression of tau 4R had no or equivocal effects on transport velocities.","label":"Nixon R; In the one context where axonal transpor...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Nixon Ralph A","id":"urn:lsid:swan.org:researchstatement:003b716f-b855-4dff-9181-e9f82378c3d6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:488ac956-c094-4f0a-b920-00aafdc9d5c7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:488ac956-c094-4f0a-b920-00aafdc9d5c7","type":"Claim","title":"Presenilin FAD mutation reduces Kv channel trafficking in neuroblastoma cells.","label":"Plant L et al.; Presenilin FAD mutation reduces Kv chann...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:488ac956-c094-4f0a-b920-00aafdc9d5c7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:20757228-87cd-4024-af5d-5528852ea83f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:20757228-87cd-4024-af5d-5528852ea83f","type":"Claim","title":"Loss of PS1 activity in adult brain did not rescue long-term behavioral deficits in the animals even though amyloid production was virtually shut down.","label":"Koo E; Loss of PS1 activity in adult brain did ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Koo Edward H","id":"urn:lsid:swan.org:researchstatement:20757228-87cd-4024-af5d-5528852ea83f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ee465102-278c-49b5-b255-6f9a8391c8f6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ee465102-278c-49b5-b255-6f9a8391c8f6","type":"Claim","title":"The decrease of membrane cholesterol provokes a release of Aβ peptides from the membranes, so that they accumulate in the extracellular space where they are not toxic.","label":"Russo T; The decrease of membrane cholesterol pro...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Russo Tommaso","id":"urn:lsid:swan.org:researchstatement:ee465102-278c-49b5-b255-6f9a8391c8f6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9741f8a6-8f1f-4560-8285-07ad69240eff&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9741f8a6-8f1f-4560-8285-07ad69240eff","type":"Claim","title":"GSK3 expression is also up-regulated in circulating peripheral lymphocytes in both AD and in mild cognitive impairment.","label":"Hooper C et al.; GSK3 expression is also up-regulated in ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:9741f8a6-8f1f-4560-8285-07ad69240eff"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:77e03c1e-8615-4eac-aa69-6bca750dc88d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:77e03c1e-8615-4eac-aa69-6bca750dc88d","type":"Claim","title":"A diagnostic battery of morphological and biochemical assays was used to examine if Aβ-mediated neurodegeneration in vitro occurs by necrosis or apoptosis.","label":"Cotman C et al.; A diagnostic battery of morphological an...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:77e03c1e-8615-4eac-aa69-6bca750dc88d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a4ec7e18-86ae-45a6-a264-a7ed84b7417e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a4ec7e18-86ae-45a6-a264-a7ed84b7417e","type":"Hypothesis","title":"APP causes abnormal transport of NGF and cholinergic neurodegeneration.","label":"Salehi A et al.; APP causes abnormal transport of NGF and...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Delcroix Jean-Dominique","Belichenko Pavel V","Zhan Ke","Wu Chengbiao","Valletta Janice S","Takimoto-Kimura Ryoko","Kleschevnikov Alexander M","Sambamurti Kumar","Chung Peter P","Xia Weiming","Villar Angela","Campbell William A","Kulnane Laura Shapiro","Nixon Ralph A","Lamb Bruce T","Epstein Charles J","Stokin Gorazd B","Goldstein Lawrence S","Mobley William C"],"firstAuthor":"Salehi Ahmad","referenceYear":"2006","referenceDate":"2006-07-06","id":"urn:lsid:swan.org:researchstatement:a4ec7e18-86ae-45a6-a264-a7ed84b7417e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4f4f4a42-a191-4295-a411-9fd620cd67db&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4f4f4a42-a191-4295-a411-9fd620cd67db","type":"Claim","title":"The events occurring at the dendritic spine remain to be resolved though likely involve mitochondrial alterations.","label":"Petersen R et al.; The events occurring at the dendritic sp...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Castellani Rudolph J","Nunomura Akihiko","Zhu Xiongwei","Lee Hyoung-gon","Perry George","Smith Mark A"],"firstAuthor":"Petersen R B","id":"urn:lsid:swan.org:researchstatement:4f4f4a42-a191-4295-a411-9fd620cd67db"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:62609d64-1b39-4833-bbab-73111b53782b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:62609d64-1b39-4833-bbab-73111b53782b","type":"Claim","title":"Initially vascular smooth muscle cells induce increased quantities of the amyloid precursor protein and amyloidogenic peptides, and then eventually die in response to Aβ.","label":"Cotman C et al.; Initially vascular smooth muscle cells i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:62609d64-1b39-4833-bbab-73111b53782b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b9487234-d4b5-42bd-a616-9a4e21561997&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b9487234-d4b5-42bd-a616-9a4e21561997","type":"Claim","title":"The attributable fractions of risk to be 25.5% for APOE, 8.9% for CLU and 3.8% for CR1; however, if the estimate that 60\u201380% of the Alzheimer\u2019s disease risk is due to genetic factors is correct, additional genetic susceptibility loci remain to be identified.","label":"Lambert J et al.; The attributable fractions of risk to be...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Heath Simon","Even Gael","Campion Dominique","Sleegers Kristel","Hiltunen Mikko","Combarros Onofre","Zelenika Diana","Bullido Maria J","Tavernier Béatrice","Letenneur Luc","Bettens Karolien","Berr Claudine","Pasquier Florence","Fiévet Nathalie","Barberger-Gateau Pascale","Engelborghs Sebastiaan","De Deyn Peter","Mateo Ignacio","Franck Ana","Helisalmi Seppo","Porcellini Elisa","Hanon Olivier","de Pancorbo Marian M","Lendon Corinne","Dufouil Carole","Jaillard Céline","Leveillard Thierry","Alvarez Victoria","Bosco Paolo","Mancuso Michelangelo","Panza Francesco","Nacmias Benedetta","Bossù Paola","Piccardi Paola","Annoni Giorgio","Seripa Davide","Galimberti Daniela","Hannequin Didier","Licastro Federico","Soininen Hilkka","Ritchie Karen","Blanché Hélène","Dartigues Jean-François","Tzourio Christophe","Gut Ivo","Van Broeckhoven Christine","Alpérovitch Annick","Lathrop Mark","Amouyel Philippe"],"firstAuthor":"Lambert Jean-Charles","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:b9487234-d4b5-42bd-a616-9a4e21561997"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:81f69495-aeda-42af-96e9-31f14f5dab57&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:81f69495-aeda-42af-96e9-31f14f5dab57","type":"Claim","title":"Several in vivo lines of evidence have implicated GSK3 in late-onset AD (LOAD), independent of its association with APOE.","label":"Several in vivo lines of evidence have i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:81f69495-aeda-42af-96e9-31f14f5dab57"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6e92f1fb-e570-40f5-99e3-7db95516e3db&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6e92f1fb-e570-40f5-99e3-7db95516e3db","type":"Claim","title":"Differences in urinary excretion of homocysteic acid (HA) have been observed between humans and mice, suggesting that HA toxicity is more severe in humans than mice.","label":"Hasegawa T; Differences in urinary excretion of homo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Hasegawa Tohru","id":"urn:lsid:swan.org:researchstatement:6e92f1fb-e570-40f5-99e3-7db95516e3db"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:75691995-664b-4b9c-9494-911d14386958&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:75691995-664b-4b9c-9494-911d14386958","type":"Claim","title":"Transgenic expression of wild-type human PS1 and PS2 rescued the Egl phenotype caused by a strongly hypomorphic SEL12 mutation to a level comparable with that of wild-type (wt) SEL12.","label":"Shen J et al.; Transgenic expression of wild-type human...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:75691995-664b-4b9c-9494-911d14386958"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d6e843ca-b83a-4799-b853-3178607f660c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d6e843ca-b83a-4799-b853-3178607f660c","type":"Claim","title":"Neurotoxicity of Aβ in cell culture depends on Aβ self-association, which occurs faster for the longer, more hydrophobic forms of Aβ (i.e., Aβ42 versus Aβ40).","label":"Lambert M et al.; Neurotoxicity of Aβ in cell culture depe...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:d6e843ca-b83a-4799-b853-3178607f660c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0acebc9e-fc14-46db-b480-64ebcc2131a9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0acebc9e-fc14-46db-b480-64ebcc2131a9","type":"Claim","title":"Determining which pathway (oligomerization vs fibrillogenesis) is critical for the pathogenesis of AD and will help shape the therapeutic strategy that should be used to block the pathogenic Aβ assembly process.","label":"Hartley D et al.; Determining which pathway (oligomerizati...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:0acebc9e-fc14-46db-b480-64ebcc2131a9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:86e0f22b-a8b4-482f-990d-5aab44ee4487&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:86e0f22b-a8b4-482f-990d-5aab44ee4487","type":"Claim","title":"In comparison to the effect of γ-secretase inhibition on Notch-dependent processes, Aph1BC deficiency did not affect lymphocyte maturation in thymus or spleen, nor did it alter steady-state CD4+/CD8+ ratios. The intestinal and pancreatic morphology was also unaffected in Aph1BC−/− mice.   ","label":"Serneels L et al.; In comparison to the effect of γ-secreta...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Van Biervliet Jérôme","Craessaerts Katleen","Dejaegere Tim","Horré Katrien","Van Houtvin Tine","Esselmann Hermann","Paul Sabine","Schäfer Martin K","Berezovska Oksana","Hyman Bradley T","Sprangers Ben","Sciot Raf","Moons Lieve","Jucker Mathias","Yang Zhixiang","May Patrick C","Karran Eric","Wiltfang Jens","D'Hooge Rudi","De Strooper Bart"],"firstAuthor":"Serneels Lutgarde","referenceYear":"2009","referenceDate":"2009-05-01","id":"urn:lsid:swan.org:researchstatement:86e0f22b-a8b4-482f-990d-5aab44ee4487"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4a4be072-b4d8-482c-a531-95a459b0bade&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4a4be072-b4d8-482c-a531-95a459b0bade","type":"Claim","title":"Using a hole-board memory task, a measurement of spatial learning and memory, both of which have been attributed to hippocampal function, APP23/Ar+/- mice showed improved learning and in memory performance displaying enhanced cognitive function compared with both WT and APP23 mice.","label":"McAllister C et al.; Using a hole-board memory task, a measur...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Long Jiangang","Bowers Adrienne","Walker Aaron","Cao Philip","Honda Shin-Ichiro","Harada Nobuhiro","Staufenbiel Matthias","Shen Yong","Li Rena"],"firstAuthor":"McAllister Carrie","referenceYear":"2010","referenceDate":"2010-05-26","id":"urn:lsid:swan.org:researchstatement:4a4be072-b4d8-482c-a531-95a459b0bade"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d9f4096c-e90b-435e-8928-ebf5f1f4e4c5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d9f4096c-e90b-435e-8928-ebf5f1f4e4c5","type":"Claim","title":"PS-1 binds both GSK3β and tau, and mutant forms of PS-1, associated with FAD, bind GSK3β more effectively resulting in increased tau phosphorylation.","label":"Hooper C et al.; PS-1 binds both GSK3β and tau, and mutan...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:d9f4096c-e90b-435e-8928-ebf5f1f4e4c5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:04108d9f-86da-4980-b689-2d1e4574652f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:04108d9f-86da-4980-b689-2d1e4574652f","type":"Claim","title":"The fact that γ-secretase inhibitors can mimic the effects of pathogenic PS mutations (i.e., increase Aβ42 production while inhibiting other γ-secretase activities) supports the hypothesis that pathogenic mutations cause a partial loss of PS function, equivalent to the effects of low to moderate doses of γ-secretase inhibitors.","label":"Shen J et al.; The fact that γ-secretase inhibitors can...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:04108d9f-86da-4980-b689-2d1e4574652f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9274fc8b-b99f-48c3-8972-4e6e70857292&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9274fc8b-b99f-48c3-8972-4e6e70857292","type":"Claim","title":"Although significant support exists for the idea that toxic forms of Aβ comprise large fibrils, these experiments typically have been carried out with pure Aβ allowed to aggregate out of homogeneous solutions.","label":"Lambert M et al.; Although significant support exists for ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:9274fc8b-b99f-48c3-8972-4e6e70857292"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e6e1883b-97b1-4079-967d-dd54ba237cac&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e6e1883b-97b1-4079-967d-dd54ba237cac","type":"Claim","title":"In cell-free assay of APP epsilon cleavage, all PS-containing clinical mutants and wild type PS2 showed severe loss of APP cleavage.","label":"Bentahir M et al.; In cell-free assay of APP epsilon cleava...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:e6e1883b-97b1-4079-967d-dd54ba237cac"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4a218449-b3d2-479d-82fa-3d59130cb2c3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4a218449-b3d2-479d-82fa-3d59130cb2c3","type":"Claim","title":"Autophagosomes accumulate in senescent fibroblasts.","label":"Golde T et al.; Autophagosomes accumulate in senescent f...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:4a218449-b3d2-479d-82fa-3d59130cb2c3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a8044b2e-0622-40a2-b97c-36fd771e199b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a8044b2e-0622-40a2-b97c-36fd771e199b","type":"Claim","title":"Oligodendrocytes in ErbB3/ErbB4 double mutants are capable of myelinating CNS axons without delay and at levels similar to control mice, suggesting that neuregulin/ErbB signaling is dispensable for CNS myelination in vivo.","label":"Barres B; Oligodendrocytes in ErbB3/ErbB4 double m...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Barres Ben A","id":"urn:lsid:swan.org:researchstatement:a8044b2e-0622-40a2-b97c-36fd771e199b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4b93e20e-702f-45e7-b065-c76352467627&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4b93e20e-702f-45e7-b065-c76352467627","type":"Claim","title":"Because EOAD and late-onset AD (LOAD) phenocopy each other clinically and histologically, the amyloid hypothesis\u2014although based on molecular defects isolated in EOAD\u2014was plausibly proposed to underlie all forms of the disease.","label":"Small S et al.; Because EOAD and late-onset AD (LOAD) ph...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:4b93e20e-702f-45e7-b065-c76352467627"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8bb58695-a179-40c7-8432-ce883e43f43f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8bb58695-a179-40c7-8432-ce883e43f43f","type":"Claim","title":"Preclinical AD, as detected by the CSF signature for AD in cognitively normal individuals, predicts development of symptomatic AD.","label":"Morris J et al.; Preclinical AD, as detected by the CSF s...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Roe Catherine M","Grant Elizabeth A","Head Denise","Storandt Martha","Goate Alison M","Fagan Anne M","Holtzman David M","Mintun Mark A"],"firstAuthor":"Morris John C","referenceYear":"2009","referenceDate":"2009-12","id":"urn:lsid:swan.org:researchstatement:8bb58695-a179-40c7-8432-ce883e43f43f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f61b81b9-bec0-449d-bf0a-858c2778bff5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f61b81b9-bec0-449d-bf0a-858c2778bff5","type":"Claim","title":"Intraneuronally accumulated PHF-tau does not automatically bind proteasome protein, and that other factors, such as different compartmentation of PHF-tau and of the proteasomes, might influence the degree of interaction.","label":"Keck S et al.; Intraneuronally accumulated PHF-tau does...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:f61b81b9-bec0-449d-bf0a-858c2778bff5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ef7288c0-a407-45a9-a5a2-13b8ea945b9a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ef7288c0-a407-45a9-a5a2-13b8ea945b9a","type":"Claim","title":"No significant differences were measured in the proteasome protein content in the brain tissue samples between the control and AD brains.","label":"Keck S et al.; No significant differences were measured...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:ef7288c0-a407-45a9-a5a2-13b8ea945b9a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:01259117-09a1-4abe-add2-73a227627c4f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:01259117-09a1-4abe-add2-73a227627c4f","type":"Claim","title":"The substantial quantitative differences in myelin and iron levels between humans and other species may be important to consider when extrapolating animal model results to humans and the dearth of AD animal model studies that include direct examination of myelin and species-specific differences in myelination, cholesterol, and iron may help explain the striking dichotomy of numerous positive/curative interventions in transgenic animal models of AD and their failure in human trials.","label":"Bartzokis G; The substantial quantitative differences...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:01259117-09a1-4abe-add2-73a227627c4f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:67113191-13b7-4e02-99c2-bf2ce075befe&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:67113191-13b7-4e02-99c2-bf2ce075befe","type":"Question","title":"We investigated whether or not subchronic passive immunization, using the monoclonal anti-Aβ antibody m266, could reverse object recognition memory deficits.","label":"We investigated whether or not subchroni...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:67113191-13b7-4e02-99c2-bf2ce075befe"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ac902cc4-df9c-4d7b-a1da-3a1eda52806c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ac902cc4-df9c-4d7b-a1da-3a1eda52806c","type":"Claim","title":"Degradation of the glucocorticoid hormone receptor occurs in a ubiquitin-dependent manner via the BAG1 ubiquitin-like domain. ","label":"Carrettiero D et al.; Degradation of the glucocorticoid hormon...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hernandez Israel","Neveu Pierre","Papagiannakopoulos Thales","Kosik Kenneth S"],"firstAuthor":"Carrettiero Daniel C","referenceYear":"2009","referenceDate":"2009-02-18","id":"urn:lsid:swan.org:researchstatement:ac902cc4-df9c-4d7b-a1da-3a1eda52806c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9f11fff1-fc36-4c94-b0c7-497d0b0f7d3a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9f11fff1-fc36-4c94-b0c7-497d0b0f7d3a","type":"Claim","title":"ApoE2 allele is linked to greater risk of CAA-associated vasculopathy and CNS hemorrhage.","label":"Holtzman D; ApoE2 allele is linked to greater risk o...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:9f11fff1-fc36-4c94-b0c7-497d0b0f7d3a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f252b052-556f-4631-a5bd-fd6e9a7b1c5c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f252b052-556f-4631-a5bd-fd6e9a7b1c5c","type":"Claim","title":"Tau is an axonal microtubule-associated protein that stabilizes microtubules, which serve as tracks for the axonal transport of membranous organelles (MOs), vesicles, and protein complexes.","label":"Yuan A et al.; Tau is an axonal microtubule-associated ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:f252b052-556f-4631-a5bd-fd6e9a7b1c5c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ba4e0750-5e91-4c66-8efa-a5737a5f3481&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ba4e0750-5e91-4c66-8efa-a5737a5f3481","type":"Claim","title":"Aβ oligomers may play a role in the earliest stages of AD, and even in pre-AD dysfunction.","label":"Gong Y et al.; Aβ oligomers may play a role in the earl...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:ba4e0750-5e91-4c66-8efa-a5737a5f3481"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e0878cbf-cde9-409d-bb93-94e7062fe7cb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e0878cbf-cde9-409d-bb93-94e7062fe7cb","type":"Claim","title":"Aβ oxidizes membrane cholesterol, liberates H<sub>2<\/sub>O<sub>2<\/sub> and increases oxidative stress.","label":"Aβ oxidizes membrane cholesterol, libera...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:e0878cbf-cde9-409d-bb93-94e7062fe7cb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:63efd4db-263e-47b2-9233-1c019a899466&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:63efd4db-263e-47b2-9233-1c019a899466","type":"Claim","title":"APP expression accelerates tau tangles in APP/tau double transgenic mice suggesting that Aβ accumulation causes neurofibrillary degeneration.","label":"Hardy J et al.; APP expression accelerates tau tangles i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:63efd4db-263e-47b2-9233-1c019a899466"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ac862132-1e77-439d-b41c-b728b428c6dc&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ac862132-1e77-439d-b41c-b728b428c6dc","type":"Claim","title":"Oligomer size distribution of A&#946;41, A&#946;42 and A&#946;43 is distinct from A&#946;39 or A&#946;40.","label":"Bitan G et al.; Oligomer size distribution of A&#946;41,...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:ac862132-1e77-439d-b41c-b728b428c6dc"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e817c094-537a-4238-8328-243a9a0b31ef&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e817c094-537a-4238-8328-243a9a0b31ef","type":"Claim","title":"ApoE4 is a consistently found genetic risk factor associated with late-onset AD (LOAD).","label":"ApoE4 is a consistently found genetic ri...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:e817c094-537a-4238-8328-243a9a0b31ef"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1a0897ac-71f0-4ded-81eb-c8d0591714d3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1a0897ac-71f0-4ded-81eb-c8d0591714d3","type":"Hypothesis","title":"The ER is important as a regulatory site involved in the pathogenesis of neuronal degeneration in Alzheimer disease.","label":"Mattson M et al.; The ER is important as a regulatory site...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Guo Q"],"firstAuthor":"Mattson M P","referenceYear":"1997","referenceDate":"1997-11-15","id":"urn:lsid:swan.org:researchstatement:1a0897ac-71f0-4ded-81eb-c8d0591714d3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:31f6b403-6fa2-4e43-ae8b-472ac22acc87&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:31f6b403-6fa2-4e43-ae8b-472ac22acc87","type":"Claim","title":"Peptidomimetic compounds, many of which are based on the APP substrate sequence surrounding the Aβ42 cleavage site, act as small molecule inhibitors of γ-secretase and occupy the enzyme\u2019s active site and function as analogs of the transition state intermediate in aspartic protease catalysis.","label":"Shen J et al.; Peptidomimetic compounds, many of which ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:31f6b403-6fa2-4e43-ae8b-472ac22acc87"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:acb72a1a-b010-4bf6-b6a1-f3c745885722&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:acb72a1a-b010-4bf6-b6a1-f3c745885722","type":"Claim","title":"Neuronal dendrites which perform highly elaborate information processing, are the focal sites of Alzheimer\u2019s pathology and therefore are traditionally believed to be the major sites of electrophysiological disruption.","label":"Morse T et al.; Neuronal dendrites which perform highly ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Mutalik Pradeep","Cheung Kei","Miller Perry L","Shepherd Gordon"],"firstAuthor":"Morse Thomas M","id":"urn:lsid:swan.org:researchstatement:acb72a1a-b010-4bf6-b6a1-f3c745885722"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:91eed737-af95-46f7-9c09-5e03cebb5126&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:91eed737-af95-46f7-9c09-5e03cebb5126","type":"Claim","title":"Caution should be taken in AD therapies that may subtly alter the Aβ40:42 ratio in brain tissue, either intentionally or unintentionally, because they may be effective in reducing parenchymal plaque deposition at the expense of developing CAA.","label":"Fryer J et al.; Caution should be taken in AD therapies ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:91eed737-af95-46f7-9c09-5e03cebb5126"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1f4d9830-1a0a-4844-ba44-a3c5d7fa5042&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1f4d9830-1a0a-4844-ba44-a3c5d7fa5042","type":"Claim","title":"Neuregulin also mediates cyclin-dependent kinase 5 and glycogen synthase kinase 3β (GSK3b) activity that increase tau phosphorylation and APP processing. ","label":"Bartzokis G; Neuregulin also mediates cyclin-dependen...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:1f4d9830-1a0a-4844-ba44-a3c5d7fa5042"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:23c6d83b-5dea-4beb-b502-81072f932375&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:23c6d83b-5dea-4beb-b502-81072f932375","type":"Claim","title":"Aβ stimulates a transient growth of neuronal processes, and then, as it self-assembles into small aggregates and beta-sheet structures, it evolves an ability to activate mechanisms to initiate neuronal degeneration.","label":"Cotman C et al.; Aβ stimulates a transient growth of neur...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:23c6d83b-5dea-4beb-b502-81072f932375"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b4b8fb54-0f5e-4742-86f6-ea04d1f543bf&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b4b8fb54-0f5e-4742-86f6-ea04d1f543bf","type":"Claim","title":"Microfluorimetric measurements were used to investigate disturbances in calcium homeostasis in Fura-2AM-loaded primary cortical neurons from NonTg, PS1KI and 3xTg-AD embryonic mice.","label":"Smith I et al.; Microfluorimetric measurements were used...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:b4b8fb54-0f5e-4742-86f6-ea04d1f543bf"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ab3246b0-ad7e-4891-86d8-213d7351ef74&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ab3246b0-ad7e-4891-86d8-213d7351ef74","type":"Claim","title":"Endogenous Aβ may act as a chaperone promoting trafficking of Kv subunits to the membrane.","label":"Plant L et al.; Endogenous Aβ may act as a chaperone pro...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:ab3246b0-ad7e-4891-86d8-213d7351ef74"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ee9036fd-d3e1-488e-b73c-58bff3453f57&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ee9036fd-d3e1-488e-b73c-58bff3453f57","type":"Claim","title":"The PHF-tau/proteasome ratio was about 6 microg and 2 microg PHF-tau per microg proteasome at the IC50 of the proteasome activity, providing strong evidence that PHF-tau formed in vivo is capable of impairing the proteasome system.","label":"The PHF-tau/proteasome ratio was about 6...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:ee9036fd-d3e1-488e-b73c-58bff3453f57"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d337dd5f-902a-4f90-92a3-99f7552d1d04&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d337dd5f-902a-4f90-92a3-99f7552d1d04","type":"Claim","title":"Increased accumulation of APPCOOH in the mitotic phase of dividing cells raises the possibility that activation of cdc2 kinase may alter production of potentially amyloidogenic fragments containing the entire Aβ domain, and may be important in the brain since it has recently been demonstrated that glial cells are a major source of Aβ.","label":"Suzuki T et al.; Increased accumulation of APPCOOH in the...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:d337dd5f-902a-4f90-92a3-99f7552d1d04"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6de28f61-b4e2-4630-836c-0fec6f9b6e41&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6de28f61-b4e2-4630-836c-0fec6f9b6e41","type":"Claim","title":"It is not a universal finding that the initial manifestations of Aβ accumulation begin inside neurons, not in extracellular spaces.","label":"Holtzman D; It is not a universal finding that the i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman David M","id":"urn:lsid:swan.org:researchstatement:6de28f61-b4e2-4630-836c-0fec6f9b6e41"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:7aeca3ef-77d2-4b4a-9fa8-540fc90de909&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:7aeca3ef-77d2-4b4a-9fa8-540fc90de909","type":"Question","title":"How does Aβ cause neuronal dysfunction?","label":"How does Aβ cause neuronal dysfunction?","icon":"../icons/ontological/discourse-element/research-question.png","firstAuthor":"Golde T","id":"urn:lsid:swan.org:researchquestion:7aeca3ef-77d2-4b4a-9fa8-540fc90de909"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:804308c0-7812-4d8e-94b9-0db360b328a6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:804308c0-7812-4d8e-94b9-0db360b328a6","type":"Hypothesis","title":"Inflammatory Hypothesis: immune-mediated autodestructive processes occur in Alzheimer disease.","label":"McGeer P et al.; Inflammatory Hypothesis: immune-mediated...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Rogers J"],"firstAuthor":"McGeer P L","referenceYear":"1992","referenceDate":"1992-02","id":"urn:lsid:swan.org:researchstatement:804308c0-7812-4d8e-94b9-0db360b328a6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:65a40fd3-05b8-4eff-a3f6-58875df5594a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:65a40fd3-05b8-4eff-a3f6-58875df5594a","type":"Claim","title":"A decrease in PGC-1alpha was observed following resveratrol treatment of cultured primary neurons, suggesting that SIRT1 activity is increased following resveratrol treatment of primary neurons.","label":"Kim D et al.; A decrease in PGC-1alpha was observed fo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:65a40fd3-05b8-4eff-a3f6-58875df5594a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6628bc15-77d8-4612-8b40-81d6ad0d88d5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6628bc15-77d8-4612-8b40-81d6ad0d88d5","type":"Claim","title":"Increasing evidence suggests that the mechanism by which apoE affects AD or CAA is likely to be related in large part to the ability of apoE to act as an Aβ chaperone.","label":"Fryer J et al.; Increasing evidence suggests that the me...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:6628bc15-77d8-4612-8b40-81d6ad0d88d5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:90ea03d2-bc78-4fa6-b7ca-df7aab9d2be4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:90ea03d2-bc78-4fa6-b7ca-df7aab9d2be4","type":"Hypothesis","title":"Amyloid beta peptide is a physiological modulator of neuronal 'A'-type K+ current.","label":"Plant L et al.; Amyloid beta peptide is a physiological ...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:90ea03d2-bc78-4fa6-b7ca-df7aab9d2be4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:37b2480d-f5b8-4047-ad6d-138580f55d7b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:37b2480d-f5b8-4047-ad6d-138580f55d7b","type":"Claim","title":"PICALM (phosphatidylinositol-binding clathrin assembly protein, also known as CALM, clathrin assembly lymphoid-myeloid leukemia gene) is ubiquitously expressed in all tissue types with prominent expression in neurons, where it acts like BIN1 (bridging integrator 1), and is involved in clathrin-mediated endocytosis, an essential step in the intracellular trafficking of proteins and lipids such as nutrients, growth factors and neurotransmitters.","label":"Harold D et al.; PICALM (phosphatidylinositol-binding cla...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Abraham Richard","Hollingworth Paul","Sims Rebecca","Gerrish Amy","Hamshere Marian L","Pahwa Jaspreet Singh","Moskvina Valentina","Dowzell Kimberley","Williams Amy","Jones Nicola","Thomas Charlene","Stretton Alexandra","Morgan Angharad R","Lovestone Simon","Powell John","Proitsi Petroula","Lupton Michelle K","Brayne Carol","Rubinsztein David C","Gill Michael","Lawlor Brian","Lynch Aoibhinn","Morgan Kevin","Brown Kristelle S","Passmore Peter A","Craig David","McGuinness Bernadette","Todd Stephen","Holmes Clive","Mann David","Smith A David","Love Seth","Kehoe Patrick G","Hardy John","Mead Simon","Fox Nick","Rossor Martin","Collinge John","Maier Wolfgang","Jessen Frank","Schürmann Britta","van den Bussche Hendrik","Heuser Isabella","Kornhuber Johannes","Wiltfang Jens","Dichgans Martin","Frölich Lutz","Hampel Harald","Hüll Michael","Rujescu Dan","Goate Alison M","Kauwe John S","Cruchaga Carlos","Nowotny Petra","Morris John C","Mayo Kevin","Sleegers Kristel","Bettens Karolien","Engelborghs Sebastiaan","De Deyn Peter P","Van Broeckhoven Christine","Livingston Gill","Bass Nicholas J","Gurling Hugh","McQuillin Andrew","Gwilliam Rhian","Deloukas Panagiotis","Al-Chalabi Ammar","Shaw Christopher E","Tsolaki Magda","Singleton Andrew B","Guerreiro Rita","Mühleisen Thomas W","Nöthen Markus M","Moebus Susanne","Jöckel Karl-Heinz","Klopp Norman","Wichmann H-Erich","Carrasquillo Minerva M","Pankratz V Shane","Younkin Steven G","Holmans Peter A","O'Donovan Michael","Owen Michael J","Williams Julie"],"firstAuthor":"Harold Denise","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:37b2480d-f5b8-4047-ad6d-138580f55d7b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6cf41a45-6f0f-45d3-88b3-a5bc878a9607&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6cf41a45-6f0f-45d3-88b3-a5bc878a9607","type":"Claim","title":"The e4 allele of the apolipoprotein E gene is a risk factor for developing both AD and CAA.","label":"Fryer J et al.; The e4 allele of the apolipoprotein E ge...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:6cf41a45-6f0f-45d3-88b3-a5bc878a9607"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1a3f30c2-afbc-4fa7-80fb-7e8db6acf758&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1a3f30c2-afbc-4fa7-80fb-7e8db6acf758","type":"Claim","title":"Insertion of Aβ channels into the plasma membranes could slowly cause changes in neuronal membrane potentials leading to alterations in neuronal firing.","label":"Smith I et al.; Insertion of Aβ channels into the plasma...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:1a3f30c2-afbc-4fa7-80fb-7e8db6acf758"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f47ac6db-00ad-4f46-9990-a142198f42dd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f47ac6db-00ad-4f46-9990-a142198f42dd","type":"Claim","title":"All γ-secretase complexes containing any Aph1 homologue demonstrate activity to produce APP and Notch intracellular domains, but Aph1B or Aph1C γ-secretase complexes produced a greater proportion of longer Aβ peptide species (Aβ1-42, Aβ1-45, Aβ1-46, and Aβ1-49,) relative to shorter Aβ peptides (Aβ1-37, Aβ1-38, and Aβ1-40).","label":"Serneels L et al.; All γ-secretase complexes containing any...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Van Biervliet Jérôme","Craessaerts Katleen","Dejaegere Tim","Horré Katrien","Van Houtvin Tine","Esselmann Hermann","Paul Sabine","Schäfer Martin K","Berezovska Oksana","Hyman Bradley T","Sprangers Ben","Sciot Raf","Moons Lieve","Jucker Mathias","Yang Zhixiang","May Patrick C","Karran Eric","Wiltfang Jens","D'Hooge Rudi","De Strooper Bart"],"firstAuthor":"Serneels Lutgarde","referenceYear":"2009","referenceDate":"2009-05-01","id":"urn:lsid:swan.org:researchstatement:f47ac6db-00ad-4f46-9990-a142198f42dd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:98c94035-e38c-4e35-a526-966058ddfc7e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:98c94035-e38c-4e35-a526-966058ddfc7e","type":"Claim","title":"Of the major cleavages of APP mediated by γ-secretase, PS mutations typically increase the production of Aβ42 (and Aβ43), but can impair the normally predominant γ-cleavage following Aβ residue 40 and the more distal \u2018\u2018ε-cleavage\u2019\u2019 following residue 49, resulting in significantly reduced generation of Aβ40 and AICD, respectively.","label":"Shen J et al.; Of the major cleavages of APP mediated b...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:98c94035-e38c-4e35-a526-966058ddfc7e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:75ae8143-6d30-4739-842c-6203cbb00aee&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:75ae8143-6d30-4739-842c-6203cbb00aee","type":"Claim","title":"Age of Aβ deposition follows the same timing in ApoE-/- as in ApoE +/+, onset by 8 months (APPV717F) or 10 months (APPSw), increasing dramatically by 15 months.","label":"Holtzman D; Age of Aβ deposition follows the same ti...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:75ae8143-6d30-4739-842c-6203cbb00aee"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a8dfd665-19b2-4fba-879b-71d84f0f6fcc&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a8dfd665-19b2-4fba-879b-71d84f0f6fcc","type":"Claim","title":"The quick growth of dense plaques suggests that dense plaques grow not only with Aβ monomer addition, but perhaps also by capturing oligomeric intermediates at the fiber ends, as shown earlier for prion proteins (Serio et al., 2000; Collins et al., 2004).","label":"Kumar-Singh S; The quick growth of dense plaques sugges...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Kumar-Singh Samir","id":"urn:lsid:swan.org:researchstatement:a8dfd665-19b2-4fba-879b-71d84f0f6fcc"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b1f0c433-dd2c-4f0c-8fb4-56a3406cd2fb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b1f0c433-dd2c-4f0c-8fb4-56a3406cd2fb","type":"Hypothesis","title":"Aβ clearance and catabolism contributes to risk of late-onset Alzheimer disease.","label":"Hardy J et al.; Aβ clearance and catabolism contributes ...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:b1f0c433-dd2c-4f0c-8fb4-56a3406cd2fb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3ae13021-fb1f-496b-8b14-c2d1c668a4ba&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3ae13021-fb1f-496b-8b14-c2d1c668a4ba","type":"Claim","title":"Alzheimer Disease is triggered by neurotoxic assemblies of A&#946;42.","label":"Gong Y et al.; Alzheimer Disease is triggered by neurot...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:3ae13021-fb1f-496b-8b14-c2d1c668a4ba"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0405024e-a0e2-4dd3-be30-e55722ac24e9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0405024e-a0e2-4dd3-be30-e55722ac24e9","type":"Claim","title":"Whereas more than 150 mutations of the presenilin 1 (PS1), presenilin 2 (PS2), and amyloid precursor protein (APP) genes account for many early-onset AD cases with autosomal dominant inheritance, the apolipoprotein E (APOE) ε4 allele accounts for many cases of late-onset AD (LOAD), with dementia onset after age 60.","label":"Reiman E et al.; Whereas more than 150 mutations of the p...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Jennifer A","Myers Amanda J","Hardy John","Dunckley Travis","Zismann Victoria L","Joshipura Keta D","Pearson John V","Hu-Lince Diane","Huentelman Matthew J","Craig David W","Coon Keith D","Liang Winnie S","Herbert RiLee H","Beach Thomas","Rohrer Kristen C","Zhao Alice S","Leung Doris","Bryden Leslie","Marlowe Lauren","Kaleem Mona","Mastroeni Diego","Grover Andrew","Heward Christopher B","Ravid Rivka","Rogers Joseph","Hutton Michael L","Melquist Stacey","Petersen Ron C","Alexander Gene E","Caselli Richard J","Kukull Walter","Papassotiropoulos Andreas","Stephan Dietrich A"],"firstAuthor":"Reiman Eric M","referenceYear":"2007","referenceDate":"2007-06-07","id":"urn:lsid:swan.org:researchstatement:0405024e-a0e2-4dd3-be30-e55722ac24e9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:facac65c-2fc8-46f2-86a5-b5f4abb8c216&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:facac65c-2fc8-46f2-86a5-b5f4abb8c216","type":"Hypothesis","title":"Aph1B  complex contributes to total γ-secretase activity in the human brain.","label":"Serneels L et al.; Aph1B  complex contributes to total γ-se...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Van Biervliet Jérôme","Craessaerts Katleen","Dejaegere Tim","Horré Katrien","Van Houtvin Tine","Esselmann Hermann","Paul Sabine","Schäfer Martin K","Berezovska Oksana","Hyman Bradley T","Sprangers Ben","Sciot Raf","Moons Lieve","Jucker Mathias","Yang Zhixiang","May Patrick C","Karran Eric","Wiltfang Jens","D'Hooge Rudi","De Strooper Bart"],"firstAuthor":"Serneels Lutgarde","referenceYear":"2009","referenceDate":"2009-05-01","id":"urn:lsid:swan.org:researchstatement:facac65c-2fc8-46f2-86a5-b5f4abb8c216"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:06d90273-eb2b-48fd-9e4a-fee699418feb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:06d90273-eb2b-48fd-9e4a-fee699418feb","type":"Claim","title":"cdk5 is expressed at high levels in terminally differentiated neurons which are no longer in the cell cycle.","label":"Suzuki T et al.; cdk5 is expressed at high levels in term...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:06d90273-eb2b-48fd-9e4a-fee699418feb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cd955e89-9b16-4c7e-8f03-29b01acc95c9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cd955e89-9b16-4c7e-8f03-29b01acc95c9","type":"Claim","title":"APP and BACE1 clusters in lipid rafts, facilitates beta cleavage of APP.","label":"APP and BACE1 clusters in lipid rafts, f...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:cd955e89-9b16-4c7e-8f03-29b01acc95c9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3d6cd6eb-edf4-41ca-a6d2-769312675fa2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3d6cd6eb-edf4-41ca-a6d2-769312675fa2","type":"Claim","title":"The prevailing amyloid hypothesis posits that accumulation of Aβ peptides, particularly the more hydrophobic and aggregation-prone Aβ42, triggers a pathogenic cascade, leading to neurodegeneration in AD.","label":"Shen J et al.; The prevailing amyloid hypothesis posits...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:3d6cd6eb-edf4-41ca-a6d2-769312675fa2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:661c7625-9fb9-47bd-adcd-3df97f4a7a51&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:661c7625-9fb9-47bd-adcd-3df97f4a7a51","type":"Claim","title":"In a 6 year follow up study of active Aβ42 immunization, clinical assessment results revealed no significant effect of immunization on any clinical measure despite significant Aβ lowering.  At death all treated subjects had tau pathology heavily disseminated across the cortex.","label":"Small S et al.; In a 6 year follow up study of active Aβ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:661c7625-9fb9-47bd-adcd-3df97f4a7a51"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:88688cbc-db1e-443c-87ac-bd77a4ce6538&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:88688cbc-db1e-443c-87ac-bd77a4ce6538","type":"Claim","title":"Dickkopf, a negative regulator of Wnt signaling also promotes tau phosphorylation and neurodegeneration through the activation of GSK3 and Dickkopf is up-regulated in AD.","label":"Hooper C et al.; Dickkopf, a negative regulator of Wnt si...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:88688cbc-db1e-443c-87ac-bd77a4ce6538"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:08403334-4226-4dce-abbd-ef904aa8ccd6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:08403334-4226-4dce-abbd-ef904aa8ccd6","type":"Claim","title":"Immunofluorescent detection of Kv4.2 did not detect changes in subcellular distribution of K+ channel proteins due to morphological limitations of cerebellar granule neurons.","label":"Plant L et al.; Immunofluorescent detection of Kv4.2 did...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:08403334-4226-4dce-abbd-ef904aa8ccd6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b5b4f42a-640c-43f8-a193-7ebe6ff88253&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b5b4f42a-640c-43f8-a193-7ebe6ff88253","type":"Claim","title":"SIRT1 levels correlate with neurodegeneration accompanied by progressive and severe loss of neurons, but not with β-amyloid plaque pathology in the absence of neuronal loss.","label":"Kim D et al.; SIRT1 levels correlate with neurodegener...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:b5b4f42a-640c-43f8-a193-7ebe6ff88253"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2ebb4c70-4d34-4b5c-83e5-421aedf69ab6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2ebb4c70-4d34-4b5c-83e5-421aedf69ab6","type":"Claim","title":"PHF-tau should be considered as a neurotoxic product during the pathogenesis of AD, which might contribute to an initial decline in proteasome activity and in an increased production of aggregated proteins.","label":"Keck S et al.; PHF-tau should be considered as a neurot...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:2ebb4c70-4d34-4b5c-83e5-421aedf69ab6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bc13e4ee-0a88-4fa6-a7c6-fc69c076116b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bc13e4ee-0a88-4fa6-a7c6-fc69c076116b","type":"Claim","title":"The observations in this paper are reminiscent of seeded crystal growth where once nucleation happens, growth should be very fast.","label":"Lansbury P; The observations in this paper are remin...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Lansbury Peter T","id":"urn:lsid:swan.org:researchstatement:bc13e4ee-0a88-4fa6-a7c6-fc69c076116b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6ade6b01-49ed-4ee6-9496-934d3cb8ba84&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6ade6b01-49ed-4ee6-9496-934d3cb8ba84","type":"Claim","title":"Proteasome activity was inhibited in a concentration- dependent manner by isolated PHF-tau (PHF-A) with an IC50 of about 4.5 microg/mL and completely abolished above 25 microg/mL PHF-A. Highly purified PHF-tau (PHF-B) was also capable of inhibiting isolated human proteasomes.","label":"Keck S et al.; Proteasome activity was inhibited in a c...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:6ade6b01-49ed-4ee6-9496-934d3cb8ba84"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:387c1ba9-4fd3-4738-ae61-a655599f614a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:387c1ba9-4fd3-4738-ae61-a655599f614a","type":"Claim","title":"Ectopic constitutive activation of Notch signaling by expressing either Notch1-ICD or Hes1 restores self-renewal and multilineage differentiation defects in adult subventricular zone (SVZ) neural progenitors (NPCs) derived from PS1delE9 transgenic mice.","label":"Veeraraghavalu K et al.; Ectopic constitutive activation of Notch...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Choi Se Hoon","Zhang Xiaoqiong","Sisodia Sangram S"],"firstAuthor":"Veeraraghavalu Karthikeyan","referenceYear":"2010","referenceDate":"2010-05-19","id":"urn:lsid:swan.org:researchstatement:387c1ba9-4fd3-4738-ae61-a655599f614a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2a4d9979-9b5f-4148-ab7f-149061492e2c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2a4d9979-9b5f-4148-ab7f-149061492e2c","type":"Claim","title":"GAB2 is a scaffolding protein involved in multiple signaling pathways, which could affect AD-related tau, amyloid, metabolic, or other aspects of AD pathology and cell survival in different ways, and it has been found to be coexpressed with other putative AD-related genes.","label":"Reiman E et al.; GAB2 is a scaffolding protein involved i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Jennifer A","Myers Amanda J","Hardy John","Dunckley Travis","Zismann Victoria L","Joshipura Keta D","Pearson John V","Hu-Lince Diane","Huentelman Matthew J","Craig David W","Coon Keith D","Liang Winnie S","Herbert RiLee H","Beach Thomas","Rohrer Kristen C","Zhao Alice S","Leung Doris","Bryden Leslie","Marlowe Lauren","Kaleem Mona","Mastroeni Diego","Grover Andrew","Heward Christopher B","Ravid Rivka","Rogers Joseph","Hutton Michael L","Melquist Stacey","Petersen Ron C","Alexander Gene E","Caselli Richard J","Kukull Walter","Papassotiropoulos Andreas","Stephan Dietrich A"],"firstAuthor":"Reiman Eric M","referenceYear":"2007","referenceDate":"2007-06-07","id":"urn:lsid:swan.org:researchstatement:2a4d9979-9b5f-4148-ab7f-149061492e2c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:865fe4c4-c7e4-42ee-ad32-44291d7359bd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:865fe4c4-c7e4-42ee-ad32-44291d7359bd","type":"Claim","title":"Myelination thickness depends on BACE1 cleavage of neuregulin.","label":"Bartzokis G; Myelination thickness depends on BACE1 c...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:865fe4c4-c7e4-42ee-ad32-44291d7359bd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9185a8a9-e9de-49aa-8a04-25ffc72bf5db&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9185a8a9-e9de-49aa-8a04-25ffc72bf5db","type":"Claim","title":"If more severe loss of function mutants of PS had been used, it is unlikely that rescue of the PS1 mouse knockout phenotype would have been observed, in line with the data from other approaches.","label":"Bentahir M et al.; If more severe loss of function mutants ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:9185a8a9-e9de-49aa-8a04-25ffc72bf5db"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d1666b58-3841-41c8-8a70-8e51ed93408a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d1666b58-3841-41c8-8a70-8e51ed93408a","type":"Hypothesis","title":"Neocortical Disconnection Hypothesis of Alzheimer Disease:  Alzheimer disease is a laminar, regional and neural system specific disease, not a global brain disease.","label":"Van Hoesen G et al.; Neocortical Disconnection Hypothesis of ...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Hyman B T"],"firstAuthor":"Van Hoesen G W","referenceYear":"1990","referenceDate":"1990","id":"urn:lsid:swan.org:researchstatement:d1666b58-3841-41c8-8a70-8e51ed93408a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:414abff3-03af-4828-b158-4b9ffee3b0eb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:414abff3-03af-4828-b158-4b9ffee3b0eb","type":"Claim","title":"A fundamental tenet of the amyloid hypothesis of Alzheimer\u2019s disease is that the deposition of amyloid-beta precedes and induces the neuronal abnormalities that underlie dementia.","label":"Meyer-Luehmann M et al.; A fundamental tenet of the amyloid hypot...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:414abff3-03af-4828-b158-4b9ffee3b0eb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8890ae3a-73e0-4a59-8ccb-27823ed2bef2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8890ae3a-73e0-4a59-8ccb-27823ed2bef2","type":"Claim","title":"The results from Bitan et al is significant because something other than the greater propensity of Aβ42 to form amyloid fibrils may underlie its association with early-onset AD.","label":"Tycko R; The results from Bitan et al is signific...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Tycko Robert","id":"urn:lsid:swan.org:researchstatement:8890ae3a-73e0-4a59-8ccb-27823ed2bef2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f89309bf-1d18-4f24-8c07-98a222d19308&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f89309bf-1d18-4f24-8c07-98a222d19308","type":"Claim","title":"Recombinant human tau was rapidly degraded by the 20 S proteasome in vitro.","label":"Grune T; Recombinant human tau was rapidly degrad...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Grune Tilman","id":"urn:lsid:swan.org:researchstatement:f89309bf-1d18-4f24-8c07-98a222d19308"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:7a3f4d11-2819-43c3-81ce-115bea7a3c42&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:7a3f4d11-2819-43c3-81ce-115bea7a3c42","type":"Comment","title":"G Wong on Meyer-Luehmann","label":"Wong G; G Wong on Meyer-Luehmann","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Wong Gwendolyn T","referenceYear":"2008","referenceDate":"2008-02-02","id":"urn:lsid:swan.org:comment:7a3f4d11-2819-43c3-81ce-115bea7a3c42"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:03357dbd-06fd-4e43-8025-09ed56ee2df4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:03357dbd-06fd-4e43-8025-09ed56ee2df4","type":"Claim","title":"Quantitative analyses of immunoblots revealed similar steady-state levels and proximo-distal distributions of NF-L and snap25 along optic axons in tau-null, 8c tau overexpressing, and wild-type mice.","label":"Yuan A et al.; Quantitative analyses of immunoblots rev...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:03357dbd-06fd-4e43-8025-09ed56ee2df4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c73209c8-612a-432f-93e9-7b9d8c8f8c5a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c73209c8-612a-432f-93e9-7b9d8c8f8c5a","type":"Claim","title":"Braak Stage I neuropathology is based on non-demented elderly, therefore it is unclear if neurofibrillary changes observed are predictive of AD or represent a separate process.","label":"Hardy J et al.; Braak Stage I neuropathology is based on...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:c73209c8-612a-432f-93e9-7b9d8c8f8c5a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2fc8fd58-65ae-4647-8484-ccca179f7efe&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2fc8fd58-65ae-4647-8484-ccca179f7efe","type":"Claim","title":"The enhancement of Paired Pulse Facilitation observed in the PS1KI may be due to alterations of intracellular calcium handling that is negated by the overexpression of APP in the 3xTg-AD mice.","label":"Smith I et al.; The enhancement of Paired Pulse Facilita...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:2fc8fd58-65ae-4647-8484-ccca179f7efe"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:901cf259-f8cf-4ee9-b9ae-29054d59cf6c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:901cf259-f8cf-4ee9-b9ae-29054d59cf6c","type":"Claim","title":"Changes in internal calcium stores might have potent consequences for both short and long-term plasticity, such as the induction of long-term potentiation (LTP).","label":"Smith I et al.; Changes in internal calcium stores might...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:901cf259-f8cf-4ee9-b9ae-29054d59cf6c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d5617cc9-13b6-461e-9604-d9b852b6f9a7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d5617cc9-13b6-461e-9604-d9b852b6f9a7","type":"Claim","title":"Tissue-transglutaminase-induced oligomerization and aggregation of Aβ provides a mechanism that could explain both the formation and the persistence of pathologically active Aβ species in vivo.","label":"Hartley D et al.; Tissue-transglutaminase-induced oligomer...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:d5617cc9-13b6-461e-9604-d9b852b6f9a7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:00cdd050-c6df-4932-8322-1069c0b1f570&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:00cdd050-c6df-4932-8322-1069c0b1f570","type":"Claim","title":"While it may be desirable to suppress mutant forms of tau in hereditary tauopathies or in tauopathies with an abnormal ratio of 3R versus 4R tau isoforms, reducing tau levels in AD, especially to a degree that compromises MT stability, is likely to have long-term deleterious effects.","label":"Lee V et al.; While it may be desirable to suppress mu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Trojanowski John Q"],"firstAuthor":"Lee Virginia M-Y","id":"urn:lsid:swan.org:researchstatement:00cdd050-c6df-4932-8322-1069c0b1f570"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a50b2f1a-1453-4573-b91e-c7b139545333&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a50b2f1a-1453-4573-b91e-c7b139545333","type":"Claim","title":"Any perturbation in mitochondrial function arising from Abeta-mediated inhibition of the respiratory chain will result in a dramatic alteration in intracellular calcium handling.","label":"Smith I et al.; Any perturbation in mitochondrial functi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:a50b2f1a-1453-4573-b91e-c7b139545333"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:9ce9e0a3-aab0-415a-8121-ea29eae053cd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:9ce9e0a3-aab0-415a-8121-ea29eae053cd","type":"Question","title":"Dr. Marchesi's intriguing hypothesis that membrane-retained Aβ dimers contribute to neuronal injury should be actively pursued experimentally.","label":"Dr. Marchesi's intriguing hypothesis tha...","icon":"../icons/ontological/discourse-element/research-question.png","firstAuthor":"Selkoe Dennis J","id":"urn:lsid:swan.org:researchquestion:9ce9e0a3-aab0-415a-8121-ea29eae053cd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d61a8c44-2f7a-4a52-b3fd-de6b43b1f39d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d61a8c44-2f7a-4a52-b3fd-de6b43b1f39d","type":"Claim","title":"Cholesterol efflux mechanisms including apolipoproteins, ABCA1 transporter, LXR nuclear receptors could dramatically affect cholesterol homeostasis in the brain.","label":"Cholesterol efflux mechanisms including ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:d61a8c44-2f7a-4a52-b3fd-de6b43b1f39d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bdd27ea4-9683-4a68-81c9-7ded40c3d76e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bdd27ea4-9683-4a68-81c9-7ded40c3d76e","type":"Claim","title":"In a recent case of AD, several examples of microglia were observed that may have engulfed apoptotic bodies or that were generated by their own degeneration.","label":"Cotman C et al.; In a recent case of AD, several examples...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:bdd27ea4-9683-4a68-81c9-7ded40c3d76e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e2fab562-7238-4053-8afc-1c6a0169feab&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e2fab562-7238-4053-8afc-1c6a0169feab","type":"Claim","title":"Neutral sphingomyelinase (SMase), located in axons generates signaling active ceramide in neurons.","label":"Neutral sphingomyelinase (SMase), locate...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:e2fab562-7238-4053-8afc-1c6a0169feab"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6d9fa517-7084-4327-890a-993a9995b254&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6d9fa517-7084-4327-890a-993a9995b254","type":"Claim","title":"The processing of a large and growing number of substrates by γ-secretase has led to the hypothesis that γ-secretase is conserved and ubiquitous because it efficiently removes single-transmembrane proteins from the bilayer.","label":"Selkoe D; The processing of a large and growing nu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Selkoe Dennis J","id":"urn:lsid:swan.org:researchstatement:6d9fa517-7084-4327-890a-993a9995b254"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7d9d948a-952a-44f1-a3ec-7a214b3a86a3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7d9d948a-952a-44f1-a3ec-7a214b3a86a3","type":"Claim","title":"Calsenilin interacts with Kv4 proteins.","label":"Plant L et al.; Calsenilin interacts with Kv4 proteins.","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:7d9d948a-952a-44f1-a3ec-7a214b3a86a3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:85e9af8c-bdd0-4844-ba9a-d5c60df1e1c6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:85e9af8c-bdd0-4844-ba9a-d5c60df1e1c6","type":"Claim","title":"Reversal of memory failure in transgenic mouse models of AD by Aβ-directed antibodies has been attributed to immunoneutralization of soluble Aβ assemblies.","label":"Gong Y et al.; Reversal of memory failure in transgenic...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:85e9af8c-bdd0-4844-ba9a-d5c60df1e1c6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7d2a5d46-7201-4c95-b544-e3e224c22921&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7d2a5d46-7201-4c95-b544-e3e224c22921","type":"Claim","title":"Both PS and APP C-terminal mutations elevate Aβ in cell culture models of AD, but ApoE only accelerates symptom appearance in APP mutation-affected individuals while having no effect on PS mutation-affected AD.","label":"Hardy J et al.; Both PS and APP C-terminal mutations ele...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:7d2a5d46-7201-4c95-b544-e3e224c22921"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b439cbfa-a40c-4a7c-af7c-4aac32e6eeb2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b439cbfa-a40c-4a7c-af7c-4aac32e6eeb2","type":"Claim","title":"Fibrillogenic forms of Aβ, which accumulate in AD brain, may be difficult to remove from the CNS via LRP.","label":"Tanzi R et al.; Fibrillogenic forms of Aβ, which accumul...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:b439cbfa-a40c-4a7c-af7c-4aac32e6eeb2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:232db995-9a03-4a77-83ff-11b2e411985f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:232db995-9a03-4a77-83ff-11b2e411985f","type":"Hypothesis","title":"A generalized excitotoxic mechanism leads to selective cell type vulnerability in Alzheimer's disease.","label":"May P; A generalized excitotoxic mechanism lead...","icon":"../icons/ontological/discourse-element/h-research-statement.png","firstAuthor":"May P C","referenceYear":"1989","referenceDate":"1989","id":"urn:lsid:swan.org:researchstatement:232db995-9a03-4a77-83ff-11b2e411985f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:aca5038b-d8ad-4f78-8ddf-654e4dba2b00&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:aca5038b-d8ad-4f78-8ddf-654e4dba2b00","type":"Question","title":"The great challenge that lies ahead is the identification of all the molecules and biochemical events that are involved in pathways during normal aging of the brain, and then understand their influence in AD progression.","label":"The great challenge that lies ahead is t...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:aca5038b-d8ad-4f78-8ddf-654e4dba2b00"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8fca0ff6-0566-4f37-bf5d-d7c37ae03ece&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8fca0ff6-0566-4f37-bf5d-d7c37ae03ece","type":"Claim","title":"Oligomer size distribution of A&#946;39 is identical to A&#946;40.","label":"Bitan G et al.; Oligomer size distribution of A&#946;39 ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:8fca0ff6-0566-4f37-bf5d-d7c37ae03ece"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4f222107-e686-40b4-b3c2-45ca75c30290&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4f222107-e686-40b4-b3c2-45ca75c30290","type":"Hypothesis","title":"Staging of Alzheimer-related cortical destruction: progression of tau pathology represents the morphological counterpart of clinically incipient Alzheimer disease.","label":"Braak H et al.; Staging of Alzheimer-related cortical de...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Braak E","Bohl J"],"firstAuthor":"Braak H","referenceYear":"1993","referenceDate":"1993","id":"urn:lsid:swan.org:researchstatement:4f222107-e686-40b4-b3c2-45ca75c30290"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ddf3efaa-8e40-47d0-a52d-07645ddf11d9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ddf3efaa-8e40-47d0-a52d-07645ddf11d9","type":"Claim","title":"cdc2 kinase activated at the G2/M phase of the cell cycle is responsible for APP phosphorylation. However, this does not rule out the possibility that other cdc2-related kinases in complexes with different cyclins could, under certain circumstances, also phosphorylate APP.","label":"Suzuki T et al.; cdc2 kinase activated at the G2/M phase ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:ddf3efaa-8e40-47d0-a52d-07645ddf11d9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ff3a8a70-482e-4491-8bfb-acd25e023d5a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ff3a8a70-482e-4491-8bfb-acd25e023d5a","type":"Claim","title":"In contrast to PBS-treated PDAPP mice, m266-treated PDAPP mice spent more time exploring a novel object than a familiar object and 24-month m266-treated PDAPP mice were nearly identical to younger (8-month) wild-type control mice in novel object exploration.","label":"Dodart J et al.; In contrast to PBS-treated PDAPP mice, m...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:ff3a8a70-482e-4491-8bfb-acd25e023d5a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4bfc4719-7a92-4a55-8b69-8cc912def61c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4bfc4719-7a92-4a55-8b69-8cc912def61c","type":"Claim","title":"Genome-wide association studies (GWAS) of 537,029 SNPs in 2,032 French Alzheimer\u2019s disease cases and 5,328 French controls identified several APOE-linked SNPs with strong evidence of disease association.","label":"Lambert J et al.; Genome-wide association studies (GWAS) o...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Heath Simon","Even Gael","Campion Dominique","Sleegers Kristel","Hiltunen Mikko","Combarros Onofre","Zelenika Diana","Bullido Maria J","Tavernier Béatrice","Letenneur Luc","Bettens Karolien","Berr Claudine","Pasquier Florence","Fiévet Nathalie","Barberger-Gateau Pascale","Engelborghs Sebastiaan","De Deyn Peter","Mateo Ignacio","Franck Ana","Helisalmi Seppo","Porcellini Elisa","Hanon Olivier","de Pancorbo Marian M","Lendon Corinne","Dufouil Carole","Jaillard Céline","Leveillard Thierry","Alvarez Victoria","Bosco Paolo","Mancuso Michelangelo","Panza Francesco","Nacmias Benedetta","Bossù Paola","Piccardi Paola","Annoni Giorgio","Seripa Davide","Galimberti Daniela","Hannequin Didier","Licastro Federico","Soininen Hilkka","Ritchie Karen","Blanché Hélène","Dartigues Jean-François","Tzourio Christophe","Gut Ivo","Van Broeckhoven Christine","Alpérovitch Annick","Lathrop Mark","Amouyel Philippe"],"firstAuthor":"Lambert Jean-Charles","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:4bfc4719-7a92-4a55-8b69-8cc912def61c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7b3a7213-1591-426c-9377-ab47fb24f7b8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7b3a7213-1591-426c-9377-ab47fb24f7b8","type":"Claim","title":"An initial report  has suggested that the activation of PKC pathway altered the APP processing in cells. The original data suggested that phosphorylation of APP by PKC may regulate APP processing and studies in vitro could show the phosphorylation of APP by PKC.","label":"Suzuki T; An initial report  has suggested that th...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Suzuki Toshiharu","id":"urn:lsid:swan.org:researchstatement:7b3a7213-1591-426c-9377-ab47fb24f7b8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:61fecae5-c9a6-47b2-8814-dc8d52511b7c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:61fecae5-c9a6-47b2-8814-dc8d52511b7c","type":"Claim","title":"The pattern of early cognitive decline followed by a period of stabilization in Tg2576 mice is not reflected by corresponding changes to any known Aβ species.","label":"Lesné S et al.; The pattern of early cognitive decline f...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Koh Ming Teng","Kotilinek Linda","Kayed Rakez","Glabe Charles G","Yang Austin","Gallagher Michela","Ashe Karen H"],"firstAuthor":"Lesné Sylvain","referenceYear":"2006","referenceDate":"2006-03-16","id":"urn:lsid:swan.org:researchstatement:61fecae5-c9a6-47b2-8814-dc8d52511b7c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c247a07c-f6ee-47ee-97fa-aff8b826179e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c247a07c-f6ee-47ee-97fa-aff8b826179e","type":"Claim","title":"THOP1 is associated with amyloid plaques in TgCRND8 mice.","label":"Pollio G et al.; THOP1 is associated with amyloid plaques...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hoozemans Jeroen J","Andersen Claus A","Roncarati Renza","Rosi Maria Cristina","van Haastert Elise S","Seredenina Tamara","Diamanti Daniela","Gotta Stefano","Fiorentini Anna","Magnoni Letizia","Raggiaschi Roberto","Rozemuller Annemieke J","Casamenti Fiorella","Caricasole Andrea","Terstappen Georg C"],"firstAuthor":"Pollio Giuseppe","referenceYear":"2008","referenceDate":"2008-07","id":"urn:lsid:swan.org:researchstatement:c247a07c-f6ee-47ee-97fa-aff8b826179e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:afeee4c0-1514-4bc4-871a-7d66d6ef4647&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:afeee4c0-1514-4bc4-871a-7d66d6ef4647","type":"Comment","title":"Van Leuven on Yuan","label":"Van Leuven F; Van Leuven on Yuan","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Van Leuven Fred","referenceYear":"2008","referenceDate":"2008-02-02","id":"urn:lsid:swan.org:comment:afeee4c0-1514-4bc4-871a-7d66d6ef4647"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c3f2bc18-28a8-48ae-b722-9377a5ed2b8a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c3f2bc18-28a8-48ae-b722-9377a5ed2b8a","type":"Claim","title":"Numerous alpha2-adrenergic agonists are available that can possibly provide effective therapy without intolerable adverse effects. ","label":"Olney J et al.; Numerous alpha2-adrenergic agonists are ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:c3f2bc18-28a8-48ae-b722-9377a5ed2b8a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:03f17701-b3b3-4b03-ae1b-31cb82ddf071&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:03f17701-b3b3-4b03-ae1b-31cb82ddf071","type":"Hypothesis","title":"Tau-linked disease processes drive the onset and progression of AD and related tauopathies.","label":"Ballatore C et al.; Tau-linked disease processes drive the o...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Lee Virginia M-Y","Trojanowski John Q"],"firstAuthor":"Ballatore Carlo","referenceYear":"2007","referenceDate":"2007-09","id":"urn:lsid:swan.org:researchstatement:03f17701-b3b3-4b03-ae1b-31cb82ddf071"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ed3f6c7d-e597-43f2-a790-a5aeffb966c3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ed3f6c7d-e597-43f2-a790-a5aeffb966c3","type":"Claim","title":"CAD cells that accumulate Aβ show redistribution of β-secretase (BACE1) to the processes, where it co-localizes with Aβ.","label":"Muresan Z et al.; CAD cells that accumulate Aβ show redist...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","referenceYear":"2008","referenceDate":"2008","id":"urn:lsid:swan.org:researchstatement:ed3f6c7d-e597-43f2-a790-a5aeffb966c3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f64f38ab-f9cb-498e-a980-69d19fcd64f2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f64f38ab-f9cb-498e-a980-69d19fcd64f2","type":"Claim","title":"Each APP isoform exists as immature (N-glycosylated) and mature (sulfated, N- and O-glycosylated) species.","label":"Suzuki T et al.; Each APP isoform exists as immature (N-g...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:f64f38ab-f9cb-498e-a980-69d19fcd64f2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:56757b19-7562-459c-a4e0-0f03b9b46fea&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:56757b19-7562-459c-a4e0-0f03b9b46fea","type":"Claim","title":"Receptor-mediated cholesterol reuptake and maturation of SREBP control the generation of Aβ and synaptogenesis.","label":"Receptor-mediated cholesterol reuptake a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:56757b19-7562-459c-a4e0-0f03b9b46fea"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:798ceefe-6dea-4fb0-a019-624435c08277&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:798ceefe-6dea-4fb0-a019-624435c08277","type":"Claim","title":"The GAB2 gene is completely encompassed by a single haplotype block extending from rs901104 to rs2373115, which has three major haplotypes: an extremely common \u201cGAB2 risk haplotype,\u201d a common \u201cGAB2 protective haplotype,\u201d and a relatively uncommon GAB2 haplotype unrelated to late-onset AD (LOAD) risk in APOE ε4 carriers.","label":"Reiman E et al.; The GAB2 gene is completely encompassed ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Jennifer A","Myers Amanda J","Hardy John","Dunckley Travis","Zismann Victoria L","Joshipura Keta D","Pearson John V","Hu-Lince Diane","Huentelman Matthew J","Craig David W","Coon Keith D","Liang Winnie S","Herbert RiLee H","Beach Thomas","Rohrer Kristen C","Zhao Alice S","Leung Doris","Bryden Leslie","Marlowe Lauren","Kaleem Mona","Mastroeni Diego","Grover Andrew","Heward Christopher B","Ravid Rivka","Rogers Joseph","Hutton Michael L","Melquist Stacey","Petersen Ron C","Alexander Gene E","Caselli Richard J","Kukull Walter","Papassotiropoulos Andreas","Stephan Dietrich A"],"firstAuthor":"Reiman Eric M","referenceYear":"2007","referenceDate":"2007-06-07","id":"urn:lsid:swan.org:researchstatement:798ceefe-6dea-4fb0-a019-624435c08277"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a831fb49-a75f-47b6-92e3-6209fe50cce4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a831fb49-a75f-47b6-92e3-6209fe50cce4","type":"Claim","title":"The areas occupied by Aβ deposits (the Aβ burden) in both the hippocampus and cerebral cortex of 24-month PDAPP mice after six weeks of passive immunization did not differ from those in age-matched PBS-treated PDAPP controls.","label":"Dodart J et al.; The areas occupied by Aβ deposits (the A...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:a831fb49-a75f-47b6-92e3-6209fe50cce4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2d827caa-eda0-481e-9264-bb3e92da0cad&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2d827caa-eda0-481e-9264-bb3e92da0cad","type":"Claim","title":"Lipid-free apoE increases Aβ fibril formation; E4 has a greater effect than E3.","label":"Holtzman D; Lipid-free apoE increases Aβ fibril form...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:2d827caa-eda0-481e-9264-bb3e92da0cad"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6514c19f-943d-495a-9357-88139fa025b3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6514c19f-943d-495a-9357-88139fa025b3","type":"Claim","title":"Soluble Aβ levels correlate strongly with extent of synaptic loss and cognitive impairment.","label":"Walsh D et al.; Soluble Aβ levels correlate strongly wit...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Klyubin Igor","Fadeeva Julia V","Cullen William K","Anwyl Roger","Wolfe Michael S","Rowan Michael J","Selkoe Dennis J"],"firstAuthor":"Walsh Dominic M","referenceYear":"2002","referenceDate":"2002-04-04","id":"urn:lsid:swan.org:researchstatement:6514c19f-943d-495a-9357-88139fa025b3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:dd9899ce-6746-4f87-bbb9-cbb5a15e6f71&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:dd9899ce-6746-4f87-bbb9-cbb5a15e6f71","type":"Claim","title":"Presenilins form the catalytic core of the gamma-secretase complex.","label":"Bentahir M et al.; Presenilins form the catalytic core of t...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:dd9899ce-6746-4f87-bbb9-cbb5a15e6f71"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:44175379-8334-4fdb-9473-f2dba4a0a29f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:44175379-8334-4fdb-9473-f2dba4a0a29f","type":"Claim","title":"Oligodendrocytes have the highest iron content of all brain cell types and as much as 70% of brain iron may be associated with myelin.","label":"Bartzokis G; Oligodendrocytes have the highest iron c...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:44175379-8334-4fdb-9473-f2dba4a0a29f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8a5e690b-e551-45d4-93eb-61b046a9866f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8a5e690b-e551-45d4-93eb-61b046a9866f","type":"Hypothesis","title":"Alzheimer disease is a hippocampal dementia.","label":"Ball M; Alzheimer disease is a hippocampal demen...","icon":"../icons/ontological/discourse-element/h-research-statement.png","firstAuthor":"Ball M J","referenceYear":"1977","referenceDate":"1977-02-28","id":"urn:lsid:swan.org:researchstatement:8a5e690b-e551-45d4-93eb-61b046a9866f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:44fd87db-18a5-4dea-9a49-b33a48e5b079&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:44fd87db-18a5-4dea-9a49-b33a48e5b079","type":"Claim","title":"It is important to be cautious in drawing conclusions regarding the mechanism of cell death in postmortem tissue labeled with TdT.","label":"Cotman C et al.; It is important to be cautious in drawin...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:44fd87db-18a5-4dea-9a49-b33a48e5b079"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:37be5c3b-24bd-4edd-bd9c-ffadb86126b4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:37be5c3b-24bd-4edd-bd9c-ffadb86126b4","type":"Claim","title":"SIRT1 levels may increase as a protective response to neurodegenerative conditions.","label":"Kim D et al.; SIRT1 levels may increase as a protectiv...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:37be5c3b-24bd-4edd-bd9c-ffadb86126b4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:25dcca89-2212-4d1f-b67e-6265207e0d35&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:25dcca89-2212-4d1f-b67e-6265207e0d35","type":"Claim","title":"Uncross-linked Aβ42 produces primarily a monomer band and a trimer band in SDS-gel electrophoresis but the trimer band is an SDS-induced artefact.","label":"Bitan G et al.; Uncross-linked Aβ42 produces primarily a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:25dcca89-2212-4d1f-b67e-6265207e0d35"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e3138503-237f-4bfc-abe9-58f324ea7504&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e3138503-237f-4bfc-abe9-58f324ea7504","type":"Claim","title":"Aβ aggregates induced by Tissue-transglutaminase transition through almost identical intermediates as those observed with protofibrils. Binding of Thioflavin T to Tissue-transglutaminase-induced Aβ aggregates was very similar to its binding to self-aggregated Aβ42, indicating similar formation of β-sheet structures.","label":"Hartley D et al.; Aβ aggregates induced by Tissue-transglu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:e3138503-237f-4bfc-abe9-58f324ea7504"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:91f14271-db4d-4244-ba01-e0b5efe888a6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:91f14271-db4d-4244-ba01-e0b5efe888a6","type":"Claim","title":"DR6 regulates neuronal death after trophic-factor deprivation in vitro.","label":"Nikolaev A et al.; DR6 regulates neuronal death after troph...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["McLaughlin Todd","O'Leary Dennis D","Tessier-Lavigne Marc"],"firstAuthor":"Nikolaev Anatoly","referenceYear":"2009","referenceDate":"2009-02-19","id":"urn:lsid:swan.org:researchstatement:91f14271-db4d-4244-ba01-e0b5efe888a6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fb936586-8872-43b0-bd4b-b74b9ab315cc&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fb936586-8872-43b0-bd4b-b74b9ab315cc","type":"Claim","title":"TDP-43 immunoreactivity co-localizes with ubiquitin inclusions and shows altered nuclear/cytoplasmic localization, and abnormal cleavage products in sporadic ALS autopsy specimens. ","label":"Stallings N et al.; TDP-43 immunoreactivity co-localizes wit...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Puttaparthi Krishna","Luther Christina M","Burns Dennis K","Elliott Jeffrey L"],"firstAuthor":"Stallings Nancy R","referenceYear":"2010","referenceDate":"2010-07-30","id":"urn:lsid:swan.org:researchstatement:fb936586-8872-43b0-bd4b-b74b9ab315cc"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5b096652-7ac4-47a6-88bd-d52b1bbff296&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5b096652-7ac4-47a6-88bd-d52b1bbff296","type":"Claim","title":"Associative learning was significantly rescued in p25 mice treated with resveratrol for 3 weeks, in comparison to the vehicle group or untreated p25 mice.  Resveratrol prevents cognitive decline in an animal model of CNS degeneration that features massive neuronal loss and tau pathologies.","label":"Kim D et al.; Associative learning was significantly r...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:5b096652-7ac4-47a6-88bd-d52b1bbff296"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ed137e4f-3aee-4e8e-aebc-1983ee46c239&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ed137e4f-3aee-4e8e-aebc-1983ee46c239","type":"Claim","title":"One pathogenic mechanism through which Aβ has been shown to mediate its effects is via the production of reactive oxygen species (ROS).","label":"Smith I et al.; One pathogenic mechanism through which A...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:ed137e4f-3aee-4e8e-aebc-1983ee46c239"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:14b603dd-0328-42c9-aec9-6b1723cb44a5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:14b603dd-0328-42c9-aec9-6b1723cb44a5","type":"Claim","title":"Previous studies have suggested that the reduction in cognitive impairment seen in APP transgenic mice after active immunization requires reduced brain Aβ/amyloid burden, but m266 treatment of PDAPP mice appears to contradict these findings.","label":"Dodart J et al.; Previous studies have suggested that the...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:14b603dd-0328-42c9-aec9-6b1723cb44a5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f276081e-cb1d-490e-815f-4aa1cf66befd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f276081e-cb1d-490e-815f-4aa1cf66befd","type":"Hypothesis","title":"Glucocorticoid Hypothesis: Exposure of brain cells to glucocorticoids can increase brain cell loss during aging.","label":"Landfield P; Glucocorticoid Hypothesis: Exposure of b...","icon":"../icons/ontological/discourse-element/h-research-statement.png","firstAuthor":"Landfield P W","referenceYear":"1994","referenceDate":"1994","id":"urn:lsid:swan.org:researchstatement:f276081e-cb1d-490e-815f-4aa1cf66befd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c19a0167-e6a6-4d94-b756-a4b2ba37030b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c19a0167-e6a6-4d94-b756-a4b2ba37030b","type":"Claim","title":"Extracellular Aβ, whether oligomers or aggregated fibrils, are insufficient to injure neurons or cause synaptic dysfunction.","label":"Koo E; Extracellular Aβ, whether oligomers or a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Koo Edward H","id":"urn:lsid:swan.org:researchstatement:c19a0167-e6a6-4d94-b756-a4b2ba37030b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2f1be692-b261-44c3-b7b0-b07d0f6852f6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2f1be692-b261-44c3-b7b0-b07d0f6852f6","type":"Claim","title":"The AD brain is subject to a chronic inflammatory condition, as evidenced by widespread gliosis and increased levels of numerous inflammatory factors, including, but not-limited to, chemokines, cytokines, and acute phase reactants, in the absence of overt lymphocytic or mononuclear infiltrates.","label":"Golde T et al.; The AD brain is subject to a chronic inf...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:2f1be692-b261-44c3-b7b0-b07d0f6852f6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8ecb1d5a-14ff-49b6-b68a-43d0e66bbaca&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8ecb1d5a-14ff-49b6-b68a-43d0e66bbaca","type":"Hypothesis","title":"Impaired brain microcirculation may trigger Alzheimer disease.","label":"de la Torre J; Impaired brain microcirculation may trig...","icon":"../icons/ontological/discourse-element/h-research-statement.png","firstAuthor":"de la Torre J C","referenceYear":"1994","referenceDate":"1994","id":"urn:lsid:swan.org:researchstatement:8ecb1d5a-14ff-49b6-b68a-43d0e66bbaca"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fd8dfd4d-0992-4409-b597-ebf84ee61bfa&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fd8dfd4d-0992-4409-b597-ebf84ee61bfa","type":"Claim","title":"The first phase of AD is pre-symptomatic, in which individuals are cognitively normal but have AD pathological changes, and would ultimately become symptomatic over time. ","label":"Jack C et al.; The first phase of AD is pre-symptomatic...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:fd8dfd4d-0992-4409-b597-ebf84ee61bfa"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7362f0ec-dc14-46cd-817a-c266299879b9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7362f0ec-dc14-46cd-817a-c266299879b9","type":"Claim","title":"Tau accumulates inside cells as neurofibrillary tangles and tau neurites, and mutations in tau that cause frontal temporal dementia with parkinsonism linked to chromosome 17 (FTDP-17 MAPT) also alter tau in a way that increases its likelihood to aggregate into amyloid-like structures. ","label":"Golde T et al.; Tau accumulates inside cells as neurofib...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:7362f0ec-dc14-46cd-817a-c266299879b9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:48f9a93c-25a5-435f-87d1-5c47fba91abe&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:48f9a93c-25a5-435f-87d1-5c47fba91abe","type":"Claim","title":"Cell death in human AD brains is not well correlated with Alzheimer Disease progression.","label":"Dziewczapolski G et al.; Cell death in human AD brains is not wel...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Glogowski Carolina M","Masliah Eliezer","Heinemann Stephen F"],"firstAuthor":"Dziewczapolski Gustavo","referenceYear":"2009","referenceDate":"2009-07-08","id":"urn:lsid:swan.org:researchstatement:48f9a93c-25a5-435f-87d1-5c47fba91abe"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fc8738ad-9e0c-4a7a-939f-f2bf87bbd75e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fc8738ad-9e0c-4a7a-939f-f2bf87bbd75e","type":"Claim","title":"The Aβ peptide was recognized as the primary component of AD plaques.","label":"Hardy J et al.; The Aβ peptide was recognized as the pri...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:fc8738ad-9e0c-4a7a-939f-f2bf87bbd75e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:efb6b3ea-88a1-47e9-9363-c6adf8ed5a0c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:efb6b3ea-88a1-47e9-9363-c6adf8ed5a0c","type":"Claim","title":"Studies in AD tissue reveal a surprisingly large number of TdT-labeled nuclei in the entorhinal cortex/hippocampal formation.","label":"Cotman C et al.; Studies in AD tissue reveal a surprising...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:efb6b3ea-88a1-47e9-9363-c6adf8ed5a0c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ae0bdbc2-580b-4c52-b455-bdedd3db7f97&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ae0bdbc2-580b-4c52-b455-bdedd3db7f97","type":"Claim","title":"APP695, APP751 and APP770 are the three most common forms of APP expressed in the brain.","label":"APP695, APP751 and APP770 are the three ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:ae0bdbc2-580b-4c52-b455-bdedd3db7f97"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ea96ef8c-f30d-49fd-9283-956dc7a1ecc9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ea96ef8c-f30d-49fd-9283-956dc7a1ecc9","type":"Claim","title":"Modified immunization protocols currently in clinical trials will also result in removal of plaques from brains affected by Alzheimer\u2019s disease and could prove to be safer strategies than vaccination with full-length Aβ.","label":"Holmes C et al.; Modified immunization protocols currentl...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:ea96ef8c-f30d-49fd-9283-956dc7a1ecc9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4be8e6cd-6ef2-4237-aa8d-4f5d89246d7d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4be8e6cd-6ef2-4237-aa8d-4f5d89246d7d","type":"Claim","title":"Serial Pittsburgh Compound B (PiB) imaging studies Aβ-plaque accumulation in individuals destined to become demented might begin as much as two decades before the manifestation of clinical symptoms and can be widespread in clinically asymptomatic individuals although both Aβ deposition and NFTs can be present in individuals with no symptoms.","label":"Jack C et al.; Serial Pittsburgh Compound B (PiB) imagi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:4be8e6cd-6ef2-4237-aa8d-4f5d89246d7d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c15c14be-e703-4428-9277-a0aedea36256&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c15c14be-e703-4428-9277-a0aedea36256","type":"Claim","title":"Normal functions of ceramide include: cell growth, apoptosis, lifespan, vesicular trafficking, neuronal differentiation, neuronal function.","label":"Normal functions of ceramide include: ce...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:c15c14be-e703-4428-9277-a0aedea36256"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a0216c0c-781a-4a34-9365-a8589ea8bfba&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a0216c0c-781a-4a34-9365-a8589ea8bfba","type":"Claim","title":"The impairment of proteasome function by PHF-tau might be an early and crucial step in the development of AD neuropathology.","label":"Keck S et al.; The impairment of proteasome function by...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:a0216c0c-781a-4a34-9365-a8589ea8bfba"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:401c8fa5-517d-463f-9d3b-e223425f52b5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:401c8fa5-517d-463f-9d3b-e223425f52b5","type":"Claim","title":"Monomeric tau levels 20-fold above physiological concentration did not affect axonal transport in squid axon.","label":"Takashima A; Monomeric tau levels 20-fold above physi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Takashima Akihiko","id":"urn:lsid:swan.org:researchstatement:401c8fa5-517d-463f-9d3b-e223425f52b5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:64bcd2ad-43f2-4f05-be7d-66e76ce6a330&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:64bcd2ad-43f2-4f05-be7d-66e76ce6a330","type":"Claim","title":"Biomarkers are physiological, biochemical, anatomical variables that can be measured in vivo by both imaging and biospecimen assay (ie, CSF) and that indicate specific features of disease-related pathological changes.","label":"Jack C et al.; Biomarkers are physiological, biochemica...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner Michael W","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:64bcd2ad-43f2-4f05-be7d-66e76ce6a330"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:75d433ad-1101-4f64-ac21-b3c4124fca0a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:75d433ad-1101-4f64-ac21-b3c4124fca0a","type":"Claim","title":"Intracellular ceramide increases during aging of cells or organs.","label":"Intracellular ceramide increases during ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:75d433ad-1101-4f64-ac21-b3c4124fca0a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:583b929f-9acc-45fd-a7db-6234ff7c9c2b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:583b929f-9acc-45fd-a7db-6234ff7c9c2b","type":"Claim","title":"Alzhemed, which inhibits Aβ from forming beta-pleated sheet formations, is in Phase II clinical trial.","label":"Golde T; Alzhemed, which inhibits Aβ from forming...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde T","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:583b929f-9acc-45fd-a7db-6234ff7c9c2b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:543a4002-184b-4a4b-a63a-a7e90f286a17&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:543a4002-184b-4a4b-a63a-a7e90f286a17","type":"Claim","title":"Imaging of neurite dystrophy and new plaque formation over time demonstrated that in the days after plaque formation, progressive neuritic alterations were evident: from a smooth bend around the new plaque to very tortuous changes identical in appearance to dystrophic neurites seen in Alzheimer\u2019s disease","label":"Meyer-Luehmann M et al.; Imaging of neurite dystrophy and new pla...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:543a4002-184b-4a4b-a63a-a7e90f286a17"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:486a6535-9e34-4cf7-a857-ac7fb1c913ae&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:486a6535-9e34-4cf7-a857-ac7fb1c913ae","type":"Claim","title":"Intracellular Aβ has been implicated in the pathogenesis of AD, including its relationship to extracellular amyloid plaques as well as deleterious effects on synaptic function and learning and memory.","label":"Dziewczapolski G et al.; Intracellular Aβ has been implicated in ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Glogowski Carolina M","Masliah Eliezer","Heinemann Stephen F"],"firstAuthor":"Dziewczapolski Gustavo","referenceYear":"2009","referenceDate":"2009-07-08","id":"urn:lsid:swan.org:researchstatement:486a6535-9e34-4cf7-a857-ac7fb1c913ae"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d75aab8c-cc41-4c71-806b-ac7b81fe2b56&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d75aab8c-cc41-4c71-806b-ac7b81fe2b56","type":"Hypothesis","title":"Metalloendopeptidase EC 3.4.24.15 is necessary for Alzheimer's amyloid-beta peptide degradation.","label":"Yamin R et al.; Metalloendopeptidase EC 3.4.24.15 is nec...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Malgeri E G","Sloane J A","McGraw W T","Abraham C R"],"firstAuthor":"Yamin R","referenceYear":"1999","referenceDate":"1999-06-25","id":"urn:lsid:swan.org:researchstatement:d75aab8c-cc41-4c71-806b-ac7b81fe2b56"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f4ed71ed-ec69-4847-b212-d3b12503af83&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f4ed71ed-ec69-4847-b212-d3b12503af83","type":"Claim","title":"Stimulation of the alpha-secretase pathway by agents that regulate protein phosphorylation pathways might represent a viable strategy in treatments designed to reduce the production of Aβ.","label":"Suzuki T et al.; Stimulation of the alpha-secretase pathw...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:f4ed71ed-ec69-4847-b212-d3b12503af83"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:55756e3d-6a5f-46b2-9f77-2f123c220557&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:55756e3d-6a5f-46b2-9f77-2f123c220557","type":"Claim","title":"In addition to the difficulties of comparing effects between diverse cell lines, an inherent problem is the inability to accurately control expression of foreign proteins often resulting in the analysis of systems in which there is supraphysiological levels of the protein of interest.","label":"Smith I et al.; In addition to the difficulties of compa...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:55756e3d-6a5f-46b2-9f77-2f123c220557"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8e35d0bf-a89b-400f-a5b8-67981b19e129&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8e35d0bf-a89b-400f-a5b8-67981b19e129","type":"Hypothesis","title":"Cochaperone BAG2 sweeps insoluble and phosphorylated tau from the microtubule to ubiquitin-independent protein degradation.","label":"Carrettiero D et al.; Cochaperone BAG2 sweeps insoluble and ph...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Hernandez Israel","Neveu Pierre","Papagiannakopoulos Thales","Kosik Kenneth S"],"firstAuthor":"Carrettiero Daniel C","referenceYear":"2009","referenceDate":"2009-02-18","id":"urn:lsid:swan.org:researchstatement:8e35d0bf-a89b-400f-a5b8-67981b19e129"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:145f75de-7c14-4ea0-aba6-a44d64f1022e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:145f75de-7c14-4ea0-aba6-a44d64f1022e","type":"Claim","title":"Aβ can act post-transcriptionally to promote the L-type alpha1C subunit insertion (or stabilization) into the plasma membrane.","label":"Smith I et al.; Aβ can act post-transcriptionally to pro...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:145f75de-7c14-4ea0-aba6-a44d64f1022e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a135e937-5421-4b9b-9755-294a73f1bd4c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a135e937-5421-4b9b-9755-294a73f1bd4c","type":"Claim","title":"Other CNS cells, including glia, neuroglial stem cells, and endothelial and smooth muscle cells that form the cerebrovasculature, are also likely to undergo senescent changes in response to the chronic inflammatory environment, a mechanism for \u2018aging\u2019 microglia, less efficient scavenger cells with diminished phagocytic capacity and enhanced neurotoxic potential.","label":"Golde T et al.; Other CNS cells, including glia, neurogl...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:a135e937-5421-4b9b-9755-294a73f1bd4c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f42e839c-4680-4dd5-b00e-6328e30abb7b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f42e839c-4680-4dd5-b00e-6328e30abb7b","type":"Claim","title":"APPswe/PS1d9xYFP (B6C3-YFP) transgenic mice begin to show plaque appearance at 5 to 6 months age.","label":"Meyer-Luehmann M et al.; APPswe/PS1d9xYFP (B6C3-YFP) transgenic m...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:f42e839c-4680-4dd5-b00e-6328e30abb7b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:dd7a9c41-68e7-42ab-aa6a-2337b410eaea&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:dd7a9c41-68e7-42ab-aa6a-2337b410eaea","type":"Claim","title":"The data from 8c tau transgenic mice differs significantly from observations made by others looking at the effects of tau expression on axonal transport and organelle localization.","label":"Holzbaur E; The data from 8c tau transgenic mice dif...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holzbaur Erika L F","id":"urn:lsid:swan.org:researchstatement:dd7a9c41-68e7-42ab-aa6a-2337b410eaea"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bc889d6c-4b04-41f3-9ee1-0b4a18a972b6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bc889d6c-4b04-41f3-9ee1-0b4a18a972b6","type":"Claim","title":"Dose-dependent increases in the plasma concentrations of both Aβ1\u201340 and Aβ1\u201342 peptides were observed after acute m266 treatment","label":"Dodart J et al.; Dose-dependent increases in the plasma c...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:bc889d6c-4b04-41f3-9ee1-0b4a18a972b6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ebd1b9fa-81f8-4349-a563-48e5f024e0aa&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ebd1b9fa-81f8-4349-a563-48e5f024e0aa","type":"Claim","title":"Changes in telomere length, telomere activity, and the presence of distinct heterochromatic nuclear bodies (called senescence-associated heterochromatic foci) are also well established markers of replicative senescence.","label":"Golde T et al.; Changes in telomere length, telomere act...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:ebd1b9fa-81f8-4349-a563-48e5f024e0aa"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:31da13f1-968b-49cb-8aba-61710455a410&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:31da13f1-968b-49cb-8aba-61710455a410","type":"Claim","title":"Excessive expression of the HSP72 occurs in degenerating neurons in the NRHypo model and in the AD brain, and is believed to function as a chaperone protein that intercedes to correct abnormal protein folding.","label":"Olney J et al.; Excessive expression of the HSP72 occurs...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:31da13f1-968b-49cb-8aba-61710455a410"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2e257bfb-7e9e-4331-b492-7728132eee37&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2e257bfb-7e9e-4331-b492-7728132eee37","type":"Claim","title":"The data from the in vivo test of tau effect on axonal transport do not exclude the possibility that pathological states of tau might directly or indirectly alter axonal transport.","label":"Nixon R; The data from the in vivo test of tau ef...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Nixon Ralph A","id":"urn:lsid:swan.org:researchstatement:2e257bfb-7e9e-4331-b492-7728132eee37"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bea5257b-f43d-40d8-be77-b362ab83b777&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bea5257b-f43d-40d8-be77-b362ab83b777","type":"Claim","title":"The finding that APP dimerization enhances Aβ production is consistent with the Marchesi hypothesis view.","label":"Koo E; The finding that APP dimerization enhanc...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Koo Edward H","id":"urn:lsid:swan.org:researchstatement:bea5257b-f43d-40d8-be77-b362ab83b777"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:95197e7b-e123-4668-9dfe-a3bba2d158cd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:95197e7b-e123-4668-9dfe-a3bba2d158cd","type":"Claim","title":"The binding of Aβ to RAGE has been shown to stimulate cellular responses that are potentially pathological, including expression of proinflammatory cytokines and decreased cerebral blood flow.","label":"Tanzi R et al.; The binding of Aβ to RAGE has been shown...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:95197e7b-e123-4668-9dfe-a3bba2d158cd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:12f6caa0-e097-4020-8124-82106c9f9f12&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:12f6caa0-e097-4020-8124-82106c9f9f12","type":"Claim","title":"Inactivation of PS1 expression in conditional knockout mice occurs at 4 weeks of age postnatally, and neurodegeneration becomes evident by 4 months of age. By the age of 9 months, 24% of cortical neurons and 35% of cortical volume are lost.","label":"Shen J et al.; Inactivation of PS1 expression in condit...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:12f6caa0-e097-4020-8124-82106c9f9f12"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7dd4d9de-0283-404a-ac6e-7db8366d4d8b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7dd4d9de-0283-404a-ac6e-7db8366d4d8b","type":"Claim","title":"Oligomer-depleted conditioned media did not block hippocampal LTP despite maintenance of significant levels of monomeric Aβ.","label":"Walsh D et al.; Oligomer-depleted conditioned media did ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Klyubin Igor","Fadeeva Julia V","Cullen William K","Anwyl Roger","Wolfe Michael S","Rowan Michael J","Selkoe Dennis J"],"firstAuthor":"Walsh Dominic M","referenceYear":"2002","referenceDate":"2002-04-04","id":"urn:lsid:swan.org:researchstatement:7dd4d9de-0283-404a-ac6e-7db8366d4d8b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:47a51912-2be5-4280-bd88-87ba0effbc74&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:47a51912-2be5-4280-bd88-87ba0effbc74","type":"Claim","title":"Insulin mRNA expression is reduced in AD brain. ","label":"Craft S; Insulin mRNA expression is reduced in AD...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft Suzanne","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:47a51912-2be5-4280-bd88-87ba0effbc74"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f3d48ae4-af69-45f9-8816-5d542daf4629&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f3d48ae4-af69-45f9-8816-5d542daf4629","type":"Claim","title":"Ceramide&#8217;s action as a second messenger is due to its ability to transducer signals involved in cell death, terminal differentiation, and is considered a central regulator of cellular senescence.","label":"Ceramide&#8217;s action as a second mess...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:f3d48ae4-af69-45f9-8816-5d542daf4629"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ce524ab2-a811-4d2d-90b9-dd1500c43857&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ce524ab2-a811-4d2d-90b9-dd1500c43857","type":"Claim","title":"Overexpression of SIRT1, but not SIRT1 lacking catalytic activity (H363Y), significantly rescued the rate of p25-GFP-mediated cell death (54 versus 28.7%).","label":"Kim D et al.; Overexpression of SIRT1, but not SIRT1 l...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:ce524ab2-a811-4d2d-90b9-dd1500c43857"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5a7f13db-1333-4180-a2d4-3fd93fe6c4e2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5a7f13db-1333-4180-a2d4-3fd93fe6c4e2","type":"Claim","title":"The metal-complexing agent clioquinol, a discontinued antibiotic, has been shown to attenuate beta amyloid deposition in mice and to lower plasma Aβ levels and attenuate cognitive decline in AD patients.","label":"Tanzi R et al.; The metal-complexing agent clioquinol, a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:5a7f13db-1333-4180-a2d4-3fd93fe6c4e2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:87e2c4f5-4344-4767-91ed-d25be3d04dc5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:87e2c4f5-4344-4767-91ed-d25be3d04dc5","type":"Claim","title":"APOE released from astroglia plays a role in clearing Aβ from the extracellular brain parenchyma, and that compared to other isoforms, APOE4 causes increased Aβ by decreasing its clearance.","label":"Small S et al.; APOE released from astroglia plays a rol...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:87e2c4f5-4344-4767-91ed-d25be3d04dc5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:559fa560-d07e-4a3d-a69c-f19d8ff260aa&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:559fa560-d07e-4a3d-a69c-f19d8ff260aa","type":"Claim","title":"Short-term clinical outcomes of the phase I AN1792 clinical trial were disappointing, with three of the four exploratory measures of clinical efficacy showing no significant differences between the treatment and placebo group during the initial study period.","label":"Holmes C et al.; Short-term clinical outcomes of the phas...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:559fa560-d07e-4a3d-a69c-f19d8ff260aa"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e2432125-abb9-4c7f-be02-e5d9a12f6f0f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e2432125-abb9-4c7f-be02-e5d9a12f6f0f","type":"Claim","title":"The senescent phenotype could be the key link between Aβ proteinopathy and secondary proteinopathies that are seen in the AD brain, including those involving tau, α-synuclein and TDP-43.","label":"Golde T et al.; The senescent phenotype could be the key...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:e2432125-abb9-4c7f-be02-e5d9a12f6f0f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:afa5a25d-d33d-4b28-b020-44b93178ab24&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:afa5a25d-d33d-4b28-b020-44b93178ab24","type":"Claim","title":"Loss-of-function studies comparing phenotypes of App -/- Aplp2 -/- mice to DR6 -/- mice, support a model in which a cleaved amino-terminal fragment of APP (N-APP) binds DR6 and triggers degeneration.","label":"Nikolaev A et al.; Loss-of-function studies comparing pheno...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["McLaughlin Todd","O'Leary Dennis D","Tessier-Lavigne Marc"],"firstAuthor":"Nikolaev Anatoly","referenceYear":"2009","referenceDate":"2009-02-19","id":"urn:lsid:swan.org:researchstatement:afa5a25d-d33d-4b28-b020-44b93178ab24"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1c91118e-401e-4d3b-97ac-7a806da4b5ad&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1c91118e-401e-4d3b-97ac-7a806da4b5ad","type":"Claim","title":"Aβ peptides can accumulate outside cells early on, long before clinical symptoms.","label":"Selkoe D; Aβ peptides can accumulate outside cells...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Selkoe Dennis J","id":"urn:lsid:swan.org:researchstatement:1c91118e-401e-4d3b-97ac-7a806da4b5ad"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:459428d0-8c6f-4149-ba5c-5be0bf3c3645&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:459428d0-8c6f-4149-ba5c-5be0bf3c3645","type":"Claim","title":"ApoE4 transgenic mice had more Aβ deposits and neuritic plaques than ApoE3 transgenic mice at 15 months age.","label":"Holtzman D; ApoE4 transgenic mice had more Aβ deposi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:459428d0-8c6f-4149-ba5c-5be0bf3c3645"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8a08a697-42da-42d7-9e62-e0a523bbd24c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8a08a697-42da-42d7-9e62-e0a523bbd24c","type":"Claim","title":"PS1 mutations can cause neurodegeneration and dementia in humans without increasing Aβ production, possibly by imposing a generalized reduction in PS activity.","label":"Shen J et al.; PS1 mutations can cause neurodegeneratio...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:8a08a697-42da-42d7-9e62-e0a523bbd24c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:4b4a8c4d-83b9-4c7f-bc57-7fbbd685d660&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:4b4a8c4d-83b9-4c7f-bc57-7fbbd685d660","type":"Question","title":"Future studies are planned to determine whether mutations or polymorphisms in SIRT1 affect the susceptibility of individuals to AD pathology.","label":"Future studies are planned to determine ...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:4b4a8c4d-83b9-4c7f-bc57-7fbbd685d660"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:8ed968ee-b690-4fb9-a2d8-d664e9ffbc13&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:8ed968ee-b690-4fb9-a2d8-d664e9ffbc13","type":"Question","title":"Further experiments will be needed to determine whether or not paranuclear structures and paranuclear aggregation processes occur in vivo.","label":"Further experiments will be needed to de...","icon":"../icons/ontological/discourse-element/research-question.png","firstAuthor":"Holtzman David M","id":"urn:lsid:swan.org:researchquestion:8ed968ee-b690-4fb9-a2d8-d664e9ffbc13"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f18849ec-0df2-46b4-9d31-e06b0e046548&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f18849ec-0df2-46b4-9d31-e06b0e046548","type":"Claim","title":"PDAPP mice demonstrate cognitive deficits by making more errors in a learning and memory holeboard task as compared to wild-type control mice.","label":"Dodart J et al.; PDAPP mice demonstrate cognitive deficit...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:f18849ec-0df2-46b4-9d31-e06b0e046548"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:331730e8-1406-435f-970f-66d2bc869441&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:331730e8-1406-435f-970f-66d2bc869441","type":"Claim","title":"Knocking out PS1 also disrupts calcium signaling.","label":"Smith I et al.; Knocking out PS1 also disrupts calcium s...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:331730e8-1406-435f-970f-66d2bc869441"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9b60b96e-c579-4d3a-8adb-45903ec7a213&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9b60b96e-c579-4d3a-8adb-45903ec7a213","type":"Claim","title":"Previous studies in non-neuronal cells have shown that both Ca2+ and ROS are relevant to signaling via Src family protein tyrosine kinases.","label":"Lambert M et al.; Previous studies in non-neuronal cells h...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:9b60b96e-c579-4d3a-8adb-45903ec7a213"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:21121536-e792-4382-a1c1-9e836d68cf92&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:21121536-e792-4382-a1c1-9e836d68cf92","type":"Claim","title":"The task of defining any meaningful direct connection between pathological tau and transport disruption will require that primary effects on transport be distinguished from indirect effects that are secondary to neurodegeneration, which inevitably disrupts transport.","label":"Nixon R; The task of defining any meaningful dire...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Nixon Ralph A","id":"urn:lsid:swan.org:researchstatement:21121536-e792-4382-a1c1-9e836d68cf92"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4c1fc0e6-d0d1-425b-bdbc-b3981f37c3e7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4c1fc0e6-d0d1-425b-bdbc-b3981f37c3e7","type":"Claim","title":"The early role for oxidative damage preceding Aβ accumulation has been extensively documented in Alzheimer disease, Down syndrome and in transgenic models.","label":"Petersen R et al.; The early role for oxidative damage prec...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Castellani Rudolph J","Nunomura Akihiko","Zhu Xiongwei","Lee Hyoung-gon","Perry George","Smith Mark A"],"firstAuthor":"Petersen R B","id":"urn:lsid:swan.org:researchstatement:4c1fc0e6-d0d1-425b-bdbc-b3981f37c3e7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c6b5e3a5-3fa9-4db2-94ed-274c2fd72399&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c6b5e3a5-3fa9-4db2-94ed-274c2fd72399","type":"Claim","title":"Certain cyclooxygenase inhibitors (NSAIDS) and their derivatives lacking cyclooxygenase inhibition may have direct modulation effects on γ-secretase, and thereby reduce cytopathology in APP transgenic mice.","label":"Hardy J et al.; Certain cyclooxygenase inhibitors (NSAID...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:c6b5e3a5-3fa9-4db2-94ed-274c2fd72399"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b0bea6d0-8941-4ebe-ad91-8c5c0c2393a5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b0bea6d0-8941-4ebe-ad91-8c5c0c2393a5","type":"Claim","title":"Different from native Aβ42 dimers and cell-secreted or synthetic oligomers, which are neurotoxic, Aβ42 monomers are devoid of neurotoxicity in a number of different studies.","label":"Giuffrida M et al.; Different from native Aβ42 dimers and ce...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Caraci Filippo","Pignataro Bruno","Cataldo Sebastiano","De Bona Paolo","Bruno Valeria","Molinaro Gemma","Pappalardo Giuseppe","Messina Angela","Palmigiano Angelo","Garozzo Domenico","Nicoletti Ferdinando","Rizzarelli Enrico","Copani Agata"],"firstAuthor":"Giuffrida Maria Laura","referenceYear":"2009","referenceDate":"2009-08-26","id":"urn:lsid:swan.org:researchstatement:b0bea6d0-8941-4ebe-ad91-8c5c0c2393a5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:39eaba09-eb89-4e03-b865-ac99856a93ae&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:39eaba09-eb89-4e03-b865-ac99856a93ae","type":"Claim","title":"Further insight into the mechanistic roles of the different species of tau aggregates in neurodegenerative disease relies on the discovery of a wider set of molecular tools.","label":"Ballatore C et al.; Further insight into the mechanistic rol...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Lee Virginia M-Y","Trojanowski John Q"],"firstAuthor":"Ballatore Carlo","referenceYear":"2007","referenceDate":"2007-09","id":"urn:lsid:swan.org:researchstatement:39eaba09-eb89-4e03-b865-ac99856a93ae"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:155f1761-aeb1-4901-b030-eee80a0ef8ec&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:155f1761-aeb1-4901-b030-eee80a0ef8ec","type":"Hypothesis","title":"Amyloid-beta and its ability to disrupt intracellular calcium plays a key role in the process of synaptic dysfunction.","label":"Smith I et al.; Amyloid-beta and its ability to disrupt ...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith I F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:155f1761-aeb1-4901-b030-eee80a0ef8ec"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c1f83f01-3158-4112-a92e-634f08a29872&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c1f83f01-3158-4112-a92e-634f08a29872","type":"Claim","title":"No evidence of amyloidosis or amyloid plaque formation has been observed in the NRHypo animal model, which is consistent with the hypothesis that NRHypo by itself can produce many of the neuropathological features of AD. However, a major feature of our hypothesis is that amyloidopathy plus NRHypo can explain the AD syndrome better than NRHypo alone or amyloidopathy alone. ","label":"Olney J et al.; No evidence of amyloidosis or amyloid pl...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:c1f83f01-3158-4112-a92e-634f08a29872"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:47e1e319-78ad-4d01-9a5a-0827a1dce956&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:47e1e319-78ad-4d01-9a5a-0827a1dce956","type":"Claim","title":"For self-aggregation to occur in vitro, micromolar Aβ concentrations are required.","label":"Hartley D et al.; For self-aggregation to occur in vitro, ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:47e1e319-78ad-4d01-9a5a-0827a1dce956"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:49437c35-ea22-48c7-baf8-10c4c56e431c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:49437c35-ea22-48c7-baf8-10c4c56e431c","type":"Claim","title":"An Aβ/m266 native complex was readily detected in the plasma and cerebrospinal fluid (CSF) of PDAPP mice after administration of m266.","label":"Dodart J et al.; An Aβ/m266 native complex was readily de...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:49437c35-ea22-48c7-baf8-10c4c56e431c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2eb68388-723d-4bf8-a7ef-4eb600d689cd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2eb68388-723d-4bf8-a7ef-4eb600d689cd","type":"Claim","title":"It has been previously shown that m266 does not decorate amyloid deposits in PDAPP mice after peripheral administration.","label":"Dodart J et al.; It has been previously shown that m266 d...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:2eb68388-723d-4bf8-a7ef-4eb600d689cd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ea16b411-0698-47c8-baef-b32222483859&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ea16b411-0698-47c8-baef-b32222483859","type":"Claim","title":"The discrepancy between in vitro concentrations of Aβ needed for self-assembly versus physiological levels of Aβ suggests that a pure self-assembly mechanism may not account for oligomerization and aggregation in vivo.","label":"Hartley D et al.; The discrepancy between in vitro concent...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:ea16b411-0698-47c8-baef-b32222483859"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d6300570-52c6-4151-8628-8c3a60cd38b2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d6300570-52c6-4151-8628-8c3a60cd38b2","type":"Claim","title":"Strong neuroprotective activity of THOP1 overexpression (comparable to that obtained with BCL2), resulting in rescue of Aβ25\u201335 \u2013induced detrimental effects on neurite integrity indicates that THOP1 can preserve integrity of axons and dendrites challenged with Aβ, which in turn could be important to maintain synaptic structure, connectivity and functionality, all of which are compromised in AD.","label":"Pollio G et al.; Strong neuroprotective activity of THOP1...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hoozemans Jeroen J","Andersen Claus A","Roncarati Renza","Rosi Maria Cristina","van Haastert Elise S","Seredenina Tamara","Diamanti Daniela","Gotta Stefano","Fiorentini Anna","Magnoni Letizia","Raggiaschi Roberto","Rozemuller Annemieke J","Casamenti Fiorella","Caricasole Andrea","Terstappen Georg C"],"firstAuthor":"Pollio Giuseppe","referenceYear":"2008","referenceDate":"2008-07","id":"urn:lsid:swan.org:researchstatement:d6300570-52c6-4151-8628-8c3a60cd38b2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:53c4273a-cc70-4180-a013-faa9023a82a6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:53c4273a-cc70-4180-a013-faa9023a82a6","type":"Claim","title":"Insulin transiently increases tau phosphorylation in human neuroblastoma cells, but this is soon followed by a reduction in tau phosphorylation, which correlates with the activation and subsequent inhibition of GSK3.","label":"Hooper C et al.; Insulin transiently increases tau phosph...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:53c4273a-cc70-4180-a013-faa9023a82a6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:28768e6f-71f8-4a59-bed1-75ee86230ec3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:28768e6f-71f8-4a59-bed1-75ee86230ec3","type":"Claim","title":"Difficulties in studying cholesterol metabolism in CNS has hindered understanding of cholesterol&#8217;s role in regulating neuronal function and aging.","label":"Difficulties in studying cholesterol met...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:28768e6f-71f8-4a59-bed1-75ee86230ec3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:56ab7718-5a99-42c4-ae2b-fb32bc9dac5d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:56ab7718-5a99-42c4-ae2b-fb32bc9dac5d","type":"Claim","title":"Steady state levels of the RyR were significantly increased in the cortex of both PS1KI and 3xTg-AD cortex.","label":"Smith I et al.; Steady state levels of the RyR were sign...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:56ab7718-5a99-42c4-ae2b-fb32bc9dac5d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4e3582b9-1ba5-4dc3-8020-b8fd43bb37ae&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4e3582b9-1ba5-4dc3-8020-b8fd43bb37ae","type":"Hypothesis","title":"Alzheimer disease may represent a brain-specific form of diabetes, Type 3 diabetes.","label":"de la Monte S et al.; Alzheimer disease may represent a brain-...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Tong Ming","Lester-Coll Nataniel","Plater Michael","Wands Jack R"],"firstAuthor":"de la Monte Suzanne M","referenceYear":"2006","referenceDate":"2006-09","id":"urn:lsid:swan.org:researchstatement:4e3582b9-1ba5-4dc3-8020-b8fd43bb37ae"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:47d1dae9-de2c-48d8-9c61-f8e56dc8738a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:47d1dae9-de2c-48d8-9c61-f8e56dc8738a","type":"Claim","title":"More recent studies in Drosophila have also shown that FAD-associated mutations reduce the ability of fly PS to complement Notch-like phenotypes exhibited by PS-/- mutants.","label":"Shen J et al.; More recent studies in Drosophila have a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:47d1dae9-de2c-48d8-9c61-f8e56dc8738a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0e10c156-acf8-470e-9bbd-500ff102b86d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0e10c156-acf8-470e-9bbd-500ff102b86d","type":"Claim","title":"FAD APP mutations cause axonal trafficking defects and that that, in turn, stimulates the proteolytic processing of APP and generation of Aβ","label":"Kumar-Singh S; FAD APP mutations cause axonal trafficki...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Kumar-Singh Samir","id":"urn:lsid:swan.org:researchstatement:0e10c156-acf8-470e-9bbd-500ff102b86d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fd969c6f-8754-45e5-ac7d-1c33822b2c5f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fd969c6f-8754-45e5-ac7d-1c33822b2c5f","type":"Claim","title":"Intraneuronal accumulation of A&#946;42 is the main trigger for the pathological events leading to neuron loss and brain atrophy.","label":"Bayer T; Intraneuronal accumulation of A&#946;42 ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bayer T A","id":"urn:lsid:swan.org:researchstatement:fd969c6f-8754-45e5-ac7d-1c33822b2c5f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5dd99722-07e6-4046-981d-171149f4ce80&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5dd99722-07e6-4046-981d-171149f4ce80","type":"Claim","title":"The initiation of apoptosis in many systems involves the induction of a set of genes that participate in the regulation and/or control of cellular process preceding or required for the cell suicide.","label":"Cotman C et al.; The initiation of apoptosis in many syst...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:5dd99722-07e6-4046-981d-171149f4ce80"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7efb7a31-cfb1-4440-93d8-cfcbb3718929&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7efb7a31-cfb1-4440-93d8-cfcbb3718929","type":"Claim","title":"APP and APLP1 have a GxxxG motif in the transmembrane domain, like Glycophorin A (GPA) which allows stable SDS-resistant dimers in a lipid bilayer.","label":"Marchesi V; APP and APLP1 have a GxxxG motif in the ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:7efb7a31-cfb1-4440-93d8-cfcbb3718929"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7216f9b5-7f32-4638-ad4d-f6bcd3d091a8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7216f9b5-7f32-4638-ad4d-f6bcd3d091a8","type":"Claim","title":"Resveratrol is a polyphenolic SIRT1-activating compound (STAC).","label":"Kim D et al.; Resveratrol is a polyphenolic SIRT1-acti...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:7216f9b5-7f32-4638-ad4d-f6bcd3d091a8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:248a4c4e-5e30-4933-8f8c-ada61ce7b564&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:248a4c4e-5e30-4933-8f8c-ada61ce7b564","type":"Claim","title":"Abolished cleavage of type III neuregulin-1 (and perhaps neuregulin-3) in BACE1-null mice may cause hypomyelination of nerves in the developmental central and peripheral nervous systems, delayed remyelination of adult sciatic nerves and may contribute to schizophrenia-like behaviors because genetic mutation of neuregulin-1 is linked to the pathogenesis of schizophrenia.","label":"Hu X et al.; Abolished cleavage of type III neureguli...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhou Xiangdong","He Wanxia","Yang Jun","Xiong Wencheng","Wong Philip","Wilson Christopher G","Yan Riqiang"],"firstAuthor":"Hu Xiangyou","referenceYear":"2010","referenceDate":"2010-06-30","id":"urn:lsid:swan.org:researchstatement:248a4c4e-5e30-4933-8f8c-ada61ce7b564"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:79ddd18a-d985-4fe1-981e-dcbb682ce14a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:79ddd18a-d985-4fe1-981e-dcbb682ce14a","type":"Claim","title":"DNA isolated from neurons treated with Aβ for 24 hours exhibits a ladder of oligonucleosome-length fragments, a reproducible effect observed in both short- and longterm neuronal culture paradigms.","label":"Cotman C et al.; DNA isolated from neurons treated with A...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:79ddd18a-d985-4fe1-981e-dcbb682ce14a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:812a1aef-b34f-48e7-a925-348a198781ac&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:812a1aef-b34f-48e7-a925-348a198781ac","type":"Claim","title":"There is a critical need for studies to understand how perturbations in tau expression levels or tau pathologies are linked to axonal transport failure and tau-mediated neurodegeneration in Alzheimer disease (AD) and related tauopathies.","label":"Lee V et al.; There is a critical need for studies to ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Trojanowski John Q"],"firstAuthor":"Lee Virginia M-Y","id":"urn:lsid:swan.org:researchstatement:812a1aef-b34f-48e7-a925-348a198781ac"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2cedf47a-f928-4213-b434-c311227aafbc&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2cedf47a-f928-4213-b434-c311227aafbc","type":"Claim","title":"Tramiprosate (Alzhemed™, Neurochem Inc.) is a pharmacological agent with a proposed mode of action of blocking Aβ aggregation, not reducing Aβ per se. Its development was in part based on the amyloid hypothesis.","label":"Small S et al.; Tramiprosate (Alzhemed™, Neurochem Inc.)...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:2cedf47a-f928-4213-b434-c311227aafbc"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:67327613-1ee1-45d0-9a8f-c702add6621c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:67327613-1ee1-45d0-9a8f-c702add6621c","type":"Claim","title":"High concentrations of Aβ, and protofibrillar Aβ have been shown to inhibit or block I<sub>KA<\/sub>.","label":"Plant L et al.; High concentrations of Aβ, and protofibr...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:67327613-1ee1-45d0-9a8f-c702add6621c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0396e347-dcba-4beb-bf18-54581615ed11&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0396e347-dcba-4beb-bf18-54581615ed11","type":"Claim","title":"Even moderate increases in IDE activity can lead to dramatic changes in steady-state Aβ levels as well as overall amyloid plaque burden.","label":"Tanzi R et al.; Even moderate increases in IDE activity ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:0396e347-dcba-4beb-bf18-54581615ed11"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:22a96d3d-36d4-4894-9306-3710f49e122d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:22a96d3d-36d4-4894-9306-3710f49e122d","type":"Claim","title":"Thop1 could also indirectly affect Aβ degradation by degrading a peptide inhibitor of a serine protease, acyl peptide hydrolase (APEH).","label":"Abraham C; Thop1 could also indirectly affect Aβ de...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Abraham Carmela R","id":"urn:lsid:swan.org:researchstatement:22a96d3d-36d4-4894-9306-3710f49e122d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3229a6d8-9772-4394-a004-7288670a835a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3229a6d8-9772-4394-a004-7288670a835a","type":"Claim","title":"Proteasome impairment by beta-amyloid has also been reported to result from the aggregated protein structure rather than from a specific effect of the protein itself.","label":"Keck S et al.; Proteasome impairment by beta-amyloid ha...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:3229a6d8-9772-4394-a004-7288670a835a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:86efc41e-2ba8-468b-b616-03acddc3b268&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:86efc41e-2ba8-468b-b616-03acddc3b268","type":"Claim","title":"Calsenilin is important in solubilization and membrane localization of Kv4 &#945;-subunits.","label":"Plant L et al.; Calsenilin is important in solubilizatio...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:86efc41e-2ba8-468b-b616-03acddc3b268"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:07453da8-f79b-4535-a6d1-3d47c6377be0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:07453da8-f79b-4535-a6d1-3d47c6377be0","type":"Claim","title":"In vitro evidence suggests that LDLR and LRP may be involved in apoE-mediated Aβ clearance.","label":"Holtzman D; In vitro evidence suggests that LDLR and...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:07453da8-f79b-4535-a6d1-3d47c6377be0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:342baa89-4f72-4566-96b1-84ff966c5c7e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:342baa89-4f72-4566-96b1-84ff966c5c7e","type":"Claim","title":"Decreased levels of CNP are reported in late myelinating regions in AD as well as trisomy 21.","label":"Bartzokis G; Decreased levels of CNP are reported in ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:342baa89-4f72-4566-96b1-84ff966c5c7e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:76182786-3023-4a63-9662-5d8fc0e044d0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:76182786-3023-4a63-9662-5d8fc0e044d0","type":"Claim","title":"The surprising absence of a significant effect of moderate overexpression of tau to directly impair axonal transport was clear and is compatible with existing data.","label":"Nixon R; The surprising absence of a significant ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Nixon Ralph A","id":"urn:lsid:swan.org:researchstatement:76182786-3023-4a63-9662-5d8fc0e044d0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d7fd2eb2-b65f-41ed-a0e8-ea54c9de3038&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d7fd2eb2-b65f-41ed-a0e8-ea54c9de3038","type":"Claim","title":"Genetic studies have either directly or indirectly linked GSK3 activity to late-onset AD (LOAD).","label":"Small S et al.; Genetic studies have either directly or ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:d7fd2eb2-b65f-41ed-a0e8-ea54c9de3038"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b5cc7680-252b-425c-94da-fbddc0556843&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b5cc7680-252b-425c-94da-fbddc0556843","type":"Claim","title":"Molecular pathways that control aging must be analyzed in their effects on AD pathogenesis.","label":"Molecular pathways that control aging mu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:b5cc7680-252b-425c-94da-fbddc0556843"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:aea7db4d-681d-465a-ab53-2ca6f757dbbd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:aea7db4d-681d-465a-ab53-2ca6f757dbbd","type":"Claim","title":"It has been suggested that alterations in axonal trafficking and morphological abnormalities precede and lead to senile plaques","label":"Meyer-Luehmann M et al.; It has been suggested that alterations i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:aea7db4d-681d-465a-ab53-2ca6f757dbbd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ec046b86-c01c-4a0b-9c5a-40189e3f555c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ec046b86-c01c-4a0b-9c5a-40189e3f555c","type":"Claim","title":"ADDLs have profound neurological effects well in advance of tissue damage.","label":"Lambert M et al.; ADDLs have profound neurological effects...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:ec046b86-c01c-4a0b-9c5a-40189e3f555c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5f099801-ff84-404f-b24d-7a1d950f49dd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5f099801-ff84-404f-b24d-7a1d950f49dd","type":"Claim","title":"Antibody/Aβ complex could be detected in CSF samples from PDAPP mice treated with the highest dose of m266 (250 μg), which was the lowest dose found to be effective in reversing learning and memory impairment in this experiment.","label":"Dodart J et al.; Antibody/Aβ complex could be detected in...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:5f099801-ff84-404f-b24d-7a1d950f49dd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:4ddda534-8f75-488b-a47f-525f5bcebd11&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:4ddda534-8f75-488b-a47f-525f5bcebd11","type":"Comment","title":"Holzbaur on Yuan","label":"Holzbaur E; Holzbaur on Yuan","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Holzbaur Erika L F","referenceYear":"2008","referenceDate":"2008-02-03","id":"urn:lsid:swan.org:comment:4ddda534-8f75-488b-a47f-525f5bcebd11"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:47f4c767-d021-4beb-9b59-e6a0812ef7c7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:47f4c767-d021-4beb-9b59-e6a0812ef7c7","type":"Claim","title":"Modulating cholesterol homeostasis may affect AD via an effect on APP processing.","label":"Hardy J et al.; Modulating cholesterol homeostasis may a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:47f4c767-d021-4beb-9b59-e6a0812ef7c7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bcaa7628-2726-4209-b02a-483ce5652197&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bcaa7628-2726-4209-b02a-483ce5652197","type":"Claim","title":"The oligopeptidase THOP1 as a phosphoprotein whose levels are increased upon Aβ exposure. ","label":"Pollio G et al.; The oligopeptidase THOP1 as a phosphopro...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hoozemans Jeroen J","Andersen Claus A","Roncarati Renza","Rosi Maria Cristina","van Haastert Elise S","Seredenina Tamara","Diamanti Daniela","Gotta Stefano","Fiorentini Anna","Magnoni Letizia","Raggiaschi Roberto","Rozemuller Annemieke J","Casamenti Fiorella","Caricasole Andrea","Terstappen Georg C"],"firstAuthor":"Pollio Giuseppe","referenceYear":"2008","referenceDate":"2008-07","id":"urn:lsid:swan.org:researchstatement:bcaa7628-2726-4209-b02a-483ce5652197"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:efe6697a-2a95-4f16-aef6-b0cf4e42f8c1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:efe6697a-2a95-4f16-aef6-b0cf4e42f8c1","type":"Claim","title":"One unusual feature of γ-secretase is its relaxed sequence specificity, as evidenced by lack of strong sequence similarity in its substrates and its tendency to cleave some substrates at a series of neighboring intramembranous residues.","label":"Shen J et al.; One unusual feature of γ-secretase is it...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:efe6697a-2a95-4f16-aef6-b0cf4e42f8c1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:07babaf4-68e5-423e-87e0-048bcb25378b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:07babaf4-68e5-423e-87e0-048bcb25378b","type":"Claim","title":"Binding to heat shock proteins, induction of autophagy and binding to intracellular PRRs can all activate the innate immune system.","label":"Golde T et al.; Binding to heat shock proteins, inductio...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:07babaf4-68e5-423e-87e0-048bcb25378b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:033d51a9-88f9-452b-a3df-24c13f27d197&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:033d51a9-88f9-452b-a3df-24c13f27d197","type":"Claim","title":"Missense mutations in the PS genes are a major cause of familial Alzheimer\u2019s Disease.","label":"Bentahir M et al.; Missense mutations in the PS genes are a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:033d51a9-88f9-452b-a3df-24c13f27d197"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0b74039f-4f9e-4f4d-a41d-9075b22f6c52&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0b74039f-4f9e-4f4d-a41d-9075b22f6c52","type":"Claim","title":"Aβ42 demonstrates enhanced neurotoxicity relative to Aβ40.","label":"Bitan G et al.; Aβ42 demonstrates enhanced neurotoxicity...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:0b74039f-4f9e-4f4d-a41d-9075b22f6c52"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b268df1c-668a-4fbf-ac85-b4fe182dae29&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b268df1c-668a-4fbf-ac85-b4fe182dae29","type":"Claim","title":"Proteinopathy-mediated activation of innate immunity results in chronic inflammation.","label":"Golde T et al.; Proteinopathy-mediated activation of inn...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:b268df1c-668a-4fbf-ac85-b4fe182dae29"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:48d61b2a-8981-4f09-b243-527082336cd1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:48d61b2a-8981-4f09-b243-527082336cd1","type":"Claim","title":"In hippocampus, Gab2 immunoreactivity was observed in structures with the morphology of dystrophic neurites or neuropil threads, neurons, and corpora amylacea in late-onset AD (LOAD) cases. ","label":"Reiman E et al.; In hippocampus, Gab2 immunoreactivity wa...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Jennifer A","Myers Amanda J","Hardy John","Dunckley Travis","Zismann Victoria L","Joshipura Keta D","Pearson John V","Hu-Lince Diane","Huentelman Matthew J","Craig David W","Coon Keith D","Liang Winnie S","Herbert RiLee H","Beach Thomas","Rohrer Kristen C","Zhao Alice S","Leung Doris","Bryden Leslie","Marlowe Lauren","Kaleem Mona","Mastroeni Diego","Grover Andrew","Heward Christopher B","Ravid Rivka","Rogers Joseph","Hutton Michael L","Melquist Stacey","Petersen Ron C","Alexander Gene E","Caselli Richard J","Kukull Walter","Papassotiropoulos Andreas","Stephan Dietrich A"],"firstAuthor":"Reiman Eric M","referenceYear":"2007","referenceDate":"2007-06-07","id":"urn:lsid:swan.org:researchstatement:48d61b2a-8981-4f09-b243-527082336cd1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:54ea93b4-4854-47fc-933c-056b67aa1ac9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:54ea93b4-4854-47fc-933c-056b67aa1ac9","type":"Claim","title":"Using a set of \u201ccortical signature of AD\u201d regions of interest (ROIs), patients with mild AD who carry at least one APOE ε4 allele (\u201ccarriers\u201d) from a relatively large sample of mild AD patients with a CSF molecular profile with a CSF t-tau/Aβ1\u201342 in the \u201cAD range\u201d displayed reduced cortical thickness in the medial temporal lobe (MTL), caudal temporal cortex and occipital regions and had smaller hippocampal volume than the noncarriers with the latter comparison reaching statistical significance.","label":"Wolk D et al.; Using a set of \u201ccortical signature of AD...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Dickerson Bradford C","Weiner Michael","Aiello Marilyn","Aisen Paul","Albert Marilyn S","Alexander Gene","Anderson Heather S","Anderson Karen","Apostolova Liana","Arnold Steve","Ashford Wes","Assaly Michele","Asthana Sanjay","Bandy Dan","Bartha Rob","Bates Vernice","Beckett Laurel","Bell Karen L","Benincasa Amanda L","Bergman Howard","Bernick Charles","Bernstein Matthew","Black Sandra","Blank Karen","Borrie Michael","Brand Connie","Brewer James","Brown Alice D","Burns Jeffrey M","Cairns Nigel J","Caldwell Curtis","Capote Horacio","Carlsson Cynthia M","Carmichael Owen","Cellar Janet S","Celmins Dzintra","Chen Kewei","Chertkow Howard","Chowdhury Munir","Clark David","Connor Donald","Correia Stephen","Crawford Karen","Dale Anders","de Leon Mony J","De Santi Susan M","Decarli Charles","Detoledo-Morrell Leyla","Devous Michael","Diaz-Arrastia Ramon","Dolen Sara","Donohue Michael","Doody Rachelle S","Doraiswamy P Murali","Duara Ranjan","Englert Jessica","Farlow Martin","Feldman Howard","Felmlee Joel","Fleisher Adam","Fletcher Evan","Foroud Tatiana M","Foster Norm","Fox Nick","Frank Richard","Gamst Anthony","Given Curtis A","Graff-Radford Neill R","Green Robert C","Griffith Randall","Grossman Hillel","Hake Ann M","Hardy Peter","Harvey Danielle","Heidebrink Judith L","Hendin Barry A","Herring Scott","Honig Lawrence S","Hosein Chris","Robin Hsiung Ging-Yuek","Hudson Leon","Ismail M Saleem","Jack Clifford R","Jacobson Sandra","Jagust William","Jayam-Trouth Annapurni","Johnson Kris","Johnson Heather","Johnson Nancy","Johnson Kathleen","Johnson Keith A","Johnson Sterling","Kachaturian Zaven","Karlawish Jason H","Kataki Maria","Kaye Jeffrey","Kertesz Andrew","Killiany Ronald","Kittur Smita","Koeppe Robert A","Korecka Magdalena","Kornak John","Kozauer Nicholas","Lah James J","Laubinger Mary M","Lee Virginia M-Y","Lee T-Y","Lerner Alan","Levey Allan I","Longmire Crystal Flynn","Lopez Oscar L","Lord Joanne L","Lu Po H","Macavoy Martha G","Malloy Paul","Marson Daniel","Martin-Cook Kristen","Martinez Walter","Marzloff George","Mathis Chet","Mc-Adams-Ortiz Catherine","Mesulam Marsel","Miller Bruce L","Mintun Mark A","Mintzer Jacobo","Molchan Susan","Montine Tom","Morris John","Mulnard Ruth A","Munic Donna","Nair Anil","Neu Scott","Nguyen Dana","Norbash Alexander","Oakley Maryann","Obisesan Thomas O","Ogrocki Paula","Ott Brian R","Parfitt Francine","Pawluczyk Sonia","Pearlson Godfrey","Petersen Ronald","Petrella Jeffrey R","Potkin Steven","Potter William Z","Preda Adrian","Quinn Joseph","Rainka Michelle","Reeder Stephanie","Reiman Eric M","Rentz Dorene M","Reynolds Brigid","Richard Jennifer","Roberts Peggy","Rogers John","Rosen Allyson","Rosen Howard J","Rusinek Henry","Sabbagh Marwan","Sadowsky Carl","Salloway Stephen","Santulli Robert B","Saykin Andrew J","Scharre Douglas W","Schneider Lon","Schneider Stacy","Schuff Norbert","Shah Raj C","Shaw Les","Shen Li","Silverman Daniel H","Simpson Donna M","Sink Kaycee M","Smith Charles D","Snyder Peter J","Spann Bryan M","Sperling Reisa A","Spicer Kenneth","Stefanovic Bojana","Stern Yaakov","Stopa Edward","Tang Cheuk","Tariot Pierre","Taylor-Reinwald Lisa","Thai Gaby","Thomas Ronald G","Thompson Paul","Tinklenberg Jared","Toga Arthur W","Tremont Geoffrey","Trojanowki J Q","Trost Dick","Turner Raymond Scott","van Dyck Christopher H","Vanderswag Helen","Varon Daniel","Villanueva-Meyer Javier","Villena Teresa","Walter Sarah","Wang Paul","Watkins Franklin","Weiner Michael","Williamson Jeff D","Wolk David","Wu Chuang-Kuo","Zerrate Maria","Zimmerman Earl A"],"firstAuthor":"Wolk David A","referenceYear":"2010","referenceDate":"2010-05-17","id":"urn:lsid:swan.org:researchstatement:54ea93b4-4854-47fc-933c-056b67aa1ac9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2c0b4f73-e611-4cf6-b729-3ed758045acf&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2c0b4f73-e611-4cf6-b729-3ed758045acf","type":"Claim","title":"Mutations in both genes encoding APP and tau cause dementing illness.","label":"Small S et al.; Mutations in both genes encoding APP and...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:2c0b4f73-e611-4cf6-b729-3ed758045acf"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8c2676fa-d364-4945-9dfa-e5b1f2de7586&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8c2676fa-d364-4945-9dfa-e5b1f2de7586","type":"Claim","title":"FAD PS1-A246E mutant partially rescues notch signalling-deficient phenotypes in Ps1-deficient mice, suggesting at least partial function.","label":"Bentahir M et al.; FAD PS1-A246E mutant partially rescues n...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:8c2676fa-d364-4945-9dfa-e5b1f2de7586"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:49795848-23ba-4b99-b6be-fdf66881bb5d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:49795848-23ba-4b99-b6be-fdf66881bb5d","type":"Claim","title":"Remaining unanswered questions regarding Aβ metabolism will add new therapeutic approaches and add further focus to existing strategies.","label":"Golde T; Remaining unanswered questions regarding...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde T","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:49795848-23ba-4b99-b6be-fdf66881bb5d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:17a92e67-086f-493b-9076-735d8625164a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:17a92e67-086f-493b-9076-735d8625164a","type":"Claim","title":"Whereas IP3 stimulates calcium release from the IP3R, calcium ions stimulate the release of calcium through the RyR.","label":"Smith I et al.; Whereas IP3 stimulates calcium release f...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:17a92e67-086f-493b-9076-735d8625164a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:92cd836a-3df8-443e-a5a2-4816e8d47b78&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:92cd836a-3df8-443e-a5a2-4816e8d47b78","type":"Claim","title":"Tau degradation pathways might be viewed as a hierarchy, preferentially sending misfolded tau into a ubiquitin-independent route, then to a less efficient, ubiquitin-dependent degradation pathway.  ","label":"Carrettiero D et al.; Tau degradation pathways might be viewed...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hernandez Israel","Neveu Pierre","Papagiannakopoulos Thales","Kosik Kenneth S"],"firstAuthor":"Carrettiero Daniel C","referenceYear":"2009","referenceDate":"2009-02-18","id":"urn:lsid:swan.org:researchstatement:92cd836a-3df8-443e-a5a2-4816e8d47b78"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4024f1a7-f27e-4b56-99f4-10668d3b1e19&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4024f1a7-f27e-4b56-99f4-10668d3b1e19","type":"Claim","title":"A statistical interaction between the ApoEε4 status and the CLU SNP rs11136000 was detected, and although the association was significant in both ε4 carriers and non-carriers, it was more significant in ApoEε4 carriers.","label":"Lambert J et al.; A statistical interaction between the Ap...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Heath Simon","Even Gael","Campion Dominique","Sleegers Kristel","Hiltunen Mikko","Combarros Onofre","Zelenika Diana","Bullido Maria J","Tavernier Béatrice","Letenneur Luc","Bettens Karolien","Berr Claudine","Pasquier Florence","Fiévet Nathalie","Barberger-Gateau Pascale","Engelborghs Sebastiaan","De Deyn Peter","Mateo Ignacio","Franck Ana","Helisalmi Seppo","Porcellini Elisa","Hanon Olivier","de Pancorbo Marian M","Lendon Corinne","Dufouil Carole","Jaillard Céline","Leveillard Thierry","Alvarez Victoria","Bosco Paolo","Mancuso Michelangelo","Panza Francesco","Nacmias Benedetta","Bossù Paola","Piccardi Paola","Annoni Giorgio","Seripa Davide","Galimberti Daniela","Hannequin Didier","Licastro Federico","Soininen Hilkka","Ritchie Karen","Blanché Hélène","Dartigues Jean-François","Tzourio Christophe","Gut Ivo","Van Broeckhoven Christine","Alpérovitch Annick","Lathrop Mark","Amouyel Philippe"],"firstAuthor":"Lambert Jean-Charles","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:4024f1a7-f27e-4b56-99f4-10668d3b1e19"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f9f127cb-d269-4602-b099-893c69ba39c4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f9f127cb-d269-4602-b099-893c69ba39c4","type":"Claim","title":"Autosomal dominant mutations have been identified in three separate genes which contribute to the autosomal dominant, early-onset, form of this disease: Amyloid Precursor Protein (APP), Presenilin 1 (PS1) and Presenilin 2 (PS2); these account for an estimated 5\u201310% of all AD cases.","label":"Cook L et al.; Autosomal dominant mutations have been i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Ho Luk W","Taylor Alison E","Brayne Carol","Evans John Grimley","Xuereb John","Cairns Nigel J","Pritchard Antonia","Lemmon Helen","Mann David","St Clair David","Turic Dragana","Hollingworth Paul","Moore Pamela J","Jehu Luke","Archer Nicola","Walter Sarah","Foy Catherine","Edmondson Amanda","Powell John","Lovestone Simon","Owen Michael J","Williams Julie","Lendon Corinne","Rubinsztein David C"],"firstAuthor":"Cook Lynnette J","referenceYear":"2004","referenceDate":"2004-03-25","id":"urn:lsid:swan.org:researchstatement:f9f127cb-d269-4602-b099-893c69ba39c4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c23ac44d-371d-44d7-bd93-80525ae47942&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c23ac44d-371d-44d7-bd93-80525ae47942","type":"Claim","title":"Analysis of Aβ profiles both by mass spectrometry and urea gel electrophoresis demonstrates that loss of γ-secretase activity by PS clinical mutations affected Aβ1-33/34, Aβ1-37, Aβ1-38, Aβ1-40 to a similar extent, but not the cleavage of Aβ1-42.","label":"Bentahir M et al.; Analysis of Aβ profiles both by mass spe...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:c23ac44d-371d-44d7-bd93-80525ae47942"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:07da42b5-e29d-438d-83e3-d910481bc1c2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:07da42b5-e29d-438d-83e3-d910481bc1c2","type":"Claim","title":"There is increased GSK3β activity in the frontal cortex in AD and upregulated expression in the hippocampus of AD patients and in post-synaptosomal supernatants derived from AD brain.","label":"Hooper C et al.; There is increased GSK3β activity in the...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:07da42b5-e29d-438d-83e3-d910481bc1c2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:83f3fcc9-dab5-4449-a94d-f5543de84281&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:83f3fcc9-dab5-4449-a94d-f5543de84281","type":"Claim","title":"Anti-Aβ immunization could fail to reduce the concentration of oligomeric Aβ and even increase the concentration of oligomeric Aβ during the active phase of disintegration of Aβ plaques.","label":"Holmes C et al.; Anti-Aβ immunization could fail to reduc...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:83f3fcc9-dab5-4449-a94d-f5543de84281"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cb2dce36-9ef7-430c-8874-94d359ad8f54&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cb2dce36-9ef7-430c-8874-94d359ad8f54","type":"Claim","title":"GAB2 is the principal activator of the phosphatidylinositol 3-kinase (PI3K) signaling pathway. ","label":"Reiman E et al.; GAB2 is the principal activator of the p...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Jennifer A","Myers Amanda J","Hardy John","Dunckley Travis","Zismann Victoria L","Joshipura Keta D","Pearson John V","Hu-Lince Diane","Huentelman Matthew J","Craig David W","Coon Keith D","Liang Winnie S","Herbert RiLee H","Beach Thomas","Rohrer Kristen C","Zhao Alice S","Leung Doris","Bryden Leslie","Marlowe Lauren","Kaleem Mona","Mastroeni Diego","Grover Andrew","Heward Christopher B","Ravid Rivka","Rogers Joseph","Hutton Michael L","Melquist Stacey","Petersen Ron C","Alexander Gene E","Caselli Richard J","Kukull Walter","Papassotiropoulos Andreas","Stephan Dietrich A"],"firstAuthor":"Reiman Eric M","referenceYear":"2007","referenceDate":"2007-06-07","id":"urn:lsid:swan.org:researchstatement:cb2dce36-9ef7-430c-8874-94d359ad8f54"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:aa4174f4-e1fe-457a-bbb7-eb90cb40fa24&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:aa4174f4-e1fe-457a-bbb7-eb90cb40fa24","type":"Claim","title":"γ-secretase cleaves many substrates including APP, Notch, and syndecan 3 in the hydrophobic environment of the membrane.","label":"Bentahir M et al.; γ-secretase cleaves many substrates incl...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:aa4174f4-e1fe-457a-bbb7-eb90cb40fa24"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:95ba2444-02a2-4141-8a99-0cf55019f466&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:95ba2444-02a2-4141-8a99-0cf55019f466","type":"Claim","title":"The role of tau in axonal transport is complicated, since studies have shown that Tau-4R mice have impaired axonal transport which can be rescued by GSK-3β and is aggravated by lithium","label":"Van Leuven F; The role of tau in axonal transport is c...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Van Leuven Fred","id":"urn:lsid:swan.org:researchstatement:95ba2444-02a2-4141-8a99-0cf55019f466"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:10867c13-f1a7-45ce-b2d3-4bf2c90ecfa5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:10867c13-f1a7-45ce-b2d3-4bf2c90ecfa5","type":"Claim","title":"In m266-immunized mice, plasma Aβ concentrations increase markedly and can be completely depleted when samples are treated with protein G, indicating that the antibody binds to and completely sequesters plasma Aβ.","label":"Dodart J et al.; In m266-immunized mice, plasma Aβ concen...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:10867c13-f1a7-45ce-b2d3-4bf2c90ecfa5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:51726373-3c8d-406a-9d7f-ea8743fee3f6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:51726373-3c8d-406a-9d7f-ea8743fee3f6","type":"Claim","title":"Histopathological studies that show co-localization of inflammatory cells and mediators with amyloid plaques and in vivo studies using multiphoton imaging that show the rapid mobilization of microglia to newly formed plaques.","label":"Golde T et al.; Histopathological studies that show co-l...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:51726373-3c8d-406a-9d7f-ea8743fee3f6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fb58fb10-82e7-4574-aa05-8d15582ba09d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fb58fb10-82e7-4574-aa05-8d15582ba09d","type":"Claim","title":"BAG2 lacks the ubiquitin-like domain, and therefore, may be suited to triage client proteins independently of ubiquitin.","label":"Carrettiero D et al.; BAG2 lacks the ubiquitin-like domain, an...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hernandez Israel","Neveu Pierre","Papagiannakopoulos Thales","Kosik Kenneth S"],"firstAuthor":"Carrettiero Daniel C","referenceYear":"2009","referenceDate":"2009-02-18","id":"urn:lsid:swan.org:researchstatement:fb58fb10-82e7-4574-aa05-8d15582ba09d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:da3c2a89-2a0a-4b1b-b2bf-1f1362921419&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:da3c2a89-2a0a-4b1b-b2bf-1f1362921419","type":"Claim","title":"In AD brains Thop1 was upregulated and associated with the plaque and tangle neuropathology, including tangles, as we showed earlier that tangles and neuritic abnormalities are immunoreactive with THOP1 monoclonal antibodies we produced. ","label":"In AD brains Thop1 was upregulated and a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:da3c2a89-2a0a-4b1b-b2bf-1f1362921419"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5e07e798-f2a1-484d-aa66-9390e0c81cd2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5e07e798-f2a1-484d-aa66-9390e0c81cd2","type":"Claim","title":"γ-secretase inhibitors bind at different sites of the γ-secretase complex,","label":"Bentahir M et al.; γ-secretase inhibitors bind at different...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:5e07e798-f2a1-484d-aa66-9390e0c81cd2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b48377d8-8fab-4e29-b2d8-b39ff3b8cc66&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b48377d8-8fab-4e29-b2d8-b39ff3b8cc66","type":"Claim","title":"c-Jun is also induced with a similar time course in the Concanavalin A model of activation-induced cell death, mimicking some aspects of Aβ toxicity in cultured neurons.","label":"Cotman C et al.; c-Jun is also induced with a similar tim...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:b48377d8-8fab-4e29-b2d8-b39ff3b8cc66"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e6dcc9aa-6d9f-44d2-b55d-bd05ad6018dd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e6dcc9aa-6d9f-44d2-b55d-bd05ad6018dd","type":"Claim","title":"Neuronal loss may be caused by mechanisms of necrosis or apoptosis.","label":"Cotman C et al.; Neuronal loss may be caused by mechanism...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:e6dcc9aa-6d9f-44d2-b55d-bd05ad6018dd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ed42f63c-4704-4ea7-801e-184a4fa2b606&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ed42f63c-4704-4ea7-801e-184a4fa2b606","type":"Claim","title":"Blocking the α7nicotinic acetylcholine receptor with an antagonist could lessen some of the symptoms of AD.","label":"Dziewczapolski G et al.; Blocking the α7nicotinic acetylcholine r...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Glogowski Carolina M","Masliah Eliezer","Heinemann Stephen F"],"firstAuthor":"Dziewczapolski Gustavo","referenceYear":"2009","referenceDate":"2009-07-08","id":"urn:lsid:swan.org:researchstatement:ed42f63c-4704-4ea7-801e-184a4fa2b606"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0beebcba-48d4-4c44-b9e4-aa061561024d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0beebcba-48d4-4c44-b9e4-aa061561024d","type":"Claim","title":"Formation of Aβ ion channels in the mitochondrial membranes may disrupt mitochondrial membrane potential impairing energy production and leading to apoptosis.","label":"Smith I et al.; Formation of Aβ ion channels in the mito...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:0beebcba-48d4-4c44-b9e4-aa061561024d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:279d48e0-27eb-415a-9ca1-c9f0e12e1381&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:279d48e0-27eb-415a-9ca1-c9f0e12e1381","type":"Hypothesis","title":"Statins reduce risk of Alzheimer disease.","label":"Wolozin B et al.; Statins reduce risk of Alzheimer disease...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Kellman W","Ruosseau P","Celesia G G","Siegel G"],"firstAuthor":"Wolozin B","referenceYear":"2000","referenceDate":"2000-10","id":"urn:lsid:swan.org:researchstatement:279d48e0-27eb-415a-9ca1-c9f0e12e1381"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e1486c88-81f3-4c2c-b9b7-41c407131bd9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e1486c88-81f3-4c2c-b9b7-41c407131bd9","type":"Claim","title":"Soluble oligomers of Aβ, not monomeric Aβ or insoluble fibrillar Aβ, may be responsible for synaptic dysfunction in brains of AD patients and animal models of AD.","label":"Hardy J et al.; Soluble oligomers of Aβ, not monomeric A...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:e1486c88-81f3-4c2c-b9b7-41c407131bd9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ad8e0c22-c990-4bbd-a617-4dcf474e42b0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ad8e0c22-c990-4bbd-a617-4dcf474e42b0","type":"Claim","title":"Cells with high levels of anti-apoptotic proteins often undergo senescence whereas cells with lower levels of anti-apoptotic factors seem prone to undergo apoptosis.","label":"Golde T et al.; Cells with high levels of anti-apoptotic...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:ad8e0c22-c990-4bbd-a617-4dcf474e42b0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:08df1530-67d6-4c49-809a-8b5f4fa1b47c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:08df1530-67d6-4c49-809a-8b5f4fa1b47c","type":"Claim","title":"APPSw but not APPV717F develop prominent CAA.","label":"Holtzman D; APPSw but not APPV717F develop prominent...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:08df1530-67d6-4c49-809a-8b5f4fa1b47c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:46311a65-9231-4868-af6f-322ae4a725b0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:46311a65-9231-4868-af6f-322ae4a725b0","type":"Claim","title":"Although murine apoE is homologous to human apoE, it differs by 25% at the amino acid level.","label":"Fryer J et al.; Although murine apoE is homologous to hu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:46311a65-9231-4868-af6f-322ae4a725b0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:78033f18-1ef9-4f8b-80be-41a444ee11cf&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:78033f18-1ef9-4f8b-80be-41a444ee11cf","type":"Claim","title":"It has been hypothesized that the α7 nicotinic acetylcholine receptor subunit plays a role in AD.","label":"Dziewczapolski G et al.; It has been hypothesized that the α7 nic...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Glogowski Carolina M","Masliah Eliezer","Heinemann Stephen F"],"firstAuthor":"Dziewczapolski Gustavo","referenceYear":"2009","referenceDate":"2009-07-08","id":"urn:lsid:swan.org:researchstatement:78033f18-1ef9-4f8b-80be-41a444ee11cf"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:256c690e-109c-4844-ba03-e0ce6bd3a371&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:256c690e-109c-4844-ba03-e0ce6bd3a371","type":"Claim","title":"In AD and other CNS proteinopathies some species of the aggregated misfolded protein are directly neurotoxic.","label":"Golde T et al.; In AD and other CNS proteinopathies some...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:256c690e-109c-4844-ba03-e0ce6bd3a371"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a3649a1f-0fae-4b80-acc0-7b3ae95dbaf0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a3649a1f-0fae-4b80-acc0-7b3ae95dbaf0","type":"Claim","title":"PrPc participates in cellular signaling. ","label":"Prado M; PrPc participates in cellular signaling....","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Prado Marco","referenceYear":"2009","referenceDate":"2009-03-24","id":"urn:lsid:swan.org:researchstatement:a3649a1f-0fae-4b80-acc0-7b3ae95dbaf0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:61739237-2bfc-4a46-b1e2-13bee12ae85b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:61739237-2bfc-4a46-b1e2-13bee12ae85b","type":"Claim","title":"Blockage of the hyperpolarizing A-type K+ channels makes the dendrites more excitable, by raising the resting membrane potential closer to the firing threshold and preventing the repolarization during action potentials.","label":"Morse T et al.; Blockage of the hyperpolarizing A-type K...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Mutalik Pradeep","Cheung Kei","Miller Perry L","Shepherd Gordon"],"firstAuthor":"Morse Thomas M","id":"urn:lsid:swan.org:researchstatement:61739237-2bfc-4a46-b1e2-13bee12ae85b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ffaef271-3ae0-4740-a3be-933df02e78f4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ffaef271-3ae0-4740-a3be-933df02e78f4","type":"Claim","title":"To date, 38 mutations have been identified in ALS cases, corresponding to approximately 1% of sporadic ALS and 4% of familial ALS.","label":"Warraich S et al.; To date, 38 mutations have been identifi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Yang Shu","Nicholson Garth A","Blair Ian P"],"firstAuthor":"Warraich Sadaf T","referenceYear":"2010","referenceDate":"2010-06-25","id":"urn:lsid:swan.org:researchstatement:ffaef271-3ae0-4740-a3be-933df02e78f4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:eeeaf5a5-1905-4167-9ce2-14e0c36244bc&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:eeeaf5a5-1905-4167-9ce2-14e0c36244bc","type":"Claim","title":"Alzheimer Disease is associated with increased incidence of epilepsy, pointing to a generalized increase in cortical neuronal excitability.","label":"Morse T et al.; Alzheimer Disease is associated with inc...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Mutalik Pradeep","Cheung Kei","Miller Perry L","Shepherd Gordon"],"firstAuthor":"Morse Thomas M","id":"urn:lsid:swan.org:researchstatement:eeeaf5a5-1905-4167-9ce2-14e0c36244bc"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:94528c9d-1679-4ecc-a8be-75dc72e26f3c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:94528c9d-1679-4ecc-a8be-75dc72e26f3c","type":"Claim","title":"Greater decreases in fluorodeoxyglucose (FDG) uptake correlate with greater cognitive impairment along the continuum from normal cognitive status to MCI to AD dementia with a good correlation between the ante-mortem FDG-PET diagnosis of AD and post-mortem confirmation.","label":"Jack C et al.; Greater decreases in fluorodeoxyglucose ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:94528c9d-1679-4ecc-a8be-75dc72e26f3c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:74636b22-a791-4dce-a431-b45a9fce3e6e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:74636b22-a791-4dce-a431-b45a9fce3e6e","type":"Claim","title":"Aggregated Aβ are able to activate and become bound by C3b.","label":"Lambert J et al.; Aggregated Aβ are able to activate and b...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Heath Simon","Even Gael","Campion Dominique","Sleegers Kristel","Hiltunen Mikko","Combarros Onofre","Zelenika Diana","Bullido Maria J","Tavernier Béatrice","Letenneur Luc","Bettens Karolien","Berr Claudine","Pasquier Florence","Fiévet Nathalie","Barberger-Gateau Pascale","Engelborghs Sebastiaan","De Deyn Peter","Mateo Ignacio","Franck Ana","Helisalmi Seppo","Porcellini Elisa","Hanon Olivier","de Pancorbo Marian M","Lendon Corinne","Dufouil Carole","Jaillard Céline","Leveillard Thierry","Alvarez Victoria","Bosco Paolo","Mancuso Michelangelo","Panza Francesco","Nacmias Benedetta","Bossù Paola","Piccardi Paola","Annoni Giorgio","Seripa Davide","Galimberti Daniela","Hannequin Didier","Licastro Federico","Soininen Hilkka","Ritchie Karen","Blanché Hélène","Dartigues Jean-François","Tzourio Christophe","Gut Ivo","Van Broeckhoven Christine","Alpérovitch Annick","Lathrop Mark","Amouyel Philippe"],"firstAuthor":"Lambert Jean-Charles","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:74636b22-a791-4dce-a431-b45a9fce3e6e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ff0963b3-1b91-492c-8020-74a418755035&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ff0963b3-1b91-492c-8020-74a418755035","type":"Claim","title":"Reduced CSF insulin levels in AD patients correlate with dementia severity.","label":"Craft S; Reduced CSF insulin levels in AD patient...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft Suzanne","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:ff0963b3-1b91-492c-8020-74a418755035"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:12c11b39-9f3b-41f5-b0c5-3aa86d34cb72&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:12c11b39-9f3b-41f5-b0c5-3aa86d34cb72","type":"Claim","title":"Incubation of V717F APP751 transfected cell conditioned media with insulin degrading enzyme selectively degraded and removed monomeric Aβ leaving Aβ oligomers unchanged.","label":"Walsh D et al.; Incubation of V717F APP751 transfected c...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Klyubin Igor","Fadeeva Julia V","Cullen William K","Anwyl Roger","Wolfe Michael S","Rowan Michael J","Selkoe Dennis J"],"firstAuthor":"Walsh Dominic M","referenceYear":"2002","referenceDate":"2002-04-04","id":"urn:lsid:swan.org:researchstatement:12c11b39-9f3b-41f5-b0c5-3aa86d34cb72"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a506c2fe-cba7-4153-bf93-901c90bb5c91&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a506c2fe-cba7-4153-bf93-901c90bb5c91","type":"Claim","title":"Non-assembled recombinant human tau did not inhibit the isolated proteasomes.","label":"Keck S et al.; Non-assembled recombinant human tau did ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:a506c2fe-cba7-4153-bf93-901c90bb5c91"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f0289296-d05f-48e4-bc3c-ca8d22d35058&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f0289296-d05f-48e4-bc3c-ca8d22d35058","type":"Claim","title":"There is no unequivocal evidence that tau is overexpressed in AD or any other known human tauopathy.","label":"Lee V et al.; There is no unequivocal evidence that ta...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Trojanowski John Q"],"firstAuthor":"Lee Virginia M-Y","id":"urn:lsid:swan.org:researchstatement:f0289296-d05f-48e4-bc3c-ca8d22d35058"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d8e836c7-5586-4988-9f90-565bbac34563&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d8e836c7-5586-4988-9f90-565bbac34563","type":"Claim","title":"Nearly 100% concordance is present between abnormally low CSF Aβ42 and positive Pittsburgh compound B (PiB) amyloid imaging findings in AD patients who have undergone both tests.","label":"Jack C et al.; Nearly 100% concordance is present betwe...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:d8e836c7-5586-4988-9f90-565bbac34563"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4dbb1a16-882f-45ed-b415-9ad2f9c0d1f1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4dbb1a16-882f-45ed-b415-9ad2f9c0d1f1","type":"Claim","title":"PS mutations can cause neurodegenerative dementia in the absence of Aβ accumulation, whereas the variable protein aggregates associated with PS mutations do not play an essential role in the pathogenic mechanism leading to neurodegeneration and dementia.","label":"Shen J et al.; PS mutations can cause neurodegenerative...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:4dbb1a16-882f-45ed-b415-9ad2f9c0d1f1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:66a52c1a-0971-43c8-98ce-4e86e308fa3f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:66a52c1a-0971-43c8-98ce-4e86e308fa3f","type":"Hypothesis","title":"Presenilin gain of function causes early onset autosomal dominant Alzheimer disease.","label":"Duff K et al.; Presenilin gain of function causes early...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Eckman C","Zehr C","Yu X","Prada C M","Perez-tur J","Hutton M","Buee L","Harigaya Y","Yager D","Morgan D","Gordon M N","Holcomb L","Refolo L","Zenk B","Hardy J","Younkin S"],"firstAuthor":"Duff K","referenceYear":"1996","referenceDate":"1996-10-24","id":"urn:lsid:swan.org:researchstatement:66a52c1a-0971-43c8-98ce-4e86e308fa3f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f144d4d5-e93d-4216-9eef-0af6c803346b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f144d4d5-e93d-4216-9eef-0af6c803346b","type":"Claim","title":"The induction of SIRT1 expression levels in various neurotoxic conditions may be interpreted as a neuroprotective adaptation response, implying a role for SIRT1 as an important stress sensor molecule that links aging to neurodegeneration.","label":"Kim D et al.; The induction of SIRT1 expression levels...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:f144d4d5-e93d-4216-9eef-0af6c803346b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7afd4ef3-7560-450c-b4bd-00de075279ca&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7afd4ef3-7560-450c-b4bd-00de075279ca","type":"Claim","title":"Transgenic mice overexpressing human APP have demonstrated failure of LTP maintenance, but such studies have not identified the biochemically defined assembly forms responsible for LTP failure.","label":"Walsh D et al.; Transgenic mice overexpressing human APP...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Klyubin Igor","Fadeeva Julia V","Cullen William K","Anwyl Roger","Wolfe Michael S","Rowan Michael J","Selkoe Dennis J"],"firstAuthor":"Walsh Dominic M","referenceYear":"2002","referenceDate":"2002-04-04","id":"urn:lsid:swan.org:researchstatement:7afd4ef3-7560-450c-b4bd-00de075279ca"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2fd7c1d1-20ff-4330-9d19-ee4e0ba4e800&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2fd7c1d1-20ff-4330-9d19-ee4e0ba4e800","type":"Claim","title":"DR6\u2014one of eight members of TNF receptor superfamily14 possesses a cytoplasmic death domain and is widely expressed by neurons as they differentiate and enter a pro-apoptotic state. ","label":"Nikolaev A et al.; DR6\u2014one of eight members of TNF receptor...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["McLaughlin Todd","O'Leary Dennis D","Tessier-Lavigne Marc"],"firstAuthor":"Nikolaev Anatoly","referenceYear":"2009","referenceDate":"2009-02-19","id":"urn:lsid:swan.org:researchstatement:2fd7c1d1-20ff-4330-9d19-ee4e0ba4e800"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ff90fcdc-7c5b-48eb-9fc7-d9ecf186cfb5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ff90fcdc-7c5b-48eb-9fc7-d9ecf186cfb5","type":"Claim","title":"In addition to Bcl-2, Bax, and Ref-1, the DNA repair enzyme GADD45 could also be a component of a dynamic and extended competition between cell death processes and compensatory responses in the AD brain.","label":"Cotman C; In addition to Bcl-2, Bax, and Ref-1, th...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Cotman Carl W","id":"urn:lsid:swan.org:researchstatement:ff90fcdc-7c5b-48eb-9fc7-d9ecf186cfb5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:be25c22e-9f77-4fa1-bf9e-2e1b1959bc6b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:be25c22e-9f77-4fa1-bf9e-2e1b1959bc6b","type":"Claim","title":"Aβ assemblies [in animal models] can mimic some of the symptomatology of AD, including alterations in synaptic function, memory and learning, and behavior, suggesting their early involvement in the progression of AD.","label":"Hartley D et al.; Aβ assemblies [in animal models] can mim...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:be25c22e-9f77-4fa1-bf9e-2e1b1959bc6b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:e65048a5-165f-4063-bee5-904558279360&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:e65048a5-165f-4063-bee5-904558279360","type":"Question","title":"If tau overexpression induces axonal transport, and that it may be a cause of neuronal dysfunction or synapse loss in tauopathy, the question still remains how tau impairs neuronal function in a specific brain region in tauopathy.","label":"If tau overexpression induces axonal tra...","icon":"../icons/ontological/discourse-element/research-question.png","firstAuthor":"Takashima Akihiko","id":"urn:lsid:swan.org:researchquestion:e65048a5-165f-4063-bee5-904558279360"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:009410eb-2bab-494f-844e-e76e85a83812&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:009410eb-2bab-494f-844e-e76e85a83812","type":"Hypothesis","title":"Inappropriate reactivation of the cell cycle is an early and important event in the development of Alzheimer disease.","label":"Vincent I et al.; Inappropriate reactivation of the cell c...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Rosado M","Davies P"],"firstAuthor":"Vincent I","referenceYear":"1996","referenceDate":"1996-02","id":"urn:lsid:swan.org:researchstatement:009410eb-2bab-494f-844e-e76e85a83812"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:733c1e62-3421-450e-8e83-7ce9afb69746&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:733c1e62-3421-450e-8e83-7ce9afb69746","type":"Claim","title":"reuse","label":"reuse","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:733c1e62-3421-450e-8e83-7ce9afb69746"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e2d30f0f-2d65-450e-a90b-fc830187001a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e2d30f0f-2d65-450e-a90b-fc830187001a","type":"Claim","title":"Because Aβ itself has been found to interact with wnt receptors, ApoE4, Gsk-3 and retromer deficiency can be co-opted by the amyloid hypothesis to link Aβ to tau hyperphosphorylation in a serial manner. ","label":"Small S et al.; Because Aβ itself has been found to inte...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:e2d30f0f-2d65-450e-a90b-fc830187001a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0bf9a270-601b-440d-b279-e62d951d0138&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0bf9a270-601b-440d-b279-e62d951d0138","type":"Claim","title":"In vitro studies suggest that senescence is an alternative pathway to apoptosis and that senescent cells are resistant to apoptosis, showing that senescent keratinocytes die by autophagic cell death, a cell death pathway characterized by an increase in macroautophagic activity that has been implicated as an alternative to apoptotic or necrotic mechanisms in neurodegeneration.","label":"Golde T et al.; In vitro studies suggest that senescence...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:0bf9a270-601b-440d-b279-e62d951d0138"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1fc8c0f7-f243-4264-b0a3-1bf2452f13a0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1fc8c0f7-f243-4264-b0a3-1bf2452f13a0","type":"Hypothesis","title":"Intramembranous Aβ dimer may be toxic.","label":"Marchesi V; Intramembranous Aβ dimer may be toxic.","icon":"../icons/ontological/discourse-element/h-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:1fc8c0f7-f243-4264-b0a3-1bf2452f13a0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:956a1c67-b426-4e31-be39-d7b8695b75d4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:956a1c67-b426-4e31-be39-d7b8695b75d4","type":"Claim","title":"In transgenic mouse studies, both mutant human APP and mutant human tau undergo increased formation of tau-positive tangles (as compared with mice overexpressing tau alone), whereas the structure and number of their amyloid plaques are essentially unaltered.","label":"Hardy J et al.; In transgenic mouse studies, both mutant...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:956a1c67-b426-4e31-be39-d7b8695b75d4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1f63ceaa-168b-4f88-b107-281b6756dda3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1f63ceaa-168b-4f88-b107-281b6756dda3","type":"Claim","title":"There was an increased co-precipitation of Ser212/Thr214 hyperphosphorylated tau (PHF-tau) and high molecular weight PHF-tau aggregates bound to the precipitated 20S proteasome protein with decreasing proteasome activity.","label":"Keck S et al.; There was an increased co-precipitation ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:1f63ceaa-168b-4f88-b107-281b6756dda3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a45c25ea-ccde-4574-ac7c-b66b9afb6694&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a45c25ea-ccde-4574-ac7c-b66b9afb6694","type":"Claim","title":"Diffuse Aβ deposits are analogous to early fatty streaks of cholesterol that appear prior to mature atherosclerotic plaques.","label":"Hardy J et al.; Diffuse Aβ deposits are analogous to ear...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:a45c25ea-ccde-4574-ac7c-b66b9afb6694"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:671bff20-bd6c-47ea-b7a5-cda153ce15a5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:671bff20-bd6c-47ea-b7a5-cda153ce15a5","type":"Claim","title":"Cycloheximide treatment to block protein synthesis prevented Aβ-induced increase current.","label":"Plant L et al.; Cycloheximide treatment to block protein...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:671bff20-bd6c-47ea-b7a5-cda153ce15a5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:821e68eb-b999-4868-a57d-bee90a2340b7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:821e68eb-b999-4868-a57d-bee90a2340b7","type":"Claim","title":"There is no evidence of CAA in APPSw+/-, apoE-/- mice at 12 months age, and no evidence of fibrillar Aβ in cerebral blood vessels up to 21 months age.","label":"Holtzman D; There is no evidence of CAA in APPSw+/-,...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:821e68eb-b999-4868-a57d-bee90a2340b7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:347843d6-c22a-4c7a-bb10-ca992dc7f340&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:347843d6-c22a-4c7a-bb10-ca992dc7f340","type":"Claim","title":"Cognitively normal individuals can accumulate substantial Aβ load with no immediate effect on gross brain structure or cognition, and have normal structural MRI studies.","label":"Jack C et al.; Cognitively normal individuals can accum...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:347843d6-c22a-4c7a-bb10-ca992dc7f340"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ae52029b-854f-42e1-be3d-e9808361699a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ae52029b-854f-42e1-be3d-e9808361699a","type":"Claim","title":"The myelin model of the human brain proposes that myelin plays a critical role in the complex connectivity of the human brain and myelin metabolism underlies the human species\u2019 unique cognitive and behavioral development, including vulnerability to schizophrenia and Alzheimer disease. ","label":"Bartzokis G; The myelin model of the human brain prop...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:ae52029b-854f-42e1-be3d-e9808361699a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:031eb982-8494-4c35-8ce1-e28cd93d742b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:031eb982-8494-4c35-8ce1-e28cd93d742b","type":"Claim","title":"In a transgenic model Aβ may act as a stimulus to induce apoptotic degeneration restricted to regions of the brain affected in AD.","label":"Cotman C et al.; In a transgenic model Aβ may act as a st...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:031eb982-8494-4c35-8ce1-e28cd93d742b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7076c294-f759-4af9-923e-4e448dd9a9cd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7076c294-f759-4af9-923e-4e448dd9a9cd","type":"Claim","title":"The AD patients presented an average 40% loss of synapse density, compared to age-matched control subjects in the midfrontal (MF) and inferior parietal (IP) region.","label":"Terry R et al.; The AD patients presented an average 40%...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Masliah E","Salmon D P","Butters N","DeTeresa R","Hill R","Hansen L A","Katzman R"],"firstAuthor":"Terry R D","referenceYear":"1991","referenceDate":"1991-10","id":"urn:lsid:swan.org:researchstatement:7076c294-f759-4af9-923e-4e448dd9a9cd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c488d468-cb88-48e0-a290-131bae31ca1b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c488d468-cb88-48e0-a290-131bae31ca1b","type":"Claim","title":"Aβ aggregation dependence on Cu2+ and Zn2+ metal ions is being tested in vivo.","label":"Hardy J et al.; Aβ aggregation dependence on Cu2+ and Zn...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:c488d468-cb88-48e0-a290-131bae31ca1b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2366faed-0f82-4811-a27f-c4ff0b2410fa&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2366faed-0f82-4811-a27f-c4ff0b2410fa","type":"Claim","title":"Expression of Notch1 and its target genes (HES1, HES5, and ACSL1), which are directly or indirectly dependent on γ-secretase activity, were similar in hippocampi of APPPS1+/0;Aph1BC−/− and APPPS1+/0;Aph1BC+/+ mice.","label":"Serneels L et al.; Expression of Notch1 and its target gene...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Van Biervliet Jérôme","Craessaerts Katleen","Dejaegere Tim","Horré Katrien","Van Houtvin Tine","Esselmann Hermann","Paul Sabine","Schäfer Martin K","Berezovska Oksana","Hyman Bradley T","Sprangers Ben","Sciot Raf","Moons Lieve","Jucker Mathias","Yang Zhixiang","May Patrick C","Karran Eric","Wiltfang Jens","D'Hooge Rudi","De Strooper Bart"],"firstAuthor":"Serneels Lutgarde","referenceYear":"2009","referenceDate":"2009-05-01","id":"urn:lsid:swan.org:researchstatement:2366faed-0f82-4811-a27f-c4ff0b2410fa"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c22a2aae-88c0-486f-8b01-66b4894132b2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c22a2aae-88c0-486f-8b01-66b4894132b2","type":"Claim","title":"Aβ-lowering compounds that prevent intra- or extracellular oligomerization would be an attractive therapeutic approach to selectively reduce synaptotoxicity.","label":"Walsh D et al.; Aβ-lowering compounds that prevent intra...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Klyubin Igor","Fadeeva Julia V","Cullen William K","Anwyl Roger","Wolfe Michael S","Rowan Michael J","Selkoe Dennis J"],"firstAuthor":"Walsh Dominic M","referenceYear":"2002","referenceDate":"2002-04-04","id":"urn:lsid:swan.org:researchstatement:c22a2aae-88c0-486f-8b01-66b4894132b2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:eadac37a-cd87-4232-ad89-a5b3c28fd8e4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:eadac37a-cd87-4232-ad89-a5b3c28fd8e4","type":"Claim","title":"Like Aβ42, clusterin is up-regulated in AD brain and occurs in amyloid plaques, clearly in proximity to Aβ42.","label":"Lambert M et al.; Like Aβ42, clusterin is up-regulated in ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:eadac37a-cd87-4232-ad89-a5b3c28fd8e4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:eb1ef06d-bcae-488e-a411-963e62e2732f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:eb1ef06d-bcae-488e-a411-963e62e2732f","type":"Hypothesis","title":"The cystatin C allele CST3-A is a risk factor for early onset Alzheimer Disease.  ","label":"Beyer K et al.; The cystatin C allele CST3-A is a risk f...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Lao J I","Gómez M","Riutort N","Latorre P","Mate J L","Ariza A"],"firstAuthor":"Beyer K","referenceYear":"2001","referenceDate":"2001-11-23","id":"urn:lsid:swan.org:researchstatement:eb1ef06d-bcae-488e-a411-963e62e2732f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3488ffa2-abc3-4f4c-9dbb-32260e217832&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3488ffa2-abc3-4f4c-9dbb-32260e217832","type":"Claim","title":"GSK3α in addition to GSK3β, has been shown to function in the destruction complex and the Wnt signaling pathway, suggesting that this enzyme is equally as important in Wnt biology as is GSK3β.","label":"Hooper C et al.; GSK3α in addition to GSK3β, has been sho...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:3488ffa2-abc3-4f4c-9dbb-32260e217832"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5374e45c-939b-41bf-b43e-bb87473c942e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5374e45c-939b-41bf-b43e-bb87473c942e","type":"Claim","title":"Insulin and Aβ demonstrate reciprocity of effect, as Aβ inhibition of LTP is significantly improved with insulin.","label":"Craft S; Insulin and Aβ demonstrate reciprocity o...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft S","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:5374e45c-939b-41bf-b43e-bb87473c942e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4ebf7af2-3d92-4172-bdb8-6803bdbe0330&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4ebf7af2-3d92-4172-bdb8-6803bdbe0330","type":"Claim","title":"No significant alterations in steady state levels of NF-L and snap25 were observed in the retinas of tau-null and 8c tau overexpressing mice compared with those of wild-type.","label":"Yuan A et al.; No significant alterations in steady sta...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:4ebf7af2-3d92-4172-bdb8-6803bdbe0330"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c8e65a55-8bd3-4a69-8282-d30686552fb9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c8e65a55-8bd3-4a69-8282-d30686552fb9","type":"Claim","title":"Neurodegeneration in PS1 conditional knockout mice is preceded by memory loss, synaptic plasticity impairments, reductions in NMDA receptor mediated synaptic responses, and decreases in cAMP-response element (CRE)-dependent gene expression (e.g., BDNF, c-fos), suggesting that these molecular defects mediate the subsequent neurodegeneration.","label":"Shen J et al.; Neurodegeneration in PS1 conditional kno...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:c8e65a55-8bd3-4a69-8282-d30686552fb9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b91b7b22-725c-4c86-9921-138d8d14a6c4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b91b7b22-725c-4c86-9921-138d8d14a6c4","type":"Claim","title":"Undue stress in the ER has been shown to lead to activation of caspase 12\u2014a caspase implicated in the pathogenesis of AD.","label":"Smith I et al.; Undue stress in the ER has been shown to...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:b91b7b22-725c-4c86-9921-138d8d14a6c4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1a83965b-9f1c-41ae-8ceb-198df69e6c73&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1a83965b-9f1c-41ae-8ceb-198df69e6c73","type":"Claim","title":"Pronounced increases in plasma Aβ concentrations were measured after m266 treatment, and an Aβ/m266 complex could be readily detected in both plasma and CSF.","label":"Dodart J et al.; Pronounced increases in plasma Aβ concen...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:1a83965b-9f1c-41ae-8ceb-198df69e6c73"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c3722ffe-bef6-4e5d-9824-3ef45831f23b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c3722ffe-bef6-4e5d-9824-3ef45831f23b","type":"Hypothesis","title":"Aβ Cascade Hypothesis: Aβ aggregates lead to Alzheimer disease neurodegeneration.","label":"Golde T et al.; Aβ Cascade Hypothesis: Aβ aggregates lea...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Dickson Dennis","Hutton Michael"],"firstAuthor":"Golde Todd E","referenceYear":"2006","referenceDate":"2006-12","id":"urn:lsid:swan.org:researchstatement:c3722ffe-bef6-4e5d-9824-3ef45831f23b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4b0f98de-3645-4c5b-9b1a-7cf31ab93499&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4b0f98de-3645-4c5b-9b1a-7cf31ab93499","type":"Claim","title":"Myelin abnormalities may precede evidence of axonopathies and may disrupt fast axonal transport in the underlying axons.","label":"Bartzokis G; Myelin abnormalities may precede evidenc...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:4b0f98de-3645-4c5b-9b1a-7cf31ab93499"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:65a06dfa-83a7-4dfd-b548-4f8536acf594&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:65a06dfa-83a7-4dfd-b548-4f8536acf594","type":"Claim","title":"A sporadic or hereditary primary dysfunction of the ubiquitinâ\u0080\u0093proteasome system may cause the progressing intraneuronal accumulation of deposits of damaged proteins in neurodegenerative diseases.","label":"Keck S et al.; A sporadic or hereditary primary dysfunc...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:65a06dfa-83a7-4dfd-b548-4f8536acf594"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1e39b51c-03a8-4528-a421-c6096d2f0ae8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1e39b51c-03a8-4528-a421-c6096d2f0ae8","type":"Claim","title":"Treatment of primary cortical neurons with either ionomycin or H2O2 rapidly induced SIRT1 protein expression, and did so in a dose-dependent manner.","label":"Kim D et al.; Treatment of primary cortical neurons wi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:1e39b51c-03a8-4528-a421-c6096d2f0ae8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e27a0289-814e-47cd-8506-49caf860a181&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e27a0289-814e-47cd-8506-49caf860a181","type":"Claim","title":"FAD PS1-G384A and PS1-A246E mutant proteins were as efficient as wild type PS1 in processing APP, syndecan 3 and N-cadherin CTF substrates.","label":"Bentahir M et al.; FAD PS1-G384A and PS1-A246E mutant prote...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:e27a0289-814e-47cd-8506-49caf860a181"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b38cc18e-eb7f-4423-afc3-a063a8a72889&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b38cc18e-eb7f-4423-afc3-a063a8a72889","type":"Claim","title":"Cell culture systems do not reflect the complexity of Aβ effects in the brain.","label":"Hardy J et al.; Cell culture systems do not reflect the ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:b38cc18e-eb7f-4423-afc3-a063a8a72889"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5abae512-aaf0-4d05-8c9a-8477ea170a49&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5abae512-aaf0-4d05-8c9a-8477ea170a49","type":"Claim","title":"Inactivation of c-Jun by intracellular injection of antibodies or the introduction of the dominant negative gene blocks apoptosis in neurons.","label":"Cotman C et al.; Inactivation of c-Jun by intracellular i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:5abae512-aaf0-4d05-8c9a-8477ea170a49"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4d4d24c4-3b29-49b5-87b6-52d31e6e5982&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4d4d24c4-3b29-49b5-87b6-52d31e6e5982","type":"Claim","title":"The observed kinetics of plaque growth and stabilization through microglia raise the possibility that the long degenerative process of Alzheimer Disease is marked by countless sudden changes in cortical structure.","label":"Meyer-Luehmann M et al.; The observed kinetics of plaque growth a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:4d4d24c4-3b29-49b5-87b6-52d31e6e5982"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cf394a4a-c836-470e-b544-36b3278cd8dd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cf394a4a-c836-470e-b544-36b3278cd8dd","type":"Claim","title":"Immunoreactivity for c-Jun increases in AD as compared to control brain, and co-localizes with neuronal pathology. It appears that c-Jun is the most prominent immediate early gene induced in AD brain tissue suggesting that this gene may be a candidate marker for the activation of apoptosis.","label":"Cotman C et al.; Immunoreactivity for c-Jun increases in ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:cf394a4a-c836-470e-b544-36b3278cd8dd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fb4493e2-7044-4c1c-a60e-c5465c5e8e9d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fb4493e2-7044-4c1c-a60e-c5465c5e8e9d","type":"Claim","title":"Extracellular application of Aβ has been shown to cause a dramatic increase in IP3-mediated calcium release in SH-SY5Y cells.","label":"Smith I et al.; Extracellular application of Aβ has been...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:fb4493e2-7044-4c1c-a60e-c5465c5e8e9d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5e0208ba-f631-441e-ac3d-3c64b0b049a7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5e0208ba-f631-441e-ac3d-3c64b0b049a7","type":"Claim","title":"A&#946;42 oligomerizes rapidly to form pentamer or hexamer units, existing in equilibrium with monomers.","label":"Bitan G et al.; A&#946;42 oligomerizes rapidly to form p...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:5e0208ba-f631-441e-ac3d-3c64b0b049a7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:60b56907-e426-486f-a590-cf1620b4b26f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:60b56907-e426-486f-a590-cf1620b4b26f","type":"Claim","title":"Relatively low LRP activity has been observed in brain microvessels in AD patients and mutant APP mouse models of beta amyloidosis.","label":"Tanzi R et al.; Relatively low LRP activity has been obs...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:60b56907-e426-486f-a590-cf1620b4b26f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6a8efc77-64f3-4ca8-85cc-ff988d6b4db0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6a8efc77-64f3-4ca8-85cc-ff988d6b4db0","type":"Claim","title":"Intracellular Aβ is much more closely located near tau protein and the kinases needed to phosphorylate tau to induce intraneuronal tangles.","label":"Dewachter I et al.; Intracellular Aβ is much more closely lo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Van Leuven Fred"],"firstAuthor":"Dewachter Ilse","id":"urn:lsid:swan.org:researchstatement:6a8efc77-64f3-4ca8-85cc-ff988d6b4db0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:03e2d28a-894c-49dd-b738-754af86ccfc0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:03e2d28a-894c-49dd-b738-754af86ccfc0","type":"Claim","title":"Misfolded self protein aggregates are not likely to strongly activate the adaptive immune response as the key step in activation of adaptive immunity, major histocompatibility complex (MHC) presentation of non-self peptides, is likely to limit such activation.","label":"Golde T et al.; Misfolded self protein aggregates are no...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:03e2d28a-894c-49dd-b738-754af86ccfc0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:dca1e5c5-74b9-4378-a8e8-4af141913f73&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:dca1e5c5-74b9-4378-a8e8-4af141913f73","type":"Claim","title":"Aβ can also form rudimentary ion channels in lipid bilayers, alongside similar hydrophobic peptides such as the prion protein associated with Creutzfeldt-Jakob disease.","label":"Smith I et al.; Aβ can also form rudimentary ion channel...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:dca1e5c5-74b9-4378-a8e8-4af141913f73"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:536854c2-1528-4066-a2ae-c87f6f7e9dfb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:536854c2-1528-4066-a2ae-c87f6f7e9dfb","type":"Claim","title":"Inability to detect neuron loss in APP transgenic mice may represent species differences in neuronal vulnerability, absence of human tau, expression of inflammatory mediators or the short duration of Aβ; exposure.","label":"Hardy J et al.; Inability to detect neuron loss in APP t...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:536854c2-1528-4066-a2ae-c87f6f7e9dfb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:40a79da6-45c3-4ae5-b830-4b536c718da5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:40a79da6-45c3-4ae5-b830-4b536c718da5","type":"Claim","title":"At least in some individuals, levels of CSF Aβ42 may decline with the initial appearance in the cerebral cortex of diffuse amyloid deposits and prior to sufficient fibrillar changes to permit adequate PiB binding for detection by PET.","label":"Morris J et al.; At least in some individuals, levels of ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Roe Catherine M","Grant Elizabeth A","Head Denise","Storandt Martha","Goate Alison M","Fagan Anne M","Holtzman David M","Mintun Mark A"],"firstAuthor":"Morris John C","referenceYear":"2009","referenceDate":"2009-12","id":"urn:lsid:swan.org:researchstatement:40a79da6-45c3-4ae5-b830-4b536c718da5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:eb64d642-d227-477e-b8b9-445cfe449a0b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:eb64d642-d227-477e-b8b9-445cfe449a0b","type":"Comment","title":"Apoptosis in AD is a mathematical improbability.","label":"Smith M et al.; Apoptosis in AD is a mathematical improb...","icon":"../icons/ontological/discourse-element/comment.png","otherAuthors":["Perry George","Zhu Xiongwei"],"firstAuthor":"Smith Mark A","id":"urn:lsid:swan.org:comment:eb64d642-d227-477e-b8b9-445cfe449a0b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:acb736d6-0613-4187-81d9-864b6d5bbdb1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:acb736d6-0613-4187-81d9-864b6d5bbdb1","type":"Claim","title":"Knockdown of the SIRT1 gene in cultured mouse dorsal roots ganglion sensory neurons abrogates the protective effects of increased NAD+ synthesis on axonal degeneration following acute axotomy.","label":"Kim D et al.; Knockdown of the SIRT1 gene in cultured ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:acb736d6-0613-4187-81d9-864b6d5bbdb1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2126e76e-5027-4544-8d6e-7c78deb85cd5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2126e76e-5027-4544-8d6e-7c78deb85cd5","type":"Claim","title":"In the AD brain neurons strongly stain for MCP-1 and IL-6, suggesting that these inflammatory mediators are being \u2018ectopically expressed\u2019, or at least dramatically upregulated, in cells that are not professional immune cells.","label":"Golde T et al.; In the AD brain neurons strongly stain f...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:2126e76e-5027-4544-8d6e-7c78deb85cd5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4b0429c4-564d-429c-8188-d5b598545fd6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4b0429c4-564d-429c-8188-d5b598545fd6","type":"Claim","title":"In Fyn knockout mice, LTP is abnormal, but in animals with Fyn restored postnatally, LTP is improved, indicating the electrophysiological effect of Fyn knockout is not developmental.\n","label":"Lambert M et al.; In Fyn knockout mice, LTP is abnormal, b...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:4b0429c4-564d-429c-8188-d5b598545fd6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b6be5f2b-888f-4799-b738-7b8e756092b9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b6be5f2b-888f-4799-b738-7b8e756092b9","type":"Hypothesis","title":"Enhanced peripheral clearance and/or sequestration of soluble Aβ in brain may rapidly reverse memory impairment in AD.","label":"Dodart J et al.; Enhanced peripheral clearance and/or seq...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:b6be5f2b-888f-4799-b738-7b8e756092b9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d33e419d-7ead-4e21-9a6a-e31e9987056a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d33e419d-7ead-4e21-9a6a-e31e9987056a","type":"Claim","title":"Oligodendrocyte and myelin abnormalities can slow or stop axonal fast axonal transport.","label":"Bartzokis G; Oligodendrocyte and myelin abnormalities...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:d33e419d-7ead-4e21-9a6a-e31e9987056a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3d9d3cda-8fe7-459d-9b6b-35d630fe538b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3d9d3cda-8fe7-459d-9b6b-35d630fe538b","type":"Claim","title":"Using either histone H1 or APP<sup>645-694<\/sup> substrate, a much higher level of cdc2 kinase activity is detected in immunoprecipitated samples from synchronized HeLa G2/M phase cells than in samples immunoprecipitated from GI phase cells.","label":"Suzuki T et al.; Using either histone H1 or APP<sup>645-6...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:3d9d3cda-8fe7-459d-9b6b-35d630fe538b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:20d95d1c-9507-4269-9332-2f59f71b98ca&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:20d95d1c-9507-4269-9332-2f59f71b98ca","type":"Claim","title":"Lipid-free apoE3 and apoE4 decrease Aβ fibrillogenesis by inhibition of Aβ seeding or nucleation","label":"Holtzman D; Lipid-free apoE3 and apoE4 decrease Aβ f...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:20d95d1c-9507-4269-9332-2f59f71b98ca"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4ddd589d-863f-40e2-9862-47ccd94736f5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4ddd589d-863f-40e2-9862-47ccd94736f5","type":"Hypothesis","title":"The α7 Nicotinic Acetylcholine Receptor gene mediates cognitive deficits and synaptic pathology.","label":"Dziewczapolski G et al.; The α7 Nicotinic Acetylcholine Receptor ...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Glogowski Carolina M","Masliah Eliezer","Heinemann Stephen F"],"firstAuthor":"Dziewczapolski Gustavo","referenceYear":"2009","referenceDate":"2009-07-08","id":"urn:lsid:swan.org:researchstatement:4ddd589d-863f-40e2-9862-47ccd94736f5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ce3edaa6-5da5-4597-a4f3-f4520671b44c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ce3edaa6-5da5-4597-a4f3-f4520671b44c","type":"Claim","title":"Soluble Aβ also is increased in brains from Down\u2019s patients.","label":"Lambert M et al.; Soluble Aβ also is increased in brains f...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:ce3edaa6-5da5-4597-a4f3-f4520671b44c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7657701c-211d-47db-ab7b-dd740ced8e35&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7657701c-211d-47db-ab7b-dd740ced8e35","type":"Claim","title":"Human wild-type tau (the longest form), expressed about threefold over endogenous levels, induces neural dysfunction in entorhinal cortex at old age (more than 20 months), accompanied by synapse loss and accumulation of hyperphosphorylated tau resulting in a memory deficit, while adult mice (>12 months old) are no different from non-Tg.","label":"Takashima A; Human wild-type tau (the longest form), ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Takashima Akihiko","id":"urn:lsid:swan.org:researchstatement:7657701c-211d-47db-ab7b-dd740ced8e35"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:22e228b5-ac35-4151-9ff3-aa171bae9bdd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:22e228b5-ac35-4151-9ff3-aa171bae9bdd","type":"Claim","title":"Initial oligomerization of Aβ does not involve significant conformational rearrangement.","label":"Bitan G et al.; Initial oligomerization of Aβ does not i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:22e228b5-ac35-4151-9ff3-aa171bae9bdd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6ec72c30-a3d7-41a5-bfdc-2eb8a363dc1d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6ec72c30-a3d7-41a5-bfdc-2eb8a363dc1d","type":"Claim","title":"u-PA, tPA, and plasmin may be expected to have a more significant impact on cerebrovascular amyloid deposits or congophilic amyloid angiopathy.","label":"Tanzi R et al.; u-PA, tPA, and plasmin may be expected t...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:6ec72c30-a3d7-41a5-bfdc-2eb8a363dc1d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fe51f779-6e48-4745-acb1-5c4e21629e8d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fe51f779-6e48-4745-acb1-5c4e21629e8d","type":"Claim","title":"AD diffusible ligands (ADDLs) or protofibrils cause injury to cultured neurons.","label":"Hardy J et al.; AD diffusible ligands (ADDLs) or protofi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:fe51f779-6e48-4745-acb1-5c4e21629e8d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:aa606bb0-b16e-48e3-b9ad-bfdc4a2eee78&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:aa606bb0-b16e-48e3-b9ad-bfdc4a2eee78","type":"Claim","title":"Tau levels in AD brain may be elevated, but this is still controversial.","label":"Yuan A et al.; Tau levels in AD brain may be elevated, ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:aa606bb0-b16e-48e3-b9ad-bfdc4a2eee78"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:523942c0-454f-40d3-840a-368d67105b8d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:523942c0-454f-40d3-840a-368d67105b8d","type":"Claim","title":"Exogenously applied Aβ can be neurotoxic, yet this effect is abrogated when cell cultures are incubated in calcium-free solutions.","label":"Smith I et al.; Exogenously applied Aβ can be neurotoxic...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:523942c0-454f-40d3-840a-368d67105b8d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f5c444b4-7975-4ab4-8cdb-e7840ac79c5d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f5c444b4-7975-4ab4-8cdb-e7840ac79c5d","type":"Claim","title":"Predominantly, Alzheimer Disease is late-onset (<65 years of age) and does not show a clear mendelian pattern of segregation.","label":"Predominantly, Alzheimer Disease is late...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:f5c444b4-7975-4ab4-8cdb-e7840ac79c5d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:20f718e7-1406-4300-88ab-f6723cf07e9e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:20f718e7-1406-4300-88ab-f6723cf07e9e","type":"Claim","title":"Active immunization of mice genetically modified to develop Aβ plaques as they age with full-length Aβ (Aβ42) resulted in a reduction of plaque burden and improved cognitive function.","label":"Holmes C et al.; Active immunization of mice genetically ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:20f718e7-1406-4300-88ab-f6723cf07e9e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:97faa673-ee5f-451a-aef4-d76135273e15&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:97faa673-ee5f-451a-aef4-d76135273e15","type":"Claim","title":"One study failed to identify significant DNA damage in AD postmortem brain tissues.","label":"Cotman C et al.; One study failed to identify significant...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:97faa673-ee5f-451a-aef4-d76135273e15"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a3b26670-3ccd-430f-9818-4878598295d9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a3b26670-3ccd-430f-9818-4878598295d9","type":"Claim","title":"DLB-AD transgenic mice exhibit deficits in an inhibitory avoidance task at earlier ages than 3xTg-AD, M83-h, and control mice.","label":"Clinton L et al.; DLB-AD transgenic mice exhibit deficits ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Blurton-Jones Mathew","Myczek Kristoffer","Trojanowski John Q","LaFerla Frank M"],"firstAuthor":"Clinton Lani K","referenceYear":"2010","referenceDate":"2010-05-26","id":"urn:lsid:swan.org:researchstatement:a3b26670-3ccd-430f-9818-4878598295d9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:04cf2109-ed0d-4d24-894d-1c468b89b06c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:04cf2109-ed0d-4d24-894d-1c468b89b06c","type":"Claim","title":"Nondemented persons with Aβ cerebral deposits, as imaged by positron emission tomography (PET) using amyloid tracers such as [11C] Pittsburgh Compound B (PiB), is associated with a greater risk of symptomatic AD.","label":"Morris J et al.; Nondemented persons with Aβ cerebral dep...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Roe Catherine M","Grant Elizabeth A","Head Denise","Storandt Martha","Goate Alison M","Fagan Anne M","Holtzman David M","Mintun Mark A"],"firstAuthor":"Morris John C","referenceYear":"2009","referenceDate":"2009-12","id":"urn:lsid:swan.org:researchstatement:04cf2109-ed0d-4d24-894d-1c468b89b06c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3b863771-4043-493b-bbc1-f0ff9c1d510b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3b863771-4043-493b-bbc1-f0ff9c1d510b","type":"Claim","title":"It is likely that Aβ plays a pivotal role in the mechanisms and cause of the adverse effects of LTP.","label":"Smith I et al.; It is likely that Aβ plays a pivotal rol...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:3b863771-4043-493b-bbc1-f0ff9c1d510b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d827eaa0-74ac-48b9-880b-125503760421&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d827eaa0-74ac-48b9-880b-125503760421","type":"Claim","title":"Post-mortem analysis of AD brain sections reveals evidence of wide-spread oxidative damage, particularly increased levels of lipid peroxidation, and these levels increase further in areas of extensive neurodegeneration.","label":"Smith I et al.; Post-mortem analysis of AD brain section...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:d827eaa0-74ac-48b9-880b-125503760421"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c8a62788-fe0e-46a2-b6aa-1340c4eb3250&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c8a62788-fe0e-46a2-b6aa-1340c4eb3250","type":"Claim","title":"Several reports describe aberrant regulation of cell cycle factors in AD brain.","label":"Suzuki T; Several reports describe aberrant regula...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Suzuki Toshiharu","id":"urn:lsid:swan.org:researchstatement:c8a62788-fe0e-46a2-b6aa-1340c4eb3250"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c11af0b4-5d3c-4391-b0d5-b6b5c7290262&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c11af0b4-5d3c-4391-b0d5-b6b5c7290262","type":"Claim","title":"Rapid increase of Kv4.2 expression induced by amyloid beta may be due to increased production and trafficking of K+ channels.","label":"Plant L et al.; Rapid increase of Kv4.2 expression induc...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:c11af0b4-5d3c-4391-b0d5-b6b5c7290262"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5ad6fcec-70de-4674-8ad2-19d1b839b574&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5ad6fcec-70de-4674-8ad2-19d1b839b574","type":"Claim","title":"Previous studies showed that brain tau is absent in tau knock-out mice and is overexpressed in 8c mice.","label":"Yuan A et al.; Previous studies showed that brain tau i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:5ad6fcec-70de-4674-8ad2-19d1b839b574"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:aa26bb46-6b2b-4e6c-a65f-a820899e9072&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:aa26bb46-6b2b-4e6c-a65f-a820899e9072","type":"Claim","title":"ApoE is critical for the neuritic dystrophy (neuritic plaques) of AD because it is associated with fibrillar amyloid formation.","label":"Holtzman D; ApoE is critical for the neuritic dystro...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:aa26bb46-6b2b-4e6c-a65f-a820899e9072"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:91525c98-886e-4b89-9007-f5041a8af376&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:91525c98-886e-4b89-9007-f5041a8af376","type":"Claim","title":"The overall pattern of NRHypo neurodegeneration is similar to the pattern that has been described in the AD brain by various researchers. ","label":"Olney J et al.; The overall pattern of NRHypo neurodegen...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:91525c98-886e-4b89-9007-f5041a8af376"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8f341456-3420-477d-89c5-bdf3fccc9d9a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8f341456-3420-477d-89c5-bdf3fccc9d9a","type":"Claim","title":"Previous studies indicated that agents regulating protein kinase and/or protein phosphatase activities increased the normal metabolic processing of APP.","label":"Suzuki T et al.; Previous studies indicated that agents r...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:8f341456-3420-477d-89c5-bdf3fccc9d9a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a965cfe8-8cc1-4683-8d29-ac1951e1b721&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a965cfe8-8cc1-4683-8d29-ac1951e1b721","type":"Claim","title":"Increased concentrations and higher activity of Tissue-transglutaminase have been found in Alzheimer\u2019s patients relative to age-matched controls.","label":"Hartley D et al.; Increased concentrations and higher acti...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:a965cfe8-8cc1-4683-8d29-ac1951e1b721"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bff2a38c-6a8e-44ad-899a-109a46d9a83c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bff2a38c-6a8e-44ad-899a-109a46d9a83c","type":"Claim","title":"Over-expression of GSK3β in mice prevents the induction of LTP and causes a decrease in spatial learning. ","label":"Hooper C et al.; Over-expression of GSK3β in mice prevent...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:bff2a38c-6a8e-44ad-899a-109a46d9a83c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:21bad931-12bc-4e58-ad12-9aad02a65d76&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:21bad931-12bc-4e58-ad12-9aad02a65d76","type":"Claim","title":"Aβ is a normal metabolic product of APP and is measurable from tissues sources throughout life.","label":"Hardy J et al.; Aβ is a normal metabolic product of APP ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:21bad931-12bc-4e58-ad12-9aad02a65d76"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:39b5d6af-83c8-42ce-81b2-78088f8eefbc&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:39b5d6af-83c8-42ce-81b2-78088f8eefbc","type":"Claim","title":"Evidence of disordered glucose uptake in cognitively normal young and middle-aged APOE ε4 carriers up to decades before disease-related clinical symptoms has no consensus interpretation, and these findings could be either neurodevelopmental in origin or early indicators of AD.","label":"Jack C et al.; Evidence of disordered glucose uptake in...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:39b5d6af-83c8-42ce-81b2-78088f8eefbc"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c99c9aae-707d-4df1-bf4d-792b886c2466&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c99c9aae-707d-4df1-bf4d-792b886c2466","type":"Claim","title":"PS2-N141I causes a severe loss of Abeta40 and significant increase of Abeta42 production in PS1 deficient fibroblasts stably expressing APP695Swe.","label":"Bentahir M et al.; PS2-N141I causes a severe loss of Abeta4...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:c99c9aae-707d-4df1-bf4d-792b886c2466"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:02352b5f-af8d-49f5-9244-11667aac7bd5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:02352b5f-af8d-49f5-9244-11667aac7bd5","type":"Claim","title":"Some Aβ peptides may never leave the membrane.","label":"Marchesi V; Some Aβ peptides may never leave the mem...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:02352b5f-af8d-49f5-9244-11667aac7bd5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:b2139c1b-ffcc-4a1a-9ce7-9fc7f8a78dff&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:b2139c1b-ffcc-4a1a-9ce7-9fc7f8a78dff","type":"Question","title":"It is possible that for larger cargos undergoing longer-distance transport, molecular-level changes of kinesin motors are damped out.  This is an interesting question that needs to be investigated further with high-resolution assays.","label":"It is possible that for larger cargos un...","icon":"../icons/ontological/discourse-element/research-question.png","firstAuthor":"Holzbaur Erika L F","id":"urn:lsid:swan.org:researchquestion:b2139c1b-ffcc-4a1a-9ce7-9fc7f8a78dff"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:a051fe71-c25a-43a8-97b6-4fca330d4192&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:a051fe71-c25a-43a8-97b6-4fca330d4192","type":"Question","title":"Will blocking α7nicotinic acetylcholine receptor activation alleviate symptoms of Alzheimer disease?","label":"Will blocking α7nicotinic acetylcholine ...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:a051fe71-c25a-43a8-97b6-4fca330d4192"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9e16afdc-f038-4d2a-bb09-3e62b7e0422b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9e16afdc-f038-4d2a-bb09-3e62b7e0422b","type":"Claim","title":"Impairment of the γ-secretase-dependent S3 cleavage of Notch and consequent reduction in production of NICD have been well documented with a variety of PS mutations.","label":"Shen J et al.; Impairment of the γ-secretase-dependent ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:9e16afdc-f038-4d2a-bb09-3e62b7e0422b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b4362d3a-4ad0-4660-b2c3-a82f136369a4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b4362d3a-4ad0-4660-b2c3-a82f136369a4","type":"Claim","title":"BAG2 mediates ubiquitin independent degradation of tau through the proteasome, in a pathway that may allow access to internal folding defects, and thereby effectively degrade natively disordered substrates such as the cyclin-dependent kinase inhibitor p21cip1, translation initiation factors eIF4G and eIF3a, p53, and α-synuclein at internal peptide bonds.","label":"Carrettiero D et al.; BAG2 mediates ubiquitin independent degr...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hernandez Israel","Neveu Pierre","Papagiannakopoulos Thales","Kosik Kenneth S"],"firstAuthor":"Carrettiero Daniel C","referenceYear":"2009","referenceDate":"2009-02-18","id":"urn:lsid:swan.org:researchstatement:b4362d3a-4ad0-4660-b2c3-a82f136369a4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3fe61b6b-7d7c-458c-8b92-d6d3d93978e1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3fe61b6b-7d7c-458c-8b92-d6d3d93978e1","type":"Hypothesis","title":"Alzheimer changes in hypothalamic nuclei: Their relationship to neuronal activity and clinical symptoms.","label":"Lucassen P et al.; Alzheimer changes in hypothalamic nuclei...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Salehi A","Pool C W","Gonatas N K","Swaab D F"],"firstAuthor":"Lucassen P J","referenceYear":"1994","referenceDate":"1994-12","id":"urn:lsid:swan.org:researchstatement:3fe61b6b-7d7c-458c-8b92-d6d3d93978e1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8d1e3c2e-444e-4fb0-ba9f-2d2993c985a8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8d1e3c2e-444e-4fb0-ba9f-2d2993c985a8","type":"Claim","title":"In E22Q APP (Dutch) transgenic mice bred to a human PS1 G384A transgenic mouse model (PS45), young mice had a low Aβ40:42 ratio, and the pathology in aged mice was shifted from CAA to parenchymal plaque deposition.","label":"Fryer J et al.; In E22Q APP (Dutch) transgenic mice bred...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:8d1e3c2e-444e-4fb0-ba9f-2d2993c985a8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2d4ce99e-48eb-4989-8bb9-2b464fdd1c99&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2d4ce99e-48eb-4989-8bb9-2b464fdd1c99","type":"Claim","title":"The clinical phenotype of AD reflects an amalgamation of relatively selective regional brain pathology, the distribution of which may be influenced in part by APOE genotype, molecular influences driven at least in part by genetic variants dictate the degree to which distinct brain systems are affected by a class of neuropathology.","label":"Wolk D et al.; The clinical phenotype of AD reflects an...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Dickerson Bradford C","Weiner Michael","Aiello Marilyn","Aisen Paul","Albert Marilyn S","Alexander Gene","Anderson Heather S","Anderson Karen","Apostolova Liana","Arnold Steve","Ashford Wes","Assaly Michele","Asthana Sanjay","Bandy Dan","Bartha Rob","Bates Vernice","Beckett Laurel","Bell Karen L","Benincasa Amanda L","Bergman Howard","Bernick Charles","Bernstein Matthew","Black Sandra","Blank Karen","Borrie Michael","Brand Connie","Brewer James","Brown Alice D","Burns Jeffrey M","Cairns Nigel J","Caldwell Curtis","Capote Horacio","Carlsson Cynthia M","Carmichael Owen","Cellar Janet S","Celmins Dzintra","Chen Kewei","Chertkow Howard","Chowdhury Munir","Clark David","Connor Donald","Correia Stephen","Crawford Karen","Dale Anders","de Leon Mony J","De Santi Susan M","Decarli Charles","Detoledo-Morrell Leyla","Devous Michael","Diaz-Arrastia Ramon","Dolen Sara","Donohue Michael","Doody Rachelle S","Doraiswamy P Murali","Duara Ranjan","Englert Jessica","Farlow Martin","Feldman Howard","Felmlee Joel","Fleisher Adam","Fletcher Evan","Foroud Tatiana M","Foster Norm","Fox Nick","Frank Richard","Gamst Anthony","Given Curtis A","Graff-Radford Neill R","Green Robert C","Griffith Randall","Grossman Hillel","Hake Ann M","Hardy Peter","Harvey Danielle","Heidebrink Judith L","Hendin Barry A","Herring Scott","Honig Lawrence S","Hosein Chris","Robin Hsiung Ging-Yuek","Hudson Leon","Ismail M Saleem","Jack Clifford R","Jacobson Sandra","Jagust William","Jayam-Trouth Annapurni","Johnson Kris","Johnson Heather","Johnson Nancy","Johnson Kathleen","Johnson Keith A","Johnson Sterling","Kachaturian Zaven","Karlawish Jason H","Kataki Maria","Kaye Jeffrey","Kertesz Andrew","Killiany Ronald","Kittur Smita","Koeppe Robert A","Korecka Magdalena","Kornak John","Kozauer Nicholas","Lah James J","Laubinger Mary M","Lee Virginia M-Y","Lee T-Y","Lerner Alan","Levey Allan I","Longmire Crystal Flynn","Lopez Oscar L","Lord Joanne L","Lu Po H","Macavoy Martha G","Malloy Paul","Marson Daniel","Martin-Cook Kristen","Martinez Walter","Marzloff George","Mathis Chet","Mc-Adams-Ortiz Catherine","Mesulam Marsel","Miller Bruce L","Mintun Mark A","Mintzer Jacobo","Molchan Susan","Montine Tom","Morris John","Mulnard Ruth A","Munic Donna","Nair Anil","Neu Scott","Nguyen Dana","Norbash Alexander","Oakley Maryann","Obisesan Thomas O","Ogrocki Paula","Ott Brian R","Parfitt Francine","Pawluczyk Sonia","Pearlson Godfrey","Petersen Ronald","Petrella Jeffrey R","Potkin Steven","Potter William Z","Preda Adrian","Quinn Joseph","Rainka Michelle","Reeder Stephanie","Reiman Eric M","Rentz Dorene M","Reynolds Brigid","Richard Jennifer","Roberts Peggy","Rogers John","Rosen Allyson","Rosen Howard J","Rusinek Henry","Sabbagh Marwan","Sadowsky Carl","Salloway Stephen","Santulli Robert B","Saykin Andrew J","Scharre Douglas W","Schneider Lon","Schneider Stacy","Schuff Norbert","Shah Raj C","Shaw Les","Shen Li","Silverman Daniel H","Simpson Donna M","Sink Kaycee M","Smith Charles D","Snyder Peter J","Spann Bryan M","Sperling Reisa A","Spicer Kenneth","Stefanovic Bojana","Stern Yaakov","Stopa Edward","Tang Cheuk","Tariot Pierre","Taylor-Reinwald Lisa","Thai Gaby","Thomas Ronald G","Thompson Paul","Tinklenberg Jared","Toga Arthur W","Tremont Geoffrey","Trojanowki J Q","Trost Dick","Turner Raymond Scott","van Dyck Christopher H","Vanderswag Helen","Varon Daniel","Villanueva-Meyer Javier","Villena Teresa","Walter Sarah","Wang Paul","Watkins Franklin","Weiner Michael","Williamson Jeff D","Wolk David","Wu Chuang-Kuo","Zerrate Maria","Zimmerman Earl A"],"firstAuthor":"Wolk David A","referenceYear":"2010","referenceDate":"2010-05-17","id":"urn:lsid:swan.org:researchstatement:2d4ce99e-48eb-4989-8bb9-2b464fdd1c99"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f5727b2f-1952-458a-8c74-67147a8234ca&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f5727b2f-1952-458a-8c74-67147a8234ca","type":"Claim","title":"The amyloid cascade hypothesis proposed in 1992, identifies insoluble Aβ fibrils as the primary molecular pathogens of AD.","label":"Gong Y et al.; The amyloid cascade hypothesis proposed ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:f5727b2f-1952-458a-8c74-67147a8234ca"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:56370624-505c-4c43-8f2d-18058af314b3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:56370624-505c-4c43-8f2d-18058af314b3","type":"Claim","title":"The A246E mutation exhibits reduced ability to rescue phenotypes caused by PS homologue deficiency in C. elegans and Drosophila, further arguing that this mutation does indeed compromise the biological activity of PS1.","label":"Shen J et al.; The A246E mutation exhibits reduced abil...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:56370624-505c-4c43-8f2d-18058af314b3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e3a8ce37-1112-46d0-bc75-c449a732e7bb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e3a8ce37-1112-46d0-bc75-c449a732e7bb","type":"Claim","title":"EM analysis shows that the Tissue-transglutaminase-induced Aβ assemblies have the same morphologies as the previously described protofibrils that result from self-aggregation.","label":"Hartley D et al.; EM analysis shows that the Tissue-transg...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:e3a8ce37-1112-46d0-bc75-c449a732e7bb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7662e0ea-adac-4420-9e12-b32909a61a3a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7662e0ea-adac-4420-9e12-b32909a61a3a","type":"Claim","title":"The overwhelming majority of initial studies examining the effects of PS1 and PS2 mutations were performed using overexpression systems in diverse cell lines such as Xenopus oocytes or PC12 cells.","label":"Smith I et al.; The overwhelming majority of initial stu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:7662e0ea-adac-4420-9e12-b32909a61a3a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c40629a1-5dc5-4938-8cca-5059f3590da8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c40629a1-5dc5-4938-8cca-5059f3590da8","type":"Claim","title":"The constituents of amyloid plaques and neurofibrillary tangles, the hallmark histological features of AD, were identified as Aβ peptide, a cleaved product of the amyloid precursor protein (APP), as the core biochemical element of plaques, while hyperphosphorylated tau, a microtubule binding protein, was at the core of tangles.","label":"Small S et al.; The constituents of amyloid plaques and ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:c40629a1-5dc5-4938-8cca-5059f3590da8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b9f01ab5-b99d-4696-8d69-d81318206370&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b9f01ab5-b99d-4696-8d69-d81318206370","type":"Claim","title":"Because fewer than half of all AD sufferers possess the e4 allele and not all e4 carriers develop disease, therefore additional genes must also be implicated in AD.","label":"Cook L et al.; Because fewer than half of all AD suffer...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Ho Luk W","Taylor Alison E","Brayne Carol","Evans John Grimley","Xuereb John","Cairns Nigel J","Pritchard Antonia","Lemmon Helen","Mann David","St Clair David","Turic Dragana","Hollingworth Paul","Moore Pamela J","Jehu Luke","Archer Nicola","Walter Sarah","Foy Catherine","Edmondson Amanda","Powell John","Lovestone Simon","Owen Michael J","Williams Julie","Lendon Corinne","Rubinsztein David C"],"firstAuthor":"Cook Lynnette J","referenceYear":"2004","referenceDate":"2004-03-25","id":"urn:lsid:swan.org:researchstatement:b9f01ab5-b99d-4696-8d69-d81318206370"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c55e79aa-db18-463d-90af-27500c9661dd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c55e79aa-db18-463d-90af-27500c9661dd","type":"Hypothesis","title":"Aβ Plaques Lead to Aberrant Regulation of Calcium Homeostasis In Vivo Resulting in Structural and Functional Disruption of Neuronal Networks.","label":"Kuchibhotla K et al.; Aβ Plaques Lead to Aberrant Regulation o...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Goldman Samuel T","Lattarulo Carli R","Wu Hai-Yan","Hyman Bradley T","Bacskai Brian J"],"firstAuthor":"Kuchibhotla Kishore V","referenceYear":"2008","referenceDate":"2008-07-31","id":"urn:lsid:swan.org:researchstatement:c55e79aa-db18-463d-90af-27500c9661dd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:16a55bac-6a03-41e6-828f-7c4e0eb97eb6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:16a55bac-6a03-41e6-828f-7c4e0eb97eb6","type":"Claim","title":"Ser655 (numbering for APP695 isoform) is phosphorylated in vitro by both protein kinase C (PKC) and calcium/calmodulin-dependent protein kinase II (CaM kinase II), and Thr654 is also phosphorylated in vitro by CaM kinase II.","label":"Suzuki T et al.; Ser655 (numbering for APP695 isoform) is...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:16a55bac-6a03-41e6-828f-7c4e0eb97eb6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:578ae29f-9765-44ff-8477-c2224b9c55c1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:578ae29f-9765-44ff-8477-c2224b9c55c1","type":"Comment","title":"April 2008 Update of the Amyloid Hypothesis contributed by John Hardy and Dennis Selkoe","label":"Hardy J et al.; April 2008 Update of the Amyloid Hypothe...","icon":"../icons/ontological/discourse-element/comment.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","id":"urn:lsid:swan.org:comment:578ae29f-9765-44ff-8477-c2224b9c55c1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:18919b47-684c-40d5-9688-ad003a7fc50c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:18919b47-684c-40d5-9688-ad003a7fc50c","type":"Claim","title":"ApoE4 has since been found to accelerate symptom appearance in PS mutation-affected AD carriers. Our 1994 (Von Broeckhoven) paper was cited to support this claim, but in hindsight it was an overly simple interpretation of the ApoE effect. The 2003 Pastor article corrected this.","label":"Hardy J et al.; ApoE4 has since been found to accelerate...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","id":"urn:lsid:swan.org:researchstatement:18919b47-684c-40d5-9688-ad003a7fc50c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1cc9b6e0-ecd2-4761-8915-4d81677b4566&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1cc9b6e0-ecd2-4761-8915-4d81677b4566","type":"Claim","title":"Evidence also exists to suggest that 10%\u2013 15% Aβ can enter into the cerebral spinal fluid (CSF) from the brain interstitial fluid and onward into the bloodstream.","label":"Tanzi R et al.; Evidence also exists to suggest that 10%...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:1cc9b6e0-ecd2-4761-8915-4d81677b4566"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3137773e-f805-4870-a9b2-534dc0688891&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3137773e-f805-4870-a9b2-534dc0688891","type":"Claim","title":"THOP 1 increases in abundance by 1.21 fold change after 4 h incubation with Aβ25\u201335 no significant expression changes evident at the RNA level, indicating that the observed change is mediated by posttranscriptional mechanisms, possibly by increased protein stability.","label":"Pollio G et al.; THOP 1 increases in abundance by 1.21 fo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hoozemans Jeroen J","Andersen Claus A","Roncarati Renza","Rosi Maria Cristina","van Haastert Elise S","Seredenina Tamara","Diamanti Daniela","Gotta Stefano","Fiorentini Anna","Magnoni Letizia","Raggiaschi Roberto","Rozemuller Annemieke J","Casamenti Fiorella","Caricasole Andrea","Terstappen Georg C"],"firstAuthor":"Pollio Giuseppe","referenceYear":"2008","referenceDate":"2008-07","id":"urn:lsid:swan.org:researchstatement:3137773e-f805-4870-a9b2-534dc0688891"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:579216e7-7812-4ee6-9ec7-603e8a913b9e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:579216e7-7812-4ee6-9ec7-603e8a913b9e","type":"Claim","title":"Amyloid peptides can aggregate and become embedded in the membrane&#8212;or vice versa&#8212;to form pores that allow exchange of chemicals and ions between cellular compartments and with the neuronal environment.","label":"Dewachter I et al.; Amyloid peptides can aggregate and becom...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Van Leuven Fred"],"firstAuthor":"Dewachter Ilse","id":"urn:lsid:swan.org:researchstatement:579216e7-7812-4ee6-9ec7-603e8a913b9e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:845520c4-87fc-43ad-a6d3-c83e6e052768&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:845520c4-87fc-43ad-a6d3-c83e6e052768","type":"Claim","title":"ApoE interacts with Aβ after it is produced to affect both Aβ conformation and clearance.","label":"Holtzman D; ApoE interacts with Aβ after it is produ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:845520c4-87fc-43ad-a6d3-c83e6e052768"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9ae6a74e-d2a4-4d56-8a6d-1f2588501667&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9ae6a74e-d2a4-4d56-8a6d-1f2588501667","type":"Claim","title":"Young APP transgenic mice undergo synaptic, electrophysiological and behavioral changes before amyloid plaque deposition.","label":"Walsh D et al.; Young APP transgenic mice undergo synapt...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Klyubin Igor","Fadeeva Julia V","Cullen William K","Anwyl Roger","Wolfe Michael S","Rowan Michael J","Selkoe Dennis J"],"firstAuthor":"Walsh Dominic M","referenceYear":"2002","referenceDate":"2002-04-04","id":"urn:lsid:swan.org:researchstatement:9ae6a74e-d2a4-4d56-8a6d-1f2588501667"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c199c5b7-1aa1-4884-8340-e12386d31aa3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c199c5b7-1aa1-4884-8340-e12386d31aa3","type":"Hypothesis","title":"Systemic inflammation, infection and ApoE4 are associated with Alzheimer disease.","label":"Finch C et al.; Systemic inflammation, infection and Apo...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Morgan Todd E"],"firstAuthor":"Finch Caleb E","referenceYear":"2007","referenceDate":"2007-04","id":"urn:lsid:swan.org:researchstatement:c199c5b7-1aa1-4884-8340-e12386d31aa3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f7709c3e-c5ae-45a5-9a24-fec138f4d903&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f7709c3e-c5ae-45a5-9a24-fec138f4d903","type":"Claim","title":"Elevated tau expression has been proposed as a possible basis for impaired axonal transport in AD","label":"Yuan A et al.; Elevated tau expression has been propose...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:f7709c3e-c5ae-45a5-9a24-fec138f4d903"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3c5d0cf3-13a7-47c0-a071-ee28dd2f8c6e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3c5d0cf3-13a7-47c0-a071-ee28dd2f8c6e","type":"Claim","title":"Soluble Aβ has been detected in AD CSF and conditioned media of neuronal cultures.","label":"Plant L et al.; Soluble Aβ has been detected in AD CSF a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:3c5d0cf3-13a7-47c0-a071-ee28dd2f8c6e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5a1de8eb-2903-428b-841c-dcfe83177f60&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5a1de8eb-2903-428b-841c-dcfe83177f60","type":"Claim","title":"Replicative senescence results in cells with altered morphology, telomere shortening or telomerase malfunction, distinct senescence-associated hetrochromatic foci, increased expression of a panel of senescence-associated biomarkers (for example, senescence-associated β-galactosidase activity, INK4A, IL-6), and is a process that does not appear to be easily reversible. ","label":"Golde T et al.; Replicative senescence results in cells ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:5a1de8eb-2903-428b-841c-dcfe83177f60"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ae7c6c55-d002-4cfc-8fbd-88df3f05eb8d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ae7c6c55-d002-4cfc-8fbd-88df3f05eb8d","type":"Claim","title":"It has been generally accepted, based on in vitro studies of protein aggregation, that amyloid-beta aggregation is time dependent and follows a relatively slow nucleation-dependent polymerization process.","label":"Meyer-Luehmann M et al.; It has been generally accepted, based on...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:ae7c6c55-d002-4cfc-8fbd-88df3f05eb8d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b45ee55c-42ec-4086-a0a1-a5de6cd8f78f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b45ee55c-42ec-4086-a0a1-a5de6cd8f78f","type":"Claim","title":"In the studies of mice overexpressing tau 4R the inference that axonal transport may be disrupted is based on neuropathological detection of focal organelle accumulations in the degenerating axons of tg mice.","label":"Nixon R; In the studies of mice overexpressing ta...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Nixon Ralph A","id":"urn:lsid:swan.org:researchstatement:b45ee55c-42ec-4086-a0a1-a5de6cd8f78f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7d42b30f-221f-4c6f-95a6-c21eed38a4b9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7d42b30f-221f-4c6f-95a6-c21eed38a4b9","type":"Claim","title":"Pro-inflammatory secreted proteins can act in an autocrine manner to further maintain the senescent state, drive senescence of neighboring cells in a paracrine fashion, and promote degenerative or proliferative changes in neighboring cells. ","label":"Golde T et al.; Pro-inflammatory secreted proteins can a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:7d42b30f-221f-4c6f-95a6-c21eed38a4b9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:068bac45-a33c-4164-ba86-4606b4f29cc3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:068bac45-a33c-4164-ba86-4606b4f29cc3","type":"Claim","title":"FAD clinical mutant PS increase Abeta42:40 ratio as a consequence of either lowering Ab40, increasing Ab42, or both.","label":"Bentahir M et al.; FAD clinical mutant PS increase Abeta42:...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:068bac45-a33c-4164-ba86-4606b4f29cc3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:98345d0e-8d01-4710-b34c-151de737ee70&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:98345d0e-8d01-4710-b34c-151de737ee70","type":"Claim","title":"ADDL-like oligomers also occur spontaneously at very low concentrations in medium conditioned by amyloid precursor protein (APP)-transfected CHO cells.","label":"Lambert M et al.; ADDL-like oligomers also occur spontaneo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:98345d0e-8d01-4710-b34c-151de737ee70"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:63a58dad-0ac0-4523-9f61-9ec5a09ac45a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:63a58dad-0ac0-4523-9f61-9ec5a09ac45a","type":"Claim","title":"Neuritic beading morphology, and corresponding severe elevations in intracellular calcium, could be antagonized by inhibiting the Ca2+/calmodulin-dependent protein phosphatase 2B (calcineurin, CaN).","label":"Kuchibhotla K et al.; Neuritic beading morphology, and corresp...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Goldman Samuel T","Lattarulo Carli R","Wu Hai-Yan","Hyman Bradley T","Bacskai Brian J"],"firstAuthor":"Kuchibhotla Kishore V","referenceYear":"2008","referenceDate":"2008-07-31","id":"urn:lsid:swan.org:researchstatement:63a58dad-0ac0-4523-9f61-9ec5a09ac45a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3edafb1f-5728-4fdf-9aec-65c867e927a4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3edafb1f-5728-4fdf-9aec-65c867e927a4","type":"Claim","title":"In humans, APOE4 is associated with larger amounts of CAA in patients with AD, and some APOE4 homozygous individuals examined at older ages have been shown to have substantial CAA.","label":"Fryer J et al.; In humans, APOE4 is associated with larg...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:3edafb1f-5728-4fdf-9aec-65c867e927a4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0fd694d5-1fe1-4027-94d9-4a573c98e3ea&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0fd694d5-1fe1-4027-94d9-4a573c98e3ea","type":"Claim","title":"Both active and passive immunization against Aβ have recently been reported to prevent Aβ and amyloid deposition in transgenic mouse models of AD","label":"Dodart J et al.; Both active and passive immunization aga...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:0fd694d5-1fe1-4027-94d9-4a573c98e3ea"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:409bbe27-785b-413b-9694-1b7706bce1cc&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:409bbe27-785b-413b-9694-1b7706bce1cc","type":"Claim","title":"Monomers of Aβ (either 1-42 or 42-1), carrying the familiar AD Arctic mutation (E22G) lacked any neuroprotective activity.","label":"Giuffrida M et al.; Monomers of Aβ (either 1-42 or 42-1), ca...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Caraci Filippo","Pignataro Bruno","Cataldo Sebastiano","De Bona Paolo","Bruno Valeria","Molinaro Gemma","Pappalardo Giuseppe","Messina Angela","Palmigiano Angelo","Garozzo Domenico","Nicoletti Ferdinando","Rizzarelli Enrico","Copani Agata"],"firstAuthor":"Giuffrida Maria Laura","referenceYear":"2009","referenceDate":"2009-08-26","id":"urn:lsid:swan.org:researchstatement:409bbe27-785b-413b-9694-1b7706bce1cc"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:40bea353-71c7-4098-9abe-9417a2d3acf8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:40bea353-71c7-4098-9abe-9417a2d3acf8","type":"Claim","title":"Aβ has been shown to exacerbate neurodegeneration in cultured neurons when glucose levels are reduced.","label":"Cotman C et al.; Aβ has been shown to exacerbate neurodeg...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:40bea353-71c7-4098-9abe-9417a2d3acf8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:35d9ea6a-1f0e-4e61-81ec-e8cd8898815e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:35d9ea6a-1f0e-4e61-81ec-e8cd8898815e","type":"Question","title":"Although Aβ can also enter from the bloodstream into the brain primarily via the RAGE receptor, it is not clear what proportion of Aβ that undergoes influx into the brain from the plasma was originally generated in the CNS versus the periphery. This will obviously be an important topic for future studies.","label":"Although Aβ can also enter from the bloo...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:35d9ea6a-1f0e-4e61-81ec-e8cd8898815e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c219eb92-f2d8-4ec0-bb19-2702b795b7c7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c219eb92-f2d8-4ec0-bb19-2702b795b7c7","type":"Claim","title":"Two attempts to formulate alternate molecular hypotheses which account for the genetic data are the presenilin inhibition hypothesis and the double hit hypothesis. ","label":"Hardy ; Two attempts to formulate alternate mole...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Hardy","referenceYear":"2009","referenceDate":"2009-05-18","id":"urn:lsid:swan.org:researchstatement:c219eb92-f2d8-4ec0-bb19-2702b795b7c7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:09191481-af32-4369-8c48-5db862d62c65&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:09191481-af32-4369-8c48-5db862d62c65","type":"Claim","title":"A major ongoing debate in the AD and the larger neurodegenerative disease field is whether small soluble aggregates (oligomers) or larger, less soluble aggregates (fibrils) are the principle toxic species.","label":"Golde T et al.; A major ongoing debate in the AD and the...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:09191481-af32-4369-8c48-5db862d62c65"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:61dccb06-2f5d-4961-9065-ec53cf74040c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:61dccb06-2f5d-4961-9065-ec53cf74040c","type":"Claim","title":"Intranasal insulin administration can \u201cnormalize\u201d reduced CNS insulin in patients with amnestic MCI or early AD, improve memory using a Delayed Story Recall task, as well as attention improvement using the Stroop test. ","label":"Craft S; Intranasal insulin administration can \u201cn...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft Suzanne","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:61dccb06-2f5d-4961-9065-ec53cf74040c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:00eab92c-3bfb-48f2-8fff-2001f51c1bab&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:00eab92c-3bfb-48f2-8fff-2001f51c1bab","type":"Claim","title":"The regulation of myelin thickness through neuregulin 1 (neuregulin) signaling influences transmission speed and refractory time involves cleavage of neuregulin and its receptors by the BACE1 and γ-secretase complexes.","label":"Bartzokis G; The regulation of myelin thickness throu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:00eab92c-3bfb-48f2-8fff-2001f51c1bab"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e35c6490-f915-44de-8366-3cb55b566354&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e35c6490-f915-44de-8366-3cb55b566354","type":"Hypothesis","title":"[ADNI]  Models of Alzheimer Disease Biomarkers: Disease stage and clinical symptom severity are related to dynamic changes of biomarkers.","label":"Jack C et al.; [ADNI]  Models of Alzheimer Disease Biom...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner Michael W","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","id":"urn:lsid:swan.org:researchstatement:e35c6490-f915-44de-8366-3cb55b566354"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a656890e-0c85-431e-a3d7-ce6d48617c79&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a656890e-0c85-431e-a3d7-ce6d48617c79","type":"Claim","title":"The increased level of co-precipitated 20S proteasome - PHF-tau aggregates were also positive for Ser202 phosphorylation (AT8) and paralleled a decrease in the proteasome activity.","label":"Keck S et al.; The increased level of co-precipitated 2...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:a656890e-0c85-431e-a3d7-ce6d48617c79"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9597da67-bc1d-491e-8606-f02ebeb3e2bd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9597da67-bc1d-491e-8606-f02ebeb3e2bd","type":"Claim","title":"Clinical trials need to be organized in those in the very earliest stages of Alzheimer Disease.","label":"Clinical trials need to be organized in ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:9597da67-bc1d-491e-8606-f02ebeb3e2bd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:247d06d5-8d46-4664-bcb4-ee509ba5116f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:247d06d5-8d46-4664-bcb4-ee509ba5116f","type":"Claim","title":"Several previous studies have shown that direct intracerebral administration of Aβ disrupts memory in rodents.","label":"Dodart J et al.; Several previous studies have shown that...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:247d06d5-8d46-4664-bcb4-ee509ba5116f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:29a1f336-e122-4b6c-8da4-d5f026185ede&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:29a1f336-e122-4b6c-8da4-d5f026185ede","type":"Claim","title":"FAD PS1 N141I is inefficient at CTF turnover of syndecan 3 and N-cadherin, but rescued APP CTF turnover to wild type levels.","label":"Bentahir M et al.; FAD PS1 N141I is inefficient at CTF turn...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:29a1f336-e122-4b6c-8da4-d5f026185ede"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ac1a71b5-7435-42ce-8f2e-d5f78149cf2d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ac1a71b5-7435-42ce-8f2e-d5f78149cf2d","type":"Claim","title":"In cognitively normal elderly individuals, correlations are seen between decreased FDG-PET uptake and both low CSF Aβ42 and increased CSF tau.","label":"Jack C et al.; In cognitively normal elderly individual...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:ac1a71b5-7435-42ce-8f2e-d5f78149cf2d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9005277e-f94c-4591-a96a-527c31012852&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9005277e-f94c-4591-a96a-527c31012852","type":"Claim","title":"There is normal CNS myelination in the absence of neuregulin.","label":"Barres B; There is normal CNS myelination in the a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Barres Ben A","id":"urn:lsid:swan.org:researchstatement:9005277e-f94c-4591-a96a-527c31012852"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c2f0ab2e-22b6-41f8-a17a-e36ec2465828&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c2f0ab2e-22b6-41f8-a17a-e36ec2465828","type":"Claim","title":"Insulin uses two major signaling pathways, with the phosphatidylinositol 3-kinase (PI3K) pathway being associated with synaptic remodeling, memory processing, tau phosphorylation, neuronal survival, and beta amyloid regulation.","label":"Craft S; Insulin uses two major signaling pathway...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft Suzanne","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:c2f0ab2e-22b6-41f8-a17a-e36ec2465828"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:37f4505c-ba86-480c-b442-d9f5231df583&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:37f4505c-ba86-480c-b442-d9f5231df583","type":"Claim","title":"Synaptic changes associated with soluble forms of aggregated Aβ have been predictive of cognitive decline.","label":"Hartley D et al.; Synaptic changes associated with soluble...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:37f4505c-ba86-480c-b442-d9f5231df583"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5590976f-0631-4948-a2fb-a7e8194b504f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5590976f-0631-4948-a2fb-a7e8194b504f","type":"Claim","title":"Excitotoxic neuronal death contributes to the overall neurodegeneration in AD and other CNS disorders.","label":"Giuffrida M et al.; Excitotoxic neuronal death contributes t...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Caraci Filippo","Pignataro Bruno","Cataldo Sebastiano","De Bona Paolo","Bruno Valeria","Molinaro Gemma","Pappalardo Giuseppe","Messina Angela","Palmigiano Angelo","Garozzo Domenico","Nicoletti Ferdinando","Rizzarelli Enrico","Copani Agata"],"firstAuthor":"Giuffrida Maria Laura","referenceYear":"2009","referenceDate":"2009-08-26","id":"urn:lsid:swan.org:researchstatement:5590976f-0631-4948-a2fb-a7e8194b504f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c8972a2e-f711-4a21-8788-e5b0403e423b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c8972a2e-f711-4a21-8788-e5b0403e423b","type":"Claim","title":"The site of phosphorylation of APP by cdc2 kinase (Thr668) is within the proposed domain of interaction of APP with Go, suggesting the possibility that phosphorylation could modulate this process.","label":"Suzuki T et al.; The site of phosphorylation of APP by cd...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:c8972a2e-f711-4a21-8788-e5b0403e423b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c50fb58c-94b2-4d74-b726-2237c7a47087&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c50fb58c-94b2-4d74-b726-2237c7a47087","type":"Claim","title":"When kinesin motor protein encountered tau patches on microtubules, composed of 10 tau molecules, it detached from microtubules.","label":"Takashima A; When kinesin motor protein encountered t...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Takashima Akihiko","id":"urn:lsid:swan.org:researchstatement:c50fb58c-94b2-4d74-b726-2237c7a47087"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:98257fb3-55b5-4b8a-80e8-77dc097bf946&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:98257fb3-55b5-4b8a-80e8-77dc097bf946","type":"Claim","title":"It is possible that the increased levels of THOP1 may favor conversion of Aβ42 to Aβ40, as recently reported for another zinc peptidase, the angiotensin-converting enzyme, in mouse and human brain homogenates.","label":"Pollio G et al.; It is possible that the increased levels...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hoozemans Jeroen J","Andersen Claus A","Roncarati Renza","Rosi Maria Cristina","van Haastert Elise S","Seredenina Tamara","Diamanti Daniela","Gotta Stefano","Fiorentini Anna","Magnoni Letizia","Raggiaschi Roberto","Rozemuller Annemieke J","Casamenti Fiorella","Caricasole Andrea","Terstappen Georg C"],"firstAuthor":"Pollio Giuseppe","referenceYear":"2008","referenceDate":"2008-07","id":"urn:lsid:swan.org:researchstatement:98257fb3-55b5-4b8a-80e8-77dc097bf946"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8c274892-171a-43ad-969a-cd8e6af5f6c1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8c274892-171a-43ad-969a-cd8e6af5f6c1","type":"Claim","title":"The CSF signature of AD is reduced Aβ42 and elevated tau or phosphorylated tau.","label":"Morris J et al.; The CSF signature of AD is reduced Aβ42 ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Roe Catherine M","Grant Elizabeth A","Head Denise","Storandt Martha","Goate Alison M","Fagan Anne M","Holtzman David M","Mintun Mark A"],"firstAuthor":"Morris John C","referenceYear":"2009","referenceDate":"2009-12","id":"urn:lsid:swan.org:researchstatement:8c274892-171a-43ad-969a-cd8e6af5f6c1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9a830f87-0f43-418b-9ef4-435d8b5350ed&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9a830f87-0f43-418b-9ef4-435d8b5350ed","type":"Claim","title":"γ-secretase may have a more complex regulatory role that involves not only generation but also inhibition of Aβ.","label":"Marchesi V; γ-secretase may have a more complex regu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:9a830f87-0f43-418b-9ef4-435d8b5350ed"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0b260aac-bdda-4fe7-9e7a-73b903c819e5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0b260aac-bdda-4fe7-9e7a-73b903c819e5","type":"Claim","title":"Aβ accumulation is the initial step that triggers all AD related pathologies, including accumulation of tau or synuclein, inflammatory response, oxidative stress, neuronal dysfunction and dementia.","label":"Golde T; Aβ accumulation is the initial step that...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde T","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:0b260aac-bdda-4fe7-9e7a-73b903c819e5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a6f712f7-dc26-4c6e-a688-dff5ecac87f3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a6f712f7-dc26-4c6e-a688-dff5ecac87f3","type":"Claim","title":"Soluble Aβ from Alzheimer\u2019s Disease cortex facilitated LTD, but vehicle or control soluble cortical extracts did not facilitate LTD induction.","label":"Shankar G et al.; Soluble Aβ from Alzheimer\u2019s Disease cort...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Li Shaomin","Mehta Tapan H","Garcia-Munoz Amaya","Shepardson Nina E","Smith Imelda","Brett Francesca M","Farrell Michael A","Rowan Michael J","Lemere Cynthia A","Regan Ciaran M","Walsh Dominic M","Sabatini Bernardo L","Selkoe Dennis J"],"firstAuthor":"Shankar Ganesh M","referenceYear":"2008","referenceDate":"2008-08","id":"urn:lsid:swan.org:researchstatement:a6f712f7-dc26-4c6e-a688-dff5ecac87f3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d78245f0-83de-4bbb-b389-432aa8bd8c52&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d78245f0-83de-4bbb-b389-432aa8bd8c52","type":"Claim","title":"Tau itself is transported at a unique slow rate of transport, which on average is somewhat faster than tubulin and slower than other MAPs","label":"Yuan A et al.; Tau itself is transported at a unique sl...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:d78245f0-83de-4bbb-b389-432aa8bd8c52"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:65d94551-47d8-44e5-8bb5-7d071b52db5d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:65d94551-47d8-44e5-8bb5-7d071b52db5d","type":"Claim","title":"BACE (beta secretase) inhibitors are being developed.","label":"Golde T; BACE (beta secretase) inhibitors are bei...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde Todd E","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:65d94551-47d8-44e5-8bb5-7d071b52db5d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bbb5eca7-3611-4650-8315-6e68e37f7a8e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bbb5eca7-3611-4650-8315-6e68e37f7a8e","type":"Claim","title":"Some neurons that display TdT-positive labeling also exhibit the early stages of tangle formation.","label":"Cotman C et al.; Some neurons that display TdT-positive l...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:bbb5eca7-3611-4650-8315-6e68e37f7a8e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:7fcc4a6d-7124-4d21-8b52-92da21ef2d7d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:7fcc4a6d-7124-4d21-8b52-92da21ef2d7d","type":"Question","title":"The identification and characterization of additional biochemical, morphological, and physiological alterations will be required at the ages when neuronal cell cycle events (CCEs) first become evident in vivo.","label":"The identification and characterization ...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:7fcc4a6d-7124-4d21-8b52-92da21ef2d7d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e9aa821a-99f2-418b-b104-4f49d3c6bade&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e9aa821a-99f2-418b-b104-4f49d3c6bade","type":"Claim","title":"The data reported by Yuan et al. also appear to differ from studies that reported on tau transgenic mice that overexpress the smallest human tau isoform to perturb the 3R-to-4R tau ratio in these mice.","label":"Lee V et al.; The data reported by Yuan et al. also ap...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Trojanowski John Q"],"firstAuthor":"Lee Virginia M-Y","id":"urn:lsid:swan.org:researchstatement:e9aa821a-99f2-418b-b104-4f49d3c6bade"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5aaa50b9-f8f8-4f17-9836-abe1969ec214&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5aaa50b9-f8f8-4f17-9836-abe1969ec214","type":"Claim","title":"Individual dense-core plaque\u2019s formation represents an acute event.  This is unexpected because it takes months for many plaques to accumulate, even in accelerated mouse models of Alzheimer\u2019s disease","label":"Meyer-Luehmann M et al.; Individual dense-core plaque\u2019s formation...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:5aaa50b9-f8f8-4f17-9836-abe1969ec214"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f9d8ef3e-8066-4bb4-84dc-7620f24da0ab&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f9d8ef3e-8066-4bb4-84dc-7620f24da0ab","type":"Claim","title":"Changes in the density of the presynaptic marker synaptophysin are better correlated with disease progression than Aβ plaque load or cell death.","label":"Dziewczapolski G et al.; Changes in the density of the presynapti...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Glogowski Carolina M","Masliah Eliezer","Heinemann Stephen F"],"firstAuthor":"Dziewczapolski Gustavo","referenceYear":"2009","referenceDate":"2009-07-08","id":"urn:lsid:swan.org:researchstatement:f9d8ef3e-8066-4bb4-84dc-7620f24da0ab"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d0fa4e5b-4790-4705-89b3-27f2f3cca057&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d0fa4e5b-4790-4705-89b3-27f2f3cca057","type":"Claim","title":"APP23/Ar+/- male mice exhibit reduced amyloid accumulation and plaque formation in the brain compared with control mice, as evidenced by the significantly reduction of the ratio of Aβ42 to Aβ40 in APP23/Ar+/- mice at 9 and 18 months of age compared with the ratio in age-matched APP23 mice, suggesting the possible role of testosterone in prohibiting Aβ42 accumulation.","label":"McAllister C et al.; APP23/Ar+/- male mice exhibit reduced am...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Long Jiangang","Bowers Adrienne","Walker Aaron","Cao Philip","Honda Shin-Ichiro","Harada Nobuhiro","Staufenbiel Matthias","Shen Yong","Li Rena"],"firstAuthor":"McAllister Carrie","referenceYear":"2010","referenceDate":"2010-05-26","id":"urn:lsid:swan.org:researchstatement:d0fa4e5b-4790-4705-89b3-27f2f3cca057"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:db3ff4f1-7fae-42ce-995a-33bea9b9bd07&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:db3ff4f1-7fae-42ce-995a-33bea9b9bd07","type":"Claim","title":"ApoE regulates the amount of fibrillar Aβ deposited.","label":"Golde T; ApoE regulates the amount of fibrillar A...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde Todd E","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:db3ff4f1-7fae-42ce-995a-33bea9b9bd07"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cf4536c7-e5c4-4c4b-86f9-28736e8a0e37&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cf4536c7-e5c4-4c4b-86f9-28736e8a0e37","type":"Claim","title":"Human brain is approximately 25% myelin with a disproportionate amount devoted to myelinating thin axons that are disproportionately impacted by the neuregulin-ErbB signaling.  ","label":"Bartzokis G; Human brain is approximately 25% myelin ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","id":"urn:lsid:swan.org:researchstatement:cf4536c7-e5c4-4c4b-86f9-28736e8a0e37"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c40f87ee-a1c5-4df2-bbea-d43d7bee0a59&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c40f87ee-a1c5-4df2-bbea-d43d7bee0a59","type":"Claim","title":"By definition, the distinct oligomer size distributions of Abeta40 vs Abeta42 are related to the C-Terminal amino acid residues Ile(41)-Ala(42).","label":"Bitan G et al.; By definition, the distinct oligomer siz...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:c40f87ee-a1c5-4df2-bbea-d43d7bee0a59"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9fc5988e-163b-4656-afd7-b4bf1096f787&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9fc5988e-163b-4656-afd7-b4bf1096f787","type":"Claim","title":"The extracellular signal-regulated kinases (ERKs) or mitogen-activated protein kinases (MAPKs) phosphorylate consensus sequences containing serine-proline and threonine-proline motifs.","label":"Suzuki T et al.; The extracellular signal-regulated kinas...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:9fc5988e-163b-4656-afd7-b4bf1096f787"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:aaf694b0-e798-48e7-8896-cac586c8c6e2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:aaf694b0-e798-48e7-8896-cac586c8c6e2","type":"Claim","title":"Measures of the neurodegenerative portion of the cascade (eg, CSF tau, FDG-PET, or structural MRI) should be used in AD therapeutic clinical trials as evidence of therapeutic modification of the neurodegenerative aspect of the AD pathological process and a combination of biomarkers might be needed in clinical trials to select appropriate participants and to follow disease progression.","label":"Jack C et al.; Measures of the neurodegenerative portio...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner Michael W","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:aaf694b0-e798-48e7-8896-cac586c8c6e2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:faee77f6-02c9-4844-993b-f61a11104d3a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:faee77f6-02c9-4844-993b-f61a11104d3a","type":"Claim","title":"Enhanced expression of THOP1 observed in the Aβ surroundings of aged APP transgenic mice might be neuroprotective by favoring the homeostatic maintenance of the brain immune system. ","label":"Pollio G et al.; Enhanced expression of THOP1 observed in...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hoozemans Jeroen J","Andersen Claus A","Roncarati Renza","Rosi Maria Cristina","van Haastert Elise S","Seredenina Tamara","Diamanti Daniela","Gotta Stefano","Fiorentini Anna","Magnoni Letizia","Raggiaschi Roberto","Rozemuller Annemieke J","Casamenti Fiorella","Caricasole Andrea","Terstappen Georg C"],"firstAuthor":"Pollio Giuseppe","referenceYear":"2008","referenceDate":"2008-07","id":"urn:lsid:swan.org:researchstatement:faee77f6-02c9-4844-993b-f61a11104d3a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0cccb153-63c8-4732-9ec8-145137837ab0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0cccb153-63c8-4732-9ec8-145137837ab0","type":"Claim","title":"Expression of cell cycle proteins and DNA synthesis is observed in neurons susceptible to death in AD. ","label":"Varvel N et al.; Expression of cell cycle proteins and DN...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bhaskar Kiran","Patil Anita R","Pimplikar Sanjay W","Herrup Karl","Lamb Bruce T"],"firstAuthor":"Varvel Nicholas H","referenceYear":"2008","referenceDate":"2008-10-22","id":"urn:lsid:swan.org:researchstatement:0cccb153-63c8-4732-9ec8-145137837ab0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:542a876d-5db9-4679-bc1b-0c6f76e75ba2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:542a876d-5db9-4679-bc1b-0c6f76e75ba2","type":"Claim","title":"Ceramide transduces signals that are involved in the overall regulation of terminal differentiation of neurons, cellular senescence, proliferation and death.","label":"Ceramide transduces signals that are inv...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:542a876d-5db9-4679-bc1b-0c6f76e75ba2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:7d66c89c-5aa4-412e-8ba2-fb308d213762&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:7d66c89c-5aa4-412e-8ba2-fb308d213762","type":"Question","title":"What are the pathways or mechanisms that could explain Thop1\u2019s neuroprotective functions?","label":"What are the pathways or mechanisms that...","icon":"../icons/ontological/discourse-element/research-question.png","firstAuthor":"Abraham C R","id":"urn:lsid:swan.org:researchquestion:7d66c89c-5aa4-412e-8ba2-fb308d213762"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:926c22b5-47d7-44da-bbc3-91adef57153c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:926c22b5-47d7-44da-bbc3-91adef57153c","type":"Claim","title":"The rate of growth measured in this study is exactly what the nucleation model would predict and it is gratifying to see this occur in vivo.","label":"Lansbury P; The rate of growth measured in this stud...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Lansbury Peter T","id":"urn:lsid:swan.org:researchstatement:926c22b5-47d7-44da-bbc3-91adef57153c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ce02d487-d90c-4e29-90ad-3b355496fffe&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ce02d487-d90c-4e29-90ad-3b355496fffe","type":"Claim","title":"Apoptosis was originally detected by characteristic morphologies that include shrinkage of the cells, membrane blebbing, chromatin condensation, and nuclear fragmentation.","label":"Cotman C et al.; Apoptosis was originally detected by cha...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:ce02d487-d90c-4e29-90ad-3b355496fffe"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ab6ecc40-8eaf-41ae-91c2-2e3af963eb2b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ab6ecc40-8eaf-41ae-91c2-2e3af963eb2b","type":"Claim","title":"Fast transport rates of two cargoes (p135 and snap25), analyzed at 5 hours after injection in tau-null mice were not significantly different from those in wild-type.","label":"Yuan A et al.; Fast transport rates of two cargoes (p13...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:ab6ecc40-8eaf-41ae-91c2-2e3af963eb2b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d06b3802-0ee4-4263-a1a9-1bae78e2d5ce&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d06b3802-0ee4-4263-a1a9-1bae78e2d5ce","type":"Claim","title":"The electrophysiology of neurons can be altered even when they are morphologically normal, without detectable pathology or cell death.","label":"Morse T et al.; The electrophysiology of neurons can be ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Mutalik Pradeep","Cheung Kei","Miller Perry L","Shepherd Gordon"],"firstAuthor":"Morse Thomas M","id":"urn:lsid:swan.org:researchstatement:d06b3802-0ee4-4263-a1a9-1bae78e2d5ce"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:19ec8466-04cd-47fa-a53c-e8dd8f364f64&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:19ec8466-04cd-47fa-a53c-e8dd8f364f64","type":"Claim","title":"I<sub>KA<\/sub> may be mediated by voltage-gated K  channel &#945;-subunits Kv4.2 and Kv4.3, members of the Shal related gene family.","label":"Plant L et al.; I<sub>KA<\/sub> may be mediated by voltag...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:19ec8466-04cd-47fa-a53c-e8dd8f364f64"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4e975dd6-f9ab-4792-903f-420c2c66e174&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4e975dd6-f9ab-4792-903f-420c2c66e174","type":"Claim","title":"The reduced proteasome activity in AD is neither the result of diminished proteasome protein expression nor post-mortem proteasome decomposition in the course of overall post-mortem autolytic tissue degradation.","label":"Keck S et al.; The reduced proteasome activity in AD is...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:4e975dd6-f9ab-4792-903f-420c2c66e174"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:dec39f92-0ab9-4d95-9ee8-dcba16231305&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:dec39f92-0ab9-4d95-9ee8-dcba16231305","type":"Claim","title":"Autophagy is a key mechanism in immune responses to intracellular pathogens.","label":"Golde T et al.; Autophagy is a key mechanism in immune r...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:dec39f92-0ab9-4d95-9ee8-dcba16231305"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:abeb6f72-fd60-4dac-bb80-83f5cf3f3848&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:abeb6f72-fd60-4dac-bb80-83f5cf3f3848","type":"Question","title":"Why don&#8217;t animal models of AD fully mimic human AD?","label":"Why don&#8217;t animal models of AD full...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:abeb6f72-fd60-4dac-bb80-83f5cf3f3848"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:43505a4f-b80e-4744-86b3-53d237306b08&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:43505a4f-b80e-4744-86b3-53d237306b08","type":"Question","title":"Fluctuations of tau steady-state levels that possibly might be achieved in pathological states are unlikely to affect neuronal function by altering global axonal transport rates, in the absence of other changes in tau biophysical properties.  Such possibilities have yet to be investigated systematically in animal models in which tau is pathologically altered.","label":"Fluctuations of tau steady-state levels ...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:43505a4f-b80e-4744-86b3-53d237306b08"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6933762c-7295-468d-85f0-6569598388c6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6933762c-7295-468d-85f0-6569598388c6","type":"Claim","title":"Mild cognitive impairment (MCI, a term used to describe a preliminary stage leading to AD) can convert equally to AD or Vascular Dementia (VaD).","label":"Aliev G; Mild cognitive impairment (MCI, a term u...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Aliev Gjumrakch","id":"urn:lsid:swan.org:researchstatement:6933762c-7295-468d-85f0-6569598388c6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:99ad228a-a74b-4e0e-81a0-57589326e85e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:99ad228a-a74b-4e0e-81a0-57589326e85e","type":"Claim","title":"Agents such as sterols that modify properties of the lipid bilayer may modify transmembrane subunit interactions.","label":"Marchesi V; Agents such as sterols that modify prope...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:99ad228a-a74b-4e0e-81a0-57589326e85e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0114e4d5-abb7-4e1c-b2dd-6dbc56adbf3f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0114e4d5-abb7-4e1c-b2dd-6dbc56adbf3f","type":"Claim","title":"Conditional knockout mice in which PS1 and PS2 are selectively inactivated in the adult cerebral cortex develop age-related, progressive neurodegeneration characterized by hallmarks of AD neuropathology, including synaptic loss, neuronal cell death, astrogliosis and tau hyperphosphorylation.","label":"Shen J et al.; Conditional knockout mice in which PS1 a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:0114e4d5-abb7-4e1c-b2dd-6dbc56adbf3f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c8f20507-b774-4b59-b2f7-b9ec4a596ff7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c8f20507-b774-4b59-b2f7-b9ec4a596ff7","type":"Hypothesis","title":"BACE1 overactivity occurs in sporadic Alzheimer disease.","label":"Fukumoto H et al.; BACE1 overactivity occurs in sporadic Al...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Cheung Bonnie S","Hyman Bradley T","Irizarry Michael C"],"firstAuthor":"Fukumoto Hiroaki","referenceYear":"2002","referenceDate":"2002-09","id":"urn:lsid:swan.org:researchstatement:c8f20507-b774-4b59-b2f7-b9ec4a596ff7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d0b8ecf6-ab14-4202-a24e-2575c93ba49e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d0b8ecf6-ab14-4202-a24e-2575c93ba49e","type":"Hypothesis","title":"Alpha-1 antichymotripsin contributes to the development of amyloid deposits.","label":"Abraham C et al.; Alpha-1 antichymotripsin contributes to ...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Selkoe D J","Potter H"],"firstAuthor":"Abraham C R","referenceYear":"1988","referenceDate":"1988-02-26","id":"urn:lsid:swan.org:researchstatement:d0b8ecf6-ab14-4202-a24e-2575c93ba49e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:45092fa1-733b-4e0c-927a-35562fa2bd70&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:45092fa1-733b-4e0c-927a-35562fa2bd70","type":"Claim","title":"Insulin signaling leads to the activation of phosphatidylinositol 3-kinase (PI3K) and subsequently the activation of acutely transforming retrovirus Akt8 (protein kinase B) in rodent T cell lymphoma, which in turn phosphorylates free cytoplasmic GSK3β and GSK3α at serine (Ser) residues 9 and 21, respectively.","label":"Hooper C et al.; Insulin signaling leads to the activatio...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:45092fa1-733b-4e0c-927a-35562fa2bd70"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2adaffc2-13b0-4fbf-a8c1-ea269c0527a5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2adaffc2-13b0-4fbf-a8c1-ea269c0527a5","type":"Claim","title":"Therapies that target the proteinopathy trigger of disease are likely to be much more effective as primary prevention and may have little therapeutic benefit once degeneration is entrenched.","label":"Golde T et al.; Therapies that target the proteinopathy ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:2adaffc2-13b0-4fbf-a8c1-ea269c0527a5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:18d9e52f-8584-4a2f-a50b-30d6003e3dff&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:18d9e52f-8584-4a2f-a50b-30d6003e3dff","type":"Comment","title":"Wolozin comment on Dodart hypothesis \u201cEnhanced peripheral clearance and/or sequestration of soluble Aβ in brain may rapidly reverse memory impairment in AD.\u201d","label":"Wolozin B; Wolozin comment on Dodart hypothesis \u201cEn...","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Wolozin B L","referenceYear":"2002","referenceDate":"2002-06-05","id":"urn:lsid:swan.org:comment:18d9e52f-8584-4a2f-a50b-30d6003e3dff"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e7b1908f-c69a-47f5-b6d9-b2a79386d3c3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e7b1908f-c69a-47f5-b6d9-b2a79386d3c3","type":"Claim","title":"Protein aggregates have been widely assumed to significantly inhibit proteasome function, independent of their molecular origin.","label":"Keck S et al.; Protein aggregates have been widely assu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:e7b1908f-c69a-47f5-b6d9-b2a79386d3c3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4bd51e41-1f6a-46c1-a928-35d6e4cb0aea&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4bd51e41-1f6a-46c1-a928-35d6e4cb0aea","type":"Claim","title":"In order for myelin expansion to continue into adulthood, synapses and axons are sacrificed, allowing the human brain to reach maturity in middle age when myelin content reaches its peak at approximately 25% of brain volume.","label":"Bartzokis G; In order for myelin expansion to continu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:4bd51e41-1f6a-46c1-a928-35d6e4cb0aea"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:aca794b3-60b3-4890-828d-020f79d0524a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:aca794b3-60b3-4890-828d-020f79d0524a","type":"Claim","title":"Physiologically \u2018functional\u2019 mammalian amyloids, currently limited to select peptide hormones in secretory granules of the pituitary, amyloid present in semen, and Pmel17 in melanocytes, challenges, to some degree, the notion that all aggregated misfolded proteins are pathogen-associated molecular patterns (PAMPs). However, both the secretory granule amyloid and Pmel17 amyloid are contained within intracellular vesicles that most likely sequester them from interaction with PRRs and other forms of innate immune surveillance. ","label":"Golde T et al.; Physiologically \u2018functional\u2019 mammalian a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:aca794b3-60b3-4890-828d-020f79d0524a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6e075df7-0eef-4d42-9c2a-95124a75471d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6e075df7-0eef-4d42-9c2a-95124a75471d","type":"Hypothesis","title":"LRP is the major neuronal receptor of Aβ-ApoE complexes and mediates Aβ neurotoxicity.","label":"Tanzi R et al.; LRP is the major neuronal receptor of Aβ...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Kovacs D M","Kim T W","Moir R D","Guenette S Y","Wasco W"],"firstAuthor":"Tanzi R E","referenceYear":"1996","referenceDate":"1996","id":"urn:lsid:swan.org:researchstatement:6e075df7-0eef-4d42-9c2a-95124a75471d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:294a95f5-930d-453d-9dc9-62498f0f1700&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:294a95f5-930d-453d-9dc9-62498f0f1700","type":"Claim","title":"The proteosome may also play a key role in degrading intracellularly localized Aβ, for example, as part of the process of endoplasmic reticulum (ER)-associated proteolytic degradation.","label":"Tanzi R et al.; The proteosome may also play a key role ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:294a95f5-930d-453d-9dc9-62498f0f1700"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:488a7dcd-8756-4ee3-863d-a8f2fc0634c6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:488a7dcd-8756-4ee3-863d-a8f2fc0634c6","type":"Claim","title":"By 12 months of age, DLB-AD mice display a marked increase in detergent-insoluble Aβ40 and Aβ42 as well as an increase in detergent-soluble Aβ40 compared with age matched 3xTg-AD mice, correlating well with the appearance of thioflavin-positive dense-core plaques within the subiculum.","label":"Clinton L et al.; By 12 months of age, DLB-AD mice display...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Blurton-Jones Mathew","Myczek Kristoffer","Trojanowski John Q","LaFerla Frank M"],"firstAuthor":"Clinton Lani K","referenceYear":"2010","referenceDate":"2010-05-26","id":"urn:lsid:swan.org:researchstatement:488a7dcd-8756-4ee3-863d-a8f2fc0634c6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0506dc11-e001-4f6e-850e-1af2723d564c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0506dc11-e001-4f6e-850e-1af2723d564c","type":"Claim","title":"The apolipoprotein E (APOE) gene e4 allele is the only known genetic variant that is unequivocally associated with increased late-onset AD risk.","label":"Cook L et al.; The apolipoprotein E (APOE) gene e4 alle...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Ho Luk W","Taylor Alison E","Brayne Carol","Evans John Grimley","Xuereb John","Cairns Nigel J","Pritchard Antonia","Lemmon Helen","Mann David","St Clair David","Turic Dragana","Hollingworth Paul","Moore Pamela J","Jehu Luke","Archer Nicola","Walter Sarah","Foy Catherine","Edmondson Amanda","Powell John","Lovestone Simon","Owen Michael J","Williams Julie","Lendon Corinne","Rubinsztein David C"],"firstAuthor":"Cook Lynnette J","referenceYear":"2004","referenceDate":"2004-03-25","id":"urn:lsid:swan.org:researchstatement:0506dc11-e001-4f6e-850e-1af2723d564c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:378a6aed-6121-4d6c-894a-63613299db97&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:378a6aed-6121-4d6c-894a-63613299db97","type":"Claim","title":"In 6 month old 3xTg-AD mice there is no apparent extracellular Aβ, suggesting that intraneuronal Aβ accumulation is most likely responsible for the deficits in LTP observed.","label":"Smith I et al.; In 6 month old 3xTg-AD mice there is no ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:378a6aed-6121-4d6c-894a-63613299db97"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:404c3236-34ed-4a30-bfe1-8d6cea6c2e49&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:404c3236-34ed-4a30-bfe1-8d6cea6c2e49","type":"Claim","title":"Electrophysiological experiments suggest that soluble Aβ can affect the electrical properties of hippocampal CA1 neurons by direct effects on A-type ion channels.","label":"Morse T et al.; Electrophysiological experiments suggest...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Mutalik Pradeep","Cheung Kei","Miller Perry L","Shepherd Gordon"],"firstAuthor":"Morse Thomas M","id":"urn:lsid:swan.org:researchstatement:404c3236-34ed-4a30-bfe1-8d6cea6c2e49"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6f80adda-4ffd-4f43-b6d9-91347bade729&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6f80adda-4ffd-4f43-b6d9-91347bade729","type":"Claim","title":"Different apoE-dependent mechanisms seem to be involved in Aβ transport within the CNS versus peripheral circulation.","label":"Fryer J et al.; Different apoE-dependent mechanisms seem...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:6f80adda-4ffd-4f43-b6d9-91347bade729"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7f0d84bf-4535-4ac0-9d82-1f247d260769&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7f0d84bf-4535-4ac0-9d82-1f247d260769","type":"Claim","title":"Kinetic differences in fibril assembly may not underlie the biological differences between Aβ40 vs. Aβ42.","label":"Bitan G et al.; Kinetic differences in fibril assembly m...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:7f0d84bf-4535-4ac0-9d82-1f247d260769"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6291c6c6-f18f-417c-92bb-6fab1fd3b22d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6291c6c6-f18f-417c-92bb-6fab1fd3b22d","type":"Claim","title":"miR-134 knockdown rescues the LTP and memory impairments caused by SIRT1 deficiency.","label":"Gao J et al.; miR-134 knockdown rescues the LTP and me...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wang Wen-Yuan","Mao Ying-Wei","Gräff Johannes","Guan Ji-Song","Pan Ling","Mak Gloria","Kim Dohoon","Su Susan C","Tsai Li-Huei"],"firstAuthor":"Gao Jun","referenceYear":"2010","referenceDate":"2010-07-11","id":"urn:lsid:swan.org:researchstatement:6291c6c6-f18f-417c-92bb-6fab1fd3b22d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:dd80e57b-ec37-4b20-992c-5a2b965577e2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:dd80e57b-ec37-4b20-992c-5a2b965577e2","type":"Claim","title":"Expression cloning experiments identify the cellular prion protein (PrPC) as an Aβ oligomer receptor.","label":"Laurén J et al.; Expression cloning experiments identify ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Gimbel David A","Nygaard Haakon B","Gilbert John W","Strittmatter Stephen M"],"firstAuthor":"Laurén Juha","referenceYear":"2009","referenceDate":"2009-02-26","id":"urn:lsid:swan.org:researchstatement:dd80e57b-ec37-4b20-992c-5a2b965577e2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f92cd7d4-afa0-4f39-a02d-515525a2efa1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f92cd7d4-afa0-4f39-a02d-515525a2efa1","type":"Claim","title":"Inhibiting GSK3 activity reverses some of the pathological effects of over-expression of mutated APP and tau in the animal models of AD, implicating GSK3 inhibitors as a novel treatment strategy for AD.","label":"Hooper C et al.; Inhibiting GSK3 activity reverses some o...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:f92cd7d4-afa0-4f39-a02d-515525a2efa1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b8e2cc96-cbaa-45bc-b4dd-36438094d22d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b8e2cc96-cbaa-45bc-b4dd-36438094d22d","type":"Claim","title":"Relevant Aβ toxicity has barely been demonstrated, and none of the data amounts to convincing support that Aβ toxicity causes massive cell loss seen in Alzheimer Disease. ","label":"Hardy ; Relevant Aβ toxicity has barely been dem...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Hardy","referenceYear":"2009","referenceDate":"2009-05-18","id":"urn:lsid:swan.org:researchstatement:b8e2cc96-cbaa-45bc-b4dd-36438094d22d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4fd140c4-889d-4451-a42f-1e513bf79739&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4fd140c4-889d-4451-a42f-1e513bf79739","type":"Hypothesis","title":"Cholinergic Hypothesis of Alzheimer Disease:  Alzheimer disease is the result of a breakdown of central cholinergic transmission.","label":"Perry E; Cholinergic Hypothesis of Alzheimer Dise...","icon":"../icons/ontological/discourse-element/h-research-statement.png","firstAuthor":"Perry E K","referenceYear":"1980","referenceDate":"1980-02","id":"urn:lsid:swan.org:researchstatement:4fd140c4-889d-4451-a42f-1e513bf79739"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:18fa3d97-d2a1-4b82-9b4b-199c340f8923&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:18fa3d97-d2a1-4b82-9b4b-199c340f8923","type":"Claim","title":"A compelling mechanism linking APOE, GSK3, and tau phosphorylation is based on cell surface LDL and LDL receptor-related proteins (LRP5 and LRP6) to which APOE binds.  ","label":"Small S et al.; A compelling mechanism linking APOE, GSK...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:18fa3d97-d2a1-4b82-9b4b-199c340f8923"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5f141508-1aed-43d2-bfe6-c66e27ddc828&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5f141508-1aed-43d2-bfe6-c66e27ddc828","type":"Claim","title":"Lipid-associated apoE2 and E3 forms SDS-stable complexes with Aβ to a greater extent than lipid-associated E4.","label":"Holtzman D; Lipid-associated apoE2 and E3 forms SDS-...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:5f141508-1aed-43d2-bfe6-c66e27ddc828"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:edae5e29-5b3d-4705-bf1c-c8f566061f3c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:edae5e29-5b3d-4705-bf1c-c8f566061f3c","type":"Claim","title":"Apoptosis in most neurons can be induced by a variety of stimuli and these same conditions are also present in the AD brain.","label":"Cotman C et al.; Apoptosis in most neurons can be induced...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:edae5e29-5b3d-4705-bf1c-c8f566061f3c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:74c26892-feaa-4d5a-a00b-2760a47b58df&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:74c26892-feaa-4d5a-a00b-2760a47b58df","type":"Claim","title":"Ceramide regulates APP processing into Aβ by affecting stability of BACE1.","label":"Ceramide regulates APP processing into A...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:74c26892-feaa-4d5a-a00b-2760a47b58df"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0710829b-6ee9-494b-ae1e-696d88b6ef79&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0710829b-6ee9-494b-ae1e-696d88b6ef79","type":"Claim","title":"Although twin studies suggest that there are several susceptibility genes which, along with the APOE ε4 allele, contribute to up to 80% of late-onset AD (LOAD) cases, discovery of other susceptibility genes has been elusive.","label":"Reiman E et al.; Although twin studies suggest that there...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Jennifer A","Myers Amanda J","Hardy John","Dunckley Travis","Zismann Victoria L","Joshipura Keta D","Pearson John V","Hu-Lince Diane","Huentelman Matthew J","Craig David W","Coon Keith D","Liang Winnie S","Herbert RiLee H","Beach Thomas","Rohrer Kristen C","Zhao Alice S","Leung Doris","Bryden Leslie","Marlowe Lauren","Kaleem Mona","Mastroeni Diego","Grover Andrew","Heward Christopher B","Ravid Rivka","Rogers Joseph","Hutton Michael L","Melquist Stacey","Petersen Ron C","Alexander Gene E","Caselli Richard J","Kukull Walter","Papassotiropoulos Andreas","Stephan Dietrich A"],"firstAuthor":"Reiman Eric M","referenceYear":"2007","referenceDate":"2007-06-07","id":"urn:lsid:swan.org:researchstatement:0710829b-6ee9-494b-ae1e-696d88b6ef79"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:27d8129c-0165-4523-8bcc-07e577644b43&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:27d8129c-0165-4523-8bcc-07e577644b43","type":"Claim","title":"Published evidence suggests that the re-entrance of neurons into the cell cycle is associated with neurodegeneration.","label":"Varvel N et al.; Published evidence suggests that the re-...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bhaskar Kiran","Patil Anita R","Pimplikar Sanjay W","Herrup Karl","Lamb Bruce T"],"firstAuthor":"Varvel Nicholas H","referenceYear":"2008","referenceDate":"2008-10-22","id":"urn:lsid:swan.org:researchstatement:27d8129c-0165-4523-8bcc-07e577644b43"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2195a19a-3bd2-41ff-8b35-70acb02a239d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2195a19a-3bd2-41ff-8b35-70acb02a239d","type":"Claim","title":"Plaque initiation in AD may occur in two steps: increased accumulation of Aβ and formation of seeds.","label":"Muresan Z et al.; Plaque initiation in AD may occur in two...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","referenceYear":"2008","referenceDate":"2008","id":"urn:lsid:swan.org:researchstatement:2195a19a-3bd2-41ff-8b35-70acb02a239d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cd518f04-e509-416d-9dbe-8b71d28970e6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cd518f04-e509-416d-9dbe-8b71d28970e6","type":"Claim","title":"Oxidative stress can also arise independently of inflammatory pathways in CNS proteinopathies, including mitochondrial dysfunction has also been reported to be associated with numerous neurodegenerative proteinopathies.","label":"Golde T et al.; Oxidative stress can also arise independ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:cd518f04-e509-416d-9dbe-8b71d28970e6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:13d2ec60-afe0-4136-82b6-d2f3b6361726&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:13d2ec60-afe0-4136-82b6-d2f3b6361726","type":"Claim","title":"Sir2 seems to block extreme lifespan in post-mitotic cells in yeast, raising the possibility that SIRT1 may play a dual role in the CNS.","label":"Kim D et al.; Sir2 seems to block extreme lifespan in ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:13d2ec60-afe0-4136-82b6-d2f3b6361726"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9a9505da-8a81-4093-96f4-e2df5aa36dac&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9a9505da-8a81-4093-96f4-e2df5aa36dac","type":"Claim","title":"ApoE isoforms influence both AD and cerebral amyloid angiopathy (CAA) through effects on Aβ. Most likely, this is not via apoE affecting Aβ production.","label":"Holtzman D; ApoE isoforms influence both AD and cere...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:9a9505da-8a81-4093-96f4-e2df5aa36dac"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:64bb89e0-97d3-4598-b6dd-8aa51818abea&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:64bb89e0-97d3-4598-b6dd-8aa51818abea","type":"Claim","title":"A synthetic Aβ40 peptide dimer (Aβ40-S26C) inhibited LTP nearly 20 times more potently than did wild-type synthetic Aβ40.","label":"Shankar G et al.; A synthetic Aβ40 peptide dimer (Aβ40-S26...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Li Shaomin","Mehta Tapan H","Garcia-Munoz Amaya","Shepardson Nina E","Smith Imelda","Brett Francesca M","Farrell Michael A","Rowan Michael J","Lemere Cynthia A","Regan Ciaran M","Walsh Dominic M","Sabatini Bernardo L","Selkoe Dennis J"],"firstAuthor":"Shankar Ganesh M","referenceYear":"2008","referenceDate":"2008-08","id":"urn:lsid:swan.org:researchstatement:64bb89e0-97d3-4598-b6dd-8aa51818abea"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e9dfdd44-aa51-435b-a7e2-7c7a7f0e24ab&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e9dfdd44-aa51-435b-a7e2-7c7a7f0e24ab","type":"Claim","title":"Any observed effect of tau at altered expression levels will need to be evaluated in the light of disease relevance, namely, clear evidence that tau levels are comparably altered in Alzheimer disease or other tauopathies.","label":"Nixon R; Any observed effect of tau at altered ex...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Nixon Ralph A","id":"urn:lsid:swan.org:researchstatement:e9dfdd44-aa51-435b-a7e2-7c7a7f0e24ab"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2464fc0c-b317-4740-91ee-09f871604eca&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2464fc0c-b317-4740-91ee-09f871604eca","type":"Claim","title":"DR6 links passive and active apoptotic degeneration mechanisms, in which Casp3 mediates cell body degeneration requiring BAX, whereas Casp6, acting downstream of Bax, affects axon degeneration. ","label":"Nikolaev A et al.; DR6 links passive and active apoptotic d...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["McLaughlin Todd","O'Leary Dennis D","Tessier-Lavigne Marc"],"firstAuthor":"Nikolaev Anatoly","referenceYear":"2009","referenceDate":"2009-02-19","id":"urn:lsid:swan.org:researchstatement:2464fc0c-b317-4740-91ee-09f871604eca"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:4b39e960-e348-4db7-af63-cd3c395a7e50&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:4b39e960-e348-4db7-af63-cd3c395a7e50","type":"Comment","title":"Dewachter and Van Leuven, on Marchesi","label":"Dewachter I et al.; Dewachter and Van Leuven, on Marchesi","icon":"../icons/ontological/discourse-element/comment.png","otherAuthors":["Van Leuven Fred"],"firstAuthor":"Dewachter Ilse","referenceYear":"2007","referenceDate":"2007-08-02","id":"urn:lsid:swan.org:comment:4b39e960-e348-4db7-af63-cd3c395a7e50"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c2164004-709b-4cac-a967-a844e0b05de9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c2164004-709b-4cac-a967-a844e0b05de9","type":"Claim","title":"A transgenic model of the most common subtype of AD, the Lewy body variant of AD (DLB-AD), was generated by crossing homozygous 3xTg-AD mice to hemizygous α-synA53T-expressing mice (M83-h line) and performed repeated backcrossing and genotyping to restore homozygosity for the presenilin-M146V, APPswe, and Taup301L transgenes and establish hemizygosity for the α-syn-A53T transgene. ","label":"Clinton L et al.; A transgenic model of the most common su...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Blurton-Jones Mathew","Myczek Kristoffer","Trojanowski John Q","LaFerla Frank M"],"firstAuthor":"Clinton Lani K","referenceYear":"2010","referenceDate":"2010-05-26","id":"urn:lsid:swan.org:researchstatement:c2164004-709b-4cac-a967-a844e0b05de9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b4309c05-a9e2-422d-9a5f-fb96d151d84a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b4309c05-a9e2-422d-9a5f-fb96d151d84a","type":"Claim","title":"It is the electrophysiological output of a neuron (action potential) and the manner in which it affects the next neuron (synaptic and extrasynaptic function) that is the final common path that affects cognition.","label":"Morse T et al.; It is the electrophysiological output of...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Mutalik Pradeep","Cheung Kei","Miller Perry L","Shepherd Gordon"],"firstAuthor":"Morse Thomas M","id":"urn:lsid:swan.org:researchstatement:b4309c05-a9e2-422d-9a5f-fb96d151d84a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6c0b8d66-3cb6-4390-b754-969a35ad1a7a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6c0b8d66-3cb6-4390-b754-969a35ad1a7a","type":"Claim","title":"By analyzing axonal transport in optic axons from two different lines of mice that either overexpress or lack tau, it was determined that rates of fast and slow transport are not significantly impaired by modulating tau expression.","label":"Yuan A et al.; By analyzing axonal transport in optic a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Rao Mala V","Sasaki Takahiro","Chen Yuanxin","Kumar Asok","Veeranna","Liem Ronald K","Eyer Joel","Peterson Alan C","Julien Jean-Pierre","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2006","referenceDate":"2006-09-27","id":"urn:lsid:swan.org:researchstatement:6c0b8d66-3cb6-4390-b754-969a35ad1a7a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3f289e51-e57d-4e67-80d9-67571171625d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3f289e51-e57d-4e67-80d9-67571171625d","type":"Claim","title":"Neurons do undergo physiological senescence and that this senescence, defined functionally by its inability to respond appropriately to growth factors and its expression of senescence-associated proteins, is accelerated in AD and other CNS proteinopathies by inflammatory and oxidative stimuli.","label":"Golde T et al.; Neurons do undergo physiological senesce...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:3f289e51-e57d-4e67-80d9-67571171625d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ea5d8973-6b64-4d68-8d1d-3b16d553f5eb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ea5d8973-6b64-4d68-8d1d-3b16d553f5eb","type":"Claim","title":"Cholesterol is implicated with AD pathogenesis.","label":"Cholesterol is implicated with AD pathog...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:ea5d8973-6b64-4d68-8d1d-3b16d553f5eb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cdc701ce-63e4-4907-9bdd-f77a18c4a11a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cdc701ce-63e4-4907-9bdd-f77a18c4a11a","type":"Claim","title":"Products of protein damage, such as advanced glycation end products, aldehydic modifications  and carbonyls, accumulate in NFTs.","label":"Keck S et al.; Products of protein damage, such as adva...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:cdc701ce-63e4-4907-9bdd-f77a18c4a11a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f8883092-3864-4f73-8a28-75935ed866ea&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f8883092-3864-4f73-8a28-75935ed866ea","type":"Claim","title":"CLU, like ApoE, may participate in Aβ clearance from the brain across the blood-brain barrier, mainly of the highly pathogenic Aβ42 peptide.","label":"Lambert J et al.; CLU, like ApoE, may participate in Aβ cl...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Heath Simon","Even Gael","Campion Dominique","Sleegers Kristel","Hiltunen Mikko","Combarros Onofre","Zelenika Diana","Bullido Maria J","Tavernier Béatrice","Letenneur Luc","Bettens Karolien","Berr Claudine","Pasquier Florence","Fiévet Nathalie","Barberger-Gateau Pascale","Engelborghs Sebastiaan","De Deyn Peter","Mateo Ignacio","Franck Ana","Helisalmi Seppo","Porcellini Elisa","Hanon Olivier","de Pancorbo Marian M","Lendon Corinne","Dufouil Carole","Jaillard Céline","Leveillard Thierry","Alvarez Victoria","Bosco Paolo","Mancuso Michelangelo","Panza Francesco","Nacmias Benedetta","Bossù Paola","Piccardi Paola","Annoni Giorgio","Seripa Davide","Galimberti Daniela","Hannequin Didier","Licastro Federico","Soininen Hilkka","Ritchie Karen","Blanché Hélène","Dartigues Jean-François","Tzourio Christophe","Gut Ivo","Van Broeckhoven Christine","Alpérovitch Annick","Lathrop Mark","Amouyel Philippe"],"firstAuthor":"Lambert Jean-Charles","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:f8883092-3864-4f73-8a28-75935ed866ea"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:58a37f73-db78-41e0-a536-14be683d9356&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:58a37f73-db78-41e0-a536-14be683d9356","type":"Hypothesis","title":"Ion channel activity of the amyloid beta polypeptide may be the basis of its neurotoxic effects.","label":"Pollard H et al.; Ion channel activity of the amyloid beta...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Rojas E","Arispe N"],"firstAuthor":"Pollard H B","referenceYear":"1993","referenceDate":"1993-09-24","id":"urn:lsid:swan.org:researchstatement:58a37f73-db78-41e0-a536-14be683d9356"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7168865d-32b1-48e5-87f5-63be29235fcf&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7168865d-32b1-48e5-87f5-63be29235fcf","type":"Claim","title":"Insulin resistance and hyperinsulinemia decreases PI3-kinase-mediated vasodilation through nitric oxide but increases mitogen-activated protein kinase (MAPK)-mediated vasoconstriction.","label":"Craft S; Insulin resistance and hyperinsulinemia ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft S","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:7168865d-32b1-48e5-87f5-63be29235fcf"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:15fa15be-c539-4055-8d42-db4de5e279ee&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:15fa15be-c539-4055-8d42-db4de5e279ee","type":"Claim","title":"Although some animal studies suggest that Aβ plaque removal can occur within days of the injection of anti-Aβ antibodies into the brain, other studies suggest that plaque removal occurs progressively over a period of months.","label":"Holmes C et al.; Although some animal studies suggest tha...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:15fa15be-c539-4055-8d42-db4de5e279ee"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:f0e3f10f-46c6-4b6b-8f15-20ceb8e23696&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:f0e3f10f-46c6-4b6b-8f15-20ceb8e23696","type":"Comment","title":"T Russo on Marchesi","label":"Russo T; T Russo on Marchesi","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Russo Tommaso","referenceYear":"2005","referenceDate":"2005-09-04","id":"urn:lsid:swan.org:comment:f0e3f10f-46c6-4b6b-8f15-20ceb8e23696"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7bdd80f4-593b-44e8-9644-0f5655247e30&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7bdd80f4-593b-44e8-9644-0f5655247e30","type":"Claim","title":"A concern associated with secretase inhibitors remains that Aβ bearing fragments of APP will accumulate and be toxic.","label":"Golde T; A concern associated with secretase inhi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde T","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:7bdd80f4-593b-44e8-9644-0f5655247e30"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:08f361ba-d87e-4b7a-8551-b1b54bd7afd1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:08f361ba-d87e-4b7a-8551-b1b54bd7afd1","type":"Claim","title":"Vaccination with full-length Aβ42 could result in over-activation of the innate immune system.","label":"Holmes C et al.; Vaccination with full-length Aβ42 could ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:08f361ba-d87e-4b7a-8551-b1b54bd7afd1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:87b1d06e-00e3-47bb-ab46-a03ab3bed6e9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:87b1d06e-00e3-47bb-ab46-a03ab3bed6e9","type":"Claim","title":"The tau protein triage system uses a complex consisting of the E3 ligase CHIP (C terminus of Hsp70-interacting protein) in conjunction with several chaperones to refold tau or direct it toward the degradation machinery.","label":"Carrettiero D et al.; The tau protein triage system uses a com...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hernandez Israel","Neveu Pierre","Papagiannakopoulos Thales","Kosik Kenneth S"],"firstAuthor":"Carrettiero Daniel C","referenceYear":"2009","referenceDate":"2009-02-18","id":"urn:lsid:swan.org:researchstatement:87b1d06e-00e3-47bb-ab46-a03ab3bed6e9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8aeb1457-2078-4143-b0a1-cfdf489051e7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8aeb1457-2078-4143-b0a1-cfdf489051e7","type":"Claim","title":"Low concentrations of CSF Aβ42 correlate with both the clinical diagnosis of AD and Aβ neuropathology at autopsy.","label":"Jack C et al.; Low concentrations of CSF Aβ42 correlate...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:8aeb1457-2078-4143-b0a1-cfdf489051e7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c0b64d94-c6eb-4b05-910f-7dc41a7de6e6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c0b64d94-c6eb-4b05-910f-7dc41a7de6e6","type":"Claim","title":"The motility of individual kinesin motors was strongly affected when the motors encountered patches of tau bound along the microtubule, resulting in either pausing of the motor or detachment of the kinesin from the microtubule.","label":"Holzbaur E; The motility of individual kinesin motor...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holzbaur Erika L F","id":"urn:lsid:swan.org:researchstatement:c0b64d94-c6eb-4b05-910f-7dc41a7de6e6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:25524016-6126-4d91-9f4d-43c8c45297f6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:25524016-6126-4d91-9f4d-43c8c45297f6","type":"Claim","title":"Incubation with low concentrations of Aβ peptides enhance whole cell calcium currents in a variety of cell lines and primary neurons, as measured by whole cell patch clamping.","label":"Smith I et al.; Incubation with low concentrations of Aβ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:25524016-6126-4d91-9f4d-43c8c45297f6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e47c8839-5257-4a17-a305-87a905a27680&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e47c8839-5257-4a17-a305-87a905a27680","type":"Claim","title":"Transgenic mice expressing a mutant form of superoxide dismutase 1 (SOD1G37R), which has been linked to human amyotrophic lateral sclerosis (ALS), exhibit severe motor neuron and axon degeneration in spinal cord.","label":"Kim D et al.; Transgenic mice expressing a mutant form...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:e47c8839-5257-4a17-a305-87a905a27680"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:dd815e4e-261e-4e74-9d03-4fefda67b810&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:dd815e4e-261e-4e74-9d03-4fefda67b810","type":"Claim","title":"In situ data from autopsied AD brain tissue parallels in vitro observations from models of neuronal beta amyloid toxicity on both morphological and biochemical levels.","label":"Cotman C et al.; In situ data from autopsied AD brain tis...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:dd815e4e-261e-4e74-9d03-4fefda67b810"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:eb088423-9b50-42df-8976-7e068e901078&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:eb088423-9b50-42df-8976-7e068e901078","type":"Claim","title":"THOP1 levels are increased in human AD brain tissue.","label":"Pollio G et al.; THOP1 levels are increased in human AD b...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hoozemans Jeroen J","Andersen Claus A","Roncarati Renza","Rosi Maria Cristina","van Haastert Elise S","Seredenina Tamara","Diamanti Daniela","Gotta Stefano","Fiorentini Anna","Magnoni Letizia","Raggiaschi Roberto","Rozemuller Annemieke J","Casamenti Fiorella","Caricasole Andrea","Terstappen Georg C"],"firstAuthor":"Pollio Giuseppe","referenceYear":"2008","referenceDate":"2008-07","id":"urn:lsid:swan.org:researchstatement:eb088423-9b50-42df-8976-7e068e901078"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0009e6f4-8533-4339-acf1-bf57ab5dbda9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0009e6f4-8533-4339-acf1-bf57ab5dbda9","type":"Claim","title":"Two presenilin (PS1 and PS2) genes and two APH1 (APH1A and APH1B) genes, which are alternatively spliced, contribute to the heterogeneity of the complexes. ","label":"Serneels L et al.; Two presenilin (PS1 and PS2) genes and t...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Van Biervliet Jérôme","Craessaerts Katleen","Dejaegere Tim","Horré Katrien","Van Houtvin Tine","Esselmann Hermann","Paul Sabine","Schäfer Martin K","Berezovska Oksana","Hyman Bradley T","Sprangers Ben","Sciot Raf","Moons Lieve","Jucker Mathias","Yang Zhixiang","May Patrick C","Karran Eric","Wiltfang Jens","D'Hooge Rudi","De Strooper Bart"],"firstAuthor":"Serneels Lutgarde","referenceYear":"2009","referenceDate":"2009-05-01","id":"urn:lsid:swan.org:researchstatement:0009e6f4-8533-4339-acf1-bf57ab5dbda9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b6a0d231-148d-4f4c-a018-ecb2660c8f52&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b6a0d231-148d-4f4c-a018-ecb2660c8f52","type":"Claim","title":"Work is in progress to develop other MT-stabilizing compounds that could go on to become potential disease-modifying therapies for tauopathy patients since there are several problems with taxol for use as therapy for AD and related tauopathies.","label":"Lee V et al.; Work is in progress to develop other MT-...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Trojanowski John Q"],"firstAuthor":"Lee Virginia M-Y","id":"urn:lsid:swan.org:researchstatement:b6a0d231-148d-4f4c-a018-ecb2660c8f52"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9c7c2dd0-803d-48e2-af86-d3189b96c500&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9c7c2dd0-803d-48e2-af86-d3189b96c500","type":"Claim","title":"The T allele of the CHRNΒ2 G1053T RFLP showed a significant under-representation in our AD cases when compared to controls; however, no significant disease association was found for the CHRNΒ2 G2245A and C2086T RFLP\u2019s or the two CHRNΑ4 RFLP\u2019s investigated. ","label":"Cook L et al.; The T allele of the CHRNΒ2 G1053T RFLP s...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Ho Luk W","Taylor Alison E","Brayne Carol","Evans John Grimley","Xuereb John","Cairns Nigel J","Pritchard Antonia","Lemmon Helen","Mann David","St Clair David","Turic Dragana","Hollingworth Paul","Moore Pamela J","Jehu Luke","Archer Nicola","Walter Sarah","Foy Catherine","Edmondson Amanda","Powell John","Lovestone Simon","Owen Michael J","Williams Julie","Lendon Corinne","Rubinsztein David C"],"firstAuthor":"Cook Lynnette J","referenceYear":"2004","referenceDate":"2004-03-25","id":"urn:lsid:swan.org:researchstatement:9c7c2dd0-803d-48e2-af86-d3189b96c500"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f81bdc97-810e-487c-bd56-b2c883c432cb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f81bdc97-810e-487c-bd56-b2c883c432cb","type":"Claim","title":"The rapid changes observed in this study are reminiscent of a previous finding that AD model mice demonstrate immediate cognitive improvement after passive anti-Aβ immunization.","label":"Wong G; The rapid changes observed in this study...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Wong Gwendolyn T","id":"urn:lsid:swan.org:researchstatement:f81bdc97-810e-487c-bd56-b2c883c432cb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e51f7138-8d6f-4e8b-80ab-3ecf7710ac45&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e51f7138-8d6f-4e8b-80ab-3ecf7710ac45","type":"Claim","title":"A greater extent of TdT labeling in AD brain was present in cases that had a mini-mental status exam score of 15/30 or greater than on cases of very severe dementia with scores in the 1 to 3 range.","label":"Cotman C et al.; A greater extent of TdT labeling in AD b...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:e51f7138-8d6f-4e8b-80ab-3ecf7710ac45"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e8079a57-fb93-4c18-942b-385ba4a22952&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e8079a57-fb93-4c18-942b-385ba4a22952","type":"Claim","title":"Immunoreactivity for Bcl-2 was found to be elevated in human postmortem tissue from AD cases.","label":"Cotman C et al.; Immunoreactivity for Bcl-2 was found to ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:e8079a57-fb93-4c18-942b-385ba4a22952"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a747c10a-5049-4cbf-8635-6af0724f86c4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a747c10a-5049-4cbf-8635-6af0724f86c4","type":"Claim","title":"In APP/IDE double transgenic mice, Aβ plaque burden was diminished by 50% and there was a significant reduction in the rate of premature death as compared to age-matched APP transgenic littermates.","label":"Tanzi R et al.; In APP/IDE double transgenic mice, Aβ pl...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:a747c10a-5049-4cbf-8635-6af0724f86c4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7abaf127-9125-4a2e-9141-580f69f0f2ec&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7abaf127-9125-4a2e-9141-580f69f0f2ec","type":"Claim","title":"Dystrophic processes are quite dynamic.","label":"Meyer-Luehmann M et al.; Dystrophic processes are quite dynamic.","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:7abaf127-9125-4a2e-9141-580f69f0f2ec"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a680e994-5e69-4fcc-925f-d462db589423&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a680e994-5e69-4fcc-925f-d462db589423","type":"Claim","title":"Although phosphotau might be a more specific indicator of AD, concentrations of both phosphotau and total tau increase in AD.","label":"Jack C et al.; Although phosphotau might be a more spec...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:a680e994-5e69-4fcc-925f-d462db589423"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:92bc48c5-9936-42d8-8378-31ed69f21e66&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:92bc48c5-9936-42d8-8378-31ed69f21e66","type":"Claim","title":"Aβ42 and the α7nicotinic acetylcholine receptor are both colocalized in neuritic plaques in human brains with AD.","label":"Dziewczapolski G et al.; Aβ42 and the α7nicotinic acetylcholine r...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Glogowski Carolina M","Masliah Eliezer","Heinemann Stephen F"],"firstAuthor":"Dziewczapolski Gustavo","referenceYear":"2009","referenceDate":"2009-07-08","id":"urn:lsid:swan.org:researchstatement:92bc48c5-9936-42d8-8378-31ed69f21e66"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:41275d38-c5c1-4751-878c-fb6734f20ae1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:41275d38-c5c1-4751-878c-fb6734f20ae1","type":"Claim","title":"ApoE is a 299-amino acid protein secreted at high levels in the liver and the brain.","label":"Fryer J et al.; ApoE is a 299-amino acid protein secrete...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:41275d38-c5c1-4751-878c-fb6734f20ae1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:773532ae-ffb0-4d21-9aa3-d9fac27b2777&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:773532ae-ffb0-4d21-9aa3-d9fac27b2777","type":"Claim","title":"As studies in vitro have suggested the phosphorylation of APP by PKC, several researchers have tried to detect APP phosphorylation in cells.  Contrary to in vitro results, prelabeled APP in cells has identified the phosphorylation of Thr668 in the cytoplasmic domain.","label":"As studies in vitro have suggested the p...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:773532ae-ffb0-4d21-9aa3-d9fac27b2777"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a6a80ee1-f2be-4196-8f81-ed475d75c9ca&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a6a80ee1-f2be-4196-8f81-ed475d75c9ca","type":"Claim","title":"CAS and karyopherin-α2 are reduced in post-mortem brain samples from patients with Frontotemporal lobar degeneration with trans-activation response DNA-binding protein (TDP-43) positive ubiquitinated inclusions (FTLD\u2013TDP) compared to controls but no significant change for karyopherin-β1, karyopherin-α1 and karyopherin-α6.  ","label":"Nishimura A et al.; CAS and karyopherin-α2 are reduced in po...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zupunski Vera","Troakes Claire","Kathe Claudia","Fratta Pietro","Howell Michael","Gallo Jean-Marc","Hortobágyi Tibor","Shaw Christopher E","Rogelj Boris"],"firstAuthor":"Nishimura Agnes L","referenceYear":"2010","referenceDate":"2010-06","id":"urn:lsid:swan.org:researchstatement:a6a80ee1-f2be-4196-8f81-ed475d75c9ca"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cad99652-cea6-4207-9bec-2b99bd8e03aa&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cad99652-cea6-4207-9bec-2b99bd8e03aa","type":"Claim","title":"Increased Aβ levels may also inhibit the expression of normal levels of γ-secretase, because Aβ negatively regulates cAMP-response element (CRE)-dependent gene expression, and expression of the genes encoding both PS1 and the essential γ-secretase subunit Pen-2 is CRE-dependent.","label":"Shen J et al.; Increased Aβ levels may also inhibit the...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:cad99652-cea6-4207-9bec-2b99bd8e03aa"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f7a414ee-ae19-4362-af27-bdf7bf5d9b30&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f7a414ee-ae19-4362-af27-bdf7bf5d9b30","type":"Claim","title":"Reductions in glucose metabolism have been suggested to contribute to neurodegeneration in AD.","label":"Cotman C et al.; Reductions in glucose metabolism have be...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:f7a414ee-ae19-4362-af27-bdf7bf5d9b30"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:eb9147fe-2418-4c15-9fb7-5540c7ac0876&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:eb9147fe-2418-4c15-9fb7-5540c7ac0876","type":"Claim","title":"Primary cultures of rat cortical neurons exposed to Aβ demonstrate dendritic degeneration and cell death, and this molecular response has been charted through microarray and proteomics studies.","label":"Pollio G et al.; Primary cultures of rat cortical neurons...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hoozemans Jeroen J","Andersen Claus A","Roncarati Renza","Rosi Maria Cristina","van Haastert Elise S","Seredenina Tamara","Diamanti Daniela","Gotta Stefano","Fiorentini Anna","Magnoni Letizia","Raggiaschi Roberto","Rozemuller Annemieke J","Casamenti Fiorella","Caricasole Andrea","Terstappen Georg C"],"firstAuthor":"Pollio Giuseppe","referenceYear":"2008","referenceDate":"2008-07","id":"urn:lsid:swan.org:researchstatement:eb9147fe-2418-4c15-9fb7-5540c7ac0876"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:74dab4e4-9584-4f99-bb18-9d795059c631&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:74dab4e4-9584-4f99-bb18-9d795059c631","type":"Claim","title":"The data from the in vivo test of tau effect on axonal transport is consistent with the data presented in a previous study as well as the suggestion that tau tg mice should show neuronal dysfunction in the entire brain from a young age on.","label":"Nixon R; The data from the in vivo test of tau ef...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Nixon Ralph A","id":"urn:lsid:swan.org:researchstatement:74dab4e4-9584-4f99-bb18-9d795059c631"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e911ccda-560a-4721-8909-d7809f0f65b1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e911ccda-560a-4721-8909-d7809f0f65b1","type":"Claim","title":"The amyloid cascade hypothesis has been modified to include soluble Aβ oligomers","label":"Gong Y et al.; The amyloid cascade hypothesis has been ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:e911ccda-560a-4721-8909-d7809f0f65b1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4ce3eb80-30cf-40ac-9aaa-32137cd441eb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4ce3eb80-30cf-40ac-9aaa-32137cd441eb","type":"Claim","title":"Substitution of a charged with a neutral amino acid (E22G) in the central portion of the Arctic peptides might cause a substantial change in polypeptide conformational features (i.e., a more bent structure as suggested by AFM imaging) and the rapid aggregation kinetics of the Arctic peptide may contribute to complete loss of neuroprotective activity and might explain the aggressive and early-onset AD associated with this mutation.","label":"Giuffrida M et al.; Substitution of a charged with a neutral...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Caraci Filippo","Pignataro Bruno","Cataldo Sebastiano","De Bona Paolo","Bruno Valeria","Molinaro Gemma","Pappalardo Giuseppe","Messina Angela","Palmigiano Angelo","Garozzo Domenico","Nicoletti Ferdinando","Rizzarelli Enrico","Copani Agata"],"firstAuthor":"Giuffrida Maria Laura","referenceYear":"2009","referenceDate":"2009-08-26","id":"urn:lsid:swan.org:researchstatement:4ce3eb80-30cf-40ac-9aaa-32137cd441eb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3b05587e-548c-4dd8-8cf2-0ce63d946ba9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3b05587e-548c-4dd8-8cf2-0ce63d946ba9","type":"Claim","title":"Increasing amounts of the 19S complex are absorbed by PHF-tau; this might affect the proteolytic function of the 26S proteasome, which degrades ubiquitinated proteins in an ATP-dependent manner.","label":"Keck S et al.; Increasing amounts of the 19S complex ar...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:3b05587e-548c-4dd8-8cf2-0ce63d946ba9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8c01bcc6-de46-41da-8b7a-2ba6418ef5e3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8c01bcc6-de46-41da-8b7a-2ba6418ef5e3","type":"Claim","title":"Aβ peptides are neurotoxic and key to neurodegeneration in AD.","label":"Plant L et al.; Aβ peptides are neurotoxic and key to ne...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:8c01bcc6-de46-41da-8b7a-2ba6418ef5e3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6cae5be3-1993-4434-aa75-bc1f18070134&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6cae5be3-1993-4434-aa75-bc1f18070134","type":"Claim","title":"Large amounts of high molecular weight tau protein, phosphorylated at Ser212/ Thr214, could be detected with AT100 in AD brain tissue.","label":"Keck S et al.; Large amounts of high molecular weight t...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:6cae5be3-1993-4434-aa75-bc1f18070134"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:db2b9062-7784-4b39-8227-23d245013ce8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:db2b9062-7784-4b39-8227-23d245013ce8","type":"Claim","title":"Many elderly individuals have Aβ plaques in equivalent densities to patients with Alzheimer\u2019s disease but remain cognitively intact.","label":"Holmes C et al.; Many elderly individuals have Aβ plaques...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:db2b9062-7784-4b39-8227-23d245013ce8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6014dc71-d62d-4e5c-8d63-1c250d1195d4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6014dc71-d62d-4e5c-8d63-1c250d1195d4","type":"Claim","title":"Immunological approaches have been implemented to reduce Aβ load in the CNS.","label":"Tanzi R et al.; Immunological approaches have been imple...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:6014dc71-d62d-4e5c-8d63-1c250d1195d4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9a9f6d42-37f8-49b2-9085-0fdd130e259e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9a9f6d42-37f8-49b2-9085-0fdd130e259e","type":"Claim","title":"Caspase cleavage of APP modulates Aβ toxicity.","label":"Lu D et al.; Caspase cleavage of APP modulates Aβ tox...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Soriano Salvador","Bredesen Dale E","Koo Edward H"],"firstAuthor":"Lu Daniel C","referenceYear":"2003","referenceDate":"2003-11","id":"urn:lsid:swan.org:researchstatement:9a9f6d42-37f8-49b2-9085-0fdd130e259e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b7b8de6c-784c-4339-aac1-9a2742ded269&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b7b8de6c-784c-4339-aac1-9a2742ded269","type":"Claim","title":"Newly formed plaques represent typical plaques, and are not significantly different in area or diameter from those observed post mortem.","label":"Meyer-Luehmann M et al.; Newly formed plaques represent typical p...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:b7b8de6c-784c-4339-aac1-9a2742ded269"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3586a1bf-40ff-47bb-87f4-d89f0b98f07c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3586a1bf-40ff-47bb-87f4-d89f0b98f07c","type":"Claim","title":"Initial observations regarding the role of the presenilins in calcium signalling were identified using in vitro expression studies, with a consistent finding being an upregulation of calcium release resulting from overexpression of mutant PS1.","label":"Smith I et al.; Initial observations regarding the role ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:3586a1bf-40ff-47bb-87f4-d89f0b98f07c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b28f4624-288d-4f6d-83a6-e36cad234405&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b28f4624-288d-4f6d-83a6-e36cad234405","type":"Claim","title":"Blank","label":"Blank","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:b28f4624-288d-4f6d-83a6-e36cad234405"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:42bdbb14-03ea-4aa3-b4fd-0f6e025d017c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:42bdbb14-03ea-4aa3-b4fd-0f6e025d017c","type":"Claim","title":"Wnt signaling regulates GSK3 activity by physically displacing complexed GSK3 from a number of regulatory binding partners consequently preventing the phosphorylation and degradation of β-catenin.","label":"Hooper C et al.; Wnt signaling regulates GSK3 activity by...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:42bdbb14-03ea-4aa3-b4fd-0f6e025d017c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a131f691-79c1-41f7-baa4-f8d87a9fe05e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a131f691-79c1-41f7-baa4-f8d87a9fe05e","type":"Hypothesis","title":"Synapse loss is the physical basis and major correlate of cognitive impairment in Alzheimer Disease.","label":"Terry R et al.; Synapse loss is the physical basis and m...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Masliah Eliezer","Salmon D P","Butters N","DeTeresa R","Hill R","Hansen L A","Katzman R"],"firstAuthor":"Terry R D","referenceYear":"1991","referenceDate":"1991-10","id":"urn:lsid:swan.org:researchstatement:a131f691-79c1-41f7-baa4-f8d87a9fe05e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a73296d3-9031-43ec-a9da-173eebd14c12&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a73296d3-9031-43ec-a9da-173eebd14c12","type":"Claim","title":"Suggestive evidence was found for AD risk association with the genes encoding bridging integrator 1 (BIN1), which produces a protein involved in synaptic vesicle endoctyosis, and the disabled homolog 1 (DAB1), whose product is involved with tyrosine phosphorylation and microtubule function in neurons.","label":"Harold D et al.; Suggestive evidence was found for AD ris...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Abraham Richard","Hollingworth Paul","Sims Rebecca","Gerrish Amy","Hamshere Marian L","Pahwa Jaspreet Singh","Moskvina Valentina","Dowzell Kimberley","Williams Amy","Jones Nicola","Thomas Charlene","Stretton Alexandra","Morgan Angharad R","Lovestone Simon","Powell John","Proitsi Petroula","Lupton Michelle K","Brayne Carol","Rubinsztein David C","Gill Michael","Lawlor Brian","Lynch Aoibhinn","Morgan Kevin","Brown Kristelle S","Passmore Peter A","Craig David","McGuinness Bernadette","Todd Stephen","Holmes Clive","Mann David","Smith A David","Love Seth","Kehoe Patrick G","Hardy John","Mead Simon","Fox Nick","Rossor Martin","Collinge John","Maier Wolfgang","Jessen Frank","Schürmann Britta","van den Bussche Hendrik","Heuser Isabella","Kornhuber Johannes","Wiltfang Jens","Dichgans Martin","Frölich Lutz","Hampel Harald","Hüll Michael","Rujescu Dan","Goate Alison M","Kauwe John S","Cruchaga Carlos","Nowotny Petra","Morris John C","Mayo Kevin","Sleegers Kristel","Bettens Karolien","Engelborghs Sebastiaan","De Deyn Peter P","Van Broeckhoven Christine","Livingston Gill","Bass Nicholas J","Gurling Hugh","McQuillin Andrew","Gwilliam Rhian","Deloukas Panagiotis","Al-Chalabi Ammar","Shaw Christopher E","Tsolaki Magda","Singleton Andrew B","Guerreiro Rita","Mühleisen Thomas W","Nöthen Markus M","Moebus Susanne","Jöckel Karl-Heinz","Klopp Norman","Wichmann H-Erich","Carrasquillo Minerva M","Pankratz V Shane","Younkin Steven G","Holmans Peter A","O'Donovan Michael","Owen Michael J","Williams Julie"],"firstAuthor":"Harold Denise","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:a73296d3-9031-43ec-a9da-173eebd14c12"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e65b31d4-3ab1-4235-9b1b-7987acf74034&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e65b31d4-3ab1-4235-9b1b-7987acf74034","type":"Hypothesis","title":"Insulin-degrading enzyme is the main soluble beta-amyloid degrading enzyme.","label":"Farris W et al.; Insulin-degrading enzyme is the main sol...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Mansourian Stefan","Chang Yang","Lindsley Loren","Eckman Elizabeth A","Frosch Matthew P","Eckman Christopher B","Tanzi Rudolph E","Selkoe Dennis J","Guenette Suzanne"],"firstAuthor":"Farris Wesley","referenceYear":"2003","referenceDate":"2003-04-01","id":"urn:lsid:swan.org:researchstatement:e65b31d4-3ab1-4235-9b1b-7987acf74034"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:559cc7a9-6254-4005-bc9a-37d410dc2d63&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:559cc7a9-6254-4005-bc9a-37d410dc2d63","type":"Claim","title":"Aged AppV717F +/-, ApoE-/- mice (22 months) have Aβ deposited in hippocampus but not as fibrillar (thioflavine-S positive) form, whereas age-matched ApoE +/+  mice have dramatically higher accumulation of Aβ deposits, some in fibrillar form, in both neocortex and hippocampus.","label":"Holtzman D; Aged AppV717F +/-, ApoE-/- mice (22 mont...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:559cc7a9-6254-4005-bc9a-37d410dc2d63"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:211c68d9-43f2-465f-be28-c82f5bf59205&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:211c68d9-43f2-465f-be28-c82f5bf59205","type":"Claim","title":"Increased synaptic activity leads to the elevated endocytosis of synaptic vesicle proteins and increased clathrin-mediated endocytosis, driving more APP into endocytotic compartments which results in increased Aβ production and release.","label":"Harold D et al.; Increased synaptic activity leads to the...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Abraham Richard","Hollingworth Paul","Sims Rebecca","Gerrish Amy","Hamshere Marian L","Pahwa Jaspreet Singh","Moskvina Valentina","Dowzell Kimberley","Williams Amy","Jones Nicola","Thomas Charlene","Stretton Alexandra","Morgan Angharad R","Lovestone Simon","Powell John","Proitsi Petroula","Lupton Michelle K","Brayne Carol","Rubinsztein David C","Gill Michael","Lawlor Brian","Lynch Aoibhinn","Morgan Kevin","Brown Kristelle S","Passmore Peter A","Craig David","McGuinness Bernadette","Todd Stephen","Holmes Clive","Mann David","Smith A David","Love Seth","Kehoe Patrick G","Hardy John","Mead Simon","Fox Nick","Rossor Martin","Collinge John","Maier Wolfgang","Jessen Frank","Schürmann Britta","van den Bussche Hendrik","Heuser Isabella","Kornhuber Johannes","Wiltfang Jens","Dichgans Martin","Frölich Lutz","Hampel Harald","Hüll Michael","Rujescu Dan","Goate Alison M","Kauwe John S","Cruchaga Carlos","Nowotny Petra","Morris John C","Mayo Kevin","Sleegers Kristel","Bettens Karolien","Engelborghs Sebastiaan","De Deyn Peter P","Van Broeckhoven Christine","Livingston Gill","Bass Nicholas J","Gurling Hugh","McQuillin Andrew","Gwilliam Rhian","Deloukas Panagiotis","Al-Chalabi Ammar","Shaw Christopher E","Tsolaki Magda","Singleton Andrew B","Guerreiro Rita","Mühleisen Thomas W","Nöthen Markus M","Moebus Susanne","Jöckel Karl-Heinz","Klopp Norman","Wichmann H-Erich","Carrasquillo Minerva M","Pankratz V Shane","Younkin Steven G","Holmans Peter A","O'Donovan Michael","Owen Michael J","Williams Julie"],"firstAuthor":"Harold Denise","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:211c68d9-43f2-465f-be28-c82f5bf59205"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d2eb250a-0bcd-4c5f-87d8-bb7f334dbf91&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d2eb250a-0bcd-4c5f-87d8-bb7f334dbf91","type":"Hypothesis","title":"ApoE and LRP colocalize to and may be involved in the metabolism of amyloid plaques.","label":"Rebeck G et al.; ApoE and LRP colocalize to and may be in...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Reiter J S","Strickland D K","Hyman B T"],"firstAuthor":"Rebeck G W","referenceYear":"1993","referenceDate":"1993-10","id":"urn:lsid:swan.org:researchstatement:d2eb250a-0bcd-4c5f-87d8-bb7f334dbf91"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5a6bb42c-24a0-40b2-a4a1-3f50e0c07e52&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5a6bb42c-24a0-40b2-a4a1-3f50e0c07e52","type":"Claim","title":"Clioquinol is postulated to inhibit Aβ fibril formation by binding zinc and copper, and is being tested in clinical trials.","label":"Golde T; Clioquinol is postulated to inhibit Aβ f...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde T","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:5a6bb42c-24a0-40b2-a4a1-3f50e0c07e52"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6e125cda-77c6-4f75-880f-e573d9d91b5e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6e125cda-77c6-4f75-880f-e573d9d91b5e","type":"Claim","title":"Oligomeric forms of Aβ may be responsible for synaptic dysfunction.","label":"Smith I et al.; Oligomeric forms of Aβ may be responsibl...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:6e125cda-77c6-4f75-880f-e573d9d91b5e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9851b7c1-df2c-4386-be15-361a70517983&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9851b7c1-df2c-4386-be15-361a70517983","type":"Claim","title":"Myelin membrane may itself produce ATP without mitochondria and could help explain reports of surprisingly low brain mitochondria concentrations compared to other organs.","label":"Bartzokis G; Myelin membrane may itself produce ATP w...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:9851b7c1-df2c-4386-be15-361a70517983"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:67c6dda7-40f4-4d2d-8792-4dcb63ed7bf2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:67c6dda7-40f4-4d2d-8792-4dcb63ed7bf2","type":"Question","title":"Which species of Aβ oligomers are sufficient to induce neuronal cell cycle events (CCEs) in vitro?","label":"Which species of Aβ oligomers are suffic...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:67c6dda7-40f4-4d2d-8792-4dcb63ed7bf2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:27dbdbdd-293c-46c7-88af-e3bb0c9613f1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:27dbdbdd-293c-46c7-88af-e3bb0c9613f1","type":"Claim","title":"Application of caffeine to PS1KI neurons and 3xTg-AD neurons evoked a peak rise of [Ca2+]i that was significantly greater than those observed in NonTg neurons, although all groups had similar decay rates of their Ca2+ transient.  This finding suggests that Ca2+ stores are greater in both PS1KI and 3xTg-AD neurons as calculated by the integral of the caffeine-induced Ca2+ transient signal.","label":"Smith I et al.; Application of caffeine to PS1KI neurons...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:27dbdbdd-293c-46c7-88af-e3bb0c9613f1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f2b65df9-780c-4a96-aaed-c9405d1fe4a9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f2b65df9-780c-4a96-aaed-c9405d1fe4a9","type":"Claim","title":"Pathogen-associated molecular patterns (PAMPs) are characterized by a repetitive molecular motif that is recognized as non-self and can bind and activate evolutionarily conserved pattern recognition receptors (PRRs) that initiate innate immune signaling.","label":"Golde T et al.; Pathogen-associated molecular patterns (...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:f2b65df9-780c-4a96-aaed-c9405d1fe4a9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6d6b4366-ae1c-4d98-a865-315aae9c2414&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6d6b4366-ae1c-4d98-a865-315aae9c2414","type":"Claim","title":"Cytoplasmic or nuclear protein markers associated with senescent cells are often cell-cycle proteins, tumor suppressors, or cell-cycle regulators.","label":"Golde T et al.; Cytoplasmic or nuclear protein markers a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:6d6b4366-ae1c-4d98-a865-315aae9c2414"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:672ac677-1c77-49bd-b462-ac4fdc18720a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:672ac677-1c77-49bd-b462-ac4fdc18720a","type":"Claim","title":"ApoE protein from human CSF binds to synthetic immobilized Aβ peptide.","label":"Holtzman D; ApoE protein from human CSF binds to syn...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:672ac677-1c77-49bd-b462-ac4fdc18720a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a270155a-db00-44ff-b8e2-9784e0ca48cb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a270155a-db00-44ff-b8e2-9784e0ca48cb","type":"Claim","title":"The clearance of Aβ from brain parenchyma has been proposed to occur along periarterial interstitial fluid drainage pathways.","label":"Fryer J et al.; The clearance of Aβ from brain parenchym...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:a270155a-db00-44ff-b8e2-9784e0ca48cb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8d6e0e46-ecc0-43de-9c0e-a08e58ab9d22&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8d6e0e46-ecc0-43de-9c0e-a08e58ab9d22","type":"Claim","title":"Whereas 30% of cognitively normal individuals aged 80 to 88 years are PiB-positive, 50% of these same individuals had reduced CSF levels of Aβ42 suggesting that PiB may be less sensitive in identifying cerebral Aβ deposits (including those that are nonfibrillar) than CSF biomarkers.","label":"Morris J et al.; Whereas 30% of cognitively normal indivi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Roe Catherine M","Grant Elizabeth A","Head Denise","Storandt Martha","Goate Alison M","Fagan Anne M","Holtzman David M","Mintun Mark A"],"firstAuthor":"Morris John C","referenceYear":"2009","referenceDate":"2009-12","id":"urn:lsid:swan.org:researchstatement:8d6e0e46-ecc0-43de-9c0e-a08e58ab9d22"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d4a06b90-ee7d-4977-93b8-c234c599f856&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d4a06b90-ee7d-4977-93b8-c234c599f856","type":"Claim","title":"AD cases with severe CAA had a significantly lower parenchymal Aβ load.","label":"Fryer J et al.; AD cases with severe CAA had a significa...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:d4a06b90-ee7d-4977-93b8-c234c599f856"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:18c360cf-f0fd-4785-97e4-acd507d555cb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:18c360cf-f0fd-4785-97e4-acd507d555cb","type":"Claim","title":"Other bona fide metalloendopeptidase candidates for peptidolytic removal of Aβ include endothelin converting enzyme or ECE, as well as properly positioned circulating serine proteases, such as urokinase-type plasminogen activator (u-PA), tissue plasminogen activator (tPA), and plasmin.","label":"Tanzi R et al.; Other bona fide metalloendopeptidase can...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:18c360cf-f0fd-4785-97e4-acd507d555cb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2681b2c8-7a08-4b01-9aad-952a78e3e371&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2681b2c8-7a08-4b01-9aad-952a78e3e371","type":"Claim","title":"CAA is a frequent cause of CNS hemorrhage and stroke in the elderly.","label":"Holtzman D; CAA is a frequent cause of CNS hemorrhag...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:2681b2c8-7a08-4b01-9aad-952a78e3e371"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6930b308-798e-43c4-8523-1b3576cb7663&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6930b308-798e-43c4-8523-1b3576cb7663","type":"Claim","title":"Differences in the primary structure of human and mouse HMW tau may account for the difference in electrophoretic mobility of these proteins.","label":"Yuan A et al.; Differences in the primary structure of ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:6930b308-798e-43c4-8523-1b3576cb7663"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:703bb499-edc1-41e1-9cb1-623770ec9e8d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:703bb499-edc1-41e1-9cb1-623770ec9e8d","type":"Claim","title":"ApoE plays a critical and isoform specific role in conversion of Aβ to a fibrillar form with ensuing neuritic-plaque formation, a key pathological hallmark of AD.","label":"Holtzman D; ApoE plays a critical and isoform specif...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:703bb499-edc1-41e1-9cb1-623770ec9e8d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6a31b91d-8fa9-436c-aa88-559452fb1a9d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6a31b91d-8fa9-436c-aa88-559452fb1a9d","type":"Claim","title":"Mutant presenilin genes, which elevate production of Aβ42 and are associated with familial AD, increase the abundance of these stable Aβ oligomers.\n","label":"Lambert M et al.; Mutant presenilin genes, which elevate p...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:6a31b91d-8fa9-436c-aa88-559452fb1a9d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5c5f920c-74b1-4bea-bf14-de4aeba7476c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5c5f920c-74b1-4bea-bf14-de4aeba7476c","type":"Hypothesis","title":"Amyloid Cascade Hypothesis:  The neurodegeneration of Alzheimer Disease is caused by Aβ deposited into plaques in brain tissue.","label":"Hardy J et al.; Amyloid Cascade Hypothesis:  The neurode...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Higgins G A"],"firstAuthor":"Hardy J","referenceYear":"1992","referenceDate":"1992-04-10","id":"urn:lsid:swan.org:researchstatement:5c5f920c-74b1-4bea-bf14-de4aeba7476c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:844589c3-1d46-4eb5-a17b-ec1b50af2de0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:844589c3-1d46-4eb5-a17b-ec1b50af2de0","type":"Claim","title":"Both GSK3β and GSK3α induce the hyper-phosphorylation of tau implicating GSK3 as an important tau-kinase possibly involved in the formation of NFTs in vivo.","label":"Hooper C et al.; Both GSK3β and GSK3α induce the hyper-ph...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:844589c3-1d46-4eb5-a17b-ec1b50af2de0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9b440e28-8743-48df-b1e5-8437210c761e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9b440e28-8743-48df-b1e5-8437210c761e","type":"Claim","title":"The locus coeruleus is affected by tau pathology (presence of neurofibrillary tangles) in AD.","label":"Muresan Z et al.; The locus coeruleus is affected by tau p...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","referenceYear":"2008","referenceDate":"2008","id":"urn:lsid:swan.org:researchstatement:9b440e28-8743-48df-b1e5-8437210c761e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4c979cdb-62a0-4e29-a0d9-f500808efb03&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4c979cdb-62a0-4e29-a0d9-f500808efb03","type":"Claim","title":"The in vivo Aβ stable-isotope-labeling kinetics (SILK) study method involves 13C6 Leucine intravenously administered to rhesus monkeys for 12 h; CSF is collected from the cisterna magna port during and after administration and the incorporation of the label into Aβ is quantitated by immunoprecipitation paired with LC-MS, and the results are used to calculate production and clearance rates.","label":"Cook J et al.; The in vivo Aβ stable-isotope-labeling k...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wildsmith Kristin R","Gilberto David B","Holahan Marie A","Kinney Gene G","Mathers Parker D","Michener Maria S","Price Eric A","Shearman Mark S","Simon Adam J","Wang Jennifer X","Wu Guoxin","Yarasheski Kevin E","Bateman Randall J"],"firstAuthor":"Cook Jacquelynn J","referenceYear":"2010","referenceDate":"2010-05-12","id":"urn:lsid:swan.org:researchstatement:4c979cdb-62a0-4e29-a0d9-f500808efb03"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:03fed7be-df7a-4b57-a4ca-9ad20ad72d54&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:03fed7be-df7a-4b57-a4ca-9ad20ad72d54","type":"Claim","title":"A phase I clinical trial of immunization of patients with Alzheimer\u2019s disease with an Aβ42 synthetic peptide (AN1792; Elan Pharmaceuticals, Dublin, Ireland) showed that there is a highly variable, largely dose-independent, antibody response to AN1792 in addition to variable clearance of amyloid plaques.","label":"Holmes C et al.; A phase I clinical trial of immunization...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:03fed7be-df7a-4b57-a4ca-9ad20ad72d54"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:32cf195a-eda3-4988-ae8d-807e16a02e2c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:32cf195a-eda3-4988-ae8d-807e16a02e2c","type":"Claim","title":"Tau proteins expressed at levels 50-fold higher than normal nonspecifically inhibited axonal transport, independently of their microtubule-binding activity.","label":"Yuan A et al.; Tau proteins expressed at levels 50-fold...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:32cf195a-eda3-4988-ae8d-807e16a02e2c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ea3d2cce-a328-4465-8d0c-5249e4a11a59&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ea3d2cce-a328-4465-8d0c-5249e4a11a59","type":"Claim","title":"A form of oligomeric soluble Aβ may be the neurotoxic species, and ApoE may facilitate the formation of these species.","label":"Holtzman D; A form of oligomeric soluble Aβ may be t...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:ea3d2cce-a328-4465-8d0c-5249e4a11a59"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:021ddbce-b361-4264-bbae-2a25efbe8775&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:021ddbce-b361-4264-bbae-2a25efbe8775","type":"Claim","title":"It is rational to select patients for inclusion in anti-Aβ therapy clinical trials on the basis of biomarker evidence of Aβ in the brain by use of either amyloid PET imaging or CSF Aβ42 although change in Aβ load over time has little relation to change in cognition.","label":"Jack C et al.; It is rational to select patients for in...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:021ddbce-b361-4264-bbae-2a25efbe8775"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:297b4e7c-c3a7-4298-8946-9e9d0535a2fa&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:297b4e7c-c3a7-4298-8946-9e9d0535a2fa","type":"Hypothesis","title":"TGF-beta may contribute to the formation of amyloid plaques in Alzheimer disease.","label":"Wyss-Coray T et al.; TGF-beta may contribute to the formation...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Feng L","Masliah E","Ruppe M D","Lee H S","Toggas S M","Rockenstein E M","Mucke L"],"firstAuthor":"Wyss-Coray T","referenceYear":"1995","referenceDate":"1995-07","id":"urn:lsid:swan.org:researchstatement:297b4e7c-c3a7-4298-8946-9e9d0535a2fa"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2d2f1a33-f320-4a56-8bbf-e2a120c88216&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2d2f1a33-f320-4a56-8bbf-e2a120c88216","type":"Claim","title":"The \"channel hypothesis\" proposes that extracellular Aβ can re-insert into the membrane, associate together and create channels that allow lethal levels of calcium into the cell.","label":"Marchesi V; The \"channel hypothesis\" proposes that e...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:2d2f1a33-f320-4a56-8bbf-e2a120c88216"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5490cfca-4f87-4b36-bd97-9d4dcac63d1a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5490cfca-4f87-4b36-bd97-9d4dcac63d1a","type":"Claim","title":"Immunodepletion of Aβ with R1282 specifically removed Aβ monomers and oligomers from V717F APP751 conditioned media, and did not reduce amount of APPs from conditioned media.","label":"Walsh D et al.; Immunodepletion of Aβ with R1282 specifi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Klyubin Igor","Fadeeva Julia V","Cullen William K","Anwyl Roger","Wolfe Michael S","Rowan Michael J","Selkoe Dennis J"],"firstAuthor":"Walsh Dominic M","referenceYear":"2002","referenceDate":"2002-04-04","id":"urn:lsid:swan.org:researchstatement:5490cfca-4f87-4b36-bd97-9d4dcac63d1a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3f75e6c0-9fbe-4418-afaf-7aa192386f7b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3f75e6c0-9fbe-4418-afaf-7aa192386f7b","type":"Claim","title":"m266 can reduce Aβ burden by facilitating Aβ efflux or clearance from brain.","label":"Dodart J et al.; m266 can reduce Aβ burden by facilitatin...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:3f75e6c0-9fbe-4418-afaf-7aa192386f7b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f6f0171b-f983-49c7-9201-394efa8812d6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f6f0171b-f983-49c7-9201-394efa8812d6","type":"Claim","title":"Ceramide synthesis correlates with post-transcriptional maturation of SREBP, therefore having effects on cholesterol metabolism and brain distribution of cholesterol.","label":"Ceramide synthesis correlates with post-...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:f6f0171b-f983-49c7-9201-394efa8812d6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:08ef590a-8630-48d1-b469-5759b056a43c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:08ef590a-8630-48d1-b469-5759b056a43c","type":"Claim","title":"A key feature of the identified clinical mutations is that they all cause elevated production of Abeta1\u201342. Biochemical assays in plasma and cultured human skin fibroblasts revealed a selective elevation of Abeta1\u201342 in these patients.","label":"Smith I et al.; A key feature of the identified clinical...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:08ef590a-8630-48d1-b469-5759b056a43c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0e96415f-2211-46e4-9b62-fbe47fc911ce&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0e96415f-2211-46e4-9b62-fbe47fc911ce","type":"Claim","title":"In AD and other neurodegenerative diseases there is often marked upregulation of cyclins, p53 and related proteins, and cyclin-dependent kinase inhibitors that have also been implicated in the senescent phenotype, often upregulated in tangle-bearing neurons.","label":"Golde T et al.; In AD and other neurodegenerative diseas...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:0e96415f-2211-46e4-9b62-fbe47fc911ce"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6057cabd-d293-44d8-b4e0-3f56af33799b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6057cabd-d293-44d8-b4e0-3f56af33799b","type":"Claim","title":"In additional collections totaling 3,978 probable Alzheimer\u2019s disease cases and 3,297 controls obtained from Belgium, Finland, Italy and Spain, five SNPs at two loci showed association with AD risk, CLU on 8p21-p12, and the second spans the gene encoding complement component (3b/4b) receptor 1 (CR1) on 1q32.","label":"Lambert J et al.; In additional collections totaling 3,978...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Heath Simon","Even Gael","Campion Dominique","Sleegers Kristel","Hiltunen Mikko","Combarros Onofre","Zelenika Diana","Bullido Maria J","Tavernier Béatrice","Letenneur Luc","Bettens Karolien","Berr Claudine","Pasquier Florence","Fiévet Nathalie","Barberger-Gateau Pascale","Engelborghs Sebastiaan","De Deyn Peter","Mateo Ignacio","Franck Ana","Helisalmi Seppo","Porcellini Elisa","Hanon Olivier","de Pancorbo Marian M","Lendon Corinne","Dufouil Carole","Jaillard Céline","Leveillard Thierry","Alvarez Victoria","Bosco Paolo","Mancuso Michelangelo","Panza Francesco","Nacmias Benedetta","Bossù Paola","Piccardi Paola","Annoni Giorgio","Seripa Davide","Galimberti Daniela","Hannequin Didier","Licastro Federico","Soininen Hilkka","Ritchie Karen","Blanché Hélène","Dartigues Jean-François","Tzourio Christophe","Gut Ivo","Van Broeckhoven Christine","Alpérovitch Annick","Lathrop Mark","Amouyel Philippe"],"firstAuthor":"Lambert Jean-Charles","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:6057cabd-d293-44d8-b4e0-3f56af33799b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3914ace0-559d-4ce8-918c-1a3bacd25e4c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3914ace0-559d-4ce8-918c-1a3bacd25e4c","type":"Hypothesis","title":"β-Amyloid Monomers Are Neuroprotective.","label":"Giuffrida M et al.; β-Amyloid Monomers Are Neuroprotective.","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Caraci Filippo","Pignataro Bruno","Cataldo Sebastiano","De Bona Paolo","Bruno Valeria","Molinaro Gemma","Pappalardo Giuseppe","Messina Angela","Palmigiano Angelo","Garozzo Domenico","Nicoletti Ferdinando","Rizzarelli Enrico","Copani Agata"],"firstAuthor":"Giuffrida Maria Laura","referenceYear":"2009","referenceDate":"2009-08-26","id":"urn:lsid:swan.org:researchstatement:3914ace0-559d-4ce8-918c-1a3bacd25e4c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e90d4e22-d571-47f1-b869-e46be03c77f8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e90d4e22-d571-47f1-b869-e46be03c77f8","type":"Claim","title":"Neuritic accumulation of Aβ is restricted to a small population of neighboring cells, in CAD cell cultures.","label":"Muresan Z et al.; Neuritic accumulation of Aβ is restricte...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","referenceYear":"2008","referenceDate":"2008","id":"urn:lsid:swan.org:researchstatement:e90d4e22-d571-47f1-b869-e46be03c77f8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1dbc405c-1a86-4516-ba94-45b859ff929b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1dbc405c-1a86-4516-ba94-45b859ff929b","type":"Claim","title":"DNA fragmentation is not a non-specific consequence of neuronal injury, as neurons exposed to the calcium ionophore A23187 show only random DNA degradation.","label":"Cotman C et al.; DNA fragmentation is not a non-specific ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:1dbc405c-1a86-4516-ba94-45b859ff929b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:26fcd0da-3944-49b9-a12f-306de4fd8303&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:26fcd0da-3944-49b9-a12f-306de4fd8303","type":"Claim","title":"The cellular concentration of tau has been estimated to be about 1 microM or less, whereas the IC50 of the proteasome activity is about 70 nM (in the case of isolated PHF-tau) or 25 nM (in the case of in vitro assembled PHFtau).","label":"Keck S et al.; The cellular concentration of tau has be...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:26fcd0da-3944-49b9-a12f-306de4fd8303"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:554ddcf2-a783-48f0-a016-ab1a01520ed4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:554ddcf2-a783-48f0-a016-ab1a01520ed4","type":"Claim","title":"An additional study extends the finding that conditioned media depleted of Aβ monomers blocked LTP, by comparing the effect of size exclusion chromatography (SEC) separated monomer and oligomers, and by demonstrating that the effect can be blocked using mouse hippocampii.","label":"Walsh D; An additional study extends the finding ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Walsh Dominic M","id":"urn:lsid:swan.org:researchstatement:554ddcf2-a783-48f0-a016-ab1a01520ed4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:26370e01-26ff-4f66-9930-f8e4cf99a2b6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:26370e01-26ff-4f66-9930-f8e4cf99a2b6","type":"Claim","title":"The \u2018Hayflick limit\u2019 refers to the limited replicative capacity of primary human fibroblasts or other diploid cell lines to prolonged passaging in tissue culture, the most common manner in which senescence has been studied.","label":"Golde T et al.; The \u2018Hayflick limit\u2019 refers to the limit...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:26370e01-26ff-4f66-9930-f8e4cf99a2b6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d519e806-8534-46f6-b28b-7a34575657b9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d519e806-8534-46f6-b28b-7a34575657b9","type":"Claim","title":"Membrane-bound Aβ might form chimeric dimers with APP.","label":"Marchesi V; Membrane-bound Aβ might form chimeric di...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:d519e806-8534-46f6-b28b-7a34575657b9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1d2e2173-cfc1-4b1e-b9f1-0c62157a3a32&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1d2e2173-cfc1-4b1e-b9f1-0c62157a3a32","type":"Claim","title":"Markers of the phosphatidylinositol binding clathrin assembly protein gene PICALM on chromosome 11 for which association with AD has been confirmed in the French GWAS cohorts.","label":"Lambert J et al.; Markers of the phosphatidylinositol bind...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Heath Simon","Even Gael","Campion Dominique","Sleegers Kristel","Hiltunen Mikko","Combarros Onofre","Zelenika Diana","Bullido Maria J","Tavernier Béatrice","Letenneur Luc","Bettens Karolien","Berr Claudine","Pasquier Florence","Fiévet Nathalie","Barberger-Gateau Pascale","Engelborghs Sebastiaan","De Deyn Peter","Mateo Ignacio","Franck Ana","Helisalmi Seppo","Porcellini Elisa","Hanon Olivier","de Pancorbo Marian M","Lendon Corinne","Dufouil Carole","Jaillard Céline","Leveillard Thierry","Alvarez Victoria","Bosco Paolo","Mancuso Michelangelo","Panza Francesco","Nacmias Benedetta","Bossù Paola","Piccardi Paola","Annoni Giorgio","Seripa Davide","Galimberti Daniela","Hannequin Didier","Licastro Federico","Soininen Hilkka","Ritchie Karen","Blanché Hélène","Dartigues Jean-François","Tzourio Christophe","Gut Ivo","Van Broeckhoven Christine","Alpérovitch Annick","Lathrop Mark","Amouyel Philippe"],"firstAuthor":"Lambert Jean-Charles","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:1d2e2173-cfc1-4b1e-b9f1-0c62157a3a32"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4bed7a84-8372-4eff-af5d-7c7ffcce7fda&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4bed7a84-8372-4eff-af5d-7c7ffcce7fda","type":"Claim","title":"In AD, early memory loss and subsequent catastrophic dementia could be caused by pathogenic ADDLs, which first disrupt synaptic plasticity and subsequently cause neuronal death via mechanisms that require specific binding and signal transduction molecules.","label":"Lambert M et al.; In AD, early memory loss and subsequent ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:4bed7a84-8372-4eff-af5d-7c7ffcce7fda"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e6c7327b-2ddc-4b1b-8692-1e863da52526&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e6c7327b-2ddc-4b1b-8692-1e863da52526","type":"Claim","title":"MTT assay of cell proliferation demonstrated that synthetic ADDLs were selectively toxic to cortical cells, and not toxic to cerebellar cells at any concentration tested.","label":"Gong Y et al.; MTT assay of cell proliferation demonstr...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:e6c7327b-2ddc-4b1b-8692-1e863da52526"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:dbf195d3-b22c-466e-8b1d-0ccd610d930a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:dbf195d3-b22c-466e-8b1d-0ccd610d930a","type":"Claim","title":"The idea that areas with a high density of dystrophies would be a prime location for plaque development was tested over days to weeks, but observations at sites containing dystrophies but no plaques failed to demonstrate a new plaque appearing at a site of high dystrophic neurite density, although the number of observations was relatively small.","label":"Meyer-Luehmann M et al.; The idea that areas with a high density ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:dbf195d3-b22c-466e-8b1d-0ccd610d930a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d0fccabb-5777-4991-8d81-31ea4c4af871&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d0fccabb-5777-4991-8d81-31ea4c4af871","type":"Claim","title":"Mechanisms that may explain how transgenic animals with high anti-Aβ antibody titers have reduced amyloid load include either that anti-Aβ antibodies may cross the BBB and bind to Aβ in the brain, prompting digestion by activated microglia or that antibodies may bind and sequester Aβ in the periphery and either promote efflux from or inhibit influx back into brain.","label":"Tanzi R et al.; Mechanisms that may explain how transgen...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:d0fccabb-5777-4991-8d81-31ea4c4af871"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8245ee7e-b945-4029-9b24-814790d935c5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8245ee7e-b945-4029-9b24-814790d935c5","type":"Claim","title":"Conditioned media from V717F APP751 transfected cells did not affect baseline transmission in the absence of high-frequency stimulation.","label":"Walsh D et al.; Conditioned media from V717F APP751 tran...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Klyubin Igor","Fadeeva Julia V","Cullen William K","Anwyl Roger","Wolfe Michael S","Rowan Michael J","Selkoe Dennis J"],"firstAuthor":"Walsh Dominic M","referenceYear":"2002","referenceDate":"2002-04-04","id":"urn:lsid:swan.org:researchstatement:8245ee7e-b945-4029-9b24-814790d935c5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0b12b8a6-a123-4bea-b898-3e5996657e13&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0b12b8a6-a123-4bea-b898-3e5996657e13","type":"Claim","title":"Hyperphosphorylation of tau at old age itself, rather than tau-induced impairment of axonal transport, may be a cause of neuronal dysfunction in the entorhinal cortex, which shows the earliest pathological change in AD.","label":"Takashima A; Hyperphosphorylation of tau at old age i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Takashima Akihiko","id":"urn:lsid:swan.org:researchstatement:0b12b8a6-a123-4bea-b898-3e5996657e13"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:dc016391-85c2-42be-b679-1d009cc8f562&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:dc016391-85c2-42be-b679-1d009cc8f562","type":"Claim","title":"Ceramide is a lipid backbone for sphingolipid metabolism and a lipid second messenger.","label":"Ceramide is a lipid backbone for sphingo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:dc016391-85c2-42be-b679-1d009cc8f562"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6f63aa32-806d-4c5d-ab88-260c16b249d0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6f63aa32-806d-4c5d-ab88-260c16b249d0","type":"Claim","title":"Most mutations of PS cause partial loss of function of the γ-secretase complex.","label":"Bentahir M et al.; Most mutations of PS cause partial loss ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:6f63aa32-806d-4c5d-ab88-260c16b249d0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9c14bc83-f317-4791-af84-69497e72c6ed&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9c14bc83-f317-4791-af84-69497e72c6ed","type":"Claim","title":"A region of the cytoplasmic domain of APP may interact with the GTP binding protein G<sub>o<\/sub>.","label":"Suzuki T et al.; A region of the cytoplasmic domain of AP...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:9c14bc83-f317-4791-af84-69497e72c6ed"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1be2e026-c6fa-433e-8de5-bd4f9ef12e39&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1be2e026-c6fa-433e-8de5-bd4f9ef12e39","type":"Claim","title":"Regardless of the exact mechanism, it is clear that the reversal of memory impairment by m266 in these two memory tasks occurs too quickly to be due to an effect on brain Aβ burden.","label":"Dodart J et al.; Regardless of the exact mechanism, it is...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:1be2e026-c6fa-433e-8de5-bd4f9ef12e39"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:649dd02c-a025-48bf-9571-2d9578fde035&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:649dd02c-a025-48bf-9571-2d9578fde035","type":"Claim","title":"It is unclear what the real mechanism or specificity is of the relationship between ApoE4 and Aβ deposition, although ApoE4 is clearly the most important risk factor for the disease.","label":"Hardy ; It is unclear what the real mechanism or...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Hardy","referenceYear":"2009","referenceDate":"2009-05-18","id":"urn:lsid:swan.org:researchstatement:649dd02c-a025-48bf-9571-2d9578fde035"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0e357f32-236b-4392-8d27-d610d8a48266&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0e357f32-236b-4392-8d27-d610d8a48266","type":"Claim","title":"Imaging microglia before and after plaque formation in PDAPP mice crossed with EGFP expressed in microglia showed rapid plaque formation and attraction of microglia to new plaques within 24 h.","label":"Meyer-Luehmann M et al.; Imaging microglia before and after plaqu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:0e357f32-236b-4392-8d27-d610d8a48266"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5edf0bc1-c184-4910-a410-af77cf7f69b9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5edf0bc1-c184-4910-a410-af77cf7f69b9","type":"Claim","title":"Many natural extracellular activators of apoptosis interact with membrane proteins, and produce a novel signal that leads to apoptosis.","label":"Cotman C et al.; Many natural extracellular activators of...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:5edf0bc1-c184-4910-a410-af77cf7f69b9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:43848f9e-cea5-4d6a-84d9-8d3fba4758d4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:43848f9e-cea5-4d6a-84d9-8d3fba4758d4","type":"Claim","title":"Aβ oligomers may be novel targets for AD drug discovery.","label":"Gong Y et al.; Aβ oligomers may be novel targets for AD...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:43848f9e-cea5-4d6a-84d9-8d3fba4758d4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:96729a22-a9af-4640-920b-976b68a1e63b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:96729a22-a9af-4640-920b-976b68a1e63b","type":"Comment","title":"Muresan comment on statement \"Neurons that show Aβ accumulations may attempt to reenter the cell cycle.\"","label":"Muresan Z et al.; Muresan comment on statement \"Neurons th...","icon":"../icons/ontological/discourse-element/comment.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","id":"urn:lsid:swan.org:comment:96729a22-a9af-4640-920b-976b68a1e63b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4b099ee4-333e-4f59-a5c4-164b13297562&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4b099ee4-333e-4f59-a5c4-164b13297562","type":"Claim","title":"A model for γ-secretase is that the substrate-binding site is distinct from the catalytic active site and that, once the substrate is \u2018docked\u2019, it is subsequently displaced to the catalytic site of the enzyme.","label":"Bentahir M et al.; A model for γ-secretase is that the subs...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:4b099ee4-333e-4f59-a5c4-164b13297562"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1b5036a3-c442-4b47-aa62-7b87116b7eb6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1b5036a3-c442-4b47-aa62-7b87116b7eb6","type":"Claim","title":"Tau pathology begins in discrete, disease-specific regions, but eventually involves much larger areas of the brain. ","label":"Frost B et al.; Tau pathology begins in discrete, diseas...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Jacks Rachel L","Diamond Marc I"],"firstAuthor":"Frost Bess","referenceYear":"2009","referenceDate":"2009-05-08","id":"urn:lsid:swan.org:researchstatement:1b5036a3-c442-4b47-aa62-7b87116b7eb6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:19a7b665-8dd1-47f0-9dc1-41b1faa8cc02&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:19a7b665-8dd1-47f0-9dc1-41b1faa8cc02","type":"Claim","title":"It is likely that PS1 mutations might affect intracellular calcium signaling by modulating release from the ER.","label":"Kuchibhotla K et al.; It is likely that PS1 mutations might af...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Goldman Samuel T","Lattarulo Carli R","Wu Hai-Yan","Hyman Bradley T","Bacskai Brian J"],"firstAuthor":"Kuchibhotla Kishore V","referenceYear":"2008","referenceDate":"2008-07-31","id":"urn:lsid:swan.org:researchstatement:19a7b665-8dd1-47f0-9dc1-41b1faa8cc02"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3a832bb3-1b74-4f53-bfa8-99fbbb94f18e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3a832bb3-1b74-4f53-bfa8-99fbbb94f18e","type":"Claim","title":"Members of the BAG family interact with the ATPase domain of Hsp70 through their BAG domains and stimulate the degradation of the chaperone clients in the proteasome.","label":"Carrettiero D et al.; Members of the BAG family interact with ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hernandez Israel","Neveu Pierre","Papagiannakopoulos Thales","Kosik Kenneth S"],"firstAuthor":"Carrettiero Daniel C","referenceYear":"2009","referenceDate":"2009-02-18","id":"urn:lsid:swan.org:researchstatement:3a832bb3-1b74-4f53-bfa8-99fbbb94f18e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e5a7240d-d958-41c9-a055-ba0bddb7cce7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e5a7240d-d958-41c9-a055-ba0bddb7cce7","type":"Claim","title":"The cholinergic system is hyperactive in early stage AD and is not reduced to a hypoactive deficit condition until late AD, as evidenced by an apparent loss of noncholinergic neurons but not a loss of cholinergic neurons in early stage AD.","label":"Olney J et al.; The cholinergic system is hyperactive in...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:e5a7240d-d958-41c9-a055-ba0bddb7cce7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f0a46e2b-44b1-49b3-b6ec-e4d148d453d8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f0a46e2b-44b1-49b3-b6ec-e4d148d453d8","type":"Claim","title":"An association of AD with diabetes and insulin resistance has been reported and genetic studies find insulin signaling genes to be susceptibility loci for AD.","label":"Hooper C et al.; An association of AD with diabetes and i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:f0a46e2b-44b1-49b3-b6ec-e4d148d453d8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f035be4e-d9c5-46b0-a4fd-03a69cb820e2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f035be4e-d9c5-46b0-a4fd-03a69cb820e2","type":"Claim","title":"APP may have a role in membrane adhesion involved in maintenance of both pre- and post-synaptic adhesion as well as axonal myelin adherence at perinodal regions.","label":"Bartzokis G; APP may have a role in membrane adhesion...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:f035be4e-d9c5-46b0-a4fd-03a69cb820e2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:53df16a1-48c2-4c06-8025-83bbf53e6050&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:53df16a1-48c2-4c06-8025-83bbf53e6050","type":"Claim","title":"The posterior cingulate and retrosplenial (PC/RS) cortex has also been shown to be markedly atrophic late in AD. In contrast, neurodegeneration in the anterior cingulate cortex is less severe in the AD brain and in the NRHypo animal model.","label":"Olney J et al.; The posterior cingulate and retrosplenia...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:53df16a1-48c2-4c06-8025-83bbf53e6050"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:eb694171-a64a-474b-8d37-16cdc15d6af8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:eb694171-a64a-474b-8d37-16cdc15d6af8","type":"Claim","title":"Recent studies have demonstrated that soluble Aβ species correlate with onset of memory and synaptic plasticity impairments before detectable amyloid plaques.","label":"Walsh D; Recent studies have demonstrated that so...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Walsh Dominic M","id":"urn:lsid:swan.org:researchstatement:eb694171-a64a-474b-8d37-16cdc15d6af8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e3679e2d-3104-47ae-a031-597daef7849d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e3679e2d-3104-47ae-a031-597daef7849d","type":"Claim","title":"An impairment of the proteasome system, the major proteolytic system for degrading damaged proteins, may cause accumulation of protein damage products into NFTs.","label":"Keck S et al.; An impairment of the proteasome system, ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:e3679e2d-3104-47ae-a031-597daef7849d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:860c7622-3183-429f-9886-f27e3bedbdb7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:860c7622-3183-429f-9886-f27e3bedbdb7","type":"Claim","title":"The neuroprotective effect of Fyn is selective; hippocampal cell death evoked by N-methyl-D-aspartate (NMDA) receptor agonists was unaffected.","label":"Lambert M et al.; The neuroprotective effect of Fyn is sel...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:860c7622-3183-429f-9886-f27e3bedbdb7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:45b6d8a0-c193-49a7-bf56-8e30e2a2f4a9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:45b6d8a0-c193-49a7-bf56-8e30e2a2f4a9","type":"Hypothesis","title":"GAB2 alleles modify Alzheimer\u2019s risk in APOE ε4 carriers.  ","label":"Reiman E et al.; GAB2 alleles modify Alzheimer\u2019s risk in ...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Webster Jennifer A","Myers Amanda J","Hardy John","Dunckley Travis","Zismann Victoria L","Joshipura Keta D","Pearson John V","Hu-Lince Diane","Huentelman Matthew J","Craig David W","Coon Keith D","Liang Winnie S","Herbert RiLee H","Beach Thomas","Rohrer Kristen C","Zhao Alice S","Leung Doris","Bryden Leslie","Marlowe Lauren","Kaleem Mona","Mastroeni Diego","Grover Andrew","Heward Christopher B","Ravid Rivka","Rogers Joseph","Hutton Michael L","Melquist Stacey","Petersen Ron C","Alexander Gene E","Caselli Richard J","Kukull Walter","Papassotiropoulos Andreas","Stephan Dietrich A"],"firstAuthor":"Reiman Eric M","referenceYear":"2007","referenceDate":"2007-06-07","id":"urn:lsid:swan.org:researchstatement:45b6d8a0-c193-49a7-bf56-8e30e2a2f4a9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d665c75f-e081-4432-bd08-e9bad8ef2112&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d665c75f-e081-4432-bd08-e9bad8ef2112","type":"Claim","title":"A role for PS1 effect on disturbances of intracellular calcium homeostasis in synaptic dysfunction is still less clear.","label":"Smith I et al.; A role for PS1 effect on disturbances of...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:d665c75f-e081-4432-bd08-e9bad8ef2112"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ff17ca7b-57ba-4d95-be81-ea090e48d734&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ff17ca7b-57ba-4d95-be81-ea090e48d734","type":"Claim","title":"Tau is well known as an intracellular protein that stabilizes microtubule filaments; however, it is readily detected in cerebrospinal fluid and as extracellular aggregates, termed \u201cghost tangles,\u201d in diseased brain.","label":"Frost B et al.; Tau is well known as an intracellular pr...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Jacks Rachel L","Diamond Marc I"],"firstAuthor":"Frost Bess","referenceYear":"2009","referenceDate":"2009-05-08","id":"urn:lsid:swan.org:researchstatement:ff17ca7b-57ba-4d95-be81-ea090e48d734"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:84f8e2f8-30e8-4d86-a7a6-731ecddc1e39&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:84f8e2f8-30e8-4d86-a7a6-731ecddc1e39","type":"Claim","title":"Loss of tau has also been reported to be associated with sporadic and familial tauopathies with frontotemporal dementia.","label":"Yuan A et al.; Loss of tau has also been reported to be...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:84f8e2f8-30e8-4d86-a7a6-731ecddc1e39"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:478e74b3-a667-4964-a3c2-018a82838ff0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:478e74b3-a667-4964-a3c2-018a82838ff0","type":"Claim","title":"Bath application of Aβ oligomers caused a rapid increase in intracellular calcium in SH-SY5Y cells, whereas monomeric Aβ had no effect.","label":"Smith I et al.; Bath application of Aβ oligomers caused ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:478e74b3-a667-4964-a3c2-018a82838ff0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6fb8bcf6-4974-4438-b530-4770c7c711d4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6fb8bcf6-4974-4438-b530-4770c7c711d4","type":"Claim","title":"The absence of any observed plaques in the PSAPP model with a diffuse morphology argues against the idea that dense-core plaques represent a remodeled form of diffuse, \u2018primitive\u2019 plaques.","label":"Meyer-Luehmann M et al.; The absence of any observed plaques in t...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:6fb8bcf6-4974-4438-b530-4770c7c711d4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2699ca29-91fe-4f0f-8848-0ca42e5db525&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2699ca29-91fe-4f0f-8848-0ca42e5db525","type":"Claim","title":"APP homodimers are sequestered in lipid \"rafts\" enriched with cholesterol and other sphingolipids.","label":"Marchesi V; APP homodimers are sequestered in lipid ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:2699ca29-91fe-4f0f-8848-0ca42e5db525"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2fc5ce54-c97b-44dd-843c-892009e518e8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2fc5ce54-c97b-44dd-843c-892009e518e8","type":"Claim","title":"Aβ induces local neurite degeneration referred to as neuritic apoptosis or synaptotosis which displays the morphological and biochemical characteristics of apoptosis.  Thus neurite degeneration may use mechanisms common to apoptotsis.","label":"Cotman C; Aβ induces local neurite degeneration re...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Cotman Carl W","id":"urn:lsid:swan.org:researchstatement:2fc5ce54-c97b-44dd-843c-892009e518e8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:51150dbb-c595-4da2-b984-da17b0ec3333&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:51150dbb-c595-4da2-b984-da17b0ec3333","type":"Claim","title":"Several lines of evidence indicate that smaller Aβ oligomers, rather than full-fledged fibrils, may be the primary neurotoxic form.","label":"Tycko R; Several lines of evidence indicate that ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Tycko Robert","id":"urn:lsid:swan.org:researchstatement:51150dbb-c595-4da2-b984-da17b0ec3333"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:de4331cf-aa19-4809-bd42-306d4460859a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:de4331cf-aa19-4809-bd42-306d4460859a","type":"Claim","title":"Mature neurons, which are known to express high levels of anti-apoptotic proteins, may respond to potentially apoptotic stresses by senescing and at least in culture, a lower level of oxidative stress can drive senescence whereas a higher level can drive apoptosis.","label":"Golde T et al.; Mature neurons, which are known to expre...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:de4331cf-aa19-4809-bd42-306d4460859a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4c6b5014-1863-4c5c-be74-8d872815e8e8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4c6b5014-1863-4c5c-be74-8d872815e8e8","type":"Claim","title":"Increasing intraneuronal Aβ42 leads to an age-dependent neuron loss in hippocampus in two different APP/PS1 transgenic mouse models with no correlation to extracellular Aβ.","label":"Bayer T; Increasing intraneuronal Aβ42 leads to a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bayer T A","id":"urn:lsid:swan.org:researchstatement:4c6b5014-1863-4c5c-be74-8d872815e8e8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:be989b19-3d87-4bb9-b3fc-b56619b2a255&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:be989b19-3d87-4bb9-b3fc-b56619b2a255","type":"Claim","title":"Soluble aggregates of Aβ, termed Aβ oligomers, may play a causative role in AD pathogenesis.","label":"Varvel N et al.; Soluble aggregates of Aβ, termed Aβ olig...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bhaskar Kiran","Patil Anita R","Pimplikar Sanjay W","Herrup Karl","Lamb Bruce T"],"firstAuthor":"Varvel Nicholas H","referenceYear":"2008","referenceDate":"2008-10-22","id":"urn:lsid:swan.org:researchstatement:be989b19-3d87-4bb9-b3fc-b56619b2a255"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:53061505-fb3d-4704-ae23-359efc0bbe67&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:53061505-fb3d-4704-ae23-359efc0bbe67","type":"Claim","title":"Understanding the molecular basis of aging will allow a change in the degree of influence of risk factors on disease.","label":"Understanding the molecular basis of agi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:53061505-fb3d-4704-ae23-359efc0bbe67"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:32e3fca9-dd88-40d3-9d66-b7a38b9e63ac&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:32e3fca9-dd88-40d3-9d66-b7a38b9e63ac","type":"Claim","title":"In contrast to rapid onset of cell cycle events in cortical layers II/III, only ~1% of the neurons exhibited evidence of cyclin A and D expression in cortical layers V/VI at 6 months increasing to nearly 45% at 12 months in the R1.40 transgenic mice.  ","label":"Varvel N et al.; In contrast to rapid onset of cell cycle...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bhaskar Kiran","Patil Anita R","Pimplikar Sanjay W","Herrup Karl","Lamb Bruce T"],"firstAuthor":"Varvel Nicholas H","referenceYear":"2008","referenceDate":"2008-10-22","id":"urn:lsid:swan.org:researchstatement:32e3fca9-dd88-40d3-9d66-b7a38b9e63ac"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5045a8d4-8a79-445a-b438-41c870311254&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5045a8d4-8a79-445a-b438-41c870311254","type":"Claim","title":"Rapidly inactivating \"A\" type current (IKA) is increased by Aβ applied to cerebellar granule neurons in a concentration-dependent manner.","label":"Plant L et al.; Rapidly inactivating \"A\" type current (I...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:5045a8d4-8a79-445a-b438-41c870311254"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1a1cbb12-412e-46b9-8c9d-f811c98efa88&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1a1cbb12-412e-46b9-8c9d-f811c98efa88","type":"Claim","title":"Tissue-transglutaminase may determine the degree to which Aβ folding is directed towards a pathogenic rather than nonpathogenic pathway.","label":"Hartley D et al.; Tissue-transglutaminase may determine th...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:1a1cbb12-412e-46b9-8c9d-f811c98efa88"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8da9eed5-2e26-4888-92f2-306d5717e58b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8da9eed5-2e26-4888-92f2-306d5717e58b","type":"Claim","title":"LRP antagonists have been shown to specifically reduce the efflux of Aβ from brain by up to 90% in mice injected with radiolabeled Aβ40.","label":"Tanzi R et al.; LRP antagonists have been shown to speci...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:8da9eed5-2e26-4888-92f2-306d5717e58b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9fbc5dfc-0c25-4feb-9610-a8c46df57f55&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9fbc5dfc-0c25-4feb-9610-a8c46df57f55","type":"Claim","title":"While Alzheimer Disease pathology is characterized by amyloid plaques, tau tangles and cell death, the degree of cognitive deficits can be largely independent of the degree of these changes in individual subjects.","label":"Morse T et al.; While Alzheimer Disease pathology is cha...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Mutalik Pradeep","Cheung Kei","Miller Perry L","Shepherd Gordon"],"firstAuthor":"Morse Thomas M","id":"urn:lsid:swan.org:researchstatement:9fbc5dfc-0c25-4feb-9610-a8c46df57f55"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:86a4e252-f745-4f74-a48c-079fed1d3090&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:86a4e252-f745-4f74-a48c-079fed1d3090","type":"Claim","title":"The presence of ubiquitinated inclusions points to a defect in tau protein triage, a single molecule decision system that assesses each tau protein and decides whether the protein is functional, or misfolded and salvageable, or beyond repair and subject to proteolysis.","label":"Carrettiero D et al.; The presence of ubiquitinated inclusions...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hernandez Israel","Neveu Pierre","Papagiannakopoulos Thales","Kosik Kenneth S"],"firstAuthor":"Carrettiero Daniel C","referenceYear":"2009","referenceDate":"2009-02-18","id":"urn:lsid:swan.org:researchstatement:86a4e252-f745-4f74-a48c-079fed1d3090"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:03a7627f-df4c-45cf-9208-90ac635f6db4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:03a7627f-df4c-45cf-9208-90ac635f6db4","type":"Claim","title":"The degree of tau overexpression is critical to any observed effects on axonal transport.","label":"Nixon R; The degree of tau overexpression is crit...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Nixon Ralph A","id":"urn:lsid:swan.org:researchstatement:03a7627f-df4c-45cf-9208-90ac635f6db4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:07ff2b33-4102-4e4e-a315-68930b20d06a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:07ff2b33-4102-4e4e-a315-68930b20d06a","type":"Hypothesis","title":"Aβ oligomers induce neuronal cell cycle events in Alzheimer disease.","label":"Varvel N et al.; Aβ oligomers induce neuronal cell cycle ...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Bhaskar Kiran","Patil Anita R","Pimplikar Sanjay W","Herrup Karl","Lamb Bruce T"],"firstAuthor":"Varvel Nicholas H","referenceYear":"2008","referenceDate":"2008-10-22","id":"urn:lsid:swan.org:researchstatement:07ff2b33-4102-4e4e-a315-68930b20d06a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ba4cbbfa-bd5a-4442-974c-89261ec9139f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ba4cbbfa-bd5a-4442-974c-89261ec9139f","type":"Claim","title":"Activated microglia may be the nidus for initiation of amyloid fibrils.","label":"Meyer-Luehmann M et al.; Activated microglia may be the nidus for...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:ba4cbbfa-bd5a-4442-974c-89261ec9139f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:19ef8aa4-3390-473f-a9fe-b308a339cc4c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:19ef8aa4-3390-473f-a9fe-b308a339cc4c","type":"Claim","title":"Trophic-factor deprivation triggers the shedding of surface APP in a β-secretase (BACE)-dependent manner.","label":"Nikolaev A et al.; Trophic-factor deprivation triggers the ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["McLaughlin Todd","O'Leary Dennis D","Tessier-Lavigne Marc"],"firstAuthor":"Nikolaev Anatoly","referenceYear":"2009","referenceDate":"2009-02-19","id":"urn:lsid:swan.org:researchstatement:19ef8aa4-3390-473f-a9fe-b308a339cc4c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:433ead00-e67b-4737-9902-61edbfb0aa9e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:433ead00-e67b-4737-9902-61edbfb0aa9e","type":"Claim","title":"The degree of dementia in AD correlates with concentration of soluble Aβ.","label":"Hardy J et al.; The degree of dementia in AD correlates ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:433ead00-e67b-4737-9902-61edbfb0aa9e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7397e21f-939c-4a33-b6e9-346de603b6f5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7397e21f-939c-4a33-b6e9-346de603b6f5","type":"Claim","title":"Data from animal models have shown that downregulation of RAGE is able to inhibit the influx of Aβ from the periphery into the CNS.","label":"Tanzi R et al.; Data from animal models have shown that ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:7397e21f-939c-4a33-b6e9-346de603b6f5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:07e6f536-ec33-48db-a3a1-60d01faf7e32&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:07e6f536-ec33-48db-a3a1-60d01faf7e32","type":"Claim","title":"Normal aging is characterized by moderate but not severe accumulation of Aβ into senile plaques and by loss of synaptic plasticity.","label":"Normal aging is characterized by moderat...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:07e6f536-ec33-48db-a3a1-60d01faf7e32"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bb5d3434-c761-451b-be0e-fe5b53047101&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bb5d3434-c761-451b-be0e-fe5b53047101","type":"Claim","title":"LRP is a multifunctional signaling and scavenger receptor consisting of a heavy chain that can bind a variety of ligands, such as apolipoprotein E (apoE), alpha2-macroglobulin (alpha2M), and APP.","label":"Tanzi R et al.; LRP is a multifunctional signaling and s...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:bb5d3434-c761-451b-be0e-fe5b53047101"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a013f52e-a394-48c7-b0d2-b062faca7798&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a013f52e-a394-48c7-b0d2-b062faca7798","type":"Claim","title":"Clusterin is expressed in all mammalian tissues as predominantly a secreted heterodimeric glycoprotein of 75\u201380 kDa and there is strong evidence that CLU expression is elevated in a number of pathological conditions involving injury or chronic inflammation of the brain.","label":"Harold D et al.; Clusterin is expressed in all mammalian ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Abraham Richard","Hollingworth Paul","Sims Rebecca","Gerrish Amy","Hamshere Marian L","Pahwa Jaspreet Singh","Moskvina Valentina","Dowzell Kimberley","Williams Amy","Jones Nicola","Thomas Charlene","Stretton Alexandra","Morgan Angharad R","Lovestone Simon","Powell John","Proitsi Petroula","Lupton Michelle K","Brayne Carol","Rubinsztein David C","Gill Michael","Lawlor Brian","Lynch Aoibhinn","Morgan Kevin","Brown Kristelle S","Passmore Peter A","Craig David","McGuinness Bernadette","Todd Stephen","Holmes Clive","Mann David","Smith A David","Love Seth","Kehoe Patrick G","Hardy John","Mead Simon","Fox Nick","Rossor Martin","Collinge John","Maier Wolfgang","Jessen Frank","Schürmann Britta","van den Bussche Hendrik","Heuser Isabella","Kornhuber Johannes","Wiltfang Jens","Dichgans Martin","Frölich Lutz","Hampel Harald","Hüll Michael","Rujescu Dan","Goate Alison M","Kauwe John S","Cruchaga Carlos","Nowotny Petra","Morris John C","Mayo Kevin","Sleegers Kristel","Bettens Karolien","Engelborghs Sebastiaan","De Deyn Peter P","Van Broeckhoven Christine","Livingston Gill","Bass Nicholas J","Gurling Hugh","McQuillin Andrew","Gwilliam Rhian","Deloukas Panagiotis","Al-Chalabi Ammar","Shaw Christopher E","Tsolaki Magda","Singleton Andrew B","Guerreiro Rita","Mühleisen Thomas W","Nöthen Markus M","Moebus Susanne","Jöckel Karl-Heinz","Klopp Norman","Wichmann H-Erich","Carrasquillo Minerva M","Pankratz V Shane","Younkin Steven G","Holmans Peter A","O'Donovan Michael","Owen Michael J","Williams Julie"],"firstAuthor":"Harold Denise","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:a013f52e-a394-48c7-b0d2-b062faca7798"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:58e4c133-805e-4431-943f-b95ac5d052d5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:58e4c133-805e-4431-943f-b95ac5d052d5","type":"Comment","title":"Striking differences between mouse and human brains are observed when stained for myelin.","label":"Bartzokis G; Striking differences between mouse and h...","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Bartzokis George","id":"urn:lsid:swan.org:comment:58e4c133-805e-4431-943f-b95ac5d052d5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:805a3651-b7e3-4388-940d-48d4a69ade2a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:805a3651-b7e3-4388-940d-48d4a69ade2a","type":"Claim","title":"Despite the poorer delayed memory of APOE ε4 carriers, the APOE ε4 noncarriers performed less well on the first immediate recall trial of the Auditory Verbal Learning Test (AVLT), that does not correlate with medial temporal lobe (MTL) atrophy but rather is most strongly associated with atrophy of the angular gyrus in the posterior parietal cortex/inferior parietal lobule, as well as greater impairment in cognitive assessment tests Trails A and Trails B, measures usually thought to represent visuomotor speed and executive function (sequencing), requiring sustained attention, working memory, and lexical access.","label":"Wolk D et al.; Despite the poorer delayed memory of APO...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Dickerson Bradford C","Weiner Michael","Aiello Marilyn","Aisen Paul","Albert Marilyn S","Alexander Gene","Anderson Heather S","Anderson Karen","Apostolova Liana","Arnold Steve","Ashford Wes","Assaly Michele","Asthana Sanjay","Bandy Dan","Bartha Rob","Bates Vernice","Beckett Laurel","Bell Karen L","Benincasa Amanda L","Bergman Howard","Bernick Charles","Bernstein Matthew","Black Sandra","Blank Karen","Borrie Michael","Brand Connie","Brewer James","Brown Alice D","Burns Jeffrey M","Cairns Nigel J","Caldwell Curtis","Capote Horacio","Carlsson Cynthia M","Carmichael Owen","Cellar Janet S","Celmins Dzintra","Chen Kewei","Chertkow Howard","Chowdhury Munir","Clark David","Connor Donald","Correia Stephen","Crawford Karen","Dale Anders","de Leon Mony J","De Santi Susan M","Decarli Charles","Detoledo-Morrell Leyla","Devous Michael","Diaz-Arrastia Ramon","Dolen Sara","Donohue Michael","Doody Rachelle S","Doraiswamy P Murali","Duara Ranjan","Englert Jessica","Farlow Martin","Feldman Howard","Felmlee Joel","Fleisher Adam","Fletcher Evan","Foroud Tatiana M","Foster Norm","Fox Nick","Frank Richard","Gamst Anthony","Given Curtis A","Graff-Radford Neill R","Green Robert C","Griffith Randall","Grossman Hillel","Hake Ann M","Hardy Peter","Harvey Danielle","Heidebrink Judith L","Hendin Barry A","Herring Scott","Honig Lawrence S","Hosein Chris","Robin Hsiung Ging-Yuek","Hudson Leon","Ismail M Saleem","Jack Clifford R","Jacobson Sandra","Jagust William","Jayam-Trouth Annapurni","Johnson Kris","Johnson Heather","Johnson Nancy","Johnson Kathleen","Johnson Keith A","Johnson Sterling","Kachaturian Zaven","Karlawish Jason H","Kataki Maria","Kaye Jeffrey","Kertesz Andrew","Killiany Ronald","Kittur Smita","Koeppe Robert A","Korecka Magdalena","Kornak John","Kozauer Nicholas","Lah James J","Laubinger Mary M","Lee Virginia M-Y","Lee T-Y","Lerner Alan","Levey Allan I","Longmire Crystal Flynn","Lopez Oscar L","Lord Joanne L","Lu Po H","Macavoy Martha G","Malloy Paul","Marson Daniel","Martin-Cook Kristen","Martinez Walter","Marzloff George","Mathis Chet","Mc-Adams-Ortiz Catherine","Mesulam Marsel","Miller Bruce L","Mintun Mark A","Mintzer Jacobo","Molchan Susan","Montine Tom","Morris John","Mulnard Ruth A","Munic Donna","Nair Anil","Neu Scott","Nguyen Dana","Norbash Alexander","Oakley Maryann","Obisesan Thomas O","Ogrocki Paula","Ott Brian R","Parfitt Francine","Pawluczyk Sonia","Pearlson Godfrey","Petersen Ronald","Petrella Jeffrey R","Potkin Steven","Potter William Z","Preda Adrian","Quinn Joseph","Rainka Michelle","Reeder Stephanie","Reiman Eric M","Rentz Dorene M","Reynolds Brigid","Richard Jennifer","Roberts Peggy","Rogers John","Rosen Allyson","Rosen Howard J","Rusinek Henry","Sabbagh Marwan","Sadowsky Carl","Salloway Stephen","Santulli Robert B","Saykin Andrew J","Scharre Douglas W","Schneider Lon","Schneider Stacy","Schuff Norbert","Shah Raj C","Shaw Les","Shen Li","Silverman Daniel H","Simpson Donna M","Sink Kaycee M","Smith Charles D","Snyder Peter J","Spann Bryan M","Sperling Reisa A","Spicer Kenneth","Stefanovic Bojana","Stern Yaakov","Stopa Edward","Tang Cheuk","Tariot Pierre","Taylor-Reinwald Lisa","Thai Gaby","Thomas Ronald G","Thompson Paul","Tinklenberg Jared","Toga Arthur W","Tremont Geoffrey","Trojanowki J Q","Trost Dick","Turner Raymond Scott","van Dyck Christopher H","Vanderswag Helen","Varon Daniel","Villanueva-Meyer Javier","Villena Teresa","Walter Sarah","Wang Paul","Watkins Franklin","Weiner Michael","Williamson Jeff D","Wolk David","Wu Chuang-Kuo","Zerrate Maria","Zimmerman Earl A"],"firstAuthor":"Wolk David A","referenceYear":"2010","referenceDate":"2010-05-17","id":"urn:lsid:swan.org:researchstatement:805a3651-b7e3-4388-940d-48d4a69ade2a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fc9f4699-d35f-47a3-9cdc-81b7b3c78d02&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fc9f4699-d35f-47a3-9cdc-81b7b3c78d02","type":"Claim","title":"Aggregated tau on microtubules, but not monomeric tau, may induce inhibition of axonal transport.","label":"Takashima A; Aggregated tau on microtubules, but not ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Takashima Akihiko","id":"urn:lsid:swan.org:researchstatement:fc9f4699-d35f-47a3-9cdc-81b7b3c78d02"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ae262008-b904-4e18-8e81-ced168522f4e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ae262008-b904-4e18-8e81-ced168522f4e","type":"Claim","title":"Paranuclei do not exhibit the significant α-helix content identified at later stages of Aβ aggregation nor the β-sheet structure characteristic of amyloid fibrils.","label":"Tycko R; Paranuclei do not exhibit the significan...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Tycko Robert","id":"urn:lsid:swan.org:researchstatement:ae262008-b904-4e18-8e81-ced168522f4e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:20cabad2-37b4-42e0-8ae7-cd06bb80865d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:20cabad2-37b4-42e0-8ae7-cd06bb80865d","type":"Claim","title":"A characteristic biochemical feature of many cell types undergoing apoptosis is the degradation of DNA into oligonucleosome-length fragments in many models.","label":"Cotman C et al.; A characteristic biochemical feature of ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:20cabad2-37b4-42e0-8ae7-cd06bb80865d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0cc773c9-3881-4b5d-838e-9e4321526d6a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0cc773c9-3881-4b5d-838e-9e4321526d6a","type":"Claim","title":"APP is a type I membrane protein, thus, the intracellular transport and metabolism are regulated by the cytoplasmic tail composing of 47 amino acids. There have been many reports of proteins which bind to the APP cytoplasmic domain. It is well known that some of these regulate the metabolism and trafficking of APP.","label":"Suzuki T; APP is a type I membrane protein, thus, ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Suzuki Toshiharu","id":"urn:lsid:swan.org:researchstatement:0cc773c9-3881-4b5d-838e-9e4321526d6a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:62011294-be55-4965-be5c-0c1664e9dd45&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:62011294-be55-4965-be5c-0c1664e9dd45","type":"Claim","title":"The NMDA receptor system becomes hypofunctional in the normal brain or the AD brain after having first gone through an early stage of NRHyper, in which hyperactivation of NMDA receptors can result in excitotoxic degeneration of the dendritic spines on which NMDA receptors are located or in degeneration of the entire NMDA receptor-bearing neuron.","label":"Olney J et al.; The NMDA receptor system becomes hypofun...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:62011294-be55-4965-be5c-0c1664e9dd45"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:15e33cbd-360a-4d73-a88c-df9632d10e54&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:15e33cbd-360a-4d73-a88c-df9632d10e54","type":"Claim","title":"Suppression of tau may potentially be beneficial in AD.","label":"Ballatore C et al.; Suppression of tau may potentially be be...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Lee Virginia M-Y","Trojanowski John Q"],"firstAuthor":"Ballatore Carlo","referenceYear":"2007","referenceDate":"2007-09","id":"urn:lsid:swan.org:researchstatement:15e33cbd-360a-4d73-a88c-df9632d10e54"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fcce54b9-f087-43e6-9d3e-ed849e2dca7a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fcce54b9-f087-43e6-9d3e-ed849e2dca7a","type":"Claim","title":"Initial tests to compare ADDL binding sites with the receptor for advanced glycation end products (RAGE) indicate no overlap, consistent with reports that RAGE accounts for only 60% of the Aβ associated with neurons.","label":"Lambert M et al.; Initial tests to compare ADDL binding si...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:fcce54b9-f087-43e6-9d3e-ed849e2dca7a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8b32968e-bf0a-477a-a609-2ac726bd4e3b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8b32968e-bf0a-477a-a609-2ac726bd4e3b","type":"Claim","title":"Taxol, an MT-stabilizing drug, makes up for the loss of tau function that results from tau sequestration in fibrillary tau inclusions in the T44 line.","label":"Lee V et al.; Taxol, an MT-stabilizing drug, makes up ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Trojanowski John Q"],"firstAuthor":"Lee Virginia M-Y","id":"urn:lsid:swan.org:researchstatement:8b32968e-bf0a-477a-a609-2ac726bd4e3b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ded0313e-d022-406a-9d90-8d9be72449cb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ded0313e-d022-406a-9d90-8d9be72449cb","type":"Claim","title":"The data presented in Meyer-Luehmann et al., (2008) abrogates all prior preconceived notions that plaques grow slowly over life and that given time, all plaques would reach a maximum size.","label":"Kumar-Singh S; The data presented in Meyer-Luehmann et ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Kumar-Singh Samir","id":"urn:lsid:swan.org:researchstatement:ded0313e-d022-406a-9d90-8d9be72449cb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:54767ca1-4736-4f14-a966-91bee5287896&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:54767ca1-4736-4f14-a966-91bee5287896","type":"Claim","title":"γ-secretase is biologically and biochemically heterogeneous, consisting of at least 4 or more different complexes.","label":"Bentahir M et al.; γ-secretase is biologically and biochemi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:54767ca1-4736-4f14-a966-91bee5287896"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2e64ff4d-25e4-48f6-95c6-5eed9596616e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2e64ff4d-25e4-48f6-95c6-5eed9596616e","type":"Claim","title":"In transgenic mice, an increase in C3 expression coincides with a smaller degree of Aβ deposition and neuropathology.","label":"Lambert J et al.; In transgenic mice, an increase in C3 ex...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Heath Simon","Even Gael","Campion Dominique","Sleegers Kristel","Hiltunen Mikko","Combarros Onofre","Zelenika Diana","Bullido Maria J","Tavernier Béatrice","Letenneur Luc","Bettens Karolien","Berr Claudine","Pasquier Florence","Fiévet Nathalie","Barberger-Gateau Pascale","Engelborghs Sebastiaan","De Deyn Peter","Mateo Ignacio","Franck Ana","Helisalmi Seppo","Porcellini Elisa","Hanon Olivier","de Pancorbo Marian M","Lendon Corinne","Dufouil Carole","Jaillard Céline","Leveillard Thierry","Alvarez Victoria","Bosco Paolo","Mancuso Michelangelo","Panza Francesco","Nacmias Benedetta","Bossù Paola","Piccardi Paola","Annoni Giorgio","Seripa Davide","Galimberti Daniela","Hannequin Didier","Licastro Federico","Soininen Hilkka","Ritchie Karen","Blanché Hélène","Dartigues Jean-François","Tzourio Christophe","Gut Ivo","Van Broeckhoven Christine","Alpérovitch Annick","Lathrop Mark","Amouyel Philippe"],"firstAuthor":"Lambert Jean-Charles","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:2e64ff4d-25e4-48f6-95c6-5eed9596616e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:252104ee-6d9c-4183-91a7-43a9b60b23f2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:252104ee-6d9c-4183-91a7-43a9b60b23f2","type":"Claim","title":"Fyn is important to LTP, a classic paradigm for synaptic plasticity and a model for memory and learning, faculties that are selectively lost in early stage AD. ","label":"Lambert M et al.; Fyn is important to LTP, a classic parad...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:252104ee-6d9c-4183-91a7-43a9b60b23f2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:73ee10cf-f185-41f4-beaf-fade538a2efc&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:73ee10cf-f185-41f4-beaf-fade538a2efc","type":"Claim","title":"The presence of Aβ plaques might be necessary to initiate, but not to maintain, progressive neurodegeneration.","label":"Holmes C et al.; The presence of Aβ plaques might be nece...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:73ee10cf-f185-41f4-beaf-fade538a2efc"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7cadeca7-ec05-4b23-a634-dc6b27c7e4e5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7cadeca7-ec05-4b23-a634-dc6b27c7e4e5","type":"Claim","title":"The danger theory of immune activation postulates that an intracellular stress such as a protein aggregate or pathogen results in the neuron or other CNS cell generating a \u2018danger\u2019 signal that activates the immune system producing a chronic inflammatory condition.","label":"Golde T et al.; The danger theory of immune activation p...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:7cadeca7-ec05-4b23-a634-dc6b27c7e4e5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3ef30af7-992d-47bb-85df-70cd74ed689d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3ef30af7-992d-47bb-85df-70cd74ed689d","type":"Claim","title":"APP and possibly Aβ may be damage response proteins, a worrying possibility.","label":"Hardy ; APP and possibly Aβ may be damage respon...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Hardy","referenceYear":"2009","referenceDate":"2009-05-18","id":"urn:lsid:swan.org:researchstatement:3ef30af7-992d-47bb-85df-70cd74ed689d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6afdda3f-330a-4952-86b7-1adb897780be&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6afdda3f-330a-4952-86b7-1adb897780be","type":"Claim","title":"During the process of Aβ aggregation, hydrogen peroxide and hydroxyl radicals are generated that can result in lipid peroxidation with a subsequent disruption in the activity of ion motive ATPases that are intimately involved in regulating intracellular calcium elevations (such as the calcium-ATPase).","label":"Smith I et al.; During the process of Aβ aggregation, hy...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:6afdda3f-330a-4952-86b7-1adb897780be"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4df7c3d3-d2c4-462f-a67b-dab04875485e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4df7c3d3-d2c4-462f-a67b-dab04875485e","type":"Claim","title":"Monomeric Aβ has been shown to adsorb quickly and reversibly to lipid bilayers.","label":"Giuffrida M et al.; Monomeric Aβ has been shown to adsorb qu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Caraci Filippo","Pignataro Bruno","Cataldo Sebastiano","De Bona Paolo","Bruno Valeria","Molinaro Gemma","Pappalardo Giuseppe","Messina Angela","Palmigiano Angelo","Garozzo Domenico","Nicoletti Ferdinando","Rizzarelli Enrico","Copani Agata"],"firstAuthor":"Giuffrida Maria Laura","referenceYear":"2009","referenceDate":"2009-08-26","id":"urn:lsid:swan.org:researchstatement:4df7c3d3-d2c4-462f-a67b-dab04875485e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d67cc9cb-c8a3-4fd3-bef3-1a608ef2f572&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d67cc9cb-c8a3-4fd3-bef3-1a608ef2f572","type":"Claim","title":"Several in vitro studies suggest that apoE influences cellular Aβ clearance, and an in vivo study suggests that apoE in some way directly influences the half-life of soluble Aβ in the interstitial fluid of the brain.","label":"Herzig M et al.; Several in vitro studies suggest that ap...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Winkler David T","Burgermeister Patrick","Pfeifer Michelle","Kohler Esther","Schmidt Stephen D","Danner Simone","Abramowski Dorothee","Stürchler-Pierrat Christine","Bürki Kurt","van Duinen Sjoerd G","Maat-Schieman Marion L","Staufenbiel Matthias","Mathews Paul M","Jucker Mathias"],"firstAuthor":"Herzig Martin C","referenceYear":"2004","referenceDate":"2004-09","id":"urn:lsid:swan.org:researchstatement:d67cc9cb-c8a3-4fd3-bef3-1a608ef2f572"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5260c843-28fc-4467-bdd0-f94bc611aea5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5260c843-28fc-4467-bdd0-f94bc611aea5","type":"Claim","title":"Isoform-specific tau expression may affect pronounced differences in the effects of tau isoforms on microtubule motors at the single molecule level.","label":"Holzbaur E; Isoform-specific tau expression may affe...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holzbaur Erika L F","id":"urn:lsid:swan.org:researchstatement:5260c843-28fc-4467-bdd0-f94bc611aea5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:4a4171f5-93d9-4463-9545-5fc4deb783b3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:4a4171f5-93d9-4463-9545-5fc4deb783b3","type":"Comment","title":"Increased Ca2+ likely plays an integral role in AD pathogenesis, in both 'cause' and 'effect' relationships.  ","label":"Stutzmann G; Increased Ca2+ likely plays an integral ...","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Stutzmann Grace E","id":"urn:lsid:swan.org:comment:4a4171f5-93d9-4463-9545-5fc4deb783b3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:514dc0a8-f4cd-49b4-95e5-5eb4524d1a14&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:514dc0a8-f4cd-49b4-95e5-5eb4524d1a14","type":"Comment","title":"D Selkoe on Marchesi","label":"Selkoe D; D Selkoe on Marchesi","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Selkoe Dennis J","referenceYear":"2005","referenceDate":"2005-09-03","id":"urn:lsid:swan.org:comment:514dc0a8-f4cd-49b4-95e5-5eb4524d1a14"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ea10f8aa-dc15-4be6-8872-f6ddb4b177b8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ea10f8aa-dc15-4be6-8872-f6ddb4b177b8","type":"Claim","title":"Additional possibilities have been generated to try to explain the incontrovertibly negative results of a study demonstrating that clearance of amyloid plaques in patients with Alzheimer Disease did not prevent progressive neurodegeneration.","label":"Small S et al.; Additional possibilities have been gener...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:ea10f8aa-dc15-4be6-8872-f6ddb4b177b8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:284f8319-856c-40a0-911a-b6cc3e388551&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:284f8319-856c-40a0-911a-b6cc3e388551","type":"Claim","title":"Neuropathology in the APP mice model of AD is ameliorated by deleting the α7nicotinic acetylcholine receptor subunit despite similar levels of APP, Aβ expression, and plaque formation.","label":"Dziewczapolski G et al.; Neuropathology in the APP mice model of ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Glogowski Carolina M","Masliah Eliezer","Heinemann Stephen F"],"firstAuthor":"Dziewczapolski Gustavo","referenceYear":"2009","referenceDate":"2009-07-08","id":"urn:lsid:swan.org:researchstatement:284f8319-856c-40a0-911a-b6cc3e388551"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:92c4a1e4-f50f-4895-b85c-f9d5ca0d0936&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:92c4a1e4-f50f-4895-b85c-f9d5ca0d0936","type":"Question","title":"What signaling pathways are altered in AD that lead to neuronal death?","label":"What signaling pathways are altered in A...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:92c4a1e4-f50f-4895-b85c-f9d5ca0d0936"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3af0105d-67bb-4e34-9320-874adea38efc&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3af0105d-67bb-4e34-9320-874adea38efc","type":"Claim","title":"Neurons from different brain regions may show different properties pertinent to APP metabolism and susceptibility to Aβ.","label":"Muresan Z et al.; Neurons from different brain regions may...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","referenceYear":"2008","referenceDate":"2008","id":"urn:lsid:swan.org:researchstatement:3af0105d-67bb-4e34-9320-874adea38efc"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8233211d-ef23-456c-b8cf-e4806d782cc8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8233211d-ef23-456c-b8cf-e4806d782cc8","type":"Claim","title":"Conditioned media from V717F APP751 transfected cells completely blocked LTP whereas untransfected cell conditioned media had no effect.","label":"Walsh D et al.; Conditioned media from V717F APP751 tran...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Klyubin Igor","Fadeeva Julia V","Cullen William K","Anwyl Roger","Wolfe Michael S","Rowan Michael J","Selkoe Dennis J"],"firstAuthor":"Walsh Dominic M","referenceYear":"2002","referenceDate":"2002-04-04","id":"urn:lsid:swan.org:researchstatement:8233211d-ef23-456c-b8cf-e4806d782cc8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3ec961af-0f5f-4b94-856b-142e7058b076&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3ec961af-0f5f-4b94-856b-142e7058b076","type":"Claim","title":"In hippocampal slices from 26-35 day old mice LTP was significantly reduced by exposure of the hippocampal slices to 100 nM Tissue-transglutaminase-treated Aβ compared to ACSF or 100 nM Aβ receiving no Tissue-transglutaminase treatment.","label":"Hartley D et al.; In hippocampal slices from 26-35 day old...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:3ec961af-0f5f-4b94-856b-142e7058b076"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:eb11b5f6-b2f8-4137-9f0b-fba3c9136188&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:eb11b5f6-b2f8-4137-9f0b-fba3c9136188","type":"Claim","title":"In transgenic mice overexpressing familial Parkinson\u2019s Disease-linked mutant human alpha-synuclein, the development of Lewy body inclusions in some spinal motor neurons is not associated with alterations in the transport rates of slowly transported proteins, including alpha-synuclein, neurofilaments, and tubulin.","label":"Yuan A et al.; In transgenic mice overexpressing famili...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:eb11b5f6-b2f8-4137-9f0b-fba3c9136188"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cceeed3f-63dc-4c38-8724-d0f992636979&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cceeed3f-63dc-4c38-8724-d0f992636979","type":"Claim","title":"Previous studies have suggested that unlike soluble Aβ abundance, amyloid plaque burden correlates poorly with Alzheimer\u2019s disease severity.","label":"Shankar G et al.; Previous studies have suggested that unl...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Li Shaomin","Mehta Tapan H","Garcia-Munoz Amaya","Shepardson Nina E","Smith Imelda","Brett Francesca M","Farrell Michael A","Rowan Michael J","Lemere Cynthia A","Regan Ciaran M","Walsh Dominic M","Sabatini Bernardo L","Selkoe Dennis J"],"firstAuthor":"Shankar Ganesh M","referenceYear":"2008","referenceDate":"2008-08","id":"urn:lsid:swan.org:researchstatement:cceeed3f-63dc-4c38-8724-d0f992636979"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8d63df87-953b-4f4b-96d5-0b3e81404f49&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8d63df87-953b-4f4b-96d5-0b3e81404f49","type":"Claim","title":"Cells in the brain, such as vascular smooth muscle cells cultured from human autopsy tissue, degenerate over a several day period in the presence of Aβ42.","label":"Cotman C et al.; Cells in the brain, such as vascular smo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:8d63df87-953b-4f4b-96d5-0b3e81404f49"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9c764b02-0af9-443e-88b0-0eb942b4c15b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9c764b02-0af9-443e-88b0-0eb942b4c15b","type":"Claim","title":"Alzheimer's disease (AD) is characterized neuropathologically by neurofibrillary tangles (NFTs) formed by paired helical filaments (PHFs) from abnormally modified tau protein.","label":"Keck S et al.; Alzheimer's disease (AD) is characterize...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:9c764b02-0af9-443e-88b0-0eb942b4c15b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:76111f25-5398-4ff5-aa86-7aab0fa01b5c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:76111f25-5398-4ff5-aa86-7aab0fa01b5c","type":"Claim","title":"The highly conserved structure of TDP-43 resembles members of the heterogeneous ribonucleoprotein (hnRNP) RNA binding proteins, suggesting that TD)-43 proteins from human, mouse, worm and fly all share equivalent RNA and DNA recognition specificity.","label":"Warraich S et al.; The highly conserved structure of TDP-43...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Yang Shu","Nicholson Garth A","Blair Ian P"],"firstAuthor":"Warraich Sadaf T","referenceYear":"2010","referenceDate":"2010-06-25","id":"urn:lsid:swan.org:researchstatement:76111f25-5398-4ff5-aa86-7aab0fa01b5c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:5ac7e098-02f9-424a-b2e5-3045bb3e4120&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:5ac7e098-02f9-424a-b2e5-3045bb3e4120","type":"Question","title":"Which apoE-receptors play the most important role in local clearance of CNS apoE-containing lipoproteins?","label":"Which apoE-receptors play the most impor...","icon":"../icons/ontological/discourse-element/research-question.png","firstAuthor":"Holtzman David M","id":"urn:lsid:swan.org:researchquestion:5ac7e098-02f9-424a-b2e5-3045bb3e4120"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a02d93c2-8eac-4bcf-8c2b-ff6ad42bf88b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a02d93c2-8eac-4bcf-8c2b-ff6ad42bf88b","type":"Claim","title":"CAD cells are a useful model system for studying neuronal signaling pathways.","label":"Muresan Z et al.; CAD cells are a useful model system for ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","id":"urn:lsid:swan.org:researchstatement:a02d93c2-8eac-4bcf-8c2b-ff6ad42bf88b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d6b65259-52de-48c8-ae96-7052ee7a370d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d6b65259-52de-48c8-ae96-7052ee7a370d","type":"Claim","title":"Upon binding of its ligands (Delta or Jagged), the Notch receptor is cleaved at a second site (S2 cleavage) by a metalloprotease of the disintegrin and Metalloprotease (ADAM) family.","label":"Bentahir M et al.; Upon binding of its ligands (Delta or Ja...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:d6b65259-52de-48c8-ae96-7052ee7a370d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4e61e620-5ed7-43df-aabf-e4e488f45239&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4e61e620-5ed7-43df-aabf-e4e488f45239","type":"Hypothesis","title":"By using Down syndrome tissue the development of Alzheimer disease may be studied by examining the expression of ALZ-50 positive tau protein.","label":"Wolozin B et al.; By using Down syndrome tissue the develo...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Scicutella A","Davies P"],"firstAuthor":"Wolozin B","referenceYear":"1988","referenceDate":"1988-08","id":"urn:lsid:swan.org:researchstatement:4e61e620-5ed7-43df-aabf-e4e488f45239"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:48073151-077b-4b86-b9eb-bf8e073de864&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:48073151-077b-4b86-b9eb-bf8e073de864","type":"Claim","title":"In a biphasic view of Alzheimer disease progression biomarkers of Aβ deposition become abnormal early, before neurodegeneration and clinical symptoms occur followed by biomarkers of neuronal injury, dysfunction, and neurodegeneration becoming abnormal later in the disease.","label":"Jack C et al.; In a biphasic view of Alzheimer disease ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner Michael W","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:48073151-077b-4b86-b9eb-bf8e073de864"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c8201c90-c3e2-404e-8423-f2ea816db9e2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c8201c90-c3e2-404e-8423-f2ea816db9e2","type":"Claim","title":"Earliest Aβ 40 and 42 peptides accumulate within intracellular membranous compartments such as endosomes or lysosomes.","label":"Marchesi V; Earliest Aβ 40 and 42 peptides accumulat...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:c8201c90-c3e2-404e-8423-f2ea816db9e2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0eac8a10-09b5-4081-a9f1-530dff90450e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0eac8a10-09b5-4081-a9f1-530dff90450e","type":"Claim","title":"All known mutations in the PS genes result in a relative increase in the ratio of Ab42:Ab40 peptides.","label":"Bentahir M et al.; All known mutations in the PS genes resu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:0eac8a10-09b5-4081-a9f1-530dff90450e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:84ac0ed2-b389-49da-985b-d1f7ad19d9ec&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:84ac0ed2-b389-49da-985b-d1f7ad19d9ec","type":"Claim","title":"ADDLs evoke cell death even at 5 nM, and this high potency, coupled with diffusibility, makes ADDL toxicity especially pernicious.","label":"Lambert M et al.; ADDLs evoke cell death even at 5 nM, and...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:84ac0ed2-b389-49da-985b-d1f7ad19d9ec"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b4ca80cb-191d-4e77-95af-f7481c200663&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b4ca80cb-191d-4e77-95af-f7481c200663","type":"Claim","title":"In people with AD, insulin given through the intranasal route favorably alters the Aβ40/42 ratio and improves cognition.\n","label":"Hooper C et al.; In people with AD, insulin given through...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:b4ca80cb-191d-4e77-95af-f7481c200663"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c0117586-1356-45ec-9151-f2fec49d1a93&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c0117586-1356-45ec-9151-f2fec49d1a93","type":"Claim","title":"AD transgenic models suggest that reduced axonal transport rate occurs before plaque formation.","label":"Bartzokis G; AD transgenic models suggest that reduce...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:c0117586-1356-45ec-9151-f2fec49d1a93"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5ab549f8-21b7-4715-b98b-1a0b9464654d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5ab549f8-21b7-4715-b98b-1a0b9464654d","type":"Claim","title":"A frequent criticism of the amyloid hypothesis is that number of amyloid plaques does not correlate well with degree of cognitive impairment.","label":"Hardy J et al.; A frequent criticism of the amyloid hypo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:5ab549f8-21b7-4715-b98b-1a0b9464654d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2e07fd6b-370b-45d3-8e55-7a389afca0fb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2e07fd6b-370b-45d3-8e55-7a389afca0fb","type":"Claim","title":"Periods of chronic hypoxia led to the appearance of novel calcium-conducting channels in PC12 cells inhibited by Congo red or an antibody raised against the N-terminal region of Aβ.","label":"Smith I et al.; Periods of chronic hypoxia led to the ap...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:2e07fd6b-370b-45d3-8e55-7a389afca0fb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:715d7f18-7271-457a-9496-bb50f3cf1db0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:715d7f18-7271-457a-9496-bb50f3cf1db0","type":"Claim","title":"PiB staining increases with age and the presence of APOE ε4, such that 30% of cognitively normal adults aged 80 to 88 years have the PiB phenotype for AD.","label":"Morris J et al.; PiB staining increases with age and the ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Roe Catherine M","Grant Elizabeth A","Head Denise","Storandt Martha","Goate Alison M","Fagan Anne M","Holtzman David M","Mintun Mark A"],"firstAuthor":"Morris John C","referenceYear":"2009","referenceDate":"2009-12","id":"urn:lsid:swan.org:researchstatement:715d7f18-7271-457a-9496-bb50f3cf1db0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:c55b6358-ec31-4568-b165-dc41bc060e44&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:c55b6358-ec31-4568-b165-dc41bc060e44","type":"Comment","title":"Disruption in electrical activity and synaptic transmission precedes beta amyloid formation and cognitive deficits by months.  ","label":"Stutzmann G; Disruption in electrical activity and sy...","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Stutzmann Grace","id":"urn:lsid:swan.org:comment:c55b6358-ec31-4568-b165-dc41bc060e44"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6906e0db-666a-4730-9d51-5fb20148e3bb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6906e0db-666a-4730-9d51-5fb20148e3bb","type":"Claim","title":"Drugs that block non-NMDA glutamate receptors are in late-stage clinical trials (as neuroprotectants against stroke).","label":"Olney J et al.; Drugs that block non-NMDA glutamate rece...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:6906e0db-666a-4730-9d51-5fb20148e3bb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a2447929-368b-4f8b-893c-5bcd306b0952&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a2447929-368b-4f8b-893c-5bcd306b0952","type":"Claim","title":"The mammalian retromer sorting pathway, made up of multimeric coat complex, transports a transmembrane retromer-binding receptor and has been implicated in late-onset AD (LOAD). ","label":"Small S et al.; The mammalian retromer sorting pathway, ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:a2447929-368b-4f8b-893c-5bcd306b0952"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b6a062d3-b726-45f8-afd2-da6a29442352&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b6a062d3-b726-45f8-afd2-da6a29442352","type":"Claim","title":"Marchesi's hypothesis is based on the correlation of dimeric amyloid peptides in lipid rafts and the behavioral traits of APP transgenic mice.","label":"Dewachter I et al.; Marchesi's hypothesis is based on the co...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Van Leuven Fred"],"firstAuthor":"Dewachter Ilse","id":"urn:lsid:swan.org:researchstatement:b6a062d3-b726-45f8-afd2-da6a29442352"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a43fa4bd-8636-4f8c-9699-f9e7a04b21d5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a43fa4bd-8636-4f8c-9699-f9e7a04b21d5","type":"Claim","title":"Soluble cortex extracts prepared from individuals with frontotemporal dementia or dementia with Lewy bodies do not significantly alter LTP in mouse hippocampus.","label":"Shankar G et al.; Soluble cortex extracts prepared from in...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Li Shaomin","Mehta Tapan H","Garcia-Munoz Amaya","Shepardson Nina E","Smith Imelda","Brett Francesca M","Farrell Michael A","Rowan Michael J","Lemere Cynthia A","Regan Ciaran M","Walsh Dominic M","Sabatini Bernardo L","Selkoe Dennis J"],"firstAuthor":"Shankar Ganesh M","referenceYear":"2008","referenceDate":"2008-08","id":"urn:lsid:swan.org:researchstatement:a43fa4bd-8636-4f8c-9699-f9e7a04b21d5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a6e71fea-28bf-4328-8155-720cbedc6ac3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a6e71fea-28bf-4328-8155-720cbedc6ac3","type":"Claim","title":"ADDL toxicity required cell surface binding was indicated by the neuroprotective effect of cell surface tryptic peptides, which also acted as binding antagonists.","label":"Lambert M et al.; ADDL toxicity required cell surface bind...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:a6e71fea-28bf-4328-8155-720cbedc6ac3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:906382fd-aade-4826-b16a-b1303b3478d5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:906382fd-aade-4826-b16a-b1303b3478d5","type":"Claim","title":"If proteinopathy-induced inflammation drives senescence, and thereby induces neurodegeneration, therapeutic efforts designed to prevent the formation of or clear the proteinopathy may also potentially reveals new pathways that could be the focus of therapeutic efforts.","label":"Golde T et al.; If proteinopathy-induced inflammation dr...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:906382fd-aade-4826-b16a-b1303b3478d5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:df4e555e-bcc5-4dc9-a7da-1d5f0c57e1d0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:df4e555e-bcc5-4dc9-a7da-1d5f0c57e1d0","type":"Claim","title":"Genes such as CR1, CLU, and PICALM , that amplify the effect of Aβ dysmetabolism on the neurodegenerative cascade might shift the cognitive decline curve closer to the amyloid curve since Clusterin (apolipoprotein J) seems to regulate the toxicity and solubility of Aβ and might modify its clearance at the blood\u2013brain barrier; CR1 might also modify Aβ clearance and PICALM might be related to AD through a role in altering synaptic vesicle cycling or APP endocytosis.","label":"Jack C et al.; Genes such as CR1, CLU, and PICALM , tha...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:df4e555e-bcc5-4dc9-a7da-1d5f0c57e1d0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:286bf18c-91d5-489e-84a7-795cd07fb115&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:286bf18c-91d5-489e-84a7-795cd07fb115","type":"Claim","title":"Isolated PHF-tau was capable of impairing proteasome function even within a concentration range that has been considered '\u0080\u0098physiological'\u0099 in previous studies.","label":"Keck S et al.; Isolated PHF-tau was capable of impairin...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:286bf18c-91d5-489e-84a7-795cd07fb115"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:41bd4fcf-e7dc-49c9-acab-4614d4bb4de5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:41bd4fcf-e7dc-49c9-acab-4614d4bb4de5","type":"Claim","title":"Cytoplasmic mislocalization and aggregation of TDP-43 is the hallmark pathology of ALS and frontotemporal lobar degeneration with ubiquitin-positive inclusions and there is increasing evidence that this event is mechanistic in initiating neurodegeneration.","label":"Nishimura A et al.; Cytoplasmic mislocalization and aggregat...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zupunski Vera","Troakes Claire","Kathe Claudia","Fratta Pietro","Howell Michael","Gallo Jean-Marc","Hortobágyi Tibor","Shaw Christopher E","Rogelj Boris"],"firstAuthor":"Nishimura Agnes L","referenceYear":"2010","referenceDate":"2010-06","id":"urn:lsid:swan.org:researchstatement:41bd4fcf-e7dc-49c9-acab-4614d4bb4de5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:62982643-91d4-49dd-96e3-1335c8b0871c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:62982643-91d4-49dd-96e3-1335c8b0871c","type":"Claim","title":"Insulin regulates APP secretion via the PI3-kinase-dependent signaling pathway. ","label":"Craft S; Insulin regulates APP secretion via the ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft S","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:62982643-91d4-49dd-96e3-1335c8b0871c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c69dbb07-daa4-4604-8529-e36048c3a479&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c69dbb07-daa4-4604-8529-e36048c3a479","type":"Claim","title":"Dr. Marchesi's proposed feedback mechanism in which membrane-retained Aβ dimers might interact with PS1 and Aph-1 to destabilize the γ-secretase complex itself seems to lack molecular specificity.","label":"Selkoe D; Dr. Marchesi's proposed feedback mechani...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Selkoe Dennis J","id":"urn:lsid:swan.org:researchstatement:c69dbb07-daa4-4604-8529-e36048c3a479"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fa51f0f9-189b-4a02-8dc5-51a1d8e08829&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fa51f0f9-189b-4a02-8dc5-51a1d8e08829","type":"Claim","title":"Aβ peptides are the major constituents of Alzheimer Disease brain plaques.","label":"Plant L et al.; Aβ peptides are the major constituents o...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:fa51f0f9-189b-4a02-8dc5-51a1d8e08829"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b278845a-3d8b-4ea3-9775-324046a6921b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b278845a-3d8b-4ea3-9775-324046a6921b","type":"Claim","title":"TdT labeling in AD brain  occurred in distinct cells, not in clumped groups of cells as is observed in necrosis, where cell lysis and inflammation result in the involvement of clusters of nearby cells. TdT-labeled nuclei were not found in association with histological evidence suggestive of necrosis.","label":"Cotman C et al.; TdT labeling in AD brain  occurred in di...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:b278845a-3d8b-4ea3-9775-324046a6921b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a494f7e9-d7d7-4d95-affd-ac811cfc614e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a494f7e9-d7d7-4d95-affd-ac811cfc614e","type":"Claim","title":"The amyloid domain (Abeta) consists of a 39-43 amino acid peptide, derived from a region at the junction of the ecto- and transmembrane domains of APP.","label":"Suzuki T et al.; The amyloid domain (Abeta) consists of a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:a494f7e9-d7d7-4d95-affd-ac811cfc614e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:05e0fe8e-8046-4f9c-bbdc-cc877040d14d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:05e0fe8e-8046-4f9c-bbdc-cc877040d14d","type":"Claim","title":"Previous work in the SOD1 model for familial ALS did not reveal significant defects in anterograde transport until relatively late in disease, whereas live cell assays for vesicular transport that we have done on neurons from the SOD1 mouse do reveal significant changes in transport velocities.","label":"Holzbaur E; Previous work in the SOD1 model for fami...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holzbaur Erika L F","id":"urn:lsid:swan.org:researchstatement:05e0fe8e-8046-4f9c-bbdc-cc877040d14d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b9c3b835-2849-4b2f-ad45-d5ee43956b16&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b9c3b835-2849-4b2f-ad45-d5ee43956b16","type":"Claim","title":"Toxic gains of function by NFTs might play an important part in the progression of AD.","label":"Ballatore C et al.; Toxic gains of function by NFTs might pl...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Lee Virginia M-Y","Trojanowski John Q"],"firstAuthor":"Ballatore Carlo","referenceYear":"2007","referenceDate":"2007-09","id":"urn:lsid:swan.org:researchstatement:b9c3b835-2849-4b2f-ad45-d5ee43956b16"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4efdad69-aaf2-47df-9054-244771f9b2ce&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4efdad69-aaf2-47df-9054-244771f9b2ce","type":"Claim","title":"No correlations were found between anti-Aβ antibody titres at long-term follow-up and rate of decline as measured by ADAS-Cog; MMSE, or DAD at 6-year follow-up of AN1792-treated survivors at 5 or 6 years.","label":"Holmes C et al.; No correlations were found between anti-...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:4efdad69-aaf2-47df-9054-244771f9b2ce"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b2f6fca7-f885-482e-830a-d021e1da51db&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b2f6fca7-f885-482e-830a-d021e1da51db","type":"Claim","title":"Initiating Aβ aggregation could cause the incapacitation of NEP and IDE by allowing Aβ to aggregate before the monomer can be proteolytically degraded.","label":"Hartley D et al.; Initiating Aβ aggregation could cause th...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:b2f6fca7-f885-482e-830a-d021e1da51db"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6c8bf576-6038-463b-874d-81f75d0d757b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6c8bf576-6038-463b-874d-81f75d0d757b","type":"Claim","title":"In both aged APP/PS1 and Tg2576 transgenic mouse lines that develop senile plaques, but not their age-matched wildtype controls, a significant number of dendrites and axons exhibited [Ca2+]i overload.","label":"Kuchibhotla K et al.; In both aged APP/PS1 and Tg2576 transgen...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Goldman Samuel T","Lattarulo Carli R","Wu Hai-Yan","Hyman Bradley T","Bacskai Brian J"],"firstAuthor":"Kuchibhotla Kishore V","referenceYear":"2008","referenceDate":"2008-07-31","id":"urn:lsid:swan.org:researchstatement:6c8bf576-6038-463b-874d-81f75d0d757b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:581485a1-21c4-4322-8a2f-9120277e56f9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:581485a1-21c4-4322-8a2f-9120277e56f9","type":"Claim","title":"Hexamers and possibly pentamers of A&#946;42 may act as basic units that associate further to form larger assemblies.","label":"Bitan G et al.; Hexamers and possibly pentamers of A&#94...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:581485a1-21c4-4322-8a2f-9120277e56f9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:241a515f-9b91-456e-960d-3f8ea2d13547&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:241a515f-9b91-456e-960d-3f8ea2d13547","type":"Claim","title":"Aβ contains the necessary lysine and glutamine residues for Tissue-transglutaminase-catalyzed cross-linking and has previously been shown to be a substrate for Tissue-transglutaminase.","label":"Hartley D et al.; Aβ contains the necessary lysine and glu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:241a515f-9b91-456e-960d-3f8ea2d13547"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:49f9faae-2d7f-41bc-af7a-c0f24c52ee34&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:49f9faae-2d7f-41bc-af7a-c0f24c52ee34","type":"Claim","title":"Evidence supports the claim that ApoE influences Aβ deposition through clearance.","label":"Holtzman D; Evidence supports the claim that ApoE in...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman David M","id":"urn:lsid:swan.org:researchstatement:49f9faae-2d7f-41bc-af7a-c0f24c52ee34"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5dfc0e52-cef4-48d5-8775-b6cc9ae78e4d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5dfc0e52-cef4-48d5-8775-b6cc9ae78e4d","type":"Claim","title":"The mechanisms underlying paired pulse facilitation are thought to be presynaptic and probably involve residual calcium in the nerve terminal after the first stimulus, leading to increased neurotransmitter release during the second stimulus.","label":"Smith I et al.; The mechanisms underlying paired pulse f...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:5dfc0e52-cef4-48d5-8775-b6cc9ae78e4d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:41a26555-4f24-4d29-b5bf-bdf6f8217efa&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:41a26555-4f24-4d29-b5bf-bdf6f8217efa","type":"Claim","title":"Aβ peptides exist in neuronal membrane fragments as homodimers.","label":"Marchesi V; Aβ peptides exist in neuronal membrane f...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:41a26555-4f24-4d29-b5bf-bdf6f8217efa"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:dc6af532-348b-4aa1-96e8-85eaabb26031&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:dc6af532-348b-4aa1-96e8-85eaabb26031","type":"Claim","title":"The clinical phenotypes of primary progressive aphasia (PPA) and non-aphasic frontotemporal dementia (FTD) in cases with pathologic AD are only rarely associated with TDP-43 proteinopathy.","label":"Bigio E et al.; The clinical phenotypes of primary progr...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Mishra Manjari","Hatanpaa Kimmo J","White Charles L","Johnson Nancy","Rademaker Alfred","Weitner Bing Bing","Deng Han-Xiang","Dubner Steven D","Weintraub Sandra","Mesulam Marsel"],"firstAuthor":"Bigio Eileen H","referenceYear":"2010","referenceDate":"2010-07","id":"urn:lsid:swan.org:researchstatement:dc6af532-348b-4aa1-96e8-85eaabb26031"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f7875fd3-d6e9-48c2-b0fb-d9e6ce53ffb5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f7875fd3-d6e9-48c2-b0fb-d9e6ce53ffb5","type":"Claim","title":"Aβ inhibits α7nicotinic acetylcholine receptor-dependent calcium activation and acetylcholine release.","label":"Dziewczapolski G et al.; Aβ inhibits α7nicotinic acetylcholine re...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Glogowski Carolina M","Masliah Eliezer","Heinemann Stephen F"],"firstAuthor":"Dziewczapolski Gustavo","referenceYear":"2009","referenceDate":"2009-07-08","id":"urn:lsid:swan.org:researchstatement:f7875fd3-d6e9-48c2-b0fb-d9e6ce53ffb5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bc71086c-6ce5-4514-be9a-4860069ff77d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bc71086c-6ce5-4514-be9a-4860069ff77d","type":"Claim","title":"Neuronal activity modulates the formation and secretion of Aβ peptides in hippocampal slice neurons overexpressing APP, and increased production of Aβ leads to synaptic dysfunction in these mice.","label":"Smith I et al.; Neuronal activity modulates the formatio...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:bc71086c-6ce5-4514-be9a-4860069ff77d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2855cbc7-7a46-4d15-b22f-d1efab00fc63&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2855cbc7-7a46-4d15-b22f-d1efab00fc63","type":"Claim","title":"ADDL binding sites comprise particular domains of cell surface proteins and that these domains, when solubilized by trypsin, provide neuroprotective, ADDL-neutralizing activity.","label":"Lambert M et al.; ADDL binding sites comprise particular d...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:2855cbc7-7a46-4d15-b22f-d1efab00fc63"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cfd5ea21-7482-496c-9f2e-3dc6ed1230cf&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cfd5ea21-7482-496c-9f2e-3dc6ed1230cf","type":"Claim","title":"Plasticity has been demonstrated in a monosynaptic cortical pathway.","label":"Walsh D; Plasticity has been demonstrated in a mo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Walsh Dominic M","id":"urn:lsid:swan.org:researchstatement:cfd5ea21-7482-496c-9f2e-3dc6ed1230cf"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4b98d495-2d61-4fe4-8fb0-9c1657792327&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4b98d495-2d61-4fe4-8fb0-9c1657792327","type":"Hypothesis","title":"Cdk5/p25 is involved in the pathogenesis of cytoskeletal abnormalities and neuronal death in Alzheimer disease.","label":"Patrick G et al.; Cdk5/p25 is involved in the pathogenesis...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Zukerberg L","Nikolic M","de la Monte S","Dikkes P","Tsai L H"],"firstAuthor":"Patrick G N","referenceYear":"1999","referenceDate":"1999-12-09","id":"urn:lsid:swan.org:researchstatement:4b98d495-2d61-4fe4-8fb0-9c1657792327"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d91a7529-91a6-431d-91ee-ba7889fe239f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d91a7529-91a6-431d-91ee-ba7889fe239f","type":"Claim","title":"Tau aggregates can propagate a fibrillar, misfolded state from the outside to the inside of a cell.","label":"Frost B et al.; Tau aggregates can propagate a fibrillar...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Jacks Rachel L","Diamond Marc I"],"firstAuthor":"Frost Bess","referenceYear":"2009","referenceDate":"2009-05-08","id":"urn:lsid:swan.org:researchstatement:d91a7529-91a6-431d-91ee-ba7889fe239f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0fcd57c2-7b68-437d-afb0-0a966b77f573&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0fcd57c2-7b68-437d-afb0-0a966b77f573","type":"Claim","title":"Loss or alteration of dendritic spines is present early in Alzheimer Disease.","label":"Morse T et al.; Loss or alteration of dendritic spines i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Mutalik Pradeep","Cheung Kei","Miller Perry L","Shepherd Gordon"],"firstAuthor":"Morse Thomas M","id":"urn:lsid:swan.org:researchstatement:0fcd57c2-7b68-437d-afb0-0a966b77f573"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:04b2e6b8-b589-4acf-ab36-05590c5c8358&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:04b2e6b8-b589-4acf-ab36-05590c5c8358","type":"Claim","title":"The fact that APP transgenic mice that are Apoe-/- develop Aβ deposits in a different anatomical distribution suggests that apoE is involved in extracellular Aβ transport.","label":"Fryer J et al.; The fact that APP transgenic mice that a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:04b2e6b8-b589-4acf-ab36-05590c5c8358"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:72c9366b-9a39-4865-86cb-bfe83f94fab8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:72c9366b-9a39-4865-86cb-bfe83f94fab8","type":"Claim","title":"Besides RAGE, gp330/megalin has also been reported to transport circulating plasma Aβ back into the brain, in a complex with apoJ.","label":"Tanzi R et al.; Besides RAGE, gp330/megalin has also bee...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:72c9366b-9a39-4865-86cb-bfe83f94fab8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9eb5507d-7d56-4f65-ae86-39c158554e50&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9eb5507d-7d56-4f65-ae86-39c158554e50","type":"Claim","title":"The invariant accumulation of insoluble amyloid plaques in AD may signify that they serve as relatively inert reservoirs of small bioactive oligomers, and they may disassemble more readily in the presence of lipids.","label":"Shankar G et al.; The invariant accumulation of insoluble ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Li Shaomin","Mehta Tapan H","Garcia-Munoz Amaya","Shepardson Nina E","Smith Imelda","Brett Francesca M","Farrell Michael A","Rowan Michael J","Lemere Cynthia A","Regan Ciaran M","Walsh Dominic M","Sabatini Bernardo L","Selkoe Dennis J"],"firstAuthor":"Shankar Ganesh M","referenceYear":"2008","referenceDate":"2008-08","id":"urn:lsid:swan.org:researchstatement:9eb5507d-7d56-4f65-ae86-39c158554e50"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:431bd3f5-fd8c-48fd-8fd7-b111ce7052d8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:431bd3f5-fd8c-48fd-8fd7-b111ce7052d8","type":"Claim","title":"Neuritic plaques are relevant to AD.","label":"Muresan Z et al.; Neuritic plaques are relevant to AD.","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","referenceYear":"2008","referenceDate":"2008","id":"urn:lsid:swan.org:researchstatement:431bd3f5-fd8c-48fd-8fd7-b111ce7052d8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:be2a2b8b-261f-4e12-9c3a-5c8a3a2af524&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:be2a2b8b-261f-4e12-9c3a-5c8a3a2af524","type":"Claim","title":"Extracellular calcium may play a key role in Abeta-mediated cell death.","label":"Smith I et al.; Extracellular calcium may play a key rol...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:be2a2b8b-261f-4e12-9c3a-5c8a3a2af524"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8604e196-ef41-4f06-afaa-36d660ece5df&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8604e196-ef41-4f06-afaa-36d660ece5df","type":"Claim","title":"A recent finding strongly supports α7nAChR as a mediator of Aβ-induced pathology in AD by demonstrating that both α7nAChR agonists and antagonists can modulate Aβ1\u201342-induced tau phosphorylation, possibly by involving GSK-3beta.","label":"Dziewczapolski G et al.; A recent finding strongly supports α7nAC...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Glogowski Carolina M","Masliah Eliezer","Heinemann Stephen F"],"firstAuthor":"Dziewczapolski Gustavo","referenceYear":"2009","referenceDate":"2009-07-08","id":"urn:lsid:swan.org:researchstatement:8604e196-ef41-4f06-afaa-36d660ece5df"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ca6f8e86-a486-4acc-bff7-ddb003270592&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ca6f8e86-a486-4acc-bff7-ddb003270592","type":"Claim","title":"A pathological hallmark of Alzheimer\u2019s disease is an accumulation of insoluble plaque containing the Aβ peptide of 40\u201342 amino acid residues.","label":"Laurén J et al.; A pathological hallmark of Alzheimer\u2019s d...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Gimbel David A","Nygaard Haakon B","Gilbert John W","Strittmatter Stephen M"],"firstAuthor":"Laurén Juha","referenceYear":"2009","referenceDate":"2009-02-26","id":"urn:lsid:swan.org:researchstatement:ca6f8e86-a486-4acc-bff7-ddb003270592"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5ba2ffdc-5d7a-40b5-939a-8df118cf6799&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5ba2ffdc-5d7a-40b5-939a-8df118cf6799","type":"Claim","title":"Presenilin has been proposed to exist as a dimer in the γ-secretase catalytic core.","label":"Koo E; Presenilin has been proposed to exist as...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Koo Edward H","id":"urn:lsid:swan.org:researchstatement:5ba2ffdc-5d7a-40b5-939a-8df118cf6799"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2359986c-dad8-4018-9b07-0fcf570a3732&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2359986c-dad8-4018-9b07-0fcf570a3732","type":"Claim","title":"Molecules that regulate intracellular cholesterol and fatty acids will regulate ACAT activity.","label":"Molecules that regulate intracellular ch...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:2359986c-dad8-4018-9b07-0fcf570a3732"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:993d84e4-4a02-4713-8f44-c366059aa469&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:993d84e4-4a02-4713-8f44-c366059aa469","type":"Claim","title":"Chronic increase in intracellular ceramide inhibits axonal elongation and activates cell death.","label":"Chronic increase in intracellular cerami...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:993d84e4-4a02-4713-8f44-c366059aa469"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4471bc96-7a6c-483e-bff2-613f2aab2a93&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4471bc96-7a6c-483e-bff2-613f2aab2a93","type":"Claim","title":"Aβ concentrations required for in vitro self-aggregation far exceed physiological levels, even in the AD brain, which are in the low nM range.","label":"Hartley D et al.; Aβ concentrations required for in vitro ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:4471bc96-7a6c-483e-bff2-613f2aab2a93"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f51a2d39-eb3d-46fb-8c8d-86e623a70967&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f51a2d39-eb3d-46fb-8c8d-86e623a70967","type":"Claim","title":"γ-secretase inhibitor compounds might interfere with Notch signalling.","label":"Hardy J et al.; γ-secretase inhibitor compounds might in...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:f51a2d39-eb3d-46fb-8c8d-86e623a70967"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b5a62739-66a4-44f8-9464-7b95920a6306&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b5a62739-66a4-44f8-9464-7b95920a6306","type":"Hypothesis","title":"AMPA binding sites are reduced in Alzheimer disease.","label":"Dewar D et al.; AMPA binding sites are reduced in Alzhei...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Chalmers D T","Graham D I","McCulloch J"],"firstAuthor":"Dewar D","referenceYear":"1991","referenceDate":"1991-07-05","id":"urn:lsid:swan.org:researchstatement:b5a62739-66a4-44f8-9464-7b95920a6306"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c511ea8a-0f02-4df0-a967-f8787aafaa1a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c511ea8a-0f02-4df0-a967-f8787aafaa1a","type":"Claim","title":"Increased dendritic excitability can increase Ca2+ influx, which can, in early stages, influence synaptic physiology and later lead to excitotoxic effects first within the dendrites, and later on, in the entire neuron.","label":"Morse T et al.; Increased dendritic excitability can inc...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Mutalik Pradeep","Cheung Kei","Miller Perry L","Shepherd Gordon"],"firstAuthor":"Morse Thomas M","id":"urn:lsid:swan.org:researchstatement:c511ea8a-0f02-4df0-a967-f8787aafaa1a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:56ba2b8f-88b2-4673-9193-56cf10a2343f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:56ba2b8f-88b2-4673-9193-56cf10a2343f","type":"Claim","title":"Newly formed plaques were not penetrated by blood vessels, suggesting only a limited direct role of blood vessels in the formation of dense-core plaques.","label":"Meyer-Luehmann M et al.; Newly formed plaques were not penetrated...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:56ba2b8f-88b2-4673-9193-56cf10a2343f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:65882c2a-fabb-438f-8ab3-a477d5fed0c5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:65882c2a-fabb-438f-8ab3-a477d5fed0c5","type":"Question","title":"Why do Aβ oligomers not cause disease in familial AD patients early on in life, since they are presumably being generated continually?","label":"Why do Aβ oligomers not cause disease in...","icon":"../icons/ontological/discourse-element/research-question.png","firstAuthor":"Wolozin B","id":"urn:lsid:swan.org:researchquestion:65882c2a-fabb-438f-8ab3-a477d5fed0c5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2ff1f2e2-208f-46c2-b1b5-bc6d2e3de1ca&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2ff1f2e2-208f-46c2-b1b5-bc6d2e3de1ca","type":"Claim","title":"Caspase 3 inhibitors block cell body but not axonal degeneration (reflecting higher activation of caspase 3 in cell bodies compared to axons.","label":"Nikolaev A et al.; Caspase 3 inhibitors block cell body but...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["McLaughlin Todd","O'Leary Dennis D","Tessier-Lavigne Marc"],"firstAuthor":"Nikolaev Anatoly","referenceYear":"2009","referenceDate":"2009-02-19","id":"urn:lsid:swan.org:researchstatement:2ff1f2e2-208f-46c2-b1b5-bc6d2e3de1ca"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5f4779a7-a93d-419f-b86c-f07b3cdef439&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5f4779a7-a93d-419f-b86c-f07b3cdef439","type":"Claim","title":"Evidence from the only one of these studies that investigated axonal transport directly suggests that effects on transport in this case are more likely secondary to neurodegeneration than related to a primary effect of tau 4R on transport mechanisms.","label":"Nixon R; Evidence from the only one of these stud...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Nixon Ralph A","id":"urn:lsid:swan.org:researchstatement:5f4779a7-a93d-419f-b86c-f07b3cdef439"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d4efcad5-a4be-4082-9bfe-89130b5d8838&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d4efcad5-a4be-4082-9bfe-89130b5d8838","type":"Claim","title":"PS appear to form dimers within the γ-secretase complex, suggesting a possible allosteric mechanism that could allow for dominant-negative effects of PS mutations, as well as their capacity to enhance Aβ42 production while impairing other γ-secretase activities.","label":"Shen J et al.; PS appear to form dimers within the γ-se...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:d4efcad5-a4be-4082-9bfe-89130b5d8838"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2c9cfbfa-7cdd-4eac-a3bd-db79d7eafb7e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2c9cfbfa-7cdd-4eac-a3bd-db79d7eafb7e","type":"Claim","title":"Fluorodeoxyglucose (FDG)-PET studies in patients with AD, as an indicator of impaired synaptic function, show a specific topographic pattern of decreased glucose uptake in a lateral temporal-parietal and posterior cingulate, precuneus distribution.","label":"Jack C et al.; Fluorodeoxyglucose (FDG)-PET studies in ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:2c9cfbfa-7cdd-4eac-a3bd-db79d7eafb7e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:f9b77556-efa1-47f2-81e9-142bb4d9f78f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:f9b77556-efa1-47f2-81e9-142bb4d9f78f","type":"Comment","title":"Takashima on Yuan","label":"Takashima A; Takashima on Yuan","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Takashima Akihiko","referenceYear":"2008","referenceDate":"2008-02-04","id":"urn:lsid:swan.org:comment:f9b77556-efa1-47f2-81e9-142bb4d9f78f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5eb80ad6-3b09-4ac1-906a-02a9eadd12c4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5eb80ad6-3b09-4ac1-906a-02a9eadd12c4","type":"Claim","title":"The ApoE4 allele is a genetic risk factor for AD.","label":"Holtzman D; The ApoE4 allele is a genetic risk facto...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:5eb80ad6-3b09-4ac1-906a-02a9eadd12c4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:311cebe6-873f-49a6-bddf-c0e318c1e53d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:311cebe6-873f-49a6-bddf-c0e318c1e53d","type":"Claim","title":"Regardless of tau, the Hsp70- BAG2 complex is restrained from diffusing by a putative tether, probably a site on the microtubule.","label":"Carrettiero D et al.; Regardless of tau, the Hsp70- BAG2 compl...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hernandez Israel","Neveu Pierre","Papagiannakopoulos Thales","Kosik Kenneth S"],"firstAuthor":"Carrettiero Daniel C","referenceYear":"2009","referenceDate":"2009-02-18","id":"urn:lsid:swan.org:researchstatement:311cebe6-873f-49a6-bddf-c0e318c1e53d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:92f73b57-eca6-49b4-9814-19190c3bc701&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:92f73b57-eca6-49b4-9814-19190c3bc701","type":"Claim","title":"The behaviors of Aβ40 and Aβ42 in solution are qualitatively distinct even at the earliest stages of aggregation, in addition to the known distinctions with respect to fibril formation.","label":"Tycko R; The behaviors of Aβ40 and Aβ42 in soluti...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Tycko Robert","id":"urn:lsid:swan.org:researchstatement:92f73b57-eca6-49b4-9814-19190c3bc701"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5443668a-53af-4d75-b58e-56a321bbc7d2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5443668a-53af-4d75-b58e-56a321bbc7d2","type":"Claim","title":"Several steps in the processing of APP are subject to regulation by protein phosphorylation.","label":"Suzuki T et al.; Several steps in the processing of APP a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:5443668a-53af-4d75-b58e-56a321bbc7d2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:36c54172-0a7e-43fb-859d-d1bd1807e611&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:36c54172-0a7e-43fb-859d-d1bd1807e611","type":"Claim","title":"ADDLs block the reversal of LTD and formation of LTP, and may lead to synapse destabilization.","label":"Gong Y et al.; ADDLs block the reversal of LTD and form...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:36c54172-0a7e-43fb-859d-d1bd1807e611"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d0c5987c-3f39-4e64-aac6-63ae7ea6c874&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d0c5987c-3f39-4e64-aac6-63ae7ea6c874","type":"Claim","title":"Gab2 might function to protect cells from neuronal tangle formation and cell death and that a loss-of function GAB2 haplotype would diminish such protection. ","label":"Gab2 might function to protect cells fro...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:d0c5987c-3f39-4e64-aac6-63ae7ea6c874"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:53d94162-7c2f-4045-8d4b-e972641d703d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:53d94162-7c2f-4045-8d4b-e972641d703d","type":"Claim","title":"Studies have suggested that postmortem delay is less constrained by the time between death and actual tissue acquisition.","label":"Cotman C et al.; Studies have suggested that postmortem d...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:53d94162-7c2f-4045-8d4b-e972641d703d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bf040362-5358-4b53-a378-902d44143d3d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bf040362-5358-4b53-a378-902d44143d3d","type":"Claim","title":"Aβ peptides exist in neuronal membrane fragments, and the simplest interpretation of this finding is that APP dimers are cleaved by the secretases as dimers.","label":"Marchesi V; Aβ peptides exist in neuronal membrane f...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:bf040362-5358-4b53-a378-902d44143d3d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3830c8bf-afe6-4809-a107-34408d8a4c38&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3830c8bf-afe6-4809-a107-34408d8a4c38","type":"Claim","title":"Autopsy of AD brains demonstrates apoE4 dose-dependent increase in Aβ deposit density.","label":"Holtzman D; Autopsy of AD brains demonstrates apoE4 ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:3830c8bf-afe6-4809-a107-34408d8a4c38"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:45a2ef28-7305-48f1-8c00-f411afa4727f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:45a2ef28-7305-48f1-8c00-f411afa4727f","type":"Claim","title":"Kv4 &#945;-subunits interact with DPPX and aids trafficking and modulates properties of native A type currents.","label":"Plant L et al.; Kv4 &#945;-subunits interact with DPPX a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:45a2ef28-7305-48f1-8c00-f411afa4727f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:96a10865-c789-450a-8c70-56001f73aa40&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:96a10865-c789-450a-8c70-56001f73aa40","type":"Claim","title":"DR6 is an orphan receptor that triggers cell death in a Jun N-terminal kinase-dependent manner. ","label":"Nikolaev A et al.; DR6 is an orphan receptor that triggers ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["McLaughlin Todd","O'Leary Dennis D","Tessier-Lavigne Marc"],"firstAuthor":"Nikolaev Anatoly","referenceYear":"2009","referenceDate":"2009-02-19","id":"urn:lsid:swan.org:researchstatement:96a10865-c789-450a-8c70-56001f73aa40"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4c84130d-0513-489b-9da3-c4d14459449c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4c84130d-0513-489b-9da3-c4d14459449c","type":"Claim","title":"Aβ accelerates tau pathology in mice.","label":"Golde T; Aβ accelerates tau pathology in mice.","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde Todd E","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:4c84130d-0513-489b-9da3-c4d14459449c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cbe53922-6e14-47f9-b8c9-389d3b249916&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cbe53922-6e14-47f9-b8c9-389d3b249916","type":"Claim","title":"The 8c tau overexpressing mouse model is ideal to address the specific issue of tau overexpression effects on transport in the absence of tau hyperphosphorylation or brain pathology.","label":"Yuan A et al.; The 8c tau overexpressing mouse model is...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:cbe53922-6e14-47f9-b8c9-389d3b249916"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:45754d48-b50a-4ed3-a36b-d85a731002db&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:45754d48-b50a-4ed3-a36b-d85a731002db","type":"Claim","title":"Conditioned media of V717F APP751 transfected cells depleted of monomeric Aβ blocked LTP, suggesting that naturally secreted soluble human Aβ oligomers are specifically responsible for the block of hippocampal LTP.","label":"Walsh D et al.; Conditioned media of V717F APP751 transf...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Klyubin Igor","Fadeeva Julia V","Cullen William K","Anwyl Roger","Wolfe Michael S","Rowan Michael J","Selkoe Dennis J"],"firstAuthor":"Walsh Dominic M","referenceYear":"2002","referenceDate":"2002-04-04","id":"urn:lsid:swan.org:researchstatement:45754d48-b50a-4ed3-a36b-d85a731002db"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6d49d936-6d09-4a96-9ee5-10e7960f7235&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6d49d936-6d09-4a96-9ee5-10e7960f7235","type":"Claim","title":"Aβ has been shown to increase the susceptibility of neurons to excitotoxicity in both rodent and human neuronal cultures, observations that have been confirmed in the rodent brain.","label":"Cotman C et al.; Aβ has been shown to increase the suscep...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:6d49d936-6d09-4a96-9ee5-10e7960f7235"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:dfbe7f0c-cf1a-40d0-a8b4-b4cf1bd97a87&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:dfbe7f0c-cf1a-40d0-a8b4-b4cf1bd97a87","type":"Claim","title":"Intracellular determinants may confer the Aβ phenotype of CAD cells.","label":"Muresan Z et al.; Intracellular determinants may confer th...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","referenceYear":"2008","referenceDate":"2008","id":"urn:lsid:swan.org:researchstatement:dfbe7f0c-cf1a-40d0-a8b4-b4cf1bd97a87"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9ffb30f7-c36e-4bd5-9f28-5e09100ec63b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9ffb30f7-c36e-4bd5-9f28-5e09100ec63b","type":"Claim","title":"Modulation of THOP1 protein by Aβ peptides may constitute a compensatory response of neurons to Aβ challenge leading to increased Aβ degradation in a manner that is similar to compensatory mechanisms that have recently been proposed to explain the lack of neurodegeneration in transgenic mouse models of plaque deposition. ","label":"Pollio G et al.; Modulation of THOP1 protein by Aβ peptid...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hoozemans Jeroen J","Andersen Claus A","Roncarati Renza","Rosi Maria Cristina","van Haastert Elise S","Seredenina Tamara","Diamanti Daniela","Gotta Stefano","Fiorentini Anna","Magnoni Letizia","Raggiaschi Roberto","Rozemuller Annemieke J","Casamenti Fiorella","Caricasole Andrea","Terstappen Georg C"],"firstAuthor":"Pollio Giuseppe","referenceYear":"2008","referenceDate":"2008-07","id":"urn:lsid:swan.org:researchstatement:9ffb30f7-c36e-4bd5-9f28-5e09100ec63b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bcff95c6-2abf-4a21-801b-6a23dbc8ebfe&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bcff95c6-2abf-4a21-801b-6a23dbc8ebfe","type":"Claim","title":"It is possible that alpha-secretase cleavage of APP could be affected by phosphorylation of APP in G2/M phase cells.","label":"Suzuki T et al.; It is possible that alpha-secretase clea...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:bcff95c6-2abf-4a21-801b-6a23dbc8ebfe"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d754b2bc-498c-490b-9cc3-2e07a5e9a87a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d754b2bc-498c-490b-9cc3-2e07a5e9a87a","type":"Claim","title":"Synaptic transmission is impaired by Aβ-dependent endocytosis of NMDA receptors after α7nicotinic acetylcholine receptor stimulation.","label":"Dziewczapolski G et al.; Synaptic transmission is impaired by Aβ-...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Glogowski Carolina M","Masliah Eliezer","Heinemann Stephen F"],"firstAuthor":"Dziewczapolski Gustavo","referenceYear":"2009","referenceDate":"2009-07-08","id":"urn:lsid:swan.org:researchstatement:d754b2bc-498c-490b-9cc3-2e07a5e9a87a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1dea90dc-77dd-4a76-a605-34ff9feea7e8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1dea90dc-77dd-4a76-a605-34ff9feea7e8","type":"Claim","title":"Soluble Aβ oligomers have been implicated in age-dependent onset of memory failure in APP transgenic mice.","label":"Gong Y et al.; Soluble Aβ oligomers have been implicate...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:1dea90dc-77dd-4a76-a605-34ff9feea7e8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1ff8b97c-0f4f-497d-b8b5-d6a75ea4c0aa&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1ff8b97c-0f4f-497d-b8b5-d6a75ea4c0aa","type":"Claim","title":"Extracts of AD brain contained a prominent oligomer at approximately 56 kDa and pI 5.6 whereas control brain showed no immunoreactive material.","label":"Gong Y et al.; Extracts of AD brain contained a promine...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:1ff8b97c-0f4f-497d-b8b5-d6a75ea4c0aa"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a1fbf255-5635-46f2-8e6d-9ec2aaa0df14&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a1fbf255-5635-46f2-8e6d-9ec2aaa0df14","type":"Claim","title":"Amyloid toxicity is dissociated from cognitive impairment in AD patients.","label":"Hasegawa T; Amyloid toxicity is dissociated from cog...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Hasegawa Tohru","id":"urn:lsid:swan.org:researchstatement:a1fbf255-5635-46f2-8e6d-9ec2aaa0df14"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:86c764f7-486c-4855-aeaa-746dd1ca918a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:86c764f7-486c-4855-aeaa-746dd1ca918a","type":"Claim","title":"Anti-PrP antibodies prevent Aβ oligomer binding to cellular prion protein and rescue synaptic plasticity in hippocampal slices from oligomeric Aβ.","label":"Laurén J et al.; Anti-PrP antibodies prevent Aβ oligomer ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Gimbel David A","Nygaard Haakon B","Gilbert John W","Strittmatter Stephen M"],"firstAuthor":"Laurén Juha","referenceYear":"2009","referenceDate":"2009-02-26","id":"urn:lsid:swan.org:researchstatement:86c764f7-486c-4855-aeaa-746dd1ca918a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c7f0d590-42ab-48c0-b8ab-bb9ddfd073b5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c7f0d590-42ab-48c0-b8ab-bb9ddfd073b5","type":"Claim","title":"In AD patients who are rapidly declining clinically, MRI rates map well onto simultaneous cognitive deterioration, whereas neither rates of change in PiB staining nor CSF Aβ42 change significantly over time in patients with AD.","label":"Jack C et al.; In AD patients who are rapidly declining...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:c7f0d590-42ab-48c0-b8ab-bb9ddfd073b5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f84410b7-3700-45ea-8f47-6c88e661bf27&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f84410b7-3700-45ea-8f47-6c88e661bf27","type":"Claim","title":"Aβ is generated by the sequential cleavage of APP, a type I integral membrane protein anchored to the plasma membrane and internal membranes of the ER, Golgi and trans-Golgi apparatus.","label":"Smith I et al.; Aβ is generated by the sequential cleava...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:f84410b7-3700-45ea-8f47-6c88e661bf27"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4e3c44d4-6006-40c3-aaa7-29b0afcde49d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4e3c44d4-6006-40c3-aaa7-29b0afcde49d","type":"Claim","title":"Inhibitors of β- or γ-secretase currently under development are intended to lower both intracellular and cell-surface Aβ production.","label":"Selkoe D; Inhibitors of β- or γ-secretase currentl...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Selkoe Dennis J","id":"urn:lsid:swan.org:researchstatement:4e3c44d4-6006-40c3-aaa7-29b0afcde49d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d42bd506-f423-494f-a6c7-b05cbe9452cb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d42bd506-f423-494f-a6c7-b05cbe9452cb","type":"Claim","title":"Exogenous amyloid beta effect on K+ channels is likely due to increased formation of Kv channel subunits.","label":"Plant L et al.; Exogenous amyloid beta effect on K+ chan...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:d42bd506-f423-494f-a6c7-b05cbe9452cb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fa08c7e4-8bd4-4b89-a356-e2a5ab640fc3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fa08c7e4-8bd4-4b89-a356-e2a5ab640fc3","type":"Claim","title":"β-cleavage is the rate-limiting step for the generation of Aβ and probably induces a change in conformation or a shift of β-cleaved C terminal fragment of APP to allow γ-cleavage.","label":"β-cleavage is the rate-limiting step for...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:fa08c7e4-8bd4-4b89-a356-e2a5ab640fc3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ba198982-d4a6-4738-aca5-2eaa062dcb74&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ba198982-d4a6-4738-aca5-2eaa062dcb74","type":"Claim","title":"An imbalance of Aβ production and clearance results in the progression of AD.","label":"Hardy J et al.; An imbalance of Aβ production and cleara...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:ba198982-d4a6-4738-aca5-2eaa062dcb74"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:512a8d61-5a62-438c-bf23-27cd8aaaef79&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:512a8d61-5a62-438c-bf23-27cd8aaaef79","type":"Claim","title":"Insulin receptor substrate 1 (IRS1), which is a direct target of the IGF-1/ insulin receptor tyrosine kinase, was phosphorylated on tyr 1179 within 5 min of exposure to monomeric Aβ and increased phosphorylation on a serine residue (ser 302 in mice), which is required for an efficient insulin receptor signaling.","label":"Giuffrida M et al.; Insulin receptor substrate 1 (IRS1), whi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Caraci Filippo","Pignataro Bruno","Cataldo Sebastiano","De Bona Paolo","Bruno Valeria","Molinaro Gemma","Pappalardo Giuseppe","Messina Angela","Palmigiano Angelo","Garozzo Domenico","Nicoletti Ferdinando","Rizzarelli Enrico","Copani Agata"],"firstAuthor":"Giuffrida Maria Laura","referenceYear":"2009","referenceDate":"2009-08-26","id":"urn:lsid:swan.org:researchstatement:512a8d61-5a62-438c-bf23-27cd8aaaef79"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:359fa261-ccb4-4a4b-a866-09426fb7b345&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:359fa261-ccb4-4a4b-a866-09426fb7b345","type":"Claim","title":"Abnormal processing of APP to Aβ, or reduced clearance of Aβ from brain, results in the parenchymal aggregation of Aβ to form amyloid deposits which is an early and crucial event in the pathogenesis of the disease.","label":"Dodart J et al.; Abnormal processing of APP to Aβ, or red...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:359fa261-ccb4-4a4b-a866-09426fb7b345"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f461a9f8-8044-43f4-aab3-c0afe843fd3e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f461a9f8-8044-43f4-aab3-c0afe843fd3e","type":"Hypothesis","title":"Excitatory neurotransmitter receptor dysfunction contributes to symptomatology and excitotoxicity of Alzheimer Disease.","label":"Jansen K et al.; Excitatory neurotransmitter receptor dys...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Faull R L","Dragunow M","Synek B L"],"firstAuthor":"Jansen K L","referenceYear":"1990","referenceDate":"1990","id":"urn:lsid:swan.org:researchstatement:f461a9f8-8044-43f4-aab3-c0afe843fd3e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:3ef50cf8-7a82-479d-8f27-284fd771cca3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:3ef50cf8-7a82-479d-8f27-284fd771cca3","type":"Comment","title":"D Holtzman on Marchesi","label":"Holtzman D; D Holtzman on Marchesi","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Holtzman David M","referenceYear":"2005","referenceDate":"2005-10-05","id":"urn:lsid:swan.org:comment:3ef50cf8-7a82-479d-8f27-284fd771cca3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0cc264d9-9975-473a-9479-93bdba52cef3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0cc264d9-9975-473a-9479-93bdba52cef3","type":"Claim","title":"Intranasal insulin protects against brain atrophy in diabetic mouse model.","label":"Craft S; Intranasal insulin protects against brai...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft Suzanne","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:0cc264d9-9975-473a-9479-93bdba52cef3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f90a0133-6f2a-41d5-b1b1-d8ec72f46451&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f90a0133-6f2a-41d5-b1b1-d8ec72f46451","type":"Claim","title":"Aβ may activate the FAS/TNF apoptotic pathway.","label":"Cotman C; Aβ may activate the FAS/TNF apoptotic pa...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Cotman Carl W","id":"urn:lsid:swan.org:researchstatement:f90a0133-6f2a-41d5-b1b1-d8ec72f46451"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:8c4077d7-d3fb-402d-ac64-aeac1a2be880&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:8c4077d7-d3fb-402d-ac64-aeac1a2be880","type":"Comment","title":"Amyloid is the consequence, not the cause, of AD.","label":"Smith M et al.; Amyloid is the consequence, not the caus...","icon":"../icons/ontological/discourse-element/comment.png","otherAuthors":["Perry George","Castellani Rudolph J","Lee Hyoung-gon"],"firstAuthor":"Smith Mark A","id":"urn:lsid:swan.org:comment:8c4077d7-d3fb-402d-ac64-aeac1a2be880"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5a80beb6-5248-42da-9ea7-8841ee5d2a77&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5a80beb6-5248-42da-9ea7-8841ee5d2a77","type":"Claim","title":"In rhesus monkeys treated with a high dose of γ-secretase inhibitor (GSI) MK-0752 (240 mg/kg), levels of Aβ(1-14), Aβ(1-15), and Aβ(1-16) increased over vehicle levels, while levels of Aβ(1-17) decreased and these changes occurred concomitantly with an expected reduction in plasma Aβ40 and CSF Aβ40 and Aβ42, followed by peripheral but not central Aβ rebound effects.","label":"Cook J et al.; In rhesus monkeys treated with a high do...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wildsmith Kristin R","Gilberto David B","Holahan Marie A","Kinney Gene G","Mathers Parker D","Michener Maria S","Price Eric A","Shearman Mark S","Simon Adam J","Wang Jennifer X","Wu Guoxin","Yarasheski Kevin E","Bateman Randall J"],"firstAuthor":"Cook Jacquelynn J","referenceYear":"2010","referenceDate":"2010-05-12","id":"urn:lsid:swan.org:researchstatement:5a80beb6-5248-42da-9ea7-8841ee5d2a77"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:51cd1323-9a3b-40f6-b9fb-e59c650dbc5b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:51cd1323-9a3b-40f6-b9fb-e59c650dbc5b","type":"Claim","title":"Fast axonal transport of BACE1 and PS1 may be necessary to signal myelination repair, while adhesion processes of newly formed myelin onto axons and \u201crepair supply\u201d vesicles may depend partly on APP.","label":"Bartzokis G; Fast axonal transport of BACE1 and PS1 m...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:51cd1323-9a3b-40f6-b9fb-e59c650dbc5b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c20bcd7b-024a-450f-82ad-636feeaabfab&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c20bcd7b-024a-450f-82ad-636feeaabfab","type":"Claim","title":"PD-APP mice showed no significant increase in SIRT1 in the forebrain.","label":"Kim D et al.; PD-APP mice showed no significant increa...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:c20bcd7b-024a-450f-82ad-636feeaabfab"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d2bd6544-c2cc-4a4a-a4b5-2c448547806f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d2bd6544-c2cc-4a4a-a4b5-2c448547806f","type":"Claim","title":"In vivo studies with transgenic mouse models of AD demonstrate the effects of ApoE on AD and CAA-related neuropathology.","label":"Holtzman D; In vivo studies with transgenic mouse mo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:d2bd6544-c2cc-4a4a-a4b5-2c448547806f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:11bf81b4-03c8-4d22-8e5e-bcbb7fc1e50b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:11bf81b4-03c8-4d22-8e5e-bcbb7fc1e50b","type":"Claim","title":">50 kDa Aβ42  oligomers were toxic to mixed cultures of cortical cells (containing both neurons and astrocytes), but Aβ42  monomers were neuroprotective not only when combined with NMDA, but also when applied before or after the NMDA pulse, excluding a direct interaction between Aβ42 monomers and NMDA receptors.","label":"Giuffrida M et al.; >50 kDa Aβ42  oligomers were toxic to mi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Caraci Filippo","Pignataro Bruno","Cataldo Sebastiano","De Bona Paolo","Bruno Valeria","Molinaro Gemma","Pappalardo Giuseppe","Messina Angela","Palmigiano Angelo","Garozzo Domenico","Nicoletti Ferdinando","Rizzarelli Enrico","Copani Agata"],"firstAuthor":"Giuffrida Maria Laura","referenceYear":"2009","referenceDate":"2009-08-26","id":"urn:lsid:swan.org:researchstatement:11bf81b4-03c8-4d22-8e5e-bcbb7fc1e50b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2a528c55-2d9e-4ef7-aeb5-a45ced283465&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2a528c55-2d9e-4ef7-aeb5-a45ced283465","type":"Claim","title":"Enhanced APP phosphorylation at the G2/M phase has been confirmed using a phosphorylation-state specific antibody.","label":"Suzuki T; Enhanced APP phosphorylation at the G2/M...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Suzuki Toshiharu","id":"urn:lsid:swan.org:researchstatement:2a528c55-2d9e-4ef7-aeb5-a45ced283465"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:568136f6-80ef-48c4-8f72-77c863aa2aac&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:568136f6-80ef-48c4-8f72-77c863aa2aac","type":"Claim","title":"High levels of cdc2 kinase phosphorylation of APP<sup>645-694<\/sup> occurred in lysates from PC12 cells incubated with okadaic acid.","label":"Suzuki T et al.; High levels of cdc2 kinase phosphorylati...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:568136f6-80ef-48c4-8f72-77c863aa2aac"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ebefbea6-ca97-4351-a637-0c78f1cc8672&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ebefbea6-ca97-4351-a637-0c78f1cc8672","type":"Claim","title":"All eight AN1792 immunized participants had mild to moderate dementia at the start of the study; seven recipients, including the two with post-mortem evidence of almost complete Aβ plaque removal, had severe end stage dementia in the absence of any pre-terminal acute confusional state (MMSE score 0) at their last examination before death.","label":"Holmes C et al.; All eight AN1792 immunized participants ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:ebefbea6-ca97-4351-a637-0c78f1cc8672"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8e00b2c6-7915-4548-8590-45f4065f9534&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8e00b2c6-7915-4548-8590-45f4065f9534","type":"Claim","title":"In PS1 deficient fibroblasts stably expressing APP695Swe, PS1delta9, PS1-L166P and PS2-N141I demonstrated loss of function in Abeta40 production, whereas PS1-G384A and PS1-A246E effect was not statistically significant","label":"Bentahir M et al.; In PS1 deficient fibroblasts stably expr...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:8e00b2c6-7915-4548-8590-45f4065f9534"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3d3312b3-ffb7-46e2-999a-a8b99725c6c4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3d3312b3-ffb7-46e2-999a-a8b99725c6c4","type":"Claim","title":"In the course of aging and age-related neurodegenerative diseases, it is possible that select classes of molecules accumulate and can place neurons at risk through activation-induced cell death and other mechanisms.","label":"Cotman C et al.; In the course of aging and age-related n...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:3d3312b3-ffb7-46e2-999a-a8b99725c6c4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3432379f-86ee-4a58-a7b3-4eb5aec8912e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3432379f-86ee-4a58-a7b3-4eb5aec8912e","type":"Claim","title":"Active immunization with Aβ demonstrated that AD patients with robust titers showed clinical improvement.","label":"Golde T; Active immunization with Aβ demonstrated...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde T","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:3432379f-86ee-4a58-a7b3-4eb5aec8912e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8dda7d4f-d7b7-4e3e-b2c8-18fc5e944e27&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8dda7d4f-d7b7-4e3e-b2c8-18fc5e944e27","type":"Claim","title":"No endogenous proteasome activity could be detected in the tau protein isolated from either the control or AD brains.","label":"Keck S et al.; No endogenous proteasome activity could ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:8dda7d4f-d7b7-4e3e-b2c8-18fc5e944e27"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c5c6c776-612e-478a-820c-8ac9f29ac28b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c5c6c776-612e-478a-820c-8ac9f29ac28b","type":"Claim","title":"Various chemical compounds can separate the oligomerization and fibrillogenesis pathways.","label":"Hartley D et al.; Various chemical compounds can separate ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:c5c6c776-612e-478a-820c-8ac9f29ac28b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e48585f2-69c6-4e78-a9f3-3b034d4cf91a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e48585f2-69c6-4e78-a9f3-3b034d4cf91a","type":"Claim","title":"Brains of patients who died in late AD show the typical marked loss of cholinergic neurons, whereas the brains of patients who died in early AD do not show a detectable loss of cholinergic neurons, an observation that is consistent with the hypothesis that basal forebrain cholinergic neurons do not die until late in AD after they, together with certain glutamatergic neurons, have contributed to the excitotoxic demise of neurons throughout corticolimbic brain regions.","label":"Olney J et al.; Brains of patients who died in late AD s...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:e48585f2-69c6-4e78-a9f3-3b034d4cf91a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2c3005a3-c8ad-4b92-92c3-ff363482d1c3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2c3005a3-c8ad-4b92-92c3-ff363482d1c3","type":"Claim","title":"The development of dystrophic neurites in APP transgenic mice precedes plaques by more than a year.","label":"Kumar-Singh S; The development of dystrophic neurites i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Kumar-Singh Samir","id":"urn:lsid:swan.org:researchstatement:2c3005a3-c8ad-4b92-92c3-ff363482d1c3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1481d187-a1d8-422b-bfb3-8cd9a379e1d4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1481d187-a1d8-422b-bfb3-8cd9a379e1d4","type":"Claim","title":"APP processing clearly generates fragments other than Aβ, and may influence other biological activities of APP and neurons.","label":"Goldstein L; APP processing clearly generates fragmen...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Goldstein Lawrence S B","id":"urn:lsid:swan.org:researchstatement:1481d187-a1d8-422b-bfb3-8cd9a379e1d4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b9af9afe-028d-491d-bbf9-921b26e9b1d9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b9af9afe-028d-491d-bbf9-921b26e9b1d9","type":"Claim","title":"Tau hyperphosphorylation induced by okadaic acid, which inhibits protein phosphatase1 and 2A, almost completely blocked tau degradation in HT22 cells and in cell lysates to which purified proteasome was added, even though proteasome activity actually increased.","label":"Grune T; Tau hyperphosphorylation induced by okad...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Grune Tilman","id":"urn:lsid:swan.org:researchstatement:b9af9afe-028d-491d-bbf9-921b26e9b1d9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bf11d3e8-10be-484d-bfa5-9121bceac12a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bf11d3e8-10be-484d-bfa5-9121bceac12a","type":"Claim","title":"Although biomarkers of neurodegeneration correlate with clinical and pathological severity, they are not specific for AD and thus should not take precedence over Aβ biomarkers as inclusion criteria for patients in anti-amyloid therapeutic clinical trials, although an Aβ biomarker might be combined with MRI volumetrics to provide an indication of disease stage.","label":"Jack C et al.; Although biomarkers of neurodegeneration...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:bf11d3e8-10be-484d-bfa5-9121bceac12a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bd9bcb5a-f002-458b-a05e-be328e5ff353&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bd9bcb5a-f002-458b-a05e-be328e5ff353","type":"Claim","title":"γ-secretase inhibitors have demonstrated efficacy in animal models and are in Phase I human clinical trials.","label":"Golde T; γ-secretase inhibitors have demonstrated...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde T","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:bd9bcb5a-f002-458b-a05e-be328e5ff353"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d35e96d7-7f3c-43e2-ba64-a880dc476b13&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d35e96d7-7f3c-43e2-ba64-a880dc476b13","type":"Hypothesis","title":"Increased expression of the oligopeptidase THOP1 is a neuroprotective response to Aβ toxicity. ","label":"Pollio G et al.; Increased expression of the oligopeptida...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Hoozemans Jeroen J","Andersen Claus A","Roncarati Renza","Rosi Maria Cristina","van Haastert Elise S","Seredenina Tamara","Diamanti Daniela","Gotta Stefano","Fiorentini Anna","Magnoni Letizia","Raggiaschi Roberto","Rozemuller Annemieke J","Casamenti Fiorella","Caricasole Andrea","Terstappen Georg C"],"firstAuthor":"Pollio Giuseppe","referenceYear":"2008","referenceDate":"2008-07","id":"urn:lsid:swan.org:researchstatement:d35e96d7-7f3c-43e2-ba64-a880dc476b13"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:964a4875-0383-4b92-9ddf-3bf754775326&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:964a4875-0383-4b92-9ddf-3bf754775326","type":"Claim","title":"Apoptosis may not be restricted to neurons but may also occur in microglia and vascular smooth muscle cells in the brain.","label":"Cotman C et al.; Apoptosis may not be restricted to neuro...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:964a4875-0383-4b92-9ddf-3bf754775326"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:919e48fa-b728-4ff4-9a7d-8df8f7506777&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:919e48fa-b728-4ff4-9a7d-8df8f7506777","type":"Question","title":"Is permissive templating of Aβ and MAPT the reason for both the characteristic neuroanatomy of the disease as well as the reason that the disease seems to become self propagating once it has started?","label":"Is permissive templating of Aβ and MAPT ...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:919e48fa-b728-4ff4-9a7d-8df8f7506777"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:64f3437b-460d-4501-9ac9-511475a56b95&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:64f3437b-460d-4501-9ac9-511475a56b95","type":"Claim","title":"An effective peptide substrate for casein kinase II, DARPP95-107 has no effect on the phosphorylation of APP645-695 when present in a 10-fold molar excess.","label":"Suzuki T et al.; An effective peptide substrate for casei...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:64f3437b-460d-4501-9ac9-511475a56b95"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bbcf8001-3555-45bb-ba44-97f81f4cd9f2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bbcf8001-3555-45bb-ba44-97f81f4cd9f2","type":"Claim","title":"The human brain cholesterol content (approximately 25% of the total body\u2019s membrane cholesterol, 80% of which is in myelin) is synthesized almost exclusively de novo by glia (primarily oligodendrocytes and astrocytes) and peripheral cholesterol does not enter the brain.","label":"Bartzokis G; The human brain cholesterol content (app...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:bbcf8001-3555-45bb-ba44-97f81f4cd9f2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c1a29540-10fb-4d29-9cb0-db8474edd2e7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c1a29540-10fb-4d29-9cb0-db8474edd2e7","type":"Claim","title":"Insulin receptors and insulin-sensitive glucose transporters are distributed in the CNS, particularly in the hippocampus, entorhinal cortex and frontal cortex and on a cellular level, predominantly at synapses.  ","label":"Craft S; Insulin receptors and insulin-sensitive ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft Suzanne","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:c1a29540-10fb-4d29-9cb0-db8474edd2e7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c6c50a9d-3711-4bf8-998f-0c142c9f58db&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c6c50a9d-3711-4bf8-998f-0c142c9f58db","type":"Claim","title":"Conformational effects increase the likelihood that the Aβ42-43 peptide bond within the APP transmembrane domain interacts efficiently with the two catalytic aspartates of presenilin.","label":"Selkoe D; Conformational effects increase the like...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Selkoe Dennis J","id":"urn:lsid:swan.org:researchstatement:c6c50a9d-3711-4bf8-998f-0c142c9f58db"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c53c1e1d-7cff-45ea-8ffb-e984fbbd2a92&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c53c1e1d-7cff-45ea-8ffb-e984fbbd2a92","type":"Claim","title":"Oxidative stress, which almost invariably accompanies chronic inflammation, can also induce senescence.","label":"Golde T et al.; Oxidative stress, which almost invariabl...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:c53c1e1d-7cff-45ea-8ffb-e984fbbd2a92"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:84172fc3-9277-48b6-920c-cc46f0c1283a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:84172fc3-9277-48b6-920c-cc46f0c1283a","type":"Claim","title":"Immunization approaches that evade T cell response and favor B cell response are in development.","label":"Golde T; Immunization approaches that evade T cel...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde T","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:84172fc3-9277-48b6-920c-cc46f0c1283a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cb300e19-819f-4792-8baf-f14672e83b78&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cb300e19-819f-4792-8baf-f14672e83b78","type":"Claim","title":"BACE1 mRNA levels were significantly decreased in 18-month-old APP23/Ar+/-  mice compared with age-matched, APP23 male mice suggesting that the reduction of BACE1 mRNA abundance may contribute to the decreased BACE1 activity exhibited by APP23/Ar+/-  mice.","label":"McAllister C et al.; BACE1 mRNA levels were significantly dec...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Long Jiangang","Bowers Adrienne","Walker Aaron","Cao Philip","Honda Shin-Ichiro","Harada Nobuhiro","Staufenbiel Matthias","Shen Yong","Li Rena"],"firstAuthor":"McAllister Carrie","referenceYear":"2010","referenceDate":"2010-05-26","id":"urn:lsid:swan.org:researchstatement:cb300e19-819f-4792-8baf-f14672e83b78"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c0fa1c3e-5657-4e39-97eb-2ac65c1611a7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c0fa1c3e-5657-4e39-97eb-2ac65c1611a7","type":"Claim","title":"Soluble forms of Aβ can specifically bind and disrupt synapses.","label":"Hartley D et al.; Soluble forms of Aβ can specifically bin...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:c0fa1c3e-5657-4e39-97eb-2ac65c1611a7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d88192a5-90fb-4ddf-9555-10d94923002d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d88192a5-90fb-4ddf-9555-10d94923002d","type":"Claim","title":"A prodegenerative DR6 ligand(s) is present on the neuronal surface and inactive, but is shed into medium in an active form after trophic deprivation, allowing it to bind and activate DR6.","label":"Nikolaev A et al.; A prodegenerative DR6 ligand(s) is prese...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["McLaughlin Todd","O'Leary Dennis D","Tessier-Lavigne Marc"],"firstAuthor":"Nikolaev Anatoly","referenceYear":"2009","referenceDate":"2009-02-19","id":"urn:lsid:swan.org:researchstatement:d88192a5-90fb-4ddf-9555-10d94923002d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:96771abf-192e-4f2c-95b8-89e871482474&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:96771abf-192e-4f2c-95b8-89e871482474","type":"Claim","title":"Excitotoxic damage can, under some conditions, initiate apoptosis and excitotoxic damage may contribute to neurodegenerative diseases including AD.","label":"Cotman C et al.; Excitotoxic damage can, under some condi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:96771abf-192e-4f2c-95b8-89e871482474"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:63dd21a6-fbfb-4878-b04f-a99d92bfb69c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:63dd21a6-fbfb-4878-b04f-a99d92bfb69c","type":"Claim","title":"It is difficult to detect phosphorylation of APP biochemically in G2/M phase cells because the population is small in cultured non-neuronal cell lines. ","label":"Suzuki T; It is difficult to detect phosphorylatio...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Suzuki Toshiharu","id":"urn:lsid:swan.org:researchstatement:63dd21a6-fbfb-4878-b04f-a99d92bfb69c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:9465b195-7ba2-471e-bf99-2037314fddcf&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:9465b195-7ba2-471e-bf99-2037314fddcf","type":"Comment","title":"Ed Koo on Marchesi","label":"Koo E; Ed Koo on Marchesi","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Koo Edward H","referenceYear":"2005","referenceDate":"2005-09-02","id":"urn:lsid:swan.org:comment:9465b195-7ba2-471e-bf99-2037314fddcf"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:253f5da1-ac51-47d1-a45d-b5a4fcd949db&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:253f5da1-ac51-47d1-a45d-b5a4fcd949db","type":"Question","title":"A critical factor that remains to be determined is the specific pathway that amyloid-β activates to induce calcium influx.","label":"A critical factor that remains to be det...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:253f5da1-ac51-47d1-a45d-b5a4fcd949db"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ea2b77ca-258c-4cd2-8dd7-5b291e65aa5c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ea2b77ca-258c-4cd2-8dd7-5b291e65aa5c","type":"Hypothesis","title":"Aβ*56 hypothesis:  A specific amyloid-β protein assembly in the brain impairs memory.","label":"Lesné S et al.; Aβ*56 hypothesis:  A specific amyloid-β ...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Koh Ming Teng","Kotilinek Linda","Kayed Rakez","Glabe Charles G","Yang Austin","Gallagher Michela","Ashe Karen H"],"firstAuthor":"Lesné Sylvain","referenceYear":"2006","referenceDate":"2006-03-16","id":"urn:lsid:swan.org:researchstatement:ea2b77ca-258c-4cd2-8dd7-5b291e65aa5c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:43dbf1c4-877c-49e5-8ae4-33218a0661e9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:43dbf1c4-877c-49e5-8ae4-33218a0661e9","type":"Claim","title":"Aβ40 also can form oligomers, but these are not stable unless crosslinked.","label":"Lambert M et al.; Aβ40 also can form oligomers, but these ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:43dbf1c4-877c-49e5-8ae4-33218a0661e9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7c638fb6-52db-4b37-b39f-f8f909b9f235&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7c638fb6-52db-4b37-b39f-f8f909b9f235","type":"Claim","title":"Age-related accumulations of partially degraded or ubiquitinated 2\u2019,3\u2019-cyclic nucleotide phosphodiesterase (CNP) are suspected to contribute to age-related myelin disruption and subsequent axonal pathology.","label":"Bartzokis G; Age-related accumulations of partially d...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:7c638fb6-52db-4b37-b39f-f8f909b9f235"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c3235c50-d722-4934-84ef-f7dc56fbe417&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c3235c50-d722-4934-84ef-f7dc56fbe417","type":"Claim","title":"The prominent immunoreactive Aβ oligomer (ADDLs) in soluble AD brain extracts is identified as an Aβ 12-mer.","label":"Gong Y et al.; The prominent immunoreactive Aβ oligomer...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:c3235c50-d722-4934-84ef-f7dc56fbe417"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:95a2d863-dae7-4a97-b4ef-1a304a560857&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:95a2d863-dae7-4a97-b4ef-1a304a560857","type":"Claim","title":"Unilateral intracerebral injection of a lentiviral vector expressing human NEP in a transgenic mouse model of cerebral amyloidosis resulted in a remarkable 50% decrease in ipsilateral cortical amyloid deposits compared to the contralateral cortex, the first demonstration of a degradative effect by a peptidase on a preexisting Aβ-related pathological endpoint.","label":"Tanzi R et al.; Unilateral intracerebral injection of a ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:95a2d863-dae7-4a97-b4ef-1a304a560857"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:95d3d79f-2d27-4c82-9f59-6139e7505ffa&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:95d3d79f-2d27-4c82-9f59-6139e7505ffa","type":"Claim","title":"Partial inhibition of β- or &#947;-secretases to reduce Aβ production is in clinical development.","label":"Hardy J et al.; Partial inhibition of β- or &#947;-secre...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:95d3d79f-2d27-4c82-9f59-6139e7505ffa"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:eed460f3-f9f0-437a-8b49-f6139f8a9194&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:eed460f3-f9f0-437a-8b49-f6139f8a9194","type":"Claim","title":"GWAS analysis identified two loci associated at a genome-wide level of significance including the APOE locus on chromosome 19, CLU (which encodes clusterin) on chromosome 8, and PICALM on chromosome 11 with meta-analysis of combined datasets producing highly significant evidence of AD risk association.","label":"Harold D et al.; GWAS analysis identified two loci associ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Abraham Richard","Hollingworth Paul","Sims Rebecca","Gerrish Amy","Hamshere Marian L","Pahwa Jaspreet Singh","Moskvina Valentina","Dowzell Kimberley","Williams Amy","Jones Nicola","Thomas Charlene","Stretton Alexandra","Morgan Angharad R","Lovestone Simon","Powell John","Proitsi Petroula","Lupton Michelle K","Brayne Carol","Rubinsztein David C","Gill Michael","Lawlor Brian","Lynch Aoibhinn","Morgan Kevin","Brown Kristelle S","Passmore Peter A","Craig David","McGuinness Bernadette","Todd Stephen","Holmes Clive","Mann David","Smith A David","Love Seth","Kehoe Patrick G","Hardy John","Mead Simon","Fox Nick","Rossor Martin","Collinge John","Maier Wolfgang","Jessen Frank","Schürmann Britta","van den Bussche Hendrik","Heuser Isabella","Kornhuber Johannes","Wiltfang Jens","Dichgans Martin","Frölich Lutz","Hampel Harald","Hüll Michael","Rujescu Dan","Goate Alison M","Kauwe John S","Cruchaga Carlos","Nowotny Petra","Morris John C","Mayo Kevin","Sleegers Kristel","Bettens Karolien","Engelborghs Sebastiaan","De Deyn Peter P","Van Broeckhoven Christine","Livingston Gill","Bass Nicholas J","Gurling Hugh","McQuillin Andrew","Gwilliam Rhian","Deloukas Panagiotis","Al-Chalabi Ammar","Shaw Christopher E","Tsolaki Magda","Singleton Andrew B","Guerreiro Rita","Mühleisen Thomas W","Nöthen Markus M","Moebus Susanne","Jöckel Karl-Heinz","Klopp Norman","Wichmann H-Erich","Carrasquillo Minerva M","Pankratz V Shane","Younkin Steven G","Holmans Peter A","O'Donovan Michael","Owen Michael J","Williams Julie"],"firstAuthor":"Harold Denise","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:eed460f3-f9f0-437a-8b49-f6139f8a9194"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7960e02e-69e7-4fe1-a776-8dece9137ba3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7960e02e-69e7-4fe1-a776-8dece9137ba3","type":"Claim","title":"There are conflicting reports on tau levels in AD brain and soluble tau levels may be reduced 38\u201365% in affected brain regions such as frontal and temporal lobes.","label":"Yuan A et al.; There are conflicting reports on tau lev...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:7960e02e-69e7-4fe1-a776-8dece9137ba3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e117d204-9a00-491e-8ecd-02d74670898e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e117d204-9a00-491e-8ecd-02d74670898e","type":"Claim","title":"The Alzheimer pathologic process operates for many years before producing a clinically detectable impairment.","label":"Morris J et al.; The Alzheimer pathologic process operate...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Roe Catherine M","Grant Elizabeth A","Head Denise","Storandt Martha","Goate Alison M","Fagan Anne M","Holtzman David M","Mintun Mark A"],"firstAuthor":"Morris John C","referenceYear":"2009","referenceDate":"2009-12","id":"urn:lsid:swan.org:researchstatement:e117d204-9a00-491e-8ecd-02d74670898e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8ff91a89-5b03-43a4-8cfe-b083aa9a317a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8ff91a89-5b03-43a4-8cfe-b083aa9a317a","type":"Claim","title":"CREB signaling is inhibited by nondegenerative doses of Aβ under conditions that produce oligomers.","label":"Gong Y et al.; CREB signaling is inhibited by nondegene...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:8ff91a89-5b03-43a4-8cfe-b083aa9a317a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:17370b37-2197-4683-a73f-59f26cb6c581&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:17370b37-2197-4683-a73f-59f26cb6c581","type":"Claim","title":"Amyloid deposition has been postulated to cause neuronal alterations.","label":"Meyer-Luehmann M et al.; Amyloid deposition has been postulated t...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:17370b37-2197-4683-a73f-59f26cb6c581"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4f193992-363c-4f87-9fa8-2fa858f17cf3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4f193992-363c-4f87-9fa8-2fa858f17cf3","type":"Claim","title":"Fibrillar Aβ are neurotoxic in vitro.","label":"Walsh D et al.; Fibrillar Aβ are neurotoxic in vitro.","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Klyubin Igor","Fadeeva Julia V","Cullen William K","Anwyl Roger","Wolfe Michael S","Rowan Michael J","Selkoe Dennis J"],"firstAuthor":"Walsh Dominic M","referenceYear":"2002","referenceDate":"2002-04-04","id":"urn:lsid:swan.org:researchstatement:4f193992-363c-4f87-9fa8-2fa858f17cf3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:024f2b9a-88d2-4742-8706-f2a0a7841425&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:024f2b9a-88d2-4742-8706-f2a0a7841425","type":"Claim","title":"Expressing a human ApoE4 gene in APP transgenic mice increases Aβ deposition.","label":"Hardy J et al.; Expressing a human ApoE4 gene in APP tra...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","id":"urn:lsid:swan.org:researchstatement:024f2b9a-88d2-4742-8706-f2a0a7841425"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1669266d-be56-4cdb-bad1-3d36b1bf1416&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1669266d-be56-4cdb-bad1-3d36b1bf1416","type":"Claim","title":"Microglia surround senile plaques both in patients with Alzheimer\u2019s disease and transgenic mouse models.","label":"Meyer-Luehmann M et al.; Microglia surround senile plaques both i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:1669266d-be56-4cdb-bad1-3d36b1bf1416"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:819933ab-5521-4f86-b5b4-e5b1aab746d9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:819933ab-5521-4f86-b5b4-e5b1aab746d9","type":"Claim","title":"Synthetic preparations of monomeric or oligomeric Aβ were sufficient to drive primary cortical neurons in culture into an aberrant cell cycle. ","label":"Varvel N et al.; Synthetic preparations of monomeric or o...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bhaskar Kiran","Patil Anita R","Pimplikar Sanjay W","Herrup Karl","Lamb Bruce T"],"firstAuthor":"Varvel Nicholas H","referenceYear":"2008","referenceDate":"2008-10-22","id":"urn:lsid:swan.org:researchstatement:819933ab-5521-4f86-b5b4-e5b1aab746d9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:475d1667-334c-4902-9e0d-cffab748be87&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:475d1667-334c-4902-9e0d-cffab748be87","type":"Claim","title":"Transgenic mice demonstrate neurologic deficits prior to appearance of amyloid deposits.","label":"Bitan G et al.; Transgenic mice demonstrate neurologic d...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:475d1667-334c-4902-9e0d-cffab748be87"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8306608b-3a10-4e2a-b85e-bfd14f3e3a26&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8306608b-3a10-4e2a-b85e-bfd14f3e3a26","type":"Claim","title":"There is ample documentary evidence that amyloid constituents can be neurotoxic to varying degrees.","label":"Goldstein L; There is ample documentary evidence that...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Goldstein Lawrence S B","id":"urn:lsid:swan.org:researchstatement:8306608b-3a10-4e2a-b85e-bfd14f3e3a26"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d6efb0d0-deb3-4031-8df3-4287e08ad0ef&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d6efb0d0-deb3-4031-8df3-4287e08ad0ef","type":"Claim","title":"Peripheral insulin resistance increases brain amyloid burden in vivo in APP/PS1 transgenic mice.","label":"Craft S; Peripheral insulin resistance increases ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft Suzanne","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:d6efb0d0-deb3-4031-8df3-4287e08ad0ef"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:51664578-3c37-4bb4-bef1-fb773c913ce4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:51664578-3c37-4bb4-bef1-fb773c913ce4","type":"Claim","title":"Aβ oligomers are sufficient to induce cell cycle re-entry in neurons. ","label":"Varvel N et al.; Aβ oligomers are sufficient to induce ce...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bhaskar Kiran","Patil Anita R","Pimplikar Sanjay W","Herrup Karl","Lamb Bruce T"],"firstAuthor":"Varvel Nicholas H","referenceYear":"2008","referenceDate":"2008-10-22","id":"urn:lsid:swan.org:researchstatement:51664578-3c37-4bb4-bef1-fb773c913ce4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ef3f4c7e-b765-476b-8a17-07e4e3a04f07&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ef3f4c7e-b765-476b-8a17-07e4e3a04f07","type":"Claim","title":"Preliminary data suggest that much of the intracellular Aβ appears to be oligomeric.","label":"Smith I et al.; Preliminary data suggest that much of th...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:ef3f4c7e-b765-476b-8a17-07e4e3a04f07"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c6bc5082-8282-4bdd-940a-61c446eb3122&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c6bc5082-8282-4bdd-940a-61c446eb3122","type":"Claim","title":"Neurofibrillary tangles of tau are likely to occur after changes in Aβ generation, Aβ oligomerization and initial plaque formation, not before these changes occur.","label":"Hardy J et al.; Neurofibrillary tangles of tau are likel...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:c6bc5082-8282-4bdd-940a-61c446eb3122"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d0cc3315-737a-4395-a54c-de8ddbd3db86&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d0cc3315-737a-4395-a54c-de8ddbd3db86","type":"Claim","title":"Whether or not axonal transport is impaired depends not only on expression levels, as our Tau-4R mice expressed only about twofold over endogenous mouse tau, and we did not observe aggregates of tau.","label":"Van Leuven F; Whether or not axonal transport is impai...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Van Leuven Fred","id":"urn:lsid:swan.org:researchstatement:d0cc3315-737a-4395-a54c-de8ddbd3db86"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:54bc1148-699b-4db9-8eba-3a3f0135c93e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:54bc1148-699b-4db9-8eba-3a3f0135c93e","type":"Claim","title":"The formation of unique intermediates may be key to the clinical consequences of elevated Aβ42.","label":"Bitan G et al.; The formation of unique intermediates ma...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:54bc1148-699b-4db9-8eba-3a3f0135c93e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:24769bba-d960-44a8-b6bc-0f1deff7ddf2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:24769bba-d960-44a8-b6bc-0f1deff7ddf2","type":"Claim","title":"Genetic studies indicate that aging effects can be overcome: for example, when polyglutamine expansion is large enough, Huntington\u2019s disease can occur in children, indicating that the same neurodegenerative disease can be driven in a relatively young person by a genetic alteration that accelerates the induction of the proteinopathy.","label":"Golde T et al.; Genetic studies indicate that aging effe...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:24769bba-d960-44a8-b6bc-0f1deff7ddf2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f15c5e13-5272-43b9-a5fa-de9e895ca107&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f15c5e13-5272-43b9-a5fa-de9e895ca107","type":"Claim","title":"Even senescence-associated heterochromatic foci are typically only seen in human cells and have been much more difficult to demonstrate in mouse cells.","label":"Golde T et al.; Even senescence-associated heterochromat...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:f15c5e13-5272-43b9-a5fa-de9e895ca107"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1744d89d-c651-4fd6-857f-96eaba111fd7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1744d89d-c651-4fd6-857f-96eaba111fd7","type":"Claim","title":"Tau distribution pattern was not significantly affected along optic axons in tau overexpressing mice.","label":"Yuan A et al.; Tau distribution pattern was not signifi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:1744d89d-c651-4fd6-857f-96eaba111fd7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:00c43b1f-5f19-42b7-8951-731457d2d08b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:00c43b1f-5f19-42b7-8951-731457d2d08b","type":"Claim","title":"Activation-induced programmed cell death (PCD) in T lymphocytes occurs when bacterial superantigen binds to a major histocompatibility complex class II antigen, thus forming a complex that activates T cells and initiates apoptosis when it crosslinks the T cell receptors.","label":"Cotman C et al.; Activation-induced programmed cell death...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:00c43b1f-5f19-42b7-8951-731457d2d08b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7f12629c-06ff-4c30-8479-bd1a80ebfc61&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7f12629c-06ff-4c30-8479-bd1a80ebfc61","type":"Claim","title":"The 8c mice that overexpress human tau isoforms do not develop neurofibrillary tau pathology, in contrast to T44 transgenic mice that perturb the 3R-to-4R tau ratio.","label":"Lee V et al.; The 8c mice that overexpress human tau i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Trojanowski John Q"],"firstAuthor":"Lee Virginia M-Y","id":"urn:lsid:swan.org:researchstatement:7f12629c-06ff-4c30-8479-bd1a80ebfc61"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ca7169f1-ff7d-456c-b3f3-c52bec1e8074&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ca7169f1-ff7d-456c-b3f3-c52bec1e8074","type":"Hypothesis","title":"CAD cells are a useful model for studies of APP cell biology and Alzheimers disease pathology, including Aβ accumulation within neurites.","label":"Muresan Z et al.; CAD cells are a useful model for studies...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","id":"urn:lsid:swan.org:researchstatement:ca7169f1-ff7d-456c-b3f3-c52bec1e8074"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6269d606-1ceb-47ee-bc08-8467374c310f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6269d606-1ceb-47ee-bc08-8467374c310f","type":"Claim","title":"Amyloid accumulation is not an obligatory feature of dementia or neurodegeneration because neurodegenerative dementias lacking amyloid pathology (e.g., FTD) have been well described.","label":"Shen J et al.; Amyloid accumulation is not an obligator...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:6269d606-1ceb-47ee-bc08-8467374c310f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3064a62f-fc2b-437e-bf02-db6b5463477d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3064a62f-fc2b-437e-bf02-db6b5463477d","type":"Claim","title":"Transgenic mice that demonstrate progressive Aβ deposition often do not suffer neuronal loss.","label":"Hardy J et al.; Transgenic mice that demonstrate progres...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:3064a62f-fc2b-437e-bf02-db6b5463477d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2d734ed1-71f4-47ae-98f9-4a81e255c360&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2d734ed1-71f4-47ae-98f9-4a81e255c360","type":"Claim","title":"By 12 months of age, soluble α-syn phosphorylated at serine 129 (pS129) levels are significantly elevated in DLB-AD mice and insoluble α-syn is also detected compared with age-matched M83-h and 3xTg-AD mice. Importantly, only 12-month-old DLB-AD mice exhibit high-molecular- weight soluble α-syn species and accumulate detergent-insoluble α-syn, suggests that Lewy body-like pathology begins to manifest in 12- month-old DLB-AD mice, long before it appears in M83-h single transgenic α-synA53T mice.","label":"Clinton L et al.; By 12 months of age, soluble α-syn phosp...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Blurton-Jones Mathew","Myczek Kristoffer","Trojanowski John Q","LaFerla Frank M"],"firstAuthor":"Clinton Lani K","referenceYear":"2010","referenceDate":"2010-05-26","id":"urn:lsid:swan.org:researchstatement:2d734ed1-71f4-47ae-98f9-4a81e255c360"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e0c0b888-1584-4362-a3e8-d5db239af309&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e0c0b888-1584-4362-a3e8-d5db239af309","type":"Claim","title":"Four different well characterized substrates of γ-secretase include syndecan 3, N-cadherin, Notch deltaE and APP.","label":"Bentahir M et al.; Four different well characterized substr...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:e0c0b888-1584-4362-a3e8-d5db239af309"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:18949452-c7e2-4cbb-b3ef-2b1311412c23&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:18949452-c7e2-4cbb-b3ef-2b1311412c23","type":"Claim","title":"Although initial investigations of FAD-linked PS mutations in mammalian systems focused on enhancement of Aβ42 production, it has now become clear that a large number of pathogenic mutations cause impairments in other PS activities.","label":"Shen J et al.; Although initial investigations of FAD-l...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:18949452-c7e2-4cbb-b3ef-2b1311412c23"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d6381279-26dd-4db8-a2cc-24fe38d84168&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d6381279-26dd-4db8-a2cc-24fe38d84168","type":"Claim","title":"The neuronal processes with the most pronounced calcium overload in APP mice exhibited neuritic blebbing and beading\u2014a hallmark of neuronal degeneration that is nearly identical to those found by classical histopathological methods in AD.","label":"Kuchibhotla K et al.; The neuronal processes with the most pro...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Goldman Samuel T","Lattarulo Carli R","Wu Hai-Yan","Hyman Bradley T","Bacskai Brian J"],"firstAuthor":"Kuchibhotla Kishore V","referenceYear":"2008","referenceDate":"2008-07-31","id":"urn:lsid:swan.org:researchstatement:d6381279-26dd-4db8-a2cc-24fe38d84168"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8e69430d-8a32-4ab0-9c82-be338cdd8252&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8e69430d-8a32-4ab0-9c82-be338cdd8252","type":"Claim","title":"Exposure of neurons to Aβ increases GSK3β activity through the inhibition of phosphatidylinositol 3-kinase (PI3K) signalling and blockade of either GSK3β expression or activity prevents Aβ-induced neurodegeneration.","label":"Hooper C et al.; Exposure of neurons to Aβ increases GSK3...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:8e69430d-8a32-4ab0-9c82-be338cdd8252"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4fd1a3a2-e366-423d-904c-b61f58f9f1ff&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4fd1a3a2-e366-423d-904c-b61f58f9f1ff","type":"Claim","title":"GSK3 also phosphorylates and inhibits cAMP responsive element-binding protein, a universal modulator of memory.","label":"Hooper C et al.; GSK3 also phosphorylates and inhibits cA...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:4fd1a3a2-e366-423d-904c-b61f58f9f1ff"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4aee2986-1ae0-48f6-989d-1f8d484276c6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4aee2986-1ae0-48f6-989d-1f8d484276c6","type":"Claim","title":"Human brain levels of soluble Aβ oligomers are greatly elevated in AD.","label":"Gong Y et al.; Human brain levels of soluble Aβ oligome...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:4aee2986-1ae0-48f6-989d-1f8d484276c6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7102cc90-05cc-4450-b28d-c05415e1f916&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7102cc90-05cc-4450-b28d-c05415e1f916","type":"Claim","title":"Biomarkers indicate specific changes in AD that do not reach abnormal levels or peak simultaneously but do so in an ordered manner and can be measured and correlated to clinical symptoms in longitudinal observational studies.","label":"Jack C et al.; Biomarkers indicate specific changes in ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:7102cc90-05cc-4450-b28d-c05415e1f916"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:dfe0827b-4c72-4dd4-978a-ca13fbaa079f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:dfe0827b-4c72-4dd4-978a-ca13fbaa079f","type":"Claim","title":"Levels of soluble Aβ correlate best with the clinical Alzheimer\u2019s disease state.","label":"Shankar G et al.; Levels of soluble Aβ correlate best with...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Li Shaomin","Mehta Tapan H","Garcia-Munoz Amaya","Shepardson Nina E","Smith Imelda","Brett Francesca M","Farrell Michael A","Rowan Michael J","Lemere Cynthia A","Regan Ciaran M","Walsh Dominic M","Sabatini Bernardo L","Selkoe Dennis J"],"firstAuthor":"Shankar Ganesh M","referenceYear":"2008","referenceDate":"2008-08","id":"urn:lsid:swan.org:researchstatement:dfe0827b-4c72-4dd4-978a-ca13fbaa079f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f3bf4f15-fc6a-406e-ab79-9902fa996499&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f3bf4f15-fc6a-406e-ab79-9902fa996499","type":"Claim","title":"PS clinical mutations induce loss of function in Notch S3 cleavage, consistent with previous reports.","label":"Bentahir M et al.; PS clinical mutations induce loss of fun...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:f3bf4f15-fc6a-406e-ab79-9902fa996499"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b11981c9-0e42-4c2d-8704-cb6c50ed41f8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b11981c9-0e42-4c2d-8704-cb6c50ed41f8","type":"Claim","title":"Mitochondria may undergo autophagocytosis in CAD cells affected by Aβ accumulation.","label":"Muresan Z et al.; Mitochondria may undergo autophagocytosi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","referenceYear":"2008","referenceDate":"2008","id":"urn:lsid:swan.org:researchstatement:b11981c9-0e42-4c2d-8704-cb6c50ed41f8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9eebb1a5-ab21-4646-985f-9c780e1937cb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9eebb1a5-ab21-4646-985f-9c780e1937cb","type":"Claim","title":"Clusterin, like APOE, has been shown to cooperate in suppressing Aβ deposition, and both clusterin and APOE may modify Aβ clearance at the blood-brain barrier, which could suggest a role for clusterin in the amyloidogenic pathway, regulating both the toxicity of Aβ and its conversion into insoluble forms.","label":"Harold D et al.; Clusterin, like APOE, has been shown to ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Abraham Richard","Hollingworth Paul","Sims Rebecca","Gerrish Amy","Hamshere Marian L","Pahwa Jaspreet Singh","Moskvina Valentina","Dowzell Kimberley","Williams Amy","Jones Nicola","Thomas Charlene","Stretton Alexandra","Morgan Angharad R","Lovestone Simon","Powell John","Proitsi Petroula","Lupton Michelle K","Brayne Carol","Rubinsztein David C","Gill Michael","Lawlor Brian","Lynch Aoibhinn","Morgan Kevin","Brown Kristelle S","Passmore Peter A","Craig David","McGuinness Bernadette","Todd Stephen","Holmes Clive","Mann David","Smith A David","Love Seth","Kehoe Patrick G","Hardy John","Mead Simon","Fox Nick","Rossor Martin","Collinge John","Maier Wolfgang","Jessen Frank","Schürmann Britta","van den Bussche Hendrik","Heuser Isabella","Kornhuber Johannes","Wiltfang Jens","Dichgans Martin","Frölich Lutz","Hampel Harald","Hüll Michael","Rujescu Dan","Goate Alison M","Kauwe John S","Cruchaga Carlos","Nowotny Petra","Morris John C","Mayo Kevin","Sleegers Kristel","Bettens Karolien","Engelborghs Sebastiaan","De Deyn Peter P","Van Broeckhoven Christine","Livingston Gill","Bass Nicholas J","Gurling Hugh","McQuillin Andrew","Gwilliam Rhian","Deloukas Panagiotis","Al-Chalabi Ammar","Shaw Christopher E","Tsolaki Magda","Singleton Andrew B","Guerreiro Rita","Mühleisen Thomas W","Nöthen Markus M","Moebus Susanne","Jöckel Karl-Heinz","Klopp Norman","Wichmann H-Erich","Carrasquillo Minerva M","Pankratz V Shane","Younkin Steven G","Holmans Peter A","O'Donovan Michael","Owen Michael J","Williams Julie"],"firstAuthor":"Harold Denise","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:9eebb1a5-ab21-4646-985f-9c780e1937cb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4ad917e2-9503-418f-b9f0-9081a84df284&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4ad917e2-9503-418f-b9f0-9081a84df284","type":"Claim","title":"The nature of the pathogenic Aβ species in the human Alzheimer Disease brain and direct demonstration of its neurobiological effects are unresolved.","label":"Shankar G et al.; The nature of the pathogenic Aβ species ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Li Shaomin","Mehta Tapan H","Garcia-Munoz Amaya","Shepardson Nina E","Smith Imelda","Brett Francesca M","Farrell Michael A","Rowan Michael J","Lemere Cynthia A","Regan Ciaran M","Walsh Dominic M","Sabatini Bernardo L","Selkoe Dennis J"],"firstAuthor":"Shankar Ganesh M","referenceYear":"2008","referenceDate":"2008-08","id":"urn:lsid:swan.org:researchstatement:4ad917e2-9503-418f-b9f0-9081a84df284"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0d0f8d53-ed1e-436e-9115-38f91bf78e73&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0d0f8d53-ed1e-436e-9115-38f91bf78e73","type":"Claim","title":"Reuse","label":"Bartzokis G; Reuse","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:0d0f8d53-ed1e-436e-9115-38f91bf78e73"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:abb28302-a28b-4c3d-9f87-f78cdbe56bd2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:abb28302-a28b-4c3d-9f87-f78cdbe56bd2","type":"Claim","title":"ApoE may act at the nucleation step to inhibit \u201cseeding\u201d of Aβ aggregation.","label":"Holtzman D; ApoE may act at the nucleation step to i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:abb28302-a28b-4c3d-9f87-f78cdbe56bd2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:43818b03-1669-4b99-8195-f55b32f972d9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:43818b03-1669-4b99-8195-f55b32f972d9","type":"Hypothesis","title":"The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer Disease.","label":"Rogaeva E et al.; The neuronal sortilin-related receptor S...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Meng Yan","Lee Joseph H","Gu Yongjun","Kawarai Toshitaka","Zou Fanggeng","Katayama Taiichi","Baldwin Clinton T","Cheng Rong","Hasegawa Hiroshi","Chen Fusheng","Shibata Nobuto","Lunetta Kathryn L","Pardossi-Piquard Raphaelle","Bohm Christopher","Wakutani Yosuke","Cupples L Adrienne","Cuenco Karen T","Green Robert C","Pinessi Lorenzo","Rainero Innocenzo","Sorbi Sandro","Bruni Amalia","Duara Ranjan","Friedland Robert P","Inzelberg Rivka","Hampe Wolfgang","Bujo Hideaki","Song You-Qiang","Andersen Olav M","Willnow Thomas E","Graff-Radford Neill","Petersen Ronald C","Dickson Dennis","Der Sandy D","Fraser Paul E","Schmitt-Ulms Gerold","Younkin Steven","Mayeux Richard","Farrer Lindsay A","St George-Hyslop Peter"],"firstAuthor":"Rogaeva Ekaterina","referenceYear":"2007","referenceDate":"2007-02","id":"urn:lsid:swan.org:researchstatement:43818b03-1669-4b99-8195-f55b32f972d9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3638dec3-be58-44fe-9118-872d91ff2d20&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3638dec3-be58-44fe-9118-872d91ff2d20","type":"Claim","title":"In Alzheimer\u2019s disease (AD) aggregation and accumulation of the amyloid β (Aβ) protein and microtubule associated protein tau (MAPT) have both been implicated as key pathogenic \u2018triggers\u2019.","label":"Golde T et al.; In Alzheimer\u2019s disease (AD) aggregation ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:3638dec3-be58-44fe-9118-872d91ff2d20"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b6c728a2-1d19-42c4-a653-ed1ec49a877f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b6c728a2-1d19-42c4-a653-ed1ec49a877f","type":"Claim","title":"Despite sequence similarity between Aβ 40 and 42 and a 10:1 molar ratio of Aβ 40:42, the longer form Aβ42 is the predominant component of parenchymal plaques.","label":"Bitan G et al.; Despite sequence similarity between Aβ 4...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:b6c728a2-1d19-42c4-a653-ed1ec49a877f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cbe25aeb-8139-4896-98af-c1b9eedeffba&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cbe25aeb-8139-4896-98af-c1b9eedeffba","type":"Hypothesis","title":"Toxic fibril hypothesis:  Beta-amyloid neurotoxicity requires fibril formation.","label":"Lorenzo A et al.; Toxic fibril hypothesis:  Beta-amyloid n...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Yankner B A"],"firstAuthor":"Lorenzo A","referenceYear":"1994","referenceDate":"1994-12-06","id":"urn:lsid:swan.org:researchstatement:cbe25aeb-8139-4896-98af-c1b9eedeffba"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1981d0a9-309a-4f2e-ab4e-4b3194e1be58&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1981d0a9-309a-4f2e-ab4e-4b3194e1be58","type":"Hypothesis","title":"An infectious pathogen may cause Alzheimer disease.","label":"Cochran G et al.; An infectious pathogen may cause Alzheim...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Ewald P W","Cochran K D"],"firstAuthor":"Cochran G M","referenceYear":"2000","referenceDate":"2000","id":"urn:lsid:swan.org:researchstatement:1981d0a9-309a-4f2e-ab4e-4b3194e1be58"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3cb1937b-c01b-4265-956e-8c8e5837d152&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3cb1937b-c01b-4265-956e-8c8e5837d152","type":"Claim","title":"Tissue-transglutaminase is a complex protein with multiple functions, including serine kinase activity, G protein signaling, and the catalytic capability to cross-link proteins between lysine and glutamine residues, forming a covalent isodipeptide bond.","label":"Hartley D et al.; Tissue-transglutaminase is a complex pro...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:3cb1937b-c01b-4265-956e-8c8e5837d152"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8d489ce1-096d-4948-8a38-16fbd6f377a4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8d489ce1-096d-4948-8a38-16fbd6f377a4","type":"Claim","title":"Cortical neuronal electrical activity is the basis for cognitive function and dysfunction in general, and specifically in Alzheimer Disease.","label":"Morse T et al.; Cortical neuronal electrical activity is...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Mutalik Pradeep","Cheung Kei","Miller Perry L","Shepherd Gordon"],"firstAuthor":"Morse Thomas M","id":"urn:lsid:swan.org:researchstatement:8d489ce1-096d-4948-8a38-16fbd6f377a4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7578fe24-5935-49b7-a660-35b947be3c91&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7578fe24-5935-49b7-a660-35b947be3c91","type":"Claim","title":"Cognitively normal individuals with elevated PiB staining are at significantly greater risk of developing the symptomatic stages of AD than individuals with less or no PiB retention, suggesting that PiB is an in vivo indicator of preclinical AD.","label":"Morris J et al.; Cognitively normal individuals with elev...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Roe Catherine M","Grant Elizabeth A","Head Denise","Storandt Martha","Goate Alison M","Fagan Anne M","Holtzman David M","Mintun Mark A"],"firstAuthor":"Morris John C","referenceYear":"2009","referenceDate":"2009-12","id":"urn:lsid:swan.org:researchstatement:7578fe24-5935-49b7-a660-35b947be3c91"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:be87c8cd-e3e7-45e1-a9ac-6dba5b34c738&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:be87c8cd-e3e7-45e1-a9ac-6dba5b34c738","type":"Claim","title":"Formic acid solubilized Alzheimer Disease amyloid plaque cores, applied to hippocampal slices inhibited LTP.","label":"Shankar G et al.; Formic acid solubilized Alzheimer Diseas...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Li Shaomin","Mehta Tapan H","Garcia-Munoz Amaya","Shepardson Nina E","Smith Imelda","Brett Francesca M","Farrell Michael A","Rowan Michael J","Lemere Cynthia A","Regan Ciaran M","Walsh Dominic M","Sabatini Bernardo L","Selkoe Dennis J"],"firstAuthor":"Shankar Ganesh M","referenceYear":"2008","referenceDate":"2008-08","id":"urn:lsid:swan.org:researchstatement:be87c8cd-e3e7-45e1-a9ac-6dba5b34c738"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d7463285-7080-4070-8cb2-5830460bcd9f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d7463285-7080-4070-8cb2-5830460bcd9f","type":"Claim","title":"Quantitative analysis of neurite curvature showed that in the immediate vicinity of plaques the tortuosity increased gradually over the first week, and is indistinguishable from neuritic curvature observed at time of death.  This suggests that the neuritic changes that occur immediately in response to plaque is essentially to a maximal extent.","label":"Meyer-Luehmann M et al.; Quantitative analysis of neurite curvatu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:d7463285-7080-4070-8cb2-5830460bcd9f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:58d8e4e7-1250-4c93-9bc9-68e3b3692437&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:58d8e4e7-1250-4c93-9bc9-68e3b3692437","type":"Claim","title":"In accordance with increased protein levels of SIRT1 in p25 transgenic mice, there was a decrease in the acetylation state of PGC-1alpha, a target for SIRT1 deacetylase activity.","label":"Kim D et al.; In accordance with increased protein lev...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:58d8e4e7-1250-4c93-9bc9-68e3b3692437"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2bb876d5-2a56-497c-8a2b-6685fa708ad4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2bb876d5-2a56-497c-8a2b-6685fa708ad4","type":"Claim","title":"Structural MRI measures cerebral atrophy, caused by dendritic pruning and synapse and neuron loss, with a strong correlation between the severity of atrophy and the severity of cognitive impairment from normal cognitive status to AD dementia as well as a correlation between the rates of neuronal and synaptic loss and the rates of cognitive decline.","label":"Jack C et al.; Structural MRI measures cerebral atrophy...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:2bb876d5-2a56-497c-8a2b-6685fa708ad4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:532b3f55-e367-4f48-9102-77c5ecc775cd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:532b3f55-e367-4f48-9102-77c5ecc775cd","type":"Hypothesis","title":"Oxidative stress is a molecular link between β- and the γ-secretase activities, and provides a mechanistic explanation of the pathogenesis of sporadic late-onset Alzheimer disease.","label":"Tabaton M et al.; Oxidative stress is a molecular link bet...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Tamagno E"],"firstAuthor":"Tabaton M","referenceYear":"2007","referenceDate":"2007-09","id":"urn:lsid:swan.org:researchstatement:532b3f55-e367-4f48-9102-77c5ecc775cd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4350cd0f-cae9-4967-92dc-7589368162b1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4350cd0f-cae9-4967-92dc-7589368162b1","type":"Claim","title":"The Braak staging system semiquantifies the degree of tau hyperphosphorylation and/or aggregated tangles within a given region and, more importantly, the anatomical distribution of tau pathology across the brain.","label":"Small S et al.; The Braak staging system semiquantifies ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:4350cd0f-cae9-4967-92dc-7589368162b1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c37bff0c-e44c-4319-9584-35ed5393d666&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c37bff0c-e44c-4319-9584-35ed5393d666","type":"Claim","title":"Endogenous amyloid beta production is critical in maintenance of K+ channel activity regulation in cerebellar granule neurons.","label":"Plant L et al.; Endogenous amyloid beta production is cr...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:c37bff0c-e44c-4319-9584-35ed5393d666"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a8eae3cf-3f94-46f6-85bb-070c1f85cc89&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a8eae3cf-3f94-46f6-85bb-070c1f85cc89","type":"Claim","title":"In the aging and AD brain, Aβ, a 40-42 amino acid peptide, accumulates in the extracellular space as small deposits and senile plaques.","label":"Cotman C et al.; In the aging and AD brain, Aβ, a 40-42 a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:a8eae3cf-3f94-46f6-85bb-070c1f85cc89"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:749474c6-920e-4d69-beba-ac74ce03a752&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:749474c6-920e-4d69-beba-ac74ce03a752","type":"Claim","title":"Neurons that show CCE do not retract their processes before doing so.  ","label":"Muresan Z et al.; Neurons that show CCE do not retract the...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","id":"urn:lsid:swan.org:researchstatement:749474c6-920e-4d69-beba-ac74ce03a752"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1d2678cf-eeba-43a6-8f52-9dc88ccaa3f0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1d2678cf-eeba-43a6-8f52-9dc88ccaa3f0","type":"Claim","title":"Oligomeric Aβ, rather than fibrillar Aβ in plaques, may be the immediate cause of synaptic dysfunction and dementia in Alzheimer\u2019s disease.","label":"Holmes C et al.; Oligomeric Aβ, rather than fibrillar Aβ ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:1d2678cf-eeba-43a6-8f52-9dc88ccaa3f0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ec36268d-48bb-4a7e-8977-a89d518eadc5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ec36268d-48bb-4a7e-8977-a89d518eadc5","type":"Claim","title":"Since gp330/megalin would normally be saturated by abundant amounts of plasma apoJ under physiological conditions, RAGE is the most probable receptor responsible for transport of Aβ back into brain.","label":"Tanzi R et al.; Since gp330/megalin would normally be sa...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:ec36268d-48bb-4a7e-8977-a89d518eadc5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0ff04366-dc06-4369-88e8-d1d7ef8e7a76&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0ff04366-dc06-4369-88e8-d1d7ef8e7a76","type":"Claim","title":"The final phase in the evolution of AD is dementia, defined as impairments in multiple domains that are severe enough to produce loss of function.","label":"Jack C et al.; The final phase in the evolution of AD i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner Michael W","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:0ff04366-dc06-4369-88e8-d1d7ef8e7a76"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:842ced33-d866-4df6-a942-346bd148cfb7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:842ced33-d866-4df6-a942-346bd148cfb7","type":"Claim","title":"Reduction of Aβ42 correlates with reduced risk of AD.","label":"Bitan G et al.; Reduction of Aβ42 correlates with reduce...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:842ced33-d866-4df6-a942-346bd148cfb7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9b7b7fb5-27bf-4f69-af2b-c912b2aa7509&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9b7b7fb5-27bf-4f69-af2b-c912b2aa7509","type":"Claim","title":"During maturation, immature APP (N-glycosylated in the endoplasmic reticulum) moves to the Golgi complex, where complete maturation occurs with the protein becoming more highly glycosylated (N-, O-glycosylation and sulfation).","label":"Suzuki T et al.; During maturation, immature APP (N-glyco...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:9b7b7fb5-27bf-4f69-af2b-c912b2aa7509"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e4b21f5d-9937-46b0-9491-e59daa3e17ba&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e4b21f5d-9937-46b0-9491-e59daa3e17ba","type":"Claim","title":"AD pathology may actually start in the brainstem.  Catecholaminergic neurons of the locus coeruleus may play a role in AD pathobiology.","label":"Muresan Z et al.; AD pathology may actually start in the b...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","referenceYear":"2008","referenceDate":"2008","id":"urn:lsid:swan.org:researchstatement:e4b21f5d-9937-46b0-9491-e59daa3e17ba"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2f1591e8-e5bc-4b7b-b743-b9053dbaab87&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2f1591e8-e5bc-4b7b-b743-b9053dbaab87","type":"Claim","title":"A recent report has shown that in cultured neurons derived from transgenic mice overexpressing a mutant (109Q) huntingtin, resveratrol suppressed the neurotoxic effects of the mutant protein.","label":"Kim D et al.; A recent report has shown that in cultur...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:2f1591e8-e5bc-4b7b-b743-b9053dbaab87"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:26f848d7-2099-4781-bcf4-0bf3bb674eeb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:26f848d7-2099-4781-bcf4-0bf3bb674eeb","type":"Claim","title":"A surprisingly large number of different classes of drugs effectively block the neurotoxic action of NMDA receptor antagonists in the cortex. ","label":"Olney J et al.; A surprisingly large number of different...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:26f848d7-2099-4781-bcf4-0bf3bb674eeb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:33abc12f-1021-4a6a-8b39-2211b8cec27a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:33abc12f-1021-4a6a-8b39-2211b8cec27a","type":"Claim","title":"ADDLs may affect receptor trafficking.","label":"Gong Y et al.; ADDLs may affect receptor trafficking.","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:33abc12f-1021-4a6a-8b39-2211b8cec27a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5fa834ce-2a32-4b8c-9694-51dcd3de33bd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5fa834ce-2a32-4b8c-9694-51dcd3de33bd","type":"Claim","title":"Active immunization with Aβ of mutant APP TgCRND8 mice partially prevented the development of reference memory deficits in a water maze task with only a 50% reduction in the size and number of dense core amyloid deposits.","label":"Dodart J et al.; Active immunization with Aβ of mutant AP...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:5fa834ce-2a32-4b8c-9694-51dcd3de33bd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:21057cdd-b266-4d45-a02c-7b4bdc73f8d1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:21057cdd-b266-4d45-a02c-7b4bdc73f8d1","type":"Claim","title":"Clearance of Aβ can be accomplished via two major pathways: proteolytic degradation and receptor-mediated transport from the brain.","label":"Tanzi R et al.; Clearance of Aβ can be accomplished via ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:21057cdd-b266-4d45-a02c-7b4bdc73f8d1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9062ed48-bc48-4c09-ac12-a3d8c7f50af5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9062ed48-bc48-4c09-ac12-a3d8c7f50af5","type":"Claim","title":"The NMDA receptor transmitter system becomes markedly hypofunctional with advancing age, an observation made by 5 different laboratories studying 3 different species (mice, rats, and monkeys); thus it is reasonable to propose that the NMDA receptor system also becomes progressively hypofunctional in the aging human brain.","label":"Olney J et al.; The NMDA receptor transmitter system bec...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:9062ed48-bc48-4c09-ac12-a3d8c7f50af5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a98055a4-59b1-4223-896a-aa2dfa53ccad&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a98055a4-59b1-4223-896a-aa2dfa53ccad","type":"Claim","title":"Uncross-linked Aβ40 produces only a monomer band in SDS-gel electrophoresis.","label":"Bitan G et al.; Uncross-linked Aβ40 produces only a mono...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:a98055a4-59b1-4223-896a-aa2dfa53ccad"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:579a5a25-0fc7-49da-9df5-19f4e766d47b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:579a5a25-0fc7-49da-9df5-19f4e766d47b","type":"Claim","title":"An interesting candidate target for SIRT1 deacetylation activity is PGC-1alpha, which is deacetylated in a model for neurodegeneration (p25 Tg) and in the brain, in response to resveratrol treatment.  These data suggest that deacetylation and activation of PGC-1- alpha by enhanced SIRT1 activity may also be involved in neuroprotection.","label":"Kim D et al.; An interesting candidate target for SIRT...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:579a5a25-0fc7-49da-9df5-19f4e766d47b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b510d5da-856e-46fa-8be4-f8105e04e9b3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b510d5da-856e-46fa-8be4-f8105e04e9b3","type":"Hypothesis","title":"Toxic Intracellular Aβ Hypothesis:  Intraneuronal Alzheimer Aβ42 accumulates in multivesicular bodies and is associated with synaptic pathology.","label":"Takahashi R et al.; Toxic Intracellular Aβ Hypothesis:  Intr...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Milner Teresa A","Li Feng","Nam Ellen E","Edgar Mark A","Yamaguchi Haruyasu","Beal M Flint","Xu Huaxi","Greengard Paul","Gouras Gunnar K"],"firstAuthor":"Takahashi Reisuke H","referenceYear":"2002","referenceDate":"2002-11","id":"urn:lsid:swan.org:researchstatement:b510d5da-856e-46fa-8be4-f8105e04e9b3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6603e668-820b-477d-99de-5ef03cf06f1c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6603e668-820b-477d-99de-5ef03cf06f1c","type":"Hypothesis","title":"ApoE4 inhibits neurite outgrowth and may be directly involved in synaptic and neuritic maintenance in the normal and Alzheimer disease brain.","label":"Holtzman D et al.; ApoE4 inhibits neurite outgrowth and may...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Pitas R E","Kilbridge J","Nathan B","Mahley R W","Bu G","Schwartz A L"],"firstAuthor":"Holtzman D M","referenceYear":"1995","referenceDate":"1995-10-10","id":"urn:lsid:swan.org:researchstatement:6603e668-820b-477d-99de-5ef03cf06f1c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b82da896-b451-4a36-9562-7107eaae40fb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b82da896-b451-4a36-9562-7107eaae40fb","type":"Claim","title":"PS1-/- mice with only one functional PS1 allele are phenotypically normal, indicating that 50% of the normal PS1 dosage is sufficient to rescue the phenotype of PS1-/- mice.","label":"Shen J et al.; PS1-/- mice with only one functional PS1...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:b82da896-b451-4a36-9562-7107eaae40fb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d3751f99-716e-458d-8802-b2b5426c316a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d3751f99-716e-458d-8802-b2b5426c316a","type":"Claim","title":"A complete abrogation of proteasome function has been obtained with about 0.4 microM and 0.15 microM PHF-tau respectively.","label":"Keck S et al.; A complete abrogation of proteasome func...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:d3751f99-716e-458d-8802-b2b5426c316a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:86462843-94cc-443b-bc22-ba688ff5ca83&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:86462843-94cc-443b-bc22-ba688ff5ca83","type":"Claim","title":"FAD-linked PS mutations impair γ-secretase-dependent and -independent PS activities.  ","label":"Shen J et al.; FAD-linked PS mutations impair γ-secreta...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:86462843-94cc-443b-bc22-ba688ff5ca83"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a5248770-8036-48b7-963c-d4006d4bbd88&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a5248770-8036-48b7-963c-d4006d4bbd88","type":"Claim","title":"It is possible that the immune system may be involved in the normal clearance of Aβ.","label":"Tanzi R et al.; It is possible that the immune system ma...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:a5248770-8036-48b7-963c-d4006d4bbd88"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3135b960-63cc-409b-8061-3692f4b25037&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3135b960-63cc-409b-8061-3692f4b25037","type":"Claim","title":"Six different FAD-linked human presenilin mutations reduced the ability of PS1 to substitute functionally for SEL12 to varying degrees.","label":"Shen J et al.; Six different FAD-linked human presenili...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:3135b960-63cc-409b-8061-3692f4b25037"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c87f2cda-8874-4208-a3d7-045a33a34db1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c87f2cda-8874-4208-a3d7-045a33a34db1","type":"Claim","title":"Physiological temperature favors accumulation of Aβ 12-mer in synthetic preparations, immunoreactive with the same antibodies used to detect the 56 kDa oligomer from AD brain.","label":"Gong Y et al.; Physiological temperature favors accumul...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:c87f2cda-8874-4208-a3d7-045a33a34db1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:736f7c22-a8af-439d-bb30-3fe23da22e0d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:736f7c22-a8af-439d-bb30-3fe23da22e0d","type":"Claim","title":"An anti-inflammatory therapeutic strategy is based on the effect of Aβ accumulation to elicit a cortical inflammatory response.","label":"Hardy J et al.; An anti-inflammatory therapeutic strateg...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:736f7c22-a8af-439d-bb30-3fe23da22e0d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2d88f8eb-30a7-45f2-8ca9-6d50f6cbfa89&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2d88f8eb-30a7-45f2-8ca9-6d50f6cbfa89","type":"Claim","title":"By the data censoring date there was no difference in age at death between the eight AN1792 immunized participants who were examined neuropathologically and the unimmunized histological controls.","label":"Holmes C et al.; By the data censoring date there was no ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:2d88f8eb-30a7-45f2-8ca9-6d50f6cbfa89"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:60039c86-364f-42e7-b0e1-03cf3883c4c2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:60039c86-364f-42e7-b0e1-03cf3883c4c2","type":"Hypothesis","title":"The generation of free radicals and oxidative stress plays a role in neurofibrillary pathogenesis of Alzheimer disease.","label":"Smith M et al.; The generation of free radicals and oxid...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Kutty R K","Richey P L","Yan S D","Stern D","Chader G J","Wiggert B","Petersen R B","Perry G"],"firstAuthor":"Smith M A","referenceYear":"1994","referenceDate":"1994-07","id":"urn:lsid:swan.org:researchstatement:60039c86-364f-42e7-b0e1-03cf3883c4c2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2990be28-1c3e-48d3-ac7a-6294646572d4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2990be28-1c3e-48d3-ac7a-6294646572d4","type":"Claim","title":"Amyloid beta effects on K channel expression suggest that amyloid beta may be a physiological regulator of channel expression.","label":"Plant L et al.; Amyloid beta effects on K channel expres...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:2990be28-1c3e-48d3-ac7a-6294646572d4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fd055c1a-be40-42e3-bc93-d9f7127ba5a3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fd055c1a-be40-42e3-bc93-d9f7127ba5a3","type":"Hypothesis","title":"A DNA polymorphism in the Angiotensin converting enzyme (ACE) gene has been linked to the risk for late onset Alzheimer Disease.","label":"Alvarez R et al.; A DNA polymorphism in the Angiotensin co...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Alvarez V","Lahoz C H","Martínez C","Peña J","Sánchez J M","Guisasola L M","Salas-Puig J","Morís G","Vidal J A","Ribacoba R","Menes B B","Uría D","Coto E"],"firstAuthor":"Alvarez R","referenceYear":"1999","referenceDate":"1999-12","id":"urn:lsid:swan.org:researchstatement:fd055c1a-be40-42e3-bc93-d9f7127ba5a3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6fa5abd1-1926-4dcc-af4f-07a2cd3ac62d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6fa5abd1-1926-4dcc-af4f-07a2cd3ac62d","type":"Claim","title":"Replicative senescence that has been reversed in culture, typically requiring inactivation or downregulation of tumor suppressors suggest therefore that therapy to reverse replicative senescence poses serious problems as it increases the likelihood for tumorigenesis.","label":"Golde T et al.; Replicative senescence that has been rev...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:6fa5abd1-1926-4dcc-af4f-07a2cd3ac62d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b0efc247-ac5f-4b1e-9453-0c5e6c1fa637&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b0efc247-ac5f-4b1e-9453-0c5e6c1fa637","type":"Claim","title":"Primary neuronal cultures derived from IDE knockout mice are less effective at degrading radiolabeled Aβ, in vitro.","label":"Tanzi R et al.; Primary neuronal cultures derived from I...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:b0efc247-ac5f-4b1e-9453-0c5e6c1fa637"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f4cac7e0-aa5e-4d13-8ce6-f47718f9e849&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f4cac7e0-aa5e-4d13-8ce6-f47718f9e849","type":"Claim","title":"c-Jun immunoreactivity and TdT labeling are colocalized in many neurons in the AD brain, suggesting that the expression of c-Jun and presence of DNA damage may be related.","label":"Cotman C et al.; c-Jun immunoreactivity and TdT labeling ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:f4cac7e0-aa5e-4d13-8ce6-f47718f9e849"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:368f3706-91db-42fa-9b80-3a51493c66eb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:368f3706-91db-42fa-9b80-3a51493c66eb","type":"Claim","title":"Close interaction between Aβ and α7nicotinic acetylcholine receptors could turn from positive effects in a normal physiological state (low concentration of Aβ) to detrimental effects in pathological conditions (high concentration of Aβ) like Alzheimer\u2019s disease.","label":"Dziewczapolski G et al.; Close interaction between Aβ and α7nicot...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Glogowski Carolina M","Masliah Eliezer","Heinemann Stephen F"],"firstAuthor":"Dziewczapolski Gustavo","referenceYear":"2009","referenceDate":"2009-07-08","id":"urn:lsid:swan.org:researchstatement:368f3706-91db-42fa-9b80-3a51493c66eb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:64f66818-29c4-485e-b029-5745377a311f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:64f66818-29c4-485e-b029-5745377a311f","type":"Claim","title":"No significant accumulation of neurofilaments and snap25-associated vesicles were observed in the retinal ganglion cell bodies in retinas of tau-null or 8c tau overexpressing mice.","label":"Yuan A et al.; No significant accumulation of neurofila...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:64f66818-29c4-485e-b029-5745377a311f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cf4e132e-e46e-4d9d-bf8e-e04e7c2e1790&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cf4e132e-e46e-4d9d-bf8e-e04e7c2e1790","type":"Claim","title":"Men with AD have ~50% less brain testosterone than do age-matched men without AD and decreased circulating testosterone in aged men is associated with impaired cognitive function and increased risk of dementia and AD; whereas testosterone replacement therapy and high free testosterone levels in men are associated with improved verbal and spatial memory and reduced risk of AD.","label":"McAllister C et al.; Men with AD have ~50% less brain testost...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Long Jiangang","Bowers Adrienne","Walker Aaron","Cao Philip","Honda Shin-Ichiro","Harada Nobuhiro","Staufenbiel Matthias","Shen Yong","Li Rena"],"firstAuthor":"McAllister Carrie","referenceYear":"2010","referenceDate":"2010-05-26","id":"urn:lsid:swan.org:researchstatement:cf4e132e-e46e-4d9d-bf8e-e04e7c2e1790"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d8ee356b-a1c5-4c7e-81bb-3e4b79f004bc&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d8ee356b-a1c5-4c7e-81bb-3e4b79f004bc","type":"Claim","title":"The locus coeruleus is a target for other neurological disorders besides AD, including schizophrenia.","label":"Muresan Z et al.; The locus coeruleus is a target for othe...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","referenceYear":"2008","referenceDate":"2008","id":"urn:lsid:swan.org:researchstatement:d8ee356b-a1c5-4c7e-81bb-3e4b79f004bc"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1dc70dbd-4e0c-4b09-8216-f95132b3d8ed&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1dc70dbd-4e0c-4b09-8216-f95132b3d8ed","type":"Claim","title":"Anti-amyloid trials need to be carried out in individuals with APP and PSEN mutations or those with Down syndrome, of whom the amyloid hypothesis is basically true, and therefore trials can be a true test of the approach.","label":"Hardy ; Anti-amyloid trials need to be carried o...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Hardy","referenceYear":"2009","referenceDate":"2009-05-18","id":"urn:lsid:swan.org:researchstatement:1dc70dbd-4e0c-4b09-8216-f95132b3d8ed"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f105dee9-b186-41c8-b7ad-0b3cf2d5ddc4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f105dee9-b186-41c8-b7ad-0b3cf2d5ddc4","type":"Claim","title":"Mutations of APP cause Aβ deposition.","label":"Hardy J et al.; Mutations of APP cause Aβ deposition.","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:f105dee9-b186-41c8-b7ad-0b3cf2d5ddc4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7cc8a0fc-a6ef-400e-9e17-bd4f37c86fd9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7cc8a0fc-a6ef-400e-9e17-bd4f37c86fd9","type":"Claim","title":"The neurodegenerative events in AD occurring in two separate stages, by two separate mechanisms, and according to two separate patterns:  massive neurodegeneration follows the pattern of NFT formation and a less massive pattern of neuronal degeneration that corresponds with the pattern of amyloid deposition. ","label":"Olney J et al.; The neurodegenerative events in AD occur...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:7cc8a0fc-a6ef-400e-9e17-bd4f37c86fd9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f8cf6e7e-dc48-4d07-90fa-83b6392f5724&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f8cf6e7e-dc48-4d07-90fa-83b6392f5724","type":"Claim","title":"Genetic data has also shown that the presenilin genes may be involved in the regulation of apoptosis.","label":"Cotman C et al.; Genetic data has also shown that the pre...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:f8cf6e7e-dc48-4d07-90fa-83b6392f5724"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5c5ffc10-7127-4d75-9828-60bb84b010e5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5c5ffc10-7127-4d75-9828-60bb84b010e5","type":"Claim","title":"In optic axons the rates of slow transport cargoes, neurofilament NF-L, NF-M, and NF-H, were not affected significantly in the absence of mouse tau, possibly reflecting compensatory actions by other microtubule-associated proteins (MAPs) and Gem GTPase.","label":"Yuan A et al.; In optic axons the rates of slow transpo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:5c5ffc10-7127-4d75-9828-60bb84b010e5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a81b2338-0f89-41e3-814d-afe297dc51d9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a81b2338-0f89-41e3-814d-afe297dc51d9","type":"Claim","title":"Necrosis is characterized by mitochondrial swelling, nuclear flocculation, the loss of plasma membrane integrity, and cell lysis.","label":"Cotman C et al.; Necrosis is characterized by mitochondri...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:a81b2338-0f89-41e3-814d-afe297dc51d9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:32aaa030-a24f-486a-8c63-7847acaa71b6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:32aaa030-a24f-486a-8c63-7847acaa71b6","type":"Claim","title":"The aggregation state of tau rather than modification of its secondary structure appears to be responsible for the proteasome disruption.","label":"Keck S et al.; The aggregation state of tau rather than...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:32aaa030-a24f-486a-8c63-7847acaa71b6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:11ba30e2-ab7f-4ba7-b255-304446791465&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:11ba30e2-ab7f-4ba7-b255-304446791465","type":"Claim","title":"Increasing Hsp70 reduced total tau levels and attenuated tau aggregation suggesting that the CHIP/Hsp70 can promote tau degradation.","label":"Carrettiero D et al.; Increasing Hsp70 reduced total tau level...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hernandez Israel","Neveu Pierre","Papagiannakopoulos Thales","Kosik Kenneth S"],"firstAuthor":"Carrettiero Daniel C","referenceYear":"2009","referenceDate":"2009-02-18","id":"urn:lsid:swan.org:researchstatement:11ba30e2-ab7f-4ba7-b255-304446791465"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0e73fc39-ff06-4ed4-85fd-f7ac49e372fb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0e73fc39-ff06-4ed4-85fd-f7ac49e372fb","type":"Claim","title":"Pathogen-associated molecular patterns (PAMPs) and TI-2 antigens are quite reminiscent of the features of amyloid deposits: they are large in size (typically greater then 100 kDa and often much larger), and have repetitive epitopes, poor in vivo degradability, and the ability to activate complement.","label":"Golde T et al.; Pathogen-associated molecular patterns (...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:0e73fc39-ff06-4ed4-85fd-f7ac49e372fb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0a325617-527c-4e55-9d8e-855a03da7cb1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0a325617-527c-4e55-9d8e-855a03da7cb1","type":"Claim","title":"Non-linearity has been clearly shown in MRI studies, in which atrophy rates accelerate as patients approach clinical dementia.","label":"Jack C et al.; Non-linearity has been clearly shown in ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:0a325617-527c-4e55-9d8e-855a03da7cb1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:41c5f5ca-b0b6-472e-b907-e22a4ca0e93a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:41c5f5ca-b0b6-472e-b907-e22a4ca0e93a","type":"Claim","title":"TDP-43 is a multifunctional protein involved in various steps of RNA processing including transcription, pre-mRNA splicing, mRNA transport and translation.","label":"Warraich S et al.; TDP-43 is a multifunctional protein invo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Yang Shu","Nicholson Garth A","Blair Ian P"],"firstAuthor":"Warraich Sadaf T","referenceYear":"2010","referenceDate":"2010-06-25","id":"urn:lsid:swan.org:researchstatement:41c5f5ca-b0b6-472e-b907-e22a4ca0e93a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ee9804fa-189e-4f05-bd14-ec8d2991569d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ee9804fa-189e-4f05-bd14-ec8d2991569d","type":"Claim","title":"GSK3 isoforms exhibit tissue specific physiological functions:  GSK3β knock-out mice die in utero, whereas GSK3α knock-out mice are viable and display improved glucose tolerance in response to glucose load and elevated hepatic glycogen storage and insulin sensitivity.","label":"Hooper C et al.; GSK3 isoforms exhibit tissue specific ph...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:ee9804fa-189e-4f05-bd14-ec8d2991569d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0e7cbe14-43b0-4013-ab9f-b5bd69e36197&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0e7cbe14-43b0-4013-ab9f-b5bd69e36197","type":"Claim","title":"In studies on postmortem AD tissues it is always essential to evaluate the possible effects of artifacts on outcome measures; potential TdT labeling artifacts were examined for effects of postmortem delay on TdT labeling and brain area.","label":"Cotman C et al.; In studies on postmortem AD tissues it i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:0e7cbe14-43b0-4013-ab9f-b5bd69e36197"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fe860b93-c0ba-4495-8f61-98fc530973a1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fe860b93-c0ba-4495-8f61-98fc530973a1","type":"Claim","title":"It has been proposed that Aβ is toxic by inserting directly into membrane lipids.","label":"Gong Y et al.; It has been proposed that Aβ is toxic by...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:fe860b93-c0ba-4495-8f61-98fc530973a1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:52857358-2a9a-46aa-b638-25d74567d961&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:52857358-2a9a-46aa-b638-25d74567d961","type":"Claim","title":"Cadherins seem to undergo γ-secretase-dependent cleavages, although the physiological significance of this cleavage is unclear.","label":"Shen J et al.; Cadherins seem to undergo γ-secretase-de...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:52857358-2a9a-46aa-b638-25d74567d961"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:138a7b95-5c55-4bf3-a6ae-a5beb525c0b7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:138a7b95-5c55-4bf3-a6ae-a5beb525c0b7","type":"Claim","title":"BAG2 enhances tau ubiquitin independent degradation, shortens tau protein half-life, decreases the endogenous levels of phosphorylated and total pools of tau, but does not change tau synthesis.","label":"Carrettiero D et al.; BAG2 enhances tau ubiquitin independent ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hernandez Israel","Neveu Pierre","Papagiannakopoulos Thales","Kosik Kenneth S"],"firstAuthor":"Carrettiero Daniel C","referenceYear":"2009","referenceDate":"2009-02-18","id":"urn:lsid:swan.org:researchstatement:138a7b95-5c55-4bf3-a6ae-a5beb525c0b7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2201807c-672c-4a77-9371-b9f5a2130c4c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2201807c-672c-4a77-9371-b9f5a2130c4c","type":"Claim","title":"Different γ-secretase complexes containing different Presenilin or Aph1 protein subunits are present in various tissues.","label":"Serneels L et al.; Different γ-secretase complexes containi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Van Biervliet Jérôme","Craessaerts Katleen","Dejaegere Tim","Horré Katrien","Van Houtvin Tine","Esselmann Hermann","Paul Sabine","Schäfer Martin K","Berezovska Oksana","Hyman Bradley T","Sprangers Ben","Sciot Raf","Moons Lieve","Jucker Mathias","Yang Zhixiang","May Patrick C","Karran Eric","Wiltfang Jens","D'Hooge Rudi","De Strooper Bart"],"firstAuthor":"Serneels Lutgarde","referenceYear":"2009","referenceDate":"2009-05-01","id":"urn:lsid:swan.org:researchstatement:2201807c-672c-4a77-9371-b9f5a2130c4c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3d321510-7f02-4cc3-8b83-fe45d4355021&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3d321510-7f02-4cc3-8b83-fe45d4355021","type":"Claim","title":"In hippocampal slices from Fyn knockout animals, ADDL-evoked cell death does not occur.","label":"Lambert M et al.; In hippocampal slices from Fyn knockout ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:3d321510-7f02-4cc3-8b83-fe45d4355021"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bc691ebf-3d04-4575-9b66-ab5fd53ff222&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bc691ebf-3d04-4575-9b66-ab5fd53ff222","type":"Claim","title":"Aβ plays a pivotal role in disrupting intracellular calcium homeostasis.","label":"Smith I et al.; Aβ plays a pivotal role in disrupting in...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:bc691ebf-3d04-4575-9b66-ab5fd53ff222"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1063e646-7d88-44b4-aa42-a561f370f615&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1063e646-7d88-44b4-aa42-a561f370f615","type":"Claim","title":"Despite evidence that demonstrates that Aβ42 binds to membrane lipids but does not bind to the α7nicotinic acetylcholine receptor, both increases and decreases in α7nAChR number have been reported in AD animal models and human patients, making a stronger case for a relationship between AD pathology and α7nAChR.","label":"Dziewczapolski G et al.; Despite evidence that demonstrates that ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Glogowski Carolina M","Masliah Eliezer","Heinemann Stephen F"],"firstAuthor":"Dziewczapolski Gustavo","referenceYear":"2009","referenceDate":"2009-07-08","id":"urn:lsid:swan.org:researchstatement:1063e646-7d88-44b4-aa42-a561f370f615"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0be51e60-2da9-4ae6-9274-35102bedc9b3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0be51e60-2da9-4ae6-9274-35102bedc9b3","type":"Claim","title":"Manipulation of NEP and IDE in animal models shows that increasing or decreasing their activity can alter Aβ accumulation inversely as well as change synaptic function and behavior.","label":"Hartley D et al.; Manipulation of NEP and IDE in animal mo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:0be51e60-2da9-4ae6-9274-35102bedc9b3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e4e98189-3fcd-481a-b097-4abe318cd5c4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e4e98189-3fcd-481a-b097-4abe318cd5c4","type":"Claim","title":"Crosslinking of T cell receptors is required to initiate apoptosis; a binding event is insufficient to activate the apoptosis signal.","label":"Cotman C et al.; Crosslinking of T cell receptors is requ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:e4e98189-3fcd-481a-b097-4abe318cd5c4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:325f598e-b112-46bb-8c47-13f7b4656b42&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:325f598e-b112-46bb-8c47-13f7b4656b42","type":"Claim","title":"Antisense probes against candidate kinases involved in tau hyperphosphorylation will block B-amyloid induced apoptosis.","label":"Cotman C et al.; Antisense probes against candidate kinas...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:325f598e-b112-46bb-8c47-13f7b4656b42"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:48e08ef8-586a-4523-b49a-8a569b464e7e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:48e08ef8-586a-4523-b49a-8a569b464e7e","type":"Claim","title":"GABAergic neurons, which are resistant to Aβ-induced apoptosis in vitro and resistant to neurodegeneration in AD, do not express c-Jun in culture.","label":"Cotman C et al.; GABAergic neurons, which are resistant t...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:48e08ef8-586a-4523-b49a-8a569b464e7e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c037627b-2ee1-4b1d-9942-a7243878523e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c037627b-2ee1-4b1d-9942-a7243878523e","type":"Claim","title":"FAD PS1 delta 9 showed mild loss of function in CTF turnover of APP and syndecan 3 but was a strong loss of function in N-cadherin CTF turnover, causing a dramatic accumulation of N-cadherin CTF.","label":"Bentahir M et al.; FAD PS1 delta 9 showed mild loss of func...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:c037627b-2ee1-4b1d-9942-a7243878523e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a7352d43-77f8-40da-aa52-7c43e892b028&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a7352d43-77f8-40da-aa52-7c43e892b028","type":"Claim","title":"The earliest pathological event that occurs in the process of AD is probably the deposition of insoluble forms of Aβ peptide in the brain.","label":"Holtzman D; The earliest pathological event that occ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:a7352d43-77f8-40da-aa52-7c43e892b028"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ec62b1a8-20b1-413c-83b5-b210fdeffaef&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ec62b1a8-20b1-413c-83b5-b210fdeffaef","type":"Claim","title":"Transgenic mice expressing the APP mutation that results in hereditary cerebral hemorrhage with amyloidoses [i.e., E22Q (Dutch type)] have a high Aβ40:42 ratio and develop extensive CAA with few parenchymal plaques.","label":"Fryer J et al.; Transgenic mice expressing the APP mutat...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:ec62b1a8-20b1-413c-83b5-b210fdeffaef"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:421413f3-0afb-4c8f-8ffa-d40444ac53b6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:421413f3-0afb-4c8f-8ffa-d40444ac53b6","type":"Claim","title":"A&#946;42 is an amphipathic peptide derived from APP.","label":"Gong Y et al.; A&#946;42 is an amphipathic peptide deri...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:421413f3-0afb-4c8f-8ffa-d40444ac53b6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:40436b87-9077-4596-b1c6-9b4919bbe106&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:40436b87-9077-4596-b1c6-9b4919bbe106","type":"Claim","title":"Genetic and biochemical evidence suggests that Aβ, a 38-43 amino acid peptide proteolytically cleaved from APP, plays a central role in AD pathogenesis.","label":"Holtzman D; Genetic and biochemical evidence suggest...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:40436b87-9077-4596-b1c6-9b4919bbe106"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:dcdda493-dea8-4b99-b9b0-c107bd81595e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:dcdda493-dea8-4b99-b9b0-c107bd81595e","type":"Claim","title":"ApoE may be influencing Aβ deposition through clearance of Aβ, by altering the metabolic pathway by which Aβ is removed from the brain via apoE-containing lipoprotein sequestration of soluble Aβ.","label":"Holtzman D; ApoE may be influencing Aβ deposition th...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:dcdda493-dea8-4b99-b9b0-c107bd81595e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e6e92fde-4c0c-4056-9fcb-d37fa5803b45&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e6e92fde-4c0c-4056-9fcb-d37fa5803b45","type":"Claim","title":"The \"Coblaminergic\" hypothesis.","label":"McCaddon A et al.; The \"Coblaminergic\" hypothesis.","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Blennow Kaj","Hudson Peter","Hughes Alan","Barber Joan","Gray Rob","Davies Gareth","Williams John H","Duguid Jennifer","Lloyd Alwyn","Tandy Steve","Everall Marge","Cattell Howard","McCaddon Anne","Ellis Dick","Palmer Mona","Bogdanovic Nenad","Gottfries Carl-Gerhard","Zetterberg Henrik","Rymo Lars","Regland Björn"],"firstAuthor":"McCaddon Andrew","referenceYear":"2004","referenceDate":"2004","id":"urn:lsid:swan.org:researchstatement:e6e92fde-4c0c-4056-9fcb-d37fa5803b45"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:174e9b94-0c4b-4987-92d3-658eeead58c1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:174e9b94-0c4b-4987-92d3-658eeead58c1","type":"Comment","title":"A Short Circuit to Alzheimer Disease: Petersen et al Comment on Morse Hypothesis \u201cThe cognitive deficits of early Alzheimer Disease are caused by the disruption of electrical activity and information processing in dendrites of cortical pyramidal neurons.\u201d ","label":"Petersen R et al.; A Short Circuit to Alzheimer Disease: Pe...","icon":"../icons/ontological/discourse-element/comment.png","otherAuthors":["Castellani Rudolph J","Nunomura Akihiko","Zhu Xiongwei","Lee Hyoung-gon","Perry George","Smith Mark A"],"firstAuthor":"Petersen R B","id":"urn:lsid:swan.org:comment:174e9b94-0c4b-4987-92d3-658eeead58c1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fae7bab8-8d72-47dc-b599-b830712b3b18&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fae7bab8-8d72-47dc-b599-b830712b3b18","type":"Claim","title":"Multiple lines of evidence support a role for IDE in Aβ degradation but the most convincing evidence has come from IDE knockout mice.","label":"Tanzi R et al.; Multiple lines of evidence support a rol...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:fae7bab8-8d72-47dc-b599-b830712b3b18"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:975ce383-c108-4177-8bb7-8665cd3e26e5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:975ce383-c108-4177-8bb7-8665cd3e26e5","type":"Question","title":"Can overexpressed DR6 in neurons trigger ligand-independent degeneration, as reported for p75NTR?","label":"Can overexpressed DR6 in neurons trigger...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:975ce383-c108-4177-8bb7-8665cd3e26e5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8c75ad36-bb31-4675-835f-414a75f5b9b9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8c75ad36-bb31-4675-835f-414a75f5b9b9","type":"Claim","title":"TI-2 antigens are similar polymeric molecules that directly stimulate B cells to secrete IgM by crosslinking of plasma membrane immunoglobulin.","label":"Golde T et al.; TI-2 antigens are similar polymeric mole...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:8c75ad36-bb31-4675-835f-414a75f5b9b9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bd0864a9-9c87-4b0e-8eb2-91e7ae6bb348&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bd0864a9-9c87-4b0e-8eb2-91e7ae6bb348","type":"Claim","title":"It is likely that every γ-secretase complex contains 2 or more PS subunits.","label":"Bentahir M et al.; It is likely that every γ-secretase comp...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:bd0864a9-9c87-4b0e-8eb2-91e7ae6bb348"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0cf808d9-713d-46e6-a056-72e21eaad692&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0cf808d9-713d-46e6-a056-72e21eaad692","type":"Claim","title":"All previous genome-wide association studies (GWAS) which have all included fewer than 1,100 cases have identified strong evidence for Alzheimer\u2019s disease risk association to APOE but have found less convincing evidence implicating other genes.","label":"Harold D et al.; All previous genome-wide association stu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Abraham Richard","Hollingworth Paul","Sims Rebecca","Gerrish Amy","Hamshere Marian L","Pahwa Jaspreet Singh","Moskvina Valentina","Dowzell Kimberley","Williams Amy","Jones Nicola","Thomas Charlene","Stretton Alexandra","Morgan Angharad R","Lovestone Simon","Powell John","Proitsi Petroula","Lupton Michelle K","Brayne Carol","Rubinsztein David C","Gill Michael","Lawlor Brian","Lynch Aoibhinn","Morgan Kevin","Brown Kristelle S","Passmore Peter A","Craig David","McGuinness Bernadette","Todd Stephen","Holmes Clive","Mann David","Smith A David","Love Seth","Kehoe Patrick G","Hardy John","Mead Simon","Fox Nick","Rossor Martin","Collinge John","Maier Wolfgang","Jessen Frank","Schürmann Britta","van den Bussche Hendrik","Heuser Isabella","Kornhuber Johannes","Wiltfang Jens","Dichgans Martin","Frölich Lutz","Hampel Harald","Hüll Michael","Rujescu Dan","Goate Alison M","Kauwe John S","Cruchaga Carlos","Nowotny Petra","Morris John C","Mayo Kevin","Sleegers Kristel","Bettens Karolien","Engelborghs Sebastiaan","De Deyn Peter P","Van Broeckhoven Christine","Livingston Gill","Bass Nicholas J","Gurling Hugh","McQuillin Andrew","Gwilliam Rhian","Deloukas Panagiotis","Al-Chalabi Ammar","Shaw Christopher E","Tsolaki Magda","Singleton Andrew B","Guerreiro Rita","Mühleisen Thomas W","Nöthen Markus M","Moebus Susanne","Jöckel Karl-Heinz","Klopp Norman","Wichmann H-Erich","Carrasquillo Minerva M","Pankratz V Shane","Younkin Steven G","Holmans Peter A","O'Donovan Michael","Owen Michael J","Williams Julie"],"firstAuthor":"Harold Denise","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:0cf808d9-713d-46e6-a056-72e21eaad692"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6d5574c3-2124-4308-8ce3-73c7e3ffd764&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6d5574c3-2124-4308-8ce3-73c7e3ffd764","type":"Claim","title":"PSEN1 promoter polymorphisms that reduce PS1 expression have been reported as risk factors for sporadic AD, supporting a role for reduced PS expression in AD pathogenesis.","label":"Shen J et al.; PSEN1 promoter polymorphisms that reduce...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:6d5574c3-2124-4308-8ce3-73c7e3ffd764"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7e326d98-8bdc-4939-9811-166bd170a651&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7e326d98-8bdc-4939-9811-166bd170a651","type":"Claim","title":"In the AN1792 immunized participants, the degree of plaque removal varied significantly with mean antibody response attained during the treatment study period up to 84 weeks after the first dose.","label":"Holmes C et al.; In the AN1792 immunized participants, th...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:7e326d98-8bdc-4939-9811-166bd170a651"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:54054459-ed2f-429a-bb59-a89f9302cff2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:54054459-ed2f-429a-bb59-a89f9302cff2","type":"Claim","title":"Reduced fast axonal transport with resultant axonal swellings suggests white matter and myelin involvement in AD and many disorders including Huntington\u2019s disease, amyotrophic lateral sclerosis, schizophrenia, insult-based disorders such as TBI and toxic substance exposure, as well as myelin-based inflammatory disorders such as multiple sclerosis; this diversity of diseases confirms a hypothesis of a \u201cweakest link\u201d/\u201chighest repair priority\u201d status for vertebrate myelin especially in human CNS.","label":"Bartzokis G; Reduced fast axonal transport with resul...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:54054459-ed2f-429a-bb59-a89f9302cff2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9caa4ca8-9d2b-45d4-892c-69a38ba47144&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9caa4ca8-9d2b-45d4-892c-69a38ba47144","type":"Claim","title":"Previous reports describe decreased THOP1 protein levels during aging and in AD tissue to support a model in which decreased THOP1 activity in brain of AD patients would result in decreased degradation of soluble Aβ and therefore increased aggregation and plaque formation.","label":"Pollio G et al.; Previous reports describe decreased THOP...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hoozemans Jeroen J","Andersen Claus A","Roncarati Renza","Rosi Maria Cristina","van Haastert Elise S","Seredenina Tamara","Diamanti Daniela","Gotta Stefano","Fiorentini Anna","Magnoni Letizia","Raggiaschi Roberto","Rozemuller Annemieke J","Casamenti Fiorella","Caricasole Andrea","Terstappen Georg C"],"firstAuthor":"Pollio Giuseppe","referenceYear":"2008","referenceDate":"2008-07","id":"urn:lsid:swan.org:researchstatement:9caa4ca8-9d2b-45d4-892c-69a38ba47144"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:44fd9fb4-e489-4080-8573-2b68c774cc94&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:44fd9fb4-e489-4080-8573-2b68c774cc94","type":"Claim","title":"Overexpression of Bcl-2 blocks apoptosis induced by Aβ in cultured neurons, in agreement with other studies.","label":"Cotman C et al.; Overexpression of Bcl-2 blocks apoptosis...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:44fd9fb4-e489-4080-8573-2b68c774cc94"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ec9b985e-1b4d-48e0-8c97-60184f4811e3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ec9b985e-1b4d-48e0-8c97-60184f4811e3","type":"Claim","title":"Oligomeric Aβ interaction with neurons may induce synaptic changes and cognitive impairment in young APP transgenic mice.","label":"Walsh D et al.; Oligomeric Aβ interaction with neurons m...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Klyubin Igor","Fadeeva Julia V","Cullen William K","Anwyl Roger","Wolfe Michael S","Rowan Michael J","Selkoe Dennis J"],"firstAuthor":"Walsh Dominic M","referenceYear":"2002","referenceDate":"2002-04-04","id":"urn:lsid:swan.org:researchstatement:ec9b985e-1b4d-48e0-8c97-60184f4811e3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4ee05cdc-5097-4dd4-815c-1755390c1ff0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4ee05cdc-5097-4dd4-815c-1755390c1ff0","type":"Claim","title":"The tau isoform and promoter used and integration site effects are factors that must play a role in axonal transport effects by tau.","label":"Van Leuven F; The tau isoform and promoter used and in...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Van Leuven Fred","id":"urn:lsid:swan.org:researchstatement:4ee05cdc-5097-4dd4-815c-1755390c1ff0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b0e40161-0638-4e08-a1b3-63c6c63e67a0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b0e40161-0638-4e08-a1b3-63c6c63e67a0","type":"Claim","title":"A number of papers report that APP overexpression and presenilin mutations can induce serious abnormalities in axonal transport in the absence of plaque formation or human Aβ.  These findings and those of Meyer-Luehmann et al. are not in conflict and may in some sense be complementary.","label":"Goldstein L; A number of papers report that APP overe...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Goldstein Lawrence S B","id":"urn:lsid:swan.org:researchstatement:b0e40161-0638-4e08-a1b3-63c6c63e67a0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1f1a369f-1085-496f-82a1-c93c85d5a349&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1f1a369f-1085-496f-82a1-c93c85d5a349","type":"Claim","title":"The T44 model features significant neurofibrillary degeneration unlike the 8c tau transgenic mice.","label":"Nixon R; The T44 model features significant neuro...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Nixon Ralph A","id":"urn:lsid:swan.org:researchstatement:1f1a369f-1085-496f-82a1-c93c85d5a349"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d301f61c-6951-4b27-8fd9-5f37c4434b34&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d301f61c-6951-4b27-8fd9-5f37c4434b34","type":"Claim","title":"Paranuclei formed by A&#946;42 may be important therapeutic targets.","label":"Bitan G et al.; Paranuclei formed by A&#946;42 may be im...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:d301f61c-6951-4b27-8fd9-5f37c4434b34"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6aeff276-4065-4c11-a147-67fdd780bbd6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6aeff276-4065-4c11-a147-67fdd780bbd6","type":"Claim","title":"A subsequent phase IIa AN1792 clinical study, halted when 6% of the patients developed meningoencephalitis.","label":"Holmes C et al.; A subsequent phase IIa AN1792 clinical s...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:6aeff276-4065-4c11-a147-67fdd780bbd6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:40a7b4ef-a21e-4e21-9b2f-150547793d14&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:40a7b4ef-a21e-4e21-9b2f-150547793d14","type":"Claim","title":"Soluble forms of aggregated Aβ correlate best with histopathologic changes.","label":"Hartley D et al.; Soluble forms of aggregated Aβ correlate...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:40a7b4ef-a21e-4e21-9b2f-150547793d14"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1d6ce6d9-466e-4a27-9466-348706d83382&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1d6ce6d9-466e-4a27-9466-348706d83382","type":"Claim","title":"The accumulation of APP proteolytic fragments downregulates the enhanced paired pulse facilitation imparted by mutant PS1.","label":"Smith I et al.; The accumulation of APP proteolytic frag...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:1d6ce6d9-466e-4a27-9466-348706d83382"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e8182e4f-8212-4b72-90b5-119ca42aebc7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e8182e4f-8212-4b72-90b5-119ca42aebc7","type":"Claim","title":"Stimulation of PKC and inhibition of protein phosphatases 1 and/or 2A in intact cells also results in the production of C-terminal fragment","label":"Suzuki T et al.; Stimulation of PKC and inhibition of pro...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:e8182e4f-8212-4b72-90b5-119ca42aebc7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8d9947d5-7402-4066-95a6-6a5a01275bb4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8d9947d5-7402-4066-95a6-6a5a01275bb4","type":"Claim","title":"reuse","label":"Jack C et al.; reuse","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","id":"urn:lsid:swan.org:researchstatement:8d9947d5-7402-4066-95a6-6a5a01275bb4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a01b2195-0c8f-434a-a4a3-94f55f8d23d1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a01b2195-0c8f-434a-a4a3-94f55f8d23d1","type":"Claim","title":"AD brain extracts incubated with cultured rat hippocampal neurons and stained with oligomer-selective antibodies demonstrate abundant, punctate staining pattern of ADDLs along neurites, resembling synaptic terminals.","label":"Gong Y et al.; AD brain extracts incubated with culture...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:a01b2195-0c8f-434a-a4a3-94f55f8d23d1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:20bfb773-e6d0-493e-9192-cbecddc31435&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:20bfb773-e6d0-493e-9192-cbecddc31435","type":"Claim","title":"IDE is only able to degrade Aβ monomers.","label":"Tanzi R et al.; IDE is only able to degrade Aβ monomers.","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:20bfb773-e6d0-493e-9192-cbecddc31435"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fa1c023f-65cc-4ab1-8c83-9a030e2843d3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fa1c023f-65cc-4ab1-8c83-9a030e2843d3","type":"Claim","title":"The overexpression of SIRT1, but not SIRT1 lacking catalytic activity (H363Y), protected against SOD1G93A toxicity (52 versus 32.3%).","label":"Kim D et al.; The overexpression of SIRT1, but not SIR...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:fa1c023f-65cc-4ab1-8c83-9a030e2843d3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3361830e-07c6-4b9b-a9ce-fe32f66bb41d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3361830e-07c6-4b9b-a9ce-fe32f66bb41d","type":"Claim","title":"Mammalian homologue nSMase2 is highly expressed in the brain.","label":"Mammalian homologue nSMase2 is highly ex...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:3361830e-07c6-4b9b-a9ce-fe32f66bb41d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:eba3873c-821c-47f0-a554-39938e28f2bd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:eba3873c-821c-47f0-a554-39938e28f2bd","type":"Question","title":"An important question raised by the present results concerns the potential function of APP phosphorylation by cdc2 kinase in the adult nervous system.","label":"An important question raised by the pres...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:eba3873c-821c-47f0-a554-39938e28f2bd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2cd70aaa-5255-43d2-bc32-c8f7c260ee20&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2cd70aaa-5255-43d2-bc32-c8f7c260ee20","type":"Claim","title":"Multimerization of APP by Aβ contributes to neurotoxicity.","label":"Lu D et al.; Multimerization of APP by Aβ contributes...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Shaked Gideon M","Masliah Eliezer","Bredesen Dale E","Koo Edward H"],"firstAuthor":"Lu Daniel C","referenceYear":"2003","referenceDate":"2003-12","id":"urn:lsid:swan.org:researchstatement:2cd70aaa-5255-43d2-bc32-c8f7c260ee20"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8691d964-6209-4db2-b02d-3b9130180eb8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8691d964-6209-4db2-b02d-3b9130180eb8","type":"Claim","title":"Recent reports suggest that soluble Aβ may be better correlated to both neurodegeneration and memory impairment.","label":"Dodart J et al.; Recent reports suggest that soluble Aβ m...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:8691d964-6209-4db2-b02d-3b9130180eb8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0e9ca79d-0ea0-4bfc-8242-aa2fb19f4222&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0e9ca79d-0ea0-4bfc-8242-aa2fb19f4222","type":"Claim","title":"Transgenic or Knock-out mouse models do not reveal a role of genetic modification, due to redundant mechanisms to regulate cholesterol homeostasis and distribution.","label":"Transgenic or Knock-out mouse models do ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:0e9ca79d-0ea0-4bfc-8242-aa2fb19f4222"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:c7c14b18-0717-45fe-8051-8f1703c17854&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:c7c14b18-0717-45fe-8051-8f1703c17854","type":"Comment","title":"Abraham comment on Pollio et al hypothesis \"Increased expression of the oligopeptidase THOP1 is a neuroprotective response to Aβ toxicity.\"","label":"Abraham C; Abraham comment on Pollio et al hypothes...","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Abraham C R","id":"urn:lsid:swan.org:comment:c7c14b18-0717-45fe-8051-8f1703c17854"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3352c4fa-73a8-4574-bca8-2f37bdf92f43&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3352c4fa-73a8-4574-bca8-2f37bdf92f43","type":"Claim","title":"Taxol, an MT-stabilizing drug, causes an increased rate of fast axonal transport.","label":"Lee V et al.; Taxol, an MT-stabilizing drug, causes an...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Trojanowski John Q"],"firstAuthor":"Lee Virginia M-Y","id":"urn:lsid:swan.org:researchstatement:3352c4fa-73a8-4574-bca8-2f37bdf92f43"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:121bd65e-a6ff-4376-88fe-feda0275adbd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:121bd65e-a6ff-4376-88fe-feda0275adbd","type":"Claim","title":"Current data imply a high-affinity cell-surface receptor for soluble amyloid-beta oligomers on neurons\u2014one that is central to the pathophysiological process in Alzheimer\u2019s disease.","label":"Laurén J et al.; Current data imply a high-affinity cell-...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Gimbel David A","Nygaard Haakon B","Gilbert John W","Strittmatter Stephen M"],"firstAuthor":"Laurén Juha","referenceYear":"2009","referenceDate":"2009-02-26","id":"urn:lsid:swan.org:researchstatement:121bd65e-a6ff-4376-88fe-feda0275adbd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:eec93bfc-d3a8-4061-a238-f1b32fbfb797&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:eec93bfc-d3a8-4061-a238-f1b32fbfb797","type":"Claim","title":"Aging is associated with progressive oxidation of circulating lipoprotein, leads to both intracellular accumulation of oxidized esters in lysosomes.","label":"Aging is associated with progressive oxi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:eec93bfc-d3a8-4061-a238-f1b32fbfb797"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d651d2c3-2289-4f7c-b132-f9a96a3f22f6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d651d2c3-2289-4f7c-b132-f9a96a3f22f6","type":"Claim","title":"Fyn may be activated by conventional Aβ, and Fyn knockout mice have reduced apoptosis in developing hippocampus.","label":"Lambert M et al.; Fyn may be activated by conventional Aβ,...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:d651d2c3-2289-4f7c-b132-f9a96a3f22f6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:00190cd4-eb36-4cf6-a148-c562ac2ed73b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:00190cd4-eb36-4cf6-a148-c562ac2ed73b","type":"Comment","title":"Grune on Keck hypothesis: \u201cProteasomal system dysfunction causes neurodegeneration in AD.\"","label":"Grune T; Grune on Keck hypothesis: \u201cProteasomal s...","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Grune Tilman","id":"urn:lsid:swan.org:comment:00190cd4-eb36-4cf6-a148-c562ac2ed73b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0c141287-480a-4ca3-ad82-e8718198bf4f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0c141287-480a-4ca3-ad82-e8718198bf4f","type":"Claim","title":"In the absence of endogenous murine apoE, APPsw mice still develop Aβ deposits, but the vast majority of the plaques are nonfibrillar, and the formation of CAA and CAA-associated hemorrhage is completely absent even at very old ages.","label":"Fryer J et al.; In the absence of endogenous murine apoE...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:0c141287-480a-4ca3-ad82-e8718198bf4f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:14bbaa83-0f18-4003-8fce-6e73a7933bb9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:14bbaa83-0f18-4003-8fce-6e73a7933bb9","type":"Hypothesis","title":"Cytoplasmic tail of APP forms transcriptionally active complex with Fe65 and histone acetyltransferase Tip60.","label":"Cao X et al.; Cytoplasmic tail of APP forms transcript...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Südhof T C"],"firstAuthor":"Cao X","referenceYear":"2001","referenceDate":"2001-07-06","id":"urn:lsid:swan.org:researchstatement:14bbaa83-0f18-4003-8fce-6e73a7933bb9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9c1ee3d7-7b0c-4214-8e51-d7559a6f02cf&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9c1ee3d7-7b0c-4214-8e51-d7559a6f02cf","type":"Claim","title":"Heterozygous (TARDBP+/−) mutant mice showed high expression levels of TDP-43 in various regions of the central nervous system affected in neurodegenerative disorders. ","label":"Warraich S et al.; Heterozygous (TARDBP+/−) mutant mice sho...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Yang Shu","Nicholson Garth A","Blair Ian P"],"firstAuthor":"Warraich Sadaf T","referenceYear":"2010","referenceDate":"2010-06-25","id":"urn:lsid:swan.org:researchstatement:9c1ee3d7-7b0c-4214-8e51-d7559a6f02cf"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:12c5f818-5ecf-4a65-8276-36f99fc06ac6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:12c5f818-5ecf-4a65-8276-36f99fc06ac6","type":"Claim","title":"As a variant of the double hit hypothesis, acute damage response may segue into chronic damage causation, and this hypothesis is consistent with the amyloid hypothesis but with the important distinction that a \u201csecond hit\u201d is vascular damage that can both initiate amyloid damage or be caused by this deposition.","label":"Hardy ; As a variant of the double hit hypothesi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Hardy","referenceYear":"2009","referenceDate":"2009-05-18","id":"urn:lsid:swan.org:researchstatement:12c5f818-5ecf-4a65-8276-36f99fc06ac6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e4cb46a3-50ef-40c5-a515-930f369522ec&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e4cb46a3-50ef-40c5-a515-930f369522ec","type":"Claim","title":"Treatment of distal axons with ceramide inhibits uptake of LDL-associated cholesterol, which is involved in synaptogenesis.","label":"Treatment of distal axons with ceramide ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:e4cb46a3-50ef-40c5-a515-930f369522ec"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8993ce43-4a0e-4c39-966d-97ef4816c399&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8993ce43-4a0e-4c39-966d-97ef4816c399","type":"Claim","title":"Genetic manipulations to inhibit apoptosis did not block axonal degeneration in some models. ","label":"Nikolaev A et al.; Genetic manipulations to inhibit apoptos...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["McLaughlin Todd","O'Leary Dennis D","Tessier-Lavigne Marc"],"firstAuthor":"Nikolaev Anatoly","referenceYear":"2009","referenceDate":"2009-02-19","id":"urn:lsid:swan.org:researchstatement:8993ce43-4a0e-4c39-966d-97ef4816c399"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8e32bac5-6a23-4862-a48f-8e87db4b112b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8e32bac5-6a23-4862-a48f-8e87db4b112b","type":"Claim","title":"GSK3 can also be phosphorylated at Ser9/21 by p70 ribosomal S6 kinase-1 (S6K1) and by 90 kDa ribosomal protein S6 kinase (RSK), a downstream mediator of mitogen-activated protein kinase (MAPK) signaling.","label":"Hooper C et al.; GSK3 can also be phosphorylated at Ser9/...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:8e32bac5-6a23-4862-a48f-8e87db4b112b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:98298730-5bde-4c68-89df-b858fba95dc3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:98298730-5bde-4c68-89df-b858fba95dc3","type":"Claim","title":"DNA degradation occurs in both apoptosis and necrosis, both apoptotic and necrotic DNA strand breaks can be labeled by enzymes such as TdT.","label":"Cotman C et al.; DNA degradation occurs in both apoptosis...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:98298730-5bde-4c68-89df-b858fba95dc3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:24f3938b-430c-460a-8ff0-d073d8c6fec3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:24f3938b-430c-460a-8ff0-d073d8c6fec3","type":"Claim","title":"Apoptosis, also called programmed cell death (PCD), is a mechanism by which the cells program their own death","label":"Cotman C et al.; Apoptosis, also called programmed cell d...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:24f3938b-430c-460a-8ff0-d073d8c6fec3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b863c91a-b8d3-4573-9b1b-a28e158222a7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b863c91a-b8d3-4573-9b1b-a28e158222a7","type":"Claim","title":"Conversion of Aβ from a soluble form to fibrillar form occurs via \u201cseeded\u201d polymerization of Aβ40 and Aβ42.","label":"Holtzman D; Conversion of Aβ from a soluble form to ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:b863c91a-b8d3-4573-9b1b-a28e158222a7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:512a72f6-b62d-4f98-82b1-d002326281af&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:512a72f6-b62d-4f98-82b1-d002326281af","type":"Claim","title":"The most straightforward prediction of the presenilin inhibition hypothesis, that presenilin mutant mice would show tau related neurodegeneration, does not occur and the suggestion that some presenilin mutations may lead directly to tangle disease in humans, is probably not correct.","label":"Hardy ; The most straightforward prediction of t...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Hardy","referenceYear":"2009","referenceDate":"2009-05-18","id":"urn:lsid:swan.org:researchstatement:512a72f6-b62d-4f98-82b1-d002326281af"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:78c06b30-8674-4353-8c98-5c5a6d108861&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:78c06b30-8674-4353-8c98-5c5a6d108861","type":"Claim","title":"Resveratrol protected against neurotoxicity elicited by expression of SOD1G93A.","label":"Kim D et al.; Resveratrol protected against neurotoxic...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:78c06b30-8674-4353-8c98-5c5a6d108861"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a2988820-58c1-4066-aa2e-523ff3c75ca9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a2988820-58c1-4066-aa2e-523ff3c75ca9","type":"Claim","title":"In AD brains the proteasome system was not impaired primarily, but was altered secondarily as a consequence of the binding of PHF-tau.","label":"Keck S et al.; In AD brains the proteasome system was n...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:a2988820-58c1-4066-aa2e-523ff3c75ca9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:5d935363-0b82-435d-8eb0-cc310246faa4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:5d935363-0b82-435d-8eb0-cc310246faa4","type":"Comment","title":"Tycko comment on Bitan hypothesis \u201cOligomerization of Aβ 40 and 42 occurs via distinct pathways.\u201d","label":"Tycko R; Tycko comment on Bitan hypothesis \u201cOligo...","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Tycko Robert","referenceYear":"2002","referenceDate":"2002-12-24","id":"urn:lsid:swan.org:comment:5d935363-0b82-435d-8eb0-cc310246faa4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9621675d-fe5c-482d-b65d-6363c7586255&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9621675d-fe5c-482d-b65d-6363c7586255","type":"Claim","title":"Aβ42 monomers had no effect on ERK1/2 phosphorylation but activated the PI-3-K pathway, as shown by an enhanced phosphorylation of Akt.","label":"Giuffrida M et al.; Aβ42 monomers had no effect on ERK1/2 ph...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Caraci Filippo","Pignataro Bruno","Cataldo Sebastiano","De Bona Paolo","Bruno Valeria","Molinaro Gemma","Pappalardo Giuseppe","Messina Angela","Palmigiano Angelo","Garozzo Domenico","Nicoletti Ferdinando","Rizzarelli Enrico","Copani Agata"],"firstAuthor":"Giuffrida Maria Laura","referenceYear":"2009","referenceDate":"2009-08-26","id":"urn:lsid:swan.org:researchstatement:9621675d-fe5c-482d-b65d-6363c7586255"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e8ddce5c-9fe9-4458-afd1-7151b3bf5153&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e8ddce5c-9fe9-4458-afd1-7151b3bf5153","type":"Claim","title":"The accumulation of ubiquitinated tau proteins in cells could arise due to the blockade of a ubiquitin-dependent tau degradation pathway or inappropriate shuttling to the ubiquitin-dependent pathway from a preferred route.","label":"Carrettiero D et al.; The accumulation of ubiquitinated tau pr...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hernandez Israel","Neveu Pierre","Papagiannakopoulos Thales","Kosik Kenneth S"],"firstAuthor":"Carrettiero Daniel C","referenceYear":"2009","referenceDate":"2009-02-18","id":"urn:lsid:swan.org:researchstatement:e8ddce5c-9fe9-4458-afd1-7151b3bf5153"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5b12500d-fd7a-46a2-b586-8b2f36f24223&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5b12500d-fd7a-46a2-b586-8b2f36f24223","type":"Claim","title":"In addition to morphological changes and DNA damage, apoptosis induces the expression of the immediate early gene c-Jun.","label":"Cotman C et al.; In addition to morphological changes and...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:5b12500d-fd7a-46a2-b586-8b2f36f24223"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1860e14b-0a7a-40e3-a73f-478fe5c96b7a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1860e14b-0a7a-40e3-a73f-478fe5c96b7a","type":"Hypothesis","title":"\"Fatal attractions\" between brain proteins are the key pathological events underlying Alzheimer disease.","label":"Trojanowski J et al.; \"Fatal attractions\" between brain protei...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Lee V M"],"firstAuthor":"Trojanowski J Q","referenceYear":"2000","referenceDate":"2000","id":"urn:lsid:swan.org:researchstatement:1860e14b-0a7a-40e3-a73f-478fe5c96b7a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1e787957-894d-4ff8-a6f0-7978010b7ea8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1e787957-894d-4ff8-a6f0-7978010b7ea8","type":"Hypothesis","title":"Amyloid beta oligomers induce impairment of neuronal insulin receptors.","label":"Zhao W et al.; Amyloid beta oligomers induce impairment...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["De Felice Fernanda G","Fernandez Sara","Chen Hui","Lambert Mary P","Quon Michael J","Krafft Grant A","Klein William L"],"firstAuthor":"Zhao Wei-Qin","referenceYear":"2008","referenceDate":"2008-01","id":"urn:lsid:swan.org:researchstatement:1e787957-894d-4ff8-a6f0-7978010b7ea8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4d5c6119-2ea0-4309-87af-2fe6a56036d8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4d5c6119-2ea0-4309-87af-2fe6a56036d8","type":"Claim","title":"Insulin-induced change in CSF Aβ42 correlates with F2-Isoprostane (lipid peroxidation markers) change for OLDEST normal adults (>70 years age). ","label":"Craft S; Insulin-induced change in CSF Aβ42 corre...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft Suzanne","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:4d5c6119-2ea0-4309-87af-2fe6a56036d8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6ac9fd8e-e0b6-4cad-a3f3-263558a8028a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6ac9fd8e-e0b6-4cad-a3f3-263558a8028a","type":"Claim","title":"Analysis of in vitro Aβ42 oligomerization can generate artifactual results.","label":"LaDu M; Analysis of in vitro Aβ42 oligomerizatio...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"LaDu Mary Jo","id":"urn:lsid:swan.org:researchstatement:6ac9fd8e-e0b6-4cad-a3f3-263558a8028a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c93c19cc-f020-4a08-9d46-bc5b841112ee&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c93c19cc-f020-4a08-9d46-bc5b841112ee","type":"Claim","title":"Aβ1-40 and Aβ1-42 induces the enhancement of IKV current, whereas \"toxic fragment\" Aβ25-35 had no effect.","label":"Plant L et al.; Aβ1-40 and Aβ1-42 induces the enhancemen...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:c93c19cc-f020-4a08-9d46-bc5b841112ee"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:39711e39-8bcc-4dfe-a1af-8ff069860426&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:39711e39-8bcc-4dfe-a1af-8ff069860426","type":"Claim","title":"PS1 mutations are assumed to cause AD through a gain of function, increasing γ-cleavage of APP.","label":"Marchesi V; PS1 mutations are assumed to cause AD th...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:39711e39-8bcc-4dfe-a1af-8ff069860426"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:038b5fe6-7ade-4ebc-82c2-25ebad6dff5b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:038b5fe6-7ade-4ebc-82c2-25ebad6dff5b","type":"Claim","title":"In contrast to NEP cellular localization on the plasma membrane, most IDE is localized in the cytosol, while only a small fraction resides in the membrane.","label":"Tanzi R et al.; In contrast to NEP cellular localization...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:038b5fe6-7ade-4ebc-82c2-25ebad6dff5b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:80ed24c7-74f6-4d25-a943-451682d7c6c1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:80ed24c7-74f6-4d25-a943-451682d7c6c1","type":"Claim","title":"Plaques were not observed being cleared by an activated microglial response.","label":"Meyer-Luehmann M et al.; Plaques were not observed being cleared ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:80ed24c7-74f6-4d25-a943-451682d7c6c1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a378d1d7-83e0-443d-997e-5cbf921097e5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a378d1d7-83e0-443d-997e-5cbf921097e5","type":"Claim","title":"Transport impairments have been associated so far only with very high tau expression, although the emergence of pathological effects at any level of tau overexpression may be influenced by additional vulnerabilities of the animal contributed by genotype and phenotype.","label":"Nixon R; Transport impairments have been associat...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Nixon Ralph A","id":"urn:lsid:swan.org:researchstatement:a378d1d7-83e0-443d-997e-5cbf921097e5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cf56dff4-6c20-4e4c-bc7f-0c4c1b1cb510&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cf56dff4-6c20-4e4c-bc7f-0c4c1b1cb510","type":"Claim","title":"Internalization of Aβ42 is facilitated by its binding to the α7nicotinic acetylcholine receptor on neuronal cell surfaces, followed by endocytosis of the resulting complex and its accumulation within the lysosomal compartment.","label":"Dziewczapolski G et al.; Internalization of Aβ42 is facilitated b...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Glogowski Carolina M","Masliah Eliezer","Heinemann Stephen F"],"firstAuthor":"Dziewczapolski Gustavo","referenceYear":"2009","referenceDate":"2009-07-08","id":"urn:lsid:swan.org:researchstatement:cf56dff4-6c20-4e4c-bc7f-0c4c1b1cb510"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1a6c7f84-541e-4664-b849-0244a011471e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1a6c7f84-541e-4664-b849-0244a011471e","type":"Claim","title":"No alternative hypothesis with as much experimental support as the amyloid hypothesis can explain the cause and pathogenesis of AD, despite discussion on the deficiencies of the amyloid hypothesis.","label":"Hardy J et al.; No alternative hypothesis with as much e...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:1a6c7f84-541e-4664-b849-0244a011471e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:40dc1a30-6b2e-4531-b63d-6c9cd6d04462&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:40dc1a30-6b2e-4531-b63d-6c9cd6d04462","type":"Claim","title":"Aβ has been shown to spontaneously form voltage-dependent cation selective channels in lipid bilayers that can conduct calcium.","label":"Smith I et al.; Aβ has been shown to spontaneously form ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:40dc1a30-6b2e-4531-b63d-6c9cd6d04462"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:184e8de8-0c1b-4920-b4be-3d37462ab5fc&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:184e8de8-0c1b-4920-b4be-3d37462ab5fc","type":"Claim","title":"There are many neurons that exhibit apoptotic morphology and markers and show DNA damage, but do not show indications of tau tangle formation.","label":"Cotman C et al.; There are many neurons that exhibit apop...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:184e8de8-0c1b-4920-b4be-3d37462ab5fc"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a566f901-2278-477d-b593-69c06572fc56&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a566f901-2278-477d-b593-69c06572fc56","type":"Claim","title":"BACE1-null mice tend to have a lowered threshold for epileptiform activity after kainate (KA) administration, exhibit greater susceptibility and significantly higher seizure severity scores to KA-induced seizures than wild-type controls suggesting that genetic deletion of BACE1 in mice leads to increased neuronal excitability and enhanced synchronous neuronal firing.","label":"Hu X et al.; BACE1-null mice tend to have a lowered t...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhou Xiangdong","He Wanxia","Yang Jun","Xiong Wencheng","Wong Philip","Wilson Christopher G","Yan Riqiang"],"firstAuthor":"Hu Xiangyou","referenceYear":"2010","referenceDate":"2010-06-30","id":"urn:lsid:swan.org:researchstatement:a566f901-2278-477d-b593-69c06572fc56"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d657143e-aeb7-4098-9710-7a833be161a3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d657143e-aeb7-4098-9710-7a833be161a3","type":"Claim","title":"Amyloid load as measured with an in vivo imaging probe does not change as the clinical condition deteriorates.","label":"Holmes C et al.; Amyloid load as measured with an in vivo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:d657143e-aeb7-4098-9710-7a833be161a3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ece32a87-66d7-4ea9-8ab8-eef0ffcc4ae2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ece32a87-66d7-4ea9-8ab8-eef0ffcc4ae2","type":"Claim","title":"Cellular prion protein (PrPC) is a mediator of Aβ oligomer-induced synaptic dysfunction, and PrPC-specific pharmaceuticals may have therapeutic potential for Alzheimer\u2019s disease.","label":"Laurén J et al.; Cellular prion protein (PrPC) is a media...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Gimbel David A","Nygaard Haakon B","Gilbert John W","Strittmatter Stephen M"],"firstAuthor":"Laurén Juha","referenceYear":"2009","referenceDate":"2009-02-26","id":"urn:lsid:swan.org:researchstatement:ece32a87-66d7-4ea9-8ab8-eef0ffcc4ae2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ee9ce69c-777c-4da7-97c2-ad39784f91ad&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ee9ce69c-777c-4da7-97c2-ad39784f91ad","type":"Claim","title":"In contrast to previous observations, we find increased THOP1 protein levels in AD tissue and an age-dependent hippocampal increase in a transgenic mouse model of plaque deposition.","label":"Pollio G et al.; In contrast to previous observations, we...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Hoozemans Jeroen J","Andersen Claus A","Roncarati Renza","Rosi Maria Cristina","van Haastert Elise S","Seredenina Tamara","Diamanti Daniela","Gotta Stefano","Fiorentini Anna","Magnoni Letizia","Raggiaschi Roberto","Rozemuller Annemieke J","Casamenti Fiorella","Caricasole Andrea","Terstappen Georg C"],"firstAuthor":"Pollio Giuseppe","referenceYear":"2008","referenceDate":"2008-07","id":"urn:lsid:swan.org:researchstatement:ee9ce69c-777c-4da7-97c2-ad39784f91ad"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2035f1a8-0b97-4621-a2fe-9e3461381797&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2035f1a8-0b97-4621-a2fe-9e3461381797","type":"Claim","title":"Almost all other regions of interest (ROIs) and total mean cortical thickness were reduced in the patients with mild AD who do not carry at least one APOE ε4 allele (\u201cnoncarriers\u201d) reaching statistical significance in several regions, including the superior parietal lobule, precuneus, and angular gyrus. Additionally, the superior frontal gyrus and overall mean cortical thickness approached significance.","label":"Wolk D et al.; Almost all other regions of interest (RO...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Dickerson Bradford C","Weiner Michael","Aiello Marilyn","Aisen Paul","Albert Marilyn S","Alexander Gene","Anderson Heather S","Anderson Karen","Apostolova Liana","Arnold Steve","Ashford Wes","Assaly Michele","Asthana Sanjay","Bandy Dan","Bartha Rob","Bates Vernice","Beckett Laurel","Bell Karen L","Benincasa Amanda L","Bergman Howard","Bernick Charles","Bernstein Matthew","Black Sandra","Blank Karen","Borrie Michael","Brand Connie","Brewer James","Brown Alice D","Burns Jeffrey M","Cairns Nigel J","Caldwell Curtis","Capote Horacio","Carlsson Cynthia M","Carmichael Owen","Cellar Janet S","Celmins Dzintra","Chen Kewei","Chertkow Howard","Chowdhury Munir","Clark David","Connor Donald","Correia Stephen","Crawford Karen","Dale Anders","de Leon Mony J","De Santi Susan M","Decarli Charles","Detoledo-Morrell Leyla","Devous Michael","Diaz-Arrastia Ramon","Dolen Sara","Donohue Michael","Doody Rachelle S","Doraiswamy P Murali","Duara Ranjan","Englert Jessica","Farlow Martin","Feldman Howard","Felmlee Joel","Fleisher Adam","Fletcher Evan","Foroud Tatiana M","Foster Norm","Fox Nick","Frank Richard","Gamst Anthony","Given Curtis A","Graff-Radford Neill R","Green Robert C","Griffith Randall","Grossman Hillel","Hake Ann M","Hardy Peter","Harvey Danielle","Heidebrink Judith L","Hendin Barry A","Herring Scott","Honig Lawrence S","Hosein Chris","Robin Hsiung Ging-Yuek","Hudson Leon","Ismail M Saleem","Jack Clifford R","Jacobson Sandra","Jagust William","Jayam-Trouth Annapurni","Johnson Kris","Johnson Heather","Johnson Nancy","Johnson Kathleen","Johnson Keith A","Johnson Sterling","Kachaturian Zaven","Karlawish Jason H","Kataki Maria","Kaye Jeffrey","Kertesz Andrew","Killiany Ronald","Kittur Smita","Koeppe Robert A","Korecka Magdalena","Kornak John","Kozauer Nicholas","Lah James J","Laubinger Mary M","Lee Virginia M-Y","Lee T-Y","Lerner Alan","Levey Allan I","Longmire Crystal Flynn","Lopez Oscar L","Lord Joanne L","Lu Po H","Macavoy Martha G","Malloy Paul","Marson Daniel","Martin-Cook Kristen","Martinez Walter","Marzloff George","Mathis Chet","Mc-Adams-Ortiz Catherine","Mesulam Marsel","Miller Bruce L","Mintun Mark A","Mintzer Jacobo","Molchan Susan","Montine Tom","Morris John","Mulnard Ruth A","Munic Donna","Nair Anil","Neu Scott","Nguyen Dana","Norbash Alexander","Oakley Maryann","Obisesan Thomas O","Ogrocki Paula","Ott Brian R","Parfitt Francine","Pawluczyk Sonia","Pearlson Godfrey","Petersen Ronald","Petrella Jeffrey R","Potkin Steven","Potter William Z","Preda Adrian","Quinn Joseph","Rainka Michelle","Reeder Stephanie","Reiman Eric M","Rentz Dorene M","Reynolds Brigid","Richard Jennifer","Roberts Peggy","Rogers John","Rosen Allyson","Rosen Howard J","Rusinek Henry","Sabbagh Marwan","Sadowsky Carl","Salloway Stephen","Santulli Robert B","Saykin Andrew J","Scharre Douglas W","Schneider Lon","Schneider Stacy","Schuff Norbert","Shah Raj C","Shaw Les","Shen Li","Silverman Daniel H","Simpson Donna M","Sink Kaycee M","Smith Charles D","Snyder Peter J","Spann Bryan M","Sperling Reisa A","Spicer Kenneth","Stefanovic Bojana","Stern Yaakov","Stopa Edward","Tang Cheuk","Tariot Pierre","Taylor-Reinwald Lisa","Thai Gaby","Thomas Ronald G","Thompson Paul","Tinklenberg Jared","Toga Arthur W","Tremont Geoffrey","Trojanowki J Q","Trost Dick","Turner Raymond Scott","van Dyck Christopher H","Vanderswag Helen","Varon Daniel","Villanueva-Meyer Javier","Villena Teresa","Walter Sarah","Wang Paul","Watkins Franklin","Weiner Michael","Williamson Jeff D","Wolk David","Wu Chuang-Kuo","Zerrate Maria","Zimmerman Earl A"],"firstAuthor":"Wolk David A","referenceYear":"2010","referenceDate":"2010-05-17","id":"urn:lsid:swan.org:researchstatement:2035f1a8-0b97-4621-a2fe-9e3461381797"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:52179e72-64f1-4c32-8a3c-6193eb5fccd0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:52179e72-64f1-4c32-8a3c-6193eb5fccd0","type":"Claim","title":"GSK3 overactivity may lead to elevation of Aβ by affecting the enzymatic processing of APP.","label":"Small S et al.; GSK3 overactivity may lead to elevation ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:52179e72-64f1-4c32-8a3c-6193eb5fccd0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:41513659-fdee-4c21-ac4d-a49e22b2739f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:41513659-fdee-4c21-ac4d-a49e22b2739f","type":"Claim","title":"Knockdown of p53 provided a 25% increase in cell survival, which is similar to what was observed for resveratrol-treated neurons.","label":"Kim D et al.; Knockdown of p53 provided a 25% increase...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:41513659-fdee-4c21-ac4d-a49e22b2739f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7a57a738-6d29-4dd6-bed4-42a704da4919&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7a57a738-6d29-4dd6-bed4-42a704da4919","type":"Hypothesis","title":"Infiltration of the brain by pathogens causes Alzheimer's disease.","label":"Itzhaki R et al.; Infiltration of the brain by pathogens c...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Wozniak M A","Appelt D M","Balin B J"],"firstAuthor":"Itzhaki R F","referenceYear":"2004","referenceDate":"2004","id":"urn:lsid:swan.org:researchstatement:7a57a738-6d29-4dd6-bed4-42a704da4919"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:09e91212-5de7-44f0-912c-f7dd73dbd3cb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:09e91212-5de7-44f0-912c-f7dd73dbd3cb","type":"Claim","title":"Proteinopathy will largely activate the innate immune system.","label":"Golde T et al.; Proteinopathy will largely activate the ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:09e91212-5de7-44f0-912c-f7dd73dbd3cb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:31db3615-6d89-486f-a659-07ce3063fa28&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:31db3615-6d89-486f-a659-07ce3063fa28","type":"Claim","title":"Interference with microtubule-dependent axonal transport is one possible mechanism by which altered tau exerts neurotoxicity.","label":"Yuan A et al.; Interference with microtubule-dependent ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:31db3615-6d89-486f-a659-07ce3063fa28"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:17e8ff8a-8a59-4ffd-b824-5a32dc71cfd1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:17e8ff8a-8a59-4ffd-b824-5a32dc71cfd1","type":"Hypothesis","title":"Microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype.","label":"Strittmatter W et al.; Microtubule instability and paired helic...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Weisgraber K H","Goedert M","Saunders A M","Huang D","Corder E H","Dong L M","Jakes R","Alberts M J","Gilbert J R"],"firstAuthor":"Strittmatter W J","referenceYear":"1994","referenceDate":"1994-02","id":"urn:lsid:swan.org:researchstatement:17e8ff8a-8a59-4ffd-b824-5a32dc71cfd1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0b2b3eb8-d83d-4cfd-9a81-2a32cf056015&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0b2b3eb8-d83d-4cfd-9a81-2a32cf056015","type":"Claim","title":"Cells have been observed with DNA damage in autopsy material in which AD pathology has not yet progressed sufficiently to meet the CERAD criteria for AD.","label":"Cotman C et al.; Cells have been observed with DNA damage...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:0b2b3eb8-d83d-4cfd-9a81-2a32cf056015"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:91dc4fd9-127b-4f26-8916-ad270ef6ec55&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:91dc4fd9-127b-4f26-8916-ad270ef6ec55","type":"Claim","title":"Alternative proteolytic processing of APP gives rise to the production and secretion of Aβ and this process may be elevated in certain types of Alzheimer Disease.","label":"Suzuki T et al.; Alternative proteolytic processing of AP...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:91dc4fd9-127b-4f26-8916-ad270ef6ec55"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:469a59a7-92a4-4337-b786-db666de63539&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:469a59a7-92a4-4337-b786-db666de63539","type":"Claim","title":"No conclusive evidence exists for changes in axonal transport rates after tau overexpression in vivo.","label":"Yuan A et al.; No conclusive evidence exists for change...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:469a59a7-92a4-4337-b786-db666de63539"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f29e8523-5115-4636-a396-21df4e1829e5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f29e8523-5115-4636-a396-21df4e1829e5","type":"Claim","title":"Regions of the human genome may contain genes that regulate Aβ levels or deposition.","label":"Golde T; Regions of the human genome may contain ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde Todd E","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:f29e8523-5115-4636-a396-21df4e1829e5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2ec55a2d-51a2-4780-ac59-863d6d122155&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2ec55a2d-51a2-4780-ac59-863d6d122155","type":"Claim","title":"Formation of tau into PHFs occurs in an abnormal state of phosphorylation, and it is generally thought that this phosphorylation plays a role in generating a '\u0098pathological conformation' of tau.","label":"Keck S et al.; Formation of tau into PHFs occurs in an ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:2ec55a2d-51a2-4780-ac59-863d6d122155"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:135ba036-8714-4500-8a93-0073f82efd68&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:135ba036-8714-4500-8a93-0073f82efd68","type":"Claim","title":"PS1 and PS2 alter APP metabolism through a direct effect on the γ-secretase protease.","label":"Hardy J et al.; PS1 and PS2 alter APP metabolism through...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:135ba036-8714-4500-8a93-0073f82efd68"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fd0a6dc4-e0cb-4f6c-8bce-2c437cb3c949&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fd0a6dc4-e0cb-4f6c-8bce-2c437cb3c949","type":"Hypothesis","title":"Advanced Aging Plus \"Risk Factors\" May Explain Late-Onset Sporadic Alzheimer's Diease","label":"Chen  et al.; Advanced Aging Plus \"Risk Factors\" May E...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Fernandez"],"firstAuthor":"Chen","referenceYear":"2000","referenceDate":"2000-06","id":"urn:lsid:swan.org:researchstatement:fd0a6dc4-e0cb-4f6c-8bce-2c437cb3c949"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4d445f56-fd60-457e-974b-4c94288911dd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4d445f56-fd60-457e-974b-4c94288911dd","type":"Claim","title":"APOE4 causes increased deposition of Aβ in the entorhinal cortex.","label":"Small S et al.; APOE4 causes increased deposition of Aβ ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:4d445f56-fd60-457e-974b-4c94288911dd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:edd7247c-3b62-4884-8ab1-dfeb0d582e1a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:edd7247c-3b62-4884-8ab1-dfeb0d582e1a","type":"Hypothesis","title":"The accumulation of misfolded protein aggregates can result in neurodegeneration.","label":"Golde T et al.; The accumulation of misfolded protein ag...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:edd7247c-3b62-4884-8ab1-dfeb0d582e1a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:dffc49cf-3da6-4b63-addb-12b6d8b276a7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:dffc49cf-3da6-4b63-addb-12b6d8b276a7","type":"Claim","title":"Since writing the article there are now four large scale anti-amyloid treatment clinical trials that have failed: removing Aβ using active immunization, passive immunization with bapineuzumab, reducing Aβ production by inhibiting the key γ-secretase enzymatic step with tarenflurbil, and dissolving amyloid deposits with Tramiprosate (now a nutraceutical called VIVIMIND™), all of which have failed to impact the clinical syndrome, even though they may have succeeded in eliminating brain amyloid.","label":"Bartzokis G; Since writing the article there are now ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","id":"urn:lsid:swan.org:researchstatement:dffc49cf-3da6-4b63-addb-12b6d8b276a7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:54cf88b6-2e17-41bb-868e-aab49f20264e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:54cf88b6-2e17-41bb-868e-aab49f20264e","type":"Claim","title":"No organelle or neurofilaments accumulated in either RGCs or optic axons of tau-null and 8c tau overexpressing mice compared with wild-type.","label":"Yuan A et al.; No organelle or neurofilaments accumulat...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:54cf88b6-2e17-41bb-868e-aab49f20264e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f03ccec9-9db9-4531-83c2-43dd85b5924b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f03ccec9-9db9-4531-83c2-43dd85b5924b","type":"Hypothesis","title":"TNF haplotype association with AD lends further support for an inflammatory process in the pathogenesis of AD.  ","label":"Collins J et al.; TNF haplotype association with AD lends ...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Perry Rodney T","Watson Bracie","Harrell  Lindy E","Acton Ronald T","Blacker Deborah","Albert Marilyn S","Tanzi Rudolph E","Bassett Susan S","McInnis M G","Campbell R Duncan","Go R C"],"firstAuthor":"Collins Julianne S","referenceYear":"2000","referenceDate":"2000-12-04","id":"urn:lsid:swan.org:researchstatement:f03ccec9-9db9-4531-83c2-43dd85b5924b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a026a56a-8a9b-4d3a-ae8c-db71e5a92d4b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a026a56a-8a9b-4d3a-ae8c-db71e5a92d4b","type":"Claim","title":"Neuronal cell cultures apoptose following NGF withdrawal; exogenous ceramide rescues this cell death.","label":"Neuronal cell cultures apoptose followin...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:a026a56a-8a9b-4d3a-ae8c-db71e5a92d4b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:506ee43b-a9af-49cc-88a3-ee31c7108e75&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:506ee43b-a9af-49cc-88a3-ee31c7108e75","type":"Hypothesis","title":"Cerebral Angiopathy Hypothesis of Alzheimer Disease: Neurofilament proteins are intrinsic components of amyloid plaque and affected blood vessels.","label":"Powers J et al.; Cerebral Angiopathy Hypothesis of Alzhei...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Schlaepfer W W","Willingham M C","Hall B J"],"firstAuthor":"Powers J M","referenceYear":"1981","referenceDate":"1981-11","id":"urn:lsid:swan.org:researchstatement:506ee43b-a9af-49cc-88a3-ee31c7108e75"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:0032e5f9-a35f-480f-a275-a86d51216522&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:0032e5f9-a35f-480f-a275-a86d51216522","type":"Question","title":"One interesting possibility that has not previously been considered is that elevated Aβ42 levels may inhibit γ-secretase activity through a product-based negative feedback mechanism, effectively mimicking the effects of PS mutations and γ-secretase inhibitors.","label":"One interesting possibility that has not...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:0032e5f9-a35f-480f-a275-a86d51216522"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:01c2350a-2cd0-4c5e-9246-a5c199e62495&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:01c2350a-2cd0-4c5e-9246-a5c199e62495","type":"Claim","title":"If soluble Aβ is involved in the memory impairment associated with AD, as suggested by several recent studies, then passive immunization with certain antibodies may rapidly reduce cognitive impairment in AD patients apart from any effect it may have on amyloid deposition.","label":"Dodart J et al.; If soluble Aβ is involved in the memory ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:01c2350a-2cd0-4c5e-9246-a5c199e62495"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e5bea4b8-fe13-40aa-8a5c-c7de3443a606&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e5bea4b8-fe13-40aa-8a5c-c7de3443a606","type":"Hypothesis","title":"ApoE interacts with Aβ peptide, influences Aβ conformation and clearance in vivo.","label":"Holtzman D; ApoE interacts with Aβ peptide, influenc...","icon":"../icons/ontological/discourse-element/h-research-statement.png","firstAuthor":"Holtzman David M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:e5bea4b8-fe13-40aa-8a5c-c7de3443a606"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0e396037-11e0-40f1-a19b-e6eb73626723&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0e396037-11e0-40f1-a19b-e6eb73626723","type":"Claim","title":"A weak but cell permeable γ-secretase inhibitor γ-IV decreases peak I<sub>KA<\/sub> and I<sub>KV<\/sub> currents.","label":"Plant L et al.; A weak but cell permeable γ-secretase in...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:0e396037-11e0-40f1-a19b-e6eb73626723"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:28d2c860-bf13-4c15-a67e-0c6bf13bf762&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:28d2c860-bf13-4c15-a67e-0c6bf13bf762","type":"Question","title":"What are the behavioral and functional consequences of reducing CNS tau levels over the life span?","label":"What are the behavioral and functional c...","icon":"../icons/ontological/discourse-element/research-question.png","otherAuthors":["Trojanowski John Q"],"firstAuthor":"Lee Virginia M-Y","id":"urn:lsid:swan.org:researchquestion:28d2c860-bf13-4c15-a67e-0c6bf13bf762"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e2241391-0795-487a-9510-0fc05d247598&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e2241391-0795-487a-9510-0fc05d247598","type":"Claim","title":"The hippocampus is known to be especially vulnerable to AD-related neurofibrillary tangles, neuronal loss, and brain atrophy. It is preferentially involved in AD-related memory impairment.","label":"Reiman E et al.; The hippocampus is known to be especiall...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Jennifer A","Myers Amanda J","Hardy John","Dunckley Travis","Zismann Victoria L","Joshipura Keta D","Pearson John V","Hu-Lince Diane","Huentelman Matthew J","Craig David W","Coon Keith D","Liang Winnie S","Herbert RiLee H","Beach Thomas","Rohrer Kristen C","Zhao Alice S","Leung Doris","Bryden Leslie","Marlowe Lauren","Kaleem Mona","Mastroeni Diego","Grover Andrew","Heward Christopher B","Ravid Rivka","Rogers Joseph","Hutton Michael L","Melquist Stacey","Petersen Ron C","Alexander Gene E","Caselli Richard J","Kukull Walter","Papassotiropoulos Andreas","Stephan Dietrich A"],"firstAuthor":"Reiman Eric M","referenceYear":"2007","referenceDate":"2007-06-07","id":"urn:lsid:swan.org:researchstatement:e2241391-0795-487a-9510-0fc05d247598"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:206112a8-d54c-4d25-b231-e10f72da86f0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:206112a8-d54c-4d25-b231-e10f72da86f0","type":"Claim","title":"Although not statistically significant, participants in this study with high anti-Aβ antibody titres had a more rapid clinical progression than did those with moderate anti-Aβ antibody titres.","label":"Holmes C et al.; Although not statistically significant, ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:206112a8-d54c-4d25-b231-e10f72da86f0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8d121de8-1573-4724-9dce-1aa1ac1ce5e6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8d121de8-1573-4724-9dce-1aa1ac1ce5e6","type":"Hypothesis","title":"Diffusible, nonfibrillar ligands derived from Aβ42 are potent central nervous system neurotoxins.","label":"Lambert M et al.; Diffusible, nonfibrillar ligands derived...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:8d121de8-1573-4724-9dce-1aa1ac1ce5e6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b472bcf2-2f95-43c4-bf4f-4902b2c64d33&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b472bcf2-2f95-43c4-bf4f-4902b2c64d33","type":"Claim","title":"Once Aβ assemblies have formed due to Tissue-transglutaminase activity, they should persist in vivo, resulting in a progressive buildup of Aβ.","label":"Hartley D et al.; Once Aβ assemblies have formed due to Ti...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:b472bcf2-2f95-43c4-bf4f-4902b2c64d33"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5bf09bbd-30e1-44ae-abbc-da23459913ca&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5bf09bbd-30e1-44ae-abbc-da23459913ca","type":"Claim","title":"Calcium dysregulation represents a critical molecular defect of AD that potentially can be attenuated with appropriate therapies.","label":"Smith I et al.; Calcium dysregulation represents a criti...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:5bf09bbd-30e1-44ae-abbc-da23459913ca"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1c31b1c0-fa89-4016-b75c-ecfef492024f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1c31b1c0-fa89-4016-b75c-ecfef492024f","type":"Claim","title":"Treatment of APP/PS1 transgenic mice with established senile plaques, with FK-506, a potent CaN inhibitor, resulted in a marked reduction in the number of beaded and dysmorphic processes and overall decrease in the resting calcium of calcium overloaded processes.","label":"Kuchibhotla K et al.; Treatment of APP/PS1 transgenic mice wit...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Goldman Samuel T","Lattarulo Carli R","Wu Hai-Yan","Hyman Bradley T","Bacskai Brian J"],"firstAuthor":"Kuchibhotla Kishore V","referenceYear":"2008","referenceDate":"2008-07-31","id":"urn:lsid:swan.org:researchstatement:1c31b1c0-fa89-4016-b75c-ecfef492024f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:954b25fe-e5ed-491f-b16f-720943f77da7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:954b25fe-e5ed-491f-b16f-720943f77da7","type":"Claim","title":"PS holoproteins have been found to function as passive ER calcium leak channels independent of γ-secretase  activity, and two FAD-associated mutations impaired this function.","label":"Shen J et al.; PS holoproteins have been found to funct...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:954b25fe-e5ed-491f-b16f-720943f77da7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b37097b1-6781-4b00-b55b-5d488917fec6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b37097b1-6781-4b00-b55b-5d488917fec6","type":"Hypothesis","title":"Loss of glutamatergic signalling in the hippocampus may be responsible for Alzheimer disease dementia.","label":"Greenamyre J et al.; Loss of glutamatergic signalling in the ...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Penney J B","D'Amato C J","Young A B"],"firstAuthor":"Greenamyre J T","referenceYear":"1987","referenceDate":"1987-02","id":"urn:lsid:swan.org:researchstatement:b37097b1-6781-4b00-b55b-5d488917fec6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:076efaa9-51d1-43ee-83bf-8ecf298a64eb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:076efaa9-51d1-43ee-83bf-8ecf298a64eb","type":"Claim","title":"Memory failure in APP transgenic mice is reversed by anti-Aβ; antibodies, and the memory recovery is rapid, occurring within 24 h of a single injection of antibody, without reducing amyloid plaque load.","label":"Gong Y et al.; Memory failure in APP transgenic mice is...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:076efaa9-51d1-43ee-83bf-8ecf298a64eb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:eb2fdeff-3846-4c52-a070-375d217b6e44&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:eb2fdeff-3846-4c52-a070-375d217b6e44","type":"Claim","title":"Accumulation of Aβ oligomers in AD pathology is consistent with results from transgenic mouse AD models, in which oligomers increase 100-fold in a regionally specific manner.","label":"Gong Y et al.; Accumulation of Aβ oligomers in AD patho...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:eb2fdeff-3846-4c52-a070-375d217b6e44"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0700f301-0758-47bb-ba21-4f7a7252b72e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0700f301-0758-47bb-ba21-4f7a7252b72e","type":"Claim","title":"Proteins such as Bcl-2, Bax and Ref-1 could be components of a dynamic and extended competition between cell death processes and compensatory responses in the AD brain.","label":"Cotman C et al.; Proteins such as Bcl-2, Bax and Ref-1 co...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:0700f301-0758-47bb-ba21-4f7a7252b72e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:87a9246a-ebb3-409a-9639-d1e8cbcaa2ed&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:87a9246a-ebb3-409a-9639-d1e8cbcaa2ed","type":"Claim","title":"Direct LRP-mediated removal of Aβ may be limited to the less fibrillogenic species of the peptide, Aβ40. In contrast, Aβ42 may still require prior binding to the LRP ligand/chaperones apoE and alpha2M to be effectively transported out of the CNS via LRP.","label":"Tanzi R et al.; Direct LRP-mediated removal of Aβ may be...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:87a9246a-ebb3-409a-9639-d1e8cbcaa2ed"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bb156d75-a79a-40f7-a223-041e97d05475&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bb156d75-a79a-40f7-a223-041e97d05475","type":"Claim","title":"Glutamate is an agent that performs major inhibitory functions, regulating inhibitory tone and ordinarily protecting the brain against its self-destructive potential; removing this inhibitory mechanism from certain networks unleashes complex excitotoxic forces that include glutamatergic, cholinergic, and other components.","label":"Olney J et al.; Glutamate is an agent that performs majo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:bb156d75-a79a-40f7-a223-041e97d05475"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8aa82a20-9f6a-4f1f-9b47-059d34726de6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8aa82a20-9f6a-4f1f-9b47-059d34726de6","type":"Hypothesis","title":"Elevated serum and cortical neuron levels of Leuteinizing Hormone could play important roles in the pathogenesis of Alzheimer disease.","label":"Bowen R et al.; Elevated serum and cortical neuron level...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Smith Mark A","Harris Peggy L","Kubat Zvezdana","Martins Ralph N","Castellani Rudolph J","Perry George","Atwood Craig S"],"firstAuthor":"Bowen Richard L","referenceYear":"2002","referenceDate":"2002-11-01","id":"urn:lsid:swan.org:researchstatement:8aa82a20-9f6a-4f1f-9b47-059d34726de6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:90f711bb-1979-4f58-82aa-a84afab3a47c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:90f711bb-1979-4f58-82aa-a84afab3a47c","type":"Claim","title":"CAD (Cath.a-differentiated) cells, a mouse neuronal cell line, which originates in the locus coeruleus in the brainstem, have neuronal phenotype when differentiated, with characteristics of catecholaminergic neurons. ","label":"Muresan Z et al.; CAD (Cath.a-differentiated) cells, a mou...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","id":"urn:lsid:swan.org:researchstatement:90f711bb-1979-4f58-82aa-a84afab3a47c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:44bc75ef-993c-4b1c-9082-7a272c8f72ec&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:44bc75ef-993c-4b1c-9082-7a272c8f72ec","type":"Claim","title":"Preclinical AD is not benign and will eventually produce sufficient synaptic and neuronal damage to cause cognitive decline and other symptoms of AD.","label":"Morris J et al.; Preclinical AD is not benign and will ev...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Roe Catherine M","Grant Elizabeth A","Head Denise","Storandt Martha","Goate Alison M","Fagan Anne M","Holtzman David M","Mintun Mark A"],"firstAuthor":"Morris John C","referenceYear":"2009","referenceDate":"2009-12","id":"urn:lsid:swan.org:researchstatement:44bc75ef-993c-4b1c-9082-7a272c8f72ec"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d8317696-3085-420d-a6e0-8d81e8d6d37c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d8317696-3085-420d-a6e0-8d81e8d6d37c","type":"Claim","title":"Mutations in tau cause frontotemporal dementia with parkinsonism (FTDP) and are not sufficient to induce amyloid plaque formation.","label":"Hardy J et al.; Mutations in tau cause frontotemporal de...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:d8317696-3085-420d-a6e0-8d81e8d6d37c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a4d2c593-aeee-4ada-ab61-f89a81240637&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a4d2c593-aeee-4ada-ab61-f89a81240637","type":"Claim","title":"APP23/Ar+/- male mice exhibit less neuronal loss than did male APP23 mice in the CA3 region of the hippocampus, suggesting that the increased endogenous testosterone in male APP23/Ar+/- mice not only prevented amyloid deposition in the brain, but also protected against age-related neuronal loss.","label":"McAllister C et al.; APP23/Ar+/- male mice exhibit less neuro...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Long Jiangang","Bowers Adrienne","Walker Aaron","Cao Philip","Honda Shin-Ichiro","Harada Nobuhiro","Staufenbiel Matthias","Shen Yong","Li Rena"],"firstAuthor":"McAllister Carrie","referenceYear":"2010","referenceDate":"2010-05-26","id":"urn:lsid:swan.org:researchstatement:a4d2c593-aeee-4ada-ab61-f89a81240637"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:50a538ce-ef85-4b75-a282-f38e219f60c4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:50a538ce-ef85-4b75-a282-f38e219f60c4","type":"Claim","title":"In addition to serine/threonine-directed phosphorylation, other post-translational modifications of tau can also occur, including glycation, ubiquitylation, sumoylation, nitration and proteolysis.","label":"Ballatore C et al.; In addition to serine/threonine-directed...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Lee Virginia M-Y","Trojanowski John Q"],"firstAuthor":"Ballatore Carlo","referenceYear":"2007","referenceDate":"2007-09","id":"urn:lsid:swan.org:researchstatement:50a538ce-ef85-4b75-a282-f38e219f60c4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:adf4e5ac-9149-4b4b-a723-f3c6aedd53e5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:adf4e5ac-9149-4b4b-a723-f3c6aedd53e5","type":"Claim","title":"Besides APP, other substrates for cdc2 kinase have been identified as cytoskeletal or structural proteins that undergo reorganization during mitosis.","label":"Suzuki T et al.; Besides APP, other substrates for cdc2 k...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:adf4e5ac-9149-4b4b-a723-f3c6aedd53e5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ba9f5c1a-a67a-4da3-967d-61ebaee9f880&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ba9f5c1a-a67a-4da3-967d-61ebaee9f880","type":"Claim","title":"Soluble Aβ oligomers are the principal effectors of synaptic dysfunction and loss that characterize Alzheimer Disease.","label":"Walsh D et al.; Soluble Aβ oligomers are the principal e...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Klyubin Igor","Fadeeva Julia V","Cullen William K","Anwyl Roger","Wolfe Michael S","Rowan Michael J","Selkoe Dennis J"],"firstAuthor":"Walsh Dominic M","referenceYear":"2002","referenceDate":"2002-04-04","id":"urn:lsid:swan.org:researchstatement:ba9f5c1a-a67a-4da3-967d-61ebaee9f880"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:71367390-d24b-4e2d-aacd-25e9627f2375&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:71367390-d24b-4e2d-aacd-25e9627f2375","type":"Claim","title":"Aside from its well-established role in promoting the stabilization of microtubules (MTs), tau may have additional functions as a result of its interactions with other structures and enzymes.","label":"Ballatore C et al.; Aside from its well-established role in ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Lee Virginia M-Y","Trojanowski John Q"],"firstAuthor":"Ballatore Carlo","referenceYear":"2007","referenceDate":"2007-09","id":"urn:lsid:swan.org:researchstatement:71367390-d24b-4e2d-aacd-25e9627f2375"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:525f05aa-1f63-4656-b58a-3b3e9804cf3d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:525f05aa-1f63-4656-b58a-3b3e9804cf3d","type":"Claim","title":"There is a strong, almost 1 to 1 colocalization between Bcl-2 and TdT labeling in AD brain, suggesting that Bcl-2 is induced in neurons that exhibit DNA damage.","label":"Cotman C et al.; There is a strong, almost 1 to 1 colocal...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:525f05aa-1f63-4656-b58a-3b3e9804cf3d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f57e1d03-e2ac-4e29-b72c-872642c21cff&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f57e1d03-e2ac-4e29-b72c-872642c21cff","type":"Claim","title":"Synthetic Aβ aggregates, termed ADDLs, are highly toxic and inhibit hippocampal function.","label":"Wolozin B; Synthetic Aβ aggregates, termed ADDLs, a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Wolozin B","id":"urn:lsid:swan.org:researchstatement:f57e1d03-e2ac-4e29-b72c-872642c21cff"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:32a66575-9a5c-49ac-b027-410d30ad8a9e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:32a66575-9a5c-49ac-b027-410d30ad8a9e","type":"Claim","title":"PS1 and PS2 proteins are essential components of γ-secretase , a multisubunit protease complex that catalyzes the intramembranous cleavage of a number of type I transmembrane proteins, including Notch, APP, and cadherins.","label":"Shen J et al.; PS1 and PS2 proteins are essential compo...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:32a66575-9a5c-49ac-b027-410d30ad8a9e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:efd6e381-1e06-4694-885e-1fc533ea2528&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:efd6e381-1e06-4694-885e-1fc533ea2528","type":"Claim","title":"ICV Streptozotocin increases tau phosphorylation in rat brain. ","label":"Craft S; ICV Streptozotocin increases tau phospho...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft S","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:efd6e381-1e06-4694-885e-1fc533ea2528"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f8ca3f71-f578-4cd7-82bc-cafa83ce92e4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f8ca3f71-f578-4cd7-82bc-cafa83ce92e4","type":"Claim","title":"Late-onset AD (LOAD) is one of the most common age-related diseases: an estimate that by 2050, 25% of the developed world population will be >65 years old, one third likely to be affected by LOAD, total worldwide estimate of 45-50 million LOAD patients.","label":"Late-onset AD (LOAD) is one of the most ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:f8ca3f71-f578-4cd7-82bc-cafa83ce92e4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b3177ae1-cd99-4b0a-80ca-bc701747c3ad&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b3177ae1-cd99-4b0a-80ca-bc701747c3ad","type":"Claim","title":"PS1-L166P and PS2-N141I fail to produce any detectable level of Notch NICD.","label":"Bentahir M et al.; PS1-L166P and PS2-N141I fail to produce ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:b3177ae1-cd99-4b0a-80ca-bc701747c3ad"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:739ed59d-53da-4fff-b80f-082ae3a89f37&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:739ed59d-53da-4fff-b80f-082ae3a89f37","type":"Claim","title":"Insulin increases the expression of the Aβ-protease, insulin degrading enzyme (IDE) and enhances the secretion of sAPPα, which results from the non-amyloidogenic α-secretase- mediated cleavage of APP.","label":"Hooper C et al.; Insulin increases the expression of the ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:739ed59d-53da-4fff-b80f-082ae3a89f37"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f0478763-e390-4564-8dec-447fd6ee7392&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f0478763-e390-4564-8dec-447fd6ee7392","type":"Claim","title":"Markers of AD pathology (plaques and tangles) reduced in older adults with diabetes.","label":"Craft S; Markers of AD pathology (plaques and tan...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft S","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:f0478763-e390-4564-8dec-447fd6ee7392"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4ec8976d-61fe-4cfa-9ed0-c995e7b78b2d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4ec8976d-61fe-4cfa-9ed0-c995e7b78b2d","type":"Claim","title":"In parallel with characteristic AD pathology, Aβ induces the formation of dystrophic neurites in cultured neurons.","label":"Cotman C et al.; In parallel with characteristic AD patho...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:4ec8976d-61fe-4cfa-9ed0-c995e7b78b2d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7fa08520-3b46-4853-8792-f64d742121ff&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7fa08520-3b46-4853-8792-f64d742121ff","type":"Claim","title":"Familial British and Danish dementia appear to be initiated by abnormal production of an amyloidogenic peptide.","label":"Golde T; Familial British and Danish dementia app...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde T","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:7fa08520-3b46-4853-8792-f64d742121ff"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b6d38d2b-8147-4f6f-9997-da9929d58f66&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b6d38d2b-8147-4f6f-9997-da9929d58f66","type":"Claim","title":"Deficits in synaptic communication and plasticity in transgenic mouse and rat models with Aβ deposition support the idea of the importance of synaptic health in the development of the disease. ","label":"Dziewczapolski G et al.; Deficits in synaptic communication and p...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Glogowski Carolina M","Masliah Eliezer","Heinemann Stephen F"],"firstAuthor":"Dziewczapolski Gustavo","referenceYear":"2009","referenceDate":"2009-07-08","id":"urn:lsid:swan.org:researchstatement:b6d38d2b-8147-4f6f-9997-da9929d58f66"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:104cd7db-0e5b-4cba-9139-4d748dce9f54&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:104cd7db-0e5b-4cba-9139-4d748dce9f54","type":"Claim","title":"Bcl-2 and related mechanisms may arrest apoptosis and allow cells to remain viable.","label":"Cotman C et al.; Bcl-2 and related mechanisms may arrest ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:104cd7db-0e5b-4cba-9139-4d748dce9f54"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:32445ce3-9bfd-497a-9ced-b102c9d825f1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:32445ce3-9bfd-497a-9ced-b102c9d825f1","type":"Claim","title":"In the NRHypo model, the time course of degeneration is relatively protracted during which some neurons progressively degenerate and disintegrate into multiple small fragments that are slowly phagocytized, others show a mixed picture of organelle degeneration alongside abortive efforts at regeneration. ","label":"Olney J et al.; In the NRHypo model, the time course of ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:32445ce3-9bfd-497a-9ced-b102c9d825f1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bef7ab95-3bf3-4fce-a1c6-3e6e631f3fe6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bef7ab95-3bf3-4fce-a1c6-3e6e631f3fe6","type":"Claim","title":"Intramembranous Aβ could behave as chaperones of other membrane proteins.","label":"Marchesi V; Intramembranous Aβ could behave as chape...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:bef7ab95-3bf3-4fce-a1c6-3e6e631f3fe6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bd340b42-88a6-4c9c-bee3-02069a110b12&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bd340b42-88a6-4c9c-bee3-02069a110b12","type":"Claim","title":"A loss of high-affinity nicotinic acetylcholine receptors (nAChRs) in AD may potentiate the neurotoxicity of β-amyloid.","label":"Cook L et al.; A loss of high-affinity nicotinic acetyl...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Ho Luk W","Taylor Alison E","Brayne Carol","Evans John Grimley","Xuereb John","Cairns Nigel J","Pritchard Antonia","Lemmon Helen","Mann David","St Clair David","Turic Dragana","Hollingworth Paul","Moore Pamela J","Jehu Luke","Archer Nicola","Walter Sarah","Foy Catherine","Edmondson Amanda","Powell John","Lovestone Simon","Owen Michael J","Williams Julie","Lendon Corinne","Rubinsztein David C"],"firstAuthor":"Cook Lynnette J","referenceYear":"2004","referenceDate":"2004-03-25","id":"urn:lsid:swan.org:researchstatement:bd340b42-88a6-4c9c-bee3-02069a110b12"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:795fb668-f2f0-4e09-a9e4-ac16382a9c99&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:795fb668-f2f0-4e09-a9e4-ac16382a9c99","type":"Claim","title":"Neuronal cell cycle events (CCEs) do not develop within all disease-relevant neuronal populations at once.","label":"Varvel N et al.; Neuronal cell cycle events (CCEs) do not...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bhaskar Kiran","Patil Anita R","Pimplikar Sanjay W","Herrup Karl","Lamb Bruce T"],"firstAuthor":"Varvel Nicholas H","referenceYear":"2008","referenceDate":"2008-10-22","id":"urn:lsid:swan.org:researchstatement:795fb668-f2f0-4e09-a9e4-ac16382a9c99"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:494e74bc-2497-49bc-b82d-c6414dff0bf2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:494e74bc-2497-49bc-b82d-c6414dff0bf2","type":"Claim","title":"Apoptosis is an active process whereas necrosis is a passive process.","label":"Cotman C et al.; Apoptosis is an active process whereas n...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:494e74bc-2497-49bc-b82d-c6414dff0bf2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0ef8c933-2f54-4ed4-93a7-f19cdd614f4c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0ef8c933-2f54-4ed4-93a7-f19cdd614f4c","type":"Claim","title":"At nanomolar concentrations, soluble Aβ oligomers block hippocampal long-term potentiation.","label":"Laurén J et al.; At nanomolar concentrations, soluble Aβ ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Gimbel David A","Nygaard Haakon B","Gilbert John W","Strittmatter Stephen M"],"firstAuthor":"Laurén Juha","referenceYear":"2009","referenceDate":"2009-02-26","id":"urn:lsid:swan.org:researchstatement:0ef8c933-2f54-4ed4-93a7-f19cdd614f4c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9de367e9-0c91-47fe-a56e-13b0cfb5157a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9de367e9-0c91-47fe-a56e-13b0cfb5157a","type":"Claim","title":"Neurons from BACE1-null mice can be more susceptible to the occurrence of epileptic activity because of significant changes in sodium channel properties and activity.","label":"Hu X et al.; Neurons from BACE1-null mice can be more...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhou Xiangdong","He Wanxia","Yang Jun","Xiong Wencheng","Wong Philip","Wilson Christopher G","Yan Riqiang"],"firstAuthor":"Hu Xiangyou","referenceYear":"2010","referenceDate":"2010-06-30","id":"urn:lsid:swan.org:researchstatement:9de367e9-0c91-47fe-a56e-13b0cfb5157a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:85551c8f-5964-475b-88a6-572666a60fe9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:85551c8f-5964-475b-88a6-572666a60fe9","type":"Claim","title":"Synthetic ADDLs bind 140 and 260 kDa proteins from rat cortex but not rat cerebellum extracts.","label":"Gong Y et al.; Synthetic ADDLs bind 140 and 260 kDa pro...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:85551c8f-5964-475b-88a6-572666a60fe9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f7dd419f-04c7-4822-b46c-6dfa6cb736d9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f7dd419f-04c7-4822-b46c-6dfa6cb736d9","type":"Claim","title":"FTDP-17 tau gene mutations induce neurofibrillary pathology and neurofibrillary degeneration.","label":"Golde T; FTDP-17 tau gene mutations induce neurof...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde T","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:f7dd419f-04c7-4822-b46c-6dfa6cb736d9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ebeea965-9951-4ccb-a9fc-ea8b805ff044&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ebeea965-9951-4ccb-a9fc-ea8b805ff044","type":"Claim","title":"Presenilin is involved in Ca2+ storage and release via calsenilin, a Ca2+ binding protein.","label":"Plant L et al.; Presenilin is involved in Ca2+ storage a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:ebeea965-9951-4ccb-a9fc-ea8b805ff044"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b34b75af-90c4-4abb-ae22-03cd38477c16&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b34b75af-90c4-4abb-ae22-03cd38477c16","type":"Claim","title":"Many TdT-labeled cells in AD brain exhibited an apoptotic-like morphological distribution of DNA strand breaks, including granulated and marginated patterns of intense TdT labeling, shrunken, irregular cellular shape, and the presence of apoptotic-like bodies.","label":"Cotman C et al.; Many TdT-labeled cells in AD brain exhib...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:b34b75af-90c4-4abb-ae22-03cd38477c16"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:875405bc-675f-4c30-bce2-8b9d46900ecd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:875405bc-675f-4c30-bce2-8b9d46900ecd","type":"Claim","title":"ApoE4 alleles, which increase risk of AD, also increase Aβ accumulation.\n","label":"Lambert M et al.; ApoE4 alleles, which increase risk of AD...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:875405bc-675f-4c30-bce2-8b9d46900ecd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f221fee8-3ae9-4cd2-a271-dde5e4263328&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f221fee8-3ae9-4cd2-a271-dde5e4263328","type":"Claim","title":"A previous study demonstrated that chronic passive immunization with the m266 antibody reduces brain Aβ burden in PDAPP mice at least in part by altering brain Aβ clearance.","label":"Dodart J et al.; A previous study demonstrated that chron...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:f221fee8-3ae9-4cd2-a271-dde5e4263328"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1958eea8-e8d3-438c-93a7-dbdb071d5e2c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1958eea8-e8d3-438c-93a7-dbdb071d5e2c","type":"Claim","title":"A potent &#946;-secretase inhibitor &#946;SI decreases peak I<sub>KA<\/sub> and I<sub>KV<\/sub> currents.","label":"Plant L et al.; A potent &#946;-secretase inhibitor &#94...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:1958eea8-e8d3-438c-93a7-dbdb071d5e2c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ecc5d10a-1d23-4498-91eb-275e7e0a42c7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ecc5d10a-1d23-4498-91eb-275e7e0a42c7","type":"Claim","title":"We investigated the dose\u2013response relationship for m266 treatment on object recognition memory performance, and determined the presence or absence in plasma and CSF of an Aβ\u2013antibody complex.","label":"Dodart J et al.; We investigated the dose\u2013response relati...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:ecc5d10a-1d23-4498-91eb-275e7e0a42c7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:369ac707-5abf-4efc-b262-f834471b0bd0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:369ac707-5abf-4efc-b262-f834471b0bd0","type":"Claim","title":"With its ability to modulate MT-dynamics, tau contributes directly or indirectly to key structural and regulatory cellular functions.","label":"Ballatore C et al.; With its ability to modulate MT-dynamics...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Lee Virginia M-Y","Trojanowski John Q"],"firstAuthor":"Ballatore Carlo","referenceYear":"2007","referenceDate":"2007-09","id":"urn:lsid:swan.org:researchstatement:369ac707-5abf-4efc-b262-f834471b0bd0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8003fda1-0fc1-407f-b0cc-098afec6e2eb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8003fda1-0fc1-407f-b0cc-098afec6e2eb","type":"Claim","title":"Clusterin is a multifunctional molecule that interacts with the soluble form of Aβ in animal models of AD and binds soluble Aβ in a specific and reversible manner, forming complexes that have been shown to cross the blood-brain barrier.","label":"Harold D et al.; Clusterin is a multifunctional molecule ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Abraham Richard","Hollingworth Paul","Sims Rebecca","Gerrish Amy","Hamshere Marian L","Pahwa Jaspreet Singh","Moskvina Valentina","Dowzell Kimberley","Williams Amy","Jones Nicola","Thomas Charlene","Stretton Alexandra","Morgan Angharad R","Lovestone Simon","Powell John","Proitsi Petroula","Lupton Michelle K","Brayne Carol","Rubinsztein David C","Gill Michael","Lawlor Brian","Lynch Aoibhinn","Morgan Kevin","Brown Kristelle S","Passmore Peter A","Craig David","McGuinness Bernadette","Todd Stephen","Holmes Clive","Mann David","Smith A David","Love Seth","Kehoe Patrick G","Hardy John","Mead Simon","Fox Nick","Rossor Martin","Collinge John","Maier Wolfgang","Jessen Frank","Schürmann Britta","van den Bussche Hendrik","Heuser Isabella","Kornhuber Johannes","Wiltfang Jens","Dichgans Martin","Frölich Lutz","Hampel Harald","Hüll Michael","Rujescu Dan","Goate Alison M","Kauwe John S","Cruchaga Carlos","Nowotny Petra","Morris John C","Mayo Kevin","Sleegers Kristel","Bettens Karolien","Engelborghs Sebastiaan","De Deyn Peter P","Van Broeckhoven Christine","Livingston Gill","Bass Nicholas J","Gurling Hugh","McQuillin Andrew","Gwilliam Rhian","Deloukas Panagiotis","Al-Chalabi Ammar","Shaw Christopher E","Tsolaki Magda","Singleton Andrew B","Guerreiro Rita","Mühleisen Thomas W","Nöthen Markus M","Moebus Susanne","Jöckel Karl-Heinz","Klopp Norman","Wichmann H-Erich","Carrasquillo Minerva M","Pankratz V Shane","Younkin Steven G","Holmans Peter A","O'Donovan Michael","Owen Michael J","Williams Julie"],"firstAuthor":"Harold Denise","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:8003fda1-0fc1-407f-b0cc-098afec6e2eb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ef5bdce8-ef21-485e-83f7-09dfab83fa9c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ef5bdce8-ef21-485e-83f7-09dfab83fa9c","type":"Claim","title":"Rates of brain atrophy correlate well with pathological indices of neurofibrillary tangles (NFTs) and other neurodegenerative changes, but do not correlate with severity of Aβ deposition at autopsy.","label":"Jack C et al.; Rates of brain atrophy correlate well wi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:ef5bdce8-ef21-485e-83f7-09dfab83fa9c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9c1e49de-1062-40fe-91c3-d4a73dd7103a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9c1e49de-1062-40fe-91c3-d4a73dd7103a","type":"Claim","title":"Neuronal death in patients with AD is closely associated with the extensive synapse loss in the neocortex.","label":"Terry R et al.; Neuronal death in patients with AD is cl...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Masliah E","Salmon D P","Butters N","DeTeresa R","Hill R","Hansen L A","Katzman R"],"firstAuthor":"Terry R D","referenceYear":"1991","referenceDate":"1991-10","id":"urn:lsid:swan.org:researchstatement:9c1e49de-1062-40fe-91c3-d4a73dd7103a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:82427fa7-4c81-483a-b03f-0956a4cd90c2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:82427fa7-4c81-483a-b03f-0956a4cd90c2","type":"Claim","title":"Crosslinking of neuronal cell surface receptors by the plant lectin Concanavalin A will initiate activation-induced cell death.","label":"Cotman C et al.; Crosslinking of neuronal cell surface re...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:82427fa7-4c81-483a-b03f-0956a4cd90c2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c843aebe-4025-4024-a72a-385b958be108&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c843aebe-4025-4024-a72a-385b958be108","type":"Claim","title":"Genetic variations of PICALM functionally result in perturbations at the synapse, possibly through synaptic vesicle cycling, thereby increasing risk for Alzheimer\u2019s disease.","label":"Harold D et al.; Genetic variations of PICALM functionall...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Abraham Richard","Hollingworth Paul","Sims Rebecca","Gerrish Amy","Hamshere Marian L","Pahwa Jaspreet Singh","Moskvina Valentina","Dowzell Kimberley","Williams Amy","Jones Nicola","Thomas Charlene","Stretton Alexandra","Morgan Angharad R","Lovestone Simon","Powell John","Proitsi Petroula","Lupton Michelle K","Brayne Carol","Rubinsztein David C","Gill Michael","Lawlor Brian","Lynch Aoibhinn","Morgan Kevin","Brown Kristelle S","Passmore Peter A","Craig David","McGuinness Bernadette","Todd Stephen","Holmes Clive","Mann David","Smith A David","Love Seth","Kehoe Patrick G","Hardy John","Mead Simon","Fox Nick","Rossor Martin","Collinge John","Maier Wolfgang","Jessen Frank","Schürmann Britta","van den Bussche Hendrik","Heuser Isabella","Kornhuber Johannes","Wiltfang Jens","Dichgans Martin","Frölich Lutz","Hampel Harald","Hüll Michael","Rujescu Dan","Goate Alison M","Kauwe John S","Cruchaga Carlos","Nowotny Petra","Morris John C","Mayo Kevin","Sleegers Kristel","Bettens Karolien","Engelborghs Sebastiaan","De Deyn Peter P","Van Broeckhoven Christine","Livingston Gill","Bass Nicholas J","Gurling Hugh","McQuillin Andrew","Gwilliam Rhian","Deloukas Panagiotis","Al-Chalabi Ammar","Shaw Christopher E","Tsolaki Magda","Singleton Andrew B","Guerreiro Rita","Mühleisen Thomas W","Nöthen Markus M","Moebus Susanne","Jöckel Karl-Heinz","Klopp Norman","Wichmann H-Erich","Carrasquillo Minerva M","Pankratz V Shane","Younkin Steven G","Holmans Peter A","O'Donovan Michael","Owen Michael J","Williams Julie"],"firstAuthor":"Harold Denise","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:c843aebe-4025-4024-a72a-385b958be108"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:01681f8c-ce6b-49b2-b8c0-1092f8e6742d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:01681f8c-ce6b-49b2-b8c0-1092f8e6742d","type":"Claim","title":"It is not yet known whether cdc2 kinase is involved in the phosphorylation of PHF tau in intact cells, since it appears likely that mitogen-activated protein kinase (MAPK) may be responsible for much of the aberrant phosphorylation of tau.","label":"Suzuki T et al.; It is not yet known whether cdc2 kinase ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:01681f8c-ce6b-49b2-b8c0-1092f8e6742d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:47fc8f1e-30fb-446a-b7de-aeeef195b21f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:47fc8f1e-30fb-446a-b7de-aeeef195b21f","type":"Claim","title":"Aβ may play a role in normal brain function.","label":"Plant L et al.; Aβ may play a role in normal brain funct...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:47fc8f1e-30fb-446a-b7de-aeeef195b21f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fd368bd6-d0d6-468c-8fa2-e6628fd2f904&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fd368bd6-d0d6-468c-8fa2-e6628fd2f904","type":"Claim","title":"An increased amount of calcium is liberated from the RyR-senstive pool in cortical neurons isolated from AD model transgenic mice.","label":"Smith I et al.; An increased amount of calcium is libera...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:fd368bd6-d0d6-468c-8fa2-e6628fd2f904"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:95432f18-e626-4718-8cb1-27c299fd8f35&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:95432f18-e626-4718-8cb1-27c299fd8f35","type":"Claim","title":"Aβ1-40 and Aβ1-42 induces the enhancement of I<sub>KA<\/sub> current, whereas \"toxic fragment\" Aβ25-35 had no effect.","label":"Plant L et al.; Aβ1-40 and Aβ1-42 induces the enhancemen...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:95432f18-e626-4718-8cb1-27c299fd8f35"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:fb1acedc-0ce8-46d5-bb60-6f09b231e543&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:fb1acedc-0ce8-46d5-bb60-6f09b231e543","type":"Claim","title":"The second prodromal phase of AD, mild cognitive impairment (MCI), is characterized by the onset of the earliest cognitive symptoms (typically deficits in episodic memory) that do not meet the criteria for dementia but rather varies from the earliest appearance of memory dysfunction to more widespread dysfunction in other cognitive domains.","label":"Jack C et al.; The second prodromal phase of AD, mild c...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:fb1acedc-0ce8-46d5-bb60-6f09b231e543"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8818c388-490f-4e23-a752-c39aee3db10c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8818c388-490f-4e23-a752-c39aee3db10c","type":"Claim","title":"Further studies in transgenic mice provide additional evidence that ApoE isoforms affect Aβ metabolism.","label":"Holtzman D; Further studies in transgenic mice provi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman David M","id":"urn:lsid:swan.org:researchstatement:8818c388-490f-4e23-a752-c39aee3db10c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:11c857a2-6729-4e25-b5d2-d1e5ff1c1840&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:11c857a2-6729-4e25-b5d2-d1e5ff1c1840","type":"Claim","title":"Cognitive and behavioral deficits related to BACE1 inhibition may be magnified in humans who, in the context of the myelin model, are viewed as uniquely dependent on their more extensive myelination for normal function when compared to rodents and non-human primates.","label":"Bartzokis G; Cognitive and behavioral deficits relate...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:11c857a2-6729-4e25-b5d2-d1e5ff1c1840"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0dc5bfce-4fd2-420e-841b-b8bdc49eccee&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0dc5bfce-4fd2-420e-841b-b8bdc49eccee","type":"Claim","title":"In tauopathies tau no longer binds to the MTs; instead tau becomes sequestered into NFTs in neurons, and into glial tangles in astrocytes or oligodendroglia. ","label":"Ballatore C et al.; In tauopathies tau no longer binds to th...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Lee Virginia M-Y","Trojanowski John Q"],"firstAuthor":"Ballatore Carlo","referenceYear":"2007","referenceDate":"2007-09","id":"urn:lsid:swan.org:researchstatement:0dc5bfce-4fd2-420e-841b-b8bdc49eccee"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d4728e87-613b-4b6f-9157-20addb09843c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d4728e87-613b-4b6f-9157-20addb09843c","type":"Claim","title":"Many of the underlying pathogenic processes of neurodegeneration are similar, including protein misfolding, oxidative stress, cytoskeletal abnormalities, disruption of calcium homeostasis, and inflammation, all of which increase during aging.","label":"Kim D et al.; Many of the underlying pathogenic proces...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:d4728e87-613b-4b6f-9157-20addb09843c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b488f8a2-3f0f-4dbe-8733-107403b90a35&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b488f8a2-3f0f-4dbe-8733-107403b90a35","type":"Claim","title":"The finding that neurons may engage protective mechanisms is important because it suggests that if activated sufficiently early, many cells may be protected.","label":"Cotman C et al.; The finding that neurons may engage prot...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:b488f8a2-3f0f-4dbe-8733-107403b90a35"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c5a1e0b8-3a14-4f2a-b611-a9eaee84bfef&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c5a1e0b8-3a14-4f2a-b611-a9eaee84bfef","type":"Claim","title":"Aβ could form novel channels in the plasma membrane and subcellular organelle membranes, thereby causing an unregulated influx of calcium (or other ions) that may contribute to neurodegeneration.","label":"Smith I et al.; Aβ could form novel channels in the plas...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:c5a1e0b8-3a14-4f2a-b611-a9eaee84bfef"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c961f6f9-3c1c-4fbc-ad05-720a9d86b59f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c961f6f9-3c1c-4fbc-ad05-720a9d86b59f","type":"Claim","title":"Microglia are known to accumulate around Aβ plaques in AD and there is increased expression of inflammatory mediators in AD brain tissue.","label":"Hooper C et al.; Microglia are known to accumulate around...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:c961f6f9-3c1c-4fbc-ad05-720a9d86b59f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7028e92a-7f7c-4e76-a2a9-1823e5b0c145&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7028e92a-7f7c-4e76-a2a9-1823e5b0c145","type":"Claim","title":"PS-1 FAD mutations inhibit PS-1-dependent phosphatidylinositol 3-kinase (PI3K)/Akt signaling, facilitating GSK3 activity and thus tau hyper-phosphorylation. This is one potential mechanism through which FAD mutations might lead to accelerated disease progression through secondary aberrations in GSK3 activity.","label":"Hooper C et al.; PS-1 FAD mutations inhibit PS-1-dependen...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:7028e92a-7f7c-4e76-a2a9-1823e5b0c145"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:52641fe0-1c06-4f56-82de-8e4abd4a34b5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:52641fe0-1c06-4f56-82de-8e4abd4a34b5","type":"Claim","title":"DR6 is activated locally by an inactive surface ligand(s) that is released in an active form after trophic-factor deprivation.","label":"Nikolaev A et al.; DR6 is activated locally by an inactive ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["McLaughlin Todd","O'Leary Dennis D","Tessier-Lavigne Marc"],"firstAuthor":"Nikolaev Anatoly","referenceYear":"2009","referenceDate":"2009-02-19","id":"urn:lsid:swan.org:researchstatement:52641fe0-1c06-4f56-82de-8e4abd4a34b5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c2cd6ebf-a134-4f16-bde0-ec2296ef6b09&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c2cd6ebf-a134-4f16-bde0-ec2296ef6b09","type":"Claim","title":"The provided images do not show a complete walling off of plaques by activated microglia.","label":"Kumar-Singh S; The provided images do not show a comple...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Kumar-Singh Samir","id":"urn:lsid:swan.org:researchstatement:c2cd6ebf-a134-4f16-bde0-ec2296ef6b09"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2e7a3474-8ac6-416e-9b44-78e58a699f72&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2e7a3474-8ac6-416e-9b44-78e58a699f72","type":"Claim","title":"Enhanced LTP and increased afterhyperpolarizations may be due to an enhancement of the total amount of stored calcium within the ER or due to alterations in the release kinetics of stored calcium.","label":"Smith I et al.; Enhanced LTP and increased afterhyperpol...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:2e7a3474-8ac6-416e-9b44-78e58a699f72"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:211f4a97-395c-4694-b210-916da3a5c85b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:211f4a97-395c-4694-b210-916da3a5c85b","type":"Question","title":"Do the terminal processes of LC neurons with active CCEs contain Aβ accumulations?  ","label":"Do the terminal processes of LC neurons ...","icon":"../icons/ontological/discourse-element/research-question.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","id":"urn:lsid:swan.org:researchquestion:211f4a97-395c-4694-b210-916da3a5c85b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cfb9b066-4770-45e9-bad1-abbc0f94ac32&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cfb9b066-4770-45e9-bad1-abbc0f94ac32","type":"Claim","title":"Treatment of PC12 cells with okadaic acid also resulted in an increase in the phosphorylation of mature APP, immature APP and APP<sub>COOH<\/sub>.","label":"Suzuki T et al.; Treatment of PC12 cells with okadaic aci...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:cfb9b066-4770-45e9-bad1-abbc0f94ac32"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d32a59a0-a247-4fe2-817f-482bd9cb5a3c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d32a59a0-a247-4fe2-817f-482bd9cb5a3c","type":"Claim","title":"PS1- mediated gamma-secretase activity displays considerably higher specific activity than PS2-associated gamma-secretase.","label":"Bentahir M et al.; PS1- mediated gamma-secretase activity d...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:d32a59a0-a247-4fe2-817f-482bd9cb5a3c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cadeaacf-5be8-41b4-823d-027e183429a1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cadeaacf-5be8-41b4-823d-027e183429a1","type":"Claim","title":"Tissue-transglutaminase induces monomeric Aβ to rapidly form oligomers and aggregates in a time- and concentration-dependent manner.","label":"Hartley D et al.; Tissue-transglutaminase induces monomeri...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:cadeaacf-5be8-41b4-823d-027e183429a1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:be8e7365-4e08-4dfd-a4e4-cebf51ad1dac&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:be8e7365-4e08-4dfd-a4e4-cebf51ad1dac","type":"Claim","title":"Brainstem neurons, as initiators of senile plaques, have relevance for AD therapeutics and drug discovery.","label":"Muresan Z et al.; Brainstem neurons, as initiators of seni...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","referenceYear":"2008","referenceDate":"2008","id":"urn:lsid:swan.org:researchstatement:be8e7365-4e08-4dfd-a4e4-cebf51ad1dac"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d79e9779-8c8e-4ed6-b647-97061130e640&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d79e9779-8c8e-4ed6-b647-97061130e640","type":"Claim","title":"Aβ aggregates ranging from oligomers (dimers, trimers, tetramers, dodecamers to 50- to 100-mers), soluble protofibrils, actively growing fibrils, to mature fibrils have been implicated as potential pathological entities in AD.","label":"Golde T et al.; Aβ aggregates ranging from oligomers (di...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:d79e9779-8c8e-4ed6-b647-97061130e640"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:24bed20f-193d-4fe2-8574-e5b9ceca58b4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:24bed20f-193d-4fe2-8574-e5b9ceca58b4","type":"Claim","title":"The double hit hypothesis suggests that, while the amyloid hypothesis may be basically correct for the cases with autosomal dominant disease, there is a second, presumably additional, way by which tau induced neurodegeneration can be induced which relate to the molecular etiology of late onset disease.","label":"Hardy ; The double hit hypothesis suggests that,...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Hardy","referenceYear":"2009","referenceDate":"2009-05-18","id":"urn:lsid:swan.org:researchstatement:24bed20f-193d-4fe2-8574-e5b9ceca58b4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9039deff-1a4f-4c3b-bfe4-2f34f09f2bfa&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9039deff-1a4f-4c3b-bfe4-2f34f09f2bfa","type":"Claim","title":"Retardation of fibril formation by clusterin causes opposite effects on toxicity, depending on the stability of the Aβ oligomeric species.","label":"Lambert M et al.; Retardation of fibril formation by clust...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:9039deff-1a4f-4c3b-bfe4-2f34f09f2bfa"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:3c465409-e1a7-457a-a2eb-8e111bc112e9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:3c465409-e1a7-457a-a2eb-8e111bc112e9","type":"Question","title":"The particular cell surface proteins and signal transduction molecules that mediate ADDL toxicity might be important targets for drug-based therapeutic approaches to halt or reverse the disease during its early stages.","label":"The particular cell surface proteins and...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:3c465409-e1a7-457a-a2eb-8e111bc112e9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1a390765-be21-4dc1-a4ee-ee183438433e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1a390765-be21-4dc1-a4ee-ee183438433e","type":"Claim","title":"Overexpression of nSMase2 in cells does not induce apoptosis.","label":"Overexpression of nSMase2 in cells does ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:1a390765-be21-4dc1-a4ee-ee183438433e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9ca0a344-b390-44bf-b743-924bb31fb896&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9ca0a344-b390-44bf-b743-924bb31fb896","type":"Claim","title":"Resveratrol may interact with other biomolecules, besides SIRT1, to exert its neuroprotective effects.","label":"Kim D et al.; Resveratrol may interact with other biom...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:9ca0a344-b390-44bf-b743-924bb31fb896"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:18f4bffb-00a4-472e-9f26-3a13a758bca1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:18f4bffb-00a4-472e-9f26-3a13a758bca1","type":"Claim","title":"Data from nicotinic acetylcholine receptor β2 knockout mice and the decreased β2 mRNA levels observed in aged brains suggested a potential role for the β2 nAChR subunit in AD.","label":"Cook L et al.; Data from nicotinic acetylcholine recept...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Ho Luk W","Taylor Alison E","Brayne Carol","Evans John Grimley","Xuereb John","Cairns Nigel J","Pritchard Antonia","Lemmon Helen","Mann David","St Clair David","Turic Dragana","Hollingworth Paul","Moore Pamela J","Jehu Luke","Archer Nicola","Walter Sarah","Foy Catherine","Edmondson Amanda","Powell John","Lovestone Simon","Owen Michael J","Williams Julie","Lendon Corinne","Rubinsztein David C"],"firstAuthor":"Cook Lynnette J","referenceYear":"2004","referenceDate":"2004-03-25","id":"urn:lsid:swan.org:researchstatement:18f4bffb-00a4-472e-9f26-3a13a758bca1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c31cb16b-14f9-481a-b00f-d97ad90b2d8c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c31cb16b-14f9-481a-b00f-d97ad90b2d8c","type":"Claim","title":"Studies have established a link between APOE and glycogen synthase kinase 3 (GSK3), one of the main kinases that phosphorylates tau.  ","label":"Small S et al.; Studies have established a link between ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:c31cb16b-14f9-481a-b00f-d97ad90b2d8c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e8f60700-80c1-4974-b14b-cbcb7d9a91da&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e8f60700-80c1-4974-b14b-cbcb7d9a91da","type":"Claim","title":"ApoE influences Aβ metabolism to promote the conversion of Aβ to beta-sheet conformation.","label":"Holtzman D; ApoE influences Aβ metabolism to promote...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:e8f60700-80c1-4974-b14b-cbcb7d9a91da"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1374525b-abf5-46b9-a11d-46b98b628b00&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1374525b-abf5-46b9-a11d-46b98b628b00","type":"Claim","title":"A sensitive immunoassay has been developed to detect A&#946;42 oligomers.  New antibodies detect A&#946;42 oligomers at 1 fM sensitivity.","label":"Gong Y et al.; A sensitive immunoassay has been develop...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:1374525b-abf5-46b9-a11d-46b98b628b00"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c1d25c84-70b7-4293-9d57-8ca75cba4c9d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c1d25c84-70b7-4293-9d57-8ca75cba4c9d","type":"Claim","title":"In normal cells, ligand binding to APP may achieve its physiological effects by modifying intracellular second messenger pathways via an interaction with G<sub>o<\/sub>.","label":"Suzuki T et al.; In normal cells, ligand binding to APP m...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:c1d25c84-70b7-4293-9d57-8ca75cba4c9d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:38fcef2f-d901-4261-b78b-36da30439e69&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:38fcef2f-d901-4261-b78b-36da30439e69","type":"Hypothesis","title":"Clearance of Aβ peptide is a critical event in Alzheimer Disease pathogenesis.","label":"Tanzi R et al.; Clearance of Aβ peptide is a critical ev...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Moir Robert D","Wagner Steven L"],"firstAuthor":"Tanzi Rudolph E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:38fcef2f-d901-4261-b78b-36da30439e69"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:36bfd974-b3ac-4742-a9ea-ea0e10ebd0f0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:36bfd974-b3ac-4742-a9ea-ea0e10ebd0f0","type":"Claim","title":"Aβ facilitates excitotoxic cell death and subthreshold levels of oxidative insults in combination with subthreshold Aβ initiates apoptosis in primary neurons.","label":"Cotman C et al.; Aβ facilitates excitotoxic cell death an...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:36bfd974-b3ac-4742-a9ea-ea0e10ebd0f0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1fd92108-f86a-4cca-a59a-1270af34b13b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1fd92108-f86a-4cca-a59a-1270af34b13b","type":"Claim","title":"ApoE4 allele is a risk factor for early onset dementia in Down syndrome with neuropathology of AD.","label":"Holtzman D; ApoE4 allele is a risk factor for early ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:1fd92108-f86a-4cca-a59a-1270af34b13b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1894cadd-1dfb-446c-8ee0-ad7b829600e0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1894cadd-1dfb-446c-8ee0-ad7b829600e0","type":"Claim","title":"At nanomolar concentrations, soluble Aβ oligomers impair rodent spatial memory.","label":"Laurén J et al.; At nanomolar concentrations, soluble Aβ ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Gimbel David A","Nygaard Haakon B","Gilbert John W","Strittmatter Stephen M"],"firstAuthor":"Laurén Juha","referenceYear":"2009","referenceDate":"2009-02-26","id":"urn:lsid:swan.org:researchstatement:1894cadd-1dfb-446c-8ee0-ad7b829600e0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3780c198-ab88-4e83-a289-5d0ce8fcd603&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3780c198-ab88-4e83-a289-5d0ce8fcd603","type":"Claim","title":"FAD-linked PS mutations impair γ-secretase-dependent proteolysis of N-cadherin, and a series of FAD-linked mutations uniformly suppressed this cleavage.","label":"Shen J et al.; FAD-linked PS mutations impair γ-secreta...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:3780c198-ab88-4e83-a289-5d0ce8fcd603"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2e2a9845-3394-40d9-b538-355a0e6c28ae&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2e2a9845-3394-40d9-b538-355a0e6c28ae","type":"Claim","title":"One individual AN1792 immunized participant, despite the absence of a documented IgG antibody response during the study period, and a fairly high Aβ load, had clear evidence that acute mobilization of plaque Aβ had started by the time he died.","label":"Holmes C et al.; One individual AN1792 immunized particip...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:2e2a9845-3394-40d9-b538-355a0e6c28ae"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:06221a78-7da7-4f04-99ef-d0618f2243a7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:06221a78-7da7-4f04-99ef-d0618f2243a7","type":"Claim","title":"IDE (EC 3.4.24.56) is a 110 kDa zinc metalloendopeptidase that hydrolyzes several regulatory peptides including insulin, glucagon, atrial natriuretic factor, transforming growth factor alpha, β-endorphin, amylin, Aβ, and the APP intracellular domain (AICD).","label":"Tanzi R et al.; IDE (EC 3.4.24.56) is a 110 kDa zinc met...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:06221a78-7da7-4f04-99ef-d0618f2243a7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:a216d5e4-490d-40ce-9bf1-2ad06a69bdab&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:a216d5e4-490d-40ce-9bf1-2ad06a69bdab","type":"Question","title":"Why is there not a more precise correlation between Aβ deposition and AD severity?","label":"Why is there not a more precise correlat...","icon":"../icons/ontological/discourse-element/research-question.png","firstAuthor":"Golde T","id":"urn:lsid:swan.org:researchquestion:a216d5e4-490d-40ce-9bf1-2ad06a69bdab"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1d5fa889-bdfd-4b78-9aa3-b6ad423e2567&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1d5fa889-bdfd-4b78-9aa3-b6ad423e2567","type":"Hypothesis","title":"Endosomal-lysosomal disturbance is evident in neurons at risk to degenerate in Alzheimer disease brain.","label":"Cataldo A et al.; Endosomal-lysosomal disturbance is evide...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Hamilton D J","Barnett J L","Paskevich P A","Nixon R A"],"firstAuthor":"Cataldo A M","referenceYear":"1996","referenceDate":"1996-01","id":"urn:lsid:swan.org:researchstatement:1d5fa889-bdfd-4b78-9aa3-b6ad423e2567"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3f7d69a9-6d05-4fa9-864f-dd7b7ecd8fd0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3f7d69a9-6d05-4fa9-864f-dd7b7ecd8fd0","type":"Claim","title":"Treatment for diabetes (with insulin) reduces plaque and tangle load in diabetic + dementia patients.","label":"Craft S; Treatment for diabetes (with insulin) re...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft Suzanne","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:3f7d69a9-6d05-4fa9-864f-dd7b7ecd8fd0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6de21bf6-b022-4523-9802-88e567ebae2c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6de21bf6-b022-4523-9802-88e567ebae2c","type":"Claim","title":"Antibody/Aβ complex could readily be detected in all plasma samples from PDAPP mice treated with m266 by gel electrophoresis under native conditions.","label":"Dodart J et al.; Antibody/Aβ complex could readily be det...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:6de21bf6-b022-4523-9802-88e567ebae2c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:40207cd6-e1ac-4dea-8e10-52c4bd61fb56&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:40207cd6-e1ac-4dea-8e10-52c4bd61fb56","type":"Claim","title":"I disagree with the suggestion that the appearance of a plaque within a day or two does not fit in with data on nucleation-dependent polymerization","label":"Lansbury P; I disagree with the suggestion that the ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Lansbury Peter T","id":"urn:lsid:swan.org:researchstatement:40207cd6-e1ac-4dea-8e10-52c4bd61fb56"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d151a29c-99e7-4383-b336-600881561d34&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d151a29c-99e7-4383-b336-600881561d34","type":"Hypothesis","title":"[ADNI] Genetic mutations might shift AD cognitive decline curve either away from or closer to the amyloid and neurodegenerative biomarker curves.","label":"Jack C et al.; [ADNI] Genetic mutations might shift AD ...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","id":"urn:lsid:swan.org:researchstatement:d151a29c-99e7-4383-b336-600881561d34"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e99782f4-37c2-4eb0-81c0-3cc1fd4f6987&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e99782f4-37c2-4eb0-81c0-3cc1fd4f6987","type":"Claim","title":"At present, the clinical diagnosis of AD requires the presence of dementia.","label":"Jack C et al.; At present, the clinical diagnosis of AD...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner Michael W","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:e99782f4-37c2-4eb0-81c0-3cc1fd4f6987"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b0229f10-6598-4f94-93a6-be0376164e0d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b0229f10-6598-4f94-93a6-be0376164e0d","type":"Claim","title":"Aβ has also been shown to enhance Ca2+ current through the N- and L- type VGCCs in synaptosomes and the N- and P-type VGCCs in cortical neurons.","label":"Smith I et al.; Aβ has also been shown to enhance Ca2+ c...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:b0229f10-6598-4f94-93a6-be0376164e0d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4ce5748c-8538-48fa-aa69-a40c604d6bde&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4ce5748c-8538-48fa-aa69-a40c604d6bde","type":"Claim","title":"Several mechanisms have been postulated to account for the link between and APOE and GSK3.","label":"Small S et al.; Several mechanisms have been postulated ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:4ce5748c-8538-48fa-aa69-a40c604d6bde"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b1ff5097-3096-4ef1-8b1e-d4f741378da3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b1ff5097-3096-4ef1-8b1e-d4f741378da3","type":"Claim","title":"Cholesterol lowering drugs reduce pathology in APP transgenic mice.","label":"Hardy J et al.; Cholesterol lowering drugs reduce pathol...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:b1ff5097-3096-4ef1-8b1e-d4f741378da3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1e8816a1-9aba-4664-84de-fce29924fd5c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1e8816a1-9aba-4664-84de-fce29924fd5c","type":"Claim","title":"Fibrillar plaque density correlates weakly with severity of dementia in AD.","label":"Walsh D et al.; Fibrillar plaque density correlates weak...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Klyubin Igor","Fadeeva Julia V","Cullen William K","Anwyl Roger","Wolfe Michael S","Rowan Michael J","Selkoe Dennis J"],"firstAuthor":"Walsh Dominic M","referenceYear":"2002","referenceDate":"2002-04-04","id":"urn:lsid:swan.org:researchstatement:1e8816a1-9aba-4664-84de-fce29924fd5c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a0650495-c4d5-43f9-826d-7072f465d8d6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a0650495-c4d5-43f9-826d-7072f465d8d6","type":"Claim","title":"In a simple model of A&#946;42 assembly, monomers quickly assemble to form pentamer/hexamer units, \"paranuclei\" which have little regular secondary structure and which in turn aggregate to form larger oligomers of paranuclei, leading to the formation into protofibrils.","label":"Bitan G et al.; In a simple model of A&#946;42 assembly,...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:a0650495-c4d5-43f9-826d-7072f465d8d6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:92165e04-345f-46cf-8f67-488700330193&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:92165e04-345f-46cf-8f67-488700330193","type":"Claim","title":"Passive immunization, consisting of prolonged treatment with monoclonal or polyclonal anti-Aβ antibodies, can prevent the development of amyloid deposits in PDAPP mice.","label":"Dodart J et al.; Passive immunization, consisting of prol...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:92165e04-345f-46cf-8f67-488700330193"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:808a3867-3b0b-441a-aec2-9d2e8115a62f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:808a3867-3b0b-441a-aec2-9d2e8115a62f","type":"Claim","title":"Beta secretase is an attractive target for AD drug discovery because BACE knockout mice are viable with no overt phenotype.","label":"Golde T; Beta secretase is an attractive target f...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde T","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:808a3867-3b0b-441a-aec2-9d2e8115a62f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3568d2ad-7e83-4e94-92d2-198b9e09e9e2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3568d2ad-7e83-4e94-92d2-198b9e09e9e2","type":"Claim","title":"Structural MRI measures of atrophy retain a highly significant correlation with observed clinical impairment in both the mild cognitive impairment (MCI) and dementia phases of AD, and furthermore, rates of atrophy on MRI are significantly greater in patients with AD than in cognitively normal elderly individuals.","label":"Jack C et al.; Structural MRI measures of atrophy retai...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:3568d2ad-7e83-4e94-92d2-198b9e09e9e2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8008a8d6-45e6-47ce-bc5b-59ace4868113&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8008a8d6-45e6-47ce-bc5b-59ace4868113","type":"Claim","title":"No significant interactions of the rs11136000 SNP, located within an intron of CLU (which encodes clusterin) or rs3851179 SNP located 88.5 kb 5\u2019 to PICALM with APOE status were observed as influencing AD risk.","label":"Harold D et al.; No significant interactions of the rs111...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Abraham Richard","Hollingworth Paul","Sims Rebecca","Gerrish Amy","Hamshere Marian L","Pahwa Jaspreet Singh","Moskvina Valentina","Dowzell Kimberley","Williams Amy","Jones Nicola","Thomas Charlene","Stretton Alexandra","Morgan Angharad R","Lovestone Simon","Powell John","Proitsi Petroula","Lupton Michelle K","Brayne Carol","Rubinsztein David C","Gill Michael","Lawlor Brian","Lynch Aoibhinn","Morgan Kevin","Brown Kristelle S","Passmore Peter A","Craig David","McGuinness Bernadette","Todd Stephen","Holmes Clive","Mann David","Smith A David","Love Seth","Kehoe Patrick G","Hardy John","Mead Simon","Fox Nick","Rossor Martin","Collinge John","Maier Wolfgang","Jessen Frank","Schürmann Britta","van den Bussche Hendrik","Heuser Isabella","Kornhuber Johannes","Wiltfang Jens","Dichgans Martin","Frölich Lutz","Hampel Harald","Hüll Michael","Rujescu Dan","Goate Alison M","Kauwe John S","Cruchaga Carlos","Nowotny Petra","Morris John C","Mayo Kevin","Sleegers Kristel","Bettens Karolien","Engelborghs Sebastiaan","De Deyn Peter P","Van Broeckhoven Christine","Livingston Gill","Bass Nicholas J","Gurling Hugh","McQuillin Andrew","Gwilliam Rhian","Deloukas Panagiotis","Al-Chalabi Ammar","Shaw Christopher E","Tsolaki Magda","Singleton Andrew B","Guerreiro Rita","Mühleisen Thomas W","Nöthen Markus M","Moebus Susanne","Jöckel Karl-Heinz","Klopp Norman","Wichmann H-Erich","Carrasquillo Minerva M","Pankratz V Shane","Younkin Steven G","Holmans Peter A","O'Donovan Michael","Owen Michael J","Williams Julie"],"firstAuthor":"Harold Denise","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:8008a8d6-45e6-47ce-bc5b-59ace4868113"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f1a03aee-2df8-44f5-9348-880590656f2a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f1a03aee-2df8-44f5-9348-880590656f2a","type":"Claim","title":"A direct interaction between Aβ and the A-type K+ channel has not been demonstrated.","label":"Petersen R et al.; A direct interaction between Aβ and the ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Castellani Rudolph J","Nunomura Akihiko","Zhu Xiongwei","Lee Hyoung-gon","Perry George","Smith Mark A"],"firstAuthor":"Petersen R B","id":"urn:lsid:swan.org:researchstatement:f1a03aee-2df8-44f5-9348-880590656f2a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:506b6221-25af-45b8-887b-54dd50ec6979&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:506b6221-25af-45b8-887b-54dd50ec6979","type":"Claim","title":"Immunoblotting experiments revealed the co-isolation of approximately 30 ng per microg proteasome protein together with the isolated PHF-tau, whereas after further purification by gradient ultracentrifugation, no proteasome subunits could be detected.","label":"Keck S et al.; Immunoblotting experiments revealed the ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:506b6221-25af-45b8-887b-54dd50ec6979"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bf3fba4a-6379-4ee3-9e84-dc4f735bab26&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bf3fba4a-6379-4ee3-9e84-dc4f735bab26","type":"Claim","title":"The observation that the SIRT1-H363Y mutant did not confer protection demonstrates that the deacetylase activity of SIRT1 is required for neuroprotection.","label":"Kim D et al.; The observation that the SIRT1-H363Y mut...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:bf3fba4a-6379-4ee3-9e84-dc4f735bab26"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7e643d99-4f2b-451c-acfb-a4d99901525b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7e643d99-4f2b-451c-acfb-a4d99901525b","type":"Claim","title":"Active site substrates for IDE can activate the enzyme toward hydrolyzing Aβ, but not insulin.","label":"Tanzi R et al.; Active site substrates for IDE can activ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:7e643d99-4f2b-451c-acfb-a4d99901525b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:15ae5868-04c0-4fc0-8e94-ef1d8deae4d0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:15ae5868-04c0-4fc0-8e94-ef1d8deae4d0","type":"Comment","title":"Wolozin comment on Walsh hypothesis \u201cNaturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo.\u201d","label":"Wolozin B; Wolozin comment on Walsh hypothesis \u201cNat...","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Wolozin B","referenceYear":"2002","referenceDate":"2002-06-05","id":"urn:lsid:swan.org:comment:15ae5868-04c0-4fc0-8e94-ef1d8deae4d0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5b225347-5622-4d79-812d-c3a973d97607&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5b225347-5622-4d79-812d-c3a973d97607","type":"Claim","title":"In progressive supranuclear palsy (PSP) cases tau pathology in the occipitotemporal gyrus significantly correlated with TDP-43 pathology.","label":"Yokota O et al.; In progressive supranuclear palsy (PSP) ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Davidson Yvonne","Bigio Eileen H","Ishizu Hideki","Terada Seishi","Arai Tetsuaki","Hasegawa Masato","Akiyama Haruhiko","Sikkink Stephen","Pickering-Brown Stuart","Mann David M"],"firstAuthor":"Yokota Osamu","referenceYear":"2010","referenceDate":"2010-07","id":"urn:lsid:swan.org:researchstatement:5b225347-5622-4d79-812d-c3a973d97607"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:91e81bdc-0f74-49db-ac6f-e6dbc1179da2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:91e81bdc-0f74-49db-ac6f-e6dbc1179da2","type":"Claim","title":"The combination of oxidative stress plus okadaic acid treatment caused extensive tau phosphorylation and significant inhibition of tau degradation.","label":"Grune T; The combination of oxidative stress plus...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Grune Tilman","id":"urn:lsid:swan.org:researchstatement:91e81bdc-0f74-49db-ac6f-e6dbc1179da2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6bb878a3-b13d-4a81-a63d-0b5db688a808&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6bb878a3-b13d-4a81-a63d-0b5db688a808","type":"Claim","title":"Aβ is able to oxidize cholesterol and thereby affect cholesterol metabolism, since oxysterols modulate cholesterol metabolism.","label":"Aβ is able to oxidize cholesterol and th...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:6bb878a3-b13d-4a81-a63d-0b5db688a808"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9b9f44dc-783f-4710-84df-261e681c01f5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9b9f44dc-783f-4710-84df-261e681c01f5","type":"Claim","title":"The serial model of causality, even with a trigger caveat, is strained by the evidence suggesting that tau hyperphosphorylation spread throughout the brain, reaching as far as primary cortex.","label":"Small S et al.; The serial model of causality, even with...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:9b9f44dc-783f-4710-84df-261e681c01f5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8a3906de-1e2d-4031-9169-9f410ecbf807&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8a3906de-1e2d-4031-9169-9f410ecbf807","type":"Claim","title":"An additional transgenic mouse study further supports the claim that expression of human ApoE3 or ApoE4 develop neuritic Aβ deposits, but that E4 have more than E3 expressing mice.","label":"Holtzman D; An additional transgenic mouse study fur...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman David M","id":"urn:lsid:swan.org:researchstatement:8a3906de-1e2d-4031-9169-9f410ecbf807"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3180a45b-337a-4cc7-9c6c-f37d63fcf055&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3180a45b-337a-4cc7-9c6c-f37d63fcf055","type":"Claim","title":"APOE4 genotype influences mutant PS1-associated EOAD, as APOE epsilon 4 allele carriers are more likely to develop AD at an earlier age than subjects without the epsilon 4 allele.","label":"Small S et al.; APOE4 genotype influences mutant PS1-ass...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:3180a45b-337a-4cc7-9c6c-f37d63fcf055"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6394dc28-d51e-488b-9f30-b7f424803598&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6394dc28-d51e-488b-9f30-b7f424803598","type":"Claim","title":"ApoE immunoreactivity colocalizes with extracellular amyloid deposits in AD and Down&#8217;s Syndrome","label":"Holtzman D; ApoE immunoreactivity colocalizes with e...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:6394dc28-d51e-488b-9f30-b7f424803598"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:467a22b0-45d9-4b85-ba89-69cacae1ffbc&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:467a22b0-45d9-4b85-ba89-69cacae1ffbc","type":"Claim","title":"Cell type, culture conditions and form of amyloid beta are important to determine effects on K+ channels.","label":"Plant L et al.; Cell type, culture conditions and form o...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:467a22b0-45d9-4b85-ba89-69cacae1ffbc"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:b146c9be-ea9d-46d1-b243-4207443d552b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:b146c9be-ea9d-46d1-b243-4207443d552b","type":"Comment","title":"Barres comment on Bartzokis hypothesis \"The human brain\u2019s myelin sheaths underlie a unique vulnerability to Alzheimer Disease (AD).\"","label":"Barres B; Barres comment on Bartzokis hypothesis \"...","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Barres Ben A","id":"urn:lsid:swan.org:comment:b146c9be-ea9d-46d1-b243-4207443d552b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f19d75ff-4125-4aaf-ba8a-937d807be100&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f19d75ff-4125-4aaf-ba8a-937d807be100","type":"Claim","title":"Longer forms of Aβ (e.g., Aβ42) aggregate faster than shorter ones and aggregation was thought to be essential for neurotoxicity.","label":"Hartley D et al.; Longer forms of Aβ (e.g., Aβ42) aggregat...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:f19d75ff-4125-4aaf-ba8a-937d807be100"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:5aa6f256-3777-45f5-9b46-426e1b65184a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:5aa6f256-3777-45f5-9b46-426e1b65184a","type":"Claim","title":"Longitudinal in vivo microscopy data is consistent with a prediction of the amyloid hypothesis in which amyloid deposition is followed by activation and recruitment of microglia and local neuritic changes: a sequential cascade leading to neurodegeneration.","label":"Meyer-Luehmann M et al.; Longitudinal in vivo microscopy data is ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:5aa6f256-3777-45f5-9b46-426e1b65184a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3096cafe-1b85-440c-88e9-47c7677a7534&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3096cafe-1b85-440c-88e9-47c7677a7534","type":"Claim","title":"Anti-Aβ vaccines can reduce the cognitive deficit associated with the accumulation of Aβ, without removing the neuritic plaques.","label":"Wolozin B; Anti-Aβ vaccines can reduce the cognitiv...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Wolozin B L","id":"urn:lsid:swan.org:researchstatement:3096cafe-1b85-440c-88e9-47c7677a7534"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d8217951-1596-4105-a6fe-4da520010e6c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d8217951-1596-4105-a6fe-4da520010e6c","type":"Claim","title":"APP in a chimeric dimer could be preferentially cleaved, thereby generating ever increasing amounts of intramembranous Aβ.","label":"Marchesi V; APP in a chimeric dimer could be prefere...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:d8217951-1596-4105-a6fe-4da520010e6c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cfaa73e9-765f-4a59-939e-b5416f59465f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cfaa73e9-765f-4a59-939e-b5416f59465f","type":"Claim","title":"Excellent correspondence has been seen between Pittsburgh compound B (PiB) binding (specifically for fibrillar Aβ, and not to soluble Aβ or to diffuse plaques) and fibrillar Aβ deposition in the brain (or cerebral vasculature) in most, but not all AD patients.","label":"Jack C et al.; Excellent correspondence has been seen b...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:cfaa73e9-765f-4a59-939e-b5416f59465f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4c77b0a7-d5da-4758-898a-d4a64f416a50&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4c77b0a7-d5da-4758-898a-d4a64f416a50","type":"Claim","title":"Increases in CSF tau seem to indicate neuronal damage, and are seen in ischaemic and traumatic brain injury.","label":"Jack C et al.; Increases in CSF tau seem to indicate ne...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:4c77b0a7-d5da-4758-898a-d4a64f416a50"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2c06b14a-d981-4067-b467-a2dcaf63a8a4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2c06b14a-d981-4067-b467-a2dcaf63a8a4","type":"Claim","title":"Soluble forms of aggregated Aβ correlate best with synaptic loss.","label":"Hartley D et al.; Soluble forms of aggregated Aβ correlate...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:2c06b14a-d981-4067-b467-a2dcaf63a8a4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:995ec105-e9a3-41d3-8cb1-1cfcf7b6e7a8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:995ec105-e9a3-41d3-8cb1-1cfcf7b6e7a8","type":"Claim","title":"Aβ oligomers are undetected in typical pathology assays, and thus constitute missing links in the pathogenic cascade.","label":"Gong Y et al.; Aβ oligomers are undetected in typical p...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:995ec105-e9a3-41d3-8cb1-1cfcf7b6e7a8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b6961629-00ab-4933-894a-19288a5c8b6e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b6961629-00ab-4933-894a-19288a5c8b6e","type":"Claim","title":"PET imaging ligands and the magnetic resonance spectroscopy metabolite myo-inositol have been proposed as potential biomarkers of glial activation; however, neither is widely used.","label":"Jack C et al.; PET imaging ligands and the magnetic res...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner Michael W","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:b6961629-00ab-4933-894a-19288a5c8b6e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9dfd0491-3222-4b38-93fb-99fbd6a2477c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9dfd0491-3222-4b38-93fb-99fbd6a2477c","type":"Claim","title":"\u2018Danger signaling\u2019 might explain the observation that inflammatory markers are often the earliest sign of pathology in experimental models of neurodegenerative proteinopathies.","label":"Golde T et al.; \u2018Danger signaling\u2019 might explain the obs...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:9dfd0491-3222-4b38-93fb-99fbd6a2477c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2e2a5dd3-2dce-4857-9284-1470d9486b8a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2e2a5dd3-2dce-4857-9284-1470d9486b8a","type":"Claim","title":"Aging induces a progressive increase of ceramide content in the brain, which in turn can stabilize BACE and activate Aβ production and secretion.","label":"Aging induces a progressive increase of ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:2e2a5dd3-2dce-4857-9284-1470d9486b8a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f57fafea-bcbd-49c7-9651-6d6740dd939e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f57fafea-bcbd-49c7-9651-6d6740dd939e","type":"Hypothesis","title":"Hypertension and the expression of an innate pro-inflammatory cytokine profile in middle age are early risk factors of AD in old age.","label":"Hypertension and the expression of an in...","icon":"../icons/ontological/discourse-element/h-research-statement.png","id":"urn:lsid:swan.org:researchstatement:f57fafea-bcbd-49c7-9651-6d6740dd939e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9acb4446-8432-4ab7-9d2a-0e298c77ef6d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9acb4446-8432-4ab7-9d2a-0e298c77ef6d","type":"Claim","title":"Numerous epidemiologic studies link AD risk factors such as stroke, heart disease, hypertension and atherosclerosis to reduced cerebral blood flow.","label":"Aliev G; Numerous epidemiologic studies link AD r...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Aliev Gjumrakch","id":"urn:lsid:swan.org:researchstatement:9acb4446-8432-4ab7-9d2a-0e298c77ef6d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:220739b0-88e0-4e0d-b968-99b5d0ea1689&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:220739b0-88e0-4e0d-b968-99b5d0ea1689","type":"Claim","title":"The molecular mechanism(s) of Aβ production remains unclear, and alternative pathways for the processing of APP to Aβ have been proposed.","label":"Suzuki T et al.; The molecular mechanism(s) of Aβ product...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:220739b0-88e0-4e0d-b968-99b5d0ea1689"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c61d2330-9115-4df1-8320-d0c8e5538848&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c61d2330-9115-4df1-8320-d0c8e5538848","type":"Claim","title":"The vast majority of PS mutations that impair NICD production also impair AICD production, indicating a general impairment of γ-secretase dependent function that is not limited to a single substrate.","label":"Shen J et al.; The vast majority of PS mutations that i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:c61d2330-9115-4df1-8320-d0c8e5538848"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2914216b-a96e-493d-a532-557a88207974&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2914216b-a96e-493d-a532-557a88207974","type":"Claim","title":"Carriers of APOE ε4 have an earlier age of onset of dementia than non-carriers, suggesting that APOE ε4 carriers will have a leftward (earlier in time) shift of both the Aβ-plaque and neurodegenerative biomarker cascades relative to non-carriers.","label":"Jack C et al.; Carriers of APOE ε4 have an earlier age ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:2914216b-a96e-493d-a532-557a88207974"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a544caae-e495-4d32-a9e6-7b30cbcbecfb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a544caae-e495-4d32-a9e6-7b30cbcbecfb","type":"Claim","title":"γ-secretase inhibitors mimic the effects of pathogenic PS mutations.","label":"Shen J et al.; γ-secretase inhibitors mimic the effects...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:a544caae-e495-4d32-a9e6-7b30cbcbecfb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:dd9c164b-29ac-4169-85a5-75e6a2399675&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:dd9c164b-29ac-4169-85a5-75e6a2399675","type":"Claim","title":"The pathogenesis of Alzheimer Disease involves the development of neurofibrillary tangles in the soma and proximal dendrites and amyloid plaques primarily in and around the dendrites of cortical pyramidal neurons.","label":"Morse T et al.; The pathogenesis of Alzheimer Disease in...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Mutalik Pradeep","Cheung Kei","Miller Perry L","Shepherd Gordon"],"firstAuthor":"Morse Thomas M","id":"urn:lsid:swan.org:researchstatement:dd9c164b-29ac-4169-85a5-75e6a2399675"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4b517cc6-be8b-47c1-bf54-0d92e211b5b3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4b517cc6-be8b-47c1-bf54-0d92e211b5b3","type":"Claim","title":"ADDLs are responsible for plaque-independent decreases in synapse density observed in hAPP transgenic mice.","label":"Gong Y et al.; ADDLs are responsible for plaque-indepen...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:4b517cc6-be8b-47c1-bf54-0d92e211b5b3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bbdc006c-b5ee-412e-b539-ce73fb69c171&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bbdc006c-b5ee-412e-b539-ce73fb69c171","type":"Hypothesis","title":"The human brain\u2019s myelin sheaths underlie a unique vulnerability to Alzheimer Disease (AD).","label":"Bartzokis G; The human brain\u2019s myelin sheaths underli...","icon":"../icons/ontological/discourse-element/h-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:bbdc006c-b5ee-412e-b539-ce73fb69c171"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:126ce048-de27-4933-9eca-0d91dd0cb9e3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:126ce048-de27-4933-9eca-0d91dd0cb9e3","type":"Claim","title":"Soluble Aβ is produced throughout life via regulated and sequential secretase cleavage.","label":"Plant L et al.; Soluble Aβ is produced throughout life v...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:126ce048-de27-4933-9eca-0d91dd0cb9e3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7c6a7596-8f23-4738-bb13-4e3324403172&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7c6a7596-8f23-4738-bb13-4e3324403172","type":"Claim","title":"Highly insoluble Aβ aggregates such as amyloid plaque cores represent dimer-rich structures that do not readily dissociate.","label":"Shankar G et al.; Highly insoluble Aβ aggregates such as a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Li Shaomin","Mehta Tapan H","Garcia-Munoz Amaya","Shepardson Nina E","Smith Imelda","Brett Francesca M","Farrell Michael A","Rowan Michael J","Lemere Cynthia A","Regan Ciaran M","Walsh Dominic M","Sabatini Bernardo L","Selkoe Dennis J"],"firstAuthor":"Shankar Ganesh M","referenceYear":"2008","referenceDate":"2008-08","id":"urn:lsid:swan.org:researchstatement:7c6a7596-8f23-4738-bb13-4e3324403172"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3332ca2a-ad81-4d25-8479-5e4747a7b28a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3332ca2a-ad81-4d25-8479-5e4747a7b28a","type":"Claim","title":"The relative inability of Aβ40 to readily form pentamer/hexamer paranuclei may provide an explanation of the differences in neurotoxicity of the shorter peptide, despite a larger molar concentration.","label":"Bitan G et al.; The relative inability of Aβ40 to readil...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:3332ca2a-ad81-4d25-8479-5e4747a7b28a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:02e87a6b-80f6-4db6-ae6c-ec5d1f5a8b98&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:02e87a6b-80f6-4db6-ae6c-ec5d1f5a8b98","type":"Claim","title":"Soluble Alzheimer\u2019s disease cortical extracts significantly impaired memory function of rats on a step-through passive avoidance task.","label":"Shankar G et al.; Soluble Alzheimer\u2019s disease cortical ext...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Li Shaomin","Mehta Tapan H","Garcia-Munoz Amaya","Shepardson Nina E","Smith Imelda","Brett Francesca M","Farrell Michael A","Rowan Michael J","Lemere Cynthia A","Regan Ciaran M","Walsh Dominic M","Sabatini Bernardo L","Selkoe Dennis J"],"firstAuthor":"Shankar Ganesh M","referenceYear":"2008","referenceDate":"2008-08","id":"urn:lsid:swan.org:researchstatement:02e87a6b-80f6-4db6-ae6c-ec5d1f5a8b98"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6c7eac0b-ac3c-417a-9d3f-16be117419ac&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6c7eac0b-ac3c-417a-9d3f-16be117419ac","type":"Claim","title":"Increased excitability caused by blocked A-type K channels can result in the neuron\u2019s own action potentials being pathologically back-propagated into the neuronal dendritic tree for far greater distances than normal.","label":"Morse T et al.; Increased excitability caused by blocked...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Mutalik Pradeep","Cheung Kei","Miller Perry L","Shepherd Gordon"],"firstAuthor":"Morse Thomas M","id":"urn:lsid:swan.org:researchstatement:6c7eac0b-ac3c-417a-9d3f-16be117419ac"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:66673bde-b48c-436b-95f5-b0133ef86190&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:66673bde-b48c-436b-95f5-b0133ef86190","type":"Claim","title":"The development of fibrillary tau pathology is linked to MT loss, impaired fast axonal transport (FAT), and neurodegeneration.","label":"Lee V et al.; The development of fibrillary tau pathol...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Trojanowski John Q"],"firstAuthor":"Lee Virginia M-Y","id":"urn:lsid:swan.org:researchstatement:66673bde-b48c-436b-95f5-b0133ef86190"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1016f867-a5b2-4b6f-8ee8-9351ef194e82&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1016f867-a5b2-4b6f-8ee8-9351ef194e82","type":"Claim","title":"Dynamic light scattering methods to resolve the physical size of Aβ aggregates show that Aβ42 exists in 2 large populations, one at 10-20 nm hydrodynamic radius size particles and the other at approx 60 nm size.","label":"Bitan G et al.; Dynamic light scattering methods to reso...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:1016f867-a5b2-4b6f-8ee8-9351ef194e82"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:83960aff-4fab-4926-8cbd-3813ad400ff0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:83960aff-4fab-4926-8cbd-3813ad400ff0","type":"Claim","title":"A major and surprising concern about the amyloid hypothesis is that very little is known of the functions of APP other than the extracellular domain of the protease nexin form of APP (APP751/770) is part of the clotting cascade, nor is it known whether Aβ has a function or not.  ","label":"Hardy ; A major and surprising concern about the...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Hardy","referenceYear":"2009","referenceDate":"2009-05-18","id":"urn:lsid:swan.org:researchstatement:83960aff-4fab-4926-8cbd-3813ad400ff0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6d6e8e27-f519-4c39-8349-05e58fdc9661&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6d6e8e27-f519-4c39-8349-05e58fdc9661","type":"Claim","title":"In the process of LRP-mediated clearance, Aβ initially forms a complex with the LRP ligands, alpha2M or apoE, on the abluminal side of the endothelium.  The Aβ-chaperone complex then binds to LRP and is internalized to late endosomes after which they can either be delivered to lysosomes for subsequent degradation or be targeted for transcytosis across the BBB into the plasma.","label":"Tanzi R et al.; In the process of LRP-mediated clearance...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:6d6e8e27-f519-4c39-8349-05e58fdc9661"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:067b82ba-4013-425d-a2d3-d12e6965bb11&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:067b82ba-4013-425d-a2d3-d12e6965bb11","type":"Claim","title":"The role of microglia surrounding amyloid plaques remains elusive.","label":"Meyer-Luehmann M et al.; The role of microglia surrounding amyloi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:067b82ba-4013-425d-a2d3-d12e6965bb11"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:643fd0d4-7580-4959-8232-479ec0cc0013&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:643fd0d4-7580-4959-8232-479ec0cc0013","type":"Claim","title":"From the myelin model perspective, AD may be considered as a developmental disorder requiring myelination as an essential permissive step.","label":"Bartzokis G; From the myelin model perspective, AD ma...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:643fd0d4-7580-4959-8232-479ec0cc0013"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:26b77415-58c9-4fdb-bc99-8e141814e005&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:26b77415-58c9-4fdb-bc99-8e141814e005","type":"Hypothesis","title":"Cholesterol 25-Hydroxylase on Chromosome 10q is a susceptibility gene for sporadic AD.  ","label":"Papassotiropoulos A et al.; Cholesterol 25-Hydroxylase on Chromosome...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Lambert Jean-Charles","Wavrant De-Vrieze Fabienne","Wollmer M Axel","von der Kammer Heinz","Streffer Johannes R","Maddalena Alessia","Huynh Kim-Dung","Wolleb Sibylle","Lutjohann D","Schneider Brigitte","Thal Dietmar","Grimaldi Luigi  M. E.","Tsolaki Magdalini","Kapaki Elisabeth","Ravid Rivka","Konietzko Uwe","Hegi Thomas","Pasch  Thomas","Jung Hans","Braak Heiko","Amouyel Philippe","Rogaev E I","Hardy John","Hock Christoph","Nitsch Roger M"],"firstAuthor":"Papassotiropoulos Andreas","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:26b77415-58c9-4fdb-bc99-8e141814e005"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:0849d2e4-4966-4f46-80ad-910cd4c5be11&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:0849d2e4-4966-4f46-80ad-910cd4c5be11","type":"Comment","title":"The emphasis on cortical activity, to the implied exclusion of other regions such as the hippocampus and amygdala, may be an unintended overstatement, since Morse et al. base their statement/hypothesis on computational models which are not specific to a particular brain region.","label":"Stutzmann G; The emphasis on cortical activity, to th...","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Stutzmann Grace E","id":"urn:lsid:swan.org:comment:0849d2e4-4966-4f46-80ad-910cd4c5be11"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bdd5dcb4-adb3-46fd-be81-473afedc72f6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bdd5dcb4-adb3-46fd-be81-473afedc72f6","type":"Claim","title":"Comment by D. Selkoe on Deposition vs. Accumulation of Aβ and neurotoxicity.","label":"Selkoe D; Comment by D. Selkoe on Deposition vs. A...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Selkoe Dennis J","id":"urn:lsid:swan.org:researchstatement:bdd5dcb4-adb3-46fd-be81-473afedc72f6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3303dcaf-cd34-40a2-b241-28e175561636&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3303dcaf-cd34-40a2-b241-28e175561636","type":"Claim","title":"A specific form of naturally secreted Aβ blocks long-term potentiation in the absence of monomers, protofibrils and fibrils, directly in living, anesthetized rats.","label":"Selkoe D; A specific form of naturally secreted Aβ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Selkoe Dennis J","id":"urn:lsid:swan.org:researchstatement:3303dcaf-cd34-40a2-b241-28e175561636"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b99565bc-91c1-45e3-b7ca-95ae60cb5f02&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b99565bc-91c1-45e3-b7ca-95ae60cb5f02","type":"Claim","title":"While levels of APOE protein appear to be inversely proportional to APOE-ε4 allele dose levels, with protein levels reduced in ε4 homozygotes compared with heterozygotes, conversely, clusterin levels are increased in proportion to APOE-ε4 allele dose levels, suggesting an induction of clusterin in individuals with low APOE levels.","label":"Harold D et al.; While levels of APOE protein appear to b...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Abraham Richard","Hollingworth Paul","Sims Rebecca","Gerrish Amy","Hamshere Marian L","Pahwa Jaspreet Singh","Moskvina Valentina","Dowzell Kimberley","Williams Amy","Jones Nicola","Thomas Charlene","Stretton Alexandra","Morgan Angharad R","Lovestone Simon","Powell John","Proitsi Petroula","Lupton Michelle K","Brayne Carol","Rubinsztein David C","Gill Michael","Lawlor Brian","Lynch Aoibhinn","Morgan Kevin","Brown Kristelle S","Passmore Peter A","Craig David","McGuinness Bernadette","Todd Stephen","Holmes Clive","Mann David","Smith A David","Love Seth","Kehoe Patrick G","Hardy John","Mead Simon","Fox Nick","Rossor Martin","Collinge John","Maier Wolfgang","Jessen Frank","Schürmann Britta","van den Bussche Hendrik","Heuser Isabella","Kornhuber Johannes","Wiltfang Jens","Dichgans Martin","Frölich Lutz","Hampel Harald","Hüll Michael","Rujescu Dan","Goate Alison M","Kauwe John S","Cruchaga Carlos","Nowotny Petra","Morris John C","Mayo Kevin","Sleegers Kristel","Bettens Karolien","Engelborghs Sebastiaan","De Deyn Peter P","Van Broeckhoven Christine","Livingston Gill","Bass Nicholas J","Gurling Hugh","McQuillin Andrew","Gwilliam Rhian","Deloukas Panagiotis","Al-Chalabi Ammar","Shaw Christopher E","Tsolaki Magda","Singleton Andrew B","Guerreiro Rita","Mühleisen Thomas W","Nöthen Markus M","Moebus Susanne","Jöckel Karl-Heinz","Klopp Norman","Wichmann H-Erich","Carrasquillo Minerva M","Pankratz V Shane","Younkin Steven G","Holmans Peter A","O'Donovan Michael","Owen Michael J","Williams Julie"],"firstAuthor":"Harold Denise","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:b99565bc-91c1-45e3-b7ca-95ae60cb5f02"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:10d9db61-6f84-496c-a31e-26f738ba8b5b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:10d9db61-6f84-496c-a31e-26f738ba8b5b","type":"Claim","title":"In contrast, tau transgenic mice display neuronal dysfunction in the brain only after 20 months of age, when aging-related factors might combine with tau cytotoxicity to cause axonal degeneration and secondary transport failure.","label":"Nixon R; In contrast, tau transgenic mice display...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Nixon Ralph A","id":"urn:lsid:swan.org:researchstatement:10d9db61-6f84-496c-a31e-26f738ba8b5b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b1eddb58-c18c-4cdc-8c5c-281cf67c46f2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b1eddb58-c18c-4cdc-8c5c-281cf67c46f2","type":"Claim","title":"This hypothesis is reminiscent of cytotoxicity mediated by the APP C-terminal fragments that are membrane-retained APP fragments created after &#945;- and especially &#946;-secretase cleavages.","label":"Koo E; This hypothesis is reminiscent of cytoto...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Koo Edward H","id":"urn:lsid:swan.org:researchstatement:b1eddb58-c18c-4cdc-8c5c-281cf67c46f2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:01a41822-76f8-49e6-945c-aeff0e4aa7a1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:01a41822-76f8-49e6-945c-aeff0e4aa7a1","type":"Claim","title":"The model proposed by Bitan et al, that Aβ42 assembles from monomers to paranuclei, and from paranuclei to larger oligomeric protofibrillar and finally fibrillar forms needs to be validated.","label":"LaDu M; The model proposed by Bitan et al, that ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"LaDu Mary Jo","id":"urn:lsid:swan.org:researchstatement:01a41822-76f8-49e6-945c-aeff0e4aa7a1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:ed02d314-9522-4deb-ac82-cc536f1bb47a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:ed02d314-9522-4deb-ac82-cc536f1bb47a","type":"Comment","title":"Kumar-Singh on Meyer-Luehmann","label":"Kumar-Singh S; Kumar-Singh on Meyer-Luehmann","icon":"../icons/ontological/discourse-element/comment.png","firstAuthor":"Kumar-Singh Samir","id":"urn:lsid:swan.org:comment:ed02d314-9522-4deb-ac82-cc536f1bb47a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d242f047-bdb4-43cd-a772-2a3910c16fc7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d242f047-bdb4-43cd-a772-2a3910c16fc7","type":"Claim","title":"The deleterious functional impact of pathogenic presenilin mutations may reflect a general destabilization of PS structure.","label":"Shen J et al.; The deleterious functional impact of pat...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:d242f047-bdb4-43cd-a772-2a3910c16fc7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a98a5a2b-3ae8-436e-b3b9-035e495b1afa&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a98a5a2b-3ae8-436e-b3b9-035e495b1afa","type":"Claim","title":"LTP is a measure of synaptic plasticity that is disrupted by synthetic Aβ.","label":"Walsh D et al.; LTP is a measure of synaptic plasticity ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Klyubin Igor","Fadeeva Julia V","Cullen William K","Anwyl Roger","Wolfe Michael S","Rowan Michael J","Selkoe Dennis J"],"firstAuthor":"Walsh Dominic M","referenceYear":"2002","referenceDate":"2002-04-04","id":"urn:lsid:swan.org:researchstatement:a98a5a2b-3ae8-436e-b3b9-035e495b1afa"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:127c4583-73c7-4f3d-b1ec-af0cfccfdb62&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:127c4583-73c7-4f3d-b1ec-af0cfccfdb62","type":"Claim","title":"Persistence of Aβ dimers in the membrane could have significant impact on health of neurons.","label":"Marchesi V; Persistence of Aβ dimers in the membrane...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:127c4583-73c7-4f3d-b1ec-af0cfccfdb62"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e8676f3c-361b-4037-b3da-72450e61b856&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e8676f3c-361b-4037-b3da-72450e61b856","type":"Claim","title":"Transgenic expression of human genes linked to elevated Aβ42 has produced mice that exhibit certain Alzheimer\u2019s-like molecular, cellular, and behavioral phenotypes.\n","label":"Lambert M et al.; Transgenic expression of human genes lin...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:e8676f3c-361b-4037-b3da-72450e61b856"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d048911f-9cbb-4f6f-8002-41866ec61d8b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d048911f-9cbb-4f6f-8002-41866ec61d8b","type":"Claim","title":"mGluR activation was necessary for the LTD facilitation by soluble Aβ.","label":"Shankar G et al.; mGluR activation was necessary for the L...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Li Shaomin","Mehta Tapan H","Garcia-Munoz Amaya","Shepardson Nina E","Smith Imelda","Brett Francesca M","Farrell Michael A","Rowan Michael J","Lemere Cynthia A","Regan Ciaran M","Walsh Dominic M","Sabatini Bernardo L","Selkoe Dennis J"],"firstAuthor":"Shankar Ganesh M","referenceYear":"2008","referenceDate":"2008-08","id":"urn:lsid:swan.org:researchstatement:d048911f-9cbb-4f6f-8002-41866ec61d8b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ee08603c-dc40-47f7-bf46-af9de6e190a3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ee08603c-dc40-47f7-bf46-af9de6e190a3","type":"Claim","title":"The identity of the γ-secretase has been proposed to be a complex of enzymes composed of presenilin-1 or -2, (PS1 and PS2), nicastrin, aph-1 and pen-2.","label":"Smith I et al.; The identity of the γ-secretase has been...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:ee08603c-dc40-47f7-bf46-af9de6e190a3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a91fa18a-e700-47be-8f17-7018b855f83e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a91fa18a-e700-47be-8f17-7018b855f83e","type":"Claim","title":"Under physiological conditions, GSK3 is phosphorylated at Ser9/21 and increased phosphorylation of GSK3 at Tyr 216/279, less common than regulation at Ser9/21, augments GSK3 activity. ","label":"Hooper C et al.; Under physiological conditions, GSK3 is ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:a91fa18a-e700-47be-8f17-7018b855f83e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:45bc0bdb-1d3b-452d-b578-37c5f6dd3264&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:45bc0bdb-1d3b-452d-b578-37c5f6dd3264","type":"Claim","title":"The combination of tau phosphorylation and tau oxidation, which also occurs in tauopathies, may be directly responsible for the accumulation of tau aggregates.","label":"Grune T; The combination of tau phosphorylation a...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Grune Tilman","id":"urn:lsid:swan.org:researchstatement:45bc0bdb-1d3b-452d-b578-37c5f6dd3264"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:62a23874-52e0-4398-82a9-cc47016bff68&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:62a23874-52e0-4398-82a9-cc47016bff68","type":"Claim","title":"A&#946;42 seems to be so crucial for AD pathogenesis because it has two extra residues (Ile and Ala) at its C-terminus, which would add stability of the peptide within a membrane.","label":"Russo T; A&#946;42 seems to be so crucial for AD ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Russo Tommaso","id":"urn:lsid:swan.org:researchstatement:62a23874-52e0-4398-82a9-cc47016bff68"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1f5e51ca-35f2-4071-a3da-622a9ace7a41&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1f5e51ca-35f2-4071-a3da-622a9ace7a41","type":"Claim","title":"The Ala(42) residue facilitates self-association of paranuclei.","label":"Bitan G et al.; The Ala(42) residue facilitates self-ass...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:1f5e51ca-35f2-4071-a3da-622a9ace7a41"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e5d13cf9-7d89-4d5a-b311-51f0165af9b4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e5d13cf9-7d89-4d5a-b311-51f0165af9b4","type":"Claim","title":"A possible reason for discrepancies in findings is the relatively insensitive nature of the transport assay used to study 8c tau transgenic mice.","label":"Holzbaur E; A possible reason for discrepancies in f...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holzbaur Erika L F","id":"urn:lsid:swan.org:researchstatement:e5d13cf9-7d89-4d5a-b311-51f0165af9b4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a03ccc05-ad59-4728-b7bd-4dd7109b77fa&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a03ccc05-ad59-4728-b7bd-4dd7109b77fa","type":"Claim","title":"Insulin crosses the blood-brain barrier (BBB) at physiologic levels, but it is a matter of controversy as to whether insulin is made in the CNS de novo. ","label":"Craft S; Insulin crosses the blood-brain barrier ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Craft Suzanne","referenceYear":"2009","referenceDate":"2009-10-29","id":"urn:lsid:swan.org:researchstatement:a03ccc05-ad59-4728-b7bd-4dd7109b77fa"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:58c56130-2a7e-4646-9c9b-691014a956ac&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:58c56130-2a7e-4646-9c9b-691014a956ac","type":"Claim","title":"Data arguing that PS clinical mutations represent loss of function come from loss of Notch cleavage or signaling in mammalian cell lines or C. elegans.","label":"Bentahir M et al.; Data arguing that PS clinical mutations ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:58c56130-2a7e-4646-9c9b-691014a956ac"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6b54a6f4-4f40-41de-b479-4f2b0840fa5a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6b54a6f4-4f40-41de-b479-4f2b0840fa5a","type":"Claim","title":"Clusterin may retard the formation of fibrils from both Aβ40 and Aβ42 solutions.","label":"Lambert M et al.; Clusterin may retard the formation of fi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:6b54a6f4-4f40-41de-b479-4f2b0840fa5a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:15c49454-62ef-47db-9b78-f4599ec19b40&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:15c49454-62ef-47db-9b78-f4599ec19b40","type":"Claim","title":"FDG-PET changes might precede MRI changes in patients developing AD.","label":"Jack C et al.; FDG-PET changes might precede MRI change...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:15c49454-62ef-47db-9b78-f4599ec19b40"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:554aee45-59a0-4d0b-ba99-b78c158e945e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:554aee45-59a0-4d0b-ba99-b78c158e945e","type":"Claim","title":"Aging-related changes involving mitochondrial dysfunction are critical to understanding Alzheimer pathobiology and energy homeostasis: with age and diabetes, antioxidant enzymes are diminished and this sets the stage for future disease processes.","label":"Aliev G; Aging-related changes involving mitochon...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Aliev Gjumrakch","id":"urn:lsid:swan.org:researchstatement:554aee45-59a0-4d0b-ba99-b78c158e945e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0b3dfe66-f8a4-417b-8577-2aade6567b10&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0b3dfe66-f8a4-417b-8577-2aade6567b10","type":"Claim","title":"DNA variants in genes encoding alpha2M, apoE, and LRP that have been previously associated with increased risk for AD provides further support for the role of LRP-mediated clearance of Aβ.","label":"Tanzi R et al.; DNA variants in genes encoding alpha2M, ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:0b3dfe66-f8a4-417b-8577-2aade6567b10"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d32a77a7-a04f-4473-a8de-2c539cef4aef&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d32a77a7-a04f-4473-a8de-2c539cef4aef","type":"Claim","title":"Suppression of Wnt or phosphatidylinositol 3-kinase (PI3K) signaling impairs long term potentiation (LTP), the best characterized correlate of learning and memory.","label":"Hooper C et al.; Suppression of Wnt or phosphatidylinosit...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:d32a77a7-a04f-4473-a8de-2c539cef4aef"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6559c5af-0740-4f45-bf1c-1bea63ac045b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6559c5af-0740-4f45-bf1c-1bea63ac045b","type":"Claim","title":"Overexpression of wild type or A315T mutant TDP-43 in transgenic mice skeletal muscle produces a progressive myopathy with TDP-43 inclusions in muscle by a toxic gain of function paradigm, in which alterations in TDP-43 subcellular localization and TDP-43 fragmentation correlate with muscle weakness.","label":"Stallings N et al.; Overexpression of wild type or A315T mut...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Puttaparthi Krishna","Luther Christina M","Burns Dennis K","Elliott Jeffrey L"],"firstAuthor":"Stallings Nancy R","referenceYear":"2010","referenceDate":"2010-07-30","id":"urn:lsid:swan.org:researchstatement:6559c5af-0740-4f45-bf1c-1bea63ac045b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:73e4657e-ca96-4c0f-97de-1129959bc163&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:73e4657e-ca96-4c0f-97de-1129959bc163","type":"Claim","title":"APP is a DR6 ligand.","label":"Nikolaev A et al.; APP is a DR6 ligand.","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["McLaughlin Todd","O'Leary Dennis D","Tessier-Lavigne Marc"],"firstAuthor":"Nikolaev Anatoly","referenceYear":"2009","referenceDate":"2009-02-19","id":"urn:lsid:swan.org:researchstatement:73e4657e-ca96-4c0f-97de-1129959bc163"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3ef2c94f-d961-4e27-b93b-230d98c63ebf&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3ef2c94f-d961-4e27-b93b-230d98c63ebf","type":"Claim","title":"Aβ deposition has not been found to be toxic or cause damage and death of nerve cells in human or animal brain.","label":"Aliev G; Aβ deposition has not been found to be t...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Aliev Gjumrakch","id":"urn:lsid:swan.org:researchstatement:3ef2c94f-d961-4e27-b93b-230d98c63ebf"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4dbecb39-6805-45b3-836e-62aecf6c3eee&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4dbecb39-6805-45b3-836e-62aecf6c3eee","type":"Claim","title":"Several observations suggest that CR1 may have a neuroprotective role via the generation and binding of C3b, which may contribute to Aβ clearance pathways in Alzheimer Disease.","label":"Lambert J et al.; Several observations suggest that CR1 ma...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Heath Simon","Even Gael","Campion Dominique","Sleegers Kristel","Hiltunen Mikko","Combarros Onofre","Zelenika Diana","Bullido Maria J","Tavernier Béatrice","Letenneur Luc","Bettens Karolien","Berr Claudine","Pasquier Florence","Fiévet Nathalie","Barberger-Gateau Pascale","Engelborghs Sebastiaan","De Deyn Peter","Mateo Ignacio","Franck Ana","Helisalmi Seppo","Porcellini Elisa","Hanon Olivier","de Pancorbo Marian M","Lendon Corinne","Dufouil Carole","Jaillard Céline","Leveillard Thierry","Alvarez Victoria","Bosco Paolo","Mancuso Michelangelo","Panza Francesco","Nacmias Benedetta","Bossù Paola","Piccardi Paola","Annoni Giorgio","Seripa Davide","Galimberti Daniela","Hannequin Didier","Licastro Federico","Soininen Hilkka","Ritchie Karen","Blanché Hélène","Dartigues Jean-François","Tzourio Christophe","Gut Ivo","Van Broeckhoven Christine","Alpérovitch Annick","Lathrop Mark","Amouyel Philippe"],"firstAuthor":"Lambert Jean-Charles","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:4dbecb39-6805-45b3-836e-62aecf6c3eee"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6e2dbce6-6578-45b8-aa00-6a263a077080&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6e2dbce6-6578-45b8-aa00-6a263a077080","type":"Claim","title":"GSK3α and GSK3β are ubiquitously expressed, constitutively active, proline-directed serine/threonine kinases involved in a variety of cellular processes including glycogen metabolism, gene transcription, apoptosis, and microtubule stability. ","label":"Hooper C et al.; GSK3α and GSK3β are ubiquitously express...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:6e2dbce6-6578-45b8-aa00-6a263a077080"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:1c984d28-7aa1-41e9-9bd5-a9d758d91021&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:1c984d28-7aa1-41e9-9bd5-a9d758d91021","type":"Claim","title":"Reduced mRNA levels for both β2 and α4 nicotinic acetylcholine receptors (nAChR) subunits have been observed in the aged brain.","label":"Cook L et al.; Reduced mRNA levels for both β2 and α4 n...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Ho Luk W","Taylor Alison E","Brayne Carol","Evans John Grimley","Xuereb John","Cairns Nigel J","Pritchard Antonia","Lemmon Helen","Mann David","St Clair David","Turic Dragana","Hollingworth Paul","Moore Pamela J","Jehu Luke","Archer Nicola","Walter Sarah","Foy Catherine","Edmondson Amanda","Powell John","Lovestone Simon","Owen Michael J","Williams Julie","Lendon Corinne","Rubinsztein David C"],"firstAuthor":"Cook Lynnette J","referenceYear":"2004","referenceDate":"2004-03-25","id":"urn:lsid:swan.org:researchstatement:1c984d28-7aa1-41e9-9bd5-a9d758d91021"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3afba156-63d2-497b-8677-553728ca0be3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3afba156-63d2-497b-8677-553728ca0be3","type":"Claim","title":"Cloning of the APP gene and identification of its Chromosome 21 location,in the context of the invariant development of typical AD neuropathology in patients with trisomy 21 (Down syndrome) supports the hypothesis that Aβ accumulation is the primary event in AD pathogenesis.","label":"Hardy J et al.; Cloning of the APP gene and identificati...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:3afba156-63d2-497b-8677-553728ca0be3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9d5f54e4-fb47-4c7a-b5ea-6d2743d4f2b8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9d5f54e4-fb47-4c7a-b5ea-6d2743d4f2b8","type":"Claim","title":"The Aβ peptide is not produced as an independent protein entity but is instead generated by the proteolytic processing of a much larger transmembrane protein, the amyloid protein precursor (APP).","label":"Tanzi R et al.; The Aβ peptide is not produced as an ind...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:9d5f54e4-fb47-4c7a-b5ea-6d2743d4f2b8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b4e0edef-e746-498a-81ed-547ab009afd1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b4e0edef-e746-498a-81ed-547ab009afd1","type":"Claim","title":"Tau phosphorylation by GSK3β (glycogen synthase kinase 3β) significantly inhibited proteolysis.","label":"Grune T; Tau phosphorylation by GSK3β (glycogen s...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Grune Tilman","id":"urn:lsid:swan.org:researchstatement:b4e0edef-e746-498a-81ed-547ab009afd1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0ce2d8b5-ab3f-4bc3-9764-baf2f9bdbf42&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0ce2d8b5-ab3f-4bc3-9764-baf2f9bdbf42","type":"Claim","title":"Apoptosis occurs very rapidly; the induction phase requires 3 to 12 hours once the cell is committed to degenerate and the resultant apoptotic bodies persist for periods usually lasting only several hours.","label":"Cotman C et al.; Apoptosis occurs very rapidly; the induc...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:0ce2d8b5-ab3f-4bc3-9764-baf2f9bdbf42"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:19752279-42e3-4910-b489-f50c1ce25895&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:19752279-42e3-4910-b489-f50c1ce25895","type":"Claim","title":"Treatment with m266 may enhance the clearance of Aβ from brain to plasma, thereby reducing a central pool of Aβ responsible for memory impairment.","label":"Dodart J et al.; Treatment with m266 may enhance the clea...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Bales Kelly R","Gannon Kimberley S","Greene Stephen J","DeMattos Ronald B","Mathis Chantal","DeLong Cynthia A","Wu Su","Wu Xin","Holtzman David M","Paul Steven M"],"firstAuthor":"Dodart Jean-Cosme","referenceYear":"2002","referenceDate":"2002-05","id":"urn:lsid:swan.org:researchstatement:19752279-42e3-4910-b489-f50c1ce25895"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2f91bde8-9240-4929-b62d-1394a625986a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2f91bde8-9240-4929-b62d-1394a625986a","type":"Claim","title":"Aβ first is shown to accumulate abnormally during the prodromal stages of AD in diffuse extracellular Aβ deposits in Down subjects as early as 10-12 years of age.","label":"Selkoe D; Aβ first is shown to accumulate abnormal...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Selkoe Dennis J","id":"urn:lsid:swan.org:researchstatement:2f91bde8-9240-4929-b62d-1394a625986a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:44ba67fa-57ce-4c3f-8913-a24950d6985b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:44ba67fa-57ce-4c3f-8913-a24950d6985b","type":"Claim","title":"Apoptosis, is a Greek word for falling leaves, a truly natural form of cellular death.","label":"Cotman C et al.; Apoptosis, is a Greek word for falling l...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:44ba67fa-57ce-4c3f-8913-a24950d6985b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9b456b03-c138-4a79-a91e-1a1efeecc1af&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9b456b03-c138-4a79-a91e-1a1efeecc1af","type":"Claim","title":"The impaired proteasome function in AD is the consequence of, and secondary to, PHF formation rather than the primary cause of the protein pathology.","label":"Keck S et al.; The impaired proteasome function in AD i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:9b456b03-c138-4a79-a91e-1a1efeecc1af"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6a04fac3-d52c-4cf9-9558-31f76ff562bd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6a04fac3-d52c-4cf9-9558-31f76ff562bd","type":"Claim","title":"Rafts are linked to signal transduction, Aβ metabolism and synapse organization.","label":"Gong Y et al.; Rafts are linked to signal transduction,...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:6a04fac3-d52c-4cf9-9558-31f76ff562bd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:535189ba-94b1-42c4-8b3e-663c4edf7710&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:535189ba-94b1-42c4-8b3e-663c4edf7710","type":"Claim","title":"Cerebrospinal fluid (CSF) biomarkers of AD, antecedent to the symptomatic stages of the illness, may identify older adults who are predestined to develop mild cognitive impairment (MCI) or dementia.","label":"Morris J et al.; Cerebrospinal fluid (CSF) biomarkers of ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Roe Catherine M","Grant Elizabeth A","Head Denise","Storandt Martha","Goate Alison M","Fagan Anne M","Holtzman David M","Mintun Mark A"],"firstAuthor":"Morris John C","referenceYear":"2009","referenceDate":"2009-12","id":"urn:lsid:swan.org:researchstatement:535189ba-94b1-42c4-8b3e-663c4edf7710"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cb8fbc2a-e060-4d0b-ad69-d3b8235469a6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cb8fbc2a-e060-4d0b-ad69-d3b8235469a6","type":"Claim","title":"Genetically modified mice where the human PS1M146V mutation was \u2018knocked-in\u2019 to the endogenous locus, led to the exclusive production of the mutant protein in the absence of the endogenous wild-type protein.","label":"Smith I et al.; Genetically modified mice where the huma...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:cb8fbc2a-e060-4d0b-ad69-d3b8235469a6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e4966c04-5bf3-409c-87e9-3441a1863fa2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e4966c04-5bf3-409c-87e9-3441a1863fa2","type":"Claim","title":"Rescue of this pathology by GSK-3β overexpression in tau 4R mice may well be directly related to tau hyperphosphorylation, although neuroprotection could also involve reversal of transport-independent cytotoxic effects of tau.","label":"Nixon R; Rescue of this pathology by GSK-3β overe...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Nixon Ralph A","id":"urn:lsid:swan.org:researchstatement:e4966c04-5bf3-409c-87e9-3441a1863fa2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:36f6d9fe-40f8-486a-8868-90d79ce71b47&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:36f6d9fe-40f8-486a-8868-90d79ce71b47","type":"Claim","title":"In all the mouse models analyzed, as well as in human brains, SIRT1 is not only enriched in the nucleus but also localized in the cytoplasm.","label":"Kim D et al.; In all the mouse models analyzed, as wel...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:36f6d9fe-40f8-486a-8868-90d79ce71b47"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:06a38062-f7d7-40ce-be76-3ee52a1fc82a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:06a38062-f7d7-40ce-be76-3ee52a1fc82a","type":"Claim","title":"GSK3 may act as a gate through which LTP and memory are established:  GSK3 activity is increased in AD, memory failure in AD might be attributable to the inhibition of LTP with neuronal loss ensuing as the disease progresses.","label":"Hooper C et al.; GSK3 may act as a gate through which LTP...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:06a38062-f7d7-40ce-be76-3ee52a1fc82a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0dbb12ff-c887-4d91-b21d-bdbbf86132d2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0dbb12ff-c887-4d91-b21d-bdbbf86132d2","type":"Claim","title":"Impaired myelin repair may mediate the increased age-related decline of myelin integrity and cognitive performance of healthy ApoE4+ carriers resulting in increased rates of AD.","label":"Bartzokis G; Impaired myelin repair may mediate the i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:0dbb12ff-c887-4d91-b21d-bdbbf86132d2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:32eabe58-5e21-45c4-a248-4849cf5c0c33&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:32eabe58-5e21-45c4-a248-4849cf5c0c33","type":"Claim","title":"Observations of PiB positive nondemented older adults have been reported, though with a lower frequency (about 20%) that likely reflects younger samples.","label":"Morris J et al.; Observations of PiB positive nondemented...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Roe Catherine M","Grant Elizabeth A","Head Denise","Storandt Martha","Goate Alison M","Fagan Anne M","Holtzman David M","Mintun Mark A"],"firstAuthor":"Morris John C","referenceYear":"2009","referenceDate":"2009-12","id":"urn:lsid:swan.org:researchstatement:32eabe58-5e21-45c4-a248-4849cf5c0c33"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:29d8a8fa-f8a8-43e9-9cf8-e475aa13f821&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:29d8a8fa-f8a8-43e9-9cf8-e475aa13f821","type":"Claim","title":"None of the new plaques occurred immediately adjacent to resident microglia, suggesting that microglia do not form the nidus of new plaques.","label":"Meyer-Luehmann M et al.; None of the new plaques occurred immedia...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:29d8a8fa-f8a8-43e9-9cf8-e475aa13f821"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7ad55799-5b89-45ef-96d6-6ef0fdc37756&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7ad55799-5b89-45ef-96d6-6ef0fdc37756","type":"Claim","title":"The experiments of Meyer-Luehmann et al. primarily focus on cortical regions, while many of the experiments in Stokin et al. examined basal forebrain cholinergic axons, which are long projection axons in regions distinct from the cortical regions imaged in the present paper.","label":"Goldstein L; The experiments of Meyer-Luehmann et al....","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Goldstein Lawrence S B","id":"urn:lsid:swan.org:researchstatement:7ad55799-5b89-45ef-96d6-6ef0fdc37756"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:54ea9bad-612c-4e4b-9701-73fd38e6e468&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:54ea9bad-612c-4e4b-9701-73fd38e6e468","type":"Claim","title":"ApoE2 allele appears to be protective against AD.","label":"Holtzman D; ApoE2 allele appears to be protective ag...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:54ea9bad-612c-4e4b-9701-73fd38e6e468"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d9edce07-c8eb-41b0-9f42-ae35f8f8a57d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d9edce07-c8eb-41b0-9f42-ae35f8f8a57d","type":"Claim","title":"Synaptotoxicity in AD has not been ascribed to one form of Aβ.","label":"Hardy J et al.; Synaptotoxicity in AD has not been ascri...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:d9edce07-c8eb-41b0-9f42-ae35f8f8a57d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:36cee867-51a4-4622-8d47-65c3a0421f83&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:36cee867-51a4-4622-8d47-65c3a0421f83","type":"Hypothesis","title":"Metal toxicity: Copper homeostasis is an important factor in the pathological progression of Alzheimer disease.","label":"White A et al.; Metal toxicity: Copper homeostasis is an...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Reyes R","Mercer J F","Camakaris J","Zheng H","Bush A I","Multhaup G","Beyreuther K","Masters C L","Cappai R"],"firstAuthor":"White A R","referenceYear":"1999","referenceDate":"1999-09-25","id":"urn:lsid:swan.org:researchstatement:36cee867-51a4-4622-8d47-65c3a0421f83"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b450c693-da19-4b71-b51c-a96aeefd5d32&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b450c693-da19-4b71-b51c-a96aeefd5d32","type":"Claim","title":"The striatum is primarily attacked in Huntington Disease and is the target of DNA damage that varies as a function of disease progression.","label":"Cotman C et al.; The striatum is primarily attacked in Hu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:b450c693-da19-4b71-b51c-a96aeefd5d32"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b5a869cd-ac9d-4156-bdca-8c1724fba122&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b5a869cd-ac9d-4156-bdca-8c1724fba122","type":"Claim","title":"GSK3β transgenic mice display tau hyper-phosphorylation and neurodegeneration, and chronic GSK3 inhibitor lithium treatment prevents tau hyper-phosphorylation and NFT formation in double transgenic mice over-expressing GSK3β and FTDP17 mutant tau, although reversal of pre-formed tangles was not observed.","label":"Hooper C et al.; GSK3β transgenic mice display tau hyper-...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:b5a869cd-ac9d-4156-bdca-8c1724fba122"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:26f6aabc-d1ff-4005-a624-86e795d87dc5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:26f6aabc-d1ff-4005-a624-86e795d87dc5","type":"Claim","title":"Autopsy cases provide a suitable preparation for the study of cell death events in AD and probably other neurodegenerative diseases.","label":"Cotman C et al.; Autopsy cases provide a suitable prepara...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:26f6aabc-d1ff-4005-a624-86e795d87dc5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d97c6009-6653-4f56-b1e4-a57e9f6f9865&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d97c6009-6653-4f56-b1e4-a57e9f6f9865","type":"Claim","title":"No specific neurotoxic form of Aβ has been identified in vivo.","label":"Hardy J et al.; No specific neurotoxic form of Aβ has be...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:d97c6009-6653-4f56-b1e4-a57e9f6f9865"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d7f8aeab-3ed2-47ea-9d40-9960fbe583c3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d7f8aeab-3ed2-47ea-9d40-9960fbe583c3","type":"Claim","title":"The primary function of the microtubule-associated protein tau, which is particularly abundant in the axons of neurons, is to stabilize microtubules (MTs).","label":"Ballatore C et al.; The primary function of the microtubule-...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Lee Virginia M-Y","Trojanowski John Q"],"firstAuthor":"Ballatore Carlo","referenceYear":"2007","referenceDate":"2007-09","id":"urn:lsid:swan.org:researchstatement:d7f8aeab-3ed2-47ea-9d40-9960fbe583c3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:62641fb7-a346-444d-af7c-519eafc68936&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:62641fb7-a346-444d-af7c-519eafc68936","type":"Hypothesis","title":"GSK3 is a causal mediator of Alzheimer disease.","label":"Hooper C et al.; GSK3 is a causal mediator of Alzheimer d...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:62641fb7-a346-444d-af7c-519eafc68936"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:48bbbc8c-df73-41af-9863-7b1d1c91a2f6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:48bbbc8c-df73-41af-9863-7b1d1c91a2f6","type":"Claim","title":"The locus coeruleus in the brainstem is largely affected by neuronal distress and cell death early in AD.","label":"Muresan Z et al.; The locus coeruleus in the brainstem is ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","referenceYear":"2008","referenceDate":"2008","id":"urn:lsid:swan.org:researchstatement:48bbbc8c-df73-41af-9863-7b1d1c91a2f6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e8c6a556-53d5-4372-a350-9feaca81ec4a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e8c6a556-53d5-4372-a350-9feaca81ec4a","type":"Hypothesis","title":"[ADNI]  Structural magnetic resonance imaging (MRI) measurement of cerebral atrophy accompanies cognitive decline in MCI and AD.","label":"Jack C et al.; [ADNI]  Structural magnetic resonance im...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","id":"urn:lsid:swan.org:researchstatement:e8c6a556-53d5-4372-a350-9feaca81ec4a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a62e6d1d-01a9-4664-ab04-f5f6346e0b4d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a62e6d1d-01a9-4664-ab04-f5f6346e0b4d","type":"Claim","title":"Axonal degeneration requires a process that is distinct from neuronal cell body apoptosis, which requires caspase 3.","label":"Nikolaev A et al.; Axonal degeneration requires a process t...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["McLaughlin Todd","O'Leary Dennis D","Tessier-Lavigne Marc"],"firstAuthor":"Nikolaev Anatoly","referenceYear":"2009","referenceDate":"2009-02-19","id":"urn:lsid:swan.org:researchstatement:a62e6d1d-01a9-4664-ab04-f5f6346e0b4d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f7c009a9-6bcf-4e1a-9333-deb1cd237344&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f7c009a9-6bcf-4e1a-9333-deb1cd237344","type":"Claim","title":"The phosphorylation of APP<sup>645-694<\/sup> by immunoprecipitated cdc2 kinase is significantly inhibited by a 2-fold molar excess of the SV40 T antigen peptide, an excellent substrate for cdc2 kinase.","label":"Suzuki T et al.; The phosphorylation of APP<sup>645-694<\/...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:f7c009a9-6bcf-4e1a-9333-deb1cd237344"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a3e03a32-9d93-4209-bc2f-037cf3b5714a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a3e03a32-9d93-4209-bc2f-037cf3b5714a","type":"Claim","title":"Loss of tau\u2019s normal MT-stabilizing function would invariably lead to a pathological disturbance in the normal structural and regulatory functions of the cytoskeleton, compromise axonal transport and contribute to synaptic dysfunction and neurodegeneration.","label":"Ballatore C et al.; Loss of tau\u2019s normal MT-stabilizing func...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Lee Virginia M-Y","Trojanowski John Q"],"firstAuthor":"Ballatore Carlo","referenceYear":"2007","referenceDate":"2007-09","id":"urn:lsid:swan.org:researchstatement:a3e03a32-9d93-4209-bc2f-037cf3b5714a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:017ec783-94b2-4a9c-b39c-c9fa604bed1e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:017ec783-94b2-4a9c-b39c-c9fa604bed1e","type":"Claim","title":"Statin use is associated with lower incidence of AD dementia.","label":"Hardy J et al.; Statin use is associated with lower inci...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:017ec783-94b2-4a9c-b39c-c9fa604bed1e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:99243a11-fd49-4da5-8a22-b58919cd6865&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:99243a11-fd49-4da5-8a22-b58919cd6865","type":"Hypothesis","title":"Plasticity of receptors in hippocampus correlates with Alzheimer disease pathology.","label":"Geddes J et al.; Plasticity of receptors in hippocampus c...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Cotman Carl W"],"firstAuthor":"Geddes J W","referenceYear":"1986","referenceDate":"1986-09","id":"urn:lsid:swan.org:researchstatement:99243a11-fd49-4da5-8a22-b58919cd6865"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:99053811-68fd-4460-8137-4949766d3770&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:99053811-68fd-4460-8137-4949766d3770","type":"Claim","title":"Two opposing ideas exist regarding the role of PS clinical mutations in APP processing: arguing for gain of function, all PS mutations enhance the Aβ42:40 ratio; but in support of loss of function, a total loss of Ps results in a total loss of Aβ production.","label":"Bentahir M et al.; Two opposing ideas exist regarding the r...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:99053811-68fd-4460-8137-4949766d3770"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:58afd948-8128-4a97-8e37-17527a689f70&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:58afd948-8128-4a97-8e37-17527a689f70","type":"Claim","title":"High cholesterol diets increase Aβ pathology in animals.","label":"Hardy J et al.; High cholesterol diets increase Aβ patho...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:58afd948-8128-4a97-8e37-17527a689f70"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:183e8937-e409-45bd-a462-245d0b238f7b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:183e8937-e409-45bd-a462-245d0b238f7b","type":"Claim","title":"ADDLs provide an alternative to plaques as a target for drug discovery.","label":"Gong Y et al.; ADDLs provide an alternative to plaques ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:183e8937-e409-45bd-a462-245d0b238f7b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:536ec067-733d-4dde-b45b-57e28a34c9bf&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:536ec067-733d-4dde-b45b-57e28a34c9bf","type":"Claim","title":"Although APOE2 seems to protect against developing AD, it is a known risk factor for CNS hemorrhage if CAA is present.","label":"Fryer J et al.; Although APOE2 seems to protect against ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:536ec067-733d-4dde-b45b-57e28a34c9bf"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3e923730-5deb-4133-908e-8fb22e95efae&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3e923730-5deb-4133-908e-8fb22e95efae","type":"Claim","title":"The GSI MK-0752 reduction of CSF Aβ without a subsequent rebound suggests that in the absence of γ-secretase, the combined proteolytic cleavage of the Aβ precursor by β-secretase and α-secretase generates Aβ(1-14), Aβ(1-15), and Aβ(1-16), and that Aβ isoforms longer than Aβ(1-16) are reduced, potentially by endothelin converting enzyme, insulin-degrading enzyme, or matrix metalloproteinase-9, enzymes known to cleave at the Aβ(1-17) site.","label":"Cook J et al.; The GSI MK-0752 reduction of CSF Aβ with...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wildsmith Kristin R","Gilberto David B","Holahan Marie A","Kinney Gene G","Mathers Parker D","Michener Maria S","Price Eric A","Shearman Mark S","Simon Adam J","Wang Jennifer X","Wu Guoxin","Yarasheski Kevin E","Bateman Randall J"],"firstAuthor":"Cook Jacquelynn J","referenceYear":"2010","referenceDate":"2010-05-12","id":"urn:lsid:swan.org:researchstatement:3e923730-5deb-4133-908e-8fb22e95efae"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8957f859-51a1-42d8-a4d6-b6c6f20c7635&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8957f859-51a1-42d8-a4d6-b6c6f20c7635","type":"Claim","title":"Both LRP and RAGE are multiligand cell surface receptors that mediate the clearance of a large number of proteins in addition to Aβ.","label":"Tanzi R et al.; Both LRP and RAGE are multiligand cell s...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:8957f859-51a1-42d8-a4d6-b6c6f20c7635"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a5dc1150-6ad2-4fb0-9923-4fe29ce087f9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a5dc1150-6ad2-4fb0-9923-4fe29ce087f9","type":"Claim","title":"Concentrations of Aβ42 in the cerebral interstitial fluid of patients with acute brain injury increase as their neurological status improves and fall as their neurological status declines.","label":"Giuffrida M et al.; Concentrations of Aβ42 in the cerebral i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Caraci Filippo","Pignataro Bruno","Cataldo Sebastiano","De Bona Paolo","Bruno Valeria","Molinaro Gemma","Pappalardo Giuseppe","Messina Angela","Palmigiano Angelo","Garozzo Domenico","Nicoletti Ferdinando","Rizzarelli Enrico","Copani Agata"],"firstAuthor":"Giuffrida Maria Laura","referenceYear":"2009","referenceDate":"2009-08-26","id":"urn:lsid:swan.org:researchstatement:a5dc1150-6ad2-4fb0-9923-4fe29ce087f9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:comment:f078cafb-5e0e-4fa7-9d32-6da7ac314356&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:comment:f078cafb-5e0e-4fa7-9d32-6da7ac314356","type":"Comment","title":"Aliev comment on Holmes et al hypothesis  \"Plaque removal is not enough to halt progressive neurodegeneration in Alzheimer Disease.\"","label":"Aliev G et al.; Aliev comment on Holmes et al hypothesis...","icon":"../icons/ontological/discourse-element/comment.png","otherAuthors":["Palacios Hector H","Gasimov Eldar","Solis Herrera Arturo","Leszek Jerzy","Gokhman Dmitry","Bragin Valentin","Obrenovich Mark E"],"firstAuthor":"Aliev Gjumrakch","id":"urn:lsid:swan.org:comment:f078cafb-5e0e-4fa7-9d32-6da7ac314356"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b392018b-86d1-4735-812a-e84413b97e11&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b392018b-86d1-4735-812a-e84413b97e11","type":"Claim","title":"Higher educational attainment may permit individuals with preclinical AD, as ascertained by PET PiB, to better tolerate AD pathology without obvious cognitive deterioration than those with less education, suggesting that they have a greater reserve against the clinical expression of AD.","label":"Morris J et al.; Higher educational attainment may permit...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Roe Catherine M","Grant Elizabeth A","Head Denise","Storandt Martha","Goate Alison M","Fagan Anne M","Holtzman David M","Mintun Mark A"],"firstAuthor":"Morris John C","referenceYear":"2009","referenceDate":"2009-12","id":"urn:lsid:swan.org:researchstatement:b392018b-86d1-4735-812a-e84413b97e11"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d5544492-3663-4bbf-92fb-b7221ac55bdb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d5544492-3663-4bbf-92fb-b7221ac55bdb","type":"Claim","title":"Bound PHF-tau is the reason for impaired proteasome function in the AD brain","label":"Keck S et al.; Bound PHF-tau is the reason for impaired...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:d5544492-3663-4bbf-92fb-b7221ac55bdb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2f56ca70-0511-48ba-a655-da32eca3f47a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2f56ca70-0511-48ba-a655-da32eca3f47a","type":"Claim","title":"Proteolysis of APP dimers results in Aβ accumulating in the lipid bilayer.","label":"Marchesi V; Proteolysis of APP dimers results in Aβ ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:2f56ca70-0511-48ba-a655-da32eca3f47a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9057257e-d7e4-4e69-bf9c-87647add9cd5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9057257e-d7e4-4e69-bf9c-87647add9cd5","type":"Claim","title":"Whereas familial early-onset forms of Alzheimer\u2019s disease are mainly linked to genes implicated in Aβ overproduction, genetic variants at APOE and CLU and CR1 may influence susceptibility to late-onset forms of the disease as a result of roles in Aβ clearance.","label":"Lambert J et al.; Whereas familial early-onset forms of Al...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Heath Simon","Even Gael","Campion Dominique","Sleegers Kristel","Hiltunen Mikko","Combarros Onofre","Zelenika Diana","Bullido Maria J","Tavernier Béatrice","Letenneur Luc","Bettens Karolien","Berr Claudine","Pasquier Florence","Fiévet Nathalie","Barberger-Gateau Pascale","Engelborghs Sebastiaan","De Deyn Peter","Mateo Ignacio","Franck Ana","Helisalmi Seppo","Porcellini Elisa","Hanon Olivier","de Pancorbo Marian M","Lendon Corinne","Dufouil Carole","Jaillard Céline","Leveillard Thierry","Alvarez Victoria","Bosco Paolo","Mancuso Michelangelo","Panza Francesco","Nacmias Benedetta","Bossù Paola","Piccardi Paola","Annoni Giorgio","Seripa Davide","Galimberti Daniela","Hannequin Didier","Licastro Federico","Soininen Hilkka","Ritchie Karen","Blanché Hélène","Dartigues Jean-François","Tzourio Christophe","Gut Ivo","Van Broeckhoven Christine","Alpérovitch Annick","Lathrop Mark","Amouyel Philippe"],"firstAuthor":"Lambert Jean-Charles","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:9057257e-d7e4-4e69-bf9c-87647add9cd5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:752b9289-4468-4689-93fa-98941f3125cc&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:752b9289-4468-4689-93fa-98941f3125cc","type":"Claim","title":"Mutations in APP associated with stroke and cerebrovascular Aβ deposition alter the aggregation properties of Aβ.","label":"Golde T; Mutations in APP associated with stroke ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde T","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:752b9289-4468-4689-93fa-98941f3125cc"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:05559b73-90fa-4266-8680-84e6fc9b8c5c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:05559b73-90fa-4266-8680-84e6fc9b8c5c","type":"Claim","title":"Monomeric, unaggregated Aβ1\u201340 enhanced calcium currents whereas aggregated Aβ had no effect, suggesting a physiological role for Aβ in ion channel regulation in the CNS and highlighting the importance of the solubility state of Aβ.","label":"Smith I et al.; Monomeric, unaggregated Aβ1\u201340 enhanced ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:05559b73-90fa-4266-8680-84e6fc9b8c5c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6fa87b97-b764-4338-a118-2c4d831f14b4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6fa87b97-b764-4338-a118-2c4d831f14b4","type":"Claim","title":"Immunodepletion of Aβ from V717F APP751 conditioned media using R1282 antibody completely prevented the block of LTP.","label":"Walsh D et al.; Immunodepletion of Aβ from V717F APP751 ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Klyubin Igor","Fadeeva Julia V","Cullen William K","Anwyl Roger","Wolfe Michael S","Rowan Michael J","Selkoe Dennis J"],"firstAuthor":"Walsh Dominic M","referenceYear":"2002","referenceDate":"2002-04-04","id":"urn:lsid:swan.org:researchstatement:6fa87b97-b764-4338-a118-2c4d831f14b4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7373e7f2-737e-493b-844d-ac393c663383&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7373e7f2-737e-493b-844d-ac393c663383","type":"Claim","title":"Extracellular Aβ has been reported to directly cause oxidative stress through production of reactive oxygen species.","label":"Golde T et al.; Extracellular Aβ has been reported to di...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:7373e7f2-737e-493b-844d-ac393c663383"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:64f6c19a-05f1-40e7-9ffe-241065825857&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:64f6c19a-05f1-40e7-9ffe-241065825857","type":"Claim","title":"In the brain, apoE is secreted in unique high-density lipoprotein-like particles predominantly by glial cells.","label":"Fryer J et al.; In the brain, apoE is secreted in unique...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:64f6c19a-05f1-40e7-9ffe-241065825857"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:abb612c9-ef2e-47bb-a47c-5ceba02aa7e1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:abb612c9-ef2e-47bb-a47c-5ceba02aa7e1","type":"Claim","title":"Lipidated apoE has 5-10 fold higher affinity for both Aβ40 and Aβ42 than delipidated forms; lipidated E3 has a greater affinity than lipidated E4.","label":"Holtzman D; Lipidated apoE has 5-10 fold higher affi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:abb612c9-ef2e-47bb-a47c-5ceba02aa7e1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e3c54206-d9f6-424b-bcd2-b1293748fdff&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e3c54206-d9f6-424b-bcd2-b1293748fdff","type":"Claim","title":"It has been proposed that the high-affinity α4β2 nAChR may be particularly vulnerable in AD.","label":"Cook L et al.; It has been proposed that the high-affin...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Ho Luk W","Taylor Alison E","Brayne Carol","Evans John Grimley","Xuereb John","Cairns Nigel J","Pritchard Antonia","Lemmon Helen","Mann David","St Clair David","Turic Dragana","Hollingworth Paul","Moore Pamela J","Jehu Luke","Archer Nicola","Walter Sarah","Foy Catherine","Edmondson Amanda","Powell John","Lovestone Simon","Owen Michael J","Williams Julie","Lendon Corinne","Rubinsztein David C"],"firstAuthor":"Cook Lynnette J","referenceYear":"2004","referenceDate":"2004-03-25","id":"urn:lsid:swan.org:researchstatement:e3c54206-d9f6-424b-bcd2-b1293748fdff"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e2faf32e-8ef8-4349-9b4f-2c1e0cd52beb&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e2faf32e-8ef8-4349-9b4f-2c1e0cd52beb","type":"Claim","title":"Small, diffusible oligomeric assemblies of misfolded proteins may cause injury and neurodegeneration in AD, Parkinson Disease, Huntington Disease, and spinocerebellar ataxias.","label":"Hardy J et al.; Small, diffusible oligomeric assemblies ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:e2faf32e-8ef8-4349-9b4f-2c1e0cd52beb"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c5b5dfcd-6732-4f8b-8144-a5283bdb62cc&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c5b5dfcd-6732-4f8b-8144-a5283bdb62cc","type":"Claim","title":"It is possible that Aβ42 monomers facilitate the activation of IGF-1/insulin receptors by locally produced IGF-1 or, alternatively, that Aβ monomers bind to IGF-1/insulin receptors, as already shown for Aβ oligomers.","label":"Giuffrida M et al.; It is possible that Aβ42 monomers facili...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Caraci Filippo","Pignataro Bruno","Cataldo Sebastiano","De Bona Paolo","Bruno Valeria","Molinaro Gemma","Pappalardo Giuseppe","Messina Angela","Palmigiano Angelo","Garozzo Domenico","Nicoletti Ferdinando","Rizzarelli Enrico","Copani Agata"],"firstAuthor":"Giuffrida Maria Laura","referenceYear":"2009","referenceDate":"2009-08-26","id":"urn:lsid:swan.org:researchstatement:c5b5dfcd-6732-4f8b-8144-a5283bdb62cc"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:0218aef6-a3bf-4bfe-b78b-7ffa5698495d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:0218aef6-a3bf-4bfe-b78b-7ffa5698495d","type":"Question","title":"If GSK3 regulation is aberrant in AD brain, then might this impact upon the cerebral inflammatory response leading to the sustained secretion of neurotoxic inflammatory mediators by microglia, in turn causing bystander damage to neighboring neurons and contributing to neurodegenerative processes?","label":"If GSK3 regulation is aberrant in AD bra...","icon":"../icons/ontological/discourse-element/research-question.png","id":"urn:lsid:swan.org:researchquestion:0218aef6-a3bf-4bfe-b78b-7ffa5698495d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4ac7cfaa-faed-410c-92d5-84b2439c1ecd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4ac7cfaa-faed-410c-92d5-84b2439c1ecd","type":"Claim","title":"Metals such as zinc and copper not only drive the aggregation of Aβ, but can also stabilize β amyloid deposits.","label":"Tanzi R et al.; Metals such as zinc and copper not only ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:4ac7cfaa-faed-410c-92d5-84b2439c1ecd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9c211ae5-99ba-43c0-b2cb-0204b382f957&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9c211ae5-99ba-43c0-b2cb-0204b382f957","type":"Claim","title":"Blank","label":"Blank","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:9c211ae5-99ba-43c0-b2cb-0204b382f957"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f8421ed3-bb32-4163-8bac-82c4b3bd946b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f8421ed3-bb32-4163-8bac-82c4b3bd946b","type":"Claim","title":"The Aβ assemblies represent multiples of trimeric Aβ oligomers, and do not represent Aβ oligomers complexed to binding proteins.","label":"Lesné S et al.; The Aβ assemblies represent multiples of...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Koh Ming Teng","Kotilinek Linda","Kayed Rakez","Glabe Charles G","Yang Austin","Gallagher Michela","Ashe Karen H"],"firstAuthor":"Lesné Sylvain","referenceYear":"2006","referenceDate":"2006-03-16","id":"urn:lsid:swan.org:researchstatement:f8421ed3-bb32-4163-8bac-82c4b3bd946b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a9fbe1f2-70e1-464d-86d8-8364d6363bdd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a9fbe1f2-70e1-464d-86d8-8364d6363bdd","type":"Claim","title":"GSK3α, but not GSK3β, has been shown to regulate APP cleavage resulting in the increased production of Aβ.","label":"Hooper C et al.; GSK3α, but not GSK3β, has been shown to ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:a9fbe1f2-70e1-464d-86d8-8364d6363bdd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:15fb151f-9a32-40df-9696-8c7b4ef5f66b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:15fb151f-9a32-40df-9696-8c7b4ef5f66b","type":"Claim","title":"It is especially important and timely to undertake in vivo axonal transport studies using the classic Lasek paradigm for measuring rates of axonal transport in living animals as was done in the 8c study by Yuan et al., as well as in previous studies.","label":"Lee V et al.; It is especially important and timely to...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Trojanowski John Q"],"firstAuthor":"Lee Virginia M-Y","id":"urn:lsid:swan.org:researchstatement:15fb151f-9a32-40df-9696-8c7b4ef5f66b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7420a41a-cfd4-4014-aacf-f4443c56e8b5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7420a41a-cfd4-4014-aacf-f4443c56e8b5","type":"Claim","title":"Aβ oligomers may be key effectors of neurotoxicity.","label":"Bitan G et al.; Aβ oligomers may be key effectors of neu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kirkitadze Marina D","Lomakin Aleksey","Vollers Sabrina S","Benedek George B","Teplow David B"],"firstAuthor":"Bitan Gal","referenceYear":"2003","referenceDate":"2003-01-07","id":"urn:lsid:swan.org:researchstatement:7420a41a-cfd4-4014-aacf-f4443c56e8b5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3d3966b9-02a7-4d77-8bb0-8233fe5e00d5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3d3966b9-02a7-4d77-8bb0-8233fe5e00d5","type":"Claim","title":"AN1792 immunization seems to initiate a long-term process of disease modification, with post-mortem evidence of plaque removal 5 years after the last injection as well as evidence of persistently raised serum antibodies to Aβ correlating with the initial mean antibody response.  Specifically, two patients who had almost complete elimination of plaques, and the lowest Aβ loads, also had the highest mean AN1792 antibody response during the treatment phase of the study.","label":"Holmes C et al.; AN1792 immunization seems to initiate a ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:3d3966b9-02a7-4d77-8bb0-8233fe5e00d5"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7b89c04e-e467-420e-ae65-fb8169e70455&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7b89c04e-e467-420e-ae65-fb8169e70455","type":"Claim","title":"PS1 mutations cause an aggressive form of FAD with a particularly early age of onset, while PS2 mutations result in a form of FAD that is more akin to sporadic AD, bearing a later age of onset.","label":"Smith I et al.; PS1 mutations cause an aggressive form o...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:7b89c04e-e467-420e-ae65-fb8169e70455"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a5766aae-c650-411a-8efc-45ae15fc7dd1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a5766aae-c650-411a-8efc-45ae15fc7dd1","type":"Claim","title":"Aph1, part of the γ-secretase complex, has a GxxxG motif in its transmembrane domain, raising the possibility that Aβ could compete via its own GxxxG motif to interfere with assembly of gamma-secretase complex.","label":"Marchesi V; Aph1, part of the γ-secretase complex, h...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:a5766aae-c650-411a-8efc-45ae15fc7dd1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:50bdc8d6-3194-471e-b659-a92afd163aa2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:50bdc8d6-3194-471e-b659-a92afd163aa2","type":"Claim","title":"The presence of neurofibrillary tangles (NFTs) in asymptomatic individuals tends to be confined to the entorhinal cortex, Braak stage I\u2013II, whereas NFTs in symptomatic individuals are far more widespread.","label":"Jack C et al.; The presence of neurofibrillary tangles ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:50bdc8d6-3194-471e-b659-a92afd163aa2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:39b38e9b-4d4b-44da-afa0-97d174f3092b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:39b38e9b-4d4b-44da-afa0-97d174f3092b","type":"Claim","title":"Frontotemporal dementia (FTD), caused by mutations in the tau gene, is characterized by personality changes that result from frontal lobe involvement. ","label":"Frost B et al.; Frontotemporal dementia (FTD), caused by...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Jacks Rachel L","Diamond Marc I"],"firstAuthor":"Frost Bess","referenceYear":"2009","referenceDate":"2009-05-08","id":"urn:lsid:swan.org:researchstatement:39b38e9b-4d4b-44da-afa0-97d174f3092b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f4e78a08-0451-4a6e-8bcc-a3bce9186c2f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f4e78a08-0451-4a6e-8bcc-a3bce9186c2f","type":"Claim","title":"Myelin and its components such as cholesterol and myelin proteins are reduced in old age and are substantially further reduced in mild cognitive impairment (MCI) and AD.","label":"Bartzokis G; Myelin and its components such as choles...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:f4e78a08-0451-4a6e-8bcc-a3bce9186c2f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2d2f0a70-6465-47ca-ae43-072aa829fe90&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2d2f0a70-6465-47ca-ae43-072aa829fe90","type":"Claim","title":"Increased levels of Aβ may cause AD by interfering with PS function and/or expression, resulting in a loss of PS-dependent activities.","label":"Shen J et al.; Increased levels of Aβ may cause AD by i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:2d2f0a70-6465-47ca-ae43-072aa829fe90"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:67b1ba99-15a0-454a-b611-4d76542968c4&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:67b1ba99-15a0-454a-b611-4d76542968c4","type":"Claim","title":"The level of Aβ40, Aβ42, or the ratio of Aβ40:42 does not differ between any of the genotypes in the plasma of APPsw mice expressing human apoE3 or apoE4 under the control of endogenous apoE regulatory elements (\u201cknock-in\u201d mice).","label":"Fryer J et al.; The level of Aβ40, Aβ42, or the ratio of...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:67b1ba99-15a0-454a-b611-4d76542968c4"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:75664c68-77fd-4ce3-bc57-3e68eb38d8cd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:75664c68-77fd-4ce3-bc57-3e68eb38d8cd","type":"Claim","title":"Further evidence from transgenic mouse studies demonstrate the effects of ApoE on the development of cerebral amyloid angiopathy.","label":"Holtzman D; Further evidence from transgenic mouse s...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman David M","id":"urn:lsid:swan.org:researchstatement:75664c68-77fd-4ce3-bc57-3e68eb38d8cd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:816b8821-5146-4110-8efe-1e04b1c8ce67&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:816b8821-5146-4110-8efe-1e04b1c8ce67","type":"Claim","title":"It is difficult to explain how all 150  known mutations in PS1, scattered throughout the molecule, have the same gain of function effect of increasing A&#946;42.","label":"Marchesi V; It is difficult to explain how all 150  ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:816b8821-5146-4110-8efe-1e04b1c8ce67"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0ee50376-88a8-455a-98e8-b82fe514e951&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0ee50376-88a8-455a-98e8-b82fe514e951","type":"Claim","title":"It is difficult to believe that most of AD symptoms largely relate to anything other than the massive synaptic and cell loss which occurs in the disease. ","label":"Hardy ; It is difficult to believe that most of ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Hardy","referenceYear":"2009","referenceDate":"2009-05-18","id":"urn:lsid:swan.org:researchstatement:0ee50376-88a8-455a-98e8-b82fe514e951"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8537700c-21fe-4d31-84af-4f55d36ebe3a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8537700c-21fe-4d31-84af-4f55d36ebe3a","type":"Claim","title":"A focused effort to understand the functions of APP and the possible functions of Aβ should be a priority and the recent data showing that the extracellular domain of APP may have a role in axonal resculpting is an encouraging start in this direction.","label":"Hardy ; A focused effort to understand the funct...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Hardy","referenceYear":"2009","referenceDate":"2009-05-18","id":"urn:lsid:swan.org:researchstatement:8537700c-21fe-4d31-84af-4f55d36ebe3a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:dd03ba61-a797-4afd-884a-810267faf1e0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:dd03ba61-a797-4afd-884a-810267faf1e0","type":"Hypothesis","title":"Multimerization of APP by Aβ contributes to neurotoxicity.","label":"Lu D et al.; Multimerization of APP by Aβ contributes...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Shaked Gideon M","Bredesen Dale E","Masliah Eliezer","Koo Edward H"],"firstAuthor":"Lu Daniel C","referenceYear":"2003","referenceDate":"2003-12","id":"urn:lsid:swan.org:researchstatement:dd03ba61-a797-4afd-884a-810267faf1e0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:46bd1e20-aa0c-4ecf-b0d7-db555d068493&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:46bd1e20-aa0c-4ecf-b0d7-db555d068493","type":"Claim","title":"Immunotherapeutic approaches could lower cerebral Aβ burden in a way that may secondarily affect intraneuronal levels as well.","label":"Selkoe D; Immunotherapeutic approaches could lower...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Selkoe Dennis J","id":"urn:lsid:swan.org:researchstatement:46bd1e20-aa0c-4ecf-b0d7-db555d068493"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7bac01bf-9d6a-4239-82cf-f8bf22c016be&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7bac01bf-9d6a-4239-82cf-f8bf22c016be","type":"Claim","title":"The ability of mutant presenilins to suppress the Egl phenotype is dose-dependent, with higher levels of expression of some mutants resulting in full rescue, but lower levels of expression revealing a significant impairment.","label":"Shen J et al.; The ability of mutant presenilins to sup...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:7bac01bf-9d6a-4239-82cf-f8bf22c016be"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e69106c2-17ac-40a6-99d4-2d98012831a8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e69106c2-17ac-40a6-99d4-2d98012831a8","type":"Claim","title":"At nanomolar concentrations, soluble Aβ oligomers cause dendritic spine retraction from pyramidal cells.","label":"Laurén J et al.; At nanomolar concentrations, soluble Aβ ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Gimbel David A","Nygaard Haakon B","Gilbert John W","Strittmatter Stephen M"],"firstAuthor":"Laurén Juha","referenceYear":"2009","referenceDate":"2009-02-26","id":"urn:lsid:swan.org:researchstatement:e69106c2-17ac-40a6-99d4-2d98012831a8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d0bbf341-de6f-4944-a39c-550dd8dddc3c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d0bbf341-de6f-4944-a39c-550dd8dddc3c","type":"Claim","title":"Strong support for the hypothesis that Aβ is the initial trigger of Alzheimer Disease comes from human genetic data although recent advances in transgenic models have also provided critical corroborating evidence.","label":"Smith I et al.; Strong support for the hypothesis that A...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:d0bbf341-de6f-4944-a39c-550dd8dddc3c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e8c46141-70f0-4b6f-8e30-95f1adc9b3a9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e8c46141-70f0-4b6f-8e30-95f1adc9b3a9","type":"Claim","title":"Live multiphoton imaging cannot yet visualize the prior accumulation of Aβ or the nucleation event.","label":"Lansbury P; Live multiphoton imaging cannot yet visu...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Lansbury Peter T","id":"urn:lsid:swan.org:researchstatement:e8c46141-70f0-4b6f-8e30-95f1adc9b3a9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:be0ca9e2-df75-4eab-92e0-76770fc8f95c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:be0ca9e2-df75-4eab-92e0-76770fc8f95c","type":"Claim","title":"Acting via DR6 and caspase 6, the APP ectodomain contributes to Alzheimer\u2019s disease in a paracrine prodegenerative manner in strong neurons, whereas APP also is activated in an autocrine prodegenerative manner in weak neurons.","label":"Nikolaev A et al.; Acting via DR6 and caspase 6, the APP ec...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["McLaughlin Todd","O'Leary Dennis D","Tessier-Lavigne Marc"],"firstAuthor":"Nikolaev Anatoly","referenceYear":"2009","referenceDate":"2009-02-19","id":"urn:lsid:swan.org:researchstatement:be0ca9e2-df75-4eab-92e0-76770fc8f95c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7bb38b0d-da30-47cd-b5b6-f6f414487fb3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7bb38b0d-da30-47cd-b5b6-f6f414487fb3","type":"Claim","title":"ADDLs are potent neurotoxins to the principal neurons of the hippocampus (pyramidal and granule cells, respectively).","label":"Lambert M et al.; ADDLs are potent neurotoxins to the prin...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:7bb38b0d-da30-47cd-b5b6-f6f414487fb3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b2277e06-669f-4bc5-86f3-7ed1a9fe74d6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b2277e06-669f-4bc5-86f3-7ed1a9fe74d6","type":"Claim","title":"APOE appears to act as a molecular chaperone for Aβ and influences Aβ aggregation and deposition, Aβ conformation and toxicity.","label":"Harold D et al.; APOE appears to act as a molecular chape...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Abraham Richard","Hollingworth Paul","Sims Rebecca","Gerrish Amy","Hamshere Marian L","Pahwa Jaspreet Singh","Moskvina Valentina","Dowzell Kimberley","Williams Amy","Jones Nicola","Thomas Charlene","Stretton Alexandra","Morgan Angharad R","Lovestone Simon","Powell John","Proitsi Petroula","Lupton Michelle K","Brayne Carol","Rubinsztein David C","Gill Michael","Lawlor Brian","Lynch Aoibhinn","Morgan Kevin","Brown Kristelle S","Passmore Peter A","Craig David","McGuinness Bernadette","Todd Stephen","Holmes Clive","Mann David","Smith A David","Love Seth","Kehoe Patrick G","Hardy John","Mead Simon","Fox Nick","Rossor Martin","Collinge John","Maier Wolfgang","Jessen Frank","Schürmann Britta","van den Bussche Hendrik","Heuser Isabella","Kornhuber Johannes","Wiltfang Jens","Dichgans Martin","Frölich Lutz","Hampel Harald","Hüll Michael","Rujescu Dan","Goate Alison M","Kauwe John S","Cruchaga Carlos","Nowotny Petra","Morris John C","Mayo Kevin","Sleegers Kristel","Bettens Karolien","Engelborghs Sebastiaan","De Deyn Peter P","Van Broeckhoven Christine","Livingston Gill","Bass Nicholas J","Gurling Hugh","McQuillin Andrew","Gwilliam Rhian","Deloukas Panagiotis","Al-Chalabi Ammar","Shaw Christopher E","Tsolaki Magda","Singleton Andrew B","Guerreiro Rita","Mühleisen Thomas W","Nöthen Markus M","Moebus Susanne","Jöckel Karl-Heinz","Klopp Norman","Wichmann H-Erich","Carrasquillo Minerva M","Pankratz V Shane","Younkin Steven G","Holmans Peter A","O'Donovan Michael","Owen Michael J","Williams Julie"],"firstAuthor":"Harold Denise","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:b2277e06-669f-4bc5-86f3-7ed1a9fe74d6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:34c2253e-25c9-44da-b9f6-8a70c59cea64&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:34c2253e-25c9-44da-b9f6-8a70c59cea64","type":"Claim","title":"The Morse hypothesis places a significant emphasis on the underlying deficit that create the disease phenotype, memory deficit rather than simply categorizing the various molecules implicated in the disease.","label":"Petersen R et al.; The Morse hypothesis places a significan...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Castellani Rudolph J","Nunomura Akihiko","Zhu Xiongwei","Lee Hyoung-gon","Perry George","Smith Mark A"],"firstAuthor":"Petersen R B","id":"urn:lsid:swan.org:researchstatement:34c2253e-25c9-44da-b9f6-8a70c59cea64"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:eb3935aa-b84f-4dc6-bad2-0630301bf3d3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:eb3935aa-b84f-4dc6-bad2-0630301bf3d3","type":"Claim","title":"Levels of acetylation of the SIRT1 substrate PGC-1alpha were decreased in resveratrol-treated p25 animals compared to the vehicle-treated controls, suggesting that ICV injection of resveratrol resulted in the activation of SIRT1.","label":"Kim D et al.; Levels of acetylation of the SIRT1 subst...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nguyen Minh Dang","Dobbin Matthew M","Fischer Andre","Sananbenesi Farahnaz","Rodgers Joseph T","Delalle Ivana","Baur Joseph A","Sui Guangchao","Armour Sean M","Puigserver Pere","Sinclair David A","Tsai Li-Huei"],"firstAuthor":"Kim Dohoon","referenceYear":"2007","referenceDate":"2007-07-11","id":"urn:lsid:swan.org:researchstatement:eb3935aa-b84f-4dc6-bad2-0630301bf3d3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c2a90eb5-7f25-4e5c-95ee-2371cdcfe8b2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c2a90eb5-7f25-4e5c-95ee-2371cdcfe8b2","type":"Claim","title":"The predictive ability of CLU and PICALM genetic association to identify individuals at risk of AD is not clinically significant.","label":"Seshadri S et al.; The predictive ability of CLU and PICALM...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Fitzpatrick Annette L","Ikram M Arfan","DeStefano Anita L","Gudnason Vilmundur","Boada Merce","Bis Joshua C","Smith Albert V","Carassquillo Minerva M","Lambert Jean Charles","Harold Denise","Schrijvers Elisabeth M","Ramirez-Lorca Reposo","Debette Stephanie","Longstreth W T","Janssens A Cecile","Pankratz V Shane","Dartigues Jean François","Hollingworth Paul","Aspelund Thor","Hernandez Isabel","Beiser Alexa","Kuller Lewis H","Koudstaal Peter J","Dickson Dennis W","Tzourio Christophe","Abraham Richard","Antunez Carmen","Du Yangchun","Rotter Jerome I","Aulchenko Yurii S","Harris Tamara B","Petersen Ronald C","Berr Claudine","Owen Michael J","Lopez-Arrieta Jesus","Varadarajan Badri N","Becker James T","Rivadeneira Fernando","Nalls Michael A","Graff-Radford Neill R","Campion Dominique","Auerbach Sanford","Rice Kenneth","Hofman Albert","Jonsson Palmi V","Schmidt Helena","Lathrop Mark","Mosley Thomas H","Au Rhoda","Psaty Bruce M","Uitterlinden Andre G","Farrer Lindsay A","Lumley Thomas","Ruiz Agustin","Williams Julie","Amouyel Philippe","Younkin Steve G","Wolf Philip A","Launer Lenore J","Lopez Oscar L","van Duijn Cornelia M","Breteler Monique M"],"firstAuthor":"Seshadri Sudha","referenceYear":"2010","referenceDate":"2010-05-12","id":"urn:lsid:swan.org:researchstatement:c2a90eb5-7f25-4e5c-95ee-2371cdcfe8b2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3552f61e-c838-4fb7-92c1-e1cb08b5d534&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3552f61e-c838-4fb7-92c1-e1cb08b5d534","type":"Claim","title":"A higher 40:42 ratio of Aβ in the brain predisposes it to CAA.","label":"Fryer J et al.; A higher 40:42 ratio of Aβ in the brain ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:3552f61e-c838-4fb7-92c1-e1cb08b5d534"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f3a3b321-a5d3-42e9-9689-57d7baa9f870&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f3a3b321-a5d3-42e9-9689-57d7baa9f870","type":"Claim","title":"Early stages of NRHypo neurodegeneration in many brain regions involve excitotoxic degeneration of dendritic spines, a mechanism by which many synaptic complexes can be deleted from the corticolimbic regions of the brain that has been identified as the pathological change that correlates most strongly with deterioration of cognitive functions in AD.","label":"Olney J et al.; Early stages of NRHypo neurodegeneration...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:f3a3b321-a5d3-42e9-9689-57d7baa9f870"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchquestion:9aaa860e-a5b0-477d-8a9a-e96408f8dd6d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchquestion:9aaa860e-a5b0-477d-8a9a-e96408f8dd6d","type":"Question","title":"While PICUP is useful as an analytic method to uncover differences in oligomer distribution between Aβ40 and 42, it will be informative if the oligomeric assemblies stabilized using this approach retain biological activity and can be used for further study in cell-based assays.","label":"While PICUP is useful as an analytic met...","icon":"../icons/ontological/discourse-element/research-question.png","firstAuthor":"LaDu Mary Jo","id":"urn:lsid:swan.org:researchquestion:9aaa860e-a5b0-477d-8a9a-e96408f8dd6d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:2d40f4ae-9442-4ca8-a313-134ca82db252&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:2d40f4ae-9442-4ca8-a313-134ca82db252","type":"Claim","title":"The retromer sorting pathway has been implicated in late-onset AD (LOAD).","label":"Small S et al.; The retromer sorting pathway has been im...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Duff Karen"],"firstAuthor":"Small Scott A","referenceYear":"2008","referenceDate":"2008-11-26","id":"urn:lsid:swan.org:researchstatement:2d40f4ae-9442-4ca8-a313-134ca82db252"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:03c30e75-08a1-4ea6-b063-ef24850a2910&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:03c30e75-08a1-4ea6-b063-ef24850a2910","type":"Claim","title":"APP(NL)Swe increases total Aβ.","label":"Golde T; APP(NL)Swe increases total Aβ.","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde T","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:03c30e75-08a1-4ea6-b063-ef24850a2910"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:53637241-270e-4c0c-8d49-217ca226b5fc&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:53637241-270e-4c0c-8d49-217ca226b5fc","type":"Claim","title":"Aβ can cause inhibition of respiratory chain complexes with a concomitant reduction in cellular ATP levels.","label":"Smith I et al.; Aβ can cause inhibition of respiratory c...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:53637241-270e-4c0c-8d49-217ca226b5fc"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8683d88a-fce3-4327-985c-800634985150&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8683d88a-fce3-4327-985c-800634985150","type":"Claim","title":"Tissue-transglutaminase lowers the concentration for Aβ oligomerization so it can occur at physiologic Aβ levels and induces Aβ species that are resistant to degradation by metalloproteases.","label":"Hartley D et al.; Tissue-transglutaminase lowers the conce...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Zhao Chaohui","Speier Austin C","Woodard Gavitt A","Li Shaomin","Li Zongli","Walz Thomas"],"firstAuthor":"Hartley Dean M","referenceYear":"2008","referenceDate":"2008-06-13","id":"urn:lsid:swan.org:researchstatement:8683d88a-fce3-4327-985c-800634985150"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:cb62fcb6-927f-4deb-9afc-b6a3a8bccaa9&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:cb62fcb6-927f-4deb-9afc-b6a3a8bccaa9","type":"Claim","title":"Despite the presence of high amounts of Aβ and amyloid deposits, deficits in LTP in APP mice are absent in APP α7KO mice.","label":"Dziewczapolski G et al.; Despite the presence of high amounts of ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Glogowski Carolina M","Masliah Eliezer","Heinemann Stephen F"],"firstAuthor":"Dziewczapolski Gustavo","referenceYear":"2009","referenceDate":"2009-07-08","id":"urn:lsid:swan.org:researchstatement:cb62fcb6-927f-4deb-9afc-b6a3a8bccaa9"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c16b009d-01cd-4a73-a4a4-6aca8c55dff2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c16b009d-01cd-4a73-a4a4-6aca8c55dff2","type":"Claim","title":"Reports of CNS degeneration in animals carrying a mutant APP transgene but lacking amyloid deposits possibly could be explained by ADDL neurotoxicity in the transgenic animals.","label":"Lambert M et al.; Reports of CNS degeneration in animals c...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:c16b009d-01cd-4a73-a4a4-6aca8c55dff2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:75c8f7ec-08b6-4e25-8dfc-11f1b115d31f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:75c8f7ec-08b6-4e25-8dfc-11f1b115d31f","type":"Claim","title":"Aβ could be removed from the CNS or at peripheral degradation sites by enhancing the activity of the major degradation enzymes IDE and NEP.","label":"Tanzi R et al.; Aβ could be removed from the CNS or at p...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:75c8f7ec-08b6-4e25-8dfc-11f1b115d31f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:36f702d8-de14-433d-bce5-7e92d434716d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:36f702d8-de14-433d-bce5-7e92d434716d","type":"Hypothesis","title":"NMDA receptor dysfunction and Alzheimer's disease.","label":"Olney J et al.; NMDA receptor dysfunction and Alzheimer'...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1998","referenceDate":"1998","id":"urn:lsid:swan.org:researchstatement:36f702d8-de14-433d-bce5-7e92d434716d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b386b429-a2a7-4f2e-b880-ed24ffd351f2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b386b429-a2a7-4f2e-b880-ed24ffd351f2","type":"Claim","title":"DR6 function is required in axons for degeneration in vitro.","label":"Nikolaev A et al.; DR6 function is required in axons for de...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["McLaughlin Todd","O'Leary Dennis D","Tessier-Lavigne Marc"],"firstAuthor":"Nikolaev Anatoly","referenceYear":"2009","referenceDate":"2009-02-19","id":"urn:lsid:swan.org:researchstatement:b386b429-a2a7-4f2e-b880-ed24ffd351f2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a2dd42b4-c7cd-4ca5-b20e-df0b24fe3355&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a2dd42b4-c7cd-4ca5-b20e-df0b24fe3355","type":"Claim","title":"Aβ immunization is a therapeutic strategy in development to decrease Aβ levels by promoting microglial activation, or facilitating the redistribution of Aβ from brain to systemic circulation.","label":"Hardy J et al.; Aβ immunization is a therapeutic strateg...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","referenceYear":"2002","referenceDate":"2002-07-19","id":"urn:lsid:swan.org:researchstatement:a2dd42b4-c7cd-4ca5-b20e-df0b24fe3355"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d3bca7f9-1998-4377-a778-0b23111e9761&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d3bca7f9-1998-4377-a778-0b23111e9761","type":"Claim","title":"There is evidence for \u2018active\u2019 mechanisms of degeneration in which extrinsic signals trigger degeneration by means of pro-apoptotic receptors, including some members of the tumor necrosis factor (TNF) receptor superfamily such as p75NTR (also known as NGFR), Fas and TNFRSF1A (previously known as TNFR1). ","label":"Nikolaev A et al.; There is evidence for \u2018active\u2019 mechanism...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["McLaughlin Todd","O'Leary Dennis D","Tessier-Lavigne Marc"],"firstAuthor":"Nikolaev Anatoly","referenceYear":"2009","referenceDate":"2009-02-19","id":"urn:lsid:swan.org:researchstatement:d3bca7f9-1998-4377-a778-0b23111e9761"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3753bf8a-cb67-4425-8916-dd7193f3b008&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3753bf8a-cb67-4425-8916-dd7193f3b008","type":"Claim","title":"Phosphatidylinositol-3-kinase (PI-3-K) pathway is a major survival pathway in neurons.","label":"Giuffrida M et al.; Phosphatidylinositol-3-kinase (PI-3-K) p...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Caraci Filippo","Pignataro Bruno","Cataldo Sebastiano","De Bona Paolo","Bruno Valeria","Molinaro Gemma","Pappalardo Giuseppe","Messina Angela","Palmigiano Angelo","Garozzo Domenico","Nicoletti Ferdinando","Rizzarelli Enrico","Copani Agata"],"firstAuthor":"Giuffrida Maria Laura","referenceYear":"2009","referenceDate":"2009-08-26","id":"urn:lsid:swan.org:researchstatement:3753bf8a-cb67-4425-8916-dd7193f3b008"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9e7513ef-14e9-4703-a865-1bacfadf9c0c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9e7513ef-14e9-4703-a865-1bacfadf9c0c","type":"Claim","title":"Synaptic loss may well occur before disappearance of the neuronal perikaryon, and the loss of synapses in neocortex causes a functionally important disconnection between regions of the neocortex involved in cognition.","label":"Synaptic loss may well occur before disa...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:9e7513ef-14e9-4703-a865-1bacfadf9c0c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f168b4f4-d7d7-46d6-b069-be452944b50c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f168b4f4-d7d7-46d6-b069-be452944b50c","type":"Claim","title":"A statistical interaction between the ApoEε4 status and the CR1 SNP rs6656401 was detected with significant association in both carriers and non-carriers, but with a more significant association in the ApoEε4 carriers.","label":"Lambert J et al.; A statistical interaction between the Ap...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Heath Simon","Even Gael","Campion Dominique","Sleegers Kristel","Hiltunen Mikko","Combarros Onofre","Zelenika Diana","Bullido Maria J","Tavernier Béatrice","Letenneur Luc","Bettens Karolien","Berr Claudine","Pasquier Florence","Fiévet Nathalie","Barberger-Gateau Pascale","Engelborghs Sebastiaan","De Deyn Peter","Mateo Ignacio","Franck Ana","Helisalmi Seppo","Porcellini Elisa","Hanon Olivier","de Pancorbo Marian M","Lendon Corinne","Dufouil Carole","Jaillard Céline","Leveillard Thierry","Alvarez Victoria","Bosco Paolo","Mancuso Michelangelo","Panza Francesco","Nacmias Benedetta","Bossù Paola","Piccardi Paola","Annoni Giorgio","Seripa Davide","Galimberti Daniela","Hannequin Didier","Licastro Federico","Soininen Hilkka","Ritchie Karen","Blanché Hélène","Dartigues Jean-François","Tzourio Christophe","Gut Ivo","Van Broeckhoven Christine","Alpérovitch Annick","Lathrop Mark","Amouyel Philippe"],"firstAuthor":"Lambert Jean-Charles","referenceYear":"2009","referenceDate":"2009-10","id":"urn:lsid:swan.org:researchstatement:f168b4f4-d7d7-46d6-b069-be452944b50c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9ff857c9-8c20-4a40-942b-0f87eaba53db&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9ff857c9-8c20-4a40-942b-0f87eaba53db","type":"Claim","title":"A slow degenerative phenotype is hard to reconcile with a direct toxic mechanism and that if indeed there were a \u2018smoking gun\u2019 aggregate that was directly neurotoxic, that it would likely show a much better and more consistent correlation with disease or disease progression than do any of the current aggregates.","label":"Golde T et al.; A slow degenerative phenotype is hard to...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:9ff857c9-8c20-4a40-942b-0f87eaba53db"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ad64616a-48cc-4d77-8273-8f0b6919a39e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ad64616a-48cc-4d77-8273-8f0b6919a39e","type":"Claim","title":"The increased production of Aβ peptides may contribute to vascular amyloidosis and contribute to the loss of vascular smooth muscle and other cells in cerebral vessels.","label":"Cotman C et al.; The increased production of Aβ peptides ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:ad64616a-48cc-4d77-8273-8f0b6919a39e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:829414a6-af37-424a-a434-6a514272d9b7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:829414a6-af37-424a-a434-6a514272d9b7","type":"Hypothesis","title":"The degenerative process of Alzheimer disease involves a differential vulnerability of specific neuronal subsets expressing Calbindin.","label":"Hof P et al.; The degenerative process of Alzheimer di...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Morrison J H"],"firstAuthor":"Hof P R","referenceYear":"1991","referenceDate":"1991-03","id":"urn:lsid:swan.org:researchstatement:829414a6-af37-424a-a434-6a514272d9b7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:548dedd4-4194-4d52-8b5b-f53525e986a3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:548dedd4-4194-4d52-8b5b-f53525e986a3","type":"Claim","title":"Even if the A246E mutation caused a 50% reduction in PS1 activity, expression at a level equal to the normal PS1 expression level would yield a phenotypic rescue of PS1-/- mice; greater levels of overexpression would compensate or greater decrements in activity.","label":"Shen J et al.; Even if the A246E mutation caused a 50% ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:548dedd4-4194-4d52-8b5b-f53525e986a3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7da5654e-4333-4fba-a58f-fd5999ad0ccf&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7da5654e-4333-4fba-a58f-fd5999ad0ccf","type":"Claim","title":"The Aph1B complex contributes to total γ-secretase activity in the human brain, thus specific targeting of Aph1B-containing γ-secretase complexes may be helpful in generating less toxic therapies for Alzheimer\u2019s disease.","label":"Serneels L et al.; The Aph1B complex contributes to total γ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Van Biervliet Jérôme","Craessaerts Katleen","Dejaegere Tim","Horré Katrien","Van Houtvin Tine","Esselmann Hermann","Paul Sabine","Schäfer Martin K","Berezovska Oksana","Hyman Bradley T","Sprangers Ben","Sciot Raf","Moons Lieve","Jucker Mathias","Yang Zhixiang","May Patrick C","Karran Eric","Wiltfang Jens","D'Hooge Rudi","De Strooper Bart"],"firstAuthor":"Serneels Lutgarde","referenceYear":"2009","referenceDate":"2009-05-01","id":"urn:lsid:swan.org:researchstatement:7da5654e-4333-4fba-a58f-fd5999ad0ccf"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9bbc4c33-cd17-40f6-8143-797fb7537ad6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9bbc4c33-cd17-40f6-8143-797fb7537ad6","type":"Claim","title":"The size distribution of new plaques compares well with that of all plaques seen post mortem in non-imaged mice, and is similar to that observed in analyses of human AD patients.","label":"Meyer-Luehmann M et al.; The size distribution of new plaques com...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Spires-Jones Tara L","Prada Claudia","Garcia-Alloza Monica","de Calignon Alix","Rozkalne Anete","Koenigsknecht-Talboo Jessica","Holtzman David M","Bacskai Brian J","Hyman Bradley T"],"firstAuthor":"Meyer-Luehmann Melanie","referenceYear":"2008","referenceDate":"2008-02-07","id":"urn:lsid:swan.org:researchstatement:9bbc4c33-cd17-40f6-8143-797fb7537ad6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9a18509f-bfb9-47a9-99ba-c8892689320a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9a18509f-bfb9-47a9-99ba-c8892689320a","type":"Claim","title":"Neurons regulate production of ceramide via p75 neurotrophin receptor activation of nSMase.  Neurotrophin activation of the nSMase pathway induces axonal growth and inhibits cell death.","label":"Neurons regulate production of ceramide ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:9a18509f-bfb9-47a9-99ba-c8892689320a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:42e3d665-6c8d-4a9a-8c2b-4062c866c29f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:42e3d665-6c8d-4a9a-8c2b-4062c866c29f","type":"Claim","title":"ApoE4 increases Aβ deposition in the brain and is associated with increased risk of AD.","label":"Golde T; ApoE4 increases Aβ deposition in the bra...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Golde Todd E","referenceYear":"2005","referenceDate":"2005-01","id":"urn:lsid:swan.org:researchstatement:42e3d665-6c8d-4a9a-8c2b-4062c866c29f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:76e84b31-a039-43a1-a1d7-b1106dc40fac&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:76e84b31-a039-43a1-a1d7-b1106dc40fac","type":"Claim","title":"In brains of patients with AD a pattern of three AT100-positive bands between 50 and 65 kDa could be detected, as reported previously.","label":"Keck S et al.; In brains of patients with AD a pattern ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:76e84b31-a039-43a1-a1d7-b1106dc40fac"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:64299ee4-f5fe-49c6-950b-55b9c2c66154&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:64299ee4-f5fe-49c6-950b-55b9c2c66154","type":"Claim","title":"The myelin model proposes that ApoE4+ individuals are poor in recycling lipid debris for reuse in myelin repair whereas this is enhanced in ApoE2+ individuals, including the removal of myelin sulfatide debris which is also ApoE-dependent and critically important for successful repair.","label":"Bartzokis G; The myelin model proposes that ApoE4+ in...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Bartzokis George","referenceYear":"2009","referenceDate":"2009-09-21","id":"urn:lsid:swan.org:researchstatement:64299ee4-f5fe-49c6-950b-55b9c2c66154"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:efa56fb3-a0cd-4786-ad3d-f2411eb1d631&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:efa56fb3-a0cd-4786-ad3d-f2411eb1d631","type":"Claim","title":"The finding of MAPT mutations in tangle only disease is completely consistent with the amyloid hypothesis prediction that tangle formation is a closer biological event to neuronal cell death. ","label":"Hardy ; The finding of MAPT mutations in tangle ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Hardy","referenceYear":"2009","referenceDate":"2009-05-18","id":"urn:lsid:swan.org:researchstatement:efa56fb3-a0cd-4786-ad3d-f2411eb1d631"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8626dc42-1ad8-4217-93cf-5d119859c9af&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8626dc42-1ad8-4217-93cf-5d119859c9af","type":"Claim","title":"Soluble Aβ assemblies disrupt memory.","label":"Lesné S et al.; Soluble Aβ assemblies disrupt memory.","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Koh Ming Teng","Kotilinek Linda","Kayed Rakez","Glabe Charles G","Yang Austin","Gallagher Michela","Ashe Karen H"],"firstAuthor":"Lesné Sylvain","referenceYear":"2006","referenceDate":"2006-03-16","id":"urn:lsid:swan.org:researchstatement:8626dc42-1ad8-4217-93cf-5d119859c9af"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:52304826-d2a7-411a-84b6-69716a0dc8da&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:52304826-d2a7-411a-84b6-69716a0dc8da","type":"Claim","title":"The current view of AD is that both AD pathological processes and clinical decline begin to develop decades before the earliest symptoms occur, with dementia representing the end stage.","label":"Jack C et al.; The current view of AD is that both AD p...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:52304826-d2a7-411a-84b6-69716a0dc8da"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9344fc88-d8dd-411b-bef5-32b8d8cfbed1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9344fc88-d8dd-411b-bef5-32b8d8cfbed1","type":"Claim","title":"A further study demonstrates that APP regulates brain ApoE and cholesterol metabolism through LRP1.","label":"Holtzman D; A further study demonstrates that APP re...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman David M","id":"urn:lsid:swan.org:researchstatement:9344fc88-d8dd-411b-bef5-32b8d8cfbed1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:77ae02cb-3e79-4b77-91a5-1729ab99b67c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:77ae02cb-3e79-4b77-91a5-1729ab99b67c","type":"Claim","title":"ApoE may be able to influence the dynamic equilibrium of Aβ forms in a species- and isoform-specific fashion.","label":"Holtzman D; ApoE may be able to influence the dynami...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:77ae02cb-3e79-4b77-91a5-1729ab99b67c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:41f6e8e6-bbc5-4aaf-885b-62b9e1fd669b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:41f6e8e6-bbc5-4aaf-885b-62b9e1fd669b","type":"Hypothesis","title":"Plaque removal is not enough to halt progressive neurodegeneration in Alzheimer Disease.","label":"Holmes C et al.; Plaque removal is not enough to halt pro...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:41f6e8e6-bbc5-4aaf-885b-62b9e1fd669b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d2e2f177-d86c-4360-809f-1d1c06589429&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d2e2f177-d86c-4360-809f-1d1c06589429","type":"Claim","title":"The same stress that induces apoptosis in a primary embryonic neuronal culture may induce senescence in the intact mature CNS.","label":"Golde T et al.; The same stress that induces apoptosis i...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:d2e2f177-d86c-4360-809f-1d1c06589429"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:4df0c15b-026b-4b38-85bb-25b6fecb16f0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:4df0c15b-026b-4b38-85bb-25b6fecb16f0","type":"Claim","title":"Most early insights into AD tauopathies came from studies of AD. However, studies of non-AD tauopathies have shown that tau pathology is the critical underlying abnormality that links AD and human neurodegenerative tauopathies to a shared mechanism of neurodegeneration.","label":"Lee V et al.; Most early insights into AD tauopathies ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Trojanowski John Q"],"firstAuthor":"Lee Virginia M-Y","id":"urn:lsid:swan.org:researchstatement:4df0c15b-026b-4b38-85bb-25b6fecb16f0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:61fb5703-cd1d-436c-9457-1b1ec85ea5f1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:61fb5703-cd1d-436c-9457-1b1ec85ea5f1","type":"Claim","title":"One FTD-associated PS1 mutation (insR352) strongly impairs γ-secretase activity in a dominant-negative manner.","label":"Shen J et al.; One FTD-associated PS1 mutation (insR352...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:61fb5703-cd1d-436c-9457-1b1ec85ea5f1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:e3b10050-c91d-49ae-8eb3-229099bff02e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:e3b10050-c91d-49ae-8eb3-229099bff02e","type":"Claim","title":"Oxidized DNA from nuclear and mitochondrial DNA has been found at elevated levels in vulnerable brain regions of mild cognitive impairment.","label":"Cotman C; Oxidized DNA from nuclear and mitochondr...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Cotman Carl W","id":"urn:lsid:swan.org:researchstatement:e3b10050-c91d-49ae-8eb3-229099bff02e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9c8f822f-6088-4d78-828e-f857212bbd42&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9c8f822f-6088-4d78-828e-f857212bbd42","type":"Hypothesis","title":"Macroautophagy is a novel A&#946;-generating pathway that is activated early in Alzheimer disease.","label":"Yu W et al.; Macroautophagy is a novel A&#946;-genera...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Cuervo Ana Maria","Kumar Asok","Peterhoff Corrinne M","Schmidt Stephen D","Lee Ju-Hyun","Mohan Panaiyur S","Mercken Marc","Farmery Mark R","Tjernberg Lars O","Jiang Ying","Duff Karen","Uchiyama Yasuo","Näslund Jan","Mathews Paul M","Cataldo Anne M","Nixon Ralph A"],"firstAuthor":"Yu W Haung","referenceYear":"2005","referenceDate":"2005-10-10","id":"urn:lsid:swan.org:researchstatement:9c8f822f-6088-4d78-828e-f857212bbd42"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ffc49090-6ee1-4403-a219-a3de31f34873&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ffc49090-6ee1-4403-a219-a3de31f34873","type":"Claim","title":"Although the e2 allele is protective for AD, it is associated with an increased risk factor for developing hemorrhage when CAA is present.","label":"Fryer J et al.; Although the e2 allele is protective for...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:ffc49090-6ee1-4403-a219-a3de31f34873"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7f58a6e7-8f95-47b8-974a-669f9eb4f714&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7f58a6e7-8f95-47b8-974a-669f9eb4f714","type":"Claim","title":"LRP also favors Aβ40 over a more amyloidogenic, mutant form of Aβ containing two APP gene mutations (Dutch and Iowa) known to cause vascular amyloidosis.","label":"Tanzi R et al.; LRP also favors Aβ40 over a more amyloid...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Moir R D","Wagner S L"],"firstAuthor":"Tanzi R E","referenceYear":"2004","referenceDate":"2004-09-02","id":"urn:lsid:swan.org:researchstatement:7f58a6e7-8f95-47b8-974a-669f9eb4f714"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bc44bbea-6fdd-4e61-9cae-58f752a740f6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bc44bbea-6fdd-4e61-9cae-58f752a740f6","type":"Claim","title":"The p3 peptide, always considered not to be toxic, could on the contrary be even more toxic than Aβ.","label":"Russo T; The p3 peptide, always considered not to...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Russo Tommaso","id":"urn:lsid:swan.org:researchstatement:bc44bbea-6fdd-4e61-9cae-58f752a740f6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:dc311e91-bcbd-41b8-954b-47cc61a667b7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:dc311e91-bcbd-41b8-954b-47cc61a667b7","type":"Claim","title":"Gel electrophoresis of 32P end-labeled genomic DNA is an extremely sensitive technique for the detection of DNA degradation that has been used both in vitro and in vivo but does not detect DNA fragmentation in neurological disease.","label":"Cotman C et al.; Gel electrophoresis of 32P end-labeled g...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:dc311e91-bcbd-41b8-954b-47cc61a667b7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:6e65911d-ef5e-491e-8cc1-0a71ac6f68d7&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:6e65911d-ef5e-491e-8cc1-0a71ac6f68d7","type":"Claim","title":"A number of cyclin-dependent protein kinases (cdks) have been identified that are highly related to cdc2 kinase.","label":"Suzuki T et al.; A number of cyclin-dependent protein kin...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:6e65911d-ef5e-491e-8cc1-0a71ac6f68d7"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:93261d8b-4a05-4e66-bc10-901c20ad075e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:93261d8b-4a05-4e66-bc10-901c20ad075e","type":"Claim","title":"The DNA repair enzyme GADD45 is elevated in AD neurons, consistent with the hypothesis that there may be an extended process of DNA-damage/DNA-repair and cell death in AD.","label":"Cotman C; The DNA repair enzyme GADD45 is elevated...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Cotman Carl W","id":"urn:lsid:swan.org:researchstatement:93261d8b-4a05-4e66-bc10-901c20ad075e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a6469733-1ec4-4db2-8c90-18f13cd1b7a1&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a6469733-1ec4-4db2-8c90-18f13cd1b7a1","type":"Hypothesis","title":"The cause of neuronal pathology in Alzheimer's disease.","label":"Vickers J et al.; The cause of neuronal pathology in Alzhe...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Dickson T C","Adlard P A","Saunders H L","King C E","McCormack G"],"firstAuthor":"Vickers J C","referenceYear":"2000","referenceDate":"2000-02","id":"urn:lsid:swan.org:researchstatement:a6469733-1ec4-4db2-8c90-18f13cd1b7a1"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7f9834ef-8140-4f3c-bd1a-b3562bf32a4f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7f9834ef-8140-4f3c-bd1a-b3562bf32a4f","type":"Claim","title":"Specific inactivation of the Aph1B γ-secretase in a murine Alzheimer\u2019s disease model led to improvements of Alzheimer\u2019s disease-relevant phenotypic features without any Notch-related side effects. ","label":"Serneels L et al.; Specific inactivation of the Aph1B γ-sec...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Van Biervliet Jérôme","Craessaerts Katleen","Dejaegere Tim","Horré Katrien","Van Houtvin Tine","Esselmann Hermann","Paul Sabine","Schäfer Martin K","Berezovska Oksana","Hyman Bradley T","Sprangers Ben","Sciot Raf","Moons Lieve","Jucker Mathias","Yang Zhixiang","May Patrick C","Karran Eric","Wiltfang Jens","D'Hooge Rudi","De Strooper Bart"],"firstAuthor":"Serneels Lutgarde","referenceYear":"2009","referenceDate":"2009-05-01","id":"urn:lsid:swan.org:researchstatement:7f9834ef-8140-4f3c-bd1a-b3562bf32a4f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:541a2ed0-af8a-4efb-9647-e61b44a885af&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:541a2ed0-af8a-4efb-9647-e61b44a885af","type":"Claim","title":"Aβ accumulates in senile plaques, cerebral vessels, and within neurons and a common theme of genetic alterations that cause AD is that they increase the likelihood that Aβ will aggregate into amyloid.","label":"Golde T et al.; Aβ accumulates in senile plaques, cerebr...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Miller Victor M"],"firstAuthor":"Golde Todd E","referenceYear":"2009","referenceDate":"2009-10-12","id":"urn:lsid:swan.org:researchstatement:541a2ed0-af8a-4efb-9647-e61b44a885af"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8a06cdc1-730f-4d38-bbe0-0f66c484880e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8a06cdc1-730f-4d38-bbe0-0f66c484880e","type":"Claim","title":"PS2 is a less efficient generator of Aβ peptide than PS1.","label":"Bentahir M et al.; PS2 is a less efficient generator of Aβ ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nyabi Omar","Verhamme Jan","Tolia Alexandra","Horré Katrien","Wiltfang Jens","Esselmann Hermann","De Strooper Bart"],"firstAuthor":"Bentahir Mostafa","referenceYear":"2006","referenceDate":"2006-02","id":"urn:lsid:swan.org:researchstatement:8a06cdc1-730f-4d38-bbe0-0f66c484880e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f18ac203-5667-49f3-9bac-8745c5c39487&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f18ac203-5667-49f3-9bac-8745c5c39487","type":"Claim","title":"Both CSF Aβ42 and amyloid PET imaging are biomarkers of brain Aβ plaque deposition and nearly all patients who have a clinical diagnosis of AD are positive in amyloid imaging studies.","label":"Jack C et al.; Both CSF Aβ42 and amyloid PET imaging ar...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Knopman David S","Jagust William J","Shaw Leslie M","Aisen Paul S","Weiner M","Petersen Ronald C","Trojanowski John Q"],"firstAuthor":"Jack Clifford R","referenceYear":"2010","referenceDate":"2010-01","id":"urn:lsid:swan.org:researchstatement:f18ac203-5667-49f3-9bac-8745c5c39487"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:51b4a190-6cda-4695-b09e-71f308db0a74&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:51b4a190-6cda-4695-b09e-71f308db0a74","type":"Claim","title":"The ratio of CSF tau to Aβ42 in cognitively normal individuals with a mean age of about 75 years predicted the development of symptoms of AD within 3 to 4 years.","label":"Morris J et al.; The ratio of CSF tau to Aβ42 in cognitiv...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Roe Catherine M","Grant Elizabeth A","Head Denise","Storandt Martha","Goate Alison M","Fagan Anne M","Holtzman David M","Mintun Mark A"],"firstAuthor":"Morris John C","referenceYear":"2009","referenceDate":"2009-12","id":"urn:lsid:swan.org:researchstatement:51b4a190-6cda-4695-b09e-71f308db0a74"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d0b0c4e9-5506-4f0d-a479-5e318728e14e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d0b0c4e9-5506-4f0d-a479-5e318728e14e","type":"Claim","title":"The steady-state levels of insoluble and soluble tau in 8c tau overexpressing mouse retinas were approximately twofold higher than the corresponding levels in wild-type mice.","label":"Yuan A et al.; The steady-state levels of insoluble and...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kumar Asok","Peterhoff Corrinne","Duff Karen","Nixon Ralph A"],"firstAuthor":"Yuan Aidong","referenceYear":"2008","referenceDate":"2008-02-13","id":"urn:lsid:swan.org:researchstatement:d0b0c4e9-5506-4f0d-a479-5e318728e14e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:a68751ff-55e8-48ea-8c3e-a1f283b79537&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:a68751ff-55e8-48ea-8c3e-a1f283b79537","type":"Claim","title":"Apoptosis is self-regulated and thus by defining the key molecular mechanisms that initiate and drive apoptosis, it may be possible to arrest the program that causes neuronal death.","label":"Cotman C et al.; Apoptosis is self-regulated and thus by ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:a68751ff-55e8-48ea-8c3e-a1f283b79537"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8dd185dc-4d15-4aca-bec0-a41ba18b82bd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8dd185dc-4d15-4aca-bec0-a41ba18b82bd","type":"Claim","title":"In calcium overloaded dendrites, the dendritic spines no longer compartmentalized [Ca2+]i, thereby precluding independent spine signaling along the dendritic cable.","label":"Kuchibhotla K et al.; In calcium overloaded dendrites, the den...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Goldman Samuel T","Lattarulo Carli R","Wu Hai-Yan","Hyman Bradley T","Bacskai Brian J"],"firstAuthor":"Kuchibhotla Kishore V","referenceYear":"2008","referenceDate":"2008-07-31","id":"urn:lsid:swan.org:researchstatement:8dd185dc-4d15-4aca-bec0-a41ba18b82bd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:46a7485a-0e84-4299-bdc6-80c08d9d5996&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:46a7485a-0e84-4299-bdc6-80c08d9d5996","type":"Claim","title":"Connections between Aβ-mediated toxicity and tau pathology have repeatedly been proposed; however, the mechanism or mechanisms that link plaques and tangles have not yet been fully established.","label":"Ballatore C et al.; Connections between Aβ-mediated toxicity...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Lee Virginia M-Y","Trojanowski John Q"],"firstAuthor":"Ballatore Carlo","referenceYear":"2007","referenceDate":"2007-09","id":"urn:lsid:swan.org:researchstatement:46a7485a-0e84-4299-bdc6-80c08d9d5996"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:f79c612f-f082-4d2f-b4cf-25f9a2b6e32b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:f79c612f-f082-4d2f-b4cf-25f9a2b6e32b","type":"Claim","title":"Kv4.2 and Kv4.3 protein levels remain unaltered following secretase inhibitor treatment, despite decreased function of K+ channels.","label":"Plant L et al.; Kv4.2 and Kv4.3 protein levels remain un...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Nicola J","Boyle John P","Ramsden Martin","Freir Darragh B","Peers Chris","Pearson Hugh A"],"firstAuthor":"Plant Leigh D","referenceYear":"2006","referenceDate":"2006-11","id":"urn:lsid:swan.org:researchstatement:f79c612f-f082-4d2f-b4cf-25f9a2b6e32b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9aa08d0f-dbbe-4b58-b067-b27182d1ba17&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9aa08d0f-dbbe-4b58-b067-b27182d1ba17","type":"Claim","title":"The presence of DNA damage in AD cases has been reported in previous studies and this has been interpreted as supporting a role for apoptosis in AD.","label":"Cotman C et al.; The presence of DNA damage in AD cases h...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:9aa08d0f-dbbe-4b58-b067-b27182d1ba17"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:74ff7ba6-2312-416d-b511-7a899c1e64d3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:74ff7ba6-2312-416d-b511-7a899c1e64d3","type":"Claim","title":"GAB2 siRNA treatment was associated with a 1.70-fold increase in serine-262 phosphorylated tau. ","label":"Reiman E et al.; GAB2 siRNA treatment was associated with...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Webster Jennifer A","Myers Amanda J","Hardy John","Dunckley Travis","Zismann Victoria L","Joshipura Keta D","Pearson John V","Hu-Lince Diane","Huentelman Matthew J","Craig David W","Coon Keith D","Liang Winnie S","Herbert RiLee H","Beach Thomas","Rohrer Kristen C","Zhao Alice S","Leung Doris","Bryden Leslie","Marlowe Lauren","Kaleem Mona","Mastroeni Diego","Grover Andrew","Heward Christopher B","Ravid Rivka","Rogers Joseph","Hutton Michael L","Melquist Stacey","Petersen Ron C","Alexander Gene E","Caselli Richard J","Kukull Walter","Papassotiropoulos Andreas","Stephan Dietrich A"],"firstAuthor":"Reiman Eric M","referenceYear":"2007","referenceDate":"2007-06-07","id":"urn:lsid:swan.org:researchstatement:74ff7ba6-2312-416d-b511-7a899c1e64d3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:512944f6-593c-449e-a5c2-88e8eba7262d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:512944f6-593c-449e-a5c2-88e8eba7262d","type":"Claim","title":"Aβ oligomers from human AD brain demonstrate a high capacity to attach to neurons at small clusters of surface binding sites.","label":"Gong Y et al.; Aβ oligomers from human AD brain demonst...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Chang Lei","Viola Kirsten L","Lacor Pascale N","Lambert Mary P","Finch Caleb E","Krafft Grant A","Klein William L"],"firstAuthor":"Gong Yuesong","referenceYear":"2003","referenceDate":"2003-09-02","id":"urn:lsid:swan.org:researchstatement:512944f6-593c-449e-a5c2-88e8eba7262d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8921d903-b2b7-420a-9fbc-84b46736893e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8921d903-b2b7-420a-9fbc-84b46736893e","type":"Claim","title":"Mitogen-activated protein kinase (MAPK) is not activated in a cell cycle-dependent manner and MAPK does not phosphorylate APP.","label":"Suzuki T et al.; Mitogen-activated protein kinase (MAPK) ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:8921d903-b2b7-420a-9fbc-84b46736893e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:3c95e5fc-7d6b-4b55-9ae6-fb815b30210c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:3c95e5fc-7d6b-4b55-9ae6-fb815b30210c","type":"Claim","title":"APP Thr668 is phosphorylated in both intact HeLa and PCl2 cells.","label":"Suzuki T et al.; APP Thr668 is phosphorylated in both int...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Oishi M","Marshak D R","Czernik A J","Nairn A C","Greengard P"],"firstAuthor":"Suzuki T","referenceYear":"1994","referenceDate":"1994-03-01","id":"urn:lsid:swan.org:researchstatement:3c95e5fc-7d6b-4b55-9ae6-fb815b30210c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:42043472-5ffb-456e-9d83-24c96d3a03aa&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:42043472-5ffb-456e-9d83-24c96d3a03aa","type":"Claim","title":"Mutations in the carboxyterminal portion of TDP-43, including A315T and M337V, account for a small number of familial ALS (fALS) kindreds with autosomal dominant inheritance. ","label":"Stallings N et al.; Mutations in the carboxyterminal portion...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Puttaparthi Krishna","Luther Christina M","Burns Dennis K","Elliott Jeffrey L"],"firstAuthor":"Stallings Nancy R","referenceYear":"2010","referenceDate":"2010-07-30","id":"urn:lsid:swan.org:researchstatement:42043472-5ffb-456e-9d83-24c96d3a03aa"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:53581be0-1c49-428a-829e-693ce13d8eb3&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:53581be0-1c49-428a-829e-693ce13d8eb3","type":"Claim","title":"Suppression of transgenic tau in a neurodegenerative tauopathy mouse model produced improvements in memory function, even though NFTs continued to accumulate.  ","label":"Ballatore C et al.; Suppression of transgenic tau in a neuro...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Lee Virginia M-Y","Trojanowski John Q"],"firstAuthor":"Ballatore Carlo","referenceYear":"2007","referenceDate":"2007-09","id":"urn:lsid:swan.org:researchstatement:53581be0-1c49-428a-829e-693ce13d8eb3"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:665202f7-16e2-4fe4-8c03-0a1f9352345e&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:665202f7-16e2-4fe4-8c03-0a1f9352345e","type":"Claim","title":"Mutations in the genes encoding PS1 and PS2, found on chromosomes 14 and 1, respectively, serve as the major loci for FAD.  Over 135 individual mutations have been linked with PS1, only 10 have thus far been linked with PS2.","label":"Smith I et al.; Mutations in the genes encoding PS1 and ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:665202f7-16e2-4fe4-8c03-0a1f9352345e"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:d667ae62-4444-4263-ad2b-f4319e00a70a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:d667ae62-4444-4263-ad2b-f4319e00a70a","type":"Hypothesis","title":"Nicotinamide restores cognition in Alzheimer\u2019s Disease transgenic mice via a mechanism involving Sirtuin inhibition and selective reduction of Thr231-Phosphotau.","label":"Green K et al.; Nicotinamide restores cognition in Alzhe...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Steffan Joan S","Martinez-Coria Hilda","Sun Xuemin","Schreiber S S","LaFerla Frank M"],"firstAuthor":"Green Kim N","referenceYear":"2008","referenceDate":"2008-11-05","id":"urn:lsid:swan.org:researchstatement:d667ae62-4444-4263-ad2b-f4319e00a70a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7afdf45d-f452-463e-8716-82f213d64d2c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7afdf45d-f452-463e-8716-82f213d64d2c","type":"Claim","title":"Postmortem observations show that the neuropathology of AD, including cerebral deposits of amyloid-β (Aβ) and neurofibrillary changes associated with hyperphosphorylated tau, is present in an age-dependent manner in a substantial proportion of cognitively normal older adults.","label":"Morris J et al.; Postmortem observations show that the ne...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Roe Catherine M","Grant Elizabeth A","Head Denise","Storandt Martha","Goate Alison M","Fagan Anne M","Holtzman David M","Mintun Mark A"],"firstAuthor":"Morris John C","referenceYear":"2009","referenceDate":"2009-12","id":"urn:lsid:swan.org:researchstatement:7afdf45d-f452-463e-8716-82f213d64d2c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:c778a29c-6537-49ba-b5f3-29d4ddea2b3b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:c778a29c-6537-49ba-b5f3-29d4ddea2b3b","type":"Claim","title":"ApoE has been shown to bind directly to the Aβ  peptide and influence its fibrillogenesis and clearance in vitro and in vivo.","label":"Fryer J et al.; ApoE has been shown to bind directly to ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Simmons Kelly","Parsadanian Maia","Bales Kelly R","Paul Steven M","Sullivan Patrick M","Holtzman David M"],"firstAuthor":"Fryer John D","referenceYear":"2005","referenceDate":"2005-03-16","id":"urn:lsid:swan.org:researchstatement:c778a29c-6537-49ba-b5f3-29d4ddea2b3b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0c1cacd2-dbdf-4336-826b-d57b569b389c&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0c1cacd2-dbdf-4336-826b-d57b569b389c","type":"Claim","title":"If correct, the presenilin hypothesis has significant therapeutic implications, suggesting that γ-secretase inhibitors would aggravate instead of ameliorate neurodegeneration and dementia, and that boosting PS-dependent pathways or inhibiting opposing pathways will offer the most promising therapeutic strategies for AD.","label":"Shen J et al.; If correct, the presenilin hypothesis ha...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:0c1cacd2-dbdf-4336-826b-d57b569b389c"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:189cfbb9-a617-46ac-bfb3-7be02f95f048&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:189cfbb9-a617-46ac-bfb3-7be02f95f048","type":"Claim","title":"Some evidence of cognitive benefit was documented in AN-1792 anti-Aβ vaccine trial patients who developed anti-Aβ antibody titers.","label":"Hardy J et al.; Some evidence of cognitive benefit was d...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Selkoe Dennis J"],"firstAuthor":"Hardy John","id":"urn:lsid:swan.org:researchstatement:189cfbb9-a617-46ac-bfb3-7be02f95f048"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7ccfd4d6-7ebc-4a83-88ea-9b311d6c20c6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7ccfd4d6-7ebc-4a83-88ea-9b311d6c20c6","type":"Claim","title":"Iodixanol gradient fractionation identified Aβ40 and Aβ42 monomers, dimers and trimers, suggesting that the process of oligomerization is initiated soon after the generation of Aβ in discrete intracellular vesicles.","label":"Walsh D et al.; Iodixanol gradient fractionation identif...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Klyubin Igor","Fadeeva Julia V","Cullen William K","Anwyl Roger","Wolfe Michael S","Rowan Michael J","Selkoe Dennis J"],"firstAuthor":"Walsh Dominic M","referenceYear":"2002","referenceDate":"2002-04-04","id":"urn:lsid:swan.org:researchstatement:7ccfd4d6-7ebc-4a83-88ea-9b311d6c20c6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:8757967d-0b58-433d-87e2-1a4cee28f308&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:8757967d-0b58-433d-87e2-1a4cee28f308","type":"Claim","title":"Knockdown of TDP-43 in human cells resulted in dysmorphic nuclear shape, cell cycle disruption and increased apoptosis, thereby demonstrating a critical role for TDP-43 in cell survival possibly through maintaining genomic stability. ","label":"Warraich S et al.; Knockdown of TDP-43 in human cells resul...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Yang Shu","Nicholson Garth A","Blair Ian P"],"firstAuthor":"Warraich Sadaf T","referenceYear":"2010","referenceDate":"2010-06-25","id":"urn:lsid:swan.org:researchstatement:8757967d-0b58-433d-87e2-1a4cee28f308"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:61cb0c7c-6987-4582-be07-9d1bb8bb986b&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:61cb0c7c-6987-4582-be07-9d1bb8bb986b","type":"Claim","title":"GSK3β is a key mediator of apoptosis and thereby might directly contribute to neuronal loss in AD.","label":"Hooper C et al.; GSK3β is a key mediator of apoptosis and...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:61cb0c7c-6987-4582-be07-9d1bb8bb986b"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:829d6983-6b0e-441c-98b8-0c75092dbae8&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:829d6983-6b0e-441c-98b8-0c75092dbae8","type":"Claim","title":"It is assumed that every APP cleavage product leaves the membrane.","label":"Marchesi V; It is assumed that every APP cleavage pr...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Marchesi Vincent T","referenceYear":"2005","referenceDate":"2005-06-28","id":"urn:lsid:swan.org:researchstatement:829d6983-6b0e-441c-98b8-0c75092dbae8"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:07c641b5-6398-4585-b608-03939905d945&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:07c641b5-6398-4585-b608-03939905d945","type":"Hypothesis","title":"Ornithine transcarbamylase promoter polymorphisms are associated with the risk of developing Alzheimer Disease.","label":"Bensemain F et al.; Ornithine transcarbamylase promoter poly...","icon":"../icons/ontological/discourse-element/h-research-statement.png","otherAuthors":["Hot D","Ferreira S","Dumont J","Bombois S","Maurage C-A","Huot L","Hermant X","Levillain E","Hubans C","Hansmannel F","Chapuis J","Hauw J-J","Schraen S","Lemoine Y","Buée L","Berr C","Mann D","Pasquier F","Amouyel P","Lambert J-C"],"firstAuthor":"Bensemain F","referenceYear":"2009","referenceDate":"2009-01","id":"urn:lsid:swan.org:researchstatement:07c641b5-6398-4585-b608-03939905d945"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:02a3336d-dd2e-4b4d-8bd5-10bf8ecedebd&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:02a3336d-dd2e-4b4d-8bd5-10bf8ecedebd","type":"Claim","title":"FAD-linked PS1 mutations have been found to impair γ-secretase-independent activity, resulting in enhanced β-catenin stability and β-catenin-dependent signaling.","label":"Shen J et al.; FAD-linked PS1 mutations have been found...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Kelleher Raymond J"],"firstAuthor":"Shen Jie","referenceYear":"2007","referenceDate":"2007-01-09","id":"urn:lsid:swan.org:researchstatement:02a3336d-dd2e-4b4d-8bd5-10bf8ecedebd"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:449b54a5-d1e9-438c-a90b-5fdab6bb5942&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:449b54a5-d1e9-438c-a90b-5fdab6bb5942","type":"Claim","title":"No differences in time to severe dementia by AN1792 treatment group or by mean anti-Aβ antibody titre compared with the placebo group were detected.","label":"Holmes C et al.; No differences in time to severe dementi...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Boche Delphine","Wilkinson David","Yadegarfar Ghasem","Hopkins Vivienne","Bayer Anthony","Jones Roy W","Bullock Roger","Love Seth","Neal James W","Zotova Elina","Nicoll James A"],"firstAuthor":"Holmes Clive","referenceYear":"2008","referenceDate":"2008-07-19","id":"urn:lsid:swan.org:researchstatement:449b54a5-d1e9-438c-a90b-5fdab6bb5942"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0f2f3b6c-8673-45fe-8daa-14dc3934b11f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0f2f3b6c-8673-45fe-8daa-14dc3934b11f","type":"Claim","title":"Homozygous APP<sup>V717F<\/sup> transgenic bred to ApoE homozygous knockout mice (APP+/+ApoE-/-) decreased Aβ deposition relative to ApoE+/+ mice, and had little to no fibrillar plaques (thioflavine-S, Congo red positive).","label":"Holtzman D; Homozygous APP<sup>V717F<\/sup> transgeni...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Holtzman D M","referenceYear":"2001","referenceDate":"2001-10","id":"urn:lsid:swan.org:researchstatement:0f2f3b6c-8673-45fe-8daa-14dc3934b11f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:657cbda2-a01f-4c26-b528-edb441dab581&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:657cbda2-a01f-4c26-b528-edb441dab581","type":"Claim","title":"A detailed Fourier transform infrared (FT-IR) study of structural alterations after protein oxidation has revealed that protein aggregation efficiently inhibits proteasome activity.","label":"Keck S et al.; A detailed Fourier transform infrared (F...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:657cbda2-a01f-4c26-b528-edb441dab581"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:0751eb9a-c2ab-477c-80d0-dc0e65b5d464&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:0751eb9a-c2ab-477c-80d0-dc0e65b5d464","type":"Hypothesis","title":"Prolonged stress will induce Alzheimer's disease in elderly people by increased release of homocysteic acid.","label":"Hasegawa T; Prolonged stress will induce Alzheimer's...","icon":"../icons/ontological/discourse-element/h-research-statement.png","firstAuthor":"Hasegawa Tohru","referenceYear":"2007","referenceDate":"2007","id":"urn:lsid:swan.org:researchstatement:0751eb9a-c2ab-477c-80d0-dc0e65b5d464"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:979c314c-ce1c-4330-9da7-167c4decb4e2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:979c314c-ce1c-4330-9da7-167c4decb4e2","type":"Claim","title":"There is a strong in vivo inverse relationship of CSF Aβ42 and PiB amyloid burden in cognitively normal individuals, but some may have low CSF Aβ42 without detectable cortical binding of PiB.","label":"Morris J et al.; There is a strong in vivo inverse relati...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Roe Catherine M","Grant Elizabeth A","Head Denise","Storandt Martha","Goate Alison M","Fagan Anne M","Holtzman David M","Mintun Mark A"],"firstAuthor":"Morris John C","referenceYear":"2009","referenceDate":"2009-12","id":"urn:lsid:swan.org:researchstatement:979c314c-ce1c-4330-9da7-167c4decb4e2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:b30bfa8a-8037-4475-bfc9-03dd09641b59&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:b30bfa8a-8037-4475-bfc9-03dd09641b59","type":"Claim","title":"Evidence that Aβ42 monomers are neuroprotective is in line with the demonstration that inhibition of the Aβ-synthesizing enzymes, β- or γ-secretase, reduces neuronal viability.","label":"Giuffrida M et al.; Evidence that Aβ42 monomers are neuropro...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Caraci Filippo","Pignataro Bruno","Cataldo Sebastiano","De Bona Paolo","Bruno Valeria","Molinaro Gemma","Pappalardo Giuseppe","Messina Angela","Palmigiano Angelo","Garozzo Domenico","Nicoletti Ferdinando","Rizzarelli Enrico","Copani Agata"],"firstAuthor":"Giuffrida Maria Laura","referenceYear":"2009","referenceDate":"2009-08-26","id":"urn:lsid:swan.org:researchstatement:b30bfa8a-8037-4475-bfc9-03dd09641b59"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:257792b7-bf38-4455-ab03-3a655dd2b16d&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:257792b7-bf38-4455-ab03-3a655dd2b16d","type":"Claim","title":"Important sphingolipids such as sphingomyelin, acylceramide, glucosylceramide, galactosylceramide are all highly enriched in the brain.","label":"Important sphingolipids such as sphingom...","icon":"../icons/ontological/discourse-element/c-research-statement.png","id":"urn:lsid:swan.org:researchstatement:257792b7-bf38-4455-ab03-3a655dd2b16d"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:bdc4b4aa-06f6-4c6f-9bac-3cf039cf41f6&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:bdc4b4aa-06f6-4c6f-9bac-3cf039cf41f6","type":"Claim","title":"The molecular defect that is exerted by both PS1 and PS2 mutations in disruption of calcium signaling is unlikely to be an epiphenomenon but rather likely highlights a shared pathway that can cause neurodegeneration.","label":"Smith I et al.; The molecular defect that is exerted by ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Green Kim N","LaFerla Frank M"],"firstAuthor":"Smith Ian F","referenceYear":"2005","referenceDate":"2005","id":"urn:lsid:swan.org:researchstatement:bdc4b4aa-06f6-4c6f-9bac-3cf039cf41f6"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:da98ec88-3841-414a-bc2d-ad7bc7fb6bf0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:da98ec88-3841-414a-bc2d-ad7bc7fb6bf0","type":"Claim","title":"GSK3 activity is modulated by insulin and Wnt signaling, both pathways act in a negative regulatory manner.","label":"Hooper C et al.; GSK3 activity is modulated by insulin an...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Killick Richard","Lovestone Simon"],"firstAuthor":"Hooper Claudie","referenceYear":"2008","referenceDate":"2008-03","id":"urn:lsid:swan.org:researchstatement:da98ec88-3841-414a-bc2d-ad7bc7fb6bf0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:691ccc51-e765-43e0-89c4-2af72cdeae5f&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:691ccc51-e765-43e0-89c4-2af72cdeae5f","type":"Claim","title":"ADDLs of this mass are too small to contain clusterin (Mr 80,000), indicating a chaperone-like function for clusterin.","label":"Lambert M et al.; ADDLs of this mass are too small to cont...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Barlow A K","Chromy B A","Edwards C","Freed R","Liosatos M","Morgan T E","Rozovsky I","Trommer B","Viola K L","Wals P","Zhang C","Finch C E","Krafft G A","Klein W L"],"firstAuthor":"Lambert M P","referenceYear":"1998","referenceDate":"1998-05-26","id":"urn:lsid:swan.org:researchstatement:691ccc51-e765-43e0-89c4-2af72cdeae5f"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:ef040ab8-ab4a-4fe2-938a-0a337b4813ce&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:ef040ab8-ab4a-4fe2-938a-0a337b4813ce","type":"Claim","title":"Cells in the AD brain exhibit labeling for DNA strand breaks using TdT and that the morphological distribution of this labeling in many cells is consistent with apoptosis, with low levels in control cases, but frequent TdT-positive nuclei in brain tissue from AD cases.","label":"Cotman C et al.; Cells in the AD brain exhibit labeling f...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Su J H"],"firstAuthor":"Cotman C W","referenceYear":"1996","referenceDate":"1996-10","id":"urn:lsid:swan.org:researchstatement:ef040ab8-ab4a-4fe2-938a-0a337b4813ce"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:701c4b9a-b519-4ffc-bb8a-61b3013563c0&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:701c4b9a-b519-4ffc-bb8a-61b3013563c0","type":"Claim","title":"Mechanisms other than microglial activation may be involved in plaque growth inhibition, including local Aβ production and trafficking.","label":"Kumar-Singh S; Mechanisms other than microglial activat...","icon":"../icons/ontological/discourse-element/c-research-statement.png","firstAuthor":"Kumar-Singh Samir","id":"urn:lsid:swan.org:researchstatement:701c4b9a-b519-4ffc-bb8a-61b3013563c0"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:7b41c274-e8d3-459f-9200-88d66e247749&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:7b41c274-e8d3-459f-9200-88d66e247749","type":"Hypothesis","title":"Chromosome 21 nondisjunction may underlie Alzheimer disease and Down syndrome.","label":"Potter H; Chromosome 21 nondisjunction may underli...","icon":"../icons/ontological/discourse-element/h-research-statement.png","firstAuthor":"Potter H","referenceYear":"1991","referenceDate":"1991-06","id":"urn:lsid:swan.org:researchstatement:7b41c274-e8d3-459f-9200-88d66e247749"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:9e16f246-fe51-4ee7-bf9b-a005cae849a2&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:9e16f246-fe51-4ee7-bf9b-a005cae849a2","type":"Claim","title":"The proteasome activity did not correlate with the level of PHFtau, detected by the AT100 antibody which recognizes the Ser212/Thr214 phosphorylation site.","label":"Keck S et al.; The proteasome activity did not correlat...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Nitsch Robert","Grune Tilman","Ullrich Oliver"],"firstAuthor":"Keck Susi","referenceYear":"2003","referenceDate":"2003-04","id":"urn:lsid:swan.org:researchstatement:9e16f246-fe51-4ee7-bf9b-a005cae849a2"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:23d77a64-8ea0-4a47-b482-6a4a26b4839a&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:23d77a64-8ea0-4a47-b482-6a4a26b4839a","type":"Claim","title":"Olanzapine is reasonably potent in preventing the cerebrocortical injury induced by NMDA antagonist drugs in rats and, therefore, holds significant promise for arresting the stage 2 neurodegenerative process in AD. ","label":"Olney J et al.; Olanzapine is reasonably potent in preve...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Wozniak D F","Farber N B"],"firstAuthor":"Olney J W","referenceYear":"1997","referenceDate":"1997-10","id":"urn:lsid:swan.org:researchstatement:23d77a64-8ea0-4a47-b482-6a4a26b4839a"},{"lsidUrl":"/swan/browser/showEntity.action?objectId=urn:lsid:swan.org:researchstatement:045d4b3d-d091-42dd-8969-350b236a42b5&referrerLinkLabel=discourseelementslist","lsid":"urn:lsid:swan.org:researchstatement:045d4b3d-d091-42dd-8969-350b236a42b5","type":"Claim","title":"The composition of the Aβ accumulations is complex, and includes many species of Aβ oligomers.","label":"Muresan Z et al.; The composition of the Aβ accumulations ...","icon":"../icons/ontological/discourse-element/c-research-statement.png","otherAuthors":["Muresan Virgil"],"firstAuthor":"Muresan Zoia","referenceYear":"2008","referenceDate":"2008","id":"urn:lsid:swan.org:researchstatement:045d4b3d-d091-42dd-8969-350b236a42b5"}]}